Citrus Sinensis ID: 044232
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.836 | 0.335 | 0.498 | 2e-96 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.804 | 0.323 | 0.508 | 6e-96 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.710 | 0.289 | 0.576 | 7e-96 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.840 | 0.337 | 0.526 | 8e-96 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.751 | 0.300 | 0.562 | 8e-95 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.722 | 0.295 | 0.576 | 2e-93 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.715 | 0.311 | 0.552 | 3e-91 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.850 | 0.346 | 0.476 | 2e-89 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.715 | 0.290 | 0.53 | 5e-83 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.780 | 0.501 | 0.430 | 7e-74 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 352 bits (904), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 180/361 (49%), Positives = 245/361 (67%), Gaps = 14/361 (3%)
Query: 23 LFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQ 82
L + S +++ +R++R ++ DV + Y +L+ AT++F P+NK+G+
Sbjct: 646 LLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYT----FTYSELKSATQDFDPSNKLGE 701
Query: 83 GGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142
GGFG VYKG L DG A+K+LS SRQG +F+ EI I ++H NLV+LYGCC EG+H
Sbjct: 702 GGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEH 761
Query: 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK 202
R+LVY YL N SL Q L G ++ +W TR IC+GVA+GL +LHEE + IVHRD+K
Sbjct: 762 RLLVYEYLPNGSLDQALFG--EKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVK 819
Query: 203 ASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSF 262
ASNILLD L PK+SDFGLAKL+ THISTRVAGT GYLAPEYA+RG LT K D+Y+F
Sbjct: 820 ASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAF 879
Query: 263 GVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK 322
GV+ LE+VSGR N++ L E++YLLE AW L+E+G+ VEL+D L ++++EE R +
Sbjct: 880 GVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQLT-EFNMEEGKRMIG 938
Query: 323 IALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVS 382
IALLCTQ RP MS +V ML G+++V+ + SKPG L+D + + AS++S
Sbjct: 939 IALLCTQTSHALRPPMSRVVAMLSGDVEVS-DVTSKPGYLTDW------RFDDTTASSIS 991
Query: 383 G 383
G
Sbjct: 992 G 992
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 174/342 (50%), Positives = 235/342 (68%), Gaps = 8/342 (2%)
Query: 23 LFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQ 82
L + + +++ +R++R + DV ++ Y +L+ AT++F P+NK+G+
Sbjct: 647 LLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPY----IFTYSELKSATQDFDPSNKLGE 702
Query: 83 GGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142
GGFG VYKG L DG + A+K+LS SRQG +F+ EI I + H NLV+LYGCC EG+H
Sbjct: 703 GGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEH 762
Query: 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK 202
R+LVY YL N SL Q L G ++ +W TR IC+GVA+GL +LHEE IVHRD+K
Sbjct: 763 RMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVK 820
Query: 203 ASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSF 262
ASNILLD L P+ISDFGLAKL+ THISTRVAGT GYLAPEYA+RG LT K D+Y+F
Sbjct: 821 ASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAF 880
Query: 263 GVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK 322
GV+ LE+VSGR N++ L E++YLLE AW L+E+ + +EL+D L D+++EEA R +
Sbjct: 881 GVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLT-DFNMEEAKRMIG 939
Query: 323 IALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSD 364
IALLCTQ RP MS +V ML G++++ + SKPG +SD
Sbjct: 940 IALLCTQTSHALRPPMSRVVAMLSGDVEIG-DVTSKPGYVSD 980
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 7e-96, Method: Compositional matrix adjust.
Identities = 170/295 (57%), Positives = 218/295 (73%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ + ++VAT+NF PANKIG+GGFG V+KG + DGT+ A+K LSA S+QG REFL EI +
Sbjct: 660 FSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAM 719
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I ++H +LV+LYGCCVEGD +LVY YLENNSLA+ L G + I NW R+ IC+G+
Sbjct: 720 ISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGI 779
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
A+GLA+LHEE + IVHRDIKA+N+LLDK+L PKISDFGLAKL THISTRVAGT G
Sbjct: 780 ARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYG 839
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
Y+APEYA+RG LT KAD+YSFGV+ LEIV G+ NT+ R + YLL+ L E+ L+
Sbjct: 840 YMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLL 899
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEI 356
E+VD L DY+ +EA ++I +LCT P RPSMST+V+ML G VN E++
Sbjct: 900 EVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKL 954
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 8e-96, Method: Compositional matrix adjust.
Identities = 186/353 (52%), Positives = 235/353 (66%), Gaps = 4/353 (1%)
Query: 47 VEVNEDVSEIQ-DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLS 105
V+ NE++ + T + K ++ AT NF P NKIG+GGFG VYKG L DG A+K LS
Sbjct: 639 VDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLS 698
Query: 106 ADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS 165
+ S+QG REF+TEI +I ++H NLV+LYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 699 SKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ 758
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ +W TR +CIG+AKGLA+LHEE + IVHRDIKA+N+LLD L KISDFGLAKL
Sbjct: 759 RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLD 818
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
THISTR+AGT GY+APEYA+RG LT KAD+YSFGV+ LEIVSG+ NTN R E
Sbjct: 819 EEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFI 878
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
YLL+ A+ L E+G L+ELVD L +S +EA R L IALLCT P RP MS++V+ML
Sbjct: 879 YLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSML 938
Query: 346 IGEIDVNKEEISKPGLLSDLLGLRVDKGE---KDKASAVSGDSSKLDHSSFSS 395
G+I V + + S +R E +D S VS + +H S SS
Sbjct: 939 QGKIKVQPPLVKREADPSGSAAMRFKALEHLSQDSESQVSTYTRNKEHKSSSS 991
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 8e-95, Method: Compositional matrix adjust.
Identities = 176/313 (56%), Positives = 220/313 (70%), Gaps = 1/313 (0%)
Query: 47 VEVNEDVSEIQ-DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLS 105
V+ NE++ + T + K ++ AT NF P NKIG+GGFG VYKG L DG A+K LS
Sbjct: 641 VDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLS 700
Query: 106 ADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS 165
+ S+QG REF+TEI +I ++H NLV+LYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 701 SKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ 760
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ +W TR ICIG+AKGLA+LHEE + IVHRDIKA+N+LLD L KISDFGLAKL
Sbjct: 761 RLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLN 820
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
THISTR+AGT GY+APEYA+RG LT KAD+YSFGV+ LEIVSG+ NTN R E
Sbjct: 821 DDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFV 880
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
YLL+ A+ L E+G L+ELVD L +S +EA R L IALLCT P RP MS++V+ML
Sbjct: 881 YLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSML 940
Query: 346 IGEIDVNKEEISK 358
G+I V + +
Sbjct: 941 EGKIKVQPPLVKR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 174/302 (57%), Positives = 221/302 (73%), Gaps = 2/302 (0%)
Query: 59 TNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTE 118
T + + ++ AT+NF KIG+GGFGSVYKG L +G L A+K LSA SRQG REF+ E
Sbjct: 663 TGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNE 722
Query: 119 INVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSS-IQFNWQTRRNI 177
I +I ++H NLV+LYGCCVEG+ ILVY YLENN L++ L G+ SS ++ +W TR+ I
Sbjct: 723 IGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKI 782
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
+G+AKGL FLHEE + IVHRDIKASN+LLDKDL KISDFGLAKL THISTR+A
Sbjct: 783 FLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIA 842
Query: 238 GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
GT GY+APEYA+RG LT KAD+YSFGV+ LEIVSG+ NTN R + YLL+ A+ L ER
Sbjct: 843 GTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQER 902
Query: 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEIS 357
G L+ELVD +L DYS EEA L +AL+CT P RP+MS +V+++ G+ + +E +S
Sbjct: 903 GSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAM-QELLS 961
Query: 358 KP 359
P
Sbjct: 962 DP 963
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 164/297 (55%), Positives = 212/297 (71%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ + +++AT NF AN+IG+GGFG VYKG L DGT+ A+K LS S+QG REFL EI +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I + H NLV+LYGCCVEG +LVY ++ENNSLA+ L G + ++ +W TRR ICIGV
Sbjct: 672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
A+GLA+LHEE + IVHRDIKA+N+LLDK L PKISDFGLAKL + THISTR+AGT G
Sbjct: 732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFG 791
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
Y+APEYA+RG LT KAD+YSFG++ LEIV GR N R YL++ L E+ L+
Sbjct: 792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLL 851
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISK 358
ELVD L +Y+ EEA ++IA++CT P RPSMS +V ML G+ V E++ +
Sbjct: 852 ELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEE 908
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 172/361 (47%), Positives = 238/361 (65%), Gaps = 8/361 (2%)
Query: 59 TNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTE 118
T + ++ L+ AT NF ANK+G+GGFGSV+KG L DGT+ A+K LS+ S QG REF+ E
Sbjct: 658 TVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNE 717
Query: 119 INVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
I +I + H NLV+LYGCCVE D +LVY Y+ENNSLA L G+ +S++ +W R+ IC
Sbjct: 718 IGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQ--NSLKLDWAARQKIC 775
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG 238
+G+A+GL FLH+ +VHRDIK +N+LLD DL KISDFGLA+L A THIST+VAG
Sbjct: 776 VGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAG 835
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
T GY+APEYA+ GQLT KAD+YSFGV+ +EIVSG+ NT ++ + L+ A L + G
Sbjct: 836 TIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTG 895
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISK 358
++E+VD L G+++ EA R +K+AL+CT P RP+MS V ML GEI++ + +S
Sbjct: 896 DILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEI-TQVMSD 954
Query: 359 PGLLS---DLLGLR-VDKGEKDKASAVSGDSSKLDHSSFSSGNMTTSYA-TMTFNSIFDR 413
PG+ + LR +D S V+ ++ SS S ++ Y +M NS +
Sbjct: 955 PGIYGHDWSISKLRDIDTHSSSSTSGVTDQTTTTMKSSVSGCDLYPLYPESMILNSTVEN 1014
Query: 414 S 414
S
Sbjct: 1015 S 1015
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 159/300 (53%), Positives = 204/300 (68%), Gaps = 3/300 (1%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ + ++ AT++F+P NKIG+GGFG+V+KG L DG + A+K LS+ SRQG REFL EI
Sbjct: 669 FTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGA 728
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I ++H NLV+L+G CVE +L Y Y+ENNSL+ L H I +W TR IC G+
Sbjct: 729 ISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGI 788
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
AKGLAFLHEE VHRDIKA+NILLDKDLTPKISDFGLA+L THIST+VAGT G
Sbjct: 789 AKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIG 848
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
Y+APEYA+ G LT KAD+YSFGVL+LEIV+G N+N + LLE A + E G L+
Sbjct: 849 YMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLM 908
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGL 361
++VD L + +EA +K+AL+C+ P RP MS +V ML G V + S PG+
Sbjct: 909 QVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPE---STPGV 965
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 143/332 (43%), Positives = 209/332 (62%), Gaps = 8/332 (2%)
Query: 22 FLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNL-YGYKDLRVATENFSPANKI 80
F+ +++A L L+++ A + ++ +NL + Y++L AT+ FS NK+
Sbjct: 272 FVLLVSAAGFL--LKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKL 329
Query: 81 GQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG 140
GQGG GSVYKG L +G A+K L +++Q V F E+N+I + H+NLV+L GC + G
Sbjct: 330 GQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITG 389
Query: 141 DHRILVYGYLENNSLAQTLLGRGHSSIQ-FNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199
+LVY Y+ N SL L R +Q NW R I +G A+G+A+LHEE I+HR
Sbjct: 390 PESLLVYEYIANQSLHDYLFVR--KDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHR 447
Query: 200 DIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADI 259
DIK SNILL+ D TP+I+DFGLA+LFP + THIST +AGT GY+APEY +RG+LT KAD+
Sbjct: 448 DIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADV 507
Query: 260 YSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHR 319
YSFGVL++E+++G+ N + +L+ W LY + E VD L +++ EA R
Sbjct: 508 YSFGVLMIEVITGK--RNNAFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASR 565
Query: 320 YLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351
L+I LLC Q +RP+MS +V M+ G +++
Sbjct: 566 LLQIGLLCVQAAFDQRPAMSVVVKMMKGSLEI 597
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | ||||||
| 225461636 | 385 | PREDICTED: probable leucine-rich repeat | 0.908 | 0.979 | 0.715 | 1e-155 | |
| 255566575 | 368 | ATP binding protein, putative [Ricinus c | 0.872 | 0.983 | 0.733 | 1e-153 | |
| 356543219 | 389 | PREDICTED: probable leucine-rich repeat | 0.925 | 0.987 | 0.667 | 1e-147 | |
| 449438933 | 386 | PREDICTED: probable LRR receptor-like se | 0.910 | 0.979 | 0.684 | 1e-147 | |
| 224114834 | 378 | predicted protein [Populus trichocarpa] | 0.874 | 0.960 | 0.694 | 1e-147 | |
| 224121542 | 375 | predicted protein [Populus trichocarpa] | 0.874 | 0.968 | 0.708 | 1e-145 | |
| 356514587 | 487 | PREDICTED: probable LRR receptor-like se | 0.908 | 0.774 | 0.674 | 1e-145 | |
| 449460042 | 397 | PREDICTED: probable LRR receptor-like se | 0.908 | 0.949 | 0.645 | 1e-145 | |
| 255578162 | 419 | ATP binding protein, putative [Ricinus c | 0.896 | 0.887 | 0.645 | 1e-145 | |
| 449526092 | 397 | PREDICTED: probable LRR receptor-like se | 0.908 | 0.949 | 0.645 | 1e-144 |
| >gi|225461636|ref|XP_002285391.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 [Vitis vinifera] gi|302142911|emb|CBI20206.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 272/380 (71%), Positives = 318/380 (83%), Gaps = 3/380 (0%)
Query: 35 LRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK 94
R+K ASS T EV++ VS IQ+ N Y Y++LR+AT++FS ANKIG+GGFGSVYKGTL+
Sbjct: 8 FRKKVASSITRTAEVDDVVSGIQNVNRYSYRELRIATQDFSLANKIGEGGFGSVYKGTLR 67
Query: 95 DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNS 154
DGT+ AIKVLSA SRQG+REFLTE++VI I+HENLVELYGCCV+ D RILVYGYLENNS
Sbjct: 68 DGTVVAIKVLSAQSRQGLREFLTELSVISVIEHENLVELYGCCVDEDQRILVYGYLENNS 127
Query: 155 LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214
LAQTLL GHS IQF+W+TR ICIGVA+GLAFLHEEV PHIVHRDIKASNILLDKDLTP
Sbjct: 128 LAQTLLDGGHSGIQFSWKTRTKICIGVARGLAFLHEEVHPHIVHRDIKASNILLDKDLTP 187
Query: 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274
KISDFGLAKL P + TH+STRVAGT GYLAPEYAIRGQLTRKADIYSFGVLLLEIV GR
Sbjct: 188 KISDFGLAKLIPEDQTHVSTRVAGTTGYLAPEYAIRGQLTRKADIYSFGVLLLEIVCGRS 247
Query: 275 NTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR 334
N N RL Y E +LLEM W+L+ER +L + VD SLNGD+ +EE R+LKI LLCTQDMPK
Sbjct: 248 NKNTRLAYGEHFLLEMVWELHERRELADAVDTSLNGDFDIEEVCRFLKIGLLCTQDMPKS 307
Query: 335 RPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKLDHSSFS 394
RP+MST+V+ML GE DV+ + IS+PGL+S+L+G++V ++ K+ SG S KLD+SS S
Sbjct: 308 RPTMSTVVSMLTGEADVD-DNISRPGLISELMGIKVGGAQRYKSDTASG-SGKLDNSSLS 365
Query: 395 SGNMTTSYATMTFNSIFDRS 414
SG M TS ATMTFNSI+DRS
Sbjct: 366 SG-MPTSIATMTFNSIYDRS 384
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566575|ref|XP_002524272.1| ATP binding protein, putative [Ricinus communis] gi|223536463|gb|EEF38111.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1409), Expect = e-153, Method: Compositional matrix adjust.
Identities = 267/364 (73%), Positives = 309/364 (84%), Gaps = 2/364 (0%)
Query: 52 DVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG 111
++S IQ+T LY YKDL++ATENFSP NKIG+GGFGSVYKGTLKDGT+AAIKVLSADSRQG
Sbjct: 7 EISGIQNTRLYTYKDLQIATENFSPGNKIGEGGFGSVYKGTLKDGTVAAIKVLSADSRQG 66
Query: 112 VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNW 171
VREFLTEI +I D +HENLV+L+GCCVEGDHRILVYGYLENNSL+QTLLG SSIQF+W
Sbjct: 67 VREFLTEIKLITDTEHENLVKLHGCCVEGDHRILVYGYLENNSLSQTLLGGSRSSIQFSW 126
Query: 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231
R ICIG+A+GL+FLHEEVQPHIVHRDIKASNILLD++L PKISDFGLAKLFP N TH
Sbjct: 127 PVRCKICIGIARGLSFLHEEVQPHIVHRDIKASNILLDRNLRPKISDFGLAKLFPNNETH 186
Query: 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291
ISTRVAGT GYLAPEYA+RGQLTRKAD+YS+G+LLLEIV GR NTNRRLP EEQYLLE
Sbjct: 187 ISTRVAGTAGYLAPEYALRGQLTRKADVYSYGILLLEIVCGRSNTNRRLPSEEQYLLERV 246
Query: 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351
W+++E+G+L +VD SLNGDY EA R+LKI L+CTQ MPK RPSMST++ ML G IDV
Sbjct: 247 WEMHEKGELEYIVDTSLNGDYDAGEACRFLKIGLICTQVMPKLRPSMSTVLGMLTGAIDV 306
Query: 352 NKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKLDHSSFSSGNMTTSYATMTFNSIF 411
N EEISKPGLLS+L+G++ +K KA + S+ SS S +TTS+ATMTFNSI+
Sbjct: 307 NDEEISKPGLLSELVGIKGANDQKGKAKTSNSASTGTASSSLSE--VTTSHATMTFNSIY 364
Query: 412 DRSN 415
DRSN
Sbjct: 365 DRSN 368
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543219|ref|XP_003540060.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1362), Expect = e-147, Method: Compositional matrix adjust.
Identities = 257/385 (66%), Positives = 311/385 (80%), Gaps = 1/385 (0%)
Query: 32 LHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKG 91
H R+K +SS T V+ DVSEIQ+ N+Y Y++LR+ATE FS ANKIGQGGFG+VYKG
Sbjct: 5 FHLFRKKGSSSGTQLTGVDIDVSEIQNVNIYTYRELRIATEGFSSANKIGQGGFGAVYKG 64
Query: 92 TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151
L++G+LAAIKVLSA+SRQG+REFLTEI VI I+HENLV+L+GCCVE +HRILVYGYLE
Sbjct: 65 KLRNGSLAAIKVLSAESRQGIREFLTEIKVISSIEHENLVKLHGCCVEDNHRILVYGYLE 124
Query: 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211
NNSLAQTL+G GHSSIQ +W RRNICIGVA+GLAFLHEEV+P I+HRDIKASN+LLDKD
Sbjct: 125 NNSLAQTLIGSGHSSIQLSWPVRRNICIGVARGLAFLHEEVRPRIIHRDIKASNVLLDKD 184
Query: 212 LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
L PKISDFGLAKL P NLTHISTRVAGT GYLAPEYAIR Q+T K+D+YSFGVLLLEIVS
Sbjct: 185 LQPKISDFGLAKLIPPNLTHISTRVAGTAGYLAPEYAIRNQVTTKSDVYSFGVLLLEIVS 244
Query: 272 GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDM 331
GR NTNRRLP EEQYLL W LYE G++ +LVDA L GD+++EEA R+ KI LLCTQD
Sbjct: 245 GRPNTNRRLPVEEQYLLTRVWDLYESGEVEKLVDAFLEGDFNIEEAIRFCKIGLLCTQDS 304
Query: 332 PKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDS-SKLDH 390
P+ RPSMS+++ ML+GE DVN+E ++KPG++ + + + +K KA S S ++
Sbjct: 305 PQLRPSMSSVLEMLLGEKDVNEENVTKPGMIFEFVEAKSAGKQKGKAEVDSKSSLAEGKQ 364
Query: 391 SSFSSGNMTTSYATMTFNSIFDRSN 415
SS +S+ATMTF +I+DRSN
Sbjct: 365 DESSSSGTMSSFATMTFTAIYDRSN 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449438933|ref|XP_004137242.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] gi|449483147|ref|XP_004156506.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1358), Expect = e-147, Method: Compositional matrix adjust.
Identities = 260/380 (68%), Positives = 303/380 (79%), Gaps = 2/380 (0%)
Query: 36 RRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD 95
+R SS + V E++S I + LY YK+LR ATENF NK+GQGGFGSVYKG L +
Sbjct: 9 KRNSDSSVAQTIAVVEEISNIPNVRLYSYKELRKATENFRSENKLGQGGFGSVYKGRLGN 68
Query: 96 GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155
GTLAAIKVLS DS QG REFL EINVI I H+NLV+L+GCCVEG HRILVY YLEN+SL
Sbjct: 69 GTLAAIKVLSMDSSQGTREFLAEINVISVINHDNLVKLHGCCVEGQHRILVYPYLENSSL 128
Query: 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215
+ L GRGH +IQFNWQTR ICIGVA+GLAFLHEEVQPH++HRDIKASNILLDKDL PK
Sbjct: 129 DKMLFGRGHRNIQFNWQTRCKICIGVAQGLAFLHEEVQPHVIHRDIKASNILLDKDLNPK 188
Query: 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN 275
ISDFGLA+L PANLTH+STRVAGT GYLAPE+AIRGQ TR+ DIYSFGVLLLEIV GR N
Sbjct: 189 ISDFGLARLLPANLTHVSTRVAGTVGYLAPEFAIRGQATRRTDIYSFGVLLLEIVCGRYN 248
Query: 276 TNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR 335
NRRLP EE YLLEM W+ +E+G+L+ELVD SL D+ E+A RYLKI LLCTQDMPK R
Sbjct: 249 INRRLPAEEPYLLEMVWEHHEKGQLLELVDISLRQDFVTEQACRYLKIGLLCTQDMPKLR 308
Query: 336 PSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKLDHSSFSS 395
PSM+T+V ML GEID++ + IS+PG+LS+ + LR D K K + + DS K S+ SS
Sbjct: 309 PSMATVVKMLTGEIDISDQTISRPGMLSEFM-LRKDVLCK-KGESTAEDSGKPIDSTSSS 366
Query: 396 GNMTTSYATMTFNSIFDRSN 415
+M TSYAT+TF+SIFDRSN
Sbjct: 367 RHMDTSYATITFDSIFDRSN 386
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114834|ref|XP_002316869.1| predicted protein [Populus trichocarpa] gi|222859934|gb|EEE97481.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1358), Expect = e-147, Method: Compositional matrix adjust.
Identities = 259/373 (69%), Positives = 304/373 (81%), Gaps = 10/373 (2%)
Query: 52 DVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG 111
+VS Q+T Y Y++LR+AT+NF+PANK+G+GGFGSVYKG LKDGT+AA+KVLSA+SRQG
Sbjct: 7 EVSWAQNTCSYTYRELRMATDNFNPANKVGEGGFGSVYKGMLKDGTMAAVKVLSAESRQG 66
Query: 112 VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNW 171
++EFLTEI VI DI+H NLV+LYG C EG+HRILVYGYL+NNSLAQTLLG GHS+IQFNW
Sbjct: 67 LKEFLTEIKVIADIEHNNLVKLYGYCAEGNHRILVYGYLKNNSLAQTLLGGGHSNIQFNW 126
Query: 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231
TRR ICIGVA+GLAFLHEEVQPHIVHRDIKASN+LLD +L PKISDFGLAKLFPANLTH
Sbjct: 127 PTRRKICIGVARGLAFLHEEVQPHIVHRDIKASNVLLDDELEPKISDFGLAKLFPANLTH 186
Query: 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291
IST VAGT GYLAPEYAIRGQLTRKADIYSFGVLLLEIV GR NTNRR P EEQYL+E
Sbjct: 187 ISTNVAGTAGYLAPEYAIRGQLTRKADIYSFGVLLLEIVCGRSNTNRRFPLEEQYLVERV 246
Query: 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351
W Y+ +LV LVD SL GDY VEEA YLKI LLC QD+PK+RPSMST+V ML+GEI+V
Sbjct: 247 WDFYQNLELVNLVDTSLAGDYDVEEACNYLKIGLLCIQDVPKQRPSMSTVVMMLMGEIEV 306
Query: 352 NKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKLDHSSFSS---------GNMTTSY 402
N ++IS+PGLLS+ + DK K + + ++ +SS +S + TS+
Sbjct: 307 N-DKISRPGLLSEFTSFKGDKMPKHEGGKDQNNKWEMKNSSSTSVKVENSSSSSGVDTSH 365
Query: 403 ATMTFNSIFDRSN 415
ATMTF+SI+DR N
Sbjct: 366 ATMTFSSIYDRGN 378
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121542|ref|XP_002330726.1| predicted protein [Populus trichocarpa] gi|222872502|gb|EEF09633.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1345), Expect = e-145, Method: Compositional matrix adjust.
Identities = 262/370 (70%), Positives = 307/370 (82%), Gaps = 7/370 (1%)
Query: 52 DVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG 111
+VS Q+ Y +++L++ATENF+ ANK+G+GGFGSVYKG LKDGT+AAIKVLSA+SRQG
Sbjct: 7 EVSGSQNICCYTHRELQMATENFNSANKVGEGGFGSVYKGILKDGTVAAIKVLSAESRQG 66
Query: 112 VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNW 171
+REFLTEI VI DI+H NLV+LYG C +G+HRILVYGYLENNSLAQTLLG GHSSI+F+W
Sbjct: 67 LREFLTEIKVIADIEHNNLVKLYGYCADGNHRILVYGYLENNSLAQTLLGGGHSSIKFSW 126
Query: 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231
TRR IC+GVA+GLAFLHEEVQPHIVHRDIKASNILLD +L PKISDFGLAKLFP++LTH
Sbjct: 127 STRRKICVGVARGLAFLHEEVQPHIVHRDIKASNILLDSELEPKISDFGLAKLFPSHLTH 186
Query: 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291
ISTRVAGT GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR NTNRRLP EEQ LL+
Sbjct: 187 ISTRVAGTTGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRSNTNRRLPTEEQCLLKRV 246
Query: 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351
W YE+G+LV LVD SL DY EEA +YLKI LLCTQ++ K RP MST+V+ML+GE+DV
Sbjct: 247 WVFYEKGELVNLVDTSLGRDYDAEEACKYLKIGLLCTQEVSKLRPLMSTVVSMLMGEMDV 306
Query: 352 NKEEISKPGLLSDLLGLRVDKGEKDK------ASAVSGDSSKLDHSSFSSGNMTTSYATM 405
K++IS+PGLLS+ L+ DK +KD+ + S +S S SS M TSYA+M
Sbjct: 307 -KDKISRPGLLSEFRSLKGDKKQKDRDQNDKWETKKSSPNSSKLEDSSSSSGMATSYASM 365
Query: 406 TFNSIFDRSN 415
TFNSI+DRSN
Sbjct: 366 TFNSIYDRSN 375
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514587|ref|XP_003525987.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1345), Expect = e-145, Method: Compositional matrix adjust.
Identities = 259/384 (67%), Positives = 309/384 (80%), Gaps = 7/384 (1%)
Query: 36 RRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD 95
R+K +SS T V+ DVSEIQ+ N+Y Y++LR+ATE FS ANKIGQGGFG VYKG L++
Sbjct: 107 RKKGSSSGTQLTGVDLDVSEIQNVNIYTYRELRIATEGFSNANKIGQGGFGVVYKGKLRN 166
Query: 96 GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155
G+LAAIKVLSA+SRQGVREFLTEI VI I+HENLV+L+GCCVE +HRILVYGYLENNSL
Sbjct: 167 GSLAAIKVLSAESRQGVREFLTEIKVISSIEHENLVKLHGCCVEDNHRILVYGYLENNSL 226
Query: 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215
AQTL+G GHSSIQ +W RRNICIGVA+GLAFLHEEV+PHI+HRDIKASN+LLDKDL PK
Sbjct: 227 AQTLIGSGHSSIQLSWPVRRNICIGVARGLAFLHEEVRPHIIHRDIKASNVLLDKDLQPK 286
Query: 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN 275
ISDFGLAKL P NLTHISTRVAGT GYLAPEYAIR Q+TRK+D+YSFGVLLLEIVS R N
Sbjct: 287 ISDFGLAKLIPPNLTHISTRVAGTVGYLAPEYAIRNQVTRKSDVYSFGVLLLEIVSRRPN 346
Query: 276 TNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR 335
TNRRLP EEQYLL AW LYE G+ +LVDA L GD+++EEA R+ KI LLCTQD P+ R
Sbjct: 347 TNRRLPVEEQYLLTRAWDLYESGEAEKLVDAFLEGDFNIEEAVRFCKIGLLCTQDSPQLR 406
Query: 336 PSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKL----DHS 391
PSMS+++ ML+GE DVN+E ++KPG++ + + + +K KA DS L
Sbjct: 407 PSMSSVLEMLLGEKDVNEENVTKPGMIFEFVEAKSAGKQKCKAEV---DSKSLLAEGKQD 463
Query: 392 SFSSGNMTTSYATMTFNSIFDRSN 415
SS +S+ATMTF +I+DRS+
Sbjct: 464 DSSSSGTMSSFATMTFTAIYDRSD 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460042|ref|XP_004147755.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1338), Expect = e-145, Method: Compositional matrix adjust.
Identities = 260/403 (64%), Positives = 307/403 (76%), Gaps = 26/403 (6%)
Query: 21 PFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKI 80
PFLF KR T ED S +Q+ Y YK+L+VATE+FS ANKI
Sbjct: 5 PFLF------------SKRVKGPTRSSVDEEDFSSMQNVKFYTYKELKVATEDFSLANKI 52
Query: 81 GQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG 140
G+GGFGSVYKG LKDG LAAIKVLSA+SRQG+REFLTEINVI I+HENLV+LYGCCV+
Sbjct: 53 GEGGFGSVYKGKLKDGKLAAIKVLSAESRQGLREFLTEINVISKIEHENLVQLYGCCVDD 112
Query: 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200
+HRILVY YLENNSLAQTLLGRG+SSIQFNW+TR ICIG+A+GLAFLHE+VQPHI+HRD
Sbjct: 113 NHRILVYNYLENNSLAQTLLGRGYSSIQFNWRTRSKICIGIARGLAFLHEDVQPHIIHRD 172
Query: 201 IKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIY 260
IKASNILLD DL+PKISDFGLAKL PA++TH+STRVAGT GYLAPEYAIRGQ+TRK+DIY
Sbjct: 173 IKASNILLDHDLSPKISDFGLAKLIPASMTHVSTRVAGTIGYLAPEYAIRGQVTRKSDIY 232
Query: 261 SFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRY 320
SFGVLL+EIVSGR NTN +LP EQYLLE W LYE+G+LV LVD SLNGD+ E A +Y
Sbjct: 233 SFGVLLVEIVSGRWNTNTQLPIGEQYLLERTWNLYEQGELVLLVDTSLNGDFDAEMACKY 292
Query: 321 LKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASA 380
LKI LLCTQD PK RPSMST+V ML GE+ V +ISKPGL+SD + L+V E++K +
Sbjct: 293 LKIGLLCTQDSPKLRPSMSTVVKMLTGEMSVEDRKISKPGLISDFMDLKVRNPEENKGNR 352
Query: 381 -------------VSGDSS-KLDHSSFSSGNMTTSYATMTFNS 409
+ G+S+ + S+ ++G T Y TF+S
Sbjct: 353 EGVSSDSLSSGSNILGNSTMSSEASTVTTGTFTAQYDRNTFSS 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578162|ref|XP_002529950.1| ATP binding protein, putative [Ricinus communis] gi|223530548|gb|EEF32427.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-145, Method: Compositional matrix adjust.
Identities = 262/406 (64%), Positives = 312/406 (76%), Gaps = 34/406 (8%)
Query: 36 RRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD 95
R+++ SS V+E+V+ I + LY Y++L+ AT++FSP KIG+GGFGSVYKG LKD
Sbjct: 10 RKEKLSSG-----VDEEVAGIHNVKLYTYRELKNATDDFSPRTKIGEGGFGSVYKGRLKD 64
Query: 96 GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155
G AAIKVLSA+SRQG +EFLTEINVI +I+HENLV+LYGCCVEG+HRILVY YLENNSL
Sbjct: 65 GKFAAIKVLSAESRQGAKEFLTEINVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 124
Query: 156 AQTLLGRGH--SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213
AQTLLG GH S+IQF+W+TR ICIGVA+GLAFLHE+V+PHIVHRDIKASNILLDKDLT
Sbjct: 125 AQTLLGVGHNQSNIQFSWRTRSKICIGVARGLAFLHEQVRPHIVHRDIKASNILLDKDLT 184
Query: 214 PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
P+ISDFGLAKL P N+TH+STRVAGT GYLAPEYAIRGQLTR+ADIYSFGVLL+EIVSGR
Sbjct: 185 PRISDFGLAKLIPPNMTHVSTRVAGTIGYLAPEYAIRGQLTRRADIYSFGVLLVEIVSGR 244
Query: 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPK 333
CNTN RLP EEQYLLE W+LYER +LV LVD SLNGD+ EEA ++LKI LLCTQD PK
Sbjct: 245 CNTNTRLPVEEQYLLERTWELYERRELVGLVDTSLNGDFDAEEACKFLKIGLLCTQDAPK 304
Query: 334 RRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASA------------- 380
RPSMST+V +L GE DV+ +I+KPGL++D + L++ K K+
Sbjct: 305 LRPSMSTVVKLLTGEKDVDDSKITKPGLITDFMDLKIRAPPKTKSQKKTACPDNLSPQNE 364
Query: 381 ------------VSGDSSKLDHSSFSSGNMTTSYATMTFNSIFDRS 414
+S S LD + SSGN TTS T TF + +DRS
Sbjct: 365 TVYEAKNMSSCNMSSGSENLDDLTLSSGN-TTSIGT-TFTAPYDRS 408
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449526092|ref|XP_004170048.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 260/403 (64%), Positives = 306/403 (75%), Gaps = 26/403 (6%)
Query: 21 PFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKI 80
PFLF KR T ED S +Q+ Y YK L+VATE+FS ANKI
Sbjct: 5 PFLF------------SKRGKGPTRSSVDEEDFSSMQNVKFYTYKQLKVATEDFSLANKI 52
Query: 81 GQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG 140
G+GGFGSVYKG LKDG LAAIKVLSA+SRQG+REFLTEINVI I+HENLV+LYGCCV+
Sbjct: 53 GEGGFGSVYKGKLKDGKLAAIKVLSAESRQGLREFLTEINVISKIEHENLVQLYGCCVDD 112
Query: 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200
+HRILVY YLENNSLAQTLLGRG+SSIQFNW+TR ICIG+A+GLAFLHE+VQPHI+HRD
Sbjct: 113 NHRILVYNYLENNSLAQTLLGRGYSSIQFNWRTRSKICIGIARGLAFLHEDVQPHIIHRD 172
Query: 201 IKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIY 260
IKASNILLD DL+PKISDFGLAKL PA++TH+STRVAGT GYLAPEYAIRGQ+TRK+DIY
Sbjct: 173 IKASNILLDHDLSPKISDFGLAKLIPASMTHVSTRVAGTIGYLAPEYAIRGQVTRKSDIY 232
Query: 261 SFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRY 320
SFGVLL+EIVSGR NTN +LP EQYLLE W LYE+G+LV LVD SLNGD+ E A +Y
Sbjct: 233 SFGVLLVEIVSGRWNTNTQLPIGEQYLLERTWNLYEQGELVLLVDTSLNGDFDAEMACKY 292
Query: 321 LKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASA 380
LKI LLCTQD PK RPSMST+V ML GE+ V +ISKPGL+SD + L+V E++K +
Sbjct: 293 LKIGLLCTQDSPKLRPSMSTVVKMLTGEMSVEDRKISKPGLISDFMDLKVRNPEENKGNR 352
Query: 381 -------------VSGDSS-KLDHSSFSSGNMTTSYATMTFNS 409
+ G+S+ + S+ ++G T Y TF+S
Sbjct: 353 EGVSSDSLSSGSNILGNSTMSSEASTVTTGTFTAQYDRNTFSS 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | ||||||
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.778 | 0.828 | 0.713 | 4.9e-124 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.790 | 0.834 | 0.526 | 2.4e-92 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.722 | 0.290 | 0.555 | 2.5e-88 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.732 | 0.293 | 0.576 | 2.9e-87 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.720 | 0.285 | 0.561 | 2.9e-87 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.734 | 0.314 | 0.532 | 1.7e-84 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.713 | 0.310 | 0.558 | 5.6e-84 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.725 | 0.279 | 0.543 | 8.2e-83 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.742 | 0.301 | 0.522 | 3.9e-76 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.698 | 0.448 | 0.466 | 6.3e-69 |
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1219 (434.2 bits), Expect = 4.9e-124, P = 4.9e-124
Identities = 232/325 (71%), Positives = 279/325 (85%)
Query: 48 EVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD 107
EV+ +++ I + +Y Y+++R AT++FS NKIG+GGFGSVYKG LKDG LAAIKVLSA+
Sbjct: 15 EVDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAE 74
Query: 108 SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH--S 165
SRQGV+EFLTEINVI +I+HENLV+LYGCCVEG+HRILVY +LENNSL +TLL G+ S
Sbjct: 75 SRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRS 134
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
IQF+W +R NIC+GVAKGLAFLHEEV+PHI+HRDIKASNILLDK L+PKISDFGLA+L
Sbjct: 135 GIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLM 194
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
P N+TH+STRVAGT GYLAPEYA+RGQLTRKADIYSFGVLL+EIVSGR N N RLP E Q
Sbjct: 195 PPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQ 254
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
YLLE AW+LYER +LV+LVD+ LNG + EEA RYLKI LLCTQD PK RPSMST+V +L
Sbjct: 255 YLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLL 314
Query: 346 IGEIDVNKEEISKPGLLSDLLGLRV 370
GE D++ ++IS+PGL+SD + L+V
Sbjct: 315 TGEKDIDYKKISRPGLISDFMDLKV 339
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 920 (328.9 bits), Expect = 2.4e-92, P = 2.4e-92
Identities = 179/340 (52%), Positives = 241/340 (70%)
Query: 52 DVSEIQDTNL--YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR 109
+ EI N+ + Y LR AT++F P N+IG GG+G V+KG L+DGT A+K LSA+S+
Sbjct: 22 EAEEICTNNVRVFSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESK 81
Query: 110 QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQF 169
QG REFLTEIN+I +I H NLV+L GCC+EG++RILVY YLENNSLA LLG +
Sbjct: 82 QGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPL 141
Query: 170 NWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229
+W R IC+G A GLAFLHEEV+PH+VHRDIKASNILLD + +PKI DFGLAKLFP N+
Sbjct: 142 DWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNV 201
Query: 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289
TH+STRVAGT GYLAPEYA+ GQLT+KAD+YSFG+L+LE++SG +T E L+E
Sbjct: 202 THVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVE 261
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG-E 348
WKL E +L+E VD L + +E R++K+AL CTQ ++RP+M ++ ML E
Sbjct: 262 WVWKLREERRLLECVDPELT-KFPADEVTRFIKVALFCTQAAAQKRPNMKQVMEMLRRKE 320
Query: 349 IDVNKEEISKPGLLSDL--------LGLRVDKGEKDKASA 380
+++N++ +++PG+ + +GLRV +G + S+
Sbjct: 321 LNLNEDALTEPGVYRGVNRGRNHRGIGLRVGQGGSSQESS 360
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
Identities = 169/304 (55%), Positives = 221/304 (72%)
Query: 61 LYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEIN 120
++ Y +L+ AT++F P+NK+G+GGFG VYKG L DG + A+K+LS SRQG +F+ EI
Sbjct: 681 IFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIV 740
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
I + H NLV+LYGCC EG+HR+LVY YL N SL Q L G ++ +W TR IC+G
Sbjct: 741 AISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLG 798
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA+GL +LHEE IVHRD+KASNILLD L P+ISDFGLAKL+ THISTRVAGT
Sbjct: 799 VARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTI 858
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
GYLAPEYA+RG LT K D+Y+FGV+ LE+VSGR N++ L E++YLLE AW L+E+ +
Sbjct: 859 GYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRD 918
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPG 360
+EL+D L D+++EEA R + IALLCTQ RP MS +V ML G++++ + SKPG
Sbjct: 919 IELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIG-DVTSKPG 976
Query: 361 LLSD 364
+SD
Sbjct: 977 YVSD 980
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 177/307 (57%), Positives = 220/307 (71%)
Query: 47 VEVNEDVSEIQ-DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLS 105
V+ NE++ + T + K ++ AT NF P NKIG+GGFG VYKG L DG A+K LS
Sbjct: 639 VDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLS 698
Query: 106 ADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS 165
+ S+QG REF+TEI +I ++H NLV+LYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 699 SKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ 758
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ +W TR +CIG+AKGLA+LHEE + IVHRDIKA+N+LLD L KISDFGLAKL
Sbjct: 759 RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLD 818
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
THISTR+AGT GY+APEYA+RG LT KAD+YSFGV+ LEIVSG+ NTN R P EE
Sbjct: 819 EEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR-PKEEF 877
Query: 286 -YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
YLL+ A+ L E+G L+ELVD L +S +EA R L IALLCT P RP MS++V+M
Sbjct: 878 IYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSM 937
Query: 345 LIGEIDV 351
L G+I V
Sbjct: 938 LQGKIKV 944
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 170/303 (56%), Positives = 218/303 (71%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ Y +L+ AT++F +NK+G+GGFG+VYKG L DG A+K LS SRQG +F+ EI
Sbjct: 698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I + H NLV+LYGCC EGDHR+LVY YL N SL Q L G S+ +W TR IC+GV
Sbjct: 758 ISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG--DKSLHLDWSTRYEICLGV 815
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
A+GL +LHEE I+HRD+KASNILLD +L PK+SDFGLAKL+ THISTRVAGT G
Sbjct: 816 ARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIG 875
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
YLAPEYA+RG LT K D+Y+FGV+ LE+VSGR N++ L ++YLLE AW L+E+ + V
Sbjct: 876 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV 935
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGL 361
EL+D L+ +Y++EE R + IALLCTQ RP MS +V ML G+ +VN + SKPG
Sbjct: 936 ELIDDELS-EYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVN-DATSKPGY 993
Query: 362 LSD 364
L+D
Sbjct: 994 LTD 996
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 165/310 (53%), Positives = 219/310 (70%)
Query: 59 TNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTE 118
T + + L+VAT +F P NKIG+GGFGSVYKG L DGTL A+K LS+ S QG +EF+ E
Sbjct: 625 TGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNE 684
Query: 119 INVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
I +I ++H NLV+LYGCCVE + +LVY YLENN L+ L G S ++ W TR IC
Sbjct: 685 IGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFA-GRSCLKLEWGTRHKIC 743
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG 238
+G+A+GLAFLHE+ I+HRDIK +N+LLDKDL KISDFGLA+L N +HI+TRVAG
Sbjct: 744 LGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAG 803
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY--LLEMAWKLYE 296
T GY+APEYA+RG LT KAD+YSFGV+ +EIVSG+ N + P +E LL+ A+ L +
Sbjct: 804 TIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNA-KYTPDDECCVGLLDWAFVLQK 862
Query: 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEI 356
+G + E++D L G + V EA R +K++LLC RP+MS +V ML GE ++ ++ I
Sbjct: 863 KGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEI-EQII 921
Query: 357 SKPGLLSDLL 366
S PG+ SD L
Sbjct: 922 SDPGVYSDNL 931
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 841 (301.1 bits), Expect = 5.6e-84, P = 5.6e-84
Identities = 167/299 (55%), Positives = 214/299 (71%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ + +++AT NF AN+IG+GGFG VYKG L DGT+ A+K LS S+QG REFL EI +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I + H NLV+LYGCCVEG +LVY ++ENNSLA+ L G + ++ +W TRR ICIGV
Sbjct: 672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
A+GLA+LHEE + IVHRDIKA+N+LLDK L PKISDFGLAKL + THISTR+AGT G
Sbjct: 732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFG 791
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
Y+APEYA+RG LT KAD+YSFG++ LEIV GR N R YL++ L E+ L+
Sbjct: 792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLL 851
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE--IDVNK-EEIS 357
ELVD L +Y+ EEA ++IA++CT P RPSMS +V ML G+ ++V K EE S
Sbjct: 852 ELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEAS 910
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 167/307 (54%), Positives = 220/307 (71%)
Query: 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINV 121
+ + L+VAT++F+P NKIG+GGFGSVYKG L +GTL A+K LS+ S QG +EF+ EI +
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
I ++H NLV+LYGCCVE +LVY YLENN LA L GR S ++ +W+TR IC+G+
Sbjct: 725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGR--SGLKLDWRTRHKICLGI 782
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
A+GLAFLHE+ I+HRDIK +NILLDKDL KISDFGLA+L + +HI+TRVAGT G
Sbjct: 783 ARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIG 842
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY--LLEMAWKLYERGK 299
Y+APEYA+RG LT KAD+YSFGV+ +EIVSG+ N N P E LL+ A+ L ++G
Sbjct: 843 YMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYT-PDNECCVGLLDWAFVLQKKGA 901
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKP 359
E++D L G + V EA R +K++LLC+ P RP+MS +V ML GE ++ +E IS P
Sbjct: 902 FDEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEI-EEIISDP 960
Query: 360 GLLSDLL 366
G D L
Sbjct: 961 GAYGDEL 967
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 163/312 (52%), Positives = 209/312 (66%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD 124
+ ++ AT++F+P NKIG+GGFG+V+KG L DG + A+K LS+ SRQG REFL EI I
Sbjct: 672 RQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISC 731
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++H NLV+L+G CVE +L Y Y+ENNSL+ L H I +W TR IC G+AKG
Sbjct: 732 LQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKG 791
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
LAFLHEE VHRDIKA+NILLDKDLTPKISDFGLA+L THIST+VAGT GY+A
Sbjct: 792 LAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMA 851
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
PEYA+ G LT KAD+YSFGVL+LEIV+G N+N + LLE A + E G L+++V
Sbjct: 852 PEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVV 911
Query: 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSD 364
D L + +EA +K+AL+C+ P RP MS +V ML G V + S PG+ +
Sbjct: 912 DERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPE---STPGVSRN 968
Query: 365 LLGLRVDKGEKD 376
+R K KD
Sbjct: 969 AGDIRF-KAFKD 979
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 699 (251.1 bits), Expect = 6.3e-69, P = 6.3e-69
Identities = 138/296 (46%), Positives = 195/296 (65%)
Query: 59 TNL-YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLT 117
+NL + Y++L AT+ FS NK+GQGG GSVYKG L +G A+K L +++Q V F
Sbjct: 307 SNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFN 366
Query: 118 EINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ-FNWQTRRN 176
E+N+I + H+NLV+L GC + G +LVY Y+ N SL L R +Q NW R
Sbjct: 367 EVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVR--KDVQPLNWAKRFK 424
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV 236
I +G A+G+A+LHEE I+HRDIK SNILL+ D TP+I+DFGLA+LFP + THIST +
Sbjct: 425 IILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAI 484
Query: 237 AGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296
AGT GY+APEY +RG+LT KAD+YSFGVL++E+++G+ N + +L+ W LY
Sbjct: 485 AGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGK--RNNAFVQDAGSILQSVWSLYR 542
Query: 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352
+ E VD L +++ EA R L+I LLC Q +RP+MS +V M+ G ++++
Sbjct: 543 TSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKGSLEIH 598
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 415 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 92/285 (32%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
K+G+G FG VYKG LK T A+K L D S + ++FL E V+K + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGR-----GHSSIQFNWQTRRNICIGVAKGLAF 187
L G C E + LV Y+E L L + + + I +AKG+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG-----Y 242
L + VHRD+ A N L+ +DL KISDFGL++ ++ T G +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLPIRW 173
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV- 301
+APE G T K+D++SFGVLL EI T PY E+ L + +L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIF-----TLGATPYPGLSNEEVLEYLRKGYRLPK 228
Query: 302 -ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
E L Y ++ L C Q P+ RP+ S LV L
Sbjct: 229 PEYCPDEL---Y---------ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 9e-53
Identities = 87/279 (31%), Positives = 126/279 (45%), Gaps = 38/279 (13%)
Query: 79 KIGQGGFGSVYKGTLKD-----GTLAAIKVL--SADSRQGVREFLTEINVIKDIKHENLV 131
K+G+G FG VYKGTLK T A+K L A + EFL E +++K + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE-REEFLEEASIMKKLSHPNIV 64
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G C +G+ +V Y+ L L G + + + +AKG+ +L +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESK 121
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APE 246
+ VHRD+ A N L+ ++L KISDFGL++ + G L APE
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPE 174
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
G+ T K+D++SFGVLL EI T PY E+ L + +L
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIF-----TLGEQPYPGMSNEEVLELLEDGYRL----PR 225
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
N + E + L C P+ RP+ S LV L
Sbjct: 226 PENCPDELYE------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-52
Identities = 72/195 (36%), Positives = 109/195 (55%), Gaps = 13/195 (6%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHENLVELYGCC 137
+G+GGFG+VY K G AIK++ + + E L EI ++K + H N+V+LYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ +H LV Y E SL LL + + I + + +GL +LH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LLKENEG--KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 198 HRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ--LT 254
HRD+K NILLD D K++DFGL+KL ++ + + T V GT Y+APE + G+ +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPE-VLLGKGYYS 172
Query: 255 RKADIYSFGVLLLEI 269
K+DI+S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-51
Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYG 135
K+G G FG+VYK K G + A+K+L S + + EI +++ + H N+V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
+ DH LV Y E L L G + + I + + +GL +LH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-- 253
I+HRD+K NILLD++ KI+DFGLAK + + ++T V GT Y+APE + G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE-VLLGGNGY 176
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313
K D++S GV+L E+++G + P+ + +L+ + ++ S
Sbjct: 177 GPKVDVWSLGVILYELLTG------KPPFSGENILDQLQLIRRILG--PPLEFDEPKWSS 228
Query: 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
E + L I +D P +RP+ ++
Sbjct: 229 GSEEAKDL-IKKCLNKD-PSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 5e-49
Identities = 86/280 (30%), Positives = 136/280 (48%), Gaps = 40/280 (14%)
Query: 79 KIGQGGFGSVYKGTLKDG-----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
K+G+G FG VYKGTLK A+K L D S Q + EFL E +++ + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L G C E + ++V Y+ L L R + + + + + +A+G+ +L +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST-RVAGTEG---YLAPEYA 248
+ +HRD+ A N L+ ++L KISDFGL++ +L +V G + ++APE
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
G+ T K+D++SFGVLL EI T PY M+ E+++
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIF-----TLGEEPYP-----GMSNA--------EVLEYLK 218
Query: 309 NGDY--SVEEAHRYL-KIALLCTQDMPKRRPSMSTLVNML 345
G L K+ L C + P+ RP+ S LV +L
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 9e-49
Identities = 85/277 (30%), Positives = 131/277 (47%), Gaps = 35/277 (12%)
Query: 79 KIGQGGFGSVYKGTLKD-----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
K+G+G FG VYKG LK A+K L D S Q + EFL E +++ + H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L G C E + +V Y+E L L + + + + +A+G+ +L +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS-TRVAGTEG---YLAPEYA 248
+ +HRD+ A N L+ ++L KISDFGL++ +L R G + ++APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
G+ T K+D++SFGVLL EI T PY E+ L + G +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIF-----TLGEQPYPGMSNEEVLEYL-KNGYRLPQP---- 225
Query: 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
E Y + L C + P+ RP+ S LV +L
Sbjct: 226 --PNCPPE--LY-DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 85/269 (31%), Positives = 124/269 (46%), Gaps = 24/269 (8%)
Query: 78 NKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHENLVELYG 135
K+G+G FG VY K G L AIKV+ + RE L EI ++K +KH N+V LY
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
+ D LV Y E L L RG + R + L +LH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK---G 117
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
IVHRD+K NILLD+D K++DFGLA+ ++T V GT Y+APE + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 256 KADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315
DI+S GV+L E+++G + P+ L +K + K D S
Sbjct: 176 AVDIWSLGVILYELLTG------KPPFPGDDQLLELFKKIGKPKPPFP---PPEWDIS-P 225
Query: 316 EAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
EA ++ L +D P++R + +
Sbjct: 226 EAKDLIR--KLLVKD-PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-43
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
F KIG+GGFG VYK + G AIKV+ +S++ + + EI ++K KH N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
YG ++ D +V + SL L + +C + KGL +LH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
I+HRDIKA+NILL D K+ DFGL+ + T + GT ++APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE 284
KADI+S G+ +E+ + PY E
Sbjct: 174 YDYKADIWSLGITAIELA------EGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 70/202 (34%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 78 NKIGQGGFGSVYKGTLKD-GTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENLVELY 134
+G+G FGSVY KD G L A+K LS DS + + EI ++ ++H N+V Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 135 GCCV--EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
G E + + Y+ SL+ L G R + +GLA+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLHSN- 120
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR-VAGTEGYLAPEYAIRG 251
IVHRDIK +NIL+D D K++DFG AK T T V GT ++APE
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
+ R ADI+S G ++E+ +G+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 90/275 (32%), Positives = 134/275 (48%), Gaps = 44/275 (16%)
Query: 80 IGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE 139
IG+G FG V G + G A+K L DS + FL E +V+ ++H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199
G+ +V Y+ SL L RG + I + + V +G+ +L E+ + VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVI--TLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 200 DIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--VAGTEGYLAPEYAIR-GQLTRK 256
D+ A N+L+ +DL K+SDFGLAK A+ S + V T APE A+R + + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT----APE-ALREKKFSTK 179
Query: 257 ADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315
+D++SFG+LL EI S G R+P Y R L ++V G Y +E
Sbjct: 180 SDVWSFGILLWEIYSFG------RVP-------------YPRIPLKDVVPHVEKG-YRME 219
Query: 316 -----EAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
Y K+ C + P +RP+ L L
Sbjct: 220 APEGCPPEVY-KVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 73 NFSPANKIGQGGFGSVYKG-TLKDGTLAAIK--VLSADSRQGVREFLTEINVIKDIKHEN 129
N+ + IG+G FG VYKG L+ G AIK L + ++ + EI+++K++KH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI----GVAKGL 185
+V+ G D ++ Y EN SL Q + G F ++ V +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FP----ESLVAVYVYQVLQGL 112
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
A+LHE+ ++HRDIKA+NIL KD K++DFG+A + V GT ++AP
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAP 168
Query: 246 EYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
E I + +DI+S G ++E+++G
Sbjct: 169 E-VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
E F+ K+G G FG V++G K+ AIK+L +D ++F E+ +K ++H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLG-------RGHSSIQFNWQTRRNICIGVAKG 184
L+ C G+ ++ +E SL L S I Q VA+G
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL-LAFLRSPEGQVLPVASLIDMACQ--------VAEG 116
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--PANLTHISTRVAGTEGY 242
+A+L E+ + +HRD+ A NIL+ +DL K++DFGLA+L L+ ++ +
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIPYK--W 170
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE 283
APE A G + K+D++SFG+LL E+ + G+ PY
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV------PYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (323), Expect = 2e-34
Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 47/282 (16%)
Query: 78 NKIGQGGFGSVYKGT-LKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENLVELY 134
+IG+G FG VY DG L +K LS S + + L E+ ++K + H N+++ Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
E +V Y + L+Q + + F + + + + L +LH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ-L 253
I+HRDIK NI L + K+ DFG++K+ + + T V GT YL+PE + +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQNKPY 180
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK-----------LVE 302
K+DI+S G +L E+ + + P+E + LLE+A K+ +G+ L
Sbjct: 181 NYKSDIWSLGCVLYELCTL------KHPFEGENLLELALKI-LKGQYPPIPSQYSSELRN 233
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
LV + L D P+ RPS++ ++
Sbjct: 234 LVSSLLQKD--------------------PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG---VREFLTEINVIKDIKHENLVELYG 135
K+G G FG V+ GT T A+K L + G FL E ++K ++H+ LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
C E + +V Y+ SL L + + ++ +A+G+A+L +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---N 123
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQ 252
+HRD+ A NIL+ ++L KI+DFGLA+L + T G + + APE A G+
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGR 180
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
T K+D++SFG+LL EIV T R+PY
Sbjct: 181 FTIKSDVWSFGILLTEIV-----TYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKH 127
E + KIG+G G VYK T G AIK L +++ + + EI ++KD KH
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
N+V+ Y + GD +V Y++ SL + + ++ N +C V +GL +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI-STR--VAGTEGYLA 244
LH +++HRDIK+ NILL KD + K++DFG A A LT S R V GT ++A
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA----AQLTKEKSKRNSVVGTPYWMA 184
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSG 272
PE R K DI+S G++ +E+ G
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
K+G G FG V++G + T A+K L + ++FL E ++K ++H L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ +V ++ SL + L G +++ ++ VA G+A+L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD+ A N+L+ ++ K++DFGLA++ ++ + APE A+ + + K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAH 318
++SFG+LL EIV T R+PY ++++ VD
Sbjct: 187 VWSFGILLTEIV-----TYGRMPYPG----------MTNAEVLQQVDQGYRMPCPPGCPK 231
Query: 319 RYLKIALLCTQDMPKRRPSMSTLVNML 345
I L C ++ P RP+ TL L
Sbjct: 232 ELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-32
Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 31/271 (11%)
Query: 80 IGQGGFGSVYKG-TLKDGTLAAIKVLS-----ADSRQGVREFLTEINVIKDIKHENLVEL 133
+G G FGSVY+G L DG A+K +S ++ V++ EI ++ ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G E D+ + + SLA+ LL + S F R + GL +LH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQ 252
+ VHRDIK +NIL+D + K++DFG+AK S G+ ++APE + G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGG 178
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312
ADI+S G +LE+ +G + P+ + + +K+ +L + D
Sbjct: 179 YGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKIGRSKELPPIPD-----HL 227
Query: 313 SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
S +EA ++ L C Q P RP+ + L+
Sbjct: 228 S-DEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
K+G+G +GSVYK K+ G + AIKV+ + ++E + EI+++K +V+ YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ +V Y S++ + + I KGL +LH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI---STRVAGTEGYLAPEYAIRGQLT 254
HRDIKA NILL+++ K++DFG++ LT V GT ++APE
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 255 RKADIYSFGVLLLEIVSGR 273
KADI+S G+ +E+ G+
Sbjct: 178 NKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 71/205 (34%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIKVLS-ADSRQG-VREFLTEINVIKDIKHENLVELY 134
NKIG G FG VY L G L A+K + D+ ++E E+ V++ +KH NLV+ Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G V + + Y +L + L H I R + + +GLA+LH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRV-YTLQLLEGLAYLHSH--- 118
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG---YLAPEYAIRG 251
IVHRDIK +NI LD + K+ DFG A N T + V G Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 252 QLT---RKADIYSFGVLLLEIVSGR 273
+ R ADI+S G ++LE+ +G+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 90/286 (31%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVRE---FLTEINVIKDI 125
V E K+G G FG V+ G T AIK L +QG FL E N++K +
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQL 58
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
+H LV LY V + ++ Y+EN SL L + I+ ++ +A+G+
Sbjct: 59 QHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGM 115
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG---- 241
AF+ + + +HRD++A+NIL+ + L KI+DFGLA+L N EG
Sbjct: 116 AFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFP 166
Query: 242 --YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299
+ APE G T K+D++SFG+LL EIV T R+PY E+ L ERG
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV-----TYGRIPYPGMTNPEVIQNL-ERGY 220
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ D Y + LC ++ P+ RP+ L ++L
Sbjct: 221 RMPRPDNCPEELYE---------LMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 77/209 (36%), Positives = 110/209 (52%), Gaps = 22/209 (10%)
Query: 80 IGQGGFGSVYKG-TLKDGTLAAIK-----VLSADSRQGVREFLT----EINVIKDIKHEN 129
IG G FGSVY G G L A+K +SA S+ R L EI ++K+++HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+ G ++ DH + Y+ S+A L G F RN + KGL +LH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLH 123
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA-----GTEGYLA 244
I+HRDIK +NIL+D KISDFG++K AN T A G+ ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
PE + TRKADI+S G L++E+++G+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 84/274 (30%), Positives = 128/274 (46%), Gaps = 35/274 (12%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGC 136
+GQG G VYK K G + A+K + D + R + L E+ ++ + +V+ YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 137 -CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
EG+ I V Y++ SLA L G I + KGL +LH + H
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGK----IPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-T 254
I+HRDIK SN+L++ KI+DFG++K+ L +T V GT Y++PE I+G+ +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-RIQGESYS 178
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
ADI+S G+ LLE G+ P+ + EL+ A +G
Sbjct: 179 YAADIWSLGLTLLECALGKF------PFLPP----------GQPSFFELMQAICDGPPPS 222
Query: 315 EEAHRYLK-----IALLCTQDMPKRRPSMSTLVN 343
A + I+ C Q PK+RPS + L+
Sbjct: 223 LPAEEFSPEFRDFIS-ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 1e-28
Identities = 86/332 (25%), Positives = 134/332 (40%), Gaps = 27/332 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHE-NLVELY 134
K+G+G FG VY +D L A+KVL+ + V FL EI ++ + H N+V+LY
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+ LV Y++ SL LL + + I + L +LH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHSK--- 120
Query: 195 HIVHRDIKASNILLDKDLT-PKISDFGLAKLFPANLTHISTR-----VAGTEGYLAPEYA 248
I+HRDIK NILLD+D K+ DFGLAKL P + S GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 249 IRGQL---TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE--RGKLVEL 303
+ L + +DI+S G+ L E+++G P+E + + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTG------LPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLS 363
+ + L+ + + PK R S S+ ++ + KE L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 364 DLLGLRVDKGEKDKASAVSGDSSKLDHSSFSS 395
D + +S +S S
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLK 326
|
Length = 384 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
K+GQG FG V+ GT T AIK L + FL E V+K ++HE LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
E + +V Y+ SL L +G ++ +A G+A++ + + VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD++A+NIL+ ++L K++DFGLA+L N + APE A+ G+ T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPY 282
++SFG+LL E+ T R+PY
Sbjct: 186 VWSFGILLTELT-----TKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 69/199 (34%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYG 135
+G+G FG V KD G L A+KVL R+ V LTE N++ I H +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC-IGVAKGLAFLHEEVQP 194
+ LV Y L L G S + R I +A L +LH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE---ERARFYAAEIVLA--LEYLHSL--- 112
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
I++RD+K NILLD D K++DFGLAK + + +T GT YLAPE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 255 RKADIYSFGVLLLEIVSGR 273
+ D +S GVLL E+++G+
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 40/284 (14%)
Query: 80 IGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVE 132
+GQG FG VY+G K T AIK ++ ++ R EFL E +V+K+ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFN------WQTRRNICIGVAKGLA 186
L G G ++V + L L R + Q + +A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAP 245
+L + VHRD+ A N ++ +DLT KI DFG+ + ++ + + ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE----EQYLLEMAWKLYERGKLV 301
E G T K+D++SFGV+L E+ T PY+ E+ L K G +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA-----TLAEQPYQGLSNEEVL-----KFVIDGGHL 240
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+L + + + L++ +C Q PK RP+ +V+ L
Sbjct: 241 DLPENCPD---------KLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 80 IGQGGFGSVYKGTL------KDGTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHENLVE 132
+G+G FG V+ G D L A+K L S ++F E ++ + +HEN+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIG 180
YG C EGD I+V+ Y+E+ L + L R H + I +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST----RV 236
+A G+ +L + H VHRD+ N L+ DL KI DFG+++ + T RV
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRV 180
Query: 237 AGTE----GYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
G ++ PE + + T ++D++SFGV+L EI +
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 78 NKIGQGGFGSVYKGT---LKDGT--LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLV 131
++G+G FG V L D T A+K L+ Q +F EI +++ + HEN+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 132 ELYGCCVEGDHRI---LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
+ G C E L+ YL + SL L + H Q N + + KG+ +L
Sbjct: 70 KYKGVC-EKPGGRSLRLIMEYLPSGSLRDYL--QRHRD-QINLKRLLLFSSQICKGMDYL 125
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG--YLAPE 246
+ +HRD+ A NIL++ + KISDFGLAK+ P + + + G + APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
+ + +D++SFGV L E+ + + ++ P E ++ +A +L+EL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 307 S--LNG-DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
L +E + +K LC + P+ RPS + L+
Sbjct: 242 GERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 50/281 (17%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV---REFLTEINVIKDIKHENLVELYG 135
+IG G FG V+ G + AIK + R+G +F+ E V+ + H LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLG-RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
C E LV+ ++E+ L+ L RG +F+ +T +C+ V +G+A+L
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESS--- 119
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
+++HRD+ A N L+ ++ K+SDFG+ + + ST + +PE + +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
K+D++SFGVL+ E+ S + PYE + ++VE ++A
Sbjct: 180 SKSDVWSFGVLMWEVFS-----EGKTPYENR----------SNSEVVETINA-------- 216
Query: 315 EEAHRYLKIALL----------CTQDMPKRRPSMSTLVNML 345
R K L C ++ P+ RPS S L++ L
Sbjct: 217 --GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 83/281 (29%), Positives = 133/281 (47%), Gaps = 45/281 (16%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGC 136
+IG G +G VYK + G L AIKV+ + EI+++K+ +H N+V +G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 137 CVEGDHRILVYGYLENNSLAQTL-LGRGHSS---IQFNWQTRRNICIGVAKGLAFLHEEV 192
+ D +V Y SL + RG S I + +C KGLA+LHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYLHET- 120
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVA--GTEGYLAPEYA- 248
+HRDIK +NILL +D K++DFG++ A LT I+ R + GT ++APE A
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 249 --IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE----QYLLEMAWKLYERGKLVE 302
+G K DI++ G+ +E+ + P + + L ++ + KL +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQP------PMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+S H ++K L T+D PK+RP+ + L+
Sbjct: 229 ------KEKWSP-VFHDFIKKCL--TKD-PKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 83/279 (29%), Positives = 123/279 (44%), Gaps = 38/279 (13%)
Query: 78 NKIGQGGFGSVYKGT--LKDGTL--AAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
++G G FGSV KG +K G A+K L + G +EFL E +V+ + H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ--FNWQTRRNICIGVAKGLAFLHE 190
L G C +G+ +LV L + L R + + VA G+A+L
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG---TEGYLAPEY 247
+ H VHRD+ A N+LL KISDFG+++ A + AG + Y APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APEC 169
Query: 248 AIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
G+ + K+D++S+GV L E S G PY E E + E G+ + +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYG------AKPYGEMKGAE-VIAMLESGERLPRPEE 222
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
YS I L C + P+ RP+ S L +
Sbjct: 223 CPQEIYS---------IMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 43/288 (14%)
Query: 80 IGQGGFGSV----YKGTLKDGT--LAAIKVLSADSRQGVRE-FLTEINVIKDIKHENLVE 132
+G+G FG V Y DGT + A+K L + Q + EIN++K + HEN+V+
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 133 LYGCCVEGDHRIL-----------VYGYLENN--SLAQTLLGRGHSSIQFNWQTRRNICI 179
GCC E + L + YL + +LAQ LL F Q IC
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--------FAQQ----IC- 117
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
+G+A+LH + H +HRD+ A N+LLD D KI DFGLAK P + R G
Sbjct: 118 ---EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 240 EG--YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
+ A E + + +D++SFGV L E+++ C++ + P + + ++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+L+EL++ + + C + K RP+ +L+ +L
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-----FLTEINVI-KD 124
++F IG+G F +V K AIK+L D RQ ++E E V+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 125 IKHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
H +++LY + + + V Y N L Q + G + + R +
Sbjct: 59 NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILL 113
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA------ 237
L +LH I+HRD+K NILLDKD+ KI+DFG AK+ N + S +
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 238 -------------GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
GT Y++PE + +D+++ G ++ ++++G+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 74/272 (27%), Positives = 120/272 (44%), Gaps = 34/272 (12%)
Query: 80 IGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV---REFLTEINVIKDIKHENLVELYGC 136
+G G FG V+ G + AIK++ R+G +F+ E V+ + H NLV+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
C + +V Y+ N L L R + + ++C V + + +L
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GF 121
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQL 253
+HRD+ A N L+ +D K+SDFGLA+ L T GT+ + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313
+ K+D++SFGVL+ E+ S ++PYE + ++VE V A
Sbjct: 179 SSKSDVWSFGVLMWEVFSE-----GKMPYER----------FSNSEVVESVSAGYRLYRP 223
Query: 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
I C + P+ RP+ L++ L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 80 IGQGGFGSVYKGTLK-DGTLA----AIKVLSADS-RQGVREFLTEINVIKDIKHENLVEL 133
+G G FG+VYKG +G AIKVL ++ + +E L E V+ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C+ + L+ + L + R H Q N C+ +AKG+++L E+
Sbjct: 75 LGICLSSQVQ-LITQLMPLGCLLDYV--RNHKD-NIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIR 250
+VHRD+ A N+L+ KI+DFGLAKL + G + ++A E +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILH 185
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
T K+D++S+GV + E++ T PYE
Sbjct: 186 RIYTHKSDVWSYGVTVWELM-----TFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
IG+G FG+V +G G A+K + D + FL E V+ + H+NLV L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
I V + +L L RG + + + + VA+G+ +L + +VH
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQ--FSLDVAEGMEYLESK---KLVH 123
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD+ A NIL+ +D K+SDFGLA++ + + V T APE + + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAH 318
++S+GVLL E+ S R PY + L E+ + E+G +E + Y + +
Sbjct: 180 VWSYGVLLWEVFS-----YGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLMTS- 232
Query: 319 RYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348
C + PK+RPS L L E
Sbjct: 233 --------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE 128
+ E+ K+G G FG V+ GT T A+K L + FL E ++K ++H+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHD 61
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLL-GRGHSSIQFNWQTRRNICIGVAKGLAF 187
LV+LY E + +V Y+ SL L G G + ++ VA G+A+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMAY 117
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
+ + + +HRD++++NIL+ L KI+DFGLA+L N + APE
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282
A+ G+ T K+D++SFG+LL E+V T R+PY
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELV-----TKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 80 IGQGGFGSVYKGTL----KDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELY 134
IG G FG V +G L K AIK L A S R +FLTE +++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G + +++ Y+EN SL + L R + +F + G+A G+ +L E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDG-KFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTH------ISTRVAGTEGYLAPEY 247
VHRD+ A NIL++ +L K+SDFGL++ L + T+ I R + APE
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAPEA 179
Query: 248 AIRGQLTRKADIYSFGVLLLEIVS 271
+ T +D++SFG+++ E++S
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 80 IGQGGFGSVYKGTL------KDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVE 132
+G+G FG VYKG L T AIK L ++ V+ EF E ++ D++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG-HSSIQFNWQTRR-----------NICIG 180
L G C + +++ YL + L + L+ HS + +I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL-FPANLTHISTRVAGT 239
+A G+ +L H VHRD+ A N L+ + LT KISDFGL++ + A+ + ++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++ PE + G+ T ++DI+SFGV+L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFL-TEINVIKDIKHEN 129
KIG+G G V T K G A+K + +Q RE L E+ +++D +H N
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-RKQQRRELLFNEVVIMRDYQHPN 77
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN------ICIGVAK 183
+VE+Y + GD +V +LE +L + TR N +C+ V K
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLK 126
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTE 240
L+FLH + ++HRDIK+ +ILL D K+SDFG F A ++ R + GT
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTP 179
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
++APE R + DI+S G++++E+V G
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSAD-SRQGV-REFLTEINVIKDIKHENL 130
+ K+G+G +G VYK K G + A+K + D +G+ L EI+++K++KH N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
V+L LV+ Y + + L + L + ++I + +GLA+ H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH- 115
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE---- 246
I+HRD+K NIL+++D K++DFGLA+ F L + V T Y APE
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLG 172
Query: 247 -----YAIRGQLTRKADIYSFGVLLLEIVSGR 273
A+ DI+S G + E+++G+
Sbjct: 173 SKHYSTAV--------DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCC 137
IG+G +G VYK K G L AIK++ + E E N+++ H N+ YG
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGAF 72
Query: 138 VEGDHRI------LVYGYLENNS---LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
++ + LV S L + L +G ++ W I +GLA+L
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAY--ILRETLRGLAYL 129
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAP 245
HE ++HRDIK NILL K+ K+ DFG++ A L R GT ++AP
Sbjct: 130 HEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS----AQLDSTLGRRNTFIGTPYWMAP 182
Query: 246 EY-AIRGQLTR----KADIYSFGVLLLEIVSG 272
E A Q ++D++S G+ +E+ G
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 79 KIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGV--REFLTEINVIKDIKHENLVELYG 135
KIG+G +G VYK G + AIK + + L EI ++K++ H N+++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRG----HSSIQ-FNWQTRRNICIGVAKGLAFLHE 190
LV+ +++ + L + + R S I+ + +Q +GLAF H
Sbjct: 66 VFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCH- 115
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---PANLTH-ISTRVAGTEGYLAPE 246
I+HRD+K N+L++ + K++DFGLA+ F TH + TR Y APE
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE 168
Query: 247 YAIR-GQLTRKADIYSFGVLLLEIVSGR 273
+ + DI+S G + E++S R
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 43/279 (15%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHENLVELYGCC 137
KIG+G FG VYKG LK T A+K + ++ FL E ++K H N+V+L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
V+ +V + SL L + + + + + + A G+ +L + +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE---SKNCI 115
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE----GYLAPEYAIRGQL 253
HRD+ A N L+ ++ KISDFG+++ I T G + + APE G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 254 TRKADIYSFGVLLLEIVS-------GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
T ++D++S+G+LL E S G N R E Y +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP--------------- 217
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
EE +R + L C P+ RPS S + N L
Sbjct: 218 ----QLCPEEIYR---LMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTL--KDGTLA----AIKVLSAD-SRQGVREFLTEINV 121
V ++ + +G G FG VY+G +DG A+K L S Q +FL E +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTL-LGRGHSS--IQFNWQTRRNIC 178
+ H+N+V L G E R ++ + L L R +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPKISDFGLAK-LFPANLTHIST 234
VAKG +L E H +HRDI A N LL KI+DFG+A+ ++ A+
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY---EEQYLLEM 290
R ++ PE + G T K D++SFGVLL EI S G +PY Q ++E
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG------YMPYPGRTNQEVMEF 233
Query: 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ G+L D +I C Q P+ RP+ +T++ +
Sbjct: 234 ---VTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-24
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 12/204 (5%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
K+GQG FG V+ GT T AIK L + FL E ++K ++H+ LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
E + +V ++ SL L G ++ +A G+A++ + + +H
Sbjct: 72 E-EPIYIVTEFMGKGSLLD-FLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD++A+NIL+ +L KI+DFGLA+L N + APE A+ G+ T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPY 282
++SFG+LL E+V T R+PY
Sbjct: 186 VWSFGILLTELV-----TKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-24
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 11/214 (5%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE 128
+ E+ K+G G FG V+ G + T A+K L + V+ FL E N++K ++H+
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHD 61
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
LV LY + + ++ Y+ SL L + + +A+G+A++
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI 119
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
+ + +HRD++A+N+L+ + L KI+DFGLA++ N + APE
Sbjct: 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282
G T K+D++SFG+LL EIV T ++PY
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIV-----TYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKD 124
D R +NF KIG+G G V T+K G L A+K + +Q E+ +++D
Sbjct: 17 DPRTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+HEN+VE+Y + GD +V +LE +L + + + N + +C+ V K
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKA 128
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEG 241
L+ LH + ++HRDIK+ +ILL D K+SDFG F A ++ R + GT
Sbjct: 129 LSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPY 181
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
++APE R + DI+S G++++E+V G
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 8e-24
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLV 131
F+ IG+G FG VYK K + AIKV+ + + + + EI + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+ YG ++G ++ Y S LL G + + I V GL +LHEE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPG----KLDETYIAFILREVLLGLEYLHEE 117
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAPEYA 248
+ +HRDIKA+NILL ++ K++DFG++ LT ++ GT ++APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 249 IRGQLTRKADIYSFGVLLLEIVSG 272
+ KADI+S G+ +E+ G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 75/287 (26%), Positives = 112/287 (39%), Gaps = 53/287 (18%)
Query: 79 KIGQGGFGSVYKGTLKD--GTL--AAIKVLSADSRQG-VREFLTEINVIKDIKHENLVEL 133
K+G G FG V +G G + A+K L +D + +FL E ++ + HENL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 134 YGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
YG V H + +V SL L R + F T + + +A G+ +L
Sbjct: 62 YG--VVLTHPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR------VAGTEGYLAPE 246
+HRD+ A NILL D KI DFGL + P N H A + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPE 170
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ +D++ FGV L E+ + G E W ++++ +D
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYG----------------EEPWAGLSGSQILKKID 214
Query: 306 ASLNGDYSVEEAHR-------YLKIALLCTQDMPKRRPSMSTLVNML 345
E R + L C P RP+ + L L
Sbjct: 215 KEG------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGV-REFLTEINVIKDIKHEN 129
E +++G+G GSV K LK+ G + A+K ++ D + ++ L E+ + K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 130 LVELYGCCV-EGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V+ YG + E I + Y E SL + + I V KGL++
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
LH I+HRDIK SNILL + K+ DFG++ +L T GT Y+APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPE- 173
Query: 248 AIRGQ-LTRKADIYSFGVLLLEIVSGR 273
I+G+ + +D++S G+ LLE+ R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIKVLSADS-RQG-VREFLTEINVIKDIKHENLVELY 134
+IG+G +G VYK K G L A+K + ++ ++G + EI +++ ++H N+V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 135 GCCVEGDHR--ILVYGYLEN--NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
+V+ Y+++ L ++F + + +GL +LH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEGLQYLH- 117
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPE--- 246
I+HRDIK SNIL++ D K++DFGLA+ + N + RV T Y PE
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 247 ----YAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y + D++S G +L E+ G+
Sbjct: 175 GATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-23
Identities = 57/219 (26%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADSRQGVREFLTEINVI 122
+ N ++G+G FG V+ +D L A+K L S ++F E ++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 123 KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQ---------TLLGRGHSSIQFNWQT 173
+++HE++V+ YG CVEGD I+V+ Y+++ L + L+ G+ +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 174 RRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHI 232
+I +A G+ +L + H VHRD+ N L+ ++L KI DFG+++ ++ + +
Sbjct: 122 MLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++ PE + + T ++D++S GV+L EI +
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 83/330 (25%), Positives = 143/330 (43%), Gaps = 26/330 (7%)
Query: 22 FLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVAT--ENFSPANK 79
FL A +R + RVE + E+Q + K + + + N
Sbjct: 639 FLVLALVAFGFVFIRGRNNLE-LKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV 697
Query: 80 IGQGGFGSVYKGTLKDGTLAAI--KVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
I +G G+ YKG + + ++ +S +EI + ++H N+V+L G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLC 752
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
L++ Y+E +L++ L +W+ RR I IG+AK L FLH P +V
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA 257
++ I++D P + +L L T+ + Y+APE +T K+
Sbjct: 806 VGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859
Query: 258 DIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEA 317
DIY FG++L+E+++G+ + ++E A Y L +D S+ GD SV +
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 318 H--RYLKIALLCTQDMPKRRPSMSTLVNML 345
+ +AL CT P RP + ++ L
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 76/275 (27%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHEN 129
+F NKIG+G FG V+K K D + A+K LS +R+ E + E V+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFN--WQTRRNICIGVAKGLAF 187
++ Y ++ +V Y EN L + L + + + W+ I + GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAH 116
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
LH + I+HRDIK+ N+ LD KI D G+AKL N T+ + + GT YL+PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPEL 172
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
K+D+++ GV+L E +G + P++ + K+ RG
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTG------KHPFDANNQGALILKII-RGVF-----PP 220
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
++ YS + A ++ C ++RP L+
Sbjct: 221 VSQMYSQQLA----QLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-23
Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 22/267 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
K+G G FG V+ T T A+K + S V FL E NV+K ++H+ LV+L+ V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ ++ ++ SL L S + +A+G+AF+ Q + +H
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD++A+NIL+ L KI+DFGLA++ N + APE G T K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAH 318
++SFG+LL+EIV T R+PY E+ L ERG + + Y++
Sbjct: 186 VWSFGILLMEIV-----TYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNI---- 235
Query: 319 RYLKIALLCTQDMPKRRPSMSTLVNML 345
+ C ++ P+ RP+ + ++L
Sbjct: 236 -----MMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 32/215 (14%)
Query: 80 IGQGGFGSVYKGTLKD----GT---LAAIKVL---SADSRQGVREFLTEINVIKDIKHEN 129
+G G FG VY+GT D G+ A+K L + D + +EFL E +++ + H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN---ICIGVAKGLA 186
+V+L G C+ + + ++ +E L L T + IC+ VAKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 187 FLHEEVQPHIVHRDIKASNILL-----DKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+L Q H +HRD+ A N L+ D D KI DFGLA+ + + R G EG
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEG-EG 173
Query: 242 -----YLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++APE + G+ T ++D++SFGVL+ EI++
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 80 IGQGGFGSVY---KGTLKDGTLAAIKVLSADSRQG---VREFLTEINVIKDIKHENLVEL 133
I +G +G V+ K + D + AIKV+ V + LTE +++ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 134 YGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
Y +G + LV YL LA +LL + + R + L +LH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLA-SLL---ENVGSLDEDVARIYIAEIVLALEYLH--- 110
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAK-------LFPANLTHISTRVAGTEGYLAP 245
I+HRD+K NIL+D + K++DFGL+K + + R+ GT Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSG 272
E + ++ D +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 60/202 (29%), Positives = 107/202 (52%), Gaps = 21/202 (10%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKH---ENLVELY 134
IG+G +G+VY+G + G + A+K+++ D+ V + E+ ++ ++ N+ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI---GVAKGLAFLHEE 191
G ++G ++ Y E S+ +TL+ G + + I + V L ++H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIA-------EKYISVIIREVLVALKYIHKV 120
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
++HRDIKA+NIL+ K+ DFG+A L N + ST V GT ++APE G
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176
Query: 252 QL-TRKADIYSFGVLLLEIVSG 272
+ KADI+S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 69/205 (33%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYG 135
IG G VY L + AIK + + Q V E E+ + H N+V+ Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI---GVAKGLAFLHEEV 192
V GD LV YL SL + SS I V KGL +LH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGL-AKLF-PANLTHIS-TRVAGTEGYLAPEYAI 249
Q +HRDIKA NILL +D + KI+DFG+ A L + T GT ++APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 250 RGQ-LTRKADIYSFGVLLLEIVSGR 273
+ KADI+SFG+ +E+ +G
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 25/272 (9%)
Query: 73 NFSPANKIGQGGFGSVYK-GTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHEN 129
+F K+G+G +GSVYK L D A+K L + S++ + + EI ++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
++ ++G+ +V Y L++ + R Q I I + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
E+ I+HRD+K++NILL + KI D G++K+ N+ GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174
Query: 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309
+ K+DI+S G LL E+ + P+E + + ++ +K+ +RGK +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF------APPFEARSMQDLRYKV-QRGKY-----PPIP 222
Query: 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
YS + Q PK RP+ +
Sbjct: 223 PIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 78 NKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGC 136
+K+G G +G VY+G K A+K L D+ + V EFL E V+K+IKH NLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
C ++ ++ +L L + N + ++ + +L ++ +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQISSAMEYLEKK---NF 125
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQL 253
+HRD+ A N L+ ++ K++DFGL++L + T AG + + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 254 TRKADIYSFGVLLLEIVS 271
+ K+D+++FGVLL EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-22
Identities = 58/212 (27%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 79 KIGQGGFGSVYKGT------LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
++G+G FG V+ KD L A+K L + ++F E ++ +++HE++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSS-IQFNWQTRR-----------NICIG 180
YG C +GD I+V+ Y+++ L + L G + I + Q R+ +I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGT 239
+A G+ +L + H VHRD+ N L+ +L KI DFG+++ ++ + +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++ PE + + T ++D++SFGV+L EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 80 IGQGGFGSVYK---GTLKDGT--LAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELY 134
+G+G FGSV L+D T + A+K L + + +R+F EI ++K ++H+N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 135 GCCVEGDHR--ILVYGYLENNSLAQTLLGRGH-----SSIQFNWQTRRNICIGVAKGLAF 187
G C R LV YL SL L + + Q IC KG+ +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ----IC----KGMEY 123
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG--YLAP 245
L + VHRD+ NIL++ + KI DFGL K+ P + + R G + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
E + + +D++SFGV+L E+ + + + P E
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 34/276 (12%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYG 135
++G G G V K + G + A+K + + + ++ + L E++++ +V YG
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 136 CC-VEGDHRILVYGYLENNSLAQTL-LGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
GD I + Y++ SL + L +G + + I + V KGL +LHE +
Sbjct: 67 AFYNNGDISICME-YMDGGSLDKILKEVQG----RIPERILGKIAVAVLKGLTYLHE--K 119
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQ 252
I+HRD+K SNIL++ K+ DFG++ L + ++ GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312
+ K+DI+S G+ L+E+ +G R PY + + EL+ +N
Sbjct: 176 YSVKSDIWSLGLSLIELATG------RFPYPPENDPPDG--------IFELLQYIVNEPP 221
Query: 313 SVEEAHRYLKIAL----LCTQDMPKRRPSMSTLVNM 344
+ ++ LC P+ RPS L+
Sbjct: 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 76/294 (25%), Positives = 115/294 (39%), Gaps = 45/294 (15%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVL-SADSRQGVREFLTEINVIKD 124
N +G+G FG V+ K TL +K L EF E+++ +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLL-----GRGHSSIQFNWQTRRNICI 179
+ H+N+V L G C E + ++ Y + L Q L + + + +C
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK------LFPANLTHIS 233
+A G+ L VHRD+ A N L+ K+S L+K + I
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293
R +LAPE + K+D++SFGVL+ E+ T LP+ E+ +
Sbjct: 182 LR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVF-----TQGELPFYGLSDEEVLNR 230
Query: 294 LYERGKLVELVDASLNGDYSVEEA--HRYLKIALLCTQDMPKRRPSMSTLVNML 345
L GKL + V E R K+ C PK RPS S LV+ L
Sbjct: 231 LQA-GKL----------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 62/204 (30%), Positives = 113/204 (55%), Gaps = 9/204 (4%)
Query: 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGV-REFLTEINVIKDIKHENL 130
NF K+G+G + +VYKG + G + A+K + D+ +G + EI+++K++KHEN+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
V L+ + +LV+ Y++ + L + + G + T ++ + KG+AF HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCHE 118
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
++HRD+K N+L++K K++DFGLA+ F + S V T Y AP+ +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 251 GQL-TRKADIYSFGVLLLEIVSGR 273
+ + DI+S G ++ E+++GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 80 IGQGGFGSVYKGTLK----DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELY 134
IG G FG V++G LK AIK L + R +FL+E +++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVAKGLAFLHE 190
G + +++ Y+EN +L + L R H SS Q R G+A G+ +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLR-----GIAAGMKYLSD 125
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG--YLAPEYA 248
+ VHRD+ A NIL++ +L K+SDFGL+++ + T G + APE
Sbjct: 126 M---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 249 IRGQLTRKADIYSFGVLLLEIVS 271
+ T +D++SFG+++ E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
++G G FG V G + AIK++ S EF+ E V+ + HE LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ +V Y+ N L L G +F +C V +G+A+L + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQLTR 255
RD+ A N L+D K+SDFGL++ L T G++ + PE + + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 256 KADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
K+D+++FGVL+ E+ S G ++PYE + + VE V L
Sbjct: 181 KSDVWAFGVLMWEVYSLG------KMPYE----------RFNNSETVEKVSQGLRLYRPH 224
Query: 315 EEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+ + I C + + RP+ L+
Sbjct: 225 LASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
+G G FG VYK K+ G AA K++ +S + + +F+ EI+++ + KH N+V LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 139 -EGDHRILVY----GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
E IL+ G L++ L L RG + Q R +C + + L FLH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLE---LERGLTEPQI-----RYVCRQMLEALNFLHSH-- 122
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI---- 249
++HRD+KA NILL D K++DFG++ + L T + GT ++APE
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETF 180
Query: 250 -RGQLTRKADIYSFGVLLLEIVSGR 273
KADI+S G+ L+E+
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 79 KIGQGGFGSVYKGTL------KDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
++G+G FG V+ +D L A+K L S ++F E ++ ++H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLL-----------GRGHSSIQFNWQTRRNICIGV 181
YG C EG ++V+ Y+ + L + L G + Q I +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTE 240
A G+ +L H VHRD+ N L+ + L KI DFG+++ ++ + + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++ PE + + T ++DI+SFGV+L EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
KIGQG G+VY + G AIK ++ + + EI V+++ KH N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 138 VEGDHRILVYGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+ GD +V YL SL +T + G + +C + L FLH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALEFLHSN-- 134
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL 253
++HRDIK+ NILL D + K++DFG + ST V GT ++APE R
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 254 TRKADIYSFGVLLLEIVSG 272
K DI+S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKD 124
D R EN+ KIG+G G V K G A+K++ +Q E+ +++D
Sbjct: 18 DPRSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+H+N+VE+Y + G+ ++ +L+ +L + S + N + +C V +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQA 129
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
L +LH + ++HRDIK+ +ILL D K+SDFG ++ + V GT ++A
Sbjct: 130 LCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMA 185
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSG 272
PE R + DI+S G++++E+V G
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLT-EINVIKDIKHENLVELY 134
IG+G FG+V K K DG + K + + + ++ L E+N+++++KH N+V Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 135 GCCVEGDHRI---------LVYGYLENNSLAQTL--LGRGHSSI--QFNWQTRRNICIGV 181
RI +V Y E LAQ + + I +F W+ + +
Sbjct: 66 -------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA- 117
Query: 182 AKGLAFLHEEVQPH--IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
L H P ++HRD+K +NI LD + K+ DFGLAK+ + + T V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299
Y++PE K+DI+S G L+ E+ + P+ + L++A K+ + GK
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL------SPPFTARNQLQLASKI-KEGK 226
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+ YS E + +K P +RPS L+ + +
Sbjct: 227 F-----RRIPYRYS-SELNEVIK---SMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
KIG+G G V T K G A+K + +Q E+ +++D HEN+V++Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ GD +V +LE +L + + + N + +C+ V + L++LH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA 257
HRDIK+ +ILL D K+SDFG + + V GT ++APE R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 258 DIYSFGVLLLEIVSG 272
DI+S G++++E++ G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 78/302 (25%), Positives = 126/302 (41%), Gaps = 69/302 (22%)
Query: 80 IGQGGFGSVYKGTLKD------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLV 131
+G+G FG V K + A+K+L D + + + + ++E+ ++K I KH+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI------------CI 179
L G C + +V Y + +L L R + R
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
VA+G+ FL +HRD+ A N+L+ +D KI+DFGLA+ ++ HI T
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTT 192
Query: 240 EGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
G L APE T ++D++SFGVLL EI + + +P EE + L
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL------ 246
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDM-----------PKRRPSMSTLVN 343
++E +R K CTQ++ P +RP+ LV
Sbjct: 247 -------------------LKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
Query: 344 ML 345
L
Sbjct: 287 DL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-21
Identities = 78/267 (29%), Positives = 123/267 (46%), Gaps = 28/267 (10%)
Query: 80 IGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE 139
IG+G FG V G + G A+K + D+ + FL E +V+ ++H NLV+L G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 140 GDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ +V Y+ SL L RG S + + V + + +L + VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD+ A N+L+ +D K+SDFGL K A+ T + ++ + APE + + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK--WTAPEALREKKFSTKSD 181
Query: 259 IYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAH 318
++SFG+LL EI S R+PY L ++ ++ E+G ++ D Y V +
Sbjct: 182 VWSFGILLWEIYS-----FGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPVVYDVMKQ- 234
Query: 319 RYLKIALLCTQDMPKRRPSMSTLVNML 345
C RPS L L
Sbjct: 235 --------CWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 33/207 (15%)
Query: 78 NKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE-----FLTEINVIKDIKHENLV 131
K+G+G + VYK + G + AIK + R+ ++ L EI +++++KH N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 132 ELYGCCVEGDHRILVYGYLE--------NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
L + LV+ ++E + S+ +L + T R
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIK-SYMLMTLR-------- 113
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL +LH I+HRD+K +N+L+ D K++DFGLA+ F + ++ +V T Y
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 244 APE--YAIRGQLTRKADIYSFGVLLLE 268
APE + R D++S G + E
Sbjct: 170 APELLFGAR-HYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 79 KIGQGGFGSVY----KGTLK-----------DGTLAAIKVLSADSRQGVR-EFLTEINVI 122
K+G+G FG V+ +G + L A+K+L AD + R +FL EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 123 KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI----- 177
+K+ N++ L G CV D ++ Y+EN L Q L R I+ + NI
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR---EIESTFTHANNIPSVSI 128
Query: 178 ------CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLT 230
+ +A G+ +L + VHRD+ N L+ T KI+DFG+++ L+ +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
I R ++A E + G+ T +D+++FGV L E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVL-----SADSRQGVRE--FLTEINVIKDIKHENL 130
++G G FGSVY K+ G L AIK + S + +RE L ++N +H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNI 60
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
V+L E D V+ Y+E N L Q + R F+ R+I + +GLA +H+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGN-LYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHK 117
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---PANLTHISTRVAGTEGYLAPEY 247
HRD+K N+L+ KI+DFGLA+ P ++STR Y APE
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 248 AIRGQL-TRKADIYSFGVLLLEIVSGR 273
+R + DI++ G ++ E+ + R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 70/302 (23%)
Query: 80 IGQGGFGSVYKGT------LKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHENLVE 132
+G+G FG V K T T A+K+L ++ +R+ L+E N++K + H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTL----------LGRGHSS---------------- 166
LYG C + +L+ Y + SL L LG +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 167 --IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224
I F WQ +++G+ +L E +VHRD+ A N+L+ + KISDFGL++
Sbjct: 128 DLISFAWQ--------ISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSR- 175
Query: 225 FPANLTHISTRVAGTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRR 279
++ + V ++G ++A E T ++D++SFGVLL EIV+ N
Sbjct: 176 ---DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232
Query: 280 LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMS 339
+ E + L + G +E + EE + + L C + P +RP+ +
Sbjct: 233 IAPER------LFNLLKTGYRME------RPENCSEEMYN---LMLTCWKQEPDKRPTFA 277
Query: 340 TL 341
+
Sbjct: 278 DI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIK-VLSADSRQGVREF-LTEINVIKDIKHENLVELYG 135
+G+G +G V K K G + AIK ++ + V++ L E+ V++ ++HEN+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ----FNWQTRRNICIGVAKGLAFLHEE 191
LV+ Y+E L G + WQ + +A+ H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH-- 117
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+I+HRDIK NIL+ + K+ DFG A+ A T T Y APE +
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 252 QLTRKA-DIYSFGVLLLEIVSGR 273
K D+++ G ++ E++ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 73/238 (30%), Positives = 107/238 (44%), Gaps = 53/238 (22%)
Query: 70 ATENFSPANKIGQGGFGSVYKG-TLKDGTLAAIK-VLSADSRQGVREF----LTEINVIK 123
++ K+G+G FG VYK +K G + A+K +L + + G F L EI ++K
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 124 DIKHENLVELYGCCVE-----GDHRILVY-----------GYLENNSLAQTLLGRGHSSI 167
+KH N+V L VE R VY G LEN S+ T S I
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT-----ESQI 117
Query: 168 QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-- 225
+ + + +G+ +LHE HI+HRDIKA+NIL+D KI+DFGLA+ +
Sbjct: 118 -------KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 226 --------PANLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGR 273
T T + T Y PE + G + T DI+ G + E+ + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 79 KIGQGGFGSVY----KGTLK-------------DGTLAAIKVLSADSRQGVR-EFLTEIN 120
K+G+G FG V+ +G K L A+K+L D+ + R +FL EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLL-------GRGHSSIQFNWQT 173
++ +K N++ L C+ D ++ Y+EN L Q L + ++ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 174 RRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHI 232
+ +A G+ +L + VHRD+ N L+ K+ T KI+DFG+++ L+ + I
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY----EEQYLL 288
R +++ E + G+ T +D+++FGV L EI+ + PY +EQ +
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL----TLCKEQPYSQLSDEQVIE 244
Query: 289 EMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337
++G+ V L +L D K+ L C + K RPS
Sbjct: 245 NTGEFFRDQGRQVYLPKPALCPD-------SLYKLMLSCWRRNAKERPS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 80 IGQGGFGSVYKGTLK--DGTL--AAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVEL 133
+G+G FGSV +G L DG+ A+K + D + + EFL+E +KD H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 134 YGCCVEGDHR------ILVYGYLENNSLAQTLLGR--GHSSIQFNWQTRRNICIGVAKGL 185
G C E +++ ++++ L LL G + QT + +A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE-GYLA 244
+L + +HRD+ A N +L +D+T ++DFGL+K + + R+A ++A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVS 271
E T K+D+++FGV + EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 22/246 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENL 130
E + + + L A+KVL D+ R +FL E+ ++ + N+
Sbjct: 25 EADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTL-------LGRGHSSIQFNWQTRRNICIGVAK 183
L G C ++ Y+EN L Q L G +S ++ T + +A
Sbjct: 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGY 242
G+ +L + VHRD+ N L+ K+ T KI+DFG+++ L+ ++ + R +
Sbjct: 142 GMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRW 198
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE---QYLLEMAWKLYERGK 299
+A E + G+ T K+D+++FGV L EI++ C R PYE Q ++E A +
Sbjct: 199 MAWESVLLGKFTTKSDVWAFGVTLWEILT-LC---REQPYEHLTDQQVIENAGHFFRDDG 254
Query: 300 LVELVD 305
+
Sbjct: 255 RQIYLP 260
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 46/282 (16%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGV---REFLTEINVIKDIKHEN 129
F+ +IG G FG+VY ++ + AIK +S +Q ++ + E+ ++ ++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN-----ICIGVAKG 184
+E GC + LV Y LG ++ + + + IC G +G
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC---------LGSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYL 243
LA+LH + +HRDIKA NILL + T K++DFG A L PAN GT ++
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWM 178
Query: 244 APEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
APE + GQ K D++S G+ +E+ R+ P + + LY +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPL---FNMNAMSALYH---I 226
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+ +L+ + + ++ C Q +P+ RPS L+
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 5e-20
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLS------ADSRQGVREFLTEINVIKDIKHENLVE 132
+G G F S Y+ +K GTL A+K ++ ++ + V EI ++ + H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ G E H L ++ S++ L G F N + +GL++LHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN- 122
Query: 193 QPHIVHRDIKASNILLD---KDLTPKISDFGLAKLFPANLT---HISTRVAGTEGYLAPE 246
I+HRD+K +N+L+D + L +I+DFG A A T ++ GT ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 247 YAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
+RG+ R D++S G +++E+ + +
Sbjct: 179 -VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-20
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+ ++ KIGQG G+V+ + G AIK ++ + + EI V+K++K+ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
V + GD +V YL SL + Q +C + L FLH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCRECLQALEFLHA 133
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
++HRDIK+ N+LL D + K++DFG + ST V GT ++APE R
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288
K DI+S G++ +E+V G P YL+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSAD------SRQGVREFLTEINVIKDIKHENLV 131
+G+G +G+VY G G L A+K + D + + + E++++K +KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH-SSIQFNWQTRRNICIGVAKGLAFLHE 190
+ G C++ + + ++ S++ L G F T++ + G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK---LFPANLTH--ISTRVAGTEGYLAP 245
+VHRDIK +N++L + K+ DFG A+ + TH + + GT ++AP
Sbjct: 121 N---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGR 273
E RK+DI+S G + E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 73 NFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSAD-SRQGVR-EFLTEINVIKDIKHEN 129
F N+IG+G +G VY+ G + A+K + D R G+ L EI ++ +++H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 130 LVELYGCCVEGDHR---ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
+VEL V G H LV Y E + LA L + F+ + + + + +GL
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+LHE I+HRD+K SN+LL KI+DFGLA+ + ++ +V T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 247 --YAIRGQLTRKADIYSFGVLLLEIVSGR 273
T D+++ G +L E+++ +
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 80 IGQGGFGSVYKG-TLKDGTLAAIKVLS--------ADSRQG--VREFLTEINVIKDIKHE 128
IG+G +G VY + G + A+K + DSRQ V+ +EI +KD+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N+V+ G ++ + Y+ S+ L G +F Q R V +GLA+L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYL 124
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP---ANLTHISTRVAGTEGYLAP 245
H + I+HRD+KA N+L+D D KISDFG++K N ++S + G+ ++AP
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMAP 179
Query: 246 E--YAIRGQLTRKADIYSFGVLLLEIVSGR 273
E ++ + K DI+S G ++LE+ +GR
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKDIKHENLVEL 133
+GQG FG VY D G A+K S ++++ V EI ++K+++HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
YGC + + + Y+ S+ L G + + R I +G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN-- 123
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--TRVAGTEGYLAPEYAIRG 251
IVHRDIK +NIL D K+ DFG +K + + V GT +++PE I G
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISG 181
Query: 252 Q-LTRKADIYSFGVLLLEIVS 271
+ RKAD++S G ++E+++
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 23/230 (10%)
Query: 80 IGQGGFGSVYKGTLKDG--TLAAIKVLS----------ADSRQGVREFLTEINVIKD-IK 126
+G G FG VYK K+ L A+K ++ + + + + ++E+ +IK+ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H N+V Y +E D +V +E L + +F + NI + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+LH+E + IVHRD+ +NI+L +D I+DFGLAK T V GT Y PE
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296
KAD+++FG +L ++ + + P+ +L +A K+ E
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 80 IGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGCCV 138
+G+G FG V+KGTLKD T A+K D Q ++ +FL+E ++K H N+V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ R +Y +E L + + + A G+A+L + + +H
Sbjct: 63 Q---RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIH 116
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKAD 258
RD+ A N L+ ++ KISDFG+++ + S + APE G+ + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 259 IYSFGVLLLEIVS-GRC 274
++S+G+LL E S G C
Sbjct: 177 VWSYGILLWETFSLGVC 193
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 80 IGQGGFGSVYKGTL------KDGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
IGQG FG V++ + T+ A+K+L + S +F E ++ + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRR------------N 176
L G C G L++ Y+ L + L R S R+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 177 ICIG--VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHIS 233
+CI VA G+A+L E VHRD+ N L+ +++ KI+DFGL+ ++ A+ S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
A ++ PE + T ++D++++GV+L EI S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 9/198 (4%)
Query: 80 IGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
+G+G +G VY L AIK + + V+ EI + +KH N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
E + + SL+ LL ++ N QT + +GL +LH+ IVH
Sbjct: 76 ENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 199 RDIKASNILLDK-DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ--LTR 255
RDIK N+L++ KISDFG +K A + + GT Y+APE +G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 256 KADIYSFGVLLLEIVSGR 273
ADI+S G ++E+ +G+
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 68 RVATENFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK 126
R E+F +IG G +G VYK + G LAAIKV+ + + EI ++KD K
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH-SSIQFNWQTRRNICIGVAKGL 185
H N+V +G + D + + SL G S Q + +R + +GL
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
+LH + + +HRDIK +NILL + K++DFG++ A + + + GT ++AP
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAP 175
Query: 246 EYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
E A +G + DI++ G+ +E+ + P +L M ++ KL +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MTKSNFQPPKLKD 233
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+ S + H ++K+AL T++ PK+RP+ L+
Sbjct: 234 KMKWSNS-------FHHFVKMAL--TKN-PKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYG 135
N+IG G G+VYK + G L A+KV+ + VR + EI +++D+ H N+V+ +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
++ +++ SL T + Q + G+A+LH H
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ--------ILSGIAYLHRR---H 188
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
IVHRDIK SN+L++ KI+DFG++++ + ++ V GT Y++PE I L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 256 KA------DIYSFGVLLLEIVSGR 273
A DI+S GV +LE GR
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 85/288 (29%), Positives = 126/288 (43%), Gaps = 62/288 (21%)
Query: 80 IGQGGFGSVYKGTLKDG----TLAAIKVLSA-DSRQGVREFLTEINVIKDIKHENLVELY 134
IG+G FG VY GTL D A+K L+ + V +FL E ++KD H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 135 GCCVEGDHRILV-YGYLENNSLAQTLLGRGHSS-----IQFNWQTRRNICIGVAKGLAFL 188
G C+ + LV Y+++ L + H+ I F Q VAKG+ +L
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ--------VAKGMEYL 114
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-------LFPANLTHISTRVAGTEG 241
+ VHRD+ A N +LD+ T K++DFGLA+ N T V
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK---- 167
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE-------QYLLEMAWKL 294
++A E + T K+D++SFGVLL E++ T PY + YLL
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM-----TRGAPPYPDVDSFDITVYLL------ 216
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+G+ + + + Y V L C P+ RP+ S LV
Sbjct: 217 --QGRRLLQPEYCPDPLYEV---------MLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV---REFLTEINVIKDIKHENLVELYG 135
++G G FG V+ G + AIK + +G +F+ E V+ + H LV+LYG
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGR-GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
C + +V ++EN L L R G + ++C V +G+ +L +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLE---RN 119
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE-GYLAPEYAIRGQL 253
+HRD+ A N L+ K+SDFG+ + + + + S+ A + PE +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313
+ K+D++SFGVL+ E+ T ++P+E++ E+ + +L AS
Sbjct: 179 SSKSDVWSFGVLMWEVF-----TEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS------ 227
Query: 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
++ C + P+ RP+ + L+ +
Sbjct: 228 ----MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 3e-19
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+ ++ KIGQG G+VY + G AIK ++ + + EI V+++ K+ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 131 VELYGCCVEGDHRILVYGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
V + GD +V YL SL +T + G + +C + L
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALD 129
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
FLH ++HRDIK+ NILL D + K++DFG + ST V GT ++APE
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 185
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288
R K DI+S G++ +E+V G P YL+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 52/285 (18%)
Query: 80 IGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
IG G FG V G LK AIK L A + + R+FL+E +++ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G + ++V Y+EN SL L R H QF + G+A G+ +L +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL--RKHDG-QFTVIQLVGMLRGIASGMKYLSDM--- 125
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG--YLAPEYAIRGQ 252
VHRD+ A NIL++ +L K+SDFGL+++ + T G + APE +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312
T +D++S+G+++ E++S Y E+ EM+ N D
Sbjct: 186 FTSASDVWSYGIVMWEVMS----------YGERPYWEMS-----------------NQDV 218
Query: 313 --SVEEAHR----------YLKIALLCTQDMPKRRPSMSTLVNML 345
++EE +R ++ L C Q RP +V++L
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 80 IGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
IG G FG V +G LK AIK L + + + R+FL+E +++ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 135 GCCVEGDHRILVYGYLENNSLAQTL-LGRGH-SSIQFNWQTRRNICIGVAKGLAFLHEEV 192
G + +++ ++EN +L L G + IQ R G+A G+ +L E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSEM- 125
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG-----YLAPEY 247
+ VHRD+ A NIL++ +L K+SDFGL++ + + T + G + APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPEA 182
Query: 248 AIRGQLTRKADIYSFGVLLLEIVS 271
+ T +D++S+G+++ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG--VREFLTEINVIKDIKHENLVELYG 135
+IG+G G V+K + G A+K ++ +G + L EI ++ +H +V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
G +LV Y+ + L++ L ++ + KG+A++H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE--YAIRGQL 253
I+HRD+K +N+L+ D KI+DFGLA+LF + + T Y APE Y R +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KY 178
Query: 254 TRKADIYSFGVLLLEIVSGR 273
D+++ G + E+++G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 37/227 (16%)
Query: 79 KIGQGGFGSV---------------YKGTLKDG--TLAAIKVLSADSRQGVR-EFLTEIN 120
K+G+G FG V + ++ G L A+K+L D+ + R +FL E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTL---------------LGRGHS 165
++ +K N++ L G CV+ D ++ Y+EN L Q L + H
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-L 224
++ + ++ + +A G+ +L + VHRD+ N L+ ++LT KI+DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
+ + I R ++A E + G+ T +D+++FGV L EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 73 NFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS---ADSRQGVREFLTEINVIKDIKHE 128
+F IG+G FG V +D + A+K ++ + VR L E +++++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
LV L+ + ++ LV L L L + F+ + + + L +L
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H + I+HRDIK NILLD+ I+DF +A + ++T +GT GY+APE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVL 171
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
R + D +S GV E C +R PY
Sbjct: 172 CRQGYSVAVDWWSLGVTAYE-----CLRGKR-PYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGT---LKDGTLA-AIKVLSADSRQGVRE-FLTEINVI 122
+ E+ + IG+G FG VY+G ++ +A A+K + VRE FL E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 123 KDIKHENLVELYGCCVEGDHRILV----YG----YLENNSLAQTLLGRGHSSIQFNWQTR 174
+ H ++V+L G E I++ G YL+ N + L S I +++Q
Sbjct: 62 RQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLA----SLILYSYQ-- 115
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234
+ LA+L + VHRDI A N+L+ K+ DFGL++ + ++
Sbjct: 116 --LS----TALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
+ ++APE + T +D++ FGV + EI+
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 81/298 (27%), Positives = 137/298 (45%), Gaps = 50/298 (16%)
Query: 69 VATENFSPANKIGQGGFGSVY----KGTLKDG--TLAAIKVL--SADSRQGVREFLTEIN 120
VA E + + ++GQG FG VY KG +KD T AIK + +A R+ + EFL E +
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEAS 61
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG----RGHSSIQFNWQTRRN 176
V+K+ ++V L G +G +++ + L L ++ +Q ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 177 ICIG--VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234
I + +A G+A+L+ VHRD+ A N ++ +D T KI DFG+ + ++
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 235 RVAGTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE----EQ 285
G +G +++PE G T +D++SFGV+L EI T PY+ EQ
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-----TLAEQPYQGMSNEQ 229
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
L + G L++ D + ++ +C Q PK RPS +++
Sbjct: 230 VL-----RFVMEGGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSR-QGVREF-LTEINVIKDIKHENLVELYG 135
KIG+G +G+V+K ++ + A+K + D +GV L EI ++K++KH+N+V LY
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 136 CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQ--FNWQTRRNICIGVAKGLAFLHEEV 192
+ D ++ LV+ Y + + L + S + + ++ + KGLAF H
Sbjct: 67 V-LHSDKKLTLVFEYCDQD------LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+++HRD+K N+L++K+ K++DFGLA+ F + S V T Y P+ +
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 175
Query: 253 L-TRKADIYSFGVLLLEIVSG 272
L + D++S G + E+ +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 2e-18
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+ ++ KIGQG G+VY + G AI+ ++ + + EI V+++ K+ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 131 VELYGCCVEGDHRILVYGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
V + GD +V YL SL +T + G + +C + L
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALE 130
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL-AKLFPANLTHISTRVAGTEGYLAP 245
FLH ++HRDIK+ NILL D + K++DFG A++ P + + GT ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAP 185
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--AWKLYERGKLVEL 303
E R K DI+S G++ +E++ G P YL+ +L KL +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 304 VDASLNG--DYSVEE--------AHRYLKIA 324
LN D VE+ H++LKIA
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 80 IGQGGFGSV----YKGTLKDGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLV 131
+G+G FG V KGT L A+KVL D V +TE V+ KH L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+L+ C D V Y+ L + S +F+ R + GL FLHE
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAI 249
I++RD+K N+LLD + KI+DFG+ K + T + GT Y+APE +
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE-IL 168
Query: 250 RGQL-TRKADIYSFGVLLLEIVSGR 273
Q D ++ GVLL E+++G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 49/293 (16%)
Query: 80 IGQGGFGSVYK----GTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHEN 129
+G+G FG V G K+ T A+K+L +D + + + + ++E+ ++K I KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN------------I 177
++ L G C + ++ Y +L + L R +++ + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
VA+G+ +L + +HRD+ A N+L+ +D KI+DFGLA+ ++ HI
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 238 GTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292
T G ++APE T ++D++SFGVLL EI + + +P EE +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF------ 252
Query: 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
KL + G ++ N Y + C +P +RP+ LV L
Sbjct: 253 KLLKEGHRMDKPSNCTNELYMMMRD---------CWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 84/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVL--SADSRQGVREFLTEIN 120
V+ E + ++GQG FG VY+G +D T A+K + SA R+ + EFL E +
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEAS 61
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL----------AQTLLGRGHSSIQFN 170
V+K ++V L G +G ++V + + L A+ GR ++Q
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
Q I A G+A+L+ + VHRD+ A N ++ D T KI DFG+ + ++
Sbjct: 122 IQMAAEI----ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIY 170
Query: 231 HISTRVAGTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
G +G ++APE G T +D++SFGV+L EI S
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 216
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
L E ++ ++++ V D R + +C Q PK RP+ +VN+L
Sbjct: 217 -LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
Query: 346 IGEIDVNKEEIS 357
++ + E+S
Sbjct: 276 KDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-18
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
++G G FG VYK K+ G LAA KV+ S + + +++ EI ++ H +V+L G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 138 VEGDHRILVYGYLENNSLAQTLL--GRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
++ + ++ +L RG + Q + IC + + L +LH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-----QVICRQMLEALQYLHSM---K 130
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA--GTEGYLAPEYAIRGQL 253
I+HRD+KA N+LL D K++DFG++ N+ + R + GT ++APE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 254 TR-----KADIYSFGVLLLEI 269
KADI+S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 60/281 (21%), Positives = 128/281 (45%), Gaps = 33/281 (11%)
Query: 73 NFSPANKIGQGGFGS--VYKGTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHE 128
++ P +G+G FG +Y+ T +D +L K L+ S + R+ L EI ++ ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N++ Y ++ + ++ Y +L ++ + F + + ++++
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H+ I+HRDIK NI L K K+ DFG++K+ + + T V GT Y++PE
Sbjct: 118 HKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELC 173
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
+ K+DI++ G +L E+++ + + ++ + LV +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLK-------------------RTFDATNPLNLVVKIV 214
Query: 309 NGDYSVEEAHRYLKIALL---CTQDMPKRRPSMSTLVNMLI 346
G+Y+ + ++ L Q P++RP+ +++ +
Sbjct: 215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 80 IGQGGFGSVYKGT-LKDGTL----AAIKVLSADS-RQGVREFLTEINVIKDIKHENLVEL 133
+G G FG+V+KG + +G AIK + S RQ +E + + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C G LV SL + R H + Q N C+ +AKG+ +L E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+VHR++ A NILL D +I+DFG+A L+P + + + ++A E + G+
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 253 LTRKADIYSFGVLLLEIVS 271
T ++D++S+GV + E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 29/280 (10%)
Query: 73 NFSPANKIGQGGFGSVYKGT-LKDGTLAAIK------VLSADSRQGVREFLTEINVIKDI 125
NF KIG+G F VY+ T L DG A+K ++ A +R + + EI+++K +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
H N+++ Y +E + +V + L++ + +T + + L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
+H ++HRDIK +N+ + K+ D GL + F + T + V GT Y++P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
E K+DI+S G LL E+ + + P+ Y +M LY K +E D
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS------PF---YGDKM--NLYSLCKKIEQCD 224
Query: 306 -ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
L D+ EE ++ +C P++RP ++ + ++
Sbjct: 225 YPPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYK-GTLKDGTLAAIKVLSADSRQGVR-EFLTEINVIK 123
DL ++ +G G GSV K + GT+ A KV+ ++ VR + L E+ ++
Sbjct: 6 DLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH 58
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ + +V YG + ++ + +++ SL + G ++ + I + V +
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK----IAVAVVE 114
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL +L+ I+HRDIK SNIL++ K+ DFG++ + I+ GT Y+
Sbjct: 115 GLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYM 169
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
+PE G+ T K+D++S G+ ++E+ G+
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 26/281 (9%)
Query: 68 RVATENFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK 126
R ++ ++G G +G VYK L G LAA+K++ + EI ++K+ K
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH-SSIQFNWQTRRNICIGVAKGL 185
H N+V +G + + + Y SL G S +Q + R + +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGL 119
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
A+LH + + +HRDIK +NILL + K++DFG+A A + + + GT ++AP
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAP 175
Query: 246 EYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
E A G + DI++ G+ +E+ + P +L M+ ++ KL +
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MSKSNFQPPKLKD 233
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
S H ++KI+L PK+RP+ L+
Sbjct: 234 KTKWSST-------FHNFVKISLT---KNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHEN 129
E F+ +IG+G FG V+KG + + AIK++ ++ + + EI V+
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+ + YG ++G ++ YL S L Q + + KGL +LH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----ILKGLDYLH 118
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
E + +HRDIKA+N+LL + K++DFG+A +T V GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 250 RGQLTRKADIYSFGVLLLEIVSG 272
+ KADI+S G+ +E+ G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGTL-----KDGTL-AAIKVLSADSRQGVREFL-TEINVIKD 124
N S +G G FG V + T D + A+K+L + RE L +E+ ++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 125 I-KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ------FNWQTRRNI 177
+ HEN+V L G C G +++ Y L L + S + F++Q
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ----- 149
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
VAKG+AFL + + +HRD+ A N+LL KI DFGLA+ ++ + S V
Sbjct: 150 ---VAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVV 199
Query: 238 GTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292
L APE T ++D++S+G+LL EI S N PY + +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN-----PYPGMPVDSKFY 254
Query: 293 KLYERG-KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
KL + G ++ + A Y + + C P +RP+ +V ++
Sbjct: 255 KLIKEGYRMAQPEHAPAE-IYDIMKT---------CWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIK------VLSADSRQGVREFLTEINVIK 123
NF KIG+G F VYK L DG + A+K ++ A +RQ + L EI+++K
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H N+++ +E + +V + L++ + +T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
L +H + I+HRDIK +N+ + K+ D GL + F + T + V GT Y+
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 244 APEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
+PE I K+DI+S G LL E+ + + P+ Y +M LY K +E
Sbjct: 174 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQS------PF---YGDKM--NLYSLCKKIE 221
Query: 303 LVDASLNGDYSVEEAHRYLK----IALLCTQDMPKRRPSMSTLVN 343
DY A Y + + C P++RP +S ++
Sbjct: 222 ------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 79 KIGQGGFGSVYKGTL-----KDGTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHENLVE 132
++G+ FG +YKG L L AIK L ++ Q EF E +++ ++ H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG-HSSI------------QFNWQTRRNICI 179
L G + +++ YL L + L+ R HS + + +I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAG 238
+A G+ +L VH+D+ A NIL+ + L KISD GL++ ++ A+ + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
++ PE + G+ + +DI+SFGV+L EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAA---IKVLSADSR-QGVREFLTEINVIKDIKHENLVEL 133
++IG G FG V G G A +K L A + FL E+ +++ H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLG-RGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
G C+E +LV + L L RG + + + VA GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHISTRVAGTEGYLAPEYA-IR 250
Q +H D+ N L DL+ KI D+GLA + +P + A +LAPE IR
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 251 GQ------LTRKADIYSFGVLLLEIVSGRCNTNRRLPY----EEQYLLEMAWKLYERGKL 300
GQ T+K++I+S GV + E+ T PY +EQ L ++ R +
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELF-----TAADQPYPDLSDEQVLKQVV-----REQD 227
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337
++L L+ YS R+ ++ C D P+ RP+
Sbjct: 228 IKLPKPQLDLKYS----DRWYEVMQFCWLD-PETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 47/229 (20%)
Query: 67 LRVATEN-FSPANKIGQGGFGSVYKGT-LKDG----TLAAIKVL-SADSRQGVREFLTEI 119
LR+ E F +G G FG+VYKG + +G AIK L A S + +E L E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 120 NVIKDIKHENLVELYGCC----VEGDHRILVYGYL-------ENNSLAQTLLGRGHSSIQ 168
V+ + + ++ L G C V+ +++ +G L ++N +Q LL
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL-------- 112
Query: 169 FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228
NW C+ +AKG+ +L E +VHRD+ A N+L+ KI+DFGLAKL A+
Sbjct: 113 -NW------CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
Query: 229 LTHISTRVAGTEG------YLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
+ EG ++A E + T ++D++S+GV + E+++
Sbjct: 163 -----EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 80 IGQGGFGSVYK----GTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHEN 129
+G+G FG V G KD A+K+L D + + + + ++E+ ++K I KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------------NI 177
++ L G C + ++ Y +L + L R + +++ T + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
VA+G+ +L + +HRD+ A N+L+ +D KI+DFGLA+ ++ +I
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKK 192
Query: 238 GTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292
T G ++APE T ++D++SFGVLL EI + + +P EE +
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------ 246
Query: 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
KL + G + D H I C +P +RP+ LV
Sbjct: 247 KLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 79 KIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQG-------VREFLTEINVIKDIKHE 128
IG+G +G VYK K DG AIK D Q RE I +++++KHE
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHE 62
Query: 129 NLVELYGCCVE-GDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
N+V L +E D + L++ Y E++ R + +++ + G+
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTP----KISDFGLAKLFPANLTHIST--RVAGTE 240
+LH ++HRD+K +NIL+ + KI D GLA+LF A L ++ V T
Sbjct: 123 YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 241 GYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVS 271
Y APE Y T+ DI++ G + E+++
Sbjct: 180 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIK-VLSADSRQGVREF-LTEINVIKDIK---H 127
+ +IG+G +G+VYK L G A+K V S +G+ L EI ++K ++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 128 ENLVELYGCC--VEGDHRI---LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
N+V L C D + LV+ +++ + LA L +T +++ +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYL--SKCPKPGLPPETIKDLMRQLL 117
Query: 183 KGLAFLHEEVQPH-IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+G+ FLH H IVHRD+K NIL+ D KI+DFGLA+++ + T V T
Sbjct: 118 RGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLW 171
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEI 269
Y APE ++ D++S G + E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 74 FSPANKIGQGGFGSVY-KGTLKDGTLAAIKVLSADSRQGV---REFLTEINVIKDIKHEN 129
F+ +IG G FG+VY ++ + AIK +S +Q ++ + E+ ++ IKH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI-----GVAKG 184
+E GC + LV Y LG ++ + + + + I G +G
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYL 243
LA+LH +++HRDIKA NILL + K++DFG A + PAN GT ++
Sbjct: 138 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWM 188
Query: 244 APEYAI---RGQLTRKADIYSFGVLLLEI 269
APE + GQ K D++S G+ +E+
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE-NLV 131
F +G G +G VYKG +K G LAAIKV+ + E EIN++K H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 132 ELYGCCVE------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
YG ++ D LV + S+ + ++++ +W IC + +GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
A LH ++HRDIK N+LL ++ K+ DFG++ + +T + GT ++AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 246 EYAI-----RGQLTRKADIYSFGVLLLEIVSG 272
E ++DI+S G+ +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 15/246 (6%)
Query: 72 ENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHEN 129
E F+ +IG+G FG VYKG + + AIK++ ++ + + EI V+
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+ YG ++G ++ YL S A LL G + R I KGL +LH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL----KGLDYLH 118
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
E + +HRDIKA+N+LL + K++DFG+A +T V GT ++APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK----LVELVD 305
+ KADI+S G+ +E+ G + P +L+ G+ E V+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234
Query: 306 ASLNGD 311
A LN D
Sbjct: 235 ACLNKD 240
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 68/210 (32%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 80 IGQGGFGSV----YKGTLKDGTLAAIKVLSAD---SRQGVREFLTE---INVIKDIKHEN 129
+G+G FG V YK T G L AIK L +R V + E +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK---GLA 186
LV L+ C DH V Y L H I + + A GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMM------H--IHTDVFSEPRAVFYAACVVLGLQ 115
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLA 244
+LHE IV+RD+K N+LLD + KI+DFGL K + + T ST GT +LA
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLA 169
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274
PE TR D + GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 9e-17
Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 52/287 (18%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQ---GVREFLTEINVIKDIKH 127
E F ++IG G FG+VY T + A+K +S +Q ++ + E+ ++ +KH
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI-----GVA 182
N +E GC ++ LV Y LG ++ + + + + I G
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHISTRVAGTEG 241
+GLA+LH +++HRDIKA NILL + K++DFG A K PAN GT
Sbjct: 132 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPY 182
Query: 242 YLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
++APE + GQ K D++S G+ +E+ R+ P L+
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPP------------LFNMN 224
Query: 299 KLVELVDASLNGD---YSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+ L + N S E + C Q +P+ RP+ + L+
Sbjct: 225 AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 72/293 (24%), Positives = 132/293 (45%), Gaps = 49/293 (16%)
Query: 80 IGQGGFGSVY--------KGTLKDGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHEN 129
+G+G FG V K K+ A+K+L D + + + + ++E+ ++K I KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------------NI 177
++ L G C + ++ Y +L + L R +++++ R +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
VA+G+ +L + +HRD+ A N+L+ ++ KI+DFGLA+ ++ +I
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 238 GTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292
T G ++APE T ++D++SFGVL+ EI + + +P EE +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------ 249
Query: 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
KL + G ++ N Y + C +P RP+ LV L
Sbjct: 250 KLLKEGHRMDKPANCTNELYMMMRD---------CWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 74 FSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQG---VREFLTEINVIKDIKHEN 129
FS +IG G FG+VY +++ + AIK +S +Q ++ + E+ ++ ++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI-----GVAKG 184
++ GC + LV Y LG ++ + + + + I G +G
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYL 243
LA+LH +++HRD+KA NILL + K+ DFG A + PAN GT ++
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWM 178
Query: 244 APEYAI---RGQLTRKADIYSFGVLLLEI 269
APE + GQ K D++S G+ +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 65/202 (32%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLS----ADSRQGVREFLTEINVIKDIKHENLVELY 134
+G G FG V K G A+K+LS +Q V L E +++ I+H LV LY
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G + + LV Y+ L L G F R V L +LH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSL--- 120
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAPEYAIRG 251
IV+RD+K N+LLD D KI+DFG AK + R + GT YLAPE I
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPE-IILS 172
Query: 252 Q-LTRKADIYSFGVLLLEIVSG 272
+ + D ++ G+L+ E+++G
Sbjct: 173 KGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVL--SADSRQGVREFLTEINVIKDIKH-EN 129
F +G G +G VYKG +K G LAAIKV+ + D + +++ EIN++K H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64
Query: 130 LVELYGCCVE------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ YG ++ D LV + S+ + ++++ W IC + +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL+ LH Q ++HRDIK N+LL ++ K+ DFG++ + +T + GT ++
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178
Query: 244 APEYAI-----RGQLTRKADIYSFGVLLLEIVSG 272
APE K+D++S G+ +E+ G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 80 IGQGGFGSVYKGTLKDG--TLAAIKVL----SADSRQGVREFLTEINVIKDIKHENLVEL 133
+GQG FG VY D LAA +V S ++ + V EI ++K+++HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 134 YGCCVEGDHRILV--YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
YGC + + L Y+ S+ L G + + R I +G+++LH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTR-VAGTEGYLAPEYAI 249
+ IVHRDIK +NIL D K+ DFG +K L ++ R V GT +++PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR 273
RKAD++S G ++E+++ +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 32/276 (11%)
Query: 80 IGQGGFGSVYKGTL-KDGTLAAIKV----LSADSRQGVREFLTEINVIKDIKHENLVELY 134
+G+G FGSV +G L +D ++ + V ++ +R + +FL+E +K+ H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 135 GCCVEGDHR------ILVYGYLENNSLAQTLLGR--GHSSIQFNWQTRRNICIGVAKGLA 186
G C++ +++ ++++ L LL G Q +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE-GYLAP 245
+L + +HRD+ A N +L++++ ++DFGL+K + R+A ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
E T K+D++SFGV + EI T + PY E+ L + +L + D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIA-----TRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
L+G YS+ + C PK RPS TL
Sbjct: 239 C-LDGLYSLMSS---------CWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 35/208 (16%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
++G G FG VYK K+ G LAA KV+ S + + +++ EI+++ H N+V+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 67
Query: 138 VEGDHRILVYGYLENN--SLAQTLLGRGHSSIQFNWQTR------RNICIGVAKGLAFLH 189
L Y ENN L + G ++ + R +C + L +LH
Sbjct: 68 -------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA--GTEGYLAPEY 247
E I+HRD+KA NIL D K++DFG++ N I R + GT ++APE
Sbjct: 121 EN---KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPE- 173
Query: 248 AIRGQLTR------KADIYSFGVLLLEI 269
+ + ++ KAD++S G+ L+E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204
LV Y L Q + R ++ F + I V + +H + H++HRDIK++
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSA 172
Query: 205 NILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFG 263
NILL + K+ DFG +K++ A ++ + GT Y+APE R ++KAD++S G
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 264 VLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY-----SVEEAH 318
VLL E++ T +R P++ + + E+ K +L G Y S+
Sbjct: 233 VLLYELL-----TLKR-PFDGENMEEVMHK-------------TLAGRYDPLPPSISPEM 273
Query: 319 RYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+ + ALL + PKRRPS S L+NM I
Sbjct: 274 QEIVTALLSSD--PKRRPSSSKLLNMPI 299
|
Length = 496 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 80 IGQGGFGSVY------KGTLKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHENLVE 132
+G+G FG V +G G A+K L +S + + EI +++++ HEN+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 133 LYGCCVE-GDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G C E G + I L+ +L + SL + L R + I N + + + + KG+ +L
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKE-YLPRNKNKI--NLKQQLKYAVQICKGMDYLGS 127
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--VAGTEGYLAPEYA 248
VHRD+ A N+L++ + KI DFGL K + + + + + + APE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTN 277
I+ + +D++SFGV L E+++ C++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT-YCDSE 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 79 KIGQGGFGSVYKG---TLKDGTLAAIKVLSADSRQGV--REFLTEINVIKDIKHENLVEL 133
++G G FG+V KG K A+K+L D+ E L E NV++ + + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQ-TRRNI---CIGVAKGLAFLH 189
G C E + +LV E LG + +Q N T +NI V+ G+ +L
Sbjct: 62 IGIC-EAESWMLVMELAE--------LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT--EGYLAPEY 247
E + VHRD+ A N+LL KISDFGL+K A+ + + G + APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 248 AIRGQLTRKADIYSFGVLLLEIVS 271
+ + K+D++SFGVL+ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 30/207 (14%)
Query: 80 IGQGGFGSVYKGT-LKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVEL 133
+G G FG+VYKG + DG AIKVL + S + +E L E V+ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 134 YGCC----VEGDHRILVYG----YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
G C V+ +++ YG Y+ N R S NW C+ +AKG+
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENK------DRIGSQDLLNW------CVQIAKGM 122
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE-GYLA 244
++L EEV+ +VHRD+ A N+L+ KI+DFGLA+L + T ++A
Sbjct: 123 SYL-EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVS 271
E + + T ++D++S+GV + E+++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 73 NFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSR-QGV-REFLTEINVIKDIKHEN 129
NF KIG+G +G VYK G + A+K + D+ +GV + EI+++K++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+L + LV+ +L + L + + S I ++ + +GLAF H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCH 117
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
++HRD+K N+L++ + K++DFGLA+ F + + V T Y APE +
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173
Query: 250 RGQLTRKA-DIYSFGVLLLEIVSGR 273
+ A DI+S G + E+V+ R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 8e-16
Identities = 73/259 (28%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHEN 129
E F+ KIG+G FG V+KG + + AIK++ ++ + + EI V+
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+ + YG ++ ++ YL S A LL G + I + KGL +LH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG----PLDETQIATILREILKGLDYLH 118
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAPE 246
E + +HRDIKA+N+LL + K++DFG+A LT + GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPE 171
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK----LVE 302
+ KADI+S G+ +E+ G + P + +L+ G L E
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231
Query: 303 LVDASLNGDYSVEEAHRYL 321
V+A LN + S + L
Sbjct: 232 FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 80 IGQGGFGSVY----KGTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENLVEL 133
+G+G FG V+ K K + I V ++ D R E V+K + H N++E
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSHPNIIEY 64
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
Y +E ++V Y +LA+ + R +S + I + L LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD-----EDTILHFFVQILLALHHVHT 119
Query: 194 PHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
I+HRD+K NILLDK + KI DFG++K+ + + T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYT-VVGTPCYISPELCEGKP 177
Query: 253 LTRKADIYSFGVLLLEIVS 271
+K+DI++ G +L E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 58 DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFL 116
++++ G + L T+ + IG+G +G VYK T KDG+LAA+K+L S E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 117 TEINVIKDI-KHENLVELYGCCVEGDHRI-----LVYGYLENNSLAQTLLGRGHSSIQFN 170
E N+++ + H N+V+ YG + D + LV S+ + + G + +
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
I G GL LH I+HRD+K +NILL + K+ DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 231 HISTRVAGTEGYLAPEYAIRGQ-----LTRKADIYSFGVLLLEIVSG 272
+T V GT ++APE Q + D++S G+ +E+ G
Sbjct: 184 RRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 33/287 (11%)
Query: 74 FSPANKIGQGGFGSVYKGTLK--DGTL--AAIKVLSAD--SRQGVREFLTEINVIKDIKH 127
F+ +G+G FGSV + LK DG+ A+K+L AD S + EFL E +K+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 128 ENLVELYGCCVEGDHR------ILVYGYLENNSLAQTLLGR--GHSSIQFNWQTRRNICI 179
N+++L G + + +++ ++++ L LL G QT I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHISTRVAG 238
+A G+ +L + + +HRD+ A N +L++++T ++DFGL+ K++ +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
+LA E T +D+++FGV + EI+ T + PY E+ L +
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIM-----TRGQTPYAGVENSEIYNYLIKGN 232
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+L + D +E+ + ++ C PK RPS L + L
Sbjct: 233 RLKQPPDC-------LEDVY---ELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G GGFG V +K A+K + +E ++++ H +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
+ + ++ Y L L RG F+ T R V +LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR---G 113
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAIRGQ-L 253
I++RD+K N+LLD + K+ DFG AK L T T GT Y+APE I +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPE-IILNKGY 169
Query: 254 TRKADIYSFGVLLLEIVSGR 273
D +S G+LL E+++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 71/296 (23%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQ-GVREFLTEINVIKDIKH-ENLVELYGC 136
IG+G FG+V K K GT+ A+K + + + + L +++V+ +V+ YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 137 CV-EGDHRI--------------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
EGD I VY L++ + + +LG+ I +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSV-IPEEILGK--------------IAVAT 116
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
K L +L EE+ I+HRD+K SNILLD++ K+ DFG++ ++ TR AG
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRP 172
Query: 242 YLAPE---------YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292
Y+APE Y +R +D++S G+ L E+ +G + PY + W
Sbjct: 173 YMAPERIDPSARDGYDVR------SDVWSLGITLYEVATG------KFPYPK-------W 213
Query: 293 K-LYERGKLVELVDAS---LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
+++ +L ++V L+ E + ++ LC +RP L+
Sbjct: 214 NSVFD--QLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 73 NFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVL-----SADSRQGVREFLTEINVIKDIK 126
N+ +GQG FG VY D G A+K + S ++ + V EI ++K++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 127 HENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
HE +V+ YGC + R L ++ S+ L G + + R I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EG 118
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTR-VAGTEGY 242
+++LH + IVHRDIK +NIL D K+ DFG +K L L+ + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 243 LAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
++PE I G+ RKADI+S G ++E+++ +
Sbjct: 176 MSPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 42/280 (15%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIK----VLSADSRQGVREFLTEINVIKDIKHENLVEL 133
+IG+G FG V+ G L+ D T A+K L D + +FL E ++K H N+V L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 58
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C + +V ++ L G + + + A G+ +L +
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESK-- 113
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG-------YLAPE 246
H +HRD+ A N L+ + KISDFG+++ A T G + APE
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSR------EEEDGVYASTGGMKQIPVKWTAPE 166
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
G+ + ++D++SFG+LL E S +PY + + E+G + +
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGA-----VPY-ANLSNQQTREAIEQGVRLPCPEL 220
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+ Y + E C + P +RPS ST+ L
Sbjct: 221 CPDAVYRLMER---------CWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKV-LSADSRQGVREF-LTEINVIKDIKHENLVELYG 135
+G+G +G V K K+ G + AIK L ++ + V++ + EI ++K ++HENLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 136 CCVEGDHRILVYGYLEN---NSLAQTLLGRGHSSIQ-FNWQTRRNICIGVAKGLAFLHEE 191
LV+ ++++ + L + G S ++ + +Q + +G+ F H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ--------ILRGIEFCHSH 119
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+I+HRDIK NIL+ + K+ DFG A+ A + T T Y APE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 252 -QLTRKADIYSFGVLLLEIVSG 272
+ R DI++ G L+ E+++G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 27/207 (13%)
Query: 79 KIGQGGFGSVYKG-TLKDGTLAAIKVLSADSR-QGV-REFLTEINVIKDIKHENLVELYG 135
KIG+G +G VYK G + A+K + ++ +GV + EI+++K++ H N+V L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 136 CCVEGDHRI-LVYGYLEN------NSLAQTLLGRGHSSIQ-FNWQTRRNICIGVAKGLAF 187
V ++++ LV+ +L+ +S T L I+ + +Q + +G+A+
Sbjct: 66 V-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP--PLIKSYLYQ----LL----QGIAY 114
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
H ++HRD+K N+L+D++ K++DFGLA+ F + + V T Y APE
Sbjct: 115 CH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI 170
Query: 248 AIRG-QLTRKADIYSFGVLLLEIVSGR 273
+ Q + DI+S G + E+V+ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 79 KIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELY 134
++G G FG V KG K AIKVL ++ + VR E + E ++ + + +V +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI---GVAKGLAFLHEE 191
G C E + +LV L + L G+ T N+ V+ G+ +L +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEI------TVSNVVELMHQVSMGMKYLEGK 114
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE--GYLAPEYAI 249
+ VHRD+ A N+LL KISDFGL+K A+ ++ R AG + APE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 250 RGQLTRKADIYSFGVLLLEIVS 271
+ + ++D++S+G+ + E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 66/200 (33%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 80 IGQGGFGSVYKGTLKDGT-LAAIKVLSAD---SRQGVREFLTEINVIK-DIKHENLVELY 134
+G+G FG V LK AIK L D V + E V+ +H L L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+H V YL L + SS +F+ R + GL FLH++
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK--- 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL- 253
I++RD+K N+LLDKD KI+DFG+ K N ++ GT Y+APE ++GQ
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPE-ILKGQKY 173
Query: 254 TRKADIYSFGVLLLEIVSGR 273
D +SFGVLL E++ G+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 17/201 (8%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+GGFG V +K G + A K L R+G + L E +++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLG---RGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
D LV + L + G + + + IC GL LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC-----GLEHLHQR- 114
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
IV+RD+K N+LLD +ISD GLA AGT GY+APE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEV 170
Query: 253 LTRKADIYSFGVLLLEIVSGR 273
D ++ G L E+++GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 41/281 (14%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENLVELY 134
+++G+G +GSVYK + G A+K L D + + + E++++ +V+ Y
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 135 GC-CVEGDHRILVY---GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G +EG VY Y++ SL L G ++ R I V KGL FL E
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL--THISTRVAGTEGYLAPEY- 247
E I+HRD+K +N+L++ + K+ DFG++ A+L T+I G + Y+APE
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173
Query: 248 -----AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
T ++D++S G+ +LE+ G R PY + + +L +V+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALG------RYPYPPETYANIFAQL---SAIVD 224
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+L YS ++A ++ C +P RRP+ + L+
Sbjct: 225 GDPPTLPSGYS-DDAQDFVA---KCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 80 IGQGGFGSVYKGT---LKDG-----TLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
+GQG F ++KG + D T +KVL R F +++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF-LHE 190
YG CV GD I+V Y++ SL T L + + I +W+ + VAK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWK------LEVAKQLAWALHF 115
Query: 191 EVQPHIVHRDIKASNILL-----DKDLTP---KISDFGLA-KLFPANLTHISTRVAGTEG 241
+ H ++ A N+LL K P K+SD G++ + P + + R+
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERIP---- 169
Query: 242 YLAPEYAIRG--QLTRKADIYSFGVLLLEIVSG 272
++ PE I L+ AD +SFG L EI SG
Sbjct: 170 WVPPE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIK--VLSADSRQGVREFLTEINVIKDIKHENLVELYG 135
KIG+G +G V+K ++ G + AIK V S D + L EI ++K +KH NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 136 CCVEGDHRILVYGYLEN---NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
LV+ Y ++ N L + G I + I + + F H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQAVNFCH--- 117
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI-RG 251
+ + +HRD+K NIL+ K K+ DFG A++ + VA T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDT 176
Query: 252 QLTRKADIYSFGVLLLEIVSG 272
Q D+++ G + E+++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
++F +++G G G V K K G + A K++ + + +R + + E+ V+ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V YG + +++ SL Q L + + + + I V +GLA+L
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
E+ Q I+HRD+K SNIL++ K+ DFG++ + ++ GT Y++PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 175
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR 273
+ ++DI+S G+ L+E+ GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 59/250 (23%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV 103
+R E+N+ V E+ D Y++L +G G +G V G AIK
Sbjct: 2 YRQELNKTVWEVPDR----YQNLSP----------VGSGAYGQVCSAFDTKTGRKVAIKK 47
Query: 104 LSADSRQGVREFLT---------EINVIKDIKHENLVELYGCCVEGDHR------ILVYG 148
LS R F + E+ ++K + HEN++ L LV
Sbjct: 48 LS-------RPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100
Query: 149 YLE---NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205
+ NN + L H IQF + + +GL ++H I+HRD+K SN
Sbjct: 101 LMGADLNNIVKCQKLSDDH--IQF-------LVYQILRGLKYIH---SAGIIHRDLKPSN 148
Query: 206 ILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFG 263
I +++D KI DFGLA+ +T +++TR Y APE + + DI+S G
Sbjct: 149 IAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 264 VLLLEIVSGR 273
++ E+++G+
Sbjct: 204 CIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADS-RQGVREF----LTEINVIKDI 125
+ + N+I +G +G VY+ K G + A+K L + ++G F L EIN++ +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKL 61
Query: 126 KHENLVELYGCCV--EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+H N+V + V D +V Y+E++ ++L+ F + + + +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHD--LKSLMETMKQP--FLQSEVKCLMLQLLS 117
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
G+A LH+ I+HRD+K SN+LL+ KI DFGLA+ + + L T++ T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYR 173
Query: 244 APEYAI-RGQLTRKADIYSFGVLLLEIVSGR 273
APE + + + D++S G + E+++ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVL-----SADSRQGVREFLTEINVIKDI 125
N+ +G+G FG VY D G A+K + S ++ + V EI ++K++
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 126 KHENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+H+ +V+ YGC + + + L Y+ S+ L G + + R I +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA---NLTHISTRVAGTE 240
G+++LH + IVHRDIK +NIL D K+ DFG +K + T I + V GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTP 173
Query: 241 GYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVS 271
+++PE I G+ RKAD++S ++E+++
Sbjct: 174 YWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLS----ADSRQGVREFLTEINVIKDIK 126
++ +G G FG V+ + A+KV++ +Q + E V+K++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 127 HENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
H ++ L+ E D R L + Y+ L L G +F+ T +
Sbjct: 60 HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCA 113
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
L +LH + IV+RD+K NILLDK+ K++DFG AK L + + GT YLA
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLA 166
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSG 272
PE + D ++ G+L+ E++ G
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 45/277 (16%)
Query: 79 KIGQGGFG-SVYKGTLKDGTLAAIK-----VLSADSRQGVREFLTEINVIKDIKHENLVE 132
KIG+G FG ++ + +DG IK +S R+ R+ E+ V+ ++KH N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPNIVQ 63
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ----FNWQTRRNICIGVAKGLAFL 188
E + +V Y E L + + + +W + IC+ L +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHV 117
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H+ I+HRDIK+ NI L KD T K+ DFG+A++ + ++ GT YL+PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEIC 173
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
K+DI++ G +L E+ + L+ A +E G + LV +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT----------------LKHA---FEAGNMKNLVLKII 214
Query: 309 NGDYSVEEAHRYLKIALLCTQDM---PKRRPSMSTLV 342
G Y +H + L +Q P+ RPS+++++
Sbjct: 215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 80 IGQGGFGSVY---KGTLKD-GTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVE 132
+GQG FG V+ K T D G L A+KVL + R VR + E +++ ++ H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVK 62
Query: 133 L-YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L Y EG L+ +L L R + F + + +A L LH
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH-- 115
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA--GTEGYLAPEYAI 249
I++RD+K NILLD++ K++DFGL+K ++ H + GT Y+APE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 250 RGQLTRKADIYSFGVLLLEIVSG 272
R T+ AD +SFGVL+ E+++G
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE---FLTEINVIKDIKHE 128
+ KIG+G FG +Y K D IK + ++ V+E E+ ++ +KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHP 59
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTL-LGRGHSSIQFNWQTRRNICIGVAKGLAF 187
N+V + E +V Y + L + + RG + F+ + + ++ GL
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKH 116
Query: 188 LHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+H+ I+HRDIK+ NI L K+ + K+ DFG+A+ + ++ GT YL+PE
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS 271
K DI+S G +L E+ +
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 34/209 (16%)
Query: 80 IGQGGFGSVYKGT-LKDGTLA----AIKVLSADSRQGVR-EFLTEINVIKDIKHENLVEL 133
+G G FG+VYKG + +G AIK+L+ + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 134 YGCCVEGDHRI----------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
G C+ ++ L Y + +++ LL NW C+ +AK
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL--------LNW------CVQIAK 120
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE-GY 242
G+ +L E +VHRD+ A N+L+ KI+DFGLA+L + + +
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
+A E + T ++D++S+GV + E+++
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 31/205 (15%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE---------- 128
I +G FGSVY + G AIKVL + N + ++K E
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSD-------MIAKNQVTNVKAERAIMMIQGES 56
Query: 129 -NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+ +LY D+ LV YL A + G W + V G+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED--WA--KQYIAEVVLGVED 112
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
LH Q I+HRDIK N+L+D+ K++DFGL++ + + GT YLAPE
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPET 164
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSG 272
+ + +D +S G ++ E + G
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 71 TENFSPANK-IGQGGFGSVYKG-TLKDGTLAAIKVLSA--------DSRQGVRE------ 114
+E + +G+G +G V K G + AIK + RQ V
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 115 FLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR 174
L E+ ++ +IKHEN++ L VEGD LV + ++ L + + I+
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQV 121
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--------- 225
+ I + + GL LH+ + +HRD+ +NI ++ KI+DFGLA+ +
Sbjct: 122 KCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 226 -----PANLTHISTRVAGTEGYLAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
++++V T Y APE + + A D++S G + E+++G+
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 61/187 (32%), Positives = 95/187 (50%), Gaps = 29/187 (15%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIK-VLSADSRQGVREF----LTEINVIKDIKHENLV 131
KIGQG FG V+K K + A+K VL + ++G F L EI +++ +KHEN+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 132 ELYGCC---VEGDHR-----ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
L C +R LV+ + E++ LA L + +++F + + +
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKKVMKMLLN 130
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL----THISTRVAGT 239
GL ++H I+HRD+KA+NIL+ KD K++DFGLA+ F + + RV T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 240 EGYLAPE 246
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
++F +++G G G V+K + K G + A K++ + + +R + + E+ V+ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V YG + +++ SL Q L G + Q + I V KGL +L
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
E+ + I+HRD+K SNIL++ K+ DFG++ + ++ GT Y++PE
Sbjct: 121 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 175
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR 273
+ ++DI+S G+ L+E+ GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTL---AAIKVLSA-DSRQGVREFLTEINVIKDI-K 126
E+ + IG+G FG V + +K L AAIK+L S R+F E+ V+ +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 127 HENLVELYGCCVEGDHRILV-----YG----YLENNSLAQT--LLGRGHSSIQ-FNWQTR 174
H N++ L G C + + YG +L + + +T + H + Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234
VA G+ +L E+ +HRD+ A N+L+ ++L KI+DFGL++ +
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
R+ ++A E T K+D++SFGVLL EIVS PY E L
Sbjct: 179 RLPVR--WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT-----PYCGMTCAE----L 227
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
YE+ ++ N D V E R C +D P RP + +
Sbjct: 228 YEKLPQGYRMEKPRNCDDEVYELMRQ------CWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADS-RQG-----VREFLTEINVIKDIK 126
F +IG+G +G VYK KD G L A+K + D+ ++G +RE I +++ +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE----IKILRQLN 64
Query: 127 HENLVELYGCCVEGDHRI----------LVYGYLENNSLAQTLLGRGHSS-IQFNWQTRR 175
H N+V L + + LV+ Y++++ L+G S + F+ +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
+ + +GL + H++ + +HRDIK SNILL+ K++DFGLA+L+ + + T
Sbjct: 120 SFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 236 VAGTEGYLAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
T Y PE + + A D++S G +L E+ + +
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 62/198 (31%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINV-IKDIKHENLVELY 134
IG+G FG V K DG A+KVL + ++ + + E NV +K++KH LV L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
D V Y+ L L F R +A L +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSL--- 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
+I++RD+K NILLD ++DFGL K + ST GT YLAPE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174
Query: 255 RKADIYSFGVLLLEIVSG 272
R D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 49/301 (16%)
Query: 72 ENFSPANKIGQGGFGSVYK----GTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVI 122
+ +G+G FG V + G K A+K+L + + + + + ++E+ ++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 123 KDI-KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------ 175
K I KH+N++ L G C + ++ Y +L + L R + + +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 176 ------NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229
+ VA+G+ +L +HRD+ A N+L+ +D KI+DFGLA+ +
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GV 184
Query: 230 THISTRVAGTEG-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE 284
I + G ++APE T ++D++SFG+L+ EI + + +P EE
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244
Query: 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
+ KL G + D H + C +P +RP+ LV
Sbjct: 245 LF------KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289
Query: 345 L 345
L
Sbjct: 290 L 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 71 TENFSPANKIGQGGFGSV--YKGTLKDGTLAAIKVL-----SADSRQGVREFLTEINVIK 123
T + +G G FG V + L +A K++ +++ RE + ++K
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE----LKLLK 64
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSS--IQ-FNWQTRRNICIG 180
++HEN++ L + I L L + L R IQ F +Q R
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR----- 119
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGT 239
GL ++H +VHRD+K SNIL++++ KI DFGLA++ +T ++STR
Sbjct: 120 ---GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170
Query: 240 EGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
Y APE + Q + DI+S G + E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 80 IGQGGFGSVYKGTLKDGTL---AAIKVLSA-DSRQGVREFLTEINVIKDI-KHENLVELY 134
IG+G FG V K +K L AAIK + S+ R+F E+ V+ + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 135 GCCVEGDHRILVY------------GYLENNSLAQT--LLGRGHSSIQ-FNWQTRRNICI 179
G C +HR +Y +L + + +T +S+ + Q +
Sbjct: 75 GAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
VA+G+ +L Q +HRD+ A NIL+ ++ KI+DFGL++ + R+
Sbjct: 132 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299
++A E T +D++S+GVLL EIVS PY E LYE+
Sbjct: 189 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAE----LYEKLP 237
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
++ LN D V + R C ++ P RPS + ++
Sbjct: 238 QGYRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 73 NFSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSR-QGV-REFLTEINVIKDIKHEN 129
+++ KIG+G +G VYKG K G + A+K + +S +GV + EI+++K+++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTL--LGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V L ++ L++ +L + L + L L +G + + ++ + +G+ F
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQ---YMDAELVKSYLYQILQGILF 116
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE----GYL 243
H ++HRD+K N+L+D K++DFGLA+ F I RV E Y
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYR 168
Query: 244 APEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
APE + + DI+S G + E+ + +
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGC 136
K+G+G + +VYKG + +G L A+KV+S + +GV + E +++K +KH N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGR-----GHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+ V+ Y+ + LAQ ++ ++ F +Q R GLA++H +
Sbjct: 72 IHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLR--------GLAYIHGQ 122
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
HI+HRD+K N+L+ K++DFGLA+ S+ V T Y P+ + G
Sbjct: 123 ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLG 177
Query: 252 --QLTRKADIYSFGVLLLEIVSGR 273
+ DI+ G + +E++ G+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 63/199 (31%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIK-DIKHENLVELY 134
+G+G FG V+ LK AIK L D V + E V+ +H L LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
++ V YL L + S +F+ + GL FLH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSK--- 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
IV+RD+K NILLD D KI+DFG+ K T GT Y+APE + +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174
Query: 255 RKADIYSFGVLLLEIVSGR 273
D +SFGVLL E++ G+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADSRQGV-REFLTEINVIKDIKHE 128
+ + KIG+G +G VYK + + T+A K+ +GV + EI+++K+++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 129 NLVELYGCCVEGDHRI-LVYGYLENNSLAQT----LLGRGHSSIQ-FNWQTRRNICIGVA 182
N+V L V + R+ LV+ YL+ + + I+ + +Q R
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILR------- 113
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLFPANLTHISTRVAGTEG 241
G+A+ H ++HRD+K N+L+D+ K++DFGLA+ F + + V T
Sbjct: 114 -GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLW 168
Query: 242 YLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
Y APE + + DI+S G + E+V+ +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 49/231 (21%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA--DSRQGVREFLTEIN 120
Y+ L+ IG G +G V + G AIK +S D + L EI
Sbjct: 2 YELLKP----------IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK 51
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNS-------LAQTLLGRG-HSSIQFNWQ 172
+++ ++HEN++ L IL E+ + L +T L + S
Sbjct: 52 LLRHLRHENIIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD 103
Query: 173 TRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---PANL 229
+ + +GL +LH +++HRD+K SNIL++ + KI DFGLA+
Sbjct: 104 HIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 230 THISTRVAGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
++ V T Y APE Y T+ DI+S G + E+++ +
Sbjct: 161 GFLTEYVV-TRWYRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 40/273 (14%)
Query: 80 IGQGGFGS--VYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
+G+G FG + + D A ++ S V + E ++ +KH N+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA-FKES 66
Query: 138 VEGD-HRILVYGYLENNSLAQTL-LGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEV 192
E D H +V Y + L Q + L RG W + +C+GV +HE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQH----IHEK- 119
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
++HRDIK+ NI L ++ K+ DFG A+L + + T V GT Y+ PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312
K+DI+S G +L E+ + + P++ +WK L+ G Y
Sbjct: 177 YNNKSDIWSLGCILYELCT------LKHPFQAN-----SWK--------NLILKVCQGSY 217
Query: 313 SVEEAHRYLKIALLCTQDM---PKRRPSMSTLV 342
+H ++ L Q P+ RPS +T++
Sbjct: 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 28/202 (13%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGV-REFLTEINVIKDIKHENLVELYGCC 137
+G G G+VYK L + A+KV+ D + ++ ++E+ ++ ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 138 VEGDHRILVYGYLENNSL------AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+ + +++ SL + +LGR I + V KGL +L
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLGR--------------IAVAVVKGLTYLW-- 112
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
I+HRD+K SN+L++ K+ DFG++ + I+ GT Y+APE
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGE 168
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
Q +D++S G+ +E+ GR
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 62/198 (31%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIK-DIKHENLVELY 134
+G+G FG V LK G L A+KVL D V +TE ++ H L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
CC + R+ N L+ S +F+ R + L FLH++
Sbjct: 63 -CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK--- 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
I++RD+K N+LLD + K++DFG+ K N ST GT Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYG 174
Query: 255 RKADIYSFGVLLLEIVSG 272
D ++ GVLL E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 24/189 (12%)
Query: 100 AIKVLSADSRQGVRE---FLTEINVIKDIKHENLVELYGCCVEGDHRIL-VYGYLENNSL 155
AIK+L D+ + + F E + + H N+V L + V+ Y+ +L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTP 214
+ L G +T R + + V LA H + IVHRD+K NI++ + P
Sbjct: 67 REVLAADGALPAG---ETGR-LMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRP 119
Query: 215 --KISDFGLAKLFP-------ANLTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGV 264
K+ DFG+ L P A LT +T V GT Y APE +RG+ +T +D+Y++G+
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLT-RTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGL 177
Query: 265 LLLEIVSGR 273
+ LE ++G+
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 73 NFSPANKIGQGGFGSVYKGT--LKDGTLAAIKV-----LSADSRQGVREFLTEINVIKDI 125
NF KIG+G F VY+ T L +A KV + A +RQ + + EI+++K +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
H N+++ +E + +V + L+Q + +T + + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
+H ++HRDIK +N+ + K+ D GL + F + T + V GT Y++P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVS 271
E K+DI+S G LL E+ +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHEN--LVEL 133
+G+G FG V LK G A+K L D V + E V+ + EN L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTHL 61
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSI-QFNWQTRRNICIGVAKGLAFLHEEV 192
Y +H V +L L + +G + + + +C GL FLH +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHSK- 115
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIR 250
I++RD+K N++LD+D KI+DFG+ K +F N ++ GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQG 170
Query: 251 GQLTRKADIYSFGVLLLEIVSGR 273
+ T D +SFGVLL E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 79 KIGQGGFGSVYKGTL------KDGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHENLV 131
++G+ FG VYKG L + AIK L + +RE F E + ++H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRG-HSSIQFNWQTRR-----------NICI 179
L G + +++ Y ++ L + L+ R HS + + +I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAG 238
+A G+ FL H+VH+D+ N+L+ L KISD GL + ++ A+ +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
+++PE + G+ + +DI+S+GV+L E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 37/279 (13%)
Query: 80 IGQGGFGSVYKGTLKDGTL---AAIKVLSA-DSRQGVREFLTEINVIKDIKHE-NLVELY 134
IG+G FG V K +K L AAIK + S+ R+F E+ V+ + H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTL-----------LGRGHSSIQ-FNWQTRRNICIGVA 182
G C + L Y + +L L +S+ + Q + VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
+G+ +L ++ +HRD+ A NIL+ ++ KI+DFGL++ + R+ +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--W 177
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
+A E T +D++S+GVLL EIVS PY E LYE+
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAE----LYEKLPQGY 228
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
++ LN D V + R C ++ P RPS + +
Sbjct: 229 RLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
++F ++G G G V K G + A K++ + + +R + + E+ V+ +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 130 LVELYGCCV-EGDHRILVYGYLENNSLAQTL--LGRGHSSIQFNWQTRRNICIGVAKGLA 186
+V YG +G+ I + +++ SL Q L GR +I I I V +GL
Sbjct: 61 IVGFYGAFYSDGEISICME-HMDGGSLDQVLKKAGRIPENIL------GKISIAVLRGLT 113
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+L E+ + I+HRD+K SNIL++ K+ DFG++ + ++ GT Y++PE
Sbjct: 114 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 168
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGR 273
T ++DI+S G+ L+E+ GR
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE----FLTEINVI-KDIKHENLVEL 133
IG G G VYK K G + A+K + R G +E L +++V+ K +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 134 YGCCV-EGDHRILVYGYLENNSLAQTLLGRGHSSIQ--FNWQTRRNICIGVAKGLAFLHE 190
YG + + D I + L T L + IQ + + + K L +L E
Sbjct: 80 YGYFITDSDVFICM-------ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE---- 246
+ ++HRD+K SNILLD K+ DFG++ + TR AG Y+APE
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDP 188
Query: 247 ------YAIRGQLTRKADIYSFGVLLLEIVSGR-----CNT 276
Y IR AD++S G+ L+E+ +G+ C T
Sbjct: 189 PDPNPKYDIR------ADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 82 QGGFGSVYKGTLKDGTL-----AAIK-VLSADSRQGVREFLTEINVIKDIKHENLVELYG 135
+G FG ++ G L D +K V S V L E ++ + H+N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 136 CCVE-GDHRILVYGYLENNSLAQTL----LGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
C+E G+ ++Y Y+ +L L LG ++ + Q ++ I +A G+++LH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAI 249
++H+DI A N ++D++L KI+D L++ LFP + + ++A E +
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309
+ + +D++SFGVLL E++ T + PY E EMA L + +L + ++
Sbjct: 193 NKEYSSASDVWSFGVLLWELM-----TLGQTPYVEIDPFEMAAYLKDGYRLAQPINC--- 244
Query: 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ C P+ RPS S LV L
Sbjct: 245 -------PDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 53/229 (23%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGV-REFLTEINVIKDIKHEN 129
+ + IG+G +G V T K G AIK +S Q + L EI +++ KHEN
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 130 LVELYG-----------------CCVEGD-HRILVYGYLENNSLAQTLLGRGHSSIQ-FN 170
++ + +E D ++++ +L N+ H IQ F
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSND----------H--IQYFL 112
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
+Q R GL ++H +++HRD+K SN+LL+ + KI DFGLA++ A+
Sbjct: 113 YQILR--------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPE 159
Query: 231 HISTR-----VAGTEGYLAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
H T VA T Y APE + + KA DI+S G +L E++S R
Sbjct: 160 HDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 80 IGQGGFGSVYKGTLKDGT--LAAIKVLSADS---RQGVREFLTEINVIK-DIKHENLVEL 133
+G+G FG V LK GT + AIKVL D V +TE ++ KH L L
Sbjct: 3 LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+ C D V Y+ L + S +F+ R V L FLH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLH---R 114
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRG 251
+++RD+K NILLD + K++DFG+ K + T T GT Y+APE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
+ D ++ GVL+ E+++G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
E + K+G+G + +V+KG K L A+K + + +G + E++++KD+KH N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI---GVAKGLA 186
+V L+ LV+ YL+ + L Q + G N + N+ I + +GLA
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKD-LKQYMDDCG------NIMSMHNVKIFLYQILRGLA 118
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+ H ++HRD+K N+L+++ K++DFGLA+ S V T Y P+
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 174
Query: 247 YAI-RGQLTRKADIYSFGVLLLEIVSGR 273
+ + + + D++ G + E+ SGR
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 80 IGQGGFGSVY----KGTLKDGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVE 132
+G+G FG V K T G A+K+L + ++ V LTE V+++ +H L
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L D V Y L L + F+ R + L +LH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERV-FSEDRARFYGAEIVSALGYLHSC- 114
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+V+RD+K N++LDKD KI+DFGL K ++ + T GT YLAPE
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 253 LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
R D + GV++ E++ G RLP+ Q
Sbjct: 172 YGRAVDWWGLGVVMYEMMCG------RLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 57/208 (27%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
E + +K+G+G + +V+KG K L A+K + + +G + E++++K++KH N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI---GVAKGLA 186
+V L+ LV+ YL+++ L Q L G N + N+ I + +GL+
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSD-LKQYLDNCG------NLMSMHNVKIFMFQLLRGLS 117
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+ H+ I+HRD+K N+L+++ K++DFGLA+ S V T Y P+
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 173
Query: 247 YAI-RGQLTRKADIYSFGVLLLEIVSGR 273
+ + + D++ G +L E+ +GR
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
E + +K+G+G + +VYKG K L A+K + + +G + E++++KD+KH N
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V L+ LV+ YL+ + L Q L G+S N + + +GL + H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCH 121
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
++HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177
Query: 250 -RGQLTRKADIYSFGVLLLEIVSGR 273
+ + D++ G + E+ +GR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 80 IGQGGFGSVYKGTL----KDGTLAAIKVLSA---DSRQGVREFLTEINVIKDIKHENLVE 132
+G G FG + +G L K AI L A D ++ R FL E + H N+V
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHSNIVR 70
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L G G+ ++V Y+ N +L L R H Q + G+A G+ +L E
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFL--RKHEG-QLVAGQLMGMLPGLASGMKYLSEM- 126
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL--APEYAIR 250
VH+ + A +L++ DL KIS F +L I T ++G L APE
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 251 GQLTRKADIYSFGVLLLEIVS 271
+ +D++SFG+++ E++S
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVRE-----FLTEI 119
+ ++ E+F+ +G G FG V T K+ + + + + +++ +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 120 NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
++ I H V LYG + + LV ++ + G + ++ N + ++
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFV--------IGGEFFTFLRRNKRFPNDVGC 134
Query: 180 GVAKGLAFLHEEVQP-HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--- 235
A + + E +Q +IV+RD+K N+LLDKD K++DFG AK+ + TR
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYT 187
Query: 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
+ GT Y+APE + + AD ++ G+ + EI+ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 35/114 (30%), Positives = 63/114 (55%), Gaps = 20/114 (17%)
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH--IST 234
I + + K L +LH + ++HRD+K SN+L++++ K+ DFG++ L T
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKT 161
Query: 235 RVAGTEGYLAPEYAIRGQLTR-----KADIYSFGVLLLEIVSGRCNTNRRLPYE 283
AG + Y+APE I +L + K+D++S G+ ++E+ +G R PY+
Sbjct: 162 IDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATG------RFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+GGFG V ++ G + A K L R+G L E +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG--VAKGLAFLHEEVQ 193
D LV + L + G + ++ R + + GL LH+E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL 253
IV+RD+K NILLD +ISD GLA P T I RV GT GY+APE +
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRR 279
T D ++ G LL E+++G+ +R
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 74 FSPANKIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQG------VREFLTEINVIKDIK 126
+ P +IG G +G+VYK G A+K + + + VRE + + ++
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFD 60
Query: 127 HENLVELYGCCVEG--DHRI---LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
H N+V L C D LV+ +++ + +T L + +T +++
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPP-GLPAETIKDLMRQF 117
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+GL FLH IVHRD+K NIL+ K++DFGLA+++ + T V T
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLW 172
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEI 269
Y APE ++ D++S G + E+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELY 134
++GQGG+G V+ KD G + A+K + VR LTE +++ K E LV+L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+ ++ L Y+ +TLL + + R + + + + LH +
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDF-RTLLN--NLGVLSEDHARFYM-AEMFEAVDALH---EL 120
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ-L 253
+HRD+K N L+D K++DFGL+K + + V G+ Y+APE +RG+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPE-VLRGKGY 175
Query: 254 TRKADIYSFGVLLLEIVSG 272
D +S G +L E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKG-TLKDGT--LAAIKVLSADSRQGVR-EFLTEINVIKDIK- 126
+ + +IG+G +G V+K LK+G +A +V +G+ + E+ V++ ++
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 127 --HENLVELYGCC-VEGDHR----ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
H N+V L+ C V R LV+ +++ + T L + +T +++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD--LTTYLDKVPEP-GVPTETIKDMMF 117
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
+ +GL FLH +VHRD+K NIL+ K++DFGLA+++ + T V T
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 172
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y APE ++ D++S G + E+ +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+G FG V K G A+K+L + ++ V LTE V+K+ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
D V Y+ L L F+ R + L +LH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
IV+RD+K N++LDKD KI+DFGL K + + T GT YLAPE R
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 256 KADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
D + GV++ E++ G RLP+ Q
Sbjct: 175 AVDWWGLGVVMYEMMCG------RLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 80 IGQGGFGSVY----KGTLKDGTLAAIKVLSAD---SRQGVREFLTEINVIK-DIKHENLV 131
+G+G FG V KGT + L AIK+L D V + E V+ K L
Sbjct: 8 LGKGSFGKVMLAERKGTDE---LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+L+ C D V Y+ L + G +F +A GL FLH +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAI 249
I++RD+K N++LD + KI+DFG+ K +F T GT Y+APE
Sbjct: 121 ---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIAPEIIA 174
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR 273
+ D ++FGVLL E+++G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHE 128
+ P IG G +G V + G AIK + D + L E+ +++ KH+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 129 NLVELYGCCV----EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
N++ + + +V +E++ L + HS + R + +G
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESD-LHHII----HSDQPLTEEHIRYFLYQLLRG 119
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL---FPANLTHISTRVAGTEG 241
L ++H +++HRD+K SN+L+++D +I DFG+A+ P + T T
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 242 YLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGR 273
Y APE + + T D++S G + E++ GR
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 62/211 (29%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 73 NFSPANKIGQGGFGSVY----KGTLKDGTLAAIKVLS----ADSRQGVREFLTEINVIKD 124
NF +G G +G V+ G G L A+KVL + TE V++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 125 IKHEN-LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
++ LV L+ L+ Y+ L L R H F R +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESEVRVYIAEIVL 116
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
L LH Q I++RDIK NILLD + ++DFGL+K F A + GT Y+
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 244 APEYAIRGQL--TRKADIYSFGVLLLEIVSG 272
APE G + D +S GVL E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVI-KDIKHENLVELY 134
IG+G FG V K DG A+KVL +R+ + + E NV+ K++KH LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+ V ++ L L F R +A L +LH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLH---SI 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
+IV+RD+K NILLD ++DFGL K A + +T GT YLAPE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 255 RKADIYSFGVLLLEIVSG 272
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KH 127
+F+ +G+G FG V K L AIK+L D V + E V+ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
L +L+ C D V Y+ L + G +F ++ GL F
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFF 116
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV-AGTEGYLAPE 246
LH I++RD+K N++LD + KI+DFG+ K + ++TR GT Y+APE
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPE 171
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ D +++GVLL E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 41/249 (16%)
Query: 79 KIGQGGFGSVYKG-TLKDGTLAAIKVLS---ADSRQGVREFLTEINVIKDIKHENLVELY 134
IG+GG G VY A+K + +++ + FL E + D+ H +V +Y
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 135 GCCVEGDHRILVYGYLENNSLAQTL--------LGRGHSSIQFNWQTRRNICIGVAKGLA 186
C +GD Y+E +L L L + + + + +I + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA-EKTSVGAFLSIFHKICATIE 127
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA------------------N 228
++H + ++HRD+K NILL I D+G A +
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS----GRCNTNRRLPYEE 284
+T I ++ GT Y+APE + + DIY+ GV+L ++++ R R++ Y +
Sbjct: 185 MT-IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD 243
Query: 285 QYL--LEMA 291
L +E+A
Sbjct: 244 VILSPIEVA 252
|
Length = 932 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 50/222 (22%)
Query: 78 NKIGQGGFGSVYKGTLKDG--TLAAIKVLSA-----DSRQGVRE--FLTEINVIKDIKHE 128
K+G+G +G V+K + +A K+ A D+++ RE FL E+ H
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHP 67
Query: 129 NLVELYGCCV---EGDHRI-LVYGYLE---NNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
N+V+L V E D I LV+ Y+E + + +L H +R I +
Sbjct: 68 NIVKLLN--VIKAENDKDIYLVFEYMETDLHAVIRANILEDVH---------KRYIMYQL 116
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--------PANLT-HI 232
K L ++H +++HRD+K SNILL+ D K++DFGLA+ LT ++
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 233 STRVAGTEGYLAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
+TR Y APE + K D++S G +L E++ G+
Sbjct: 174 ATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
+G G G V+ D A+K + Q V+ L EI +I+ + H+N+V++Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 139 EGDHRI--------------LVYGYLEN---NSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
+ +V Y+E N L Q L H+ + F +Q R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLR------ 125
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLFPANLTHISTRVAG-- 238
GL ++H +++HRD+K +N+ ++ +DL KI DFGLA++ + +H G
Sbjct: 126 --GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 239 TEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGR 273
T+ Y +P + T+ D+++ G + E+++G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 63/300 (21%), Positives = 107/300 (35%), Gaps = 53/300 (17%)
Query: 81 GQGGFGSVYKGTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
+ K TL A+K L + S++ ++ EI + ++H N++ +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+V + S L + H I V L ++H + +H
Sbjct: 70 VDSELYVVSPLMAYGSC--EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIH 124
Query: 199 RDIKASNILLDKDLTPKISDF---------GLAKLFPANLTHISTRVAGTEGYLAPEY-- 247
R +KAS+ILL D +S G + + S + +L+PE
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQ 181
Query: 248 -AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE----QYLLE----MAWKLYERG 298
++G K+DIYS G+ E+ +G +P+++ Q LLE L ++
Sbjct: 182 QNLQG-YNEKSDIYSVGITACELANG------HVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 299 KLVELVDASLNGDYSVEEA----------HRYL-----KIALLCTQDMPKRRPSMSTLVN 343
D+ S E R + LC Q P+ RPS S L+N
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 49/238 (20%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKH 127
++F IG+G FG V+ KD G + A+KVL R + E +++ D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 128 ENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVA 182
+V+LY + + + LV Y+ L LL R + +F +A
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDL-MNLLIRKDVFPEETARFY----------IA 108
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA--------------- 227
+ + L + +HRDIK NIL+D D K++DFGL K
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 228 -------------NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
+ GT Y+APE + D +S GV+L E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVI-KDIKHENLVELY 134
IG+G FG V K DG+ A+KVL + ++ + E NV+ K++KH LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+ V Y+ L L F R VA + +LH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHSL--- 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+I++RD+K NILLD ++DFGL K + P T + GT YLAPE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEP 172
Query: 253 LTRKADIYSFGVLLLEIVSG 272
R D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+G FG V K G A+K+L + ++ V LTE V+++ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
D V Y L L F+ R + L +LH E +
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE--KN 116
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
+V+RD+K N++LDKD KI+DFGL K + + T GT YLAPE R
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 175
Query: 256 KADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
D + GV++ E++ G RLP+ Q
Sbjct: 176 AVDWWGLGVVMYEMMCG------RLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---PANLTHISTRVA 237
VA+G+ FL +HRD+ A NILL ++ KI DFGLA+ P + S R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 238 GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
++APE T ++D++SFGVLL EI S + PY + E + +
Sbjct: 240 LK--WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----PYPGVQINEEFCQRLKD 292
Query: 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
G + + + E +R I L C Q PK RP+ S LV +L
Sbjct: 293 GTRMRA------PENATPEIYR---IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 29/166 (17%)
Query: 116 LTEINVIKDIKHENLVEL-----YG---CCVEGDHRILVYGYLENNSLAQTLLGRGHSSI 167
L E +++++ H +++ + G C V + +Y YL S +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI-------- 156
Query: 168 QFNWQTRRNICI--GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ + I + +GL +LH I+HRD+K NI ++ I D G A+ F
Sbjct: 157 ------DQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-F 206
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
P +AGT APE R + KADI+S G++L E+++
Sbjct: 207 PVVAPAF-LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+G FG V K G A+K+L + ++ V +TE V+++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
D V Y L L F + R + L +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---D 115
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
+V+RDIK N++LDKD KI+DFGL K ++ + T GT YLAPE R
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 256 KADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
D + GV++ E++ G RLP+ Q
Sbjct: 175 AVDWWGLGVVMYEMMCG------RLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/200 (31%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVI-KDIKHENLVELY 134
IG+G FG V K + A+KVL + ++ + ++E NV+ K++KH LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
D V Y+ L L F R +A L +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST--RVAGTEGYLAPEYAIRGQ 252
+IV+RD+K NILLD ++DFGL K N+ H T GT YLAPE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 253 LTRKADIYSFGVLLLEIVSG 272
R D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVEL-Y 134
+G+GGFG V ++ G L A K L+ R+G + E ++ + +V L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 135 G-------CCVE-----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
C V GD R +Y E N G + + T + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--------GFPEPRACFYTAQIIS---- 108
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
GL LH Q I++RD+K N+LLD D +ISD GLA + + AGT G+
Sbjct: 109 -GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGF 163
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
+APE + D ++ GV L E+++ R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHEN 129
+++ K+G+G + +VYKG K +G L A+KV+ +G + E +++K +KH N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V L+ + LV+ Y+ + L Q + H + + + + +GL+++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTD-LCQYM--DKHPG-GLHPENVKLFLFQLLRGLSYIH 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
Q +I+HRD+K N+L+ K++DFGLA+ + +H + T Y P+ +
Sbjct: 121 ---QRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 250 -RGQLTRKADIYSFGVLLLEIVSG 272
+ + D++ G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 79 KIGQGGFGSVY----KGTLKDGTLAAIKVLSA---DSRQGVREFLTEINVIKDIKHENLV 131
++G+G FG+VY K + + L +K + + + V+ E ++ + H +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIV 65
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+ + +E D ++ Y E L L H+ + I + G+ ++H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
I+HRD+KA NI L +L KI DFG+++L + ++T GT Y++PE
Sbjct: 126 ---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQ 180
Query: 252 QLTRKADIYSFGVLLLEI 269
K+DI+S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 80 IGQGGFGSVYK-GTLKDGTLAAIKVLSADSRQGV-REFLTEINVIKDIK-HENLVELYGC 136
IG+G +G V+K K+G+ AA+K+L D + E E N++K + H N+V+ YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 137 -----CVEGDHRILVYGYLENNS---LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
GD LV S L + L RG + I GL L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPIIAYILHEALMGLQHL 140
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY- 247
H +HRD+K +NILL + K+ DFG++ + +T V GT ++APE
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 248 AIRGQLTR----KADIYSFGVLLLEIVSG 272
A QL + D++S G+ +E+ G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 73 NFSPANKIGQGGFGSV----YKGTLKDGTLAAIKVLSADS---RQGVREFLTEINVIKDI 125
+F +G G FG V +KGT G AIK L + V+ E +++ ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 126 KHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
H +V + C + ++R+ + ++ L L G +F + +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLA 130
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
+LH + I++RD+K N+LLD K++DFG AK + + + GT YLA
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLA 183
Query: 245 PEYAIRGQLTRKA-DIYSFGVLLLEIVSG 272
PE I+ + KA D ++ GVLL E ++G
Sbjct: 184 PE-VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKG-TLKDGTLAAIK-VLSADSRQGV-REFLTEINVIKDIKHE 128
+ + KIG+G +G VYK G L A+K +G+ L EI++++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 129 N-LVELYGCCVE------GDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
+V L VE G + LV+ YL+++ +T ++
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP-KISDFGLAKLFPANLTHISTRVAGT 239
+ KG+A H+ ++HRD+K N+L+DK KI+D GL + F + + + T
Sbjct: 119 LLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 240 EGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSG 272
Y APE + + DI+S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 80 IGQGGFGSVY---KGTLKD-GTLAAIKVLS----ADSRQGVREFLTEINVIKDIKHENLV 131
+G+GG+G V+ K T D G + A+KVL +++ E N+++ +KH +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+L G L+ YL L L G F T ++ L LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLH-- 117
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAI 249
Q I++RD+K NILLD K++DFGL K + +TH GT Y+APE +
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILM 173
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR---CNTNRR 279
R + D +S G L+ ++++G NR+
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 11/198 (5%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+GGFG V ++ G + A K L R+G L E +++ + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
D LV + L + G+ F + + GL LH E +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHRE---N 122
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
V+RD+K NILLD +ISD GLA P I RV GT GY+APE + T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 256 KADIYSFGVLLLEIVSGR 273
D + G L+ E++ G+
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+GGFG V ++ G + A K L R+G L E +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
D LV + L + G+ F+ Q + GL L E
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQRE---R 122
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
IV+RD+K NILLD +ISD GLA P T + RV GT GY+APE + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 256 KADIYSFGVLLLEIVSGRCNTNRR 279
D + G L+ E++ G+ +R
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 80 IGQGGFGSVY----KGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYG 135
IG+G FG V + T + L I+ SR V L E V+ + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
+ LV ++ L L G +F+ R + L LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHKF---N 113
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
+++RD+K NILLD + DFGL KL + +T GT YLAPE + T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 256 KADIYSFGVLLLEIVSG 272
D ++ GVLL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA+G+ FL +HRD+ A NILL ++ KI DFGLA+ + ++ A
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 241 -GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299
++APE T ++D++SFGVLL EI S + PY + E + + G
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----PYPGVQIDEEFCRRLKEGT 293
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ +Y+ E + I L C + P+ RP+ S LV +L
Sbjct: 294 RMR------APEYATPEIYS---IMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 70/271 (25%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 80 IGQGGFGSVYKGTL----KDGTLAAIKVLS--ADSRQGVREFLTEINVIKDIKHENLVEL 133
+G+G +G V +L DG IK L+ SR+ + E ++ +KH N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 134 YGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
Y EG+ +L V G+ E L L + + N + I +A L +LHE+
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA--LQYLHEK 121
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
HI+HRD+K N+ L + K+ D G+A++ ST + GT Y++PE
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177
Query: 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
K+D+++ G + E+ + + + + + + +++ E GKL + D
Sbjct: 178 PYNYKSDVWALGCCVYEMAT------LKHAFNAKDMNSLVYRIIE-GKL-----PPMPKD 225
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
YS E L +L + P++RPS+ +++
Sbjct: 226 YSPELGE--LIATMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLS-ADSRQGVREF-LTEINVIKDIKHENLVELYGC 136
+G+G +G V K K+ + AIK ++ + V+E L E+ +++ +K EN+VEL
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
LV+ Y+E N L L + + R I + K + + H+ I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DI 121
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRK 256
VHRDIK N+L+ + K+ DFG A+ T T Y +PE + +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 257 ADIYSFGVLLLEIVSGR 273
D++S G +L E+ G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 78 NKIGQGGFGSVYKG-TLKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIK-HENLVEL 133
KIG+G F V K + K G AIK + S + V L EI ++ + H N++ L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRL 63
Query: 134 YGCCVEGDHR--ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+ LV+ ++ N L + + GR + ++ + K L +H
Sbjct: 64 IEVLFDRKTGRLALVFELMDMN-LYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMH-- 117
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---PANLTHISTRVAGTEGYLAPEYA 248
+ I HRDIK NIL+ D+ K++DFG + P +ISTR Y APE
Sbjct: 118 -RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYISTR-----WYRAPECL 170
Query: 249 IR-GQLTRKADIYSFGVLLLEIVS 271
+ G K DI++ G + EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
+G+GGFG V +K+ G + A K L + G + L E +++ + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI--CIGVAKGLAFLHEEVQ 193
H LV + L + G ++ R I + G+ LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME----RVIHYSAQITCGILHLHSM-- 114
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL 253
IV+RD+K N+LLD ++SD GLA T T+ AGT GY+APE
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 254 TRKADIYSFGVLLLEIVSGR 273
+ D ++ G + E+V+GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHEN---LVE 132
IG+G FG VY+ KD + A+KVLS +++ V + E N++ + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L LV Y+ L L G +F+ + + L LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY- 115
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT--HISTRVAGTEGYLAPEYAIR 250
IV+RD+K NILLD + DFGL+K ANLT + GT YLAPE +
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 251 GQ-LTRKADIYSFGVLLLEIVSG 272
+ T+ D +S GVL+ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 45/243 (18%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKG-TLKDGTLAAIKV 103
+R E+N+ + E+ + +N SP +G G +GSV K G A+K
Sbjct: 4 YRQELNKTIWEVPER-----------YQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKK 49
Query: 104 LSADSRQGVREFLT--EINVIKDIKHENLVELY-----GCCVEGDHRILVYGYLE----N 152
LS + + T E+ ++K +KHEN++ L +E + + + +L N
Sbjct: 50 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 109
Query: 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212
N + L H +QF + + +GL ++H I+HRD+K SN+ +++D
Sbjct: 110 NIVKCQKLTDDH--VQF-------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 157
Query: 213 TPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIV 270
KI DFGLA+ +T +++TR Y APE + + DI+S G ++ E++
Sbjct: 158 ELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
Query: 271 SGR 273
+GR
Sbjct: 213 TGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHE 128
E ++ ++G G +GSV + G AIK LS S + E+ ++K ++HE
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 129 N---LVELYGCCVEGDHR---ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
N L++++ V GD LV Y++ + Q ++G S + + + +C
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC---- 128
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEG 241
GL ++H I+HRD+K N+ +++D KI DFGLA+ A +T ++ TR
Sbjct: 129 -GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 242 YLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
Y APE + + DI+S G ++ E+++G+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 33/182 (18%)
Query: 103 VLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGR 162
V+ A R G TE ++++ I H ++++L G + Y N +L R
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPR 164
Query: 163 GHSSIQFNWQTRRNICI--------GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214
+ + +RNI I V + + +LHE I+HRDIKA NI ++
Sbjct: 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDV 221
Query: 215 KISDFGLAKLFPANLTHISTRVAGTEGYLA---PEYAIRGQLTRKADIYSFGVLLLEIVS 271
+ DFG A FP ++ + + G G +A PE R DI+S G++L E+ +
Sbjct: 222 CLGDFG-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
Query: 272 GR 273
Sbjct: 279 CH 280
|
Length = 391 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 74 FSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHENL 130
P IG G FG V+ T +DG A+K + + + E+ ++ KH+N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 131 VELYGCCVEGD----HRILVYGYLENNSLAQTLLGRGHSSIQ----FNWQTRRNICIGVA 182
+ I V L + L + ++ S F +Q R
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR------- 114
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
GL +LH I+HRDIK N+L++ + KI DFGLA++ + + T+ T+ Y
Sbjct: 115 -GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 243 LAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
APE + + T DI+S G + E++ R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 64/241 (26%), Positives = 90/241 (37%), Gaps = 55/241 (22%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS---ADSRQGVREFLTEINVIKDIKHEN 129
F +G+G G V+ LK G L A+KVL R V+ LTE ++ + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK------ 183
L LY + LV Y L + L Q + + VA+
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL----------QRQPGKCLSEEVARFYAAEV 112
Query: 184 --GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK------------------ 223
L +LH IV+RD+K NILL + +SDF L+K
Sbjct: 113 LLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 224 ----------LFPANLTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSG 272
F + S GTE Y+APE I G D ++ G+LL E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 273 R 273
Sbjct: 229 T 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 18/166 (10%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VAKG+ FL +HRD+ A NILL ++ KI DFGLA+ + ++ A
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 241 -GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299
++APE T ++D++SFGVLL EI S + + +E++ + R
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
DY+ E ++ + L C P +RP+ S LV L
Sbjct: 305 -----------DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 80 IGQGGFGSVYKGTLKDGT--LAAIKVLSAD---SRQGVREFLTEINVIK-DIKHENLVEL 133
+G+G FG V K GT L AIK+L D V + E V+ K L +L
Sbjct: 8 LGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+ C D V Y+ L + G +F +A GL FLH +
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV-AGTEGYLAPEYAIRGQ 252
I++RD+K N++LD + KI+DFG+ K ++T+ GT Y+APE
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 253 LTRKADIYSFGVLLLEIVSGR 273
+ D ++FGVLL E+++G+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 39/90 (43%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL LH E IV+RD+K NILLD +ISD GLA P T I RV GT GY+
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
APE + T D + G L+ E++ G+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSV-YKGTLKDGTLAAIKV 103
+R EVN+ + E+ D Y+DL+ ++G G +G+V + G AIK
Sbjct: 2 YRQEVNKTIWEVPDR----YRDLK----------QVGSGAYGTVCSALDRRTGAKVAIKK 47
Query: 104 LSA--DSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161
L S + E+ ++K +KHEN++ L + + T LG
Sbjct: 48 LYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLG 107
Query: 162 R-------GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214
+ IQF + + KGL ++H I+HRD+K N+ +++D
Sbjct: 108 KLMKHEKLSEDRIQF-------LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCEL 157
Query: 215 KISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSG 272
KI DFGLA+ + +T ++ TR Y APE + T+ DI+S G ++ E+++G
Sbjct: 158 KILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 273 R 273
+
Sbjct: 213 K 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAA---IKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
+IG G FG V G + G A +K L S Q +FL E + ++H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLG-RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C E +LV + L L R + + T + + +A GL LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKL-FPANLTHISTRVAGTEGYLAPEYA--IR 250
+ +H D+ N LL DLT KI D+GL+ + + ++ ++APE +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 251 GQL-----TRKADIYSFGVLLLEI 269
G L T++++++S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 37/211 (17%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGC 136
K+G+G + +VYKG K G L A+K + + +G + E +++KD+KH N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 137 CVEGDHRILVYGYLENNSLAQTL--LGRG---HSSIQFNWQTRRNICIGVAKGLAFLHEE 191
LV+ YL+ + L Q + G G H+ F +Q R GLA+ H
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLR--------GLAYCH-- 120
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGL--AKLFPANLTHISTRVAGTEGYLAP---- 245
Q ++HRD+K N+L+ + K++DFGL AK P+ T+ + V T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVV--TLWYRPPDVLL 176
Query: 246 ---EYAIRGQLTRKADIYSFGVLLLEIVSGR 273
EY + D++ G + E+ +GR
Sbjct: 177 GSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 73 NFSPANKIGQGGFGSVY---KGTLKD-GTLAAIKVLS----ADSRQGVREFLTEINVIKD 124
NF +G G +G V+ K T D G L A+KVL + V TE NV++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 125 IKHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
++ + + + ++ L+ Y+ + L R + F+ R +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIIL 116
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
L LH + IV+RDIK NILLD + ++DFGL+K F + + GT Y+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 244 APEYAIRGQL--TRKADIYSFGVLLLEIVSG 272
APE IRG+ + D +S G+L+ E+++G
Sbjct: 174 APE-IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 46/221 (20%)
Query: 79 KIGQGGFGSV----YKGTLKDGTLAAIKVLSADSRQ-GVREFLTEINVIKDIK-HENLVE 132
++GQG +G V T ++ T+A K+ + S++ + L E+ +++ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 133 LYGCCVEGDHRIL-------VYGYLE--NNSLAQTL-----LGRGHSSIQ-FNWQTRRNI 177
LY D I+ +Y Y E L Q + L H Q F +Q +
Sbjct: 67 LY------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH--FQSFIYQI---L 115
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT----HIS 233
C GL ++H +++HRD+K N+L++ D KI DFGLA+ F N ++
Sbjct: 116 C-----GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
VA T Y APE + Q KA D++S G +L E++ +
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 39/100 (39%), Positives = 58/100 (58%), Gaps = 14/100 (14%)
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHIST 234
ICI L FLHE I++RD+K N+LLD D K++D+G+ K L P + T +
Sbjct: 105 ICIA----LNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---S 154
Query: 235 RVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
GT Y+APE +RG+ D ++ GVL+ E+++GR
Sbjct: 155 TFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL +H +V+RD+K +NILLD+ +ISD GLA F H S GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 244 APEYAIRG-QLTRKADIYSFGVLLLEIVSG 272
APE +G AD +S G +L +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 73 NFSPANKIGQGGFGSVY---KGTLKD-GTLAAIKVLS-------ADSRQGVREFLTEINV 121
NF +G G +G V+ K + D G L A+KVL A + + R TE V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQV 57
Query: 122 IKDIKHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ I+ + + D ++ L+ Y+ L L R +F Q +
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGE 113
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
+ L LH + I++RDIK NILLD + ++DFGL+K F + + GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 241 GYLAPEYAIRGQLT---RKADIYSFGVLLLEIVSG 272
Y+AP+ +RG + D +S GVL+ E+++G
Sbjct: 171 EYMAPD-IVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 22/219 (10%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDG-TLAAIKVLSADS---RQGVREFLTEIN 120
LR+ E+F IG+G FG V K + A+K+LS R F E +
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 121 VIKDIKHENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
++ E +V+L D + L V Y+ L + + I W R
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWA--RFYT 148
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN-LTHISTRVA 237
V L +H +HRD+K N+LLDK K++DFG AN + T V
Sbjct: 149 AEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204
Query: 238 GTEGYLAPEY----AIRGQLTRKADIYSFGVLLLEIVSG 272
GT Y++PE G R+ D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGCC 137
K+G+G +G VYK KDG L G+ EI +++++KH N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 138 V-EGDHRI-LVYGYLENNSLAQTLLGRGHSS----IQFNWQTRRNICIGVAKGLAFLHEE 191
+ D ++ L++ Y E++ R + +Q +++ + G+ +LH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 192 VQPHIVHRDIKASNILLDKDLTP----KISDFGLAKLFPANLTHIS--TRVAGTEGYLAP 245
++HRD+K +NIL+ + KI+D G A+LF + L ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 246 EYAIRGQ-LTRKADIYSFGVLLLEIVS 271
E + + T+ DI++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADS---RQGVREFLTE---INVIKDIKHENLVE 132
IG+GGFG VY D G + A+K L +QG L E ++++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ D + + L L G F+ + R + GL +H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF 117
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+V+RD+K +NILLD+ +ISD GLA F H S GT GY+APE +G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 253 -LTRKADIYSFGVLLLEIVSG 272
AD +S G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVELYGCC 137
K+G+G +G VYK KDG L G+ EI +++++KH N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 138 V-EGDHRI-LVYGYLENNSLAQTLLGRGHSS----IQFNWQTRRNICIGVAKGLAFLHEE 191
+ D ++ L++ Y E++ R + +Q +++ + G+ +LH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 192 VQPHIVHRDIKASNILLDKDLTP----KISDFGLAKLFPANLTHIS--TRVAGTEGYLAP 245
++HRD+K +NIL+ + KI+D G A+LF + L ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 246 EYAIRGQ-LTRKADIYSFGVLLLEIVS 271
E + + T+ DI++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAA---IKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
+IG G FG V + T A +K L A+ S + EFL + + + ++H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 135 GCCVEGDHRILVYGYLE----NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G CVE +LV+ Y E + L+Q R +S + +R C +A G+ +H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMAC-EIAAGVTHMHK 117
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT--HIST--RVAGTEGYLAPE 246
+ +H D+ N L DLT K+ D+G+ P+ +I T +LAPE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 247 YA-------IRGQLTRKADIYSFGVLLLEI 269
I + T+ +++++ GV L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 49/245 (20%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSV---YKGTLKDGTLAAI 101
+R E+N+ V E+ + Y++L +G G +GSV Y L+ A+
Sbjct: 2 YRQELNKTVWEVPER----YQNLT----------PVGSGAYGSVCSAYDTRLRQKV--AV 45
Query: 102 KVLSA--DSRQGVREFLTEINVIKDIKHEN---LVELYGCCVEGDHRILVY------GYL 150
K LS S R E+ ++K +KHEN L++++ ++ VY G
Sbjct: 46 KKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGAD 105
Query: 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK 210
NN + L H +QF + + +GL ++H I+HRD+K SN+ +++
Sbjct: 106 LNNIVKCQKLSDEH--VQF-------LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNE 153
Query: 211 DLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLE 268
D +I DFGLA+ +T +++TR Y APE + + DI+S G ++ E
Sbjct: 154 DCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 269 IVSGR 273
++ G+
Sbjct: 209 LLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 10/92 (10%)
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGY 242
L FLHE I++RD+K N+LLD + K++D+G+ K + P + T + GT Y
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNY 162
Query: 243 LAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
+APE +RG+ D ++ GVL+ E+++GR
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 58/273 (21%), Positives = 113/273 (41%), Gaps = 45/273 (16%)
Query: 87 SVYKGTLKDGTLAAIKVL---SADSRQGVREFLTEINVIKDIKHENLVELYG----CCVE 139
S+YKG + I+ + + EI ++ I N++++YG +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-QPHIVH 198
L+ Y L + L + F +T+ ++ I KGL L++ +P+
Sbjct: 94 LPRLSLILEYCTRGYLREVL--DKEKDLSF--KTKLDMAIDCCKGLYNLYKYTNKPY--- 146
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA--IRGQLTRK 256
+++ + + L+ ++ KI GL K+ L+ + Y + + I + T K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 257 ADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE- 315
DIYS GV+L EI +G ++P+E + K E+ D +N + S++
Sbjct: 203 DDIYSLGVVLWEIFTG------KIPFE-----NLTTK--------EIYDLIINKNNSLKL 243
Query: 316 --EAHRYLK-IALLCTQDMPKRRPSMSTLVNML 345
+ +K I CT +RP++ ++ L
Sbjct: 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 28/77 (36%), Positives = 51/77 (66%), Gaps = 1/77 (1%)
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLT 254
++HRD+K++NI L K+ DFG +K + +++ +++ GT YLAPE R + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 255 RKADIYSFGVLLLEIVS 271
+KAD++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 80 IGQGGFGSVYKGTLK-------DGTLAAIKVLSADSRQGVR---EFLTEINVIKDIKHEN 129
+GQG F ++YKG L+ G + V+ R F +++ + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF-L 188
LV+LYG CV ++ I+V Y++ L L R +++ +W+ + VAK LA L
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPL-DVFLHREKNNVSLHWK------LDVAKQLASAL 114
Query: 189 HEEVQPHIVHRDIKASNILLDKD-----LTP--KISDFGLAKLFPANLTHISTRVAGTEG 241
H +VH ++ NIL+ + P K+SD G+ P + RV
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERIP- 169
Query: 242 YLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSG 272
++APE GQ LT AD +SFG LLEI S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 12/96 (12%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA+G+ FL + + VHRD+ A N+LL + KI DFGLA+ ++ H S V+
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 241 GYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS 271
+L APE T +D++S+G+LL EI S
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHENL 130
+ P IG+G +G V + AIK ++ D+R + L EI +++ + HEN+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 131 VELYGCCVEGDHR------ILVYGYLENNSLAQTL-----LGRGHSSIQFNWQTRRNICI 179
+ + + HR +VY L + L Q + L H F +Q R
Sbjct: 67 IAIKDI-MPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQY-FLYQLLR---- 119
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
GL ++H +++HRD+K SN+LL+ + KI DFGLA+ ++ V T
Sbjct: 120 ----GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-T 171
Query: 240 EGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGR 273
Y APE + + T D++S G + E++ GR
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 28/171 (16%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA G+ FL + + VHRD+ A N+L+ + KI DFGLA+ ++ S ++
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGS 300
Query: 241 GYL-----APEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295
+L APE T +D++SFG+LL EI T PY E + E +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF-----TLGGTPYPELPMNEQFYNAI 355
Query: 296 ERG-KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+RG ++ + AS +E + ++ C ++ + RP S LV+++
Sbjct: 356 KRGYRMAKPAHAS-------DEIYEIMQ---KCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA+G+ FL + + +HRD+ A N+LL KI DFGLA+ + ++ V G
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 241 ----GYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLY 295
++APE T ++D++S+G+LL EI S G+ PY + +K+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS------PYPGILVNSKFYKMV 328
Query: 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS---MSTLVNMLIG 347
+RG + D++ E + +K +C P RP+ +S L+ +G
Sbjct: 329 KRGYQMS------RPDFAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VAKG++FL + + +HRD+ A NILL KI DFGLA+ ++ + S V
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIRNDSNYVVKGN 275
Query: 241 G-----YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295
++APE T ++D++S+G+LL EI S + +P + ++ +K+
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKMI 330
Query: 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ G + L+ + + E + +K C P +RP+ +V ++
Sbjct: 331 KEGYRM------LSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 72 ENFSPANKIGQGGFGSVY----KGTLKDGTLAAIKVLSAD---SRQGVREFLTEINVIKD 124
++F + +G+G FG V K T G + A+KV+ +++ V F E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGR-----GHSSIQFNWQTRRNICI 179
+ +L + D+ LV Y L +LL R QF
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY--------- 107
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
+A+ + +H Q VHRDIK N+L+D+ K++DFG A AN S GT
Sbjct: 108 -LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 240 EGYLAPEY------AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE 284
Y+APE +G + D +S GV+ E++ GR P+ E
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS------PFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLS---ADSRQGVREFLTEINVIKDI-KHENLVELY 134
IG+G + V LK + A+KV+ + + + TE +V + H LV L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI--------CIGVAKGLA 186
C V Y+ L F+ Q +R + ++ L
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL------------MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLA 244
+LHE I++RD+K N+LLD + K++D+G+ K L P + T + GT Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164
Query: 245 PEYAIRGQ-LTRKADIYSFGVLLLEIVSGR 273
PE +RG+ D ++ GVL+ E+++GR
Sbjct: 165 PE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 72 ENFSPANKIGQGGFGSVY----KGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH 127
E+F I G +G+VY K T + + I + R +++ E +++ ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V ++ H +V Y+E A L G + R L +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD----MARMYFAETVLALEY 116
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT------HIS--TR---- 235
LH IVHRD+K N+L+ K++DFGL+K+ +LT HI TR
Sbjct: 117 LHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 236 --VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
V GT Y+APE +R + D ++ G++L E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
G+ LH I+HRD+K SNI++ D T KI DFGLA+ N + T T Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYR 189
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSG 272
APE + DI+S G ++ E+V G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 65 KDLRVATENFSPANKIGQGGFGSV----YKGTLKDGTLAAIKVLSADSRQGVREFLTEIN 120
+DLR+ E++ IG+G FG V +K T K + + R F E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ +V+L+ + + +V Y+ L + + + W R
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--RFYTAE 150
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHISTRVAGT 239
V L +H +HRD+K N+LLDK K++DFG K+ + T V GT
Sbjct: 151 VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206
Query: 240 EGYLAPEYAIR----GQLTRKADIYSFGVLLLEIVSG 272
Y++PE G R+ D +S GV L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHEN 129
+N P QG + Y L AIK LS ++ + E+ ++K + H+N
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 130 LVELYGC-----CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++ L +E + + L + +L Q + ++ + + + + G
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCG 131
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
+ LH I+HRD+K SNI++ D T KI DFGLA+ A + + T T Y A
Sbjct: 132 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIV 270
PE + DI+S G ++ E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 30/78 (38%), Positives = 43/78 (55%), Gaps = 2/78 (2%)
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTR 255
I+HRD+K SNI++ D T KI DFGLA+ A + + T T Y APE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 256 KADIYSFGVLLLEIVSGR 273
DI+S G ++ E++ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 65 KDLRVATENFSPANKIGQGGFGSV----YKGTLKDGTLAAIKVLSADSRQGVREFLTEIN 120
+ L++ E++ IG+G FG V +K + K + + R F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ +V+L+ + + +V Y+ L + + + W +
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--KFYTAE 150
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTHISTRVAGT 239
V L +H ++HRD+K N+LLDK K++DFG K+ + T V GT
Sbjct: 151 VVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GT 206
Query: 240 EGYLAPEYAIR----GQLTRKADIYSFGVLLLEIVSG 272
Y++PE G R+ D +S GV L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 65/265 (24%), Positives = 98/265 (36%), Gaps = 63/265 (23%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADS---RQGVREFLTEINVIKDIKHEN 129
F +G G FG V D L A+K L R V E +++ + +E
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRG---HSSIQFNWQTRRNICIGVAKGLA 186
+V LY + D+ V Y+ + L+ G +F +A+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY----------IAELTC 112
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--------------------- 225
+ + +HRDIK NIL+D+D K++DFGL F
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 226 -------PAN------LTHISTRVA------------GTEGYLAPEYAIRGQLTRKADIY 260
PAN L + R A GT Y+APE +R T+ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 261 SFGVLLLEIVSGRCNTNRRLPYEEQ 285
S GV+L E++ G+ + P E Q
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHEN 129
+N P QG + Y L+ AIK LS ++ + E+ ++K + H+N
Sbjct: 27 QNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 130 LVELYGC-----CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++ L +E + + L + +L Q + ++ + + + + G
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCG 138
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
+ LH I+HRD+K SNI++ D T KI DFGLA+ A + + T T Y A
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
PE + DI+S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 53/232 (22%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKDGT-LAAIKVLSADSRQGVREFLTEINVIKDIK 126
R +++ N IG G FG VY+ D + AIK + D + RE L ++K++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 127 HENLVEL----YGCCVEGD-----------------HRILVYGYLENNSLAQTLLGRGHS 165
H N++ L Y C + + H+ + + Y NN L + +S
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-YARNNHALPLFLVKLYS 176
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKL 224
+C + LA++H + I HRD+K N+L+D + T K+ DFG AK
Sbjct: 177 Y---------QLC----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 225 FPA---NLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSG 272
A ++++I +R Y APE + T D++S G ++ E++ G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 101 IKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLL 160
+KVL R F +++ + H +L ++G CV G I+V ++E+ L L
Sbjct: 49 LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCL 107
Query: 161 GRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-----DLTP- 214
+ + W+ + +A L++L ++ ++VH ++ A NILL + +P
Sbjct: 108 RKEKGRVPVAWKI--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 215 -KISDFGLAKLFPANLTHIS--TRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEI 269
K+SD G++ T +S RV ++APE + G L+ AD +SFG LLEI
Sbjct: 163 IKLSDPGVS------FTALSREERVERIP-WIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214
Query: 270 V-SGRCNTNRRLPYEEQYLLEMAWKLYE 296
G R P E++ E +L E
Sbjct: 215 CFDGEVPLKERTPSEKERFYEKKHRLPE 242
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 80 IGQGGFGSVYKGTLKD---GTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHENLVELY 134
IG+G +G V + D G AIK ++ + L EI +++ ++H ++VE+
Sbjct: 8 IGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 135 GCCVEGDHR----ILVYGYLENNSLAQTL-----LGRGHSSIQFNWQTRRNICIGVAKGL 185
+ R I V L + L Q + L H F +Q R L
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-FLYQLLR--------AL 116
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL-FPANLTHIS-TRVAGTEGYL 243
++H ++ HRD+K NIL + D KI DFGLA++ F T I T T Y
Sbjct: 117 KYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 244 APEY--AIRGQLTRKADIYSFGVLLLEIVSGR 273
APE + + T DI+S G + E+++G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 67/265 (25%), Positives = 106/265 (40%), Gaps = 56/265 (21%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVL-SADSRQGVREFLTEINVIKDIKHEN 129
++F IG+G FG V KD G + A+K+L AD + +E + I +DI E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRAERDILVEA 58
Query: 130 ----LVELYGCCVEGDHRILVYGYLENNSLAQTLLGR---GHSSIQFNWQTRRNICIGVA 182
+V+++ + + L+ +L + L+ + + QF + + I
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVLAIDAI 117
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA--------KLFPANLTH--- 231
L F +HRDIK N+LLD K+SDFGL F NLTH
Sbjct: 118 HQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 232 -----------------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLE 268
++ GT Y+APE ++ + D +S GV++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 269 IVSGRCNTNRRLPYEEQYLLEMAWK 293
++ G P +E Y M WK
Sbjct: 229 MLIGYPPFCSETP-QETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVL-SAD--SRQGVREFLTEINVIKDIKH 127
E F I +G FG VY G K + L A+KV+ AD ++ V + E + + K
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V LY ++ LV YL + L G+ F+ + VA L +
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDY 119
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224
LH + I+HRD+K N+L+ + K++DFGL+K+
Sbjct: 120 LH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 21/232 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGT-LAAIKVLSA---DSRQGVREFLTEINVIKDIKH 127
++F IG+G FG V +K + A+K+L+ R F E NV+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+ + L+ + ++ LV Y L TLL + + + +A+ +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMAR-----FYIAEMVLA 114
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
+H Q H VHRDIK N+LLD + +++DFG + T S+ GT Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 248 --AIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
A+ G+ + D +S GV + E++ G P+ + L+E K+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 43/243 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
E+F IG+G FG V A +K+ +AD ++ L + ++K +
Sbjct: 1 EDFEILKVIGRGAFGEV----------AVVKLKNADKVFAMK-ILNKWEMLKRAETACFR 49
Query: 132 ELYGCCVEGDHR---ILVYGYLENNSLAQTL---LGRGHSSIQFNWQTRRNICIGVAKGL 185
E V GD++ L Y + + N+L + +G ++ ++ R + + +
Sbjct: 50 EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR------LPEDM 103
Query: 186 A--FLHEEV-------QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV 236
A +L E V Q H VHRDIK NIL+D + +++DFG + T S+
Sbjct: 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 237 AGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291
GT Y++PE +G+ + D +S GV + E++ G P+ + L+E
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETY 217
Query: 292 WKL 294
K+
Sbjct: 218 GKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 62/260 (23%), Positives = 104/260 (40%), Gaps = 46/260 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVL-SAD--SRQGVREFLTEINVIKDIKH 127
E+F IG+G FG V KD G + A+K+L AD ++ V E +++ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V+++ + + L+ +L + L+ + + T +A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLA 113
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--------LFPANLTH-------- 231
+ Q +HRDIK N+LLD K+SDFGL F NL H
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 232 ------------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
++ GT Y+APE ++ + D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 274 CNTNRRLPYEEQYLLEMAWK 293
P +E Y M WK
Sbjct: 234 PPFCSETP-QETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
QTR I + + ++H++ ++HRDIK NI L+ D + DFG A F
Sbjct: 267 KQTRA-IMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271
GT +PE DI+S G++LL+++S
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 36/140 (25%), Positives = 53/140 (37%), Gaps = 48/140 (34%)
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLF------------------------------P 226
+HRDIK NIL+D+D K++DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 227 ANLTHISTR------------VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274
L + R + GT Y+APE +R T+ D +S GV+L E++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-- 240
Query: 275 NTNRRLPYEEQYLLEMAWKL 294
+ P+ E K+
Sbjct: 241 ----QPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 29/150 (19%), Positives = 58/150 (38%), Gaps = 16/150 (10%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV--ELYGC 136
+ G VY KD +K+ + + RE E+ +++ + + L ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
L+ ++E G + + + + + +I +A+ LA LH+ +
Sbjct: 62 GESDGWSYLLMEWIE-----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFP 226
H D+ NIL+D I D+ A P
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY--AI- 249
Q VHRDIK N+LLDK+ +++DFG A+ T S GT Y++PE A+
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 250 --RGQLTRKADIYSFGVLLLEIVSG 272
+G+ + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 59/250 (23%), Positives = 95/250 (38%), Gaps = 57/250 (22%)
Query: 74 FSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHEN 129
F +G G FG V D L A+K L +R V E +++ + +E
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+LY + D+ V Y+ + L+ F R + + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVH 118
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF---------------------PAN 228
+ +HRDIK NIL+D D K++DFGL F P++
Sbjct: 119 ---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 229 L----------------------TH---ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFG 263
L H ++ + GT Y+APE +R T+ D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 264 VLLLEIVSGR 273
V+L E++ G+
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 37/231 (16%)
Query: 80 IGQGGFGSVYKGTLKDGT-------------LAAIKVLSADSRQGVREFLTEINVIKDIK 126
+G+G +Y G L +KVL R F ++++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H+++V LYG CV I+V ++E L + R + W + + +A L+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPW--KFKVAKQLASALS 119
Query: 187 FLHEEVQPHIVHRDIKASNILL-----DKDLTP--KISDFGLAKLFPANLTHISTRVAGT 239
+L ++ +VH ++ NILL D + P K+SD G+ P + V
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECVERI 172
Query: 240 EGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289
++APE + L+ AD +SFG L EI N +P +++ L E
Sbjct: 173 P-WIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 44/137 (32%)
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAK--------LFPANLTHI--------------ST 234
+HRDIK N+LLD K+SDFGL F L+H S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 235 RVA---------------GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR---CNT 276
R A GT Y+APE ++ ++ D +S GV++ E++ G C+
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 277 NRRLPYEEQYLLEMAWK 293
N + E Y + WK
Sbjct: 243 NPQ----ETYRKIINWK 255
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 52/216 (24%), Positives = 82/216 (37%), Gaps = 37/216 (17%)
Query: 80 IGQGGFGSVYKGTLKDGTL----AAIKVLSADSRQGVREFLTEINV-----------IKD 124
IG GGFG VY+ A K+ + ++ V E L N+ I +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 125 IKHENLVELYGCCVEGDHRI------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
I H + + YGC R+ L + + + + I +NI
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI-------KNIM 132
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA- 237
+ L ++HE I H DIK NI++D + I D+G+A F + HI
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 238 -----GTEGYLAPEYAIRGQLTRKADIYSFGVLLLE 268
GT Y + +TR+ D+ S G +L+
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 27/194 (13%)
Query: 96 GTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV---YGYL 150
GTL +++ + + + ++ E+ + +H N++ + G ++ Y
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK 210
NSL +T G S NI G +GL +LH Q +HR+IKAS+IL+
Sbjct: 85 SANSLLKTYFPEGMSEALI-----GNILFGALRGLNYLH---QNGYIHRNIKASHILISG 136
Query: 211 DLTPKISDFGLAKLFPANLTHISTRVA--------GTEGYLAPEYAIRGQL---TRKADI 259
D +S GL+ L+ +V +L+PE +R L K+DI
Sbjct: 137 DGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDI 193
Query: 260 YSFGVLLLEIVSGR 273
YS G+ E+ +GR
Sbjct: 194 YSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 25/162 (15%)
Query: 117 TEINVIKDIKHE---NLVELYG-----CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ 168
EI+++K I H NL+ Y C V ++ ++ Y++ +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD-----------RSGPLP 183
Query: 169 FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPA 227
+ I + + LA+LH I+HRD+K NI LD+ + DFG A KL
Sbjct: 184 L--EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEI 269
T +GT +PE K DI+S G++L E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 118 EINV---IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR 174
E V +KD + N ++LY +L+ Y+++ L L + +
Sbjct: 58 EPMVHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEV 111
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP-KISDFGLAKLFPANLTHIS 233
+ I + + L LH+ +I+H DIK N+L D+ + D+GL K+ +
Sbjct: 112 KKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-- 166
Query: 234 TRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSG 272
GT Y +PE I+G D ++ GVL E+++G
Sbjct: 167 ---DGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 59/258 (22%), Positives = 86/258 (33%), Gaps = 67/258 (25%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADSRQGVREFLTEINV 121
++F K+G+G FG VYK +L K+G VL + G E V
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKY----VLKKATEYGAVEIWMNERV 183
Query: 122 -------IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQT- 173
D + L + + D LV+ Y ++LA + + +N +
Sbjct: 184 RRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKE---FPYNVEPY 238
Query: 174 -------------RRNICIG-----VAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTP 214
R N I + L LH IVHRD+K NI+ +
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSF 295
Query: 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA----------------- 257
KI D G A + +I Y APE I T A
Sbjct: 296 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355
Query: 258 -----DIYSFGVLLLEIV 270
DIYS G++ L++
Sbjct: 356 LPDRFDIYSAGLIFLQMA 373
|
Length = 566 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 37/171 (21%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN- 129
E+F IG+G FG V KD G + A+K L S ++ L + +D+ E+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 130 ---LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQ------TRRNI--C 178
+V LY + + L+ +L L L+ + TR + C
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI---------KYDTFSEDVTRFYMAEC 110
Query: 179 I----GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ V K L F +HRDIK NIL+D+ K+SDFGL+ F
Sbjct: 111 VLAIEAVHK-LGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 67/219 (30%)
Query: 68 RVATENFSPANKIGQGGFGSVYKG---TLKDGTLAAIKVLSADS-------------RQG 111
R ++++F +K+G G FG ++G D + L+A+ RQG
Sbjct: 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG 200
Query: 112 VR-EFLTEINVIKDIKHENLVELYGC------------CVE---------------GDHR 143
VR +FL + K +VE Y C C E +
Sbjct: 201 VRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQ 260
Query: 144 ILVYGYLENNSLAQTLLGR--------------GHSSIQFNWQTRRNICI------GVAK 183
LV+ + + +L L G+ G Q +R+I + V
Sbjct: 261 WLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLT 320
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222
GL LH + IVHRDIK N+L+ D KI DFG A
Sbjct: 321 GLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 53/240 (22%), Positives = 100/240 (41%), Gaps = 34/240 (14%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVRE-----FLTE 118
Y D + KIG G FG V+ +K A S +G++E + E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 119 INVIKDIKHENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRN 176
+NV++++KH+N+V + ++ L + + + L++ + + +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 177 ICIGVAKGLAFLHE-EVQPH---IVHRDIKASNILLDKDL-----------------TPK 215
I + LA+ H + P+ ++HRD+K NI L + K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGR 273
I DFGL+K + ++ GT Y +PE + K+D+++ G ++ E+ SG+
Sbjct: 183 IGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.97 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.39 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.34 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.89 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.73 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.7 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.58 | |
| PLN02236 | 344 | choline kinase | 97.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.12 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.08 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.94 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.43 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.38 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.27 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.95 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=438.19 Aligned_cols=289 Identities=52% Similarity=0.865 Sum_probs=257.9
Q ss_pred CCcccchhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEE
Q 044232 58 DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137 (415)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 137 (415)
....|++.+++.+|++|.....||+|+||.||+|...+|..||||.+........++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988776443135699999999999999999999999
Q ss_pred EeCC-eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 138 VEGD-HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 138 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
.+.+ +.+|||||+++|+|.++|+..... +++|..+.+||.++|+||+|||+.+.+.|+||||||.|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999887544 7899999999999999999999998889999999999999999999999
Q ss_pred eeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 217 SDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 217 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
+|||+|+..+...........||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+.+|++..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976554111111111799999999999999999999999999999999999998887666677779999999999
Q ss_pred hCcchhhcccccC-CCCCH-HHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 297 RGKLVELVDASLN-GDYSV-EEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 297 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
++.+.+++|+.+. ..++. .....+..++.+|++.+|.+||+|.||+++|...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999987 66664 6788899999999999999999999999999543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=398.85 Aligned_cols=261 Identities=30% Similarity=0.510 Sum_probs=216.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-eeEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGD-HRIL 145 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 145 (415)
+...+..+.+.||+|+||+||+|.+++...||+|++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. .+++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3345556667799999999999999866669999998653 222568999999999999999999999999888 7999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCCeeecCCC-CeEEeeecccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH-IVHRDIKASNILLDKDL-TPKISDFGLAK 223 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 223 (415)
||||+++|+|.++++.. ....+++..+..|+.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++
T Consensus 118 VtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred EEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 99999999999999874 123799999999999999999999999 7 99999999999999998 99999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhh--cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAI--RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+ ...+......
T Consensus 193 ~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~---- 261 (362)
T KOG0192|consen 193 EKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVG---- 261 (362)
T ss_pred eecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc----
Confidence 654332 2233478999999999999 56999999999999999999999888776544 1222222222
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
..++..+..++..+..++.+||+.||..||++.+|+..|+....
T Consensus 262 -----~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 -----GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -----CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 33344455577889999999999999999999999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=378.58 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=212.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-eeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD-HRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 148 (415)
.+.+.++.||+|..|+|||++++ +++.+|+|.+... .....+++.+|+++++..+|||||.+||.|.... ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45667889999999999999987 7999999999655 4455578899999999999999999999999988 5999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||++|||++++...+ .+++....+|+.++++||.|||+ . +||||||||+||||+..|.|||+|||.+..+..
T Consensus 159 YMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999998765 68999999999999999999996 5 999999999999999999999999999997654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC-hhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP-YEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+ +.. ..+....+. +
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--~~~Ll~~Iv---------~- 296 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--IFELLCAIV---------D- 296 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--HHHHHHHHh---------c-
Confidence 3 55678899999999999999999999999999999999999999765411 111 111111111 1
Q ss_pred ccCCCCCH-HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSV-EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+..+. .++.++..++..||+.||.+||+++|+++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233344 37789999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=395.33 Aligned_cols=247 Identities=24% Similarity=0.414 Sum_probs=214.0
Q ss_pred cCCCCCCcccccCeEEEEEEEe-cCCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+|...+.||+|||+.||.++. .+|..||+|++.+. .....+...+|++|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999998 68999999999774 3344567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|+|++++|..++..+. ++++.+++.++.||+.||.|||+. +|+|||||..|++++++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998666 899999999999999999999999 999999999999999999999999999998865
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .+...+.+|||.|+|||++.....+..+||||+|||||-|+.|++||+.+.- .+....+...
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------kety~~Ik~~---------- 233 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KETYNKIKLN---------- 233 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHHHHHHHhc----------
Confidence 4 3445678999999999999999999999999999999999999988875421 1111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+-..|...+.+..+||.++|+.||.+|||+.+|+.
T Consensus 234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11223355677889999999999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=372.93 Aligned_cols=204 Identities=34% Similarity=0.606 Sum_probs=186.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..+|...++||+|+||+||+|+++ ++..||||.+.+. ..+..+-+..|+.+|+.++|||||++++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367889999999999999999986 6899999999877 5556667889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC------CCeEEeeecc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD------LTPKISDFGL 221 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 221 (415)
|||+||+|.++++.++ .+++.+++.++.||+.||++||++ +||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999887 799999999999999999999999 99999999999999765 4589999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
|+.+... ....+.+|++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||....+.+
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9988643 44567899999999999999999999999999999999999999998766544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=391.32 Aligned_cols=266 Identities=30% Similarity=0.459 Sum_probs=225.0
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
...+++..+.++.++.||+|.||.||.|.+++...||+|.++.... ....|.+|+++|++|+|+|||+++|+|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 4555566666777899999999999999999888999999987633 347899999999999999999999999998899
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
+||||||+.|+|.++|..... ..+...+.+.++.|||+||+||+++ ++|||||.++||||++++.+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999987332 2688899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...++.........-...|.|||.+..+.++.|||||||||+||||+|- +..|+......+.+..+
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~-----G~~py~~msn~ev~~~l--------- 417 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTY-----GRVPYPGMSNEEVLELL--------- 417 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhcc-----CCCCCCCCCHHHHHHHH---------
Confidence 6554444333444446689999999999999999999999999999985 45566665555544433
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
+...+...|..||..+.++|..||+.+|++|||+..+...|.....
T Consensus 418 -e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 418 -ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3344445677789999999999999999999999999998876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=374.40 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=210.1
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-------hHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-------GVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566888899999999999999865 8999999999765211 1223568999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEee
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISD 218 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 218 (415)
..||||||++||+|.+.+..++ .+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999998877 567778889999999999999999 99999999999999766 7899999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhhcCC---CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ---LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
||+|+.... .....+.+|||.|.|||++.++. +..++|+||+|||||-+++|..||..... ...+.+ ..
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~e----QI 394 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKE----QI 394 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHH----HH
Confidence 999997653 45567889999999999998754 34588999999999999999999875432 211222 22
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..|+. ...+.......++..+||.+||..||++|||+.|+++
T Consensus 395 ~~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 33322 1223445667888999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=359.30 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=213.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeee-EEEeCCe-eEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYG-CCVEGDH-RIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 145 (415)
..+|+++++||.|.||+||++... +|..+|.|.+..+ +....+....|+.+|++|+|||||++++ .+.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356888999999999999999865 8999999998765 3445567889999999999999999999 4555555 899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ-PHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
|||||.+|+|...++........+++.++++++.|++.||..+|++.+ .-|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999998776666789999999999999999999999421 1399999999999999999999999999998
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.++.- .+ ....+..+...
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~-L~~KI~qgd~~--- 246 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS-LCKKIEQGDYP--- 246 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH-HHHHHHcCCCC---
Confidence 87653 334557899999999999999999999999999999999999988887622 11 12222333221
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 305 DASLNGDYS-VEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 305 ~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
..+ .-.+.++..||..|+..||..||+.-.++..+..
T Consensus 247 ------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 ------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122 3456789999999999999999996555555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=365.14 Aligned_cols=243 Identities=28% Similarity=0.381 Sum_probs=206.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++++.||+|+||+||.++.+ +++.+|+|++++.. ....+...+|..+|..++||+||+++..|++...+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999876 69999999998762 3345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|+||+.||.|..+|++.+ .+++..++-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999999887 799999999999999999999999 9999999999999999999999999999965
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... .....+.+||+.|||||++.+..|+..+|+||||+++|||++|..||..... ..+..++... +
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~-k------ 241 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKG-K------ 241 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcC-c------
Confidence 433 2334558999999999999999999999999999999999999988765432 2222222221 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
....+.-...+..+++...++.+|++|-
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122222446788999999999999995
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=339.60 Aligned_cols=288 Identities=26% Similarity=0.347 Sum_probs=230.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
-++|+.++.||.|+||+|.+++.+ +|..+|+|++.+.. ..+.+...+|..+|+.+.||+++++++.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 367889999999999999999987 79999999998763 34556788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++||.|..++...+ ++++..++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999998877 799999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ..+.+|||.|+|||+++...++.++|.|||||++|||+.|..||....|... -.++. +++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~-~~~------- 257 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKIL-EGK------- 257 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHH-hCc-------
Confidence 43 4578999999999999999999999999999999999999999988766221 11111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCCccccCCCCcccccccccccCCCCCCCCcccCCCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGEKDKASAVSGDSS 386 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~s~~s~~~~ 386 (415)
-.+|.-...++.+|+...++.|-.+| +-..-.+..++..+.+.....|..+....+.....++....+++++
T Consensus 258 ---v~fP~~fs~~~kdLl~~LL~vD~t~R-----~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdts 329 (355)
T KOG0616|consen 258 ---VKFPSYFSSDAKDLLKKLLQVDLTKR-----FGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTS 329 (355)
T ss_pred ---ccCCcccCHHHHHHHHHHHhhhhHhh-----hcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccc
Confidence 12344445678899999999999988 1122224445555665555555555444444443333444556665
Q ss_pred CcccC
Q 044232 387 KLDHS 391 (415)
Q Consensus 387 ~~~~~ 391 (415)
+...-
T Consensus 330 nfd~y 334 (355)
T KOG0616|consen 330 NFDDY 334 (355)
T ss_pred ccccc
Confidence 54443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=342.71 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=208.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+.|+.+.++|+|+||.|||++.+ +|+.||||++... +..-.+-.++|+.+|++++|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999987 6999999998654 23344567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
||+..-| +-|..... .++...+.+++.|++.|+.|+|++ +++||||||+||||+.+|.+||||||.|+.+...
T Consensus 82 ~~dhTvL-~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHH-HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9977544 44544433 688999999999999999999999 9999999999999999999999999999988753
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHhhCc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYERGK 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~~~~ 299 (415)
....+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|..-|.++......+.+... ..++....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 445667788999999999887 68999999999999999999999877766554433333221 12222221
Q ss_pred ch-hhccccc------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LV-ELVDASL------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~-~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. .+.-+.. ...++ ....-+.+++..||+.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 1100001 11111 23446789999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=360.13 Aligned_cols=267 Identities=25% Similarity=0.370 Sum_probs=210.1
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-hHHHHHHHHHHHhhcC-CcceeeeeeEEEeCC-eeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIK-HENLVELYGCCVEGD-HRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 144 (415)
...++|.++++||.|.||.||+|+.+ +|..||||.++..-.. ....-++|+..|++++ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678999999999999999999865 7899999999776322 1123457999999998 999999999999888 999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|||||+ .+|++++..+.. .+++..++.|+.||++||+|+|.+ |+.|||+||+||||..+..+||+|||+||.
T Consensus 87 fVfE~Md-~NLYqLmK~R~r---~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDRNR---LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhcCC---cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 9999995 589999998843 799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCcceecccccCCCCCChhhhh-cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH-----HHhhC
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK-----LYERG 298 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~-----~~~~~ 298 (415)
.... ...+.++.|.+|+|||++. .+.|+.+.|||++|||++|+.+-+..|-+....+....+-.+.. .+..|
T Consensus 160 v~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 6543 3456678999999999876 46899999999999999999998877665544333222211110 00000
Q ss_pred -cchhhcccccC-------CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 299 -KLVELVDASLN-------GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 299 -~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+...+.-.+. ...-..++.+..+++.+|+.+||++|||+.|.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 01111111110 11122367889999999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=356.14 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=212.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 144 (415)
..+.|+.+++||+|.||.||+|+.. +|+.||+|+++.+. ........+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467888999999999999999965 89999999998774 34445677899999999999999999999876 6899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
||+|||+. +|.-++...+ ..+++.++..++.||++||+|+|++ ||+|||||..|||||.+|.+||+|||||+.
T Consensus 195 lVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999976 7888886543 3799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH-----HHHhhC
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW-----KLYERG 298 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~-----~~~~~~ 298 (415)
+........+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|+..+.+....+....+.... ..|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 877766666777789999999999875 79999999999999999999998887765444322221111 001111
Q ss_pred cch--hhcccccCCCCC-------HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLV--ELVDASLNGDYS-------VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~--~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
++. ..+.+ ...|. ...+....+|+..+|..||.+|.|+.+.++
T Consensus 348 kLP~~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 11111 01111 122456788999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=351.13 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC--eeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD--HRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 148 (415)
.+|...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999976 58999999987764444667889999999999999999999854444 6999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeeccccccCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPA 227 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 227 (415)
|+++|+|.+++...+. ++++..++.++.||++||+|||++ ||+||||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999988764 589999999999999999999999 9999999999999999 79999999999987653
Q ss_pred --CCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 --NLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
..........||+.|||||++..+ ....++|||||||++.||+||+.|+... .....+.......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~------- 238 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE------- 238 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc-------
Confidence 112223457899999999999864 3446999999999999999998887642 1111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
...+..+...+.+..+++..|+..+|+.|||+.++++..
T Consensus 239 --~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 239 --DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 122245555678899999999999999999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=384.46 Aligned_cols=265 Identities=27% Similarity=0.473 Sum_probs=220.7
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
+...+....+.||+|+||+||+|+.. +...||||.++..... ...+|.+|++++..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 44566777899999999999999854 3567999999887655 6789999999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCC----------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHS----------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
.++||+|||..|||.++|..+... ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 999999999999999999754321 22388899999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCC-CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH
Q 044232 212 LTPKISDFGLAKLFPAN-LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~ 290 (415)
..|||+|||+++..-.. .........-..+|||||.+..+++|.+||||||||||||+++- +..||.+....+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy-----G~QPy~glSn~EV 714 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY-----GKQPYYGLSNQEV 714 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc-----ccCcccccchHHH
Confidence 99999999999954332 22222234456799999999999999999999999999999983 3566666544444
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
+..+ ..|.+ ...+..+|.++..||..||+.+|.+||+++||-..|......
T Consensus 715 Ie~i-~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECI-RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHH-HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3332 22322 356778899999999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=358.73 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=214.2
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDH 142 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 142 (415)
+...++|.+++.||+|+|++|++|+.+ +++.+|||++.+.- ....+....|-.+|.+| .||.|++|+-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345688999999999999999999966 79999999997652 22334566788999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+|+|+||+++|+|.++|...+ .+++...+.++.+|+.||+|||+. |||||||||+|||+|+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999999887 799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc------------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH
Q 044232 223 KLFPANLTH------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 223 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~ 290 (415)
+.+...... ....++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+|- .
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------i 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------I 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------H
Confidence 987432211 1134789999999999999999999999999999999999999988765543 2
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+++.. +.-.++...++.+.+|+.+.|..||.+|++..+|-+.
T Consensus 296 FqkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222211 1223344445778899999999999999999999774
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=356.87 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=212.7
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
.+..+...++|+++..||+|+||.||+|+.+ +|..+|+|++++.. ..+.+..+.|-.+|....+|+||+|+..|++
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 3334556799999999999999999999976 79999999998863 4456778899999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.+.+||||||++||++..+|...+ .|++..++.++.+++.|++-||.. |+|||||||+|+|||..|++||+||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence 999999999999999999999887 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCC-----------------------CCcc----ee-------------------cccccCCCCCChhhhhcCCC
Q 044232 220 GLAKLFPA-----------------------NLTH----IS-------------------TRVAGTEGYLAPEYAIRGQL 253 (415)
Q Consensus 220 Gla~~~~~-----------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~ 253 (415)
||+.-+.. .... .. ...+|||.|||||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99953311 0000 00 12469999999999999999
Q ss_pred CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCC
Q 044232 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPK 333 (415)
Q Consensus 254 ~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 333 (415)
+..+|+||||||+||||.|.+||....|.+.-..+.. |+ ..+.-........+..+||.+|+. ||+
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n-wr------------~~l~fP~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN-WR------------ETLKFPEEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-Hh------------hhccCCCcCcccHHHHHHHHHHhc-CHH
Confidence 9999999999999999999999999887654211111 11 011111112233778899999999 999
Q ss_pred CCCC---HHHHHH
Q 044232 334 RRPS---MSTLVN 343 (415)
Q Consensus 334 ~RPs---~~evl~ 343 (415)
+|-- +.||-+
T Consensus 432 ~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 432 NRLGSKGAEEIKK 444 (550)
T ss_pred HhcCcccHHHHhc
Confidence 9974 666654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=359.36 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=217.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
...|....+||+|+.|.||.|... +++.||||.+........+-..+|+.+|+..+|+|||.+++.|..++.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 456888899999999999999855 7889999999877655556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|+||+|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999998765 589999999999999999999999 99999999999999999999999999999876553
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ...+..|||.|||||+.....|+.|.||||||++++||+-|..|+....|.... +.+..+|.. .
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng~P--------~ 488 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTP--------K 488 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcCCC--------C
Confidence 3 456788999999999999999999999999999999999999998876665443 333334422 2
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
-..+...+..+.+++.+||+.|+.+||++.|+|+
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2334455678999999999999999999999997
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.63 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=208.4
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
+++..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.++..+ +||||++++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3456688999999999999999999742 35679999987543 33446788999999999 8999999999887
Q ss_pred eC-CeeEEEEeeccCCCHHHHhhcCCCC----------------------------------------------------
Q 044232 139 EG-DHRILVYGYLENNSLAQTLLGRGHS---------------------------------------------------- 165 (415)
Q Consensus 139 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 165 (415)
.. ...++||||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 4689999999999999998753210
Q ss_pred ------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc-eeccccc
Q 044232 166 ------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAG 238 (415)
Q Consensus 166 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~g 238 (415)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 12477889999999999999999999 9999999999999999999999999999865332211 1223446
Q ss_pred CCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHH
Q 044232 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEA 317 (415)
Q Consensus 239 t~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (415)
++.|+|||++.+..++.++|||||||++|||++ |..||......+ ........+.. ...+...+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~ 303 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENAT 303 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCC
Confidence 788999999999999999999999999999997 888876533211 11111222211 11122345
Q ss_pred HHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 318 HRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 318 ~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+.+++.+||+.+|.+||++.+|++.|+..+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 67899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=363.63 Aligned_cols=266 Identities=26% Similarity=0.471 Sum_probs=217.3
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
.++|++..+.+.+...||+|.||+||+|+|.+ .||||+++.+ ..+..+.|.+|+.+|++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 36788888899999999999999999999974 3899999876 4557789999999999999999999999998877
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
. .||+.+|+|.+|+.+++... .++...+.++|+.||++||.|||.+ +|||||||..||++.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 6 99999999999999998765 3788999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC-CCcceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 222 AKLFPA-NLTHISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 222 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
+..... ..........|...|||||++.. .+|+..+||||||+|+|||++|..|+....+.. .+| ...+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq------Iif-mVGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ------IIF-MVGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh------eEE-Eecc
Confidence 975321 22233344557888999999874 379999999999999999999988876322211 111 1112
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
|.+. .|. .....+++.++.+|+..||..++++||.+.+|+..|+..+.
T Consensus 608 G~l~--pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYLM--PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccC--ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2111 110 11234677899999999999999999999999998876654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.16 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=213.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
...+.|++.+.||.|..+.||+|++. .+..||||++..+. ......+.+|++.++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 44678999999999999999999965 68999999998763 33357888999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|.||.+||+.+++...-.. .+++..+..|+.+++.||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999865433 589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcce---ecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 227 ANLTHI---STRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 227 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... ..+..||+.|||||++.. ..|+.|+||||||++..||.+|..||....|... ....+. +...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLq-n~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQ-NDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhc-CCCC
Confidence 332221 145689999999999654 3699999999999999999999999886655432 111111 2221
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...-.....+-.......+.+++..||+.||.+|||+.++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111122222334457899999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=355.16 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=208.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc----ch-HhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD----SR-QGVREFLTEINVIKDIK-HENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 142 (415)
..++|.+.+.||+|+||+|+.|... ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999865 7899999987664 12 23345668999999998 9999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeecc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGL 221 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 221 (415)
.++||||+.||+|.+++...+ ++.+..++.++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999998855 788899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCC-CC-ccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQ-LT-RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....+ ...... +..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCC
Confidence 99774 2234566789999999999999866 75 899999999999999999998876322 111111 11111
Q ss_pred chhhcccccCCCCCHHH-HHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEE-AHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .++... +.++..|+.+|+..+|.+|+++.+|++
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 112222 678899999999999999999999994
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=361.13 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=212.3
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
+.|++..+....++-||+|+.|.||+|++++ +.||||+++.-. ..+|+-|++|+||||+.+.|+|.....+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 3456666667778899999999999999974 568999875321 14788999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
||||||..|-|...|.... .+......+|..+||.||.|||.+ .|||||||.-||||..+..|||+|||-++.
T Consensus 189 IiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 9999999999999998776 688889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .....++||..|||||++.+.+.++|+||||||||||||+||..|+ .+......+|.+-
T Consensus 262 ~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY------kdVdssAIIwGVG--------- 324 (904)
T KOG4721|consen 262 LSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY------KDVDSSAIIWGVG--------- 324 (904)
T ss_pred hhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc------cccchheeEEecc---------
Confidence 6544 2234578999999999999999999999999999999999997554 4433333333221
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
...+....+..+++.+.-|+++||+..|..||+|.+|+..|.
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 224455678889999999999999999999999999999884
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=351.74 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=213.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|++|++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999977 78999999997653 3456678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+.| +|..+|...+ .+++..++.++.+++.||.|||+. +|+|||+||.|||++..|.+|++|||+|+....+
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999998876 799999999999999999999999 9999999999999999999999999999987654
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
+...+.+.|||.|||||+..+++|+..+|+||+|||+|||++|++||....- ...+..+.. |
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~--------d--- 215 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILK--------D--- 215 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhc--------C---
Confidence 4456678899999999999999999999999999999999999988764321 112211111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...++.+....+..++...|..||..|.+..+++.
T Consensus 216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12334477788999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=319.79 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=207.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|...++||+|.||.||+|+.. +|+.||||+++..... .....++|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778899999999999999965 8999999999765322 23467899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++ .+|+..+.+.. ..+....+..++.+++.||+|||++ .|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 48999997664 3788999999999999999999999 9999999999999999999999999999988765
Q ss_pred CcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc---
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV--- 304 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 304 (415)
..... ..+-|.+|+|||.+.+. .|+...||||.|||+.||+-|.+-|.+...-+. ...+.+.+......+..
T Consensus 155 ~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Ccccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence 43333 33679999999998874 799999999999999999998765555433222 22222222211111110
Q ss_pred -----------ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 305 -----------DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 305 -----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
........-..++.+..+|+..+|..||.+|.++.|.+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0011111233456777999999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.20 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=200.6
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchH---hHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCeeEEEEeec
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ---GVREFLTEINVIKDIKHENLVELYGCCVE----GDHRILVYGYL 150 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 150 (415)
..||+|++|.||+|.+ +|+.||+|.+...... ..+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 5788999999765322 24678899999999999999999999877 34789999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 9999999997654 6889999999999999999999732 7889999999999999999999999999865432
Q ss_pred ceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 231 HISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....+.+ ........+ .
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~---------~ 239 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKN---------N 239 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC---------C
Confidence 123457899999999876 689999999999999999999999987543211 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+..++..+.+++.+||+.||++|||+.+|++.|...
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1122334567899999999999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=346.91 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=215.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..|+..+.||+|.||.||+|.+. .++.||+|++..+. .....+..+|+.+|..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777799999999999999975 79999999998763 44567888999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|.||++.+.+.... .+.+..+.-++.+++.||.|||++ +.+|||||+.|||+..+|.+||+|||++-.+....
T Consensus 93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999997664 457788888999999999999999 99999999999999999999999999998776543
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.. ..+..|||.|||||++....|+.|+||||||++++||.+|.+|+....|.. ..-++.+...
T Consensus 166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~P 228 (467)
T KOG0201|consen 166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAP 228 (467)
T ss_pred hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCC
Confidence 33 367889999999999998899999999999999999999999988766633 2223333444
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+.+.......+.+++..||+.||+.||++.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 45555667889999999999999999999999863
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.72 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=204.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC-----------------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD-----------------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
.++|++.++||+|+||.||+|.+++ +..||+|++.... ......|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678899999999999999997532 3469999987653 334567999999999999999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCCHHHHhhcCCC---------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 044232 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGH---------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197 (415)
Q Consensus 133 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 197 (415)
+++++.+.+..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 112478889999999999999999999 999
Q ss_pred ecCCCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhC--Cc
Q 044232 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG--RC 274 (415)
Q Consensus 198 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg--~~ 274 (415)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543222 122334567889999999988999999999999999999974 34
Q ss_pred CCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 275 NTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 275 p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
|+....+ ................ ......+..++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5443221 1111222111111110 0011112234577899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=343.97 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=199.1
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 78999999987542 234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS 233 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 233 (415)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999997654 688999999999999999999999 9999999999999999999999999998753222 1223
Q ss_pred cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......+. ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~-~~~~~~~~----------~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------L-FELILMEE----------IRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------H-HHHHHcCC----------CCCC
Confidence 34579999999999999999999999999999999999999886532211 1 11111111 1223
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+.++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 33456788999999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=338.42 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=203.0
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999875 79999999986542 22334678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|..++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988865432 2588999999999999999999999 99999999999999999999999999998654321
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +........ ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKE----------DQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhc----------cc
Confidence 223456899999999999999999999999999999999999998765432211 111111111 01
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223334567889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=347.76 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999986 68999999987642 233457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997654 688999999999999999999999 999999999999999999999999999985533
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+.. ........ .+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~---~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKE---TLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhccc---cccCC
Confidence 233467999999999999999999999999999999999999998765432211 11111000 00001
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.........+.++.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111112345678899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.16 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=206.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467889999999999999999754 36689999987653 3334678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999976432 688999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
............++..|+|||++.+..++.++|||||||++|||++ |..||....+.. ... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~-~~~~~~----- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIK-AVEDGF----- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCCC-----
Confidence 2221111122345678999999999999999999999999999775 888876543221 111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+..++..+.+++.+||+.+|.+||++.+|++.|.+.
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122334567789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=352.91 Aligned_cols=265 Identities=30% Similarity=0.477 Sum_probs=216.5
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec--CC--CE-EEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK--DG--TL-AAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGC 136 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 136 (415)
..|+..-++....++||+|+||.||+|+++ ++ .. ||+|..+.. ......+|++|++++++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 345555667777899999999999999876 22 23 899998853 46777899999999999999999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
+.....+++|||+|.||+|.++|...+. .++..++..++.+.|.||+|||++ +++||||..+|+|++.++.+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 9999999999999999999999998764 588999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHH
Q 044232 217 SDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 217 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
+|||+++.-... ........-...|+|||.+..+.++.++|||||||++||+++ |.. ||.+....+....+.
T Consensus 304 SDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~------Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 304 SDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE------PYPGMKNYEVKAKIV 376 (474)
T ss_pred CccccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCC------CCCCCCHHHHHHHHH
Confidence 999999854311 111111234678999999999999999999999999999998 443 555554444444443
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.++. +...+...+.++..++.+||..+|++||+|.++.+.|......
T Consensus 377 ~~~~---------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 KNGY---------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred hcCc---------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 3332 2233345678889999999999999999999999999866543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.67 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67889999999999999999986 68999999987542 233457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997664 678899999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+... .. ....+..
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~-~i~~~~~------- 232 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YE-KILAGRL------- 232 (329)
T ss_pred C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HH-HHhcCCc-------
Confidence 2 2245789999999999999999999999999999999999999876544321 11 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112223456889999999999999997 677765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.78 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=203.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999976 78999999986542 233456889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997665 688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ..... ..+.
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i-~~~~-------- 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKI-LAGK-------- 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCC--------
Confidence 2 223568999999999998899999999999999999999999987654322 11111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1122223467889999999999999995 777775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=352.26 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=207.8
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEe------cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
+....++|++.+.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+.++..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 445567899999999999999999964 246689999987542 33445788999999999 8999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCC------------------------------------------------------
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGH------------------------------------------------------ 164 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 164 (415)
+.+..++||||+++|+|.+++.....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred -----------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 165 -----------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 165 -----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 012578889999999999999999999 999999999999999999999999999986543
Q ss_pred CCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 228 NLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 228 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..|+....... ........+.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~------ 334 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGY------ 334 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCc------
Confidence 3221 1122345678999999999999999999999999999998 776765432111 1112222221
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+...+.++.+|+.+||+.+|++||++.+|++.|+..
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111122346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.83 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=204.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 68899999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++++.+..+..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765543322 688999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHH-hhCc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLY-ERGK 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~-~~~~ 299 (415)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||............... +..+ ....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 333334457899999999999889999999999999999999999988764432221111100 0000 0000
Q ss_pred chhhcccccC------CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLN------GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+... ..+....+..+.+|+.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0111124567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.99 Aligned_cols=256 Identities=28% Similarity=0.384 Sum_probs=203.8
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--------------HhHHHHHHHHHHHhhcCCcceee
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--------------QGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
.+..++|++.+.||+|.||+|-+|+.. +++.||||++.+... ...+...+|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999976 799999999965321 12357789999999999999999
Q ss_pred eeeEEEe--CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 044232 133 LYGCCVE--GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK 210 (415)
Q Consensus 133 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 210 (415)
|+++..+ .+.+|||+|||..|.+...= .....+.+.++++++.+++.||+|||.+ |||||||||.|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9999976 45899999999998775322 1111389999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccccccCCC----CcceecccccCCCCCChhhhhcCC----CCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 211 DLTPKISDFGLAKLFPAN----LTHISTRVAGTEGYLAPEYAIRGQ----LTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 211 ~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
+|++||+|||.+..++.. .........|||.|+|||.+.++. -+.+.||||+||+||.|+.|+.||.....+
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999876332 122233477999999999987743 367899999999999999999988765432
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
+ ...+ +++..+.-.-..+....+.+||+++|++||+.|.+..+|....
T Consensus 326 ~------l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 E------LFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H------HHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2 1111 2222222112224567889999999999999999999998765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=333.15 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=208.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4578999999999999999999988888899999876433 346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999976432 2678889999999999999999998 99999999999999999999999999998764432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........++..|+|||++..+.++.++|||||||++|+|++ |+.|+....+.. ... ....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~-~~~~~~--------- 221 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMS-ALQRGY--------- 221 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHH-HHHcCC---------
Confidence 222223345678999999988899999999999999999998 887775432211 111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
........+.++.+++.+||+.+|++||+++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011112344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=373.38 Aligned_cols=263 Identities=30% Similarity=0.481 Sum_probs=217.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec--CCC----EEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK--DGT----LAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.+..+..+.||+|+||.||.|... ++. .||+|.+... +.+...+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456677789999999999999865 343 4899998776 456678999999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+|++|||++|+|..+|.+... ....+.....+.++.|||.|+.||+++ ++|||||..+|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987521 123688899999999999999999999 99999999999999999999999999
Q ss_pred cccccC-CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 221 LAKLFP-ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 221 la~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
+|+... ...........-...|||||.+..+.++.|+|||||||+|||++|.. ..||.+....+........|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG-----~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG-----ATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC-----CCCCCCcchHHHHHHHHhCC-
Confidence 999443 22222222223346899999999999999999999999999999853 45666655555554444444
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
+.+.+..|+..+.++|..||+.+|++||++..|++.+...+..
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2345677889999999999999999999999999987765543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.25 Aligned_cols=245 Identities=28% Similarity=0.403 Sum_probs=208.7
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDH 142 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 142 (415)
+...++|.++++||+|.||+|+++..+ +++.+|||+++++ ..+..+..+.|..|+... +||.++.++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455688999999999999999999987 6889999999887 344567788899998877 59999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+++||||+.||++..+.+.. .+++..++-++..|+.||+|||++ +|||||||.+|||+|.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999954443322 799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+..... .....+.+|||.|||||++.+..|+.++|+|||||+||||+.|..||.+....+ ....+.
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~------- 581 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIV------- 581 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHh-------
Confidence 865433 335678999999999999999999999999999999999999998887653321 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
..+..||.-.+.+...|+.++|..+|++|--+
T Consensus 582 ----~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 ----NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11345677788899999999999999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=339.77 Aligned_cols=242 Identities=26% Similarity=0.330 Sum_probs=199.2
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||++..+ +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 7899999999754 2334467888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS 233 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 233 (415)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 9999887654 688999999999999999999999 9999999999999999999999999998753222 1222
Q ss_pred cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ... ....+ ...++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~-~~~~~----------~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE-LILME----------DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHH-HhccC----------CccCC
Confidence 34579999999999998899999999999999999999999986543211 111 11111 01122
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHH
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNM 344 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 344 (415)
...+.++.+++.+||+.+|.+|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 33456788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.10 Aligned_cols=264 Identities=25% Similarity=0.421 Sum_probs=207.9
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
+....++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4455678999999999999999998742 34579999997643 33446788999999999 8999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCC------------------------------------------------------
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGH------------------------------------------------------ 164 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 164 (415)
.....++||||+++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864311
Q ss_pred ------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc-
Q 044232 165 ------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH- 231 (415)
Q Consensus 165 ------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 231 (415)
...++++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 012478889999999999999999999 9999999999999999999999999999865433221
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ........+ ...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQM 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCc
Confidence 1222345678999999998999999999999999999997 988876432211 111111111 111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+...+.++.+++.+||+.+|.+||++.+|++.|.+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=330.40 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=204.4
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 56888899999999999999988888899998865432 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++..... .+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999875432 578999999999999999999999 9999999999999999999999999999865433222
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ....... +.. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i~~-~~~---------~ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMISR-GFR---------L 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHC-CCC---------C
Confidence 2222345668999999988889999999999999999999 877776543221 1111111 111 0
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.18 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=210.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.-|++++.||.|+-|.|-+|++. +|+.+|||++.+.. ......+.+|+-+|+.+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999865 89999999997652 222345678999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||++||.|.+++...+ ++++..+.+++.||+.|+.|+|.. +|+||||||+|+|+|.++++||+|||+|..-..
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999887 899999999999999999999999 999999999999999999999999999986433
Q ss_pred CCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.....+.||.|.|.|||++.+.+| +.++||||.|||||.|+||+.||+.+ +..... ..+..|..
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LL-lKV~~G~f------ 229 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLL-LKVQRGVF------ 229 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHH-HHHHcCcc------
Confidence 234567899999999999999876 68999999999999999999888743 222221 12222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+.|...+.+..+|+.+|+..||.+|.|++||++.
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2344566788999999999999999999999984
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=332.18 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=208.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|++.+.||+|+||.||+|..+ .++.||+|.+..+.. ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 456888899999999999999976 688999999875533 346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999876432 2588999999999999999999998 99999999999999999999999999998664432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........++..|+|||.+.+..++.++|||||||++|||++ |..|+...... +. +.....+ .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~---------~ 222 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV-YELLEKG---------Y 222 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCC---------C
Confidence 222222334668999999998999999999999999999998 87776543221 11 1111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122333457799999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.23 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=206.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+++.+ ++..+|+|++... .......+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999977 6889999998765 23344678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997654 5889999999999999999999852 6999999999999999999999999999765332
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC---c------
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG---K------ 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~---~------ 299 (415)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+. ..........+ .
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccCc
Confidence 22345689999999999998999999999999999999999999864332111 00000000000 0
Q ss_pred ---------------------chhhcc---cccCCCC-CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 300 ---------------------LVELVD---ASLNGDY-SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 300 ---------------------~~~~~~---~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.....+ ....+.. ....+.++.+|+.+||+.||++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000010 11245678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.74 Aligned_cols=241 Identities=25% Similarity=0.326 Sum_probs=198.2
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||++..+ +|..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 7899999998764 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS 233 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 233 (415)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 9998887654 688999999999999999999999 9999999999999999999999999998753222 1122
Q ss_pred cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... +. ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~-~~----------~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM-EE----------IRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CC----------CCCC
Confidence 34569999999999999999999999999999999999999886543211 1111111 10 1122
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+.++.+++.+||+.+|.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 33456788999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.17 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=204.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999976 78999999997642 234456888999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999976522 689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceecccccCCCCCChhhhh------cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 228 NLTHISTRVAGTEGYLAPEYAI------RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....+.. ............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 4333334457899999999986 4567899999999999999999999987543322 111121111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ......+..+.+|+..||+ +|.+||++.++++
T Consensus 229 ~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11 0111234668899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.15 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=214.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe-eEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH-RILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 147 (415)
++|..++++|+|+||.++.++.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999877 68889999987652 2333467889999999999999999999998887 99999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
+||+||+|.+.+.+.. ..-+++..+..|+.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998776 34789999999999999999999988 999999999999999999999999999998866
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. .....+.||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...... ..+.+... .
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~----------~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINR----------G 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhh----------c
Confidence 53 2456688999999999999999999999999999999999998887654321 12222111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.....+.....++..++..|++.+|..||++.+++..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2234455667889999999999999999999999875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=345.13 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=206.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 78999999987542 234467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998763 688999999999999999999998 999999999999999999999999999986543
Q ss_pred CC----------------------------cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCC
Q 044232 228 NL----------------------------THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRR 279 (415)
Q Consensus 228 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~ 279 (415)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456899999999999999999999999999999999999998765
Q ss_pred CChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-HHHHHHH
Q 044232 280 LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-MSTLVNM 344 (415)
Q Consensus 280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~ 344 (415)
.+.. ....+.... ...........+.++.+++.+|++ +|.+||+ +.++++.
T Consensus 234 ~~~~------~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE------TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH------HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4322 111111100 000000111145778899999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=338.58 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=201.1
Q ss_pred CCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccc----hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS----RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998752 58899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997654 688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
.+............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc------
Confidence 6544333333456799999999998765 47899999999999999999999986432211111 11111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
.....+...+..+.+++.+||+.||++|| +++++++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11122233456788999999999999999 6778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.40 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=195.7
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||+|+||.||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 6889999998653 233446788899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++...+ .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence 99997654 688999999999999999999999 9999999999999999999999999999754322 122344
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +. ..++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~----------~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EP----------LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CC----------CCCCCc
Confidence 67999999999999999999999999999999999999988653221 11111111 11 122233
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+..+.+++.+||+.||.+||++..+.+.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 45678899999999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.70 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=199.4
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.|+.++.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999876 68899999997542 3344678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++++||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997654 688899999999999999999999 9999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ceecccccCCCCCChhhhhcCCCCccceEeeh
Q 044232 229 LT----------------------------------------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSF 262 (415)
Q Consensus 229 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 262 (415)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123569999999999998899999999999
Q ss_pred hHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHH--cCCcCCCCCCCHHH
Q 044232 263 GVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALL--CTQDMPKRRPSMST 340 (415)
Q Consensus 263 Gvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~e 340 (415)
||++|||++|+.||....+.... ........ ..........+.++.+++.+ |+..+|..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999998765432211 11111000 00001111234567778877 55666777999999
Q ss_pred HHHH
Q 044232 341 LVNM 344 (415)
Q Consensus 341 vl~~ 344 (415)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=356.67 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=220.1
Q ss_pred CCCCCCcccccCeEEEEEEEec-C---CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-D---GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
...+.+.||.|.||.|++|+++ . ...||||.++... .....+|+.|+.||-+++||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999986 2 4579999998874 445678999999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|||++|+|+.+|..+.. ++.+.+..-++++|+.||.||-+. ++|||||..+||||+.+..+|++|||+++.+.+
T Consensus 710 EyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999987764 689999999999999999999999 999999999999999999999999999998866
Q ss_pred CCcceeccccc--CCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 228 NLTHISTRVAG--TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 228 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
+.....++..| ..+|.|||.+...+++.++||||||+||||.++- +.-||-+....+.+ ..++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSy-----GERPYWdmSNQdVI----------kaIe 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWDMSNQDVI----------KAIE 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEeccc-----CCCcccccchHHHH----------HHHH
Confidence 55443444434 4689999999999999999999999999998862 23455444443333 3344
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
...+...|.+||..|.+||+.||+++..+||.+.||+..|.+.+.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 556667788999999999999999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.36 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=208.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998642 2579999987543 33446788999999999999999999999998999
Q ss_pred EEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 144 ILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
+++|||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 9999999999999999764211 13578899999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHH
Q 044232 212 LTPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~ 289 (415)
+.++|+|||++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||....+.+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------ 234 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 999999999998653322 122233456888999999998899999999999999999998 888876543321
Q ss_pred HHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
. ......+. ....+...+.++.+|+.+||+.+|.+||++.+|++.|.+
T Consensus 235 ~-~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 V-IEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11111111 112234556889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=330.92 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=212.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
....+|++.++||.|+||.||+|...++..+|+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567899999999999999999988889999999987766556788899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976532 2678999999999999999999999 9999999999999999999999999999866433
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....+.+ ...... .+
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~~~~~-~~--------- 220 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VYDQIT-AG--------- 220 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHH-hC---------
Confidence 211 223345678999999988899999999999999999998 777775433211 111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.....+..++..+.+++.+||+.+|.+||++.++++.|..
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112233445778999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.14 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=199.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999976 68999999986542 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997654 578889999999999999999999 9999999999999999999999999997533100
Q ss_pred C------------------------------------------cceecccccCCCCCChhhhhcCCCCccceEeehhHhH
Q 044232 229 L------------------------------------------THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLL 266 (415)
Q Consensus 229 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl 266 (415)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234699999999999999999999999999999
Q ss_pred HHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC---CHHHHHH
Q 044232 267 LEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP---SMSTLVN 343 (415)
Q Consensus 267 ~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~evl~ 343 (415)
|||++|+.||....+.+... ....... ..........+..+.+++.+|+ .+|.+|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL------KVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH------HHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999987655433211 1111000 0000111123455677777776 4999999 8899886
Q ss_pred H
Q 044232 344 M 344 (415)
Q Consensus 344 ~ 344 (415)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=344.24 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 68999999997542 234456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997654 689999999999999999999999 999999999999999999999999999875422
Q ss_pred CCcc-------------------------------------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHH
Q 044232 228 NLTH-------------------------------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIV 270 (415)
Q Consensus 228 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 270 (415)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC---HHHHHH
Q 044232 271 SGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS---MSTLVN 343 (415)
Q Consensus 271 tg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 343 (415)
+|..||....+... ............. ......+..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIINWKETLQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999876543221 1111111100000 0111234567889999997 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.63 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=209.0
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+..++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34577999999999999999999987778899999876543 34678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997654 23688999999999999999999999 9999999999999999999999999999876532
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
..........+..|+|||++.+..++.++||||||+++|||++ |+.|+....+.. . .......
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~-~~~~~~~--------- 220 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------V-LQQVDQG--------- 220 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHHHcC---------
Confidence 2211122223457999999998899999999999999999999 887776533211 1 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111223445779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=335.28 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=201.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.++||.|+||.||+|..+ ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999976 789999999875432 2234677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++ +|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 89988865432 578899999999999999999999 99999999999999999999999999997543221
Q ss_pred cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC----------
Q 044232 230 THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG---------- 298 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~---------- 298 (415)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+.+.... ........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhcccc
Confidence 12233567999999998875 5689999999999999999999999876544332211 11111000
Q ss_pred --cchhhcccccCCC----CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 --KLVELVDASLNGD----YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 --~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+..... .......+..+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=335.54 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=197.2
Q ss_pred CCcccccCeEEEEEEEec----CCCEEEEEEccccc----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 77 ANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS----RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999852 57899999987532 2233467789999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++...+ .+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999997665 578889999999999999999999 9999999999999999999999999998754322
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+.
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~-~~~--------- 216 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKIL-KGK--------- 216 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCC---------
Confidence 1 12234579999999999998889999999999999999999999987543221 111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112223346788999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=331.75 Aligned_cols=248 Identities=24% Similarity=0.407 Sum_probs=211.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEe-cCCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..+|++.+.||+|.||+|-+|.. ..|+.||||.++++. .+..-.+.+|++||+.|+||||+.+|.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999986 589999999998763 44455678999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||..+|.|++++..++ .+++..++.++.||..|+.|+|.+ +++|||||.+|||+|.|+++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999887 799999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.. ...++++|+|-|.+||++.+.+| ++.+|.|||||+||-|+.|..||++..- ...+. .+.+|...
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvr-QIs~GaYr---- 271 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVR-QISRGAYR---- 271 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHH-Hhhccccc----
Confidence 43 34567899999999999998877 5789999999999999999888876421 11111 12222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..+.+.+..-||.+||-.||++|.|+.+|...+
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112234567899999999999999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.04 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=204.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecC--CCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKD--GTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..++|++.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.++..++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998653 4689999986542 233457888999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999997665 688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ..... ..+..
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i-~~~~~---- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKI-LEGII---- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHH-hcCCC----
Confidence 5432 234579999999999999889999999999999999999999987654321 11111 11110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNM 344 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 344 (415)
.++...+..+.+++.+||+.+|.+|+ +++++++.
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222345678999999999999995 88888763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.85 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=207.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-C-CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-D-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34888999999999999999865 4 678899987666555556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++........++++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998865433344688999999999999999999999 99999999999999999999999999998764332
Q ss_pred c-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 T-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC--------
Confidence 2 2234467999999999999999999999999999999999999988653221 11111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+.++.+++.+||+.+|++||++.+++.
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122234567899999999999999999999874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.25 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=204.4
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
...++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999976 68999999986532 223345778999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999988654 477888999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcC----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRG----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~ 265 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNS 265 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCc
Confidence 543322233456799999999998653 47899999999999999999999987644321 11111111100
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNM 344 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 344 (415)
... ......+.++.+++.+||+.+|.+ ||++.++++.
T Consensus 266 ~~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 011123567889999999999988 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=334.40 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=197.8
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||++... ++..||+|++... .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 7899999998764 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
+|..++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9999887654 68999999999999999999997 6 99999999999999999999999999987532221 12
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......+. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~----------~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEE----------IRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCC----------CCC
Confidence 2345699999999999999999999999999999999999999865432111 11111111 112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNM 344 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 344 (415)
+...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 223346788999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=344.45 Aligned_cols=259 Identities=20% Similarity=0.218 Sum_probs=199.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999975 789999997532 3467899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+. ++|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 94 68888886654 688999999999999999999999 99999999999999999999999999997543322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhh----hHHHHHHHHHhh--------
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ----YLLEMAWKLYER-------- 297 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~----~~~~~~~~~~~~-------- 297 (415)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ............
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22334567999999999999999999999999999999999999876543221110 000000000000
Q ss_pred --Ccchhhc---------ccccCCCC--CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 --GKLVELV---------DASLNGDY--SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 --~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....... .+...+.. ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 1134567899999999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.34 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=203.3
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
....++|++.+.||+|+||.||+|+.. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999976 6889999998653 222335678899999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998654 478889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~ 264 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKN 264 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCc
Confidence 7643322233456799999999998754 37899999999999999999999987543321 1111211111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNM 344 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 344 (415)
. .........+..+.+++..|++.++.+ ||++.++++.
T Consensus 265 ~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 S-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 000111233566788999999865544 8999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=325.97 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=203.2
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.+|++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45888999999999999999988777899999865432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999976532 688999999999999999999999 9999999999999999999999999999765432221
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....+.+ .... ...+ ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~~---------~~~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVES-VSAG---------YRL 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHH-HHcC---------CcC
Confidence 1122234457999999998999999999999999999999 777776432211 1111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12223456799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=325.35 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=206.1
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+..++|++.++||+|+||.||+|..+++..+|+|.+...... ...+.+|+.++++++|||++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 345679999999999999999999888888999998765332 357889999999999999999999875 456889999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999976432 2578999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.........++..|+|||++.+..++.++||||||+++|+|++ |..||...... +..... ..+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~--------- 219 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQV-ERG--------- 219 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcC---------
Confidence 2222222345668999999988899999999999999999999 77777543221 111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.....+...+..+.+++.+||+.+|.+|||+.++.+.|..
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233445679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.12 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=204.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..++|++.++||+|+||.||+|..+ ++..+|+|++... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999987 6889999988765 3334467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997654 5788999999999999999999741 799999999999999999999999999975533
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc-------
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL------- 300 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~------- 300 (415)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ........+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE----LMFGCPVEGDPAESETSP 229 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH----HHhcCcccCCccccccCc
Confidence 2 123456899999999999888999999999999999999999998643221110 00000000000
Q ss_pred ----------------------hhhccc---ccCCCCC-HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 ----------------------VELVDA---SLNGDYS-VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ----------------------~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+. ...+..+ ...+.++.+|+.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000 0000000 112466889999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=325.98 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=203.7
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 56888999999999999999988777799998875433 23678999999999999999999999998889999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999876432 588999999999999999999999 9999999999999999999999999998865433222
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......++..|+|||++.+..++.++|||||||++|+|++ |..|+....+. ...... ..+.. .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~---------~ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKV-SQGLR---------L 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH-hcCCC---------C
Confidence 2222345678999999988889999999999999999998 88777543221 111111 11111 0
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..+...+..+.+++.+||+.+|.+||++.+|++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 11112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.44 Aligned_cols=268 Identities=27% Similarity=0.437 Sum_probs=218.0
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHh-HHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+.....++++||+|-||.|.++...++..||||+++.+.... .++|..|+++|.+++||||+.++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456677889999999999999999888999999999886544 479999999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..+.... +.-.....|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+-.
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998875432 34455667999999999999999 999999999999999999999999999996544
Q ss_pred C-CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 N-LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ......+..-..+|||||.+..++++.++|||+||+++||+++- ....||+.....+.+.+. +.+..--..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~----C~e~Py~~lt~e~vven~---~~~~~~~~~ 762 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFML----CREQPYSQLTDEQVVENA---GEFFRDQGR 762 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHH----HhhCchhhhhHHHHHHhh---hhhcCCCCc
Confidence 3 33344455567899999999999999999999999999999873 234566654433333221 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
......|.-++..+.+++..||..+..+||++++|...|...
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122344667889999999999999999999999999988653
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=324.82 Aligned_cols=257 Identities=32% Similarity=0.476 Sum_probs=208.4
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++..++|++.++||+|+||.||+|..++++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3456789999999999999999999888899999998765432 367889999999999999999999874 45789999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999875432 2688999999999999999999998 999999999999999999999999999986653
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
..........++..|+|||++....++.++||||||+++|||++ |+.||....+.+ ... ....+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~------- 220 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQ-NLERGY------- 220 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHH-HHHcCC-------
Confidence 32222223345678999999998899999999999999999999 888876543221 111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111222334679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=329.15 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998642 478999998765443 456899999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCC----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC
Q 044232 144 ILVYGYLENNSLAQTLLGRGH----------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 213 (415)
++||||+++++|.+++...+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976532 223578899999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHH
Q 044232 214 PKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~ 291 (415)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH
Confidence 99999999975432211 11223346788999999999999999999999999999998 988876433221 11
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
. ....+.. ...+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 235 ~-~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 E-CITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1112211 1112234577899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=339.03 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=198.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999876 68999999997542 233456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997654 689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCC
Q 044232 228 NLT----------------------------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273 (415)
Q Consensus 228 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 273 (415)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 100 0012357999999999999999999999999999999999999
Q ss_pred cCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCC--cCCCCCCCHHHHHHH
Q 044232 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQ--DMPKRRPSMSTLVNM 344 (415)
Q Consensus 274 ~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPs~~evl~~ 344 (415)
.||....+.+. ............ + ... .....++.+++.+++. .++..||++.||++.
T Consensus 234 ~Pf~~~~~~~~------~~~i~~~~~~~~-~----p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQET------YKKVMNWKETLI-F----PPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHH------HHHHHcCcCccc-C----CCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99876544321 111111100000 0 000 1123456666666443 344567999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.35 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=209.3
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcC-CcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIK-HENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 138 (415)
+....++|.+.+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4455688999999999999999999853 23469999997653 333467899999999996 999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCC------------------------------------------------------
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGH------------------------------------------------------ 164 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 164 (415)
+....+|||||+++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999998865321
Q ss_pred --------------------------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 044232 165 --------------------------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206 (415)
Q Consensus 165 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 206 (415)
....+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 012478888999999999999999999 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~ 284 (415)
|++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..|+.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 9999999999999999865332211 1223446788999999998899999999999999999997 877765432211
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
........+ .....+...+..+.+++.+||+.+|++||++.+|.+.|...+
T Consensus 348 -----~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -----TFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -----HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111111 111122345678899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=324.44 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=206.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|++.+.||+|+||.||+|.++. ...||+|.+.... ......|.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3678999999999999999998752 4579999987653 3344678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 688999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... +. ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~-~~~~~~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DV-IKAVEDGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HH-HHHHHcCC----
Confidence 522111 1222335678999999998899999999999999999998 87776543211 11 11111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+...+..+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=342.81 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=199.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++++.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999876 78999999986542 234467888999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997654 688999999999999999999999 999999999999999999999999999964321
Q ss_pred CCcc----------------------------------------------eecccccCCCCCChhhhhcCCCCccceEee
Q 044232 228 NLTH----------------------------------------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYS 261 (415)
Q Consensus 228 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 261 (415)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001246999999999999999999999999
Q ss_pred hhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCC---CCH
Q 044232 262 FGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR---PSM 338 (415)
Q Consensus 262 lGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~ 338 (415)
|||++|||++|+.||....+... ............. + .....+.++.+++.+|++ +|.+| |++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~------p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET------YRKIINWRETLYF------P-DDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCC------C-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999876544221 1111110000000 0 011234568899999998 66665 599
Q ss_pred HHHHHH
Q 044232 339 STLVNM 344 (415)
Q Consensus 339 ~evl~~ 344 (415)
.++++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=317.70 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=206.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHENLVELYGCCVE--GDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 145 (415)
.+.|+.+++|++|.||.||+|+++ +++.||+|.++.+... .--..++|+.+|.+.+|||||.+-.+... -+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 367889999999999999999987 7999999999876422 11245789999999999999999999874 357999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||||+. +|..++.... .++...++..++.|++.|++|||.+ .|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 8999988775 3789999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh--
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE-- 302 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~-- 302 (415)
.... ...+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++.|.+.........+-.......+.....
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7653 334556779999999998875 799999999999999999999988877654443222211110000000000
Q ss_pred ---hc---------ccccCCCCCHH-HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 ---LV---------DASLNGDYSVE-EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ---~~---------~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+ -..+...+... ..+.-.+|+..+|..||.+|-|+.|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 00111111111 2355678999999999999999999886
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=330.33 Aligned_cols=261 Identities=22% Similarity=0.362 Sum_probs=196.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec--CCCEEEEEEccccc--hHhHHHHHHHHHHHhhc---CCcceeeeeeEEE-----e
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADS--RQGVREFLTEINVIKDI---KHENLVELYGCCV-----E 139 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 139 (415)
++|++.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999863 47889999886542 22223556677777665 6999999999985 2
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
....++||||++ ++|.+++...... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 6899988754322 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC-
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG- 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~- 298 (415)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCC
Confidence 999865433 223445689999999999988999999999999999999999998876544322111 11100000
Q ss_pred --cchh---hcccccC--C-----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 --KLVE---LVDASLN--G-----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 --~~~~---~~~~~~~--~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ....... . ......+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 0 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=325.85 Aligned_cols=257 Identities=31% Similarity=0.478 Sum_probs=206.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..++|++.++||+|+||.||+|.+++...||+|++..... ....+.+|+++++.++||||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 4567999999999999999999987667799999976433 23578899999999999999999998754 567999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999975432 2578999999999999999999999 99999999999999999999999999998664432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........++..|+|||+..+..++.++|||||||++|+|++ |..|+....+.. ..... ..+ .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~-~~~---------~ 220 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQV-ERG---------Y 220 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHH-hcC---------C
Confidence 222223446678999999988899999999999999999999 766765443221 11111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|+...
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11223345677899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.08 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=198.1
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 68999999997642 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99999887654 689999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh--hhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE--EQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....++..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 334679999999999999999999999999999999999999986422111 11111222222222111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCC------HHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPS------MSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~ 343 (415)
..+...+..+.+++.+||+.+|.+||+ +.++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122233467889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.62 Aligned_cols=241 Identities=27% Similarity=0.361 Sum_probs=196.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCc-ceeeeeeEEEeCCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHE-NLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 147 (415)
+|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999976 67899999987542 23446678899999999765 6888999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987654 688999999999999999999999 999999999999999999999999999874322
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~-~--------- 216 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIME-H--------- 216 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-C---------
Confidence 11 12234569999999999999999999999999999999999999987543211 1111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
...++...+.++.+++.+||+.+|.+||+.
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112222345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.54 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=197.1
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|..+ +++.||+|++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6889999998764 233445677899888776 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 99998887654 689999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh--hhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE--EQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence 334679999999999999999999999999999999999999985321111 1111122222222111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCC------HHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPS------MSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~ 343 (415)
..+...+..+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 123334567889999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=309.00 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=215.4
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEE-ecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD---- 141 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 141 (415)
+.+..++|++.+.||+|||+.||+++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34567899999999999999999998 4578899999998888788889999999999999999999999875433
Q ss_pred -eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 142 -HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 142 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
..||+++|...|+|.+.+.........+++.+++.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999999988766666899999999999999999999998 3359999999999999999999999999
Q ss_pred cccccCCCCcce--------ecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH
Q 044232 221 LAKLFPANLTHI--------STRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 221 la~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~ 289 (415)
.+...+-..... ......|..|+|||.+.- ...++++|||||||+||.|+.|..||+....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------- 246 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------- 246 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence 998543221111 112347889999998863 4678999999999999999999888764321
Q ss_pred HHHHHHhhCcchhh-cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 290 MAWKLYERGKLVEL-VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 290 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+.+.-. ......-.-....+..+.+++.+|++.||.+||++.+++..+...+
T Consensus 247 ------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222111 1111111112235678999999999999999999999999887543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.85 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=205.5
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
.+..++|++.+.||+|+||.||+|.++ .+..||+|.+.... .....++.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346788999999999999999998753 25679999886542 23445788999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHS------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
...++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999998753321 12467888999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHH
Q 044232 215 KISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~ 292 (415)
+|+|||++......... ......+++.|+|||++.++.++.++|||||||++|||++ |..|+....+.. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~- 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VL- 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-
Confidence 99999998755332211 1122345778999999998899999999999999999999 666765432211 11
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.....+... ..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 232 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111111 112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=340.08 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=196.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|+.+++||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 456788899999999999999976 78999999986543 3334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.... ...+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999986432 356778889999999999999999 9999999999999999999999999999865432
Q ss_pred CcceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
. .......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ..........
T Consensus 222 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~------- 290 (353)
T PLN00034 222 M-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICM------- 290 (353)
T ss_pred c-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhc-------
Confidence 2 12234568999999998743 234568999999999999999999987322111 0111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+...+.++.+|+.+||+.+|++||++.|+++
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111222344577999999999999999999999987
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.30 Aligned_cols=237 Identities=26% Similarity=0.342 Sum_probs=189.3
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHH-HHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEIN-VIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999986542 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|...+.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 99998887654 678889999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~----------~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNIL-HKP----------LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHh-cCC----------CCC
Confidence 33457899999999999889999999999999999999999988654221 1111111 111 112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMS 339 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~ 339 (415)
+...+..+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.67 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999987 789999999875432 223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++ ++|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 678877765432 578899999999999999999999 9999999999999999999999999998754322
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc-------
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL------- 300 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~------- 300 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .............
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchh
Confidence 1 12234568999999999875 46889999999999999999999998764332211 1111111100000
Q ss_pred --hhhcccccCCCCCH---------HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 --VELVDASLNGDYSV---------EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 --~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000 11246789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.46 Aligned_cols=241 Identities=27% Similarity=0.376 Sum_probs=193.8
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|..+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987542 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987654 688999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~----------~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILN-D----------RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc-C----------CCCC
Confidence 34467999999999999889999999999999999999999988754321 11111111 1 1122
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHH-HHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMS-TLVN 343 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 343 (415)
+...+.++.+++.+||+.+|.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 333456788999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.51 Aligned_cols=248 Identities=33% Similarity=0.552 Sum_probs=194.8
Q ss_pred CCcccccCeEEEEEEEec-----CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 77 ANKIGQGGFGSVYKGTLK-----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999976 2567999999664 3344688999999999999999999999999888899999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC-C
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN-L 229 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~-~ 229 (415)
++|+|.+++.... ...+++..+..|+.||+.||.|||+. +++|+||+++||+++.++.+||+|||++...... .
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999998872 22689999999999999999999999 9999999999999999999999999999876322 1
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........+...|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+....+ ..+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTEE--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-ccccc--------
Confidence 222233456778999999999999999999999999999999 56665433 222222222 22221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
...+..++..+.+++..||+.+|.+||++.+|++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 122233457789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=306.55 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=211.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .+....+.+|++|-+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999976 78899999987652 2223568889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
++||.++|+|...|...... .+++.....++.|+|.||.|+|.+ +++||||||+|+|++.++.+||+|||-+..-
T Consensus 100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999855432 788999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
+ .....+.+||..|.|||...+...+..+|+|++|++.||++.|..||..... . +...++.
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~-----etYkrI~---------- 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-S-----ETYKRIR---------- 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-H-----HHHHHHH----------
Confidence 4 2345678999999999999999999999999999999999999988876541 1 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+-.++...+....++|.+|+..+|.+|.+..|+++.
T Consensus 236 -k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 -KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -HccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11123344556778899999999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=353.49 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=209.0
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC---
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD--- 141 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 141 (415)
+...++|++.+.||+|+||+||+|+.. +++.||+|++... .......+.+|+..+..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999865 7999999998654 3344567889999999999999999998775432
Q ss_pred -----eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 142 -----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 142 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
..++||||+++|+|.+++..+......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36899999999999999976554445789999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 217 SDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 217 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh
Confidence 9999998654322 12234567999999999999999999999999999999999999988654321 1111111
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+.. ...+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 259 -~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 -AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 11233445778999999999999999999999863
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=342.12 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=197.4
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999976 68899999987542 2344578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997654 578899999999999999999999 9999999999999999999999999997533110
Q ss_pred C----------------------------------------------cceecccccCCCCCChhhhhcCCCCccceEeeh
Q 044232 229 L----------------------------------------------THISTRVAGTEGYLAPEYAIRGQLTRKADIYSF 262 (415)
Q Consensus 229 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 262 (415)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123469999999999999999999999999
Q ss_pred hHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC---HH
Q 044232 263 GVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS---MS 339 (415)
Q Consensus 263 Gvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ 339 (415)
||++|||++|+.||....+.+.. ........ ..........+.++.+++.+|+ .+|.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ------MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH------HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999765543221 11111000 0000111122355667777765 48999997 77
Q ss_pred HHHH
Q 044232 340 TLVN 343 (415)
Q Consensus 340 evl~ 343 (415)
++++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.93 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=205.5
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
.+++...++|++.+.||+|+||.||+|+.+ +++.+|+|++... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 445556789999999999999999999987 6889999998643 222335577899999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998654 478888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcC----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRG----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 9987654333333456799999999998754 37899999999999999999999987643321 1111221
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHHh
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNML 345 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L 345 (415)
....... ......+..+.+++..|++.++.+ ||++.++++..
T Consensus 262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111 011133466888999999854443 78999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.82 Aligned_cols=265 Identities=26% Similarity=0.403 Sum_probs=208.0
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
|.+..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3455678999999999999999999642 35789999987542 33345678899999999 8999999999887
Q ss_pred e-CCeeEEEEeeccCCCHHHHhhcCCCC----------------------------------------------------
Q 044232 139 E-GDHRILVYGYLENNSLAQTLLGRGHS---------------------------------------------------- 165 (415)
Q Consensus 139 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 165 (415)
. +...+++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 45688999999999999998643210
Q ss_pred -----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc-eecccccC
Q 044232 166 -----SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGT 239 (415)
Q Consensus 166 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt 239 (415)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++..+...... ......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 12688999999999999999999999 9999999999999999999999999999865432221 12234567
Q ss_pred CCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHH
Q 044232 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAH 318 (415)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (415)
..|+|||++.+..++.++|||||||++|||++ |..||....+.+. .......+.. ...+...+.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~ 303 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATP 303 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCH
Confidence 78999999999999999999999999999998 8888765333221 1112222111 111223346
Q ss_pred HHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 319 RYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 319 ~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
++.+++.+||+.+|++||++.+|++.|...+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.44 Aligned_cols=259 Identities=21% Similarity=0.354 Sum_probs=209.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999976 7899999987542 2344457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.........+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433333688999999999999999999999 999999999999999999999999999886643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ....... ....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~-~~~~-------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI-EQCD-------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH-hcCC--------
Confidence 321 1223468889999999988889999999999999999999999875432211 1111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
..+......+..+.+++.+||+.+|++||++.+|++.|.+
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 1111122445779999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.84 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=203.2
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999976 689999999875422 223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865432 2589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......... ......... .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~ 220 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE----------D 220 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh----------c
Confidence 2 123346899999999999889999999999999999999999998764332111 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1122334556789999999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.43 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=209.9
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
+++..++|++.+.||+|+||.||++... ....+|+|.+... .......+.+|+.++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4455678999999999999999999864 2367999998764 233446788999999999 8999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCC------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRG------------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 206 (415)
.+...+++|||+++|+|..++.... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999997532 2234688999999999999999999998 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~ 284 (415)
+++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..|+.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999865432211 1122335678999999988899999999999999999997 777765432211
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. ......+. ....+...+..+.+|+.+||+.+|++|||+.++++.|.+.+
T Consensus 243 -----~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----L-FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----H-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11111111 11223344567899999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=329.69 Aligned_cols=255 Identities=22% Similarity=0.264 Sum_probs=199.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999976 6899999998753 2223456888999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975322 588999999999999999999999 999999999999999999999999999976544
Q ss_pred CCcceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..........||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+ .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCccc
Confidence 33222333569999999999873 457889999999999999999999886543221 1111211111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCC--CCCCCHHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMP--KRRPSMSTLVNM 344 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~RPs~~evl~~ 344 (415)
+ +......+..+.+++.+|+..++ ..||++.++++.
T Consensus 229 ~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 01111245667788888775533 347899999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=334.07 Aligned_cols=244 Identities=28% Similarity=0.386 Sum_probs=196.1
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHH---hhcCCcceeeeeeEEEeCCeeEEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVI---KDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999976 68999999987542 22334566666555 566899999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|...+... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888543 589999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ........|++.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... +.
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~-~~------- 217 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVN-DE------- 217 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC-------
Confidence 22 122334679999999999999999999999999999999999999987543211 1111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
..++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112233456788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.21 Aligned_cols=237 Identities=27% Similarity=0.361 Sum_probs=190.6
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHH-HHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEIN-VIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||+||+|... +|+.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 78999999987542 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999987654 688999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... +.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~----~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KPL------R----L 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CCC------C----C
Confidence 33457999999999999999999999999999999999999988654321 11111111 110 1 1
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMS 339 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~ 339 (415)
+...+..+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 122356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=321.69 Aligned_cols=275 Identities=22% Similarity=0.321 Sum_probs=211.8
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcc--ccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-----CC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLS--ADSRQGVREFLTEINVIKDIKHENLVELYGCCVE-----GD 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 141 (415)
....|...+.||+|+||.|+.|..+ +|..||+|++. .......++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666899999999999999976 79999999997 3455566788999999999999999999999864 45
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..|+|+|+| +.+|.+.+..+. .++...+..+++||++||.|+|+. +++||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 789999999 778999998775 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------
Q 044232 222 AKLFPANL-THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA-------- 291 (415)
Q Consensus 222 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~-------- 291 (415)
|+...... ....+....|.+|.|||++.. ..|+.+.||||.|||+.||++|+.-|.+........++...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99875431 223356778999999998765 58999999999999999999999888766543332222111
Q ss_pred HHHHhhCcchhhccccc-CCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH--HhhcCCCCC
Q 044232 292 WKLYERGKLVELVDASL-NGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN--MLIGEIDVN 352 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~~~ 352 (415)
...+........+.... .+..+ ........+|+.+||..||.+|+|++|.++ .|...-+..
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 01111111111111100 01111 133467789999999999999999999987 344444433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.32 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=204.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999864 333 48999987543 34456788999999999999999999999864 577
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|+||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999976532 578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcce-ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLTHI-STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
........ .....++..|+|||++.+..++.++|||||||++|||++ |+.|+....... .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~--- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE--- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCC---
Confidence 65432221 122334678999999999999999999999999999998 888876532211 111222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+..++.++..++.+||+.+|.+||++.+++..|....
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112223457889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=330.76 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=200.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 68899999986531 223345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976432 688999999999999999999999 999999999999999999999999999986654
Q ss_pred CCcceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||....+.+ .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc
Confidence 33333334579999999999875 567899999999999999999999987543321 1111111111000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNM 344 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 344 (415)
. +......+.++.+++.+|+...+.+ |++++++++.
T Consensus 229 ~------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 1111123567888999999865544 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=320.25 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=205.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCC-----
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHEN-LVELYGCCVEGD----- 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 141 (415)
...|+.+++||+|+||+||+|+.+ +|+.||+|+++....+ .-....+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345677788999999999999976 7899999999876432 2235678999999999999 999999999877
Q ss_pred -eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 142 -HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 142 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
.+++||||+ ..+|.+++.........++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 5589999987664323567789999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC-
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG- 298 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~- 298 (415)
+|+.+.-... ..+...+|.+|+|||++.+. .|+...||||+|||+.||++++.-|.+......... +.+.....
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~---If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR---IFRLLGTPN 241 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHHHcCCCC
Confidence 9997653322 24556789999999999886 799999999999999999999888877655332221 11111111
Q ss_pred --cch---hhcccc--cC-----CCCCHHHH---HHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 299 --KLV---ELVDAS--LN-----GDYSVEEA---HRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 299 --~~~---~~~~~~--~~-----~~~~~~~~---~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
... .+.+-. .. ..+....+ .+..+++.+|++.+|.+|.|++..+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000100 00 00111111 367899999999999999999999874
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.74 Aligned_cols=260 Identities=25% Similarity=0.470 Sum_probs=208.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999752 34568999987766666678999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCC---------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 145 LVYGYLENNSLAQTLLGRGH---------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
+||||+++++|.+++...+. ....+++..+..++.|++.||+|||++ +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999975431 123589999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHH
Q 044232 216 ISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 216 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~ 293 (415)
|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||....+.. .. .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~-~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VI-E 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-H
Confidence 999999985533211 11223345778999999998899999999999999999998 877765433211 11 1
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+.... .+...+..+.+++.+||+.+|.+||++.++++.|++..
T Consensus 234 ~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 112221111 11123467899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.31 Aligned_cols=266 Identities=26% Similarity=0.403 Sum_probs=203.7
Q ss_pred CCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEE
Q 044232 74 FSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRIL 145 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 145 (415)
|+..+.||+|+||+||++.. .++..||+|.+.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 257889999987653 23446788999999999999999999998753 46899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999754 589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....+... ..................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence 432211 11223456679999999888999999999999999999999988754321100 000000000000111112
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.+.......+...+..+.+++.+||+.+|++||++++|++.|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222222223344567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=337.91 Aligned_cols=263 Identities=21% Similarity=0.303 Sum_probs=197.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----CeeE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DHRI 144 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 144 (415)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999976 7899999998643 223345688999999999999999999998643 2579
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998887654 688999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCC--cceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------H
Q 044232 225 FPANL--THISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------W 292 (415)
Q Consensus 225 ~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~ 292 (415)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43221 112234578999999999876 67899999999999999999999998654332211100000 0
Q ss_pred HHHhhCcchhhc---ccccCCCC---CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELV---DASLNGDY---SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...........+ ........ ....+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000 00000000 0112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.28 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=196.7
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.+ +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 68899999987642 23345677889998866 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|...+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999887654 688999999999999999999999 99999999999999999999999999987543221 22
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... +. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~-~~----------~~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILH-DD----------VLY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CC----------CCC
Confidence 334568999999999999899999999999999999999999987543221 1111111 11 011
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCC-------CHHHHHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRP-------SMSTLVNM 344 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~~ 344 (415)
+...+.++.+++.+||+.+|++|| ++.++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 222346788999999999999999 77888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=324.23 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=197.8
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||+|+||+||++..+ +++.||+|.+.... ....+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 78899999987542 22335677899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
..++.........+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433334689999999999999999999999 999999999999999999999999999976543322 2234
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ... ...++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~---------~~~--~~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRI---------LND--SVTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhh---------ccc--CCCCccc
Confidence 57899999999999999999999999999999999999998754321110 0000000 000 0122334
Q ss_pred HHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
.+..+.+++.+||+.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.92 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=196.0
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 68899999997642 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 99999887654 689999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............+.......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC
Confidence 3346799999999999999999999999999999999999999965333222222222222222211 112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
+...+..+.+++.+||+.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22334667899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.12 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=193.2
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.+ +++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987542 23345677888888876 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 99999887654 688999999999999999999999 9999999999999999999999999998754222 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ..... ..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i-~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAI-LNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHH-hcCCC----------CC
Confidence 334579999999999999999999999999999999999999987543221 11111 11111 11
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
+...+.++.+++.+||+.||.+||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.21 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=209.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+..++|++.+.||+|+||.||+|..+++..+|+|.+..... ...++.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678999999999999999999988788899999876533 34678899999999999999999999998889999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999976542 2588999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....+.. ...... .+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~-~~--------- 220 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVE-RG--------- 220 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-cC---------
Confidence 2222222334668999999998899999999999999999998 888875432211 111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.....+...+.++.+++.+||+.+|.+||+++++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111122235678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.48 Aligned_cols=240 Identities=27% Similarity=0.379 Sum_probs=193.7
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.+ +|..||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 68899999987642 12334566788888754 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 99999987654 688899999999999999999999 9999999999999999999999999998743221 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .. .....+ ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~-~~~~~~----------~~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LF-ESIRVD----------TPHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhC----------CCCC
Confidence 345679999999999999999999999999999999999999987543211 11 111111 0112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHH-HHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMS-TLV 342 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~-evl 342 (415)
+...+.++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222346788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.68 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=204.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..++|.+.+.||+|++|.||+|.++++..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 3467889999999999999999988777799998875432 2357889999999999999999999875 4568899999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999976432 2578999999999999999999998 99999999999999999999999999998654332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........++..|+|||...+..++.++||||||+++|+|++ |+.|+....+.+ ... ....+ .
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~-~~~~~---------~ 220 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLE-QVERG---------Y 220 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHHcC---------C
Confidence 222223345678999999988899999999999999999999 777776533211 111 11111 0
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+...+..+.+++.+||+.+|++||++++|++.|..
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111223445779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.65 Aligned_cols=241 Identities=27% Similarity=0.367 Sum_probs=196.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+|++.+.||+|+||.||+|... ++..||+|++.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999976 68899999987642 22334566788888777 5889999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987654 688999999999999999999999 999999999999999999999999999975432
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... ..
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~-~~-------- 217 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIME-HN-------- 217 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC--------
Confidence 2 112334679999999999999999999999999999999999999987543211 1111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
..++...+.++.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 12233345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.65 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=204.8
Q ss_pred cCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999984 24678999998754 33444678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 044232 146 VYGYLENNSLAQTLLGRGH-------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 212 (415)
||||+++++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999854321 122578899999999999999999999 999999999999999999
Q ss_pred CeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHH
Q 044232 213 TPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~ 290 (415)
.+||+|||++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....+.. .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------V 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 99999999998653321 112233445678999999988889999999999999999998 877775432211 1
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
......+.. ...+...+..+.+++.+||+.+|.+||++.+|++.|.+
T Consensus 236 -~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111 11222345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.88 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=203.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-----CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-----DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 144 (415)
++|++.+.||+|+||.||+|..+ ++..||+|.+........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56888999999999999999742 578999999987766667789999999999999999999998754 34689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999975432 588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh----hC
Q 044232 225 FPANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE----RG 298 (415)
Q Consensus 225 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~----~~ 298 (415)
........ .....++..|+|||++.+..++.++|||||||++|||++|..++..... . .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-E---FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-h---hhhhcccccccccchH
Confidence 64432211 1112234569999999888999999999999999999998765432110 0 0000000000 00
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.+.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0001111111112223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.93 Aligned_cols=241 Identities=28% Similarity=0.338 Sum_probs=192.3
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHH-HHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEIN-VIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999976 78999999987542 223345555655 46778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 99998887654 688999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... +.. ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~-~~~------~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH-KPL------VLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc-CCc------cCCC--
Confidence 334679999999999999999999999999999999999999887543221 1111111 110 1111
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+..+.+++.+|++.+|.+||++.+.++
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 23456789999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.49 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=205.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-----RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999865 68999999886532 2234568889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987654 578899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccee--cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTHIS--TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||....+... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIAT------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhc-------
Confidence 43211111 235578899999999988899999999999999999999988765433221 111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.......+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 222 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 --QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122333455678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=337.21 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=201.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----eeE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD-----HRI 144 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 144 (415)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999975 7899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|+||+. ++|.+.+.... .+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57888876543 689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc---
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL--- 300 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~--- 300 (415)
.............+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+....... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAM 229 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHH
Confidence 543333333345688999999998774 5799999999999999999999999766543321111 100000000
Q ss_pred -------hh-hcccccC-------CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 -------VE-LVDASLN-------GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 -------~~-~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. +...... .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00 0000000 0111223567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=325.74 Aligned_cols=259 Identities=25% Similarity=0.457 Sum_probs=210.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999743 355689999877766666789999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC
Q 044232 146 VYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 213 (415)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999976432 123588999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHH
Q 044232 214 PKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~ 291 (415)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.|+....+.+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999975533221 12233456788999999998999999999999999999999 888876543321 1
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
......+... ..+...+..+.+++.+||+.+|++||++.+|++.|....
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1112222111 112234567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.43 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=204.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999975 7889999999765544456788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999987554 688999999999999999999999 99999999999999999999999999998654321
Q ss_pred cceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.|+....+..... ....... ..+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCC
Confidence 1 122346888999999874 3457889999999999999999998875433322110 0000000 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
.. ......+..+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 11122346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.80 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=206.1
Q ss_pred CCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
+|++.+.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578999887553 3344678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCC--------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 044232 146 VYGYLENNSLAQTLLGRGH--------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 205 (415)
|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864321 113578999999999999999999998 99999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChh
Q 044232 206 ILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE 283 (415)
Q Consensus 206 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~ 283 (415)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865332221 1223345678999999988899999999999999999998 888876543321
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.+.....+ .....+...+..+.+++.+||+.+|++||++.++++.|.+.+
T Consensus 238 -------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 12222211 111222334567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.23 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=197.6
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999976 7899999987654 234456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce-ec
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI-ST 234 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~ 234 (415)
.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEGP---RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999875432 578999999999999999999999 99999999999999999999999999987543221110 01
Q ss_pred ccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
...++..|+|||.+.++.++.++|||||||++|||++ |..|+....+.. ....... ......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQ---------GVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHc---------CCCCCCc
Confidence 1123456999999999899999999999999999998 766665432211 1111111 1111223
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 344567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.33 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=207.5
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
+..++|++.+.||+|+||.||+|..+. +..||+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345789999999999999999998652 3689999987553 334467889999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHS------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999999754321 12478899999999999999999998 999999999999999999999
Q ss_pred EeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHH
Q 044232 216 ISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 216 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~ 293 (415)
|+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..|+....+.. .. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~-~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL-K 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH-H
Confidence 999999986533221 12233456788999999988899999999999999999998 877765433221 11 1
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
....+.. ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 1122233678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.74 Aligned_cols=238 Identities=26% Similarity=0.314 Sum_probs=194.6
Q ss_pred CcccccCeEEEEEEEe----cCCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 78 NKIGQGGFGSVYKGTL----KDGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 2588999999876422 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999987654 689999999999999999999999 99999999999999999999999999997653321 2
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... .. ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~-~~----------~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILK-AK----------LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHc-CC----------CC
Confidence 2334678999999999998889999999999999999999999887543211 1111111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMST 340 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~e 340 (415)
.+...+..+.+++.+||+.||.+||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22234567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=315.88 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=200.1
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHH
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLA 156 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 156 (415)
+.||+|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987653 333357889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceeccc
Q 044232 157 QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV 236 (415)
Q Consensus 157 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 236 (415)
+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99865432 578999999999999999999998 999999999999999999999999999975433222212223
Q ss_pred ccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 237 AGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 237 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
.++..|+|||++.++.++.++||||||+++|+|++ |..||....... ... ....+. ....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~~~-~~~~~~---------~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------ARE-QVEKGY---------RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------HHH-HHHcCC---------CCCCCCC
Confidence 44667999999998899999999999999999998 877775432221 111 111111 1112223
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.+..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=347.02 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=215.8
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCC-CEEEEEEccccchHhHHHHHHHHHHHhhcC-Ccceeeeee-EEEe--
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDG-TLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYG-CCVE-- 139 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~-- 139 (415)
..+.+...++++.+.|.+|||+.||.|....+ ..||+|++-..+....+...+|+++|++|+ |+|||.++| ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 44556677888999999999999999998755 999999988888888899999999999996 999999999 3321
Q ss_pred ----CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 140 ----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 140 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
.-+++|.||||.||.|-+++..+... .|++.++++|+.++++|+++||.. +++|||||||-+||||+.+|..|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 12578999999999999999877654 599999999999999999999997 67899999999999999999999
Q ss_pred EeeeccccccCCCCcce--------ecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhh
Q 044232 216 ISDFGLAKLFPANLTHI--------STRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE 284 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~ 284 (415)
|||||.+...-...+.. .-...-|+.|+|||++. +...++|+|||+|||+||-|+....||+...+.
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999997432211100 01133689999999874 568999999999999999999998888754222
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.+++....-......+..+..||..||+.||++||++-+|+..+.......
T Consensus 265 -----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122222221222467789999999999999999999999999887665443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=317.59 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=210.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999987 7999999988642 2333567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.........+++..+..++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876443344689999999999999999999999 999999999999999999999999999886543
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.|+..... ...+... ....+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~--------- 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKC--------- 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcC---------
Confidence 321 12234588899999999888899999999999999999999988754321 1111111 11111
Q ss_pred cCCCCCH-HHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 308 LNGDYSV-EEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 308 ~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+. ..+..+.+++.+||+.+|++||++.+|++.|...
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111222 4456789999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.40 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=200.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 68889999986531 223345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976432 688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 228 NLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....+.. .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc
Confidence 3333333457999999999986 3468899999999999999999999987543322 1112211111000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNM 344 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 344 (415)
.+......+..+.+++.+|+..++.+ ||++.++++.
T Consensus 229 ------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111234567888888888654444 6889999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=328.52 Aligned_cols=243 Identities=26% Similarity=0.312 Sum_probs=192.8
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHH-HHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEI-NVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 67889999987542 12223444444 456788999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++.... .+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 99999997654 577888999999999999999999 9999999999999999999999999999754222 122
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+ ....... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~----------~~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILN-KP----------LQL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHh-CC----------cCC
Confidence 334679999999999999999999999999999999999999987543321 1111111 11 011
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
....+..+.+++.+||+.+|.+||++.+.+..+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 223346788999999999999999987554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.36 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=207.7
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++..++|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34567899999999999999999998777889999887643 234678899999999999999999999887 7789999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+..
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999976432 2578889999999999999999998 999999999999999999999999999986643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
..........++..|+|||++..+.++.++|||||||++|+|++ |+.|+........ ......+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~------- 220 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGY------- 220 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCC-------
Confidence 32222222345677999999998889999999999999999999 8777764322111 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus 221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.19 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----eeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD-----HRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 145 (415)
-.|+..+.+|.|+||.||+|... ++..||||.+..+.+-. .+|+++|+.+.|||||++.-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34667789999999999999976 67899999987765432 25999999999999999999987432 3468
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeeccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKL 224 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~ 224 (415)
||||++. +|.+.+.........++...+.-+..||.+||+|||+. +|+||||||.|+|||.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 79999886444445788888999999999999999998 99999999999999977 8999999999998
Q ss_pred cCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc----
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK---- 299 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~---- 299 (415)
+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.++..-.....+-.+.....+..
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 8665433 345578899999998874 799999999999999999999988877544332211111110000000
Q ss_pred --------chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 --------LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..++.......-.....+.+..+|+.++++.+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111111111133455688999999999999999999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=318.62 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=198.1
Q ss_pred cccccCeEEEEEEEec---CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 79 KIGQGGFGSVYKGTLK---DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999986543 334567899999999999999999999885 45678999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce-
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI- 232 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 232 (415)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||.||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997554 688999999999999999999999 99999999999999999999999999998664332211
Q ss_pred -ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 233 -STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 233 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....++..|+|||.+....++.++|||||||++|||++ |..||....+.+ ... ....+. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~-~i~~~~---------~~ 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQ-MIESGE---------RM 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHHCCC---------CC
Confidence 122234578999999988889999999999999999998 888876532211 111 122211 11
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+...+.++.+++.+||+.+|++||++.+|.+.|.+.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22334557789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=329.60 Aligned_cols=241 Identities=28% Similarity=0.381 Sum_probs=197.0
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||+||+|..+ +++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987642 23345677898999887 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence 99999887664 689999999999999999999999 9999999999999999999999999998743222 112
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... ..+. ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i-~~~~----------~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSI-LEDE----------VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHH-HcCC----------CCC
Confidence 234568999999999999999999999999999999999999986543211 11111 1111 112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCH-----HHHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSM-----STLVN 343 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 343 (415)
+...+..+.+++.+||+.+|++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 23345678999999999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=322.03 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=202.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++|++.+.||+|+||.||+|.+. ++. .+++|.+.... .....++..|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888999999999999999975 444 47888876442 2334577888999999999999999998764 55788
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
++||+++|+|.+++..... .+++..+..|+.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......++..|+|||.+.++.++.++|||||||++|||++ |+.|+....+... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~- 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLA- 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC-
Confidence 43322 12234557788999999998999999999999999999998 8888765433221 11222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.+..++..+..++.+||..+|.+||++.|+++.|....
T Consensus 232 --------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 --------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11123456788999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.40 Aligned_cols=241 Identities=28% Similarity=0.375 Sum_probs=194.0
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhh-cCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKD-IKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 68899999987642 2233456678888876 4999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999997654 688999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ..... ..+. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i-~~~~----------~~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSI-RMDN----------PCY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCC----------CCC
Confidence 234568999999999999899999999999999999999999987543211 11111 1110 112
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHH-HHHH
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMS-TLVN 343 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 343 (415)
+...+.++.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222346688999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.98 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|... ++..+|+|.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999965 7899999987653 2233467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433334689999999999999999999999 999999999999999999999999999886643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+....... ...... .... .
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-~~~~--------~ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-IEQC--------D 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh-hhcC--------C
Confidence 322 1223468899999999988889999999999999999999998876432210 111111 1100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+......+..+.+++.+||+.+|++|||+.+|++.+.+.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01111223456799999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=322.94 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=203.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-----------------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-----------------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
.++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998543 24468999997653 334567899999999999999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCC-------CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 044232 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSS-------IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205 (415)
Q Consensus 133 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 205 (415)
+++++...+..++||||+++++|.+++....... ..+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 9999999999999999999999999997653221 2477889999999999999999999 99999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh--CCcCCCCCCCh
Q 044232 206 ILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS--GRCNTNRRLPY 282 (415)
Q Consensus 206 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~p~~~~~p~ 282 (415)
||++.++.++|+|||++..+..... .......+++.|+|||+..++.++.++|||||||++|||++ |..|+....+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986533221 11222344678999999988899999999999999999998 55566543221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.. .......+...... .....+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 241 ~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---IENTGEFFRDQGRQ------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 11111111111000 001112234577899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=316.12 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=205.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999976 6899999988643 334456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999976522 2688999999999999999999998 99999999999999999999999999998664432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.|+....+.. ..... ..+. .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~---------~ 218 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKI-IRGV---------F 218 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HcCC---------C
Confidence 2 2233568899999999999999999999999999999999999987543211 11111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1222244567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.82 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.+|++.++||+|+||.||+|... .+..||+|++...... ....+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45777899999999999999864 2578999999765432 3456889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 044232 145 LVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 212 (415)
+++||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 99999999999999853211 112578889999999999999999999 999999999999999999
Q ss_pred CeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHH
Q 044232 213 TPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~ 290 (415)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..|+....+ .+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999886533221 11233446788999999988899999999999999999998 6666654322 111
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.. ....+. ....+..++..+.+++..||+.+|.+||++++|+..|..
T Consensus 236 ~~-~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IE-MIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 111111 112233456778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=338.00 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=210.3
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcC-CcceeeeeeEE
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIK-HENLVELYGCC 137 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 137 (415)
.+++..++|.+.+.||+|+||.||+|++. .+..||+|++.... ......+.+|+.+|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35667788999999999999999999863 34679999997653 233457889999999997 99999999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCCC-----------------------------------------------------
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRGH----------------------------------------------------- 164 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 164 (415)
...+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975421
Q ss_pred -----------------------------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 044232 165 -----------------------------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKA 203 (415)
Q Consensus 165 -----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 203 (415)
....+++..+..++.||+.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 112467778899999999999999998 999999999
Q ss_pred CCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCC
Q 044232 204 SNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLP 281 (415)
Q Consensus 204 ~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p 281 (415)
+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986532211 11223456788999999998889999999999999999998 7777654322
Q ss_pred hhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.+ ........+. ....+...+.++.+++.+||+.+|.+||++++|++.|.+.+
T Consensus 348 ~~------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE------QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH------HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111222221 11122334578999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.26 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=222.9
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
+++|+....+.....+||.|.||.||.|.|+ -.-.||||.++.+.. ...+|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 3567777777788899999999999999998 356799999987654 45899999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+|||+|||..|+|.++|...... .++.-..+.++.||+.||.||..+ ++|||||..+|+||.++..||++||||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999876533 567778899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+.+..+.........-...|.|||-+....++.|+|||+|||+|||+.|- +..||.+..+.. +..++++
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY-----GMsPYPGidlSq-VY~LLEk----- 481 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY-----GMSPYPGIDLSQ-VYGLLEK----- 481 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhc-----CCCCCCCccHHH-HHHHHhc-----
Confidence 98765533322223345679999999999999999999999999999984 355666654432 2333333
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+.+-+..|+..+.+||..||+++|.+||+++|+-+.++..+
T Consensus 482 ----gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 ----GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ----cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 3444557788899999999999999999999999998886654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=323.97 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=206.6
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
++..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999999754 24579999886553 23335688899999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHS------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
+..++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||++ +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999754311 12456778899999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHH
Q 044232 215 KISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 215 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~ 292 (415)
+|+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..|+...... +...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 9999999985533211 11122345678999999999999999999999999999998 66666542211 1111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.... +.. ...+...+..+.+++.+||+.+|++||++.++++.|.+.+
T Consensus 233 ~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMD-GGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHc-CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 111 1112233568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.91 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=196.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG-------- 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 140 (415)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999975 688999998865422 234699999999999999999887432
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeee
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDF 219 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 219 (415)
..+++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 67777654333334789999999999999999999999 999999999999999665 7999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+..+....... .......
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI---IQVLGTP 290 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCC
Confidence 9998664322 22345689999999998764 6899999999999999999999998765543321111 1111000
Q ss_pred c----------ch-----hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 K----------LV-----ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~----------~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .. ......+...++...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 00 000000111122234567899999999999999999999985
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.46 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=205.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC-----------------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD-----------------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
..+|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999987642 2458999987653 344567889999999999999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCCHHHHhhcCCC-------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 044232 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGH-------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205 (415)
Q Consensus 133 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 205 (415)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976541 112588999999999999999999999 99999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh--CCcCCCCCCCh
Q 044232 206 ILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS--GRCNTNRRLPY 282 (415)
Q Consensus 206 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~p~~~~~p~ 282 (415)
|+++.++.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986533221 22233456788999999998899999999999999999998 55555432211
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.........+..... ......+...+.++.+++.+||+.+|.+||++.+|++.|.
T Consensus 241 ---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111110 1111112234467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.08 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=205.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+.|..++.||.|+||.||-|++. +...||||.+... +.+.+.+++.|+..|++++|||++.+.|||..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667789999999999999976 7899999998765 3456678899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||| -||-.+++.-... ++.+..+..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|....+
T Consensus 106 EYC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999 5678888765543 788999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
...++|||.|||||++. .+.|+-++||||||++..||...++|.... +.......+..+..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNes----- 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES----- 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcCC-----
Confidence 34678999999999986 578999999999999999999987775432 22333333322211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+.+ ...++++.++.++..||+.-|.+|||..+++..
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 145778899999999999999999999998764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=321.95 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=210.0
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC-----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD-----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE-GD 141 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 141 (415)
+..++|++.+.||+|+||.||+|.+.+ +..|++|.+... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999765 688999988754 33445678899999999999999999998876 46
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCC----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSS----IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
..+++++|+++++|.+++....... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 7899999999999999987643221 3689999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHH
Q 044232 218 DFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 218 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.|+....+.+ .. ...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MA-AYL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HH-HHH
Confidence 99999865332221 1223446778999999988889999999999999999999 888886544322 11 111
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+. ....+..++..+.+++.+||+.+|++||++.++++.|....
T Consensus 233 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 KDGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HcCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 11112234567899999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.16 Aligned_cols=251 Identities=28% Similarity=0.369 Sum_probs=211.4
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
++..++|+.++.||+|.||+|.+++.+ +++.+|+|++++. ..+....-+.|-.+|+..+||.+..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 445688999999999999999999987 7999999999876 344556677899999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
|+||||..||.|.-+|.+.. .+++...+-+...|+.||.|||+. +||+||||.+|+|+|.||++||+|||+++
T Consensus 244 CFVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 99999999999998887755 688889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.--. ......+.+|||.|+|||++....|+.++|+|.+|||+|||++|+.||..+.... +.++
T Consensus 317 E~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeL 379 (516)
T KOG0690|consen 317 EEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFEL 379 (516)
T ss_pred hccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHH
Confidence 5322 2345677999999999999999999999999999999999999999997653211 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
+- .-.-.+|....++...|+...|..||.+|. .++||.+
T Consensus 380 Il-~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 380 IL-MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HH-hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 10 011234555567788999999999999996 4566654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=321.74 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=204.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..++|++.+.||+|++|.||+|.+.+ +..||+|...... ......|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 5678999887543 3334578999999999999999999999999889
Q ss_pred eEEEEeeccCCCHHHHhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEE
Q 044232 143 RILVYGYLENNSLAQTLLGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKI 216 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 216 (415)
.++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 123588999999999999999999999 999999999999998765 5999
Q ss_pred eeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHH
Q 044232 217 SDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 217 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....+.. .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~-~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VM-EF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HH
Confidence 999999865322111 1112233567999999999999999999999999999997 887776543321 11 11
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.... .....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 111223344577899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.65 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=201.8
Q ss_pred CCCCCcccccCeEEEEEEEec-C---CCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe-----
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-D---GTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH----- 142 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 142 (415)
|++.+.||+|+||.||+|... + +..||+|.++.. .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 367999998754 23345678999999999999999999999876554
Q ss_pred -eEEEEeeccCCCHHHHhhcCCC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 143 -RILVYGYLENNSLAQTLLGRGH--SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 143 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.++++||+++|+|..++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865421 223688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcce-ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 220 GLAKLFPANLTHI-STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 220 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+....+. +..... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~-~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYL-RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-Hc
Confidence 9998654332211 122335678999999988899999999999999999999 77776543221 111111 11
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
+. ....+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112234456799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.31 Aligned_cols=251 Identities=21% Similarity=0.373 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999865 7889999998655 334446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999997542 467888999999999999999999 9999999999999999999999999999865432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......||..|+|||++.+..++.++|||||||++|+|++|+.||........................ ..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~-- 219 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PV-- 219 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CC--
Confidence 223456899999999999889999999999999999999999998653322111111011111111100 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
......+.++.+++.+||+.+|.+||++.++++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 -LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0011234568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=334.93 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=198.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 68999999987532 233457788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997654 688999999999999999999999 999999999999999999999999999875422
Q ss_pred CCc----------------------------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCC
Q 044232 228 NLT----------------------------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273 (415)
Q Consensus 228 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 273 (415)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0012356999999999999999999999999999999999999
Q ss_pred cCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC---HHHHHH
Q 044232 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS---MSTLVN 343 (415)
Q Consensus 274 ~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 343 (415)
.||....+... ............ .... ...+.++.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~------~~~i~~~~~~~~-----~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQET------YRKVMNWKETLV-----FPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHH------HHHHHcCCCcee-----cCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99876654332 111111000000 0001 1133567778887664 9999985 556654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.54 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=196.9
Q ss_pred cccccCeEEEEEEEec---CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCC
Q 044232 79 KIGQGGFGSVYKGTLK---DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 154 (415)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35579999987653 333467889999999999999999999886 457899999999999
Q ss_pred HHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee-
Q 044232 155 LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS- 233 (415)
Q Consensus 155 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 233 (415)
|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999875432 688999999999999999999999 999999999999999999999999999986543322111
Q ss_pred -cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 234 -TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 234 -~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
....++..|+|||.+....++.++|||||||++|||++ |..|+....+.+ . ......+. ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~---------~~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------V-MSFIEQGK---------RLD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------H-HHHHHCCC---------CCC
Confidence 11223578999999988889999999999999999996 887876543211 1 11222221 122
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.+..++.++.+++.+||+.+|++||++.+|.+.|...
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2334567889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.94 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=215.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH---hHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ---GVREFLTEINVIKDIK-HENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 144 (415)
..+.|++.+.||+|.||.||++..+ +|+.+|+|++.+.... ....+.+|+++|+++. |||||.+++.+++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567999999999999999999987 5999999999776432 3457889999999998 999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----CCeEEeeec
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD----LTPKISDFG 220 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 220 (415)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. |++||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999876 289999999999999999999999 99999999999999543 579999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....+..
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 9998766 445667899999999999999999999999999999999999999998765544321 1122222
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
...............+++..|+..||.+|+++.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 23334445557888999999999999999999999984
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.20 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=199.5
Q ss_pred CCCCCcccccCeEEEEEEEecC-CC--EEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------Ce
Q 044232 74 FSPANKIGQGGFGSVYKGTLKD-GT--LAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------DH 142 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 142 (415)
|.+.+.||+|+||.||+|.+.+ +. .+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999763 33 5899988654 344457888999999999999999999987532 24
Q ss_pred eEEEEeeccCCCHHHHhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 143 RILVYGYLENNSLAQTLLGRG--HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998875322 1223588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcce-ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 221 LAKLFPANLTHI-STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 221 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....+. . .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------E-IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcC
Confidence 998764332211 122345678999999998899999999999999999999 67776543221 1 11122222
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
... ..+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 11223456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=319.71 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||+|+||.||++..+ +|+.||+|.+..... .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999976 689999999865321 1223456799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865442 2588899999999999999999999 99999999999999999999999999998654322 2234
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ .......... +. .. .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~--------~~-~~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DE--------VK-FEHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-cc--------cc-ccccc
Confidence 5689999999999988899999999999999999999999864322111 1111111111 00 00 00112
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
.+.++.+++.+||+.||.+||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 346688999999999999999998776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=321.00 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=206.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356888899999999999999642 35689999987766666678999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCC-----------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC
Q 044232 145 LVYGYLENNSLAQTLLGRGHS-----------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 213 (415)
++|||+++++|.+++...... ...+++..++.++.||+.||+|||+. +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999999764321 12578999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHH
Q 044232 214 PKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~ 291 (415)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....+.+ ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AI 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HH
Confidence 99999999975533221 11223345678999999999999999999999999999998 777765432211 11
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
... ..+. ....+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 235 ~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECI-TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH-HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111 1111 11112234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=318.87 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=205.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CC---CEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DG---TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+... .....+.+.+|+.++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456888899999999999999875 33 37999998765 23445678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987543 2688999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcceec--ccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 226 PANLTHIST--RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 226 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
......... ....+..|+|||++.+..++.++|||||||++|||++ |+.|+....+. ...... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-~~~---- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-NDG---- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-hcC----
Confidence 433221111 1223457999999998889999999999999999997 88887543221 111111 111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+...+..+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112223457789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=322.71 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=201.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC---------------CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD---------------GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 134 (415)
.++|++.+.||+|+||.||++.... ...||+|.++.. .......|.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4679999999999999999987542 235899998765 333446789999999999999999999
Q ss_pred eEEEeCCeeEEEEeeccCCCHHHHhhcCCC--------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 044232 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGH--------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206 (415)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 206 (415)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865421 112468889999999999999999999 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhC--CcCCCCCCChh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG--RCNTNRRLPYE 283 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg--~~p~~~~~p~~ 283 (415)
++++++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|+|+++ ..|+.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976533221 112233456789999999988999999999999999999984 33443322111
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.............. ......+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 241 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111100 0001112223568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.30 Aligned_cols=265 Identities=27% Similarity=0.439 Sum_probs=208.6
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
+++..++|.+.+.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.+ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3445578999999999999999999753 23469999997652 33456788899999999 79999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence 9999999999999999999999976532 113588999999999999999999998 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..|+... +.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CH
Confidence 999999999999999998765332111 1112234568999999998899999999999999999998 76676543 22
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
+. .. .....+. ....+...+.++.+++.+||+.+|++||++.+|++.|...+.
T Consensus 249 ~~-----~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 EE-----LF-KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HH-----HH-HHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 11 1111111 112233445788899999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=327.05 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=209.7
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCC 137 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 137 (415)
.+..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345678999999999999999999741 24579999987542 34456788999999999 899999999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 205 (415)
......++||||+++|+|.+++...... ...+++..+..++.||+.||.|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 9999999999999999999999764321 23578889999999999999999999 99999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChh
Q 044232 206 ILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE 283 (415)
Q Consensus 206 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~ 283 (415)
|+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..|+.... .
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-V- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-H-
Confidence 99999999999999999866432221 1222345678999999988889999999999999999998 666654322 1
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.+... ....+. ....+..++..+.+++.+||+.+|.+||++.+|++.|.+.+..
T Consensus 246 ----~~~~~-~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 ----EELFK-LLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHH-HHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111 111111 1112234557789999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.84 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=204.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999976 6889999988643 2334567888999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999998865432 2578899999999999999999999 99999999999999999999999999998664321
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||....+.. ..... ..+.. .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~-~~~~~---------~ 218 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKV-CQGSY---------K 218 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHH-hcCCC---------C
Confidence 12234568899999999998899999999999999999999999987543211 11111 11111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+...+..+.+++.+||+.+|++||++.+|+..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1222344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.93 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=206.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|++.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 367899999999999999999865 7889999998776555557788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998643 478899999999999999999999 99999999999999999999999999988654322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ......+ ...
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~--------~~~ 235 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG--------TPE 235 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCC--------CCC
Confidence 1 122346889999999999888999999999999999999999998765442211 0011111 001
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||..+|++||++.+|++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1112334567889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.28 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=205.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-C---CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-D---GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..+|++.+.||+|+||.||+|.+. + +..+|+|.+.... ......+.+|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999864 2 3379999987543 3345678999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999976532 578999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceec--ccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 226 PANLTHIST--RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 226 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
......... ...++..|+|||.+.+..++.++|||||||++||+++ |..|+....+.+ ... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~-~~~~~~--- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIK-AIEEGY--- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHH-HHhCCC---
Confidence 443222211 1223567999999998899999999999999999886 888876543321 111 111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|.+.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111223456789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=324.08 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=208.2
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCVE 139 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 139 (415)
....++|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345578999999999999999999742 35579999987653 33446788999999999 79999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.+..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +++|+||||+|||++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 1489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 220 GLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 220 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
|++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+. .......
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~ 259 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKE 259 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHc
Confidence 999865433221 1222346778999999999999999999999999999998 8887764332111 1111111
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
+. ....+...+..+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 260 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 1111122346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=328.55 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=208.8
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecC--------CCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
+++...+|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 44555679999999999999999997421 2368999887542 33456888999999999 89999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+...+..++++||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999976431 223578899999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..|+.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999865432111 1122334567999999999999999999999999999998 7666644321
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.+... ....+. ....+...+..+.+++.+||+.+|.+||++.++++.|......
T Consensus 243 -----~~~~~-~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 -----EELFK-LLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----HHHHH-HHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 11111 111111 1112223456788999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=323.23 Aligned_cols=259 Identities=28% Similarity=0.401 Sum_probs=204.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCC--EEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGT--LAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 146 (415)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999875 333 4788888743 334456788999999999 799999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 147 YGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975431 112588999999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||....+.. ...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~- 229 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE- 229 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH-
Confidence 9999999864321111 111223457999999988899999999999999999997 888876543321 111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
....+ .....+...+..+.+|+.+||+.+|.+||++.++++.|......
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11122233456789999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=315.69 Aligned_cols=250 Identities=31% Similarity=0.488 Sum_probs=206.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 467899999999999999999875 78899999977654 4578899999999999999999999999989999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999999976542 2588999999999999999999999 99999999999999999999999999998653221
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
....++..|+|||.+..+.++.++||||||+++|+|++ |..|+....+.. .......+. .
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 217 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGY---------R 217 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC---------C
Confidence 12334667999999988899999999999999999997 887775432211 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
...+...+..+.+++.+||+.+|++||++.+++++|..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11222345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.25 Aligned_cols=241 Identities=26% Similarity=0.363 Sum_probs=195.9
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 147 (415)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999976 78999999987542 233456778899988885 567888999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987654 689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~-~~-------- 217 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIME-HN-------- 217 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC--------
Confidence 21 12234568999999999999999999999999999999999999987643211 1111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
..++...+.++.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.25 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=202.6
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999976 5788999998776666667889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
++|..++.... .++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 99998876532 2689999999999999999999999 99999999999999999999999999987553321 12
Q ss_pred ecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 233 STRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.....+++.|+|||++. +..++.++|||||||++|+|++|+.|+....+... ...... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~-~~~~------ 226 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-SEPP------ 226 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhh-cCCC------
Confidence 23456899999999884 34578899999999999999999988765433221 111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 -TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122345678999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.63 Aligned_cols=264 Identities=25% Similarity=0.420 Sum_probs=207.6
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
+....++|.+.+.||+|+||.||+|... ....+|+|.+... .......+.+|+.+++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3445578899999999999999999742 2457899998754 334456788999999999 69999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+......++||||+++|+|.+++..... ....+++..+..++.||+.||.|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 9998999999999999999999976431 123588999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..|+....+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865432111 1112234567999999998899999999999999999999 77776543221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. .......+.. ...+..++.++.+++.+||+.+|++||++.++++.|.+..
T Consensus 244 ~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 E-------LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred H-------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1111111111 1122334567889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=315.41 Aligned_cols=251 Identities=27% Similarity=0.493 Sum_probs=202.4
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.+|++.+.||+|+||.||+|.+.++..+|+|.+...... ...+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999999877888999998754332 3568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999875432 578999999999999999999999 9999999999999999999999999998765332221
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......++..|+|||++.++.++.++||||||+++|||++ |+.|+...... ...... ..+ ...
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~---------~~~ 220 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI-NAG---------FRL 220 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH-hCC---------CCC
Confidence 1222335678999999998899999999999999999998 87777543221 111111 111 000
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11112346789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.95 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=202.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC--EEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT--LAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 145 (415)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.+... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467889999999999999999975 454 4577776543 334456788999999999 89999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC
Q 044232 146 VYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 213 (415)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975432 112578999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHH
Q 044232 214 PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~ 292 (415)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||......+ ...
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 234 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence 999999998643211 11111234667999999988889999999999999999998 888875433211 111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. ...+ .....+...+..+.+++.+||+.+|++||++.+++..|....
T Consensus 235 ~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 K-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred H-HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 111112234467889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.97 Aligned_cols=240 Identities=27% Similarity=0.334 Sum_probs=189.1
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc---CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI---KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
||+|+||+||+|+.+ +++.||+|++.... ......+..|..++... .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 68999999986532 12233455677777665 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999987654 688999999999999999999999 99999999999999999999999999987543221 22
Q ss_pred ecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 233 STRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+ ... ....+.. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~-~i~~~~~------~~~-- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYR-NIAFGKV------RFP-- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHH-HHHcCCC------CCC--
Confidence 3346799999999998764 58999999999999999999999986543211 111 1111111 000
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCC----CHHHHHH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRP----SMSTLVN 343 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RP----s~~evl~ 343 (415)
....+.++.+++.+||+.+|.+|| ++.++++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012346678999999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.08 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999876 6888999998765 233445688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... .+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997654 6889999999999999999999732 8999999999999999999999999998754322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC-----------
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG----------- 298 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~----------- 298 (415)
......|+..|+|||++.+..++.++|||||||++|+|++|+.|+....+.................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1234568899999999988889999999999999999999999875432211100000000000000
Q ss_pred ------cchhhccc---ccCCCCC-HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 299 ------KLVELVDA---SLNGDYS-VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 299 ------~~~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
...+..+. ...+..+ ...+.++.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000111 1134578999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.16 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=198.0
Q ss_pred CcccccCeEEEEEEEec--C--CCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK--D--GTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
++||+|+||.||+|.+. + +..+|+|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999864 2 26899999876643 34467889999999999999999999876 4568999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998664 688999999999999999999999 99999999999999999999999999998664432221
Q ss_pred ec--ccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 233 ST--RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 233 ~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.. ...++..|+|||.+.+..++.++|||||||++|+|++ |..|+....+. +. ......+. .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------~~-~~~~~~~~---------~ 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------EV-IAMLESGE---------R 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------HH-HHHHHcCC---------c
Confidence 11 1223567999999998899999999999999999998 88887653221 11 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
...+...+..+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.61 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=203.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|++.+.||+|+||.||+|.+. ++. .||+|++... .......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467889999999999999999864 444 4899998754 33345678899999999999999999999875 4578
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999976432 588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcce-ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLTHI-STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..|+....+.. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~--- 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGE--- 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCC---
Confidence 64332211 112234678999999998899999999999999999998 777775432211 111112111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|++||++.++++.|....
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 ------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11112234567889999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.06 Aligned_cols=261 Identities=24% Similarity=0.406 Sum_probs=221.6
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEecC-----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLKD-----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
+.++..+.....+.||.|.||.||+|.+.+ .--||||..+.+ ..+..+.|+.|+.+|++++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344555666677899999999999998643 234899998875 45566889999999999999999999999986
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
. ..+||||.++-|.|..+|+.+.. .++......++.||+.||+|||++ ++|||||..+||||...-.+||+||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 4 68999999999999999988764 688899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
|+++.+........+...-...|||||.+.-..++.++|||.|||++||+++ |..||.+ ..+.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg----------------vkNs 599 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG----------------VKNS 599 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc----------------cccc
Confidence 9999987776655555555778999999999999999999999999999876 5555543 2334
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.+...+....+...|..||..+..|+.+||..+|.+||.+.+|...|....
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 455556666677788899999999999999999999999999988775543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=316.27 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=201.3
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHH--HHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVR--EFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
|++.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999987 5678999999877544322 3456999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++.... .+++..+..++.||++||.+||+. +++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998433 689999999999999999999999 99999999999999999999999999997542 222
Q ss_pred ceecccccCCCCCChhhhh-cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 231 HISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.......++..|+|||++. +..++.++||||||+++|+|++|..|+......... ......... ..... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~~-~~~~~---~-- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL---EIIEKILKR-PLPSS---S-- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH---HHHHHHHHT-HHHHH---T--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh---hhhhhcccc-ccccc---c--
Confidence 3344567899999999998 788999999999999999999999888754111111 111111110 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011277999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=317.91 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=201.2
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999976 78999999886542 22234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998865432 2588999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... +........ ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~----------~~ 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE----------VQ 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh----------hh
Confidence 1 22346899999999999999999999999999999999999998754321110 111111110 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+.++.+|+.+||+.+|.+||+ +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122233466889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.60 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=204.1
Q ss_pred cCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--Cee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 143 (415)
+-|++++.||+|+||.||++.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999974 257889999987553 33446789999999999999999999998875 568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999999865432 578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC--------hhhhhHHHHHHH
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP--------YEEQYLLEMAWK 293 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p--------~~~~~~~~~~~~ 293 (415)
........ ......++..|+|||++.+..++.++|||||||++|||++++.|...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 12234567789999999888999999999999999999998765432110 001101111111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+. ....+...+..+.+|+.+||+.+|++||++.++++.|...
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 1111223457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.78 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=201.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC------
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEG------ 140 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 140 (415)
.+++.|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677899999999999999999876 688999999865532 335678899999998 799999999998753
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 468999999999999999876432 2688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
++....... .......|++.|+|||++. +..++.++|||||||++|||++|+.|+....+..... ..
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~- 228 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI- 228 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HH-
Confidence 998654322 1233456899999999986 3457889999999999999999999886543322111 01
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... .........+..+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1100 011111234467889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=315.99 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=203.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CC---CEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DG---TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.+|++.+.||+|+||.||+|.+. ++ ..||+|.+... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45778899999999999999875 33 36999998765 344557899999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999876432 588999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcce--eccccc--CCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 227 ANLTHI--STRVAG--TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 227 ~~~~~~--~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... .....+ +..|+|||.+.+..++.++|||||||++|||++ |..||....+.. ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~~~~i-~~~--- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VINAI-EQD--- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------HHHHH-HcC---
Confidence 322111 111112 357999999998999999999999999999886 888776433221 11111 111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+.+.+..+.+++.+||+.+|.+||++.+|+..|.+.
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111223456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.96 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=205.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467999999999999999999863 46789999987653 3344678899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCC------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 143 RILVYGYLENNSLAQTLLGRGH------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999974321 112578889999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|+....+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432211 11122334667999999998999999999999999999997 76666433221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
+... ....+... ..+...+.++.+++.+||+.+|.+||++.|+++.|++
T Consensus 240 ------~~~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIY-YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHH-HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 12222211 1122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=325.21 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=200.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|.+.+.||+|+||.||+|..+ ++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999976 688999999875432 2234677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++ +|.+++...+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888765432 578899999999999999999999 99999999999999999999999999997543321
Q ss_pred cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHhhCcc
Q 044232 230 THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYERGKL 300 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~~~~~ 300 (415)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+........ |........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 1223457899999998865 46899999999999999999999998765433221111100 000000000
Q ss_pred hhhcc-cccCC----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVD-ASLNG----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~-~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+ +.... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.53 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=200.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEE-eCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV-EGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +..||+|....... .+.+.+|+.+++.++|+|++++++++. .++..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457889999999999999999875 67799999865532 357889999999999999999999765 45678999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 999999999976543 2578999999999999999999999 9999999999999999999999999998754322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.|+..... ...... ...+ .
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~~---------~ 216 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR-VEKG---------Y 216 (256)
T ss_pred ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HhcC---------C
Confidence 122345668999999988899999999999999999998 8777653221 111111 1111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112223345778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=316.40 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=200.6
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999876 78999999986542 22234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++...+. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 2689999999999999999999999 99999999999999999999999999997653321
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||....+.... .......... .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~----------~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLET----------E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcc----------c
Confidence 123456899999999999889999999999999999999999998754332211 1111111111 0
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+..+.+|+..||+.+|++||+ +.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122233466789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=314.90 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 457888899999999999999875 6899999998776555556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999987655 688999999999999999999999 99999999999999999999999999987654321
Q ss_pred cceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.|+....+.... ..... .... .+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~-~~~~---~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTK-SNFQ---PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhhc-cCCC---CC
Confidence 1223456899999999874 456889999999999999999999887654332211 11111 1000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=319.76 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=206.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367999999999999999999965 7899999998765544556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 578899999999999999999999 99999999999999999999999999987654332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...... ....+ ...
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--------~~~ 234 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPE 234 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--------CCC
Confidence 1 12334688899999999998899999999999999999999999876544221100 00000 001
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122334566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=317.39 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=204.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.+.|+++++||.|+||.||+|... ++..+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999976 5899999999877766678899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|..++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999888765432 588999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 230 THISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
........+++.|+|||++. ...++.++|||||||++|||++|..|+....+.. ....... ....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~--- 233 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SEPP--- 233 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc-CCCc---
Confidence 11223345788999999885 3457889999999999999999998876543321 1111111 1000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+.++.+++.+||+.+|++||++.++++
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112234467889999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=310.68 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++|++.+.||+|+||.||+|... ++..+++|.+..... ...+.+|+.+++.++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 67899999999999999999987 488999999876533 578999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999986543 2689999999999999999999999 999999999999999999999999999986643321
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....+..... ..... .....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~-------~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNK-------PPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccC-------CCCCC
Confidence 2233457889999999998899999999999999999999999887543322110 00000 00011
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.83 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=205.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999976 68999999987542 233467899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCC-------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 148 GYLENNSLAQTLLGRGH-------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
||++||+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 112456778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc-----------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 221 LAKLFPANLT-----------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 221 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01123569999999999999999999999999999999999999986532211
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-CHHHHHHHhhcCCC
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-SMSTLVNMLIGEID 350 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~ 350 (415)
. . ...... ++ .........+..+.+++.+||+.+|++|| +++++++.|...+.
T Consensus 239 i------~----~~~~i~---~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 I------S----YRDVIL---SP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h------h----hhhhcc---Ch-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1 0 000000 00 00001123456788999999999999996 56777777765543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=311.39 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=208.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||.|+||.||+|... +++.+++|++........+.+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999975 6888999999876655667889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987652 1688999999999999999999999 99999999999999999999999999998654321
Q ss_pred cceecccccCCCCCChhhhhcC---CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRG---QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....+...... . ..... .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~-~~~~~---~-- 222 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------I-SKSNF---P-- 222 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H-HhccC---C--
Confidence 122335688899999998776 889999999999999999999998876544332110 1 11100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+.++.+++.+||+.+|.+||++.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011122345677999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=317.51 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=204.9
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEE---
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCV--- 138 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 138 (415)
+..+..+.++|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567889999999999999999999876 688999998865432 225677899999999 6999999999884
Q ss_pred --eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 139 --EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 139 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34578999999999999998864333334688999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCcceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 217 SDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 217 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
+|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....+....
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~------ 238 (286)
T cd06638 166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------ 238 (286)
T ss_pred ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH------
Confidence 9999998654321 12233468999999998753 45789999999999999999999988654332211
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
... ........ ..+...+..+.+++.+||+.+|++||++.+|++.+
T Consensus 239 ~~~-~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKI-PRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhc-cccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 01100000 01112245688999999999999999999998743
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=310.01 Aligned_cols=250 Identities=34% Similarity=0.487 Sum_probs=204.3
Q ss_pred CcccccCeEEEEEEEecC----CCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLKD----GTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|+.+++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999763 788999999876443 357888999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCC-----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 153 NSLAQTLLGRGHS-----SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 153 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 23789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 228 NLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 228 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... .......+++.|+|||.+....++.++||||||+++|+|++ |..|+....+. +... ....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~-~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLE-YLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHH-HHHcC-------
Confidence 321 12234557889999999988899999999999999999999 57777654221 1111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.....+...+.++.+++.+||+.+|.+||++.|+++.|.
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223344678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=311.88 Aligned_cols=240 Identities=23% Similarity=0.392 Sum_probs=190.2
Q ss_pred CcccccCeEEEEEEEecC-------------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 78 NKIGQGGFGSVYKGTLKD-------------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887765555567889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC-------eEEe
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT-------PKIS 217 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 217 (415)
+||||+++|+|..++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988865432 588999999999999999999999 9999999999999987664 8999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhh-cCCCCccceEeehhHhHHHHH-hCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFGVLLLEIV-SGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~ell-tg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+. ....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 99998754322 2345788899999887 467899999999999999998 46666544322111 0111
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
. +.. ........++.+|+.+||+.+|.+||++.+|++.|+
T Consensus 223 ~-~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 110 011122467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=315.73 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=204.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ....+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999864 2467999988765433 4567899999999999999999999999989999
Q ss_pred EEEeeccCCCHHHHhhcCCCCC-----CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 145 LVYGYLENNSLAQTLLGRGHSS-----IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~-~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLN-RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHH-HHHcC
Confidence 9987543222222233456778999999988889999999999999999998 6666643211 11111 11111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
... ...+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 1112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.13 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=207.7
Q ss_pred cccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHH
Q 044232 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQ 157 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 157 (415)
.||+|.||+||.|++. +...+|||.+........+-+.+|+.+.++++|.|||+++|+|.+++.+-|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999976 566789999988777777888999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCCeEEeeeccccccCCCCcceeccc
Q 044232 158 TLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLFPANLTHISTRV 236 (415)
Q Consensus 158 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 236 (415)
+|...-+ ..+-++.++-.+..||++||.|||++ .|||||||-+|+||+ -.|.+||+|||-++.+.. .+....++
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 9976533 12338889999999999999999999 999999999999996 568999999999987743 34455678
Q ss_pred ccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhCCcCCCCC-CChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 237 AGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRR-LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 237 ~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~p~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
.||..|||||++..+ .|+.++|||||||++.||.||++||..- .|... ++.-|- -...+..|
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------MFkVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------MFKVGM------YKVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------hhhhcc------eecCCCCc
Confidence 899999999999876 5889999999999999999999998642 22221 111111 13346678
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+.+.+...+|.+|+.++|.+||++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888999999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=313.19 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..|+..+.||.|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999976 68899999987543 34556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999998643 578889999999999999999998 99999999999999999999999999997654332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.......++..|+|||++.+..++.++|||||||++|||++|..|+....+.... . .+.....
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~----------~~~~~~~ 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F----------LIPKNNP 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h----------hhhcCCC
Confidence 1223346788999999998888999999999999999999999888754433211 0 0011112
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+......+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 33445667889999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.17 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=205.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998643 3468999887664 4455689999999999999999999999875 45789
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999976432 589999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
............++..|+|||.+....++.++||||||+++|||++ |..||......+ .... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~-~~~~~~---- 226 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGR-IENGER---- 226 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-HHcCCc----
Confidence 4432222223334568999999988889999999999999999986 988876543211 1111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+...+..+.+++.+||..+|.+||++.++++.|.+..
T Consensus 227 -----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 227 -----LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122334567999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=313.21 Aligned_cols=251 Identities=28% Similarity=0.413 Sum_probs=196.7
Q ss_pred CcccccCeEEEEEEEec-CCC--EEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGT--LAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|..+ ++. .+|+|.+... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999976 443 4688888753 334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 153 NSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 153 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 112578999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... +.... ...+
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~-~~~~- 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK-LPQG- 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHH-HhCC-
Confidence 986322111 1111223567999999988899999999999999999997 88877543211 11111 1111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+.++.+++.+||+.+|.+||++.++++.|...+
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111122234467889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=308.95 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=199.6
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHH
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLA 156 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 156 (415)
++||+|+||.||+|...+++.||+|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999998765433 4568899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee-cc
Q 044232 157 QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS-TR 235 (415)
Q Consensus 157 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 235 (415)
+++..... .+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99865432 578899999999999999999999 999999999999999999999999999986542211111 12
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (415)
..++..|+|||.+.++.++.++|||||||++|+|++ |..|+....+... .. ....+ .....+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~------~~-~~~~~---------~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT------RE-RIESG---------YRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH------HH-HHhcC---------CCCCCCc
Confidence 234567999999988899999999999999999999 6666654332111 11 11111 1111223
Q ss_pred HHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 315 EEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 315 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
..+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 44568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=310.43 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=201.3
Q ss_pred CcccccCeEEEEEEEecC--CC--EEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLKD--GT--LAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|++|.||+|.+.+ ++ .||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 33 689999987755 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc-
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH- 231 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 231 (415)
++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++..+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987543 3689999999999999999999999 9999999999999999999999999999876442221
Q ss_pred -eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 232 -ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 232 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+....+.+ .......... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE---------R 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC---------c
Confidence 1123456788999999998899999999999999999998 888875432221 1111111110 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
...+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1112234577899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=314.05 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=204.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999976 68899999987653 33446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998754 688999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.|+....+.. ..... ..+. .
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~-~~~~---------~ 215 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLI-PKNN---------P 215 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHh-hhcC---------C
Confidence 22234568889999999998889999999999999999999999986543211 11111 1111 1
Q ss_pred CCCCHH-HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVE-EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... .+..+.+++.+||..+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 4567889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.86 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=201.1
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec---CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
...+|++++.||+|+||.||++... .+..||+|.+... ..+.+|+.+|+.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4567999999999999999999754 3678999988653 2345799999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
||++. ++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 68888885443 689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch----
Q 044232 227 ANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV---- 301 (415)
Q Consensus 227 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~---- 301 (415)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.+........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 3322 22234679999999999999999999999999999999999999987654322111111111111100000
Q ss_pred ---------hhcccccCCCCC-------HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 302 ---------ELVDASLNGDYS-------VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 302 ---------~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..........+. ...+.++.+++.+||+.+|++||++.+++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000111111 0123567889999999999999999999873
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=311.15 Aligned_cols=248 Identities=31% Similarity=0.477 Sum_probs=202.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---------QGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999875 688999998865421 123567889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997654 678899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc-----ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 223 KLFPANLT-----HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 223 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
+....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhc-
Confidence 86643211 11123457889999999998889999999999999999999999886532211 1111100
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1112233345577899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=313.15 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=213.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+-|.++++||+|+||.||+|.++ +|+.+|+|.+..+. ..+++..|+.++++...|++|++||.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 44778899999999999999876 79999999997764 3478899999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
..|++.+.+..+.. ++.++.+..++...+.||+|||.. .-+|||||..|||++-+|.+||+|||+|-.+.+. -
T Consensus 111 GAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-M 183 (502)
T KOG0574|consen 111 GAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-M 183 (502)
T ss_pred CCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-H
Confidence 99999999987654 799999999999999999999998 8899999999999999999999999999876543 2
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
....++.|||.|||||++..-.|+.++||||||++..||..|++|+..-.|....+ ++.....+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------MIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------MIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------eccCCCCC
Confidence 34567889999999999999999999999999999999999998876655543211 11111111
Q ss_pred --CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 311 --DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 311 --~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.-+...+.++.+++.+||-.+|++|-|+.++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2356778899999999999999999999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.65 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=209.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
+..+.|+.++.||.|.-|+||+++.+ ++..+|+|++.+.. .+...+...|-+||+.++||.++.||..++.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 44567888999999999999999987 57899999998763 445567788999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
++||||+||+|..+.+.+... .+++..++-++..++.||+|||-. |||+|||||+||||-++|++-|+||.|+..
T Consensus 154 l~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999999877644 799999999999999999999999 999999999999999999999999998854
Q ss_pred cCC---------------------------------CCc----------------------ceecccccCCCCCChhhhh
Q 044232 225 FPA---------------------------------NLT----------------------HISTRVAGTEGYLAPEYAI 249 (415)
Q Consensus 225 ~~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~ 249 (415)
... ... ..+...+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 310 000 0112356999999999999
Q ss_pred cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCC
Q 044232 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQ 329 (415)
Q Consensus 250 ~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 329 (415)
+...+.++|+|+|||++|||+.|..||.+....+. ..+++. ..+.-.-....+..+.+||.+.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~---------~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVG---------QPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhc---------CCCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999988877543322 222221 112111112456778999999999
Q ss_pred cCCCCCCC----HHHHHH
Q 044232 330 DMPKRRPS----MSTLVN 343 (415)
Q Consensus 330 ~~P~~RPs----~~evl~ 343 (415)
+||.+|-. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999997 777765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=311.56 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=203.0
Q ss_pred CCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999998888999999886432 22345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997654 578999999999999999999999 99999999999999999999999999997653
Q ss_pred CCC-----cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 227 ANL-----THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 227 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~--- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHR--- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhcc---
Confidence 211 11123356889999999999888999999999999999999999988654322211 0000000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+..+...+..+.+++.+||+.+|.+||++.++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111122234567889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=317.65 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=194.2
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhc---CCcceeeeeeEEEe-----CC
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDI---KHENLVELYGCCVE-----GD 141 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 141 (415)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999976 789999999875321 1123455677766655 79999999999864 34
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999974 88888875432 2588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChh
Confidence 98654321 223456899999999999889999999999999999999999888654332211 1111111000000
Q ss_pred h----------hcccccC---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 E----------LVDASLN---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~----------~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .+.+... .......+..+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 0011123466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.91 Aligned_cols=252 Identities=26% Similarity=0.452 Sum_probs=206.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||.|+||.||+|... ++..+|+|.+........+.+.+|+.++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999975 6899999999877666667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999876432 589999999999999999999999 99999999999999999999999999987553321
Q ss_pred cceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 230 THISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.......|++.|+|||++.. ..++.++||||||+++|+|++|+.|+....+... .... ..+...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~--- 226 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKI-LKSEPP--- 226 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHH-hcCCCC---
Confidence 12233568999999998753 4577899999999999999999988875433221 1111 111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+.++.+++..||+.+|.+||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 ----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00112234467889999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.37 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=202.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEe------cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCVEG 140 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 140 (415)
...++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3457899999999999999999974 247789999997643 33446788999999999 689999999988654
Q ss_pred -CeeEEEEeeccCCCHHHHhhcCCCC------------------------------------------------------
Q 044232 141 -DHRILVYGYLENNSLAQTLLGRGHS------------------------------------------------------ 165 (415)
Q Consensus 141 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 165 (415)
...++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4678999999999999998653210
Q ss_pred ---------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc-ceecc
Q 044232 166 ---------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTR 235 (415)
Q Consensus 166 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~ 235 (415)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 999999999999999999999999999986532211 11222
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (415)
..+++.|+|||++.+..++.++||||||+++|+|++ |..|+....... ........+... ..+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~ 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM---------RAPD 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCC---------CCCC
Confidence 345678999999988899999999999999999997 777765422111 111111222111 1111
Q ss_pred HHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 315 EEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 315 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+.++.+++..||+.+|.+||++.+|++.|...+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12356889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.85 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=202.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555666678999999999999965 68889999988776666678999999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeeccccccC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFP 226 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 226 (415)
||+++++|.+++...... ...++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999764221 1227888899999999999999999 9999999999999976 6799999999987653
Q ss_pred CCCcceecccccCCCCCChhhhhcCC--CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
... .......|++.|+|||++.+.. ++.++||||||+++|+|++|+.|+........ ..+....
T Consensus 161 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~-------- 226 (268)
T cd06624 161 GIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGM-------- 226 (268)
T ss_pred cCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhh--------
Confidence 321 1222345789999999987643 78999999999999999999988764221111 0000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+..+.....++.+++.+||+.+|.+||++.+++.
T Consensus 227 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 -FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01112233345577899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.50 Aligned_cols=251 Identities=22% Similarity=0.401 Sum_probs=206.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|+..+.||.|+||.||.++.. ++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788999999999999999865 6889999987654 344456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 22688999999999999999999998 99999999999999999999999999998664432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..|+....+.+ ...... .+...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~~-------- 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QGNYT-------- 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCCC--------
Confidence 2 2334568999999999988889999999999999999999998876543322 111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..+...+.++.+++.+||+.+|.+||++.++++.+
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11233456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=318.84 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=206.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.+|++.+.||.|++|.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999865 78999999987655445577889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988643 578999999999999999999999 999999999999999999999999999886543321
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .....+ .. ..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~~-~~-------~~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TP-------EL 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC-Cc-------cc
Confidence 1233468889999999998889999999999999999999999987655433211 111111 00 01
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+++.+||..+|.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=325.15 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=198.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----- 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 141 (415)
..++|++.+.||+|+||.||+|... +|..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4588999999999999999999876 6899999998654 2334467889999999999999999999986543
Q ss_pred -eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 142 -HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 142 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999965 56665532 477888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH------------
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL------------ 288 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~------------ 288 (415)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754332 2223456899999999999999999999999999999999999998764322110000
Q ss_pred ----HHHHHHHhhC-cc-----hhhccccc---CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 289 ----EMAWKLYERG-KL-----VELVDASL---NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 289 ----~~~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... .. .+...... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 00 00000000 00011122456889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.04 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=206.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-C-----cceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-H-----ENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 142 (415)
..-+|++++.||+|.||.|.+|... +++.||||+++.... ...+...|+.+|..|+ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3447899999999999999999865 799999999987643 3456678999999996 3 479999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC--CeEEeeec
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL--TPKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG 220 (415)
+|||+|.+ ..+|+++++.+... .++...++.++.||+.||.+||+. +|||+||||+||||.+-+ .+||+|||
T Consensus 263 lciVfELL-~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999 56899999887654 688999999999999999999999 999999999999996543 79999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--------
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW-------- 292 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~-------- 292 (415)
.++..... ..+...+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+...++....+..+.
T Consensus 337 SSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865432 225667888999999999999999999999999999999987777666555433222211
Q ss_pred -------HHHhh-Ccchhhc----------------------ccccCC--------CCCHHHHHHHHHHHHHcCCcCCCC
Q 044232 293 -------KLYER-GKLVELV----------------------DASLNG--------DYSVEEAHRYLKIALLCTQDMPKR 334 (415)
Q Consensus 293 -------~~~~~-~~~~~~~----------------------~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~ 334 (415)
..+.. ....... +....+ ......-..+.+++.+||.+||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 01111 0000000 000000 111123456899999999999999
Q ss_pred CCCHHHHHH
Q 044232 335 RPSMSTLVN 343 (415)
Q Consensus 335 RPs~~evl~ 343 (415)
|+|..+.++
T Consensus 493 R~tp~qal~ 501 (586)
T KOG0667|consen 493 RITPAQALN 501 (586)
T ss_pred cCCHHHHhc
Confidence 999999987
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=338.86 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=195.6
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCC------cceeeeeeEEEe
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKH------ENLVELYGCCVE 139 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 139 (415)
+....++|++.++||+|+||+||+|... +++.||||+++.... ....+..|+.++..++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999875 688999999865322 22445667777776654 458999998876
Q ss_pred C-CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCC-----
Q 044232 140 G-DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDL----- 212 (415)
Q Consensus 140 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~----- 212 (415)
. .+.++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 4 4789999988 778998887654 68999999999999999999997 5 999999999999998765
Q ss_pred -----------CeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 213 -----------TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 213 -----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999886432 223456799999999999999999999999999999999999999976544
Q ss_pred hhhhhHHHHHH-----------------HHHhh-Ccchhhcccc-----cCCC--CCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 282 YEEQYLLEMAW-----------------KLYER-GKLVELVDAS-----LNGD--YSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 282 ~~~~~~~~~~~-----------------~~~~~-~~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
.+......... .++.. +.+....++. .... ........+.+|+.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 33222111100 00000 0000000000 0000 0001135678999999999999999
Q ss_pred CHHHHHH
Q 044232 337 SMSTLVN 343 (415)
Q Consensus 337 s~~evl~ 343 (415)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=316.17 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-----CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-----DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVE--GDHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 143 (415)
+.|++.+.||+|+||.||+|.+. ++..+|+|.+...... ....|.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999864 3678999999866443 45789999999999999999999999887 5678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976542 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhh--------hHHHHHHH
Q 044232 224 LFPANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ--------YLLEMAWK 293 (415)
Q Consensus 224 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~--------~~~~~~~~ 293 (415)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322111 11233456799999998889999999999999999999999887543211100 00111111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.... ......+..++..+.+++.+||+.+|.+||++.+|+++|.+.
T Consensus 238 ~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKE---------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHc---------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 111122234457799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=316.47 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=203.1
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999875 68899999987543 344567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 999999988643 578999999999999999999998 99999999999999999999999999997654321
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.......|+..|+|||++.+..++.++|||||||++|||++|+.|+....+.... .. .. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~---------~~~~~ 219 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IP---------KNSPP 219 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hh---------cCCCC
Confidence 1122345788999999999889999999999999999999999887654332211 10 11 11111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2233445678899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.55 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=206.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999976 68899999886543 3345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++...+ .+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999887654 6889999999999999999999731 8999999999999999999999999998754322
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhh-----hhHHHHHHHHHhhCcchhh
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE-----QYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~-----~~~~~~~~~~~~~~~~~~~ 303 (415)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||....+..+ ....+........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1 2245689999999999888999999999999999999999999875443211 1111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
..........+.++.+++.+||+.+|.+||++.|+++..
T Consensus 229 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 ---PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000011112456789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.45 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=193.1
Q ss_pred CcccccCeEEEEEEEecC---CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLKD---GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 4578999887653 233357889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc-
Q 044232 154 SLAQTLLGRGH-SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH- 231 (415)
Q Consensus 154 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 231 (415)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223567788889999999999999999 9999999999999999999999999999754322111
Q ss_pred eecccccCCCCCChhhhhcC-------CCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 232 ISTRVAGTEGYLAPEYAIRG-------QLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||....+.+. ... .. .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCC
Confidence 12234577889999988642 35789999999999999996 9888764332211 000 11 1111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.++.. ....+..+.+++..|| .+|++||++++|+..|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1223456788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.10 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=198.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-----RQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 143 (415)
.+|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999875 68899999886431 2334568889999999999999999999875 3578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997654 578899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC--cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANL--THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||....+... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHh------
Confidence 553211 1111234578899999999988899999999999999999999988865422211 11111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+..+......+..++ .||..+|++||+++||++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ---TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11112233334455667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.01 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=202.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE-GDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 148 (415)
+|++.+.||.|++|.||++..+ +++.||+|.+... .....+.+.+|+.+++.++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999976 6788999998654 23344678899999999999999999998764 446899999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... ..+++.++..++.+++.||++||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999976432 2589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. .......|++.|+|||++.+..++.++||||||+++++|++|+.|+...... ...... ..+..
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~-------- 219 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKL-------- 219 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCC--------
Confidence 2 2233456889999999999999999999999999999999999887643221 111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1223345577999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=358.94 Aligned_cols=261 Identities=28% Similarity=0.497 Sum_probs=210.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
...|...+.||+|+||.||+|... ++..||+|.+...... ...|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456788889999999999999975 7899999998654322 22468899999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++. .++|..+..|+.|++.||+|||..+.++|+||||||+||+++.++..++. ||........
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 99999999995 37899999999999999999996666699999999999999999888875 6655433211
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .....+|.............+++...
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence 2236789999999999999999999999999999999999998643322 23344454444434444445555543
Q ss_pred C--CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 310 G--DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 310 ~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. ..+.....++.+++.+||+.+|++||+|.||++.|.+..
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 3 334566778899999999999999999999999997654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=314.08 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=199.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|++|.||+|+.+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999976 68999999986542 22335678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
++ ++|.+++..... ...+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 688888865432 23688999999999999999999999 99999999999999999999999999997653321
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--------HHHHHhh-Cc
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--------AWKLYER-GK 299 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--------~~~~~~~-~~ 299 (415)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.|+....+......... .|..... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112234578899999988654 578999999999999999999988876543221111000 0000000 00
Q ss_pred chhhcccccC---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLN---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+..... .......+.++.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001123567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=324.90 Aligned_cols=260 Identities=22% Similarity=0.263 Sum_probs=195.7
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
....+|++++.||+|+||.||+|... ++..||+|+.... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999976 5788999985433 2346999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|++ .++|.+++.... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred Ecc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999 468888886543 2689999999999999999999999 999999999999999999999999999974322
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH----HHHHHHHhh-Ccchh
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL----EMAWKLYER-GKLVE 302 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~----~~~~~~~~~-~~~~~ 302 (415)
. .......||+.|+|||++.+..++.++|||||||++|||+++..++....+....... ......... +....
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1 1223456899999999999999999999999999999999976665433332211110 011111110 00000
Q ss_pred -------------hccc--ccCCCC-------CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 -------------LVDA--SLNGDY-------SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 -------------~~~~--~~~~~~-------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.++. .....+ ....+.++..+|.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0000 000000 0112345667999999999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=332.54 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=210.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+-|.++..||.|+||+||+|..+ .+...|.|++..........|+-|+.||....||+||+|++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44667889999999999999977 46667889998888888899999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
.||-++..+...+. .+.+.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||++..... ..
T Consensus 112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 99999998877654 789999999999999999999999 999999999999999999999999999864322 23
Q ss_pred ceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 231 HISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.....+.|||.|||||+..+ .+|++++||||||++|.||..+.+|-.. .+......++.... ...+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe-PPTL-- 255 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE-PPTL-- 255 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC-CCcc--
Confidence 34556889999999998754 5799999999999999999998766443 33333333332221 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
-.|..+...+.+++..||..||..||++.++++.
T Consensus 256 -----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 -----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2245567789999999999999999999999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=319.28 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=199.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||.|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999876 68899999987543 22234677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
++ ++|.+++..... .+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 589888875432 578899999999999999999999 99999999999999999999999999997543221
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh---Ccchhhcc
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER---GKLVELVD 305 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 305 (415)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+. ...+...... ........
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence 1 12234578899999988754 578999999999999999999998875433211 1111111000 00000000
Q ss_pred ---------cccCC----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ---------ASLNG----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ---------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.... ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=312.76 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=189.4
Q ss_pred cccccCeEEEEEEEecC-------------------------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeee
Q 044232 79 KIGQGGFGSVYKGTLKD-------------------------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVEL 133 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 133 (415)
+||+|+||.||+|.+.. ...||+|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876655555678899999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-
Q 044232 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL- 212 (415)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 212 (415)
++++.+....++||||+++|+|..++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998865322 578899999999999999999998 999999999999997654
Q ss_pred ------CeEEeeeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHH-hCCcCCCCCCChhh
Q 044232 213 ------TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIV-SGRCNTNRRLPYEE 284 (415)
Q Consensus 213 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~ell-tg~~p~~~~~p~~~ 284 (415)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988643221 12346788999998865 56899999999999999994 68877765443221
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
.. ...... ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~~-------~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER-------FYEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-------HHHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 111100 011112346889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=302.67 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=207.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..+.|++.+.||+|.|+.||++... +|+.+|+|++... .....+++.+|+.|-+.|+||||+++.+.+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3577888899999999999998765 7899999988654 223557788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 223 (415)
+|++.|++|..-+-.+. -+++..+-.++.||++||.|+|.+ +|||||+||+|+|+... .-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999987666553 678888999999999999999999 99999999999999543 369999999999
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.+.. ........|||+|||||++...+|+..+|||+.|||||-|+.|+.||.+..... + .+.+..+.
T Consensus 162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l----ye~I~~g~---- 228 (355)
T KOG0033|consen 162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YEQIKAGA---- 228 (355)
T ss_pred EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H----HHHHhccc----
Confidence 8763 334456789999999999999999999999999999999999999987632211 1 11111221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
-...+.+.....++..+|+.+||..||.+|.|+.|.++
T Consensus 229 --yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 --YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 12233334455677889999999999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.22 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=202.8
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--C
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE--G 140 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 140 (415)
......++|++++.||+|+||+||+|... ++..||+|++... .......+..|+.++..++|||||+++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 33455678999999999999999999976 6788999998654 23345678899999999999999999998864 3
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCC----CCcEecCCCCCCeeecC------
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ----PHIVHRDIKASNILLDK------ 210 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~------ 210 (415)
..++|||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997643223368999999999999999999998521 25999999999999964
Q ss_pred -----------CCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCC
Q 044232 211 -----------DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTN 277 (415)
Q Consensus 211 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~ 277 (415)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 235899999999865332 12234578999999999864 458899999999999999999999986
Q ss_pred CCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 278 RRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 278 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+.. ....+..+... . ....+.++.+||..||+.+|.+||++.|++.
T Consensus 245 ~~~~~~q------li~~lk~~p~l-----p-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFSQ------LISELKRGPDL-----P-----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHHH------HHHHHhcCCCC-----C-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5433221 11111111100 0 0122467889999999999999999999984
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.61 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=161.2
Q ss_pred CCcccccCeEEEEEEEec---CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEEEEeecc
Q 044232 77 ANKIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRILVYGYLE 151 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 151 (415)
.++||+|+||.||+|+.+ +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 467899999865432 2456789999999999999999999864 456899999985
Q ss_pred CCCHHHHhhcCC-----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCCeEEeeeccc
Q 044232 152 NNSLAQTLLGRG-----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLA 222 (415)
Q Consensus 152 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 222 (415)
++|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57888775322 1123588999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCc--ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCC
Q 044232 223 KLFPANLT--HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNR 278 (415)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~ 278 (415)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643321 12234678999999999877 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.29 Aligned_cols=240 Identities=26% Similarity=0.387 Sum_probs=191.5
Q ss_pred CcccccCeEEEEEEEec-C-------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLK-D-------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+.||+|+||.||+|..+ . ...+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999864 2 234888888766555557888999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC--------eEEeeecc
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT--------PKISDFGL 221 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfGl 221 (415)
+++|+|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976542 578999999999999999999999 9999999999999987765 69999998
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCC-cCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGR-CNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~-~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
+...... ....+++.|+|||++.+ ..++.++|||||||++|||++|. .|+....+... . .....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~-~~~~~-- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------L-QFYED-- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------H-HHHHc--
Confidence 8754321 23457889999999886 45899999999999999999995 34333222111 0 01110
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
....+.....++.+++.+||+.+|++||++++|++.|+
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=324.39 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=199.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------ 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 140 (415)
..++|++.+.||+|+||.||+|... .++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 6889999998754 233446778899999999999999999998643
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 56666642 478888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH------------
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL------------ 288 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~------------ 288 (415)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865332 1223456899999999999989999999999999999999999998764322211000
Q ss_pred ----HHHHHHHhhC-cch-----hhccccc---CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 289 ----EMAWKLYERG-KLV-----ELVDASL---NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 289 ----~~~~~~~~~~-~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.......... ... ....... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000 0000000 001111234578899999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=331.06 Aligned_cols=260 Identities=19% Similarity=0.231 Sum_probs=196.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|.+.+.||+|+||.||+|... .++.||+|.... ..+.+|+.+|++++|+||+++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999976 588899996432 3456799999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+ .++|.+++..... .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~-~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 4688888865432 689999999999999999999999 99999999999999999999999999998654322
Q ss_pred c-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCC--ChhhhhHHHHHHHHHhhCcc--hhhc
Q 044232 230 T-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL--PYEEQYLLEMAWKLYERGKL--VELV 304 (415)
Q Consensus 230 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~--p~~~~~~~~~~~~~~~~~~~--~~~~ 304 (415)
. .......||+.|+|||++.+..++.++|||||||++|||++|..++.... +...... ..+.+.+..... ....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~-~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD-AQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcH-HHHHHHHHhhccccccCC
Confidence 1 12234569999999999999999999999999999999999886643211 1111110 111111111100 0000
Q ss_pred -----------c----cccCCCCC-------HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 305 -----------D----ASLNGDYS-------VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 305 -----------~----~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. ........ .....++.+|+.+||+.||.+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000 0123468899999999999999999999973
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.50 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=202.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999986 7899999988654 333446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|..++.... ....+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998886532 1226899999999999999999999632 8999999999999999999999999999765332
Q ss_pred cceecccccCCCCCChhhhhcC------CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 230 THISTRVAGTEGYLAPEYAIRG------QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....+.. ......... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~------ 224 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-D------ 224 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-h------
Confidence 12334578899999998554 35889999999999999999999886532211 111111111 1
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+...+.++.+++.+||+.+|++||++.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 ---GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112233345677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.37 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=202.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999987 68999999886542 2233567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998887765443 589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--------HHHhhCc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW--------KLYERGK 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~--------~~~~~~~ 299 (415)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....+.+......... ..+....
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 1223457889999999876 568899999999999999999999987655433221111000 0000000
Q ss_pred c-hhhcccccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 L-VELVDASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~-~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .....+......+ ...+..+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000000000 122567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.94 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=204.9
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEG 140 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 140 (415)
+...+..+.++|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33445556788999999999999999999975 788999999865432 235677899999998 899999999998754
Q ss_pred -----CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 141 -----DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 141 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
...++||||+++++|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998865333334689999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhhcC-----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~ 290 (415)
|+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.|+....+...
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------ 241 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------
Confidence 999999986543211 12334688999999987643 368999999999999999999988865433221
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ..+....+ ..+......+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKI-PRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHH-hcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11111111 112233456899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.30 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=193.5
Q ss_pred CcccccCeEEEEEEEec----CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEE-eCCeeEEEEeecc
Q 044232 78 NKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCV-EGDHRILVYGYLE 151 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 151 (415)
+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543 3444568889999999999999999999876 4556889999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc-
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT- 230 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~- 230 (415)
+|+|.+++..... .+.+..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 456778889999999999999998 999999999999999999999999999975533211
Q ss_pred --ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcC-CCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 231 --HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN-TNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 231 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.......++..|+|||.+.+..++.++|||||||++|||++|+.| +....+ .+...... .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~-~~~-------- 219 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLL-QGR-------- 219 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh-cCC--------
Confidence 111233457789999999888999999999999999999996544 332211 11111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|++||++.+|++.|++..
T Consensus 220 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 -RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01111223467889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.53 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=204.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..+|++.+.||+|+||.||+|.++ +|. .+|+|...... ......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367888999999999999999865 333 58999887654 3445678899999999999999999999987 7889
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999976532 588999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCccee-cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLTHIS-TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
......... ....++..|+|||.+....++.++||||||+++|||++ |+.|+....+.+ ... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~~-- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPD-LLEKGER-- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHH-HHhCCCC--
Confidence 643322111 11223568999999988899999999999999999998 888876543211 111 1111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+..++..+.+++.+||..+|++||++.++++.|....
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1112223456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=308.04 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=191.2
Q ss_pred CcccccCeEEEEEEEecC---CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLKD---GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.||+|+||.||+|...+ ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997543 2346677766543 334568999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC-Ccce
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN-LTHI 232 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~-~~~~ 232 (415)
+|.+++..........++..+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976543333567778889999999999999998 9999999999999999999999999998643211 1112
Q ss_pred ecccccCCCCCChhhhhc-------CCCCccceEeehhHhHHHHHhC-CcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 233 STRVAGTEGYLAPEYAIR-------GQLTRKADIYSFGVLLLEIVSG-RCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~elltg-~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..|+....+ .+....... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 234567889999998753 2457899999999999999975 445433221 112222222 2222233
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
++..... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333222 3356778999999 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.33 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=204.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 147 (415)
+|++.+.||.|+||.||++... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999865 7889999998654 23344678899999999999999999998764 45679999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH-----EEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
||+++++|.+++........++++..++.++.||+.||.||| +. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765333347899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+...... ... .....+
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~---- 225 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLA-SKIKEG---- 225 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHH-HHHhcC----
Confidence 87654322 123356899999999999888999999999999999999999888754311 111 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+...+..+.+++.+||+.+|++||++.+|++
T Consensus 226 -----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 -----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112233345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.50 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=202.6
Q ss_pred CCCCCCcccccCeEEEEEEEecC--CCEEEEEEcccc----------chHhHHHHHHHHHHHhh-cCCcceeeeeeEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKD--GTLAAIKVLSAD----------SRQGVREFLTEINVIKD-IKHENLVELYGCCVE 139 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 139 (415)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 788999987532 22334567789988875 799999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISD 218 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 218 (415)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886533223368899999999999999999996 5 899999999999999999999999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ...... .+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~-~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIV-EA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHh-hc
Confidence 99998654432 2334568899999999998889999999999999999999998876432211 111111 11
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
... +......+..+.+++.+||+.||++||++.|+..++.
T Consensus 229 ~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 1111123467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.79 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=206.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--------hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--------RQGVREFLTEINVIKDI-KHENLVELYGCCVE 139 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 139 (415)
.-+.|...+.||.|..+.|-++..+ +|+.+|+|++.... ....+.-.+|+.||+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3467888899999999999998766 78888999875321 12234456799999998 79999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
+...++|+|.|+.|.|.++|...- .+++...++|+.|+.+|+.|||.. +||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999997654 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcC------CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRG------QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
|.++.+... ......+|||+|+|||.+... .|+...|+|++|||||.|+.|..||--+ ... .+.+
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR------kQm-lMLR 238 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR------KQM-LMLR 238 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH------HHH-HHHH
Confidence 999988664 334568999999999988643 5788999999999999999998776422 111 1222
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
++..|+. ....+-..+.+....+||.+||+.||.+|.|++|++.
T Consensus 239 ~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 3333432 1222333456678899999999999999999999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=306.20 Aligned_cols=251 Identities=31% Similarity=0.513 Sum_probs=202.2
Q ss_pred CCCCCcccccCeEEEEEEEecC-----CCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLKD-----GTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+++.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999763 388999999766433 5578899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999765421 289999999999999999999999 999999999999999999999999999986654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
..........+++.|+|||.+.+..++.++||||||+++++|++ |..|+..... ...... ...+..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~~~~------ 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEY-LKKGYR------ 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HhcCCC------
Confidence 32222212336789999999988889999999999999999998 6666654221 111111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
...+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222457789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.70 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=203.2
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-----RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+|+..+.||+|++|.||+|... ++..|++|.+.... .+..+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 78999999886543 23456788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997654 578999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCcceecccccCCCCCChhhhhcCC-CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....+.. ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----
Confidence 332 223456889999999987766 8999999999999999999999986543211 11111110111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+......+.+++.+||+.+|.+||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122234567889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=305.47 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=204.0
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|+||.||++... +++.||+|.+... ......++.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999875 7889999988653 233446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875432 2578899999999999999999998 99999999999999999999999999998654322
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......|++.|+|||++.+..++.++|||||||++++|++|+.|+....+. +....... +. .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~---------~ 218 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-GS---------Y 218 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-CC---------C
Confidence 1 122345888999999999889999999999999999999999887643221 11111111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+.++.+++.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122344567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.49 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=196.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEG------ 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 140 (415)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578999999999999999999875 78899999987542 22345677899999999999999999987643
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...+++++++ +++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 78998887543 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh--
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER-- 297 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~-- 297 (415)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .......
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR---IMEVVGTPS 236 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCCCC
Confidence 99865432 234568999999999877 5789999999999999999999998865432211100 0000000
Q ss_pred ---------CcchhhcccccCCCCC--------HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 ---------GKLVELVDASLNGDYS--------VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ---------~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+.. + +..+ ......+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQS-L-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhc-c-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0 0000 011245789999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.74 Aligned_cols=262 Identities=22% Similarity=0.269 Sum_probs=198.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------ 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 140 (415)
..++|++.+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999876 6889999998754 233446788899999999999999999987543
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 67776642 477888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH---------H-
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE---------M- 290 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~---------~- 290 (415)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............- .
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865332 12234568999999999999999999999999999999999999987654322111000 0
Q ss_pred ------HHHHHhhC-cc-----hhhccccc---CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 ------AWKLYERG-KL-----VELVDASL---NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 ------~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........ .. ........ ...........+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00 00000000 00111112457889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.72 Aligned_cols=247 Identities=29% Similarity=0.451 Sum_probs=199.7
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
++|++.+.||+|+||.||++.. +++.||+|.+..... ...+.+|+.+++.++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999875 567799999876532 35788999999999999999999998754 5799999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 9999999976542 2578999999999999999999998 9999999999999999999999999998754321
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......+..|+|||.+.++.++.++|||||||++|+|++ |+.|+....+.+ . ......+. ..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~---------~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V-KECVEKGY---------RM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H-HHHHhCCC---------CC
Confidence 122334567999999988899999999999999999998 877775443221 1 11112111 11
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
..+...+..+.+++.+||+.+|++||++++|++.|.+
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122345778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.12 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=191.4
Q ss_pred CcccccCeEEEEEEEecC---CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 78 NKIGQGGFGSVYKGTLKD---GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
++||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4568888876543 333457889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc-c
Q 044232 154 SLAQTLLGRGHS-SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-H 231 (415)
Q Consensus 154 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 231 (415)
+|.+++...... ....++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765422 22356788899999999999999999 999999999999999999999999999875432211 1
Q ss_pred eecccccCCCCCChhhhhc-------CCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 232 ISTRVAGTEGYLAPEYAIR-------GQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
......+++.|+|||++.. ..++.++|||||||++|||++ |..|+....+. +........+ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 1223345678999998753 356889999999999999999 66665433221 1111122211 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
..+ ..+...+..+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 222334466778889999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.42 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=202.2
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe----
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVE---- 139 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 139 (415)
++..+.+.|++.+.||.|+||.||+|... +++.+|+|++..... ....+..|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34456678999999999999999999975 688999999866533 335678899999998 79999999999853
Q ss_pred --CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 140 --GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 140 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
....+++|||+++|+|.+++...... .+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999998764422 578888999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||....+.....
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------ 236 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------ 236 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------
Confidence 9999875532211 223456889999999875 3467889999999999999999999886543322211
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ... ..........+..+.+++.+||+.+|.+||++.||++
T Consensus 237 ~~-~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI-PRN--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH-hhC--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000 0000111234567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=306.52 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=199.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-----chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--Cee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-----SRQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 143 (415)
++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999976 6899999987542 123346788899999999999999999998763 467
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987654 578888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhc-----
Confidence 5532111 112234588899999999888899999999999999999999988764322111 111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+..+......+.+++.+||. +|++||++++|++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111223344555678889999995 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.01 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=209.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec--CCC--EEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK--DGT--LAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++.+..++||+|.||.|++|.|+ +|+ .||||.++.+... ...+|++|+.+|.+|+|||+++|||+..+ ....|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 344556789999999999999987 354 4899999887544 56789999999999999999999999987 77899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||.++.|+|.+.|.... ...|.......++.|||.||.||.++ ++|||||..+|+|+-....|||+||||.+.+
T Consensus 188 V~ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HhhhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999999998722 23677888999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..+.... .....-...|+|||.+....++.++|||+|||++|||+|+. ..||.+..-... .+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyG-----EePW~G~~g~qI----------L~~ 327 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYG-----EEPWVGCRGIQI----------LKN 327 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccC-----CCCCCCCCHHHH----------HHh
Confidence 6554332 22233456799999999999999999999999999999863 345544333333 233
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+|......-+..|++++.+++..||..+|.+||+|..|.+.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 44444456677889999999999999999999999999743
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=305.69 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=203.9
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
+|+..+.||+|++|.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999864 78999999986532 1234678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKL 224 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 224 (415)
|+||+++++|.+++...+ ++++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997654 688999999999999999999999 999999999999998776 599999999976
Q ss_pred cCCCCc---ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLT---HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..|+........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhc-----
Confidence 643311 112234678899999999888899999999999999999999988864332111 111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+...+.++.+++.+||+.+|.+||++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11122334455678899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.27 Aligned_cols=265 Identities=24% Similarity=0.409 Sum_probs=203.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 68899999886542 2334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++++.+..+..... .+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766554432 588999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--------HHHh-hC
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW--------KLYE-RG 298 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~--------~~~~-~~ 298 (415)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.|+................ ..+. ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33233445678899999999887 88999999999999999999998886543221111000000 0000 00
Q ss_pred cch--hhccc----ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLV--ELVDA----SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~--~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ...+. .....++...+.++.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 00000 0000122233678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.37 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=197.6
Q ss_pred CcccccCeEEEEEEEecC-------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKD-------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999886543 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-----CeEEeeecc
Q 044232 150 LENNSLAQTLLGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-----TPKISDFGL 221 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl 221 (415)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975422 123578899999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 222 AKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 222 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
+........ .......++..|+|||++.++.++.++|||||||++|||++ |+.|+....+. +..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~-~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHV-TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHH-hcCC
Confidence 975532211 11122345678999999999999999999999999999998 88776543221 111111 1111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
....+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11122334677899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=314.16 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=201.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 689999998865422 234568889999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.++..... .+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765443 588999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHhhCc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYERGK 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~~~~ 299 (415)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+........ ........
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 2 22233557889999998875 45788999999999999999998887654332211100000 00000000
Q ss_pred ch-hhcccccCC-----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LV-ELVDASLNG-----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~-~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ....+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000000 001133567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=313.27 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 33444577999999999999875 68899999987665555667889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++... .+++..+..++.||+.||+|||++ +++||||||+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999988543 578899999999999999999999 999999999999999999999999999876543221
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....+.... .. .... ......
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~-~~~~-----~~~~~~- 239 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------RR-IRDN-----LPPRVK- 239 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhc-----CCCccc-
Confidence 223356889999999998888999999999999999999999998754432211 11 1100 111111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.....+..+..++.+||..+|.+||++.++++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111234568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=310.67 Aligned_cols=244 Identities=29% Similarity=0.408 Sum_probs=202.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999976 68999999986542 234467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997764 688999999999999999999998 999999999999999999999999999986644
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.|+....+.. ..... ..+.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~-------- 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKI-LEGK-------- 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hcCC--------
Confidence 3 234568999999999988889999999999999999999999886543211 11111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+...+..+.+++.+||+.+|.+|| +++|+++
T Consensus 215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112223356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.61 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=201.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467888999999999999999864 443 57899887653 23334788999999999999999999998754 467
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999876532 578899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
....... ......++..|+|||++.+..++.++|||||||++|||++ |+.|+....... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERL- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC-
Confidence 6433221 1222345678999999988899999999999999999997 877775432111 11122221111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+..++..+.+++..||..+|++||++.++++.|....
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=314.62 Aligned_cols=252 Identities=25% Similarity=0.297 Sum_probs=202.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999976 589999999876532 24467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987543 23689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc----------------------------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCC
Q 044232 228 NLTH----------------------------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRR 279 (415)
Q Consensus 228 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~ 279 (415)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111246788999999999888999999999999999999999998654
Q ss_pred CChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC----HHHHHH
Q 044232 280 LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS----MSTLVN 343 (415)
Q Consensus 280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 343 (415)
..... ...... ...........+..+.+++.+||+.+|++||+ +.++++
T Consensus 236 ~~~~~------~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDET------FSNILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHH------HHHHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 33211 111111 11111111124678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=303.97 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999965 68899999987543 23557889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12588999999999999999999999 99999999999999999999999999998665432
Q ss_pred cc---eecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 230 TH---ISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 230 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.|+....+.. ......... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~----- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND-P----- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC-C-----
Confidence 22 22334688999999998877 78999999999999999999999987543322 111111111 0
Q ss_pred cccCCC-CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGD-YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... .....+..+.+++.+||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011100 01234577899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=314.70 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=195.2
Q ss_pred CCCccccc--CeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 76 PANKIGQG--GFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 76 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++++||+| +||+||++..+ +|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999876 79999999987642 333456778999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++|+|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999654321 588999999999999999999999 999999999999999999999999987653321110
Q ss_pred ------ceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 231 ------HISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 231 ------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ... .. .+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~----~~-~~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE----KL-NGTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH----Hh-cCCccc
Confidence 01122346778999999876 4689999999999999999999999864322110 000 00 010000
Q ss_pred hccc------------------------------------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDA------------------------------------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.++. .............+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=312.15 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||++... .++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 68899999987653 233457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997654 688999999999999999999999 999999999999999999999999999864211
Q ss_pred CCc--------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 228 NLT--------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 228 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
... .......|+..|+|||.+.+..++.++|||||||++|||++|..||.+..+.+ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence 000 01112457889999999988889999999999999999999999886543321 1111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
... +.. . .+......+.++.+++.+||+.+|++||++.++.+.|..
T Consensus 228 ~~~-~~~---~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VIS-DDI---E----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHh-ccc---C----CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 100 0 001111345678999999999999999997777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=307.54 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=202.8
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCC------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGD------ 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 141 (415)
.+++|++.+.||+|++|.||+|..+ +++.+++|++...... ...+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999986 6889999998765443 36788999999999 7999999999997644
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999876432234789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+... .... .
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~ 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFKI-P 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHHh-h
Confidence 87654322 22233568899999998754 3467899999999999999999998864322111 1111 1
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+... ....+...+..+.+++.+||..||++|||+.+|++
T Consensus 232 ~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11110 11112234567899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.58 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=197.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|+||.||+|... +|..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999976 78999999986542 12234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
++ ++|.+++..... .+++..++.++.||++||.|||+. +++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 578887765432 589999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc------chh
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK------LVE 302 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~------~~~ 302 (415)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.|+......... ............ ...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhh
Confidence 1 12234578899999998764 4789999999999999999999886543322111 111111000000 000
Q ss_pred hcccccCC---------CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDASLNG---------DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+..... ......+.++.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 111223567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=306.49 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=202.8
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
-|+..+.||+|+||.||+|... ++..||+|+..... ......+.+|+.++..++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778899999999999999875 78899999876542 334467889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 999999988643 578999999999999999999998 99999999999999999999999999987654321
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.......++..|+|||.+.+..++.++|||||||++|+|++|..|+....+.. ..... ..+ ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~---------~~~ 219 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKN---------NPP 219 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcC---------CCC
Confidence 12223467889999999988889999999999999999999998876533221 11111 111 111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2223345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=306.35 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=200.2
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch----------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR----------QGVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 688999998754211 12346778999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++ +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997664 688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcc-eecccccCCCCCChhhhhcCC--CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 222 AKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 222 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
+......... ......|+..|+|||++.... ++.++||||||+++|+|++|..|+....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc
Confidence 9765332111 123356888999999987654 8899999999999999999998875432211 111111111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ..........+..+.+++.+||+.+|++||++.+|++
T Consensus 229 -~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 -SAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 011 1111122234578899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.78 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=207.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+|+..+..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999987 599999999877643 4457889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
+++++|.+++.... .+++..+..++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999997653 68999999999999999999999 8 9999999999999999999999999999866433
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....+.... +...... .. .
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~~-~~---------~ 219 (264)
T cd06623 154 LD-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---ELMQAIC-DG---------P 219 (264)
T ss_pred CC-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH---HHHHHHh-cC---------C
Confidence 22 122446788999999999899999999999999999999999998765421111 1111111 11 1
Q ss_pred CCCCCHH-HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVE-EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+.. .+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112222 4578999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=304.98 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=204.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|+..+.||+|++|.||+|..+ +++.+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999987 68999999987653 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997653 268899999999999999999999 7 9999999999999999999999999998755322
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....+........ .
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~----------~ 220 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE----------P 220 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC----------C
Confidence 11 12568889999999999899999999999999999999999886432111 1111111111111 0
Q ss_pred CCCCCHH-HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVE-EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+.. .+..+.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111222 5567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.73 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhh--cCCcceeeeeeEEEeCC----eeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD--IKHENLVELYGCCVEGD----HRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 145 (415)
...+..+.||+|.||.||||.+++ +.||||++... ..+.|.+|-+|++. ++|+||+++++.-...+ .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344557889999999999999964 88999999764 33568888888774 58999999999877655 8999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV------QPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
|++|.+.|+|.++|..+ .++|....+|+..+++||+|||+.. +++|+|||||..||||.+|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999877 6899999999999999999999753 778999999999999999999999999
Q ss_pred ccccccCCCCcc-eecccccCCCCCChhhhhcC-CCC-----ccceEeehhHhHHHHHhCCcCCC------CCCChhh--
Q 044232 220 GLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRG-QLT-----RKADIYSFGVLLLEIVSGRCNTN------RRLPYEE-- 284 (415)
Q Consensus 220 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwSlGvvl~elltg~~p~~------~~~p~~~-- 284 (415)
|+|..+...... ..-..+||.+|||||++.+. ++. .+.||||+|.|||||++...-.. -..||+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988644322 22236799999999999764 233 46899999999999999765442 2334441
Q ss_pred --hhHHHHHHHHHhhC-cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 285 --QYLLEMAWKLYERG-KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 285 --~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+.++.+.-.+ ....+.+..... ....-+++.+..||..||+.|-|+.=+-+.+....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11122333333222 222222222221 33567899999999999999999988888776554
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=303.93 Aligned_cols=238 Identities=27% Similarity=0.453 Sum_probs=189.9
Q ss_pred CcccccCeEEEEEEEecC-C----------CEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 78 NKIGQGGFGSVYKGTLKD-G----------TLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+.||+|+||.||+|.+.+ + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999763 3 25788887665433 5788999999999999999999999988 778999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-------CeEEeee
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-------TPKISDF 219 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df 219 (415)
|||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999976542 578899999999999999999998 999999999999999888 7999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhC-CcCCCCCCChhhhhHHHHHHHHHh
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSG-RCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg-~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
|++..... .....++..|+|||++... .++.++|||||||++|+|++| ..|+....+.+.. ..+.
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~ 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQ 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHh
Confidence 99986533 1233467789999998876 789999999999999999995 5555443221110 0111
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
... ..+......+.+++.+||..+|.+||++.+|++.|+
T Consensus 221 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 001111267889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=302.54 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=202.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|+..+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 7889999998654 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 228 (415)
+++++|.+++..... ..+++..+..++.+++.||+|||++ +++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999976532 2578999999999999999999999 999999999999998654 6899999999866433
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....+.. ....... +.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~-~~--------- 217 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS-GT--------- 217 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh-cC---------
Confidence 1 2233568889999999998889999999999999999999998886543321 1111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+..+.+++.+||+.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.90 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=203.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 147 (415)
++|+..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999986 688999999875432 3446788999999999999999999998653 4689999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988765333334688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.|+....... ....+..... .......+.+ .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~-~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYI-VNMPNPELKD-E 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHH-hcCCchhhcc-C
Confidence 21 123457889999999998999999999999999999999999987643210 0111111111 1111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+..+.+++.+||+.+|.+|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111234567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=307.48 Aligned_cols=252 Identities=22% Similarity=0.416 Sum_probs=195.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHH-HhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINV-IKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||.||+|..+ +|+.||+|.+.... ......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 69999999987642 2223455556665 566799999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++ |+|.+++.........+++..+..++.||+.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888887654333347899999999999999999999853 8999999999999999999999999999865332
Q ss_pred CcceecccccCCCCCChhhhhc----CCCCccceEeehhHhHHHHHhCCcCCCCCC-ChhhhhHHHHHHHHHhhCcchhh
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR----GQLTRKADIYSFGVLLLEIVSGRCNTNRRL-PYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltg~~p~~~~~-p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.|+.... +++. ...... +.....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~~~~ 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ------LKQVVE-EPSPQL 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH------HHHHHh-cCCCCC
Confidence 1 1223468889999998864 456889999999999999999999886421 2111 111111 111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+.++.+++.+||+.+|.+||++.+|++
T Consensus 229 --------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 --------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=304.97 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=202.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999875 789999999876543 3567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... .+++..+..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997653 578889999999999999999999 99999999999999999999999999998764432
Q ss_pred ccee---cccccCCCCCChhhhhcCC---CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 230 THIS---TRVAGTEGYLAPEYAIRGQ---LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 230 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.... ....++..|+|||++.+.. .+.++||||||+++|+|++|+.||...... ......... +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~-- 225 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GHKP-- 225 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CCCC--
Confidence 2211 1356788999999988766 899999999999999999999988643211 011111110 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ......+..+.+++.+||+.+|.+||++.+++.
T Consensus 226 ---~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 ---PI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 011123567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=309.61 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=205.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999865 6889999998765444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998654 478889999999999999999999 99999999999999999999999999987654332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .....+ ...
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~--------~~~ 234 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPE 234 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC--------CCC
Confidence 2 2233468889999999988889999999999999999999999987543322100 000000 001
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
...+...+..+.+++.+||..+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=311.92 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=200.5
Q ss_pred CCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCC
Q 044232 76 PANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 154 (415)
....||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999876 789999999876544445678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceec
Q 044232 155 LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234 (415)
Q Consensus 155 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 234 (415)
|..++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ ...
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99887543 578999999999999999999999 999999999999999999999999999976543321 223
Q ss_pred ccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCH
Q 044232 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314 (415)
Q Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (415)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....+.... ... ....... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~-~~~~~~~-------~~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRL-RDSPPPK-------LKNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hccCCCC-------ccccC
Confidence 456899999999999889999999999999999999999998754433211 111 1111000 01111
Q ss_pred HHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 315 EEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 315 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+..+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 234568899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=309.02 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=202.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|+||.||+|... +|..||+|++.... ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999976 78999999987653 33346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+ +++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 2689999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc------hh
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL------VE 302 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~------~~ 302 (415)
........|+..|+|||.+.+. .++.++|||||||++|||++|..++....+... ............. .+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999988654 568999999999999999999777655433211 1111111100000 00
Q ss_pred hcc--c---ccCC-----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVD--A---SLNG-----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~--~---~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.+ . .... ....+.+..+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0 0000 001123478899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=310.30 Aligned_cols=197 Identities=26% Similarity=0.433 Sum_probs=160.6
Q ss_pred CCcccccCeEEEEEEEec---CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEEEEeecc
Q 044232 77 ANKIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRILVYGYLE 151 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 151 (415)
..+||+|+||.||+|+.+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999865 357899998865432 2457789999999999999999999854 457899999986
Q ss_pred CCCHHHHhhcCC-----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCCeEEeeeccc
Q 044232 152 NNSLAQTLLGRG-----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLA 222 (415)
Q Consensus 152 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 222 (415)
+ +|.+++.... .....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7777765321 1123588999999999999999999999 99999999999999 56679999999999
Q ss_pred cccCCCCc--ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCC
Q 044232 223 KLFPANLT--HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRR 279 (415)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~ 279 (415)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86643322 12234568999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.61 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=200.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCCeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIK---HENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 147 (415)
.|+..+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778899999999999999975 7899999998754 2334567888999999986 999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988643 688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... ......|+..|+|||.+.++ .++.++|||||||++|+|++|..|+....+.... . ...... .+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~-~~~~~~-----~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------M-LIPKSK-----PP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------h-ccccCC-----CC
Confidence 332 22334688999999988754 5789999999999999999999998754332210 0 000000 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+.. ...+.++.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 014467889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=304.71 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=204.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+|++.+.||.|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 68999999987542 2345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++.... ++++..+..++.||++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999997653 688999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.|+....... .......... .
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~ 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------A 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------c
Confidence 2 2234568889999999988889999999999999999999999987644321 1111111110 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCH--HHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSM--STLV 342 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl 342 (415)
....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122333445789999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=308.88 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=197.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999976 7899999998754322 224567899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++ +|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 89998875532 678999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh------
Q 044232 230 THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE------ 302 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~------ 302 (415)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ....+..........
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhh
Confidence 1 1122346888999998875 46899999999999999999999888654321111 111111111000000
Q ss_pred ---hcc--------cccCCCC-CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 ---LVD--------ASLNGDY-SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ---~~~--------~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ....... ......++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=331.38 Aligned_cols=270 Identities=19% Similarity=0.241 Sum_probs=191.4
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC--CCEEEEE------------------EccccchHhHHHHHHHHHHHhhcCCc
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD--GTLAAIK------------------VLSADSRQGVREFLTEINVIKDIKHE 128 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 128 (415)
...++|+++++||+|+||+||+|..+. +..+++| .+.. .......+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987542 2222222 1111 122345678999999999999
Q ss_pred ceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 044232 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS-SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207 (415)
Q Consensus 129 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 207 (415)
||+++++++...+..++|++++ +++|.+++...... ........+..|+.||+.||.|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9999999999999999999998 45777776543211 11234566788999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcC-CCCCCChhhhh
Q 044232 208 LDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN-TNRRLPYEEQY 286 (415)
Q Consensus 208 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p-~~~~~p~~~~~ 286 (415)
++.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987654433333456799999999999999999999999999999999998754 33222222222
Q ss_pred HHHHHHHHH--hhC------cchhhcccccCC----CCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 287 LLEMAWKLY--ERG------KLVELVDASLNG----DYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 287 ~~~~~~~~~--~~~------~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+. ... .+...++..... ..+ ...+.++.+++.+||+.||.+|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 211111000 000 000000000000 000 012345778899999999999999999987
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.78 Aligned_cols=244 Identities=24% Similarity=0.416 Sum_probs=198.3
Q ss_pred CCCcccccCeEEEEEEEec-CCCEEEEEEccc----cchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe--eEEEEe
Q 044232 76 PANKIGQGGFGSVYKGTLK-DGTLAAIKVLSA----DSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH--RILVYG 148 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 148 (415)
...+||+|+|-+||+|.+. +|..||=-.++. ......++|..|+.+|+.|+||||+++|+++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999876 677776322221 234556889999999999999999999999987665 788999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeeccccccCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPA 227 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~ 227 (415)
.+..|+|..|+.+.+ ..+...+..|+.||+.||.|||++ .|+|+|||||.+||+|+.+ |.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999887 678889999999999999999998 6799999999999999866 7999999999998755
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. ...+.|||.|||||+.. ..|++.+||||||++++||+|+..|+.... ....+.+....|.....+..-
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHHHHcCCCHHHhhcc
Confidence 42 23478999999999775 889999999999999999999976654332 223333444444444333322
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. -.++.+||.+|+.. .++|||+.|+|+
T Consensus 269 ~--------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 K--------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C--------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2 25688999999999 999999999997
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=307.24 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=198.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.+.|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999976 6899999988643 233446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+||++ |+|.+++..... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 577777654322 589999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.|+....+... ....... ..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~-~~--- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-DS--- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC-CC---
Confidence 32 2346788999999874 45688999999999999999999988765432221 1111111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
........+..+.+++.+||+.+|++||++.+|+..
T Consensus 232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011122355679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.78 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=203.0
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+.+....|+++++||+||.++||++...+.+.+|+|.+... +.+...-|.+|+.+|.+| .|.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44566789999999999999999999887788888876543 566778899999999999 589999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
||||||= .-+|..+|...... ...| .++.+..|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|||+|.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred EEEeecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhc
Confidence 9999965 66899999877543 2334 7788999999999999999 999999999999985 5699999999999
Q ss_pred ccCCCCcc-eecccccCCCCCChhhhhcC-----------CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 224 LFPANLTH-ISTRVAGTEGYLAPEYAIRG-----------QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 224 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
....+.+. .....+||+.||+||.+... +.++++||||||||||+|+.|+.||+.-.. ..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~--- 579 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI--- 579 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH---
Confidence 88666443 34557899999999998543 256899999999999999999888753210 01
Q ss_pred HHHHhhCcchhhcccccCCCCCH-HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 WKLYERGKLVELVDASLNGDYSV-EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.++..+.++...-+|+. ....++.+++..||..||++||+..+||+
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12223334433222221 11233999999999999999999999987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.54 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=198.7
Q ss_pred CCCCCcccccCeEEEEEEEec----CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 74 FSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
|++.+.||+|+||.||+|.+. ++..||+|++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999854 3678999998764 3344567889999999999999999999886532
Q ss_pred eeEEEEeeccCCCHHHHhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 142 HRILVYGYLENNSLAQTLLGRG--HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
..++++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875322 1223578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 220 GLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 220 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
|+++........ ......+++.|++||.+....++.++|||||||++|+|++ |+.|+....... . ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHc
Confidence 999865432211 1122345678999999998889999999999999999999 777765432211 1 111111
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
+.. ...+...+..+.+++.+||+.+|++||++.++++.|.+.
T Consensus 231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 011123446799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.71 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=202.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.|...+.||+|++|.||++... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455679999999999999975 788999999876555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999998762 588999999999999999999999 999999999999999999999999998875543321
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.|+....+... .... ..+.. +.. .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~-~~~~~-----~~~--~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRI-RDNLP-----PKL--K 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHH-HhcCC-----CCC--c
Confidence 22335688999999999888899999999999999999999998865443221 1111 11110 000 1
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11124467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.02 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=200.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 146 (415)
++|++.+.||.|+||.||+|..+ +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999986 688999999875432 2223567899999999999999999999877 889999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++ ++|.+++..... .+++..+..++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 489988876442 589999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--------HHHHHhh
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--------AWKLYER 297 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--------~~~~~~~ 297 (415)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....+......... .|..+..
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4321 12334578899999988764 468999999999999999999999876543221111000 0000000
Q ss_pred ------CcchhhcccccCCCCCHH-HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 ------GKLVELVDASLNGDYSVE-EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+...++.. .+..+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111112221 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=308.51 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=211.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..-|.+.+.||+|.|..|-+|++- +|..||||++.+...+ ....+.+|+.-|+.++|||||++|++......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356888899999999999999865 8999999999876433 3346778999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCCeEEeeeccccccC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLFP 226 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~ 226 (415)
|.-++|+|+++|..... .+++..+.+++.||+.|+.|+|.. .+|||||||+|+.+- .-|-|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999987654 689999999999999999999999 999999999999875 55889999999998775
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCC-ccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLT-RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
+. ...++.+|...|-|||++.+..|+ +++||||||||||.|++|+.||......+. +..++|
T Consensus 171 PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImD 233 (864)
T KOG4717|consen 171 PG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMD 233 (864)
T ss_pred Cc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhc
Confidence 53 345678999999999999998876 678999999999999999999876443332 112222
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ....|.-.+.++.+||..||.-+|++|.+.++|..
T Consensus 234 C--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 C--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 22456667788999999999999999999999976
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.73 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=197.8
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999876 78999999887542 22335688899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+. ++|..++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689888865432 2688999999999999999999999 99999999999999999999999999987654321
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc---------
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK--------- 299 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~--------- 299 (415)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||.......... ... .......
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIF-RTLGTPDEVVWPGVTS 230 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH-HHhCCCChhhhhhhhH
Confidence 1 12234568899999987664 46889999999999999999999886543322111 000 0000000
Q ss_pred ch---hhcccccCC---CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LV---ELVDASLNG---DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~---~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ..+...... ......+.++.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=303.10 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=207.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
..+.|+..+.||+|++|.||+|..+ ++..+++|++..... ....+.+|+.+++.++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3567888899999999999999987 688999999976654 45678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998764 2689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.. ......++..|+|||++.+..++.++|||||||++|+|++|+.|+....+..... .... .....
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~~------ 235 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LITT-KGIPP------ 235 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-cCCCC------
Confidence 11 2233457889999999988889999999999999999999999887544432211 1111 11100
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+..+.+++.+||+.+|.+||++.+|++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111224567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.23 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=200.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-----hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-----GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999976 6899999998765322 334567899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+ +++|.+++.... ..+++..+..++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997543 2689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC-------
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG------- 298 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~------- 298 (415)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..++....+..... .........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG---KIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH---HHHHHcCCCchhhhhh
Confidence 4321 2223356788999998865 467899999999999999999977766544332111 110000000
Q ss_pred --cchhhcccccCCC-----CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 --KLVELVDASLNGD-----YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 --~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............. .....+..+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000011 11233567889999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.31 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=206.4
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||.|+||.||++..+ ++..+|+|.+.... .....++.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 78899999987542 33345778899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877443334789999999999999999999999 9999999999999999999999999999876544
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+....+.+. .. ....+ ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~-~~~~~---------~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL------RY-KVQRG---------KY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHhcC---------CC
Confidence 12234578899999999998999999999999999999999998875433211 11 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+..+...+.++.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2223355677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.08 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=198.1
Q ss_pred CCCCCCcccccCeEEEEEEEec---CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK---DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRI 144 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 144 (415)
+|++.++||+|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999998732 33345677899999999999999999999988 7899
Q ss_pred EEEeeccCCCHHHHhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC----CCCeEEeee
Q 044232 145 LVYGYLENNSLAQTLLGRGHS-SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK----DLTPKISDF 219 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 219 (415)
+||||+++ +|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 677766543222 23688999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCc--ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChh-------hhhHHH
Q 044232 220 GLAKLFPANLT--HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE-------EQYLLE 289 (415)
Q Consensus 220 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~-------~~~~~~ 289 (415)
|++........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 122345678899999988764 58899999999999999999999987543221 111111
Q ss_pred HHHHHHhhC------------cchhhcccccCCCCC---------H--HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 290 MAWKLYERG------------KLVELVDASLNGDYS---------V--EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 290 ~~~~~~~~~------------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ...+... ......+......++ . ....++.+++.+||+.+|++|||+.|+++
T Consensus 237 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 I-FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 1110000 000000000001111 0 23356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=293.95 Aligned_cols=249 Identities=31% Similarity=0.510 Sum_probs=206.1
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|+.+++.++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 788999999987765556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987653 2689999999999999999999998 999999999999999999999999999986654321
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....+..... .. ........ .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~-------~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KI-ATNGPPGL-------R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HH-HhcCCCCc-------C
Confidence 334568899999999988889999999999999999999998876543322111 01 00100000 0
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112567899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=298.81 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=198.2
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||.|++|.||+|... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999976 58899999987542 23346788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++.... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997654 578999999999999999999998 99999999999999999999999999998664432 2233
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..|+....... ........ +......++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCcc
Confidence 468899999999988889999999999999999999999987654211 11111111 01112223333
Q ss_pred HHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
.+.++.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3678999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=306.57 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=197.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCe-----
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIK-HENLVELYGCCVEGDH----- 142 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 142 (415)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 689999998765422 23356788999999995 6999999999987665
Q ss_pred eEEEEeeccCCCHHHHhhcCCCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeec
Q 044232 143 RILVYGYLENNSLAQTLLGRGHS-SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 220 (415)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 788888654322 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+...... .........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCCCC
Confidence 9986533211 1122356888999998865 4579999999999999999999988876543322110 000000000
Q ss_pred ch------hhcc----cccC----CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LV------ELVD----ASLN----GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~------~~~~----~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ...+ +... .......+..+.+++.+||+.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 0000 0001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.38 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=196.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999875 6889999998654322 22356789999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+. ++|.+.+..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 677777654321 577888999999999999999999 9999999999999999999999999998754322
Q ss_pred CcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC---------
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG--------- 298 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~--------- 298 (415)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+.... ....+......
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 S-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhh
Confidence 1 112234578899999988754 5789999999999999999999998754332111 11111110000
Q ss_pred cchhhccccc----CCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLVELVDASL----NGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~~~~~~~----~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... .... ....+..+.+++.+|+..+|.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.80 Aligned_cols=259 Identities=26% Similarity=0.304 Sum_probs=214.5
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
..+++...++|.+++.||+|+||.|..++.+ +++.||+|++++.. .....-|..|-.+|..-+.+.|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3556677899999999999999999999987 69999999998742 2334568899999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.+++|+||||++||+|..++...+ .+++..++-++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998776 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhh----c-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAI----R-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
|.+..+..+....+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||... .+.+.--++
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence 999988877777788889999999999986 2 57999999999999999999998777543 222222222
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC---HHHHHH
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS---MSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 343 (415)
........+. ...+.+....+||...+.. |+.|.. +.++-.
T Consensus 294 m~hk~~l~FP-------~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 294 MNHKESLSFP-------DETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKN 337 (1317)
T ss_pred hchhhhcCCC-------cccccCHHHHHHHHHHhcC-hhhhcccccHHHHHh
Confidence 2221111111 1133567778888877764 778887 888765
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.76 Aligned_cols=247 Identities=27% Similarity=0.358 Sum_probs=204.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.+.|+.-+.||+||||.||-+..+ +|+.+|.|.+.+.. +......++|-.+|.+++.+.||.+-..|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466888899999999999999876 79999999886642 33345678999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+..|.||+|.-+|.+.+.. .++++.++-++.+|+.||++||+. +||+|||||+|||+|++|+++|+|+|+|..++
T Consensus 264 LtlMNGGDLkfHiyn~g~~--gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNP--GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCCC--CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999877653 799999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
..... ...+||.+|||||+++++.|+...|+|||||++|||+.|+.||.....-... +.+.+...
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~---------- 403 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTL---------- 403 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHh----------
Confidence 65332 3347999999999999999999999999999999999999888653221111 00110000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 337 (415)
.....|+...+++..+|....|+.||.+|.-
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1123455566677888888999999999973
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.85 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=201.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 68889999986542 12335678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 228 (415)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999976442 2578999999999999999999999 999999999999999886 4699999999866433
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..|+....+. ........ +..
T Consensus 156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-------- 219 (257)
T cd08225 156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYF-------- 219 (257)
T ss_pred c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccC--------
Confidence 2 2223345889999999998888999999999999999999999887654321 11211111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+..+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.25 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Cee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 143 (415)
+++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 7899999998643 233446688899999999999999999987654 357
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++|+||++ ++|.+.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 4888877543 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc-
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK- 299 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~- 299 (415)
........ ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCH
Confidence 65432211 1123568899999998765 56899999999999999999999888654321110 00110000000
Q ss_pred ----------chhhccc-ccCCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH--hhcCCCC
Q 044232 300 ----------LVELVDA-SLNGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM--LIGEIDV 351 (415)
Q Consensus 300 ----------~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~ 351 (415)
....+.. ...... ....+.++.+++.+||+.+|++||++.++++. +....+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000000 000000 01224668899999999999999999999985 5544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.06 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=199.7
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEEEEe
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRILVYG 148 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 148 (415)
|++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999998763 33345688899999999999999999999988 89999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886553 2688999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC---c---ch
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG---K---LV 301 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~---~---~~ 301 (415)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....+..... ......... . ..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccc
Confidence 3222333456888999997765 467899999999999999999998887654322111 111100000 0 00
Q ss_pred h-----------hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 E-----------LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .....+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000011112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=296.95 Aligned_cols=251 Identities=25% Similarity=0.453 Sum_probs=207.6
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||.|+||.||++... ++..+|+|++..... .....+.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999976 688999999876532 4556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543334789999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+....+. ....... ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKIL-KGQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHh-cCC---------C
Confidence 2233456889999999998888999999999999999999999887654321 1111111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=306.11 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=187.8
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEccccchHhH-----------HHHHHHHHHHhhcCCcceeee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSADSRQGV-----------REFLTEINVIKDIKHENLVEL 133 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 133 (415)
+..++|++.+.||+|+||.||+|.+.+ +..+|+|+......... .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345789999999999999999999763 45677776443321110 112234445567789999999
Q ss_pred eeEEEeCC----eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 044232 134 YGCCVEGD----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 134 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 209 (415)
++++.... ..+++++++. .++.+.+.... ..++..+..|+.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99876543 3467888774 46666665432 357788899999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccccccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 210 KDLTPKISDFGLAKLFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 210 ~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
.++.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999866432111 1123469999999999999999999999999999999999999987642211
Q ss_pred hhhH---HHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 284 EQYL---LEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 284 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
.... .+.... ...+. . ....++..+.+++..||+.+|++||++.+|++.|
T Consensus 241 ~~~~~~~~~~~~~-~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKR-LHEGK--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHH-hhhhh--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100 011111 11111 0 0112357789999999999999999999999876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=297.52 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=200.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-----chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--Cee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-----SRQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 143 (415)
.+|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999975 6899999987532 223446788999999999999999999998764 468
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++++||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987654 578889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------ 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIA------ 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHH------
Confidence 6532111 11223568899999999988889999999999999999999999886532221 111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+..+......+.+++.+||+ +|..||+..+++.
T Consensus 223 ---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 ---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112223344556779999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.51 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=198.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------ 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 140 (415)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999976 7899999998643 233445677899999999999999999998643
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887753 277888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH------------
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL------------ 288 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~------------ 288 (415)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654321 123345788999999999999999999999999999999999988654321110000
Q ss_pred ---HHHH-HHHhhCc------chhhcccccC----CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 289 ---EMAW-KLYERGK------LVELVDASLN----GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 289 ---~~~~-~~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ....... .......... .......+..+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0000000 0001111000 0111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=303.22 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=195.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666788999999999999976 68999999987542 334467889999999996 9999999999999999999999
Q ss_pred eccCCCHHHHhhcC-CCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 149 YLENNSLAQTLLGR-GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 149 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|+.. ++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9854 555443211 011136899999999999999999999742 899999999999999999999999999976543
Q ss_pred CCcceecccccCCCCCChhhhhcC---CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRG---QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... ..+....... +..
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~---- 228 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GDP---- 228 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CCC----
Confidence 221 1234588999999998766 689999999999999999999988764321 1111111111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+..........+.++.+|+.+||+.+|++||++.+|++
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111222335667999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.14 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=199.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+.|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+++++.++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999975 6889999998643 2334457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++ +|.+.+..... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99964 77777754332 689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
. ....|++.|+|||++. .+.++.++|||||||++|||++|+.|+....+... .......+.
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~----- 241 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES----- 241 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhccC-----
Confidence 2 2346888999999874 45789999999999999999999988765322111 111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
........+..+.+++.+||+.+|.+||++.+|++.+..
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 011122345678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=301.24 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=200.7
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+|++.+.||.|++|.||+|+.. +|..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999986 689999999876532 23356778999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++ +|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 88888865542 23689999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHhhCcch
Q 044232 231 HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYERGKLV 301 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~~~~~~ 301 (415)
......++..|+|||++.+. .++.++|||||||++|+|++|+.|+....+.+........ +..... ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cc
Confidence 12234578899999988664 5789999999999999999999998765432211110000 000000 00
Q ss_pred hhccccc------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASL------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....... ........+..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00111123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.78 Aligned_cols=247 Identities=30% Similarity=0.481 Sum_probs=205.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999876 688999999877643 4556889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999997663 689999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.. .....++..|+|||...+..++.++||||||+++|+|++|+.|+....+.. ..+.... . ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~---------~~ 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQ-D---------DH 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-c---------CC
Confidence 21 234568889999999988888999999999999999999998876533211 1111111 1 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1222233567889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.21 Aligned_cols=244 Identities=27% Similarity=0.364 Sum_probs=194.6
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||+|+||+||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999866 68999999986532 22334667899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999976543 2588999999999999999999999 9999999999999999999999999998765432 12233
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .. ..... ......+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~----~~~~~------~~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---EL----KRRTL------EMAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HH----Hhccc------cccccCCcc
Confidence 457889999999988889999999999999999999999986543321111 00 00000 011122233
Q ss_pred HHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
.+..+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 457789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=305.04 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=200.8
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC---
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGD--- 141 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 141 (415)
+...++|++.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345688999999999999999999986 688999999875422 22346678999999999999999999987654
Q ss_pred -------eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 142 -------HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 142 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
..++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999976 6777776542 2689999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+....+... ...+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHH
Confidence 999999998664433222233346788999998865 3578999999999999999999988875433221 111111
Q ss_pred HHhhCcch---hhc--------cc------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 LYERGKLV---ELV--------DA------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ~~~~~~~~---~~~--------~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........ .+. +. ..... ....+..+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000 000 00 00000 0123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=299.95 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=189.6
Q ss_pred cccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHh---hcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIK---DIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 68999999886542 111223444544433 3479999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++...+ .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999987654 689999999999999999999999 99999999999999999999999999987553321
Q ss_pred eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ..... .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~----------~~~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT----------LTVNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh----------hcCCc
Confidence 123468999999998864 568999999999999999999999986543221111 11110 01112
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNM 344 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 344 (415)
..+...+.++.+++.+||+.||.+|| +++++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23334567889999999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.23 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=207.8
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRILVY 147 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 147 (415)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999987 789999999876542 4557889999999999999999999999988 8999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998664 789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|+.|+..... .....+.... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------S 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------c
Confidence 4221 12345688899999999888899999999999999999999998875431 1111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+...+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112233344678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.43 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=198.0
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+.+++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999976 79999999987543 222356888999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
+ ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 689998876542 2589999999999999999999998 999999999999999999999999999976533211
Q ss_pred ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC---------cc
Q 044232 231 HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG---------KL 300 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~---------~~ 300 (415)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||....+.... .... ...... .+
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIF-RTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhCCCChHHhhhhhhc
Confidence 1 1223568899999987664 5789999999999999999999888654332211 1100 000000 00
Q ss_pred hhh---cccc---cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VEL---VDAS---LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~---~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... +... .........+..+.+++.+||+.+|.+||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000 000111123367889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=296.99 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=198.3
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||.|+||.||++... +++.+|+|.+..... .....+.+|+.++++++||||+++++.+..++..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 599999999876533 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc-----
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT----- 230 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~----- 230 (415)
.+++...+ .+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997654 689999999999999999999999 999999999999999999999999999875433211
Q ss_pred --ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 231 --HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 231 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.......++..|+|||...+...+.++||||||+++|+|++|..|+....+.. ...... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~-------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNIL-NGKI-------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCc--------
Confidence 12233557889999999988889999999999999999999999887554321 111111 1111
Q ss_pred CCCCCHH--HHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 309 NGDYSVE--EAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 309 ~~~~~~~--~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
..+.. .+..+.+++.+||+.+|.+||++.++.+.|.
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111 2577899999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=305.34 Aligned_cols=265 Identities=27% Similarity=0.371 Sum_probs=197.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 145 (415)
.++|++.+.||+|+||.||+|... +|..||+|.+..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999976 689999999865422 1223456799999999999999999998765 46899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+. ++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 47888886543 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHh
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYE 296 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~ 296 (415)
..... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......... |....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 43321 1222345788999998865 46899999999999999999999988765443321111100 00000
Q ss_pred hCcchhhcccccCC--CC---CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKLVELVDASLNG--DY---SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~~~~~~~~~~~--~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+...... .. ....+..+.+++.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000000 00 0112566789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.65 Aligned_cols=244 Identities=27% Similarity=0.439 Sum_probs=198.8
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
..+||+|+||.||++..+ ++..||+|.+..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 7899999998665555556788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987543 578899999999999999999999 999999999999999999999999999876543321 1233
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..|+....+..... ..... ...... ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-------~~~~~-----~~~~~~--~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDN-----LPPKLK--NLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhh-----CCcccC--Cccc
Confidence 568899999999988889999999999999999999999886543322111 11110 000100 0112
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+..+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=307.89 Aligned_cols=265 Identities=20% Similarity=0.320 Sum_probs=200.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVE----GDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 143 (415)
.++|++.+.||+|+||.||+|..+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999976 69999999987642 2344667789999999999999999998763 3568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 68988886554 589999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCc---ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------
Q 044232 224 LFPANLT---HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA-------- 291 (415)
Q Consensus 224 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~-------- 291 (415)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 6533211 11223568899999998865 46899999999999999999999998765432211110000
Q ss_pred HHHHhhCcchhhccc-ccCCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 WKLYERGKLVELVDA-SLNGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.............+. ...... ....+.++.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000011100 000011 1223577999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=309.97 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Ce
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 142 (415)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999875 7899999998653 233345677899999999999999999988654 35
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68988887654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh-----
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE----- 296 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~----- 296 (415)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChH
Confidence 8654322 22234467889999998865 4689999999999999999999999865432111 111111100
Q ss_pred ------hCcchhhccc---ccCC---CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 297 ------RGKLVELVDA---SLNG---DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 297 ------~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+.....+.. .... ......+.++.+++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0000 0112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.35 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=202.1
Q ss_pred CCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccc----hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS----RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+|++.+.||+|++|.||++... ++..||+|.+.... ......+.+|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777899999999999999742 57889999986532 22335678899999999 699999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987543 688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCC--CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
.+............|+..|+|||.+.+.. .+.++||||||+++|+|++|..|+........ ..+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~---- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc----
Confidence 65443322233456889999999987655 78899999999999999999998864322111 11111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+...+..+.+++.+||+.+|++|||+.++.+.|..
T Consensus 228 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 112223344678899999999999999999988887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.39 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=194.1
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeC--CeeEEEEe
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIK-HENLVELYGCCVEG--DHRILVYG 148 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 148 (415)
|++.+.||+|+||.||+|... ++..||+|++.... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999976 68999999987642 122234457888898885 99999999999987 88999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|++ ++|.+.+.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 57888876543 2689999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH-----------h
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY-----------E 296 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~-----------~ 296 (415)
.. .....++..|+|||++.. +.++.++|||||||++|||++|..||....+.+.. ....... .
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhc
Confidence 21 223457889999997654 56789999999999999999999888765443211 1111110 0
Q ss_pred hCcchhhcccccCC----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKLVELVDASLNG----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001134678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=299.48 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=204.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 146 (415)
++|.+.+.||+|+||.||+|... ++..||+|++... .......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 7999999998753 2233467888999999998 99999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc-------------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhH
Q 044232 227 ANLT-------------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYL 287 (415)
Q Consensus 227 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~ 287 (415)
.... .......++..|+|||.+.+..++.++||||||+++++|++|+.|+.....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 3221 122234578899999999888899999999999999999999988875432111
Q ss_pred HHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH----HHHHH
Q 044232 288 LEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM----STLVN 343 (415)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~ 343 (415)
...... .....+...+..+.+++.+||+.+|.+||++ .++++
T Consensus 231 ---~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ---FQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 1112223335678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=303.84 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=195.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999976 68999999886542 222235668999999999999999999987644
Q ss_pred --eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 142 --HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 142 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
..++||||+. ++|.+.+.... ..+++..+..++.||+.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 57888876543 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcc---eecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 220 GLAKLFPANLTH---ISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 220 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+..............
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999865432211 12234578889999988664 47889999999999999999998887654432221111110000
Q ss_pred h-----hCcchhhccccc-CCCC---------CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 E-----RGKLVELVDASL-NGDY---------SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~-----~~~~~~~~~~~~-~~~~---------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ........+... .... +......+.+++.+||+.+|.+||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000000000 0000 0011345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=292.93 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=191.3
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHH-hhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVI-KDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 689999999865432 2223344555444 455899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997654 688999999999999999999999 999999999999999999999999999875432
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..|+....+.. . +.....+.. ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~------~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------V-FDNILSRRI------NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHhccc------CCCCcc
Confidence 223468889999999988889999999999999999999999986543321 1 111111111 001111
Q ss_pred CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 313 SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
....+..+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 223457789999999999999999876665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=303.10 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=194.0
Q ss_pred Cccccc--CeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQG--GFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
..||+| +||+||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999975 7999999998754 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876542 2588999999999999999999998 99999999999999999999999998664332111100
Q ss_pred ------ecccccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc-----
Q 044232 233 ------STRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK----- 299 (415)
Q Consensus 233 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~----- 299 (415)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 232 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLD 232 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCcc
Confidence 1112345679999998764 478999999999999999999998865432111 000000000
Q ss_pred -------------------------------chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 -------------------------------LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 -------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.................+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00001111112223446678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=298.69 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=198.4
Q ss_pred CCCCCCcccccCeEEEEEEEe----cCCCEEEEEEccccc----hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 73 NFSPANKIGQGGFGSVYKGTL----KDGTLAAIKVLSADS----RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+|++.+.||.|+||.||+|.. .+|..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368899999987532 22335678899999999 699999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997654 678899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~---- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc----
Confidence 6544322223345688999999998753 468899999999999999999988864322111 11111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...++...+..+.+++.+||+.+|++|| +..++++
T Consensus 228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1122333456788999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=308.71 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=199.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC--Cee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDI-KHENLVELYGCCVEG--DHR 143 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 143 (415)
..++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 6889999988543 223345677899999999 999999999998653 368
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||++ ++|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 5898888653 578889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc----ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH-------
Q 044232 224 LFPANLT----HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA------- 291 (415)
Q Consensus 224 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~------- 291 (415)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6643321 12234568999999998765 56789999999999999999999998654433211110000
Q ss_pred -HHHHhhCcchhhccccc---C---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 292 -WKLYERGKLVELVDASL---N---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 292 -~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+..........+++... . .......+.++.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000010000 0 00111135778999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.79 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=197.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999976 789999999865422 233567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeeccccccCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPA 227 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 227 (415)
|++ ++|.+++..... ..+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 578888765432 2467888899999999999999999 9999999999999985 55799999999976533
Q ss_pred CCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc-
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD- 305 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~- 305 (415)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+.+.... ........ .....+
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~-~~~~~~~ 230 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTP-NEETWPG 230 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCC-Chhhccc
Confidence 21 11233457889999998876 4678999999999999999999988875443221111 11110000 000000
Q ss_pred -----------cccCC----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 -----------ASLNG----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 -----------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.... ......+.++.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001123456889999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.65 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=200.9
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999876 789999999876532 23467888999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888886643 2689999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC------cchh-
Q 044232 231 HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG------KLVE- 302 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~------~~~~- 302 (415)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... ....... ....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhh
Confidence 122234578889999998876 7899999999999999999999888654432211110 0000000 0000
Q ss_pred -------hccc--ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 -------LVDA--SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 -------~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+. ..........+.++.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0000112234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=291.58 Aligned_cols=244 Identities=21% Similarity=0.281 Sum_probs=191.8
Q ss_pred HhcCCCCCCcc--cccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKI--GQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34677777776 99999999999875 788999999865422111 22222222 79999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKL 224 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 224 (415)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999997664 789999999999999999999999 999999999999999998 999999999876
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... ....|+..|+|||++.+..++.++||||||+++|+|++|+.|+..... .......+.... ..
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~------ 225 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--QK------ 225 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--cc------
Confidence 5432 234588999999999988999999999999999999999999874322 111111111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-HHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-MSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 343 (415)
........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01112245577899999999999999995 688874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=299.02 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=197.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+.|+..+.||+|+||.||+|+.. ++..+|+|.+... ......++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777889999999999999976 6888999988642 2334467888999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+. |+|.+.+..... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 578777754332 578999999999999999999999 999999999999999999999999999876533
Q ss_pred CCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
. ....|++.|+|||.+. ...++.++|||||||++|+|++|+.|+........ ..... .+...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~~~--- 232 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNESP--- 232 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHh-hcCCC---
Confidence 2 2346788999999875 35678899999999999999999988754322111 11111 11110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
.......+..+.+++.+||+.+|.+||++.++++..
T Consensus 233 -----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011223456788999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=293.23 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=189.1
Q ss_pred cccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHH---HHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEIN---VIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 688999999865421 11122334443 4444589999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
||+|.+++...+ .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999886554 689999999999999999999998 99999999999999999999999999987553321
Q ss_pred eecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||.......... ...... ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~----------~~~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL----------TMAV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhh----------ccCC
Confidence 2234689999999998754 68999999999999999999999987543222111 000100 0111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
..+...+.++.+++.+||..+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22223457789999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.57 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=208.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
...|.+.+.||+|.|++|.+|+.. ++..||+|++.+.. ....+.+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467899999999999999999976 79999999998763 333355889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+.+|.+.+++...+ ...+..+..++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999887 566688999999999999999999 999999999999999999999999999998864
Q ss_pred CCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.....+.+|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||++..-.+-. . ..+..
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~----rvl~g 270 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------P----RVLRG 270 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------c----hheee
Confidence 345567899999999999998765 68999999999999999999888765432210 0 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.. ..+.-..-++.+++.+++-.+|.+|++++++.+.
T Consensus 271 k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 1122233457789999999999999999999763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.60 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=202.8
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----eeE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGD-----HRI 144 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 144 (415)
+|++.+.||.|++|.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999976 58999999987643 344567889999999999999999999998765 789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||++ ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58988887654 789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc--ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--------H
Q 044232 225 FPANLT--HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW--------K 293 (415)
Q Consensus 225 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~--------~ 293 (415)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 644321 122334578899999999887 88999999999999999999999987654322111000000 0
Q ss_pred HHhhCcchhhccc-ccC-----CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 294 LYERGKLVELVDA-SLN-----GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 294 ~~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..........+.. ... .......+..+.+++.+||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000 000 00111235678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.97 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=192.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEE--------
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCV-------- 138 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-------- 138 (415)
.-..+|+.++.||+||||.||+++.+ ||+.||||++... .........+|+..|.+|+|||||+++..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34578999999999999999999998 9999999998766 3344567889999999999999999872100
Q ss_pred ----------------------------------------------------------------------e---------
Q 044232 139 ----------------------------------------------------------------------E--------- 139 (415)
Q Consensus 139 ----------------------------------------------------------------------~--------- 139 (415)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHH
Q 044232 140 ------------------------G--------DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187 (415)
Q Consensus 140 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 187 (415)
+ ..+||=||||+..+|.+++..+.... .....++++.+|++||+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 0 23578899999988887777654211 367789999999999999
Q ss_pred HHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC-----------------CCCcceecccccCCCCCChhhhhc
Q 044232 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP-----------------ANLTHISTRVAGTEGYLAPEYAIR 250 (415)
Q Consensus 188 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 250 (415)
+|++ |||||||||.||++++++.|||+|||+|.... .......+..+||..|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998621 000112345679999999999876
Q ss_pred C---CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHc
Q 044232 251 G---QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLC 327 (415)
Q Consensus 251 ~---~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 327 (415)
. .|+.|+|+||||||++||+. ||... +.......+ ++.+.+..- ..+..+....=..+|.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~-LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTN-LRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHh-cccCCCCCC------cccccccchHHHHHHHHH
Confidence 4 59999999999999999984 34322 111222222 223332221 222333344556899999
Q ss_pred CCcCCCCCCCHHHHHH
Q 044232 328 TQDMPKRRPSMSTLVN 343 (415)
Q Consensus 328 l~~~P~~RPs~~evl~ 343 (415)
++.||++|||+.|+|+
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.25 Aligned_cols=260 Identities=21% Similarity=0.262 Sum_probs=193.7
Q ss_pred CCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 76 PANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+.+.+|.|+++.||++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555666666665554 6889999998765 3445578999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc---
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT--- 230 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--- 230 (415)
+|.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999765322 578899999999999999999999 999999999999999999999999999875532211
Q ss_pred ---ceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH----HHhhC---
Q 044232 231 ---HISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK----LYERG--- 298 (415)
Q Consensus 231 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~----~~~~~--- 298 (415)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....+... ..+.... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 11223457788999999876 3588999999999999999999999875432211 0010000 00000
Q ss_pred ----cchh--------hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 ----KLVE--------LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ----~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ................++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000111223344567889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.68 Aligned_cols=243 Identities=27% Similarity=0.443 Sum_probs=194.8
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
|...++||+|+||.||+|+.. ++..||+|++... .......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999975 6889999998653 223445788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+. |+|.+++..... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 577777765432 688999999999999999999999 999999999999999999999999999864322
Q ss_pred cceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.....|+..|+|||++. ...++.++|||||||++|+|++|..|+....+.... ...... ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~~~---- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DSPT---- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CCCC----
Confidence 22456888999999974 456889999999999999999999887654332221 111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+..+.+++.+||+.+|.+||++.+++.
T Consensus 240 ----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 ----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123356889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=292.41 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=197.5
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-----chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-----SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+|.+.+.||+|+||.||+++.. .+..+++|+++.. .......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999875 3455556655431 122234566799999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998875433334789999999999999999999999 9999999999999975 579999999987654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+....... ...... .+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~-------- 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EG-------- 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cC--------
Confidence 322 22234568889999999988888999999999999999999998876432211 111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+...+.++.+++.+||+.+|++||++.++++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112233455678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.74 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=195.4
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhc---CCcceeeeeeEEEeCCe-----
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDI---KHENLVELYGCCVEGDH----- 142 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 142 (415)
|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 589999999875422 2224566788777666 59999999999988776
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.+++|||+++ +|.+++...... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP--GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999964 898888764422 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc---
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK--- 299 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~--- 299 (415)
........ .....++..|+|||++.+..++.++|||||||++|+|++|..|+....+.+. ..+....-.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 226 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ------LDKIFDVIGLPS 226 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH------HHHHHHHcCCCC
Confidence 86643321 1233478899999999999999999999999999999999888765443221 111111000
Q ss_pred c----------hhhcccccC---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 L----------VELVDASLN---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~----------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ......... .......+..+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 0111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.42 Aligned_cols=252 Identities=21% Similarity=0.382 Sum_probs=200.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++.+.+..||.|..|.||+++.+ +|...|||.+... ..+..++++..+.++.+-. .|+||+.+|+|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 355666788999999999999977 6999999999776 4455677888888877664 899999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|.| ...++.++..... ++++..+-++...++.||.||.++. +|+|||+||+|||+|..|++||+|||++-.+-+
T Consensus 171 elM-s~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHH-HHHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 988 4456777665543 6899999999999999999998874 999999999999999999999999999976644
Q ss_pred CCcceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCC-CCChhhhhHHHHHHHHHhhCcchhh
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNR-RLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~-~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.. ..+...|-+.|||||.+.- ..|+-++||||||++++||.||+.|+.+ ...|+. ...+.++..
T Consensus 245 Sk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------ltkvln~eP---- 312 (391)
T KOG0983|consen 245 SK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------LTKVLNEEP---- 312 (391)
T ss_pred cc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------HHHHHhcCC----
Confidence 32 2345678999999998864 3688899999999999999999999875 333432 222222211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+.+. .....+..+.+++..||+.|+.+||...++++.
T Consensus 313 --P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 --PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111 111246789999999999999999999999873
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.82 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=196.7
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEeec
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
|++.+.||+|++|.||+|... +++.||+|.+..... .......+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 588899999865422 12234557999999998 999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
+|+|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 8899998876542 2689999999999999999999999 99999999999999999999999999998654321
Q ss_pred ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH----------HHHHHHhhCc
Q 044232 231 HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE----------MAWKLYERGK 299 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~----------~~~~~~~~~~ 299 (415)
......++..|+|||++.+ ..++.++|+||||+++|+|++|+.|+....+........ +.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 1233457889999998754 467999999999999999999998886544322111000 0000000000
Q ss_pred chhhcccccC---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLN---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+..... .......+..+.+++.+||+.+|.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0001112467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=296.60 Aligned_cols=255 Identities=23% Similarity=0.390 Sum_probs=196.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 145 (415)
...++|++.+.||+|+||.||+|.++ +++.||+|.+.... ......+..|+.++.+. .||||+++++++.+....++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34577899999999999999999987 48999999987542 23345667788777666 49999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+. ++|.+++..... .+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+
T Consensus 92 v~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999985 577777655332 6889999999999999999999731 8999999999999999999999999999765
Q ss_pred CCCCcceecccccCCCCCChhhhhcCC----CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQ----LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... ..
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~ 237 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PP 237 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CC
Confidence 43221 12335788999999987553 789999999999999999999887542111 11111111111 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. . ......+.++.+++.+||+.+|.+||++.++++.
T Consensus 238 ~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 S-----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 0111234678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=301.10 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=197.1
Q ss_pred hcCCCC-CCcccccCeEEEEEEEec-CCCEEEEEEccccchHh--------------HHHHHHHHHHHhhcCCcceeeee
Q 044232 71 TENFSP-ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQG--------------VREFLTEINVIKDIKHENLVELY 134 (415)
Q Consensus 71 ~~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 134 (415)
.++|.. .+.||.|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 355654 467999999999999976 68999999986542211 12467899999999999999999
Q ss_pred eEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
+++..++..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999996 68999887544 688999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCC-------------cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCC
Q 044232 215 KISDFGLAKLFPANL-------------THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRL 280 (415)
Q Consensus 215 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~ 280 (415)
+|+|||++....... ........+++.|+|||.+.+. .++.++|||||||++|+|++|+.|+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997654110 1111223467889999998764 47899999999999999999998887654
Q ss_pred ChhhhhHHHHHHHHHhhCcchhh-----------cccccCC---CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 281 PYEEQYLLEMAWKLYERGKLVEL-----------VDASLNG---DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 281 p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.+. ...+............ ....... ......+.++.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3221 1111111111100000 0000000 001123567889999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.30 Aligned_cols=252 Identities=29% Similarity=0.376 Sum_probs=204.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.+-+|+-..+||.|.||.||-|... +|...|+|.+.... ........+|+.+|..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3556777889999999999999854 79999999876543 33445677899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
||||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|....
T Consensus 1313 MEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999997654 466677778889999999999999 99999999999999999999999999998775
Q ss_pred CCCcc---eecccccCCCCCChhhhhcC---CCCccceEeehhHhHHHHHhCCcCCCCC-CChhhhhHHHHHHHHHhhCc
Q 044232 227 ANLTH---ISTRVAGTEGYLAPEYAIRG---QLTRKADIYSFGVLLLEIVSGRCNTNRR-LPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 227 ~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~p~~~~-~p~~~~~~~~~~~~~~~~~~ 299 (415)
..... ......||+.|||||++.+. ....++||||||||++||+||+.||..- ..|.- +. .+..|
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------My-~V~~g- 1457 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------MY-HVAAG- 1457 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH------Hh-HHhcc-
Confidence 54311 12346799999999999764 3578999999999999999999887541 11111 11 11122
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
-.+..|...+.+=.+++.+||+.||++|-++.|+++.
T Consensus 1458 --------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 --------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2234455566777899999999999999888888764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.70 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=196.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC---------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG--------- 140 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 140 (415)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999976 6899999998776555567788999999999999999999876543
Q ss_pred -----CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCe
Q 044232 141 -----DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTP 214 (415)
Q Consensus 141 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 214 (415)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999996 5898887543 588999999999999999999999 9999999999999974 5578
Q ss_pred EEeeeccccccCCCCcc--eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 215 KISDFGLAKLFPANLTH--ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
+|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999765332111 1122357889999998754 56889999999999999999999998765443221111000
Q ss_pred --------HHHHhhCcchhhcc-cccCCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 --------WKLYERGKLVELVD-ASLNGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 --------~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... ....... ....... ....+.++.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000000 0000000 1123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.39 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=199.7
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------eeEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD------HRIL 145 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 145 (415)
|...+.||+|+||.||+|+.+ +|+.||||.++... ....+...+|+++|++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 89999999998753 233456788999999999999999999866543 5689
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee--cCCC--CeEEeeecc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL--DKDL--TPKISDFGL 221 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfGl 221 (415)
|||||.||||...|.+.. +...+++...+.++.+++.||.|||++ +|+||||||.||++ ..+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999997653 345799999999999999999999999 99999999999998 3334 479999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhh-hHHHHHHHHHhhCc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ-YLLEMAWKLYERGK 299 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~-~~~~~~~~~~~~~~ 299 (415)
|+.++.+. ....+.||+.|++||+..+ +.|+.-+|.|||||++|+++||..||.. +.+. ...+.+|....+..
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p---~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP---FGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc---CCCccccchhhhhhhccCC
Confidence 99887654 5667889999999999985 8899999999999999999999999864 2222 23445555444432
Q ss_pred chhhc--ccccC------------CCCCHHHHHHHHHHHHHcCCcCCCCCC--CHHHHHHHh
Q 044232 300 LVELV--DASLN------------GDYSVEEAHRYLKIALLCTQDMPKRRP--SMSTLVNML 345 (415)
Q Consensus 300 ~~~~~--~~~~~------------~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~L 345 (415)
-...+ .+..+ ..........+-..+..+|..+|.+|- .+.+....+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 21111 11111 111222334455566677778888887 444444433
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=296.78 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=195.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|++.+.||+|+||.||+|..+ +++.+|+|.+...... ....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 6889999988654221 2245678999999999999999999875433
Q ss_pred --eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 142 --HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 142 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
..++|+||+.+ +|...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 6777765432 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcc----------eecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH
Q 044232 220 GLAKLFPANLTH----------ISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288 (415)
Q Consensus 220 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~ 288 (415)
|++......... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....+.....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~-- 237 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH-- 237 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 999865332111 11234578889999987654 58899999999999999999998887654432211
Q ss_pred HHHHHHHhhC---------cchhhcccccCCCCC-------HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 289 EMAWKLYERG---------KLVELVDASLNGDYS-------VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 289 ~~~~~~~~~~---------~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...... .+....+.......+ ......+.+++.+||+.+|.+|||+.+++.
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 -LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111000 000000000000000 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.51 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=213.5
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec----C----CCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeee
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK----D----GTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYG 135 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 135 (415)
.+++..++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ .||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46666777778889999999999999743 1 3468999998653 34557899999999999 6999999999
Q ss_pred EEEeCCeeEEEEeeccCCCHHHHhhcCC---CC-------C--CccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 044232 136 CCVEGDHRILVYGYLENNSLAQTLLGRG---HS-------S--IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKA 203 (415)
Q Consensus 136 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 203 (415)
+|......++|+||+..|+|.+++.... .. . ..+.....+.++.|||.||+||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 10 1 1388899999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEeeeccccccCCCCcceeccccc--CCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 204 SNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG--TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 204 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
+|||++.+..+||+|||+++..............| ...|||||.+....|+.++|||||||+||||+|... .|
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~-----~P 521 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG-----TP 521 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC-----CC
Confidence 99999999999999999999654433332222222 346999999999999999999999999999998643 34
Q ss_pred hhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
|.+......+.+....| .+...|..+..++.++|..||+.+|++||++.++.+.+...
T Consensus 522 Yp~~~~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCcHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 44322111123333333 33344566678899999999999999999999999999874
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=302.98 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=197.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC---
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEG--- 140 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 140 (415)
+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 4446789999999999999999999865 78999999987542 22345678899999999999999999988643
Q ss_pred ---CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 141 ---DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 141 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3467888877 78998887643 588999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH------
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM------ 290 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~------ 290 (415)
|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....+.........
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998754322 234567889999998876 5688999999999999999999998865433221110000
Q ss_pred --HHHHHhhCcc---hhhcccccCC---CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 --AWKLYERGKL---VELVDASLNG---DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 --~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... ...+...... ......+.++.+++.+|++.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000 0000000000 000112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=297.96 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=198.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE-GDHRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 144 (415)
..+++|++.+.||.|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35788999999999999999999876 7899999987543 22234567789999999999999999999875 56789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|+||+ +++|.+++... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 66898887643 578888899999999999999999 999999999999999999999999999875
Q ss_pred cCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--------HHHHH
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--------AWKLY 295 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--------~~~~~ 295 (415)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....+......... .....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 123457889999998765 5689999999999999999999988865433111100000 00000
Q ss_pred hhCcchhhccc-ccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 296 ERGKLVELVDA-SLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 296 ~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+.....+.. ......+ ...+..+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000111100 0011111 1234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=297.76 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=197.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----- 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 141 (415)
..++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999865 7899999998643 2233456889999999999999999999987553
Q ss_pred -eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 142 -HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 142 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
..++||||+ +++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 77998888643 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH--------HH
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE--------MA 291 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~--------~~ 291 (415)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||............. ..
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99865332 223457889999999876 468899999999999999999999987543221100000 00
Q ss_pred HHHHhhCcchhhccc--ccC----CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 WKLYERGKLVELVDA--SLN----GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............... ... .......+..+.+++.+|++.+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 000 0011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=301.62 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=193.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999975 68999999986532 223356788999999999999999999987543
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999996 47776652 1578899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH-----
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY----- 295 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~----- 295 (415)
++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.... .......
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGP 236 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCH
Confidence 8754322 223457889999999876 46899999999999999999999998764332211 1111100
Q ss_pred ------hhCcchhhcc---cccCCCC---CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ------ERGKLVELVD---ASLNGDY---SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ------~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... ....... ....+..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000 0000000 0123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.44 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=199.4
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
|+..+.||+|++|.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 59999999987653 233456788999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999997653 2688999999999999999999999 999999999999999999999999999986643321
Q ss_pred ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH--------HHHHHHhh----
Q 044232 231 HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE--------MAWKLYER---- 297 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~--------~~~~~~~~---- 297 (415)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+............. ..|.....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234467789999998776 88999999999999999999988886543222111000 00000000
Q ss_pred -CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 -GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............ ......+..+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 001112567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=298.35 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=193.0
Q ss_pred CCCCCCcccccCeEEEEEEEec-C--CCEEEEEEcccc--chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC----Ce
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-D--GTLAAIKVLSAD--SRQGVREFLTEINVIKDI-KHENLVELYGCCVEG----DH 142 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 142 (415)
+|++.+.||+|+||.||++... . +..||+|.+... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999976 4 788999998653 222345678899999999 599999999975432 45
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.+++++|+. ++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 68998886544 688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc---eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH---------H
Q 044232 223 KLFPANLTH---ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL---------E 289 (415)
Q Consensus 223 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~---------~ 289 (415)
..+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ +
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1233568999999998765 46899999999999999999999888754322110000 0
Q ss_pred HHHHHHhhCcchhh---cccccCCC---CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 290 MAWKLYERGKLVEL---VDASLNGD---YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 290 ~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..... ........ ........ ........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRI-GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhh-hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 00000000 00000000 00112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=291.69 Aligned_cols=267 Identities=27% Similarity=0.372 Sum_probs=202.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhh--cCCcceeeeeeEEEeC----Ce
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD--IKHENLVELYGCCVEG----DH 142 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~ 142 (415)
....+..+.+.||+|.||.||+|.|+ |..||||++...+. +.+.+|.+|++. |+|+||+.+++.-..+ ..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 35677888999999999999999997 66799999976544 456678888875 4999999999875433 36
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE-----VQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
++||++|.+.|||+|+|... .++....++++..+|.||++||.. .+|.|.|||||+.||||.+++...|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 89999999999999999875 688899999999999999999964 47889999999999999999999999
Q ss_pred eeccccccCCCCc---ceecccccCCCCCChhhhhcCC------CCccceEeehhHhHHHHHhCC----------cCCCC
Q 044232 218 DFGLAKLFPANLT---HISTRVAGTEGYLAPEYAIRGQ------LTRKADIYSFGVLLLEIVSGR----------CNTNR 278 (415)
Q Consensus 218 DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltg~----------~p~~~ 278 (415)
|+|||........ ......+||-+|||||++...- --..+||||||.|+||+.... .||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999987654422 2234578999999999986531 224689999999999997532 23333
Q ss_pred CCChhhhhHHHHHHHHHhhCcchhhcccccCC-CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNG-DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
-.|.... .+.+.+.+= .+.+.+.+.. -.+.+....+.+||..||..||.-|-|+--|-+.|.+...
T Consensus 439 ~Vp~DPs--~eeMrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPS--FEEMRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCC--HHHHhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2221111 011111100 1111111111 1234667889999999999999999999999998877653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.38 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=198.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe----
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH---- 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 142 (415)
..++|++.+.||+|++|.||+|+.. ++..||+|++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999986 6889999998653 23334567789999999999999999998876554
Q ss_pred --eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 143 --RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 143 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
.++|+||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67999988652 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh---
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE--- 296 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~--- 296 (415)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..... .......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~---~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK---RIMNLVGTPD 236 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCCC
Confidence 99865432 233467889999998865 367899999999999999999999886544322111 0000000
Q ss_pred --------hCcchhhcc---cccCCCC---CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 --------RGKLVELVD---ASLNGDY---SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 --------~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+. ......+ ....+..+.+++.+||+.+|.+|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 0000000 0112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.35 Aligned_cols=236 Identities=29% Similarity=0.372 Sum_probs=194.5
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
||.|+||.||++... +++.+|+|++..... .....+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 588999999876532 2446788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 235 (415)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997664 588999999999999999999998 99999999999999999999999999998654321 12334
Q ss_pred cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 236 VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+..... ......... + ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~----------~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-D----------PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-C----------CCCCCCC
Confidence 5678899999999888899999999999999999999988865432 111111111 1 1122233
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMST 340 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~e 340 (415)
.+..+.+++.+||..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3577899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.29 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=199.3
Q ss_pred HhcCCCCC-CcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe----CCe
Q 044232 70 ATENFSPA-NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVE----GDH 142 (415)
Q Consensus 70 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 142 (415)
.+++|++- ++||-|-.|+|-.+..+ +++.+|+|++... ....+|+++.-.. .|||||.+++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 36677665 58999999999999876 7999999999654 3345688776555 79999999999864 346
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeee
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDF 219 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 219 (415)
+.+|||.|+||.|...+++++.. .+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+. |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 78999999999999999988743 799999999999999999999999 9999999999999964 457999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
|+|+..... ....+.+-||.|.|||++...+|+...|+||+||++|-|++|.+||....... ...-....+..|.
T Consensus 209 GFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq 283 (400)
T KOG0604|consen 209 GFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ 283 (400)
T ss_pred ccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC
Confidence 999865432 23345678999999999999999999999999999999999999997543211 0111111111111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ....+-....++...++|..+|..+|.+|.|+.++++
T Consensus 284 y------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 Y------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 1111122345677889999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.00 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=204.3
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEe-cCCCEEEEEEccccc-------hHhHHHHHHHHHHHhhcCCcceeeeee
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLSADS-------RQGVREFLTEINVIKDIKHENLVELYG 135 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~ 135 (415)
+.+.....++|-.+..||+|||+.||+|.+ ...++||+|+-.... ..-.+...+|..|.+.|.||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 344455667888899999999999999975 468899999864331 112345678999999999999999999
Q ss_pred EEE-eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---C
Q 044232 136 CCV-EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---D 211 (415)
Q Consensus 136 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~ 211 (415)
++. +.+.+|-|+|||+|.+|+-+|.... .+++..++.|+.||+.||.||.+. +++|||-||||.|||+-+ -
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 996 5567889999999999999998876 689999999999999999999987 679999999999999943 4
Q ss_pred CCeEEeeeccccccCCCCc------ceecccccCCCCCChhhhhcC----CCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 212 LTPKISDFGLAKLFPANLT------HISTRVAGTEGYLAPEYAIRG----QLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
|.+||+|||+++++..+.. .......||.+|++||.+.-+ ..+.|+||||.|||+|+++.|+.||+....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 7899999999998865432 234567899999999987633 578999999999999999999999986544
Q ss_pred hhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHH
Q 044232 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342 (415)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 342 (415)
-.+. +....+...-.-... .-+....+...+|.+||++.-++|....++.
T Consensus 690 QQdI---------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 QQDI---------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHH---------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 3321 222222111110110 0112335677899999999999998777765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.10 Aligned_cols=208 Identities=29% Similarity=0.425 Sum_probs=181.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEe-cCCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..-|..++.||-|+||+|.+++. ++...+|+|.+++.+ +........|-.||...+.+.||+||-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34577889999999999999974 468889999998763 34456678899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|+|++||++..+|.+.+ -+.+..++-++..+..|+++.|.. |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999887 688999999999999999999999 99999999999999999999999999996442
Q ss_pred CCCc--------ce---------------------------------ecccccCCCCCChhhhhcCCCCccceEeehhHh
Q 044232 227 ANLT--------HI---------------------------------STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVL 265 (415)
Q Consensus 227 ~~~~--------~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvv 265 (415)
.... +. ....+||+.|+|||++....++..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1100 00 002469999999999999999999999999999
Q ss_pred HHHHHhCCcCCCCCCChhhh
Q 044232 266 LLEIVSGRCNTNRRLPYEEQ 285 (415)
Q Consensus 266 l~elltg~~p~~~~~p~~~~ 285 (415)
||||+.|+.||....|.+.+
T Consensus 861 l~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHHHhhCCCCccCCCCCcce
Confidence 99999999999998887754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.79 Aligned_cols=145 Identities=31% Similarity=0.461 Sum_probs=131.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999987 78999999987542 333467888999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
||+.+++|.+++...+ .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 578889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.07 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=208.8
Q ss_pred CCCCCcccccCeEEEEEEEec-C----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-D----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+.+++||+|+||+||+|.+- . +-+||+|++... ..+...++++|+-+|.+++|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445688999999999999863 2 457899998765 3445578999999999999999999999998766 88999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
+|++.|+|.++++.+.. .+..+..+.|+.|||+||.|||++ ++|||||..+||||..-..+||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987643 678899999999999999999999 999999999999999999999999999998876
Q ss_pred CCcceecc-cccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTR-VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
+....... ..-.+.|||-|.+....++.++|||||||++|||+|= +..|+.+....+ +.+++..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTF-----Ga~Py~gi~~~e----------I~dlle~ 915 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTF-----GAKPYDGIPAEE----------IPDLLEK 915 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhc-----CCCccCCCCHHH----------hhHHHhc
Confidence 65443332 2234579999999999999999999999999999982 233444433222 2223333
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+...+..++.++..++.+||..|+..||+++++...+.+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 3344567788899999999999999999999999999887654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=279.13 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=199.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec---C--CCEEEEEEccccchH--hHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK---D--GTLAAIKVLSADSRQ--GVREFLTEINVIKDIKHENLVELYGCCVE-GDHR 143 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 143 (415)
..|+.+++||+|.||.||+|..+ + .+.+|+|.++..... .-....+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56889999999999999999643 2 236899998765221 12356789999999999999999999887 7789
Q ss_pred EEEEeeccCCCHHHHhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----CCeEEee
Q 044232 144 ILVYGYLENNSLAQTLLGRG-HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD----LTPKISD 218 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 218 (415)
+|++||.+. +|+..|+-.. .....++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 7888886432 2234788999999999999999999999 89999999999999888 8999999
Q ss_pred eccccccCCCCcc--eecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCC-------CChhhhhHH
Q 044232 219 FGLAKLFPANLTH--ISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRR-------LPYEEQYLL 288 (415)
Q Consensus 219 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~-------~p~~~~~~~ 288 (415)
||+++.+...... ....++-|.+|+|||.+.+. .||.+.|||+.|||+.||+|-.+-|.+. .||....+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988654332 23457789999999999875 7999999999999999999988777643 244433222
Q ss_pred HHHHHHHhhCcchhhcccccCCC------------CCHH-----------HHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 289 EMAWKLYERGKLVELVDASLNGD------------YSVE-----------EAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~-----------~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
... +++.-.......+-..-++ +... -++.-.+|+.++|+.||.+|-|+++.++.
T Consensus 260 rIf-~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIF-EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHH-HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 221 1111100000000000000 0000 01236789999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.32 Aligned_cols=244 Identities=28% Similarity=0.378 Sum_probs=202.1
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDH 142 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 142 (415)
++-..+|..+..||+|+||+|.+|..+ +...+|||+++++. .+..+--+.|-.+|... +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 555678999999999999999999877 57889999998762 12223344577777666 46799999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+|+||||+.||+|.-.+++-+ .+.+..+.-++..||-||-+||++ ||++||||.+|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999999998887 678888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+.--.. .....+.+|||.|+|||++...+|+.++|+|||||+||||+.|+.||++....+ ....+.+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~e------ 564 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIME------ 564 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHH------
Confidence 843222 233456899999999999999999999999999999999999999988753322 1222211
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
-+..|+...+.+...+....+..+|.+|.
T Consensus 565 -----hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 -----HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 12356666777888899999999999995
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.76 Aligned_cols=269 Identities=23% Similarity=0.325 Sum_probs=206.9
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC--Ccc----eeeeee
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK--HEN----LVELYG 135 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~ 135 (415)
-|+.....+++|.++..+|+|.||.|-++... .+..||+|+++.-..- .+..+-|+++|+++. -|+ +|++.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34444556899999999999999999999765 5789999999765332 244566999999993 232 888999
Q ss_pred EEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec------
Q 044232 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD------ 209 (415)
Q Consensus 136 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~------ 209 (415)
+|.-.++.|||+|.+ |-|+.++|..+.. .+++...++.|+.|+++++++||+. +++|.||||+|||+.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 999999999999988 7799999987654 3789999999999999999999999 999999999999993
Q ss_pred --------------CCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcC
Q 044232 210 --------------KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN 275 (415)
Q Consensus 210 --------------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p 275 (415)
.+..++|+|||.|...... ...++.|..|.|||++.+-.++.++||||+||||+||.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1345899999999854332 2567789999999999999999999999999999999999988
Q ss_pred CCCCCChhhhhHHHHHH--------------HHHhhCcchhhcccccCC----------------CCCHHHHHHHHHHHH
Q 044232 276 TNRRLPYEEQYLLEMAW--------------KLYERGKLVELVDASLNG----------------DYSVEEAHRYLKIAL 325 (415)
Q Consensus 276 ~~~~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~ 325 (415)
|..-..-+.....+.+. +.+..+++. ..+..... .....+..+|.+|+.
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rld-w~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLD-WPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccccc-CccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 87654434332222221 111122110 00000000 112234567999999
Q ss_pred HcCCcCCCCCCCHHHHHH
Q 044232 326 LCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 326 ~cl~~~P~~RPs~~evl~ 343 (415)
.||..||.+|+|+.|++.
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.14 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=214.7
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe---
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVE--- 139 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 139 (415)
..+...++.|++.+.||.|.+|.||+++.. +++.+|+|+...+.... ++...|.++|+.+ .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334445778999999999999999999865 89999999998775443 5667799999887 79999999999863
Q ss_pred --CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 140 --GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 140 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
++.++||||||.+||..++++... ...+.|..+..|++.++.||.+||.+ .++|||||-.|||++.++.|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 568999999999999999998765 44899999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhhcC-----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
|||++..+... .....+..|||.|||||++... .|+..+|+||||++..||.-|.+|+....|...
T Consensus 166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 99999877543 3345567899999999998753 477899999999999999999888776555432
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
++.. .-++.....-+.....++.++|..||..|..+||++.++++
T Consensus 237 -LF~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 -LFLI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hccC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111 01222233446778899999999999999999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=276.85 Aligned_cols=219 Identities=21% Similarity=0.137 Sum_probs=177.1
Q ss_pred cCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhc
Q 044232 83 GGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161 (415)
Q Consensus 83 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 161 (415)
|.+|.||++... +++.+|+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999976 78999999997653 233455555566799999999999999999999999999999999876
Q ss_pred CCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCC
Q 044232 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241 (415)
Q Consensus 162 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 241 (415)
.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 FL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 54 588999999999999999999998 9999999999999999999999999988654332 223445778
Q ss_pred CCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHH
Q 044232 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYL 321 (415)
Q Consensus 242 y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (415)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... . .......+...+..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N---------THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c---------cccccCCcccCCHHHH
Confidence 999999988889999999999999999999987654321100 0 0000112223346788
Q ss_pred HHHHHcCCcCCCCCCCH
Q 044232 322 KIALLCTQDMPKRRPSM 338 (415)
Q Consensus 322 ~li~~cl~~~P~~RPs~ 338 (415)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=297.30 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=196.8
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++.|.+...+|.|+|+.|-.+... +++..++|++.....+ -.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3678889999999999999998866 6888999999776222 23467666555 7999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-cCCCCeEEeeeccccccC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL-DKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~ 226 (415)
|.+.|+-|.+.+.... .....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888876553 22377888999999999999999 99999999999999 688999999999998765
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ..+.+-|..|.|||++....|++++|+||||++||+|++|+.|+...... .+ +.. .
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~e-i~~------------~ 525 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IE-IHT------------R 525 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HH-HHH------------h
Confidence 54 23345688899999999999999999999999999999999998764322 11 111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+.+....+....+|+.+||+.+|.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122333556678899999999999999999999976
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=274.34 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=197.7
Q ss_pred CcccccCeEEEEEEE-ecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 78 NKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
+.||+|+|+.|--+. ..+|..+|||++.+...-...+..+|++++.+. .|+||++++++|++++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999887 568999999999887555667888999999888 699999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEEeeeccccccCCC----
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKISDFGLAKLFPAN---- 228 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~---- 228 (415)
..+|+.+. -+++.++.++..+|+.||.+||.+ ||.||||||+|||..+.. -+||+||.+..-....
T Consensus 164 LshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99999887 689999999999999999999999 999999999999997655 4899999887643211
Q ss_pred --CcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCC----hhhhhHH----HHHHH
Q 044232 229 --LTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP----YEEQYLL----EMAWK 293 (415)
Q Consensus 229 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p----~~~~~~~----~~~~~ 293 (415)
.+....+.+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+.-. |.....- .....
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 112223457888999999864 23689999999999999999999999976443 1111100 01111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
-+.+|... ....-....+.+..+++...+..++.+|-++.++++
T Consensus 317 sIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11112110 001112234567788999999999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.68 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=196.9
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
.+.||+|.||+||-|+.+ +|+.||||++.+- ..++...+.+|++||+++.||.||.+.-.|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 478999999999999865 8999999998764 22333678899999999999999999999999999999999995 5
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEeeeccccccCCCCc
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~ 230 (415)
++.+.|...... .+++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||.|+.....
T Consensus 648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 555555443322 788888889999999999999999 99999999999999654 37999999999988654
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.....+.|||.|+|||++.++.|+..-|+||.|||+|--++|..||+.+....+ .++ +-.. ...+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----QIQ----NAaF------MyPp 785 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----QIQ----NAAF------MYPP 785 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----Hhh----cccc------ccCC
Confidence 334567899999999999999999999999999999999999999886432221 111 1100 1122
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+......+||...|+..-.+|.+..+-+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 334556677888999999999999998877654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=273.02 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=203.1
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+...+|.+++.||+|+|.+|.+++++ +.+.+|+|++++. ..+.+.-.+.|-.+..+. +||.+|.++.+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34578999999999999999999976 7889999999765 333445566788887766 799999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++|.||++||+|.-+++++. ++++..++-+...|+.||.|||+. ||++||||.+|+|+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999998888776 799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCC-CChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRR-LPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~-~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
.--.. .....+.+|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+.- ....+++..++..+++.+..+
T Consensus 400 e~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 400 EGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred cCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence 53222 34456789999999999999999999999999999999999999998741 222233334444443332211
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
..+...+-....++...|+.||.+|.
T Consensus 477 --------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11222223445678889999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=291.15 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=209.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCC-EEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGT-LAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..+++.+..||-||||.|=++..++.. .+|+|++++. +..+.+....|-++|...+.|.||++|..|.+....||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456677888999999999999876433 4888888765 344556788899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
||-|-||.|+..|.+++ .++..+.+-++.++++|++|||++ +||+|||||+|+|++.+|-+||.|||.|+.+.
T Consensus 499 mEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999888 788889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ...-+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+..|...-+++ -+|- |
T Consensus 572 ~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------LkGi-----d- 636 (732)
T KOG0614|consen 572 SG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------LKGI-----D- 636 (732)
T ss_pred cC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------Hhhh-----h-
Confidence 54 3455789999999999999999999999999999999999999999987775543221 1110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
.-.+|........+|+.+....+|.+|.- +.+|-+
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 01334455567788999999999999975 556654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=271.55 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=196.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++.+.+..||.|+||+|+|-.++ .|+..|||.++.... ...++++.|.+...+- +.||||++||.+..+..++|-|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 345556788999999999998876 799999999987643 4557888888876555 7899999999999999999999
Q ss_pred eeccCCCHHHHhhcC-CCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 148 GYLENNSLAQTLLGR-GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 148 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|.| .-||+.+...- ......+++..+-.|....+.||.||-+.. .|||||+||+|||++..|.+||+|||++-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 45676544321 111226888999999999999999998764 89999999999999999999999999998664
Q ss_pred CCCcceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .+.-.|-..|||||.+.. ..|+-++||||||++|||+.||+.|...- .. ..+.+.. ...|....+.
T Consensus 220 ~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w---~s--vfeql~~-Vv~gdpp~l~ 291 (361)
T KOG1006|consen 220 DSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW---DS--VFEQLCQ-VVIGDPPILL 291 (361)
T ss_pred HHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH---HH--HHHHHHH-HHcCCCCeec
Confidence 4322 234467888999998864 34889999999999999999998775431 11 1222222 2233333222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
...-. ......+..++..|+..|.++||.+.++.++
T Consensus 292 ~~~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Ccccc----cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22111 2234678899999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.00 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=196.0
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+|.-.++||+|.||+||+|+.+ +++.||+|.++.++. .--...++|+-+|+.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556688999999999999966 689999999887632 2235678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|+ .+|..+.....+ .++.+.++.++.|+++||.++|++ ++.||||||.|.||+.+|.+||+|||+++.+.-..
T Consensus 83 cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 94 478888765443 688899999999999999999999 99999999999999999999999999999876543
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH--HhhC---cchhh
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL--YERG---KLVEL 303 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~--~~~~---~~~~~ 303 (415)
... ....-|.+|.+|.++.+. -|+...|+||-||++.|+.....|........+ .+....+.+ ..+. .+..+
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccC
Confidence 332 334468999999999875 588999999999999999987666433222111 122222211 0011 11222
Q ss_pred cccccCCCCCHHH-----HH----HHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEE-----AH----RYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~-----~~----~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.|-...+.++... .+ .=.+++...+.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222233333211 11 1245777777788999999887765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.10 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=171.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-C----CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeE------EE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-D----GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGC------CV 138 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 138 (415)
..++|++.+.||+|+||.||+|.+. + +..||+|.+...... +.+.+| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999976 5 789999987653221 111111 1122222222222211 24
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCC----------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHS----------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK 202 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 202 (415)
.+...++|+||+++++|.+++...... ........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566899999999999999998754310 00112344668999999999999999 99999999
Q ss_pred CCCeeecC-CCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC----------------------CCCccceE
Q 044232 203 ASNILLDK-DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG----------------------QLTRKADI 259 (415)
Q Consensus 203 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 259 (415)
|+|||++. ++.+||+|||+++.+............+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986654444444567789999999966432 23456799
Q ss_pred eehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc-h---hhcccccCCC----C--CHHHHHHHHHHHHHcCC
Q 044232 260 YSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL-V---ELVDASLNGD----Y--SVEEAHRYLKIALLCTQ 329 (415)
Q Consensus 260 wSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~----~--~~~~~~~l~~li~~cl~ 329 (415)
|||||+||||+++..+.... .......+...+.. . ..+......+ + .........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999876543221 01110001010100 0 0001100000 0 00012234589999999
Q ss_pred cCCCCCCCHHHHHH
Q 044232 330 DMPKRRPSMSTLVN 343 (415)
Q Consensus 330 ~~P~~RPs~~evl~ 343 (415)
.||.+|||++++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.02 Aligned_cols=238 Identities=29% Similarity=0.417 Sum_probs=194.0
Q ss_pred CeEEEEEEEec-CCCEEEEEEccccchHh-HHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhc
Q 044232 84 GFGSVYKGTLK-DGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161 (415)
Q Consensus 84 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 161 (415)
+||.||+|... +++.+|+|++....... .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 58999999998765443 57889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCC
Q 044232 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241 (415)
Q Consensus 162 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 241 (415)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 54 378899999999999999999999 99999999999999999999999999998765432 2334567889
Q ss_pred CCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHH
Q 044232 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYL 321 (415)
Q Consensus 242 y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (415)
|++||.+.+..++.++||||||+++++|++|..|+....... ........+.... .......+.++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHHH
Confidence 999999988889999999999999999999988876521111 1111111111100 000000446789
Q ss_pred HHHHHcCCcCCCCCCCHHHHHH
Q 044232 322 KIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 322 ~li~~cl~~~P~~RPs~~evl~ 343 (415)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=267.11 Aligned_cols=266 Identities=26% Similarity=0.382 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--------C
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVE--------G 140 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 140 (415)
..|+-..+||+|.||.||+|+.+ +|+.||+|++-.+. ...-...++|+.+|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44666788999999999999976 57888988765432 1222456789999999999999999998853 2
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
..+|+||++|+. +|..+|.+.. ..++..++.+++.++..||.|+|+. .|+|||+||.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 348999999966 7888886553 3789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc---ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH--
Q 044232 221 LAKLFPANLT---HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL-- 294 (415)
Q Consensus 221 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~-- 294 (415)
+++.+..... ...+..+-|.+|++||.+.+ ..|+.+.|||+-|||+.||.+|.+-+.+........++......
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9987754322 22344556999999998886 47999999999999999999998777665443333333222111
Q ss_pred ------HhhCcchhhcccc-c-CCCCC--HH------HHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 295 ------YERGKLVELVDAS-L-NGDYS--VE------EAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 295 ------~~~~~~~~~~~~~-~-~~~~~--~~------~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.++-++.+.+... + .+.+. .+ ..++.++|+..++..||.+|+.+.++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111111000 0 00000 00 12356789999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=268.05 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=211.2
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCC 137 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 137 (415)
+++.+...+++....+-+|.||.||.|.|.+ .+.|.+|.++.. +..+...++.|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4556677888989999999999999996642 345677877765 344667899999999999999999999998
Q ss_pred Ee-CCeeEEEEeeccCCCHHHHhhcCC----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 044232 138 VE-GDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212 (415)
Q Consensus 138 ~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 212 (415)
.+ ....++++.++.-|+|..++.... .....+...+...++.|++.|++|||+. ++||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 75 456788899999999999998322 2234567778889999999999999999 999999999999999999
Q ss_pred CeEEeeecccccc-CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 213 TPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 213 ~~kl~DfGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
++||+|=.+++.+ +.+.............||+||.+.+..|+.++|||||||+||||+|-. ..|+.+....++.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg-----~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG-----KLPYAEIDPFEME 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC-----CCCccccCHHHHH
Confidence 9999999999855 433333333444567899999999999999999999999999999832 3444443333332
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.-+.+ ..+...|.+||+++..++.-||...|++||+++|++..|..
T Consensus 509 ~ylkd----------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 HYLKD----------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHhc----------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22222 23334467889999999999999999999999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=283.91 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=182.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEe-----------------cCCCEEEEEEccccchHhHHHHH--------------HH
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTL-----------------KDGTLAAIKVLSADSRQGVREFL--------------TE 118 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~E 118 (415)
..++|++.++||+|+||.||+|.. ..++.||||.+........++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23567999998765433333333 46
Q ss_pred HHHHhhcCCcce-----eeeeeEEEe--------CCeeEEEEeeccCCCHHHHhhcCCC--------------------C
Q 044232 119 INVIKDIKHENL-----VELYGCCVE--------GDHRILVYGYLENNSLAQTLLGRGH--------------------S 165 (415)
Q Consensus 119 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 165 (415)
+.++.+++|.++ ++++++|.. ....++||||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766554 677777653 3468999999999999999875321 0
Q ss_pred CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCCh
Q 044232 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245 (415)
Q Consensus 166 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 245 (415)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999 999999999999999999999999999976543322222223358899999
Q ss_pred hhhhcCC--------------------C--CccceEeehhHhHHHHHhCCc-CCCCCCChhhhhH----HHHHHHHHhhC
Q 044232 246 EYAIRGQ--------------------L--TRKADIYSFGVLLLEIVSGRC-NTNRRLPYEEQYL----LEMAWKLYERG 298 (415)
Q Consensus 246 E~~~~~~--------------------~--~~~~DvwSlGvvl~elltg~~-p~~~~~p~~~~~~----~~~~~~~~~~~ 298 (415)
|.+.... + ..+.||||+||++++|++|.. |+.....+..... ....|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 234799999999999999875 4432211211100 00111111111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCC---CCCCCHHHHHH
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMP---KRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~ 343 (415)
. ..-...........+|+.+++..+| .+|+|++|+++
T Consensus 460 ~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 K--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 1111112334667889999998765 68999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=259.76 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-----eeE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD-----HRI 144 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 144 (415)
+.+..+.||.|+||.||.+.+. +|+.||+|++..- .-..-+.+.+|+++|.-++|.|++..++...-.. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455688999999999999875 8999999988654 2233467889999999999999999999876433 467
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+++|.| ..+|.+.+..-. .++...+.-+++||++||.|||+. +|.||||||.|+|++.|..+||+|||+++.
T Consensus 134 V~TELm-QSDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-HhhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 788888 457777775544 788888999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--------HHH
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW--------KLY 295 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~--------~~~ 295 (415)
...+.....+...-|-.|+|||++.+. .|+.+.||||.|||+.||+..+..|....|.+...++.... +..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 766655556666678899999999875 79999999999999999999998888887766544432211 000
Q ss_pred hhCcchhhcccccC-C--------CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 296 ERGKLVELVDASLN-G--------DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 296 ~~~~~~~~~~~~~~-~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
-+|...-++..... + .-+.....+...+...++..+|++|.+..+.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01111111111111 0 11123345566788889999999999998887754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=243.71 Aligned_cols=215 Identities=25% Similarity=0.422 Sum_probs=176.3
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEG 140 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 140 (415)
...+++..++...+..||+|++|.|-+-++. +|+..|+|.+... ..+..++.++|+.+..+- ..|.+|.+||.....
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 3446777788888899999999999888865 8999999998765 344456778888877554 799999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++.||.| ..||+.+...--.....+++..+-+|+..++.||.|||++. .++|||+||+||||+.+|++|++|||
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 9999999999 55887766543333447899999999999999999999985 89999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc----CCCCccceEeehhHhHHHHHhCCcCCCC-CCChh
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR----GQLTRKADIYSFGVLLLEIVSGRCNTNR-RLPYE 283 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltg~~p~~~-~~p~~ 283 (415)
.+-.+.+.... +-..|--.|||||.+.. ..|+-++||||||+++.||.+++.|+.. ..||+
T Consensus 195 IsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~ 260 (282)
T KOG0984|consen 195 ISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ 260 (282)
T ss_pred cceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence 99876543221 11346677999998764 3688999999999999999999998764 34444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=261.40 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-----C---cceeeeeeEEEe---
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-----H---ENLVELYGCCVE--- 139 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 139 (415)
.+|.+.++||.|.|++||+|.+. +.+.||+|+.+... .-.+..+.||.+|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 78889999999999999999865 78899999986542 22356778999999883 3 359999999974
Q ss_pred -CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-------
Q 044232 140 -GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD------- 211 (415)
Q Consensus 140 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 211 (415)
+.+.|||+|++ |.+|..+|...... .++...+.+|+.||+.||.|||.+| +|||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 56899999999 77888888876544 6788999999999999999999998 99999999999999200
Q ss_pred --------------------------------------------------------------------------------
Q 044232 212 -------------------------------------------------------------------------------- 211 (415)
Q Consensus 212 -------------------------------------------------------------------------------- 211 (415)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 044232 212 -------------------------------------------------------------------------------L 212 (415)
Q Consensus 212 -------------------------------------------------------------------------------~ 212 (415)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred CeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC--hh--hhhHH
Q 044232 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP--YE--EQYLL 288 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p--~~--~~~~~ 288 (415)
++||+|||-|+.+.... +.-..|..|+|||++.+..|+..+||||++|+++||+||-..|+...- |. +..+.
T Consensus 392 ~vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 13556666555433221 223468889999999999999999999999999999999987764322 11 11111
Q ss_pred HH-------HHHHHhhCcc-hhhccccc-------------------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHH
Q 044232 289 EM-------AWKLYERGKL-VELVDASL-------------------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341 (415)
Q Consensus 289 ~~-------~~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 341 (415)
.+ .+.+...|+. .++++..- ...++.+...++.+++.-||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 11 1222222221 11221100 125567788999999999999999999999999
Q ss_pred HH
Q 044232 342 VN 343 (415)
Q Consensus 342 l~ 343 (415)
++
T Consensus 548 l~ 549 (590)
T KOG1290|consen 548 LK 549 (590)
T ss_pred hc
Confidence 86
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=281.52 Aligned_cols=245 Identities=27% Similarity=0.385 Sum_probs=185.2
Q ss_pred CCCCCcccccCeEE-EEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 74 FSPANKIGQGGFGS-VYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 74 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
|...+.+|.|..|+ ||+|... |+.||||.+-.... .-..+|++.|+.- .|||||++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34446789999985 5899885 67899998865433 3456799999887 7999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---C--CCeEEeeeccccccC
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---D--LTPKISDFGLAKLFP 226 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGla~~~~ 226 (415)
..+|.+++...............+.++.|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999987411111111144577889999999999998 9999999999999976 3 479999999999886
Q ss_pred CCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhC-CcCCCCCCChhhhhHHHHHHHHHhhC-cchh
Q 044232 227 ANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG-RCNTNRRLPYEEQYLLEMAWKLYERG-KLVE 302 (415)
Q Consensus 227 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg-~~p~~~~~p~~~~~~~~~~~~~~~~~-~~~~ 302 (415)
.+... ......||.+|+|||++....-+.++||||||||+|+.++| .+||+....-+. ++.... .+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee
Confidence 54332 23457799999999999999889999999999999999998 567664321110 011111 1110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+. ...++ +..+||.+|++.+|..||++.+|+.
T Consensus 735 -----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 11111 6789999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=242.09 Aligned_cols=280 Identities=17% Similarity=0.327 Sum_probs=207.6
Q ss_pred ccccccccccCCcccchhhHHH---HhcCCCCCCcccccCeEEEEEEEe-cCCCEEEEEEccccchHhHHHHHHHHHHHh
Q 044232 48 EVNEDVSEIQDTNLYGYKDLRV---ATENFSPANKIGQGGFGSVYKGTL-KDGTLAAIKVLSADSRQGVREFLTEINVIK 123 (415)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~ 123 (415)
.+..++.+..+...+.|+...+ ..++|++.+++|+|.++.|+.|.. .++..++||++++... +...+|+.+|.
T Consensus 11 Rvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~ 87 (338)
T KOG0668|consen 11 RVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQ 87 (338)
T ss_pred hhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHH
Confidence 4455566666666777766544 368899999999999999999984 5788899999987543 45678999999
Q ss_pred hcC-CcceeeeeeEEEeC--CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 044232 124 DIK-HENLVELYGCCVEG--DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200 (415)
Q Consensus 124 ~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 200 (415)
.|. ||||++++++..+. ....+|+||+++.+...+.. .++...++.++.+++.||.|+|+. ||.|||
T Consensus 88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRD 157 (338)
T KOG0668|consen 88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRD 157 (338)
T ss_pred hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---Cccccc
Confidence 996 99999999999864 46789999999988876654 566778899999999999999999 999999
Q ss_pred CCCCCeeecCCC-CeEEeeeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCC
Q 044232 201 IKASNILLDKDL-TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNR 278 (415)
Q Consensus 201 lkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~ 278 (415)
+||.|++||... .++|+|+|+|..+...... .-...+..|--||.+-. ..|+.+-|+|||||++..|+..+.||-.
T Consensus 158 VKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CCcceeeechhhceeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 999999999765 6999999999988665332 22335667889998875 5689999999999999999999999764
Q ss_pred CCChhhhhHHHHHH--------HHHhhCc------chhhccccc--------CCCCCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 279 RLPYEEQYLLEMAW--------KLYERGK------LVELVDASL--------NGDYSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 279 ~~p~~~~~~~~~~~--------~~~~~~~------~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
...-.++. ...+. ..+.+-. ...++.... ..+-..-..++..+++...|..|-.+||
T Consensus 236 G~dN~DQL-VkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl 314 (338)
T KOG0668|consen 236 GHDNYDQL-VKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL 314 (338)
T ss_pred CCCCHHHH-HHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc
Confidence 32222211 11111 1111110 001110100 0111111246788999999999999999
Q ss_pred CHHHHHH
Q 044232 337 SMSTLVN 343 (415)
Q Consensus 337 s~~evl~ 343 (415)
|++|.+.
T Consensus 315 TakEam~ 321 (338)
T KOG0668|consen 315 TAKEAMA 321 (338)
T ss_pred chHHHhc
Confidence 9999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=236.41 Aligned_cols=210 Identities=34% Similarity=0.602 Sum_probs=183.9
Q ss_pred ccccCeEEEEEEEec-CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHH
Q 044232 80 IGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQ 157 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 157 (415)
||+|++|.||++... +++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 4899999999876442 34678899999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeeccccccCCCCcceeccc
Q 044232 158 TLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPANLTHISTRV 236 (415)
Q Consensus 158 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 236 (415)
++.... ..+++..+..++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987652 2578899999999999999999999 9999999999999999 89999999999986644321 12334
Q ss_pred ccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHH
Q 044232 237 AGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE 315 (415)
Q Consensus 237 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (415)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578889999998877 889999999999999998
Q ss_pred HHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 316 EAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=271.59 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=209.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|+.+..+|+|.||.|||++++ .++.+|+|+++....+...-..+|+-+++..+|||||.++|.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 478999999999999999999976 7999999999888766667778899999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|.+|+|.+..+.-+ ++++.++..++...++||+|||++ +=+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-
Confidence 99999999887665 899999999999999999999999 8899999999999999999999999999866443
Q ss_pred cceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
-.......||+.|||||+.. .+.|...+|||++|+...|+-.-+.|.....|.....+. ...+ +++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm------TkS~-----~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM------TKSG-----FQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh------hccC-----CCC
Confidence 22345578999999999864 567999999999999999998877776555554332211 1111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ...-.......+-++++.|+..+|++||+++.++.
T Consensus 235 p-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 P-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C-cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 11122345677889999999999999999887754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=257.83 Aligned_cols=274 Identities=20% Similarity=0.269 Sum_probs=209.9
Q ss_pred ccchhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC------Ccceeee
Q 044232 61 LYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK------HENLVEL 133 (415)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 133 (415)
.|.+.-.++...+|.+....|+|-|++|..|... .|..||||++...... .+.=+.|+++|++|+ --|++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3556666778899999999999999999999976 5779999999876433 245567999999994 3579999
Q ss_pred eeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-C
Q 044232 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-L 212 (415)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 212 (415)
+-.|...+++|||||-+ ..+|.+.|...+. ...|....++.++.|+..||..|-.. +|+|.||||+||||++. .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999988 5689999988764 34688899999999999999999998 99999999999999866 4
Q ss_pred CeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH-
Q 044232 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA- 291 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~- 291 (415)
.+||||||.|.....+. .+.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+...-...-+....
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 68999999998654432 22333456799999999999999999999999999999999888765543321111111
Q ss_pred ----HHHHhhCcc-hhhcccccC----------------------------------CCCC---HHHHHHHHHHHHHcCC
Q 044232 292 ----WKLYERGKL-VELVDASLN----------------------------------GDYS---VEEAHRYLKIALLCTQ 329 (415)
Q Consensus 292 ----~~~~~~~~~-~~~~~~~~~----------------------------------~~~~---~~~~~~l~~li~~cl~ 329 (415)
.+++.+|.+ .+-+|..++ ..++ ......+.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 111222211 001111100 0122 2345678899999999
Q ss_pred cCCCCCCCHHHHHH
Q 044232 330 DMPKRRPSMSTLVN 343 (415)
Q Consensus 330 ~~P~~RPs~~evl~ 343 (415)
.||++|-|..+.|+
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=259.58 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=168.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH--------hHHHHHHHHHHHhhcC---CcceeeeeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ--------GVREFLTEINVIKDIK---HENLVELYGCCV 138 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 138 (415)
..+|..++.||.|+||.|+.|.++ +...|++|.+.+..-- ..-..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456899999999999999999987 6778999998765211 0112345999999997 999999999999
Q ss_pred eCCeeEEEEeec-cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 139 EGDHRILVYGYL-ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 139 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
+++.+||+||-- ++-+|.++|.... .+++..+..|+.|++.|+++||++ +|||||||-+|+.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 999999999976 4568999997665 789999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCC
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTN 277 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~ 277 (415)
|||.+...... ....+.||..|.|||++.+..| +..-|||++|++||.++....|+.
T Consensus 713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999765432 2346789999999999988765 677899999999999998877754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=234.68 Aligned_cols=199 Identities=36% Similarity=0.556 Sum_probs=173.5
Q ss_pred CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
|.+.+.||.|++|.||++... +++.+|+|.+...... ..+.+.+|+..+..++|+|++++++++...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 566788999999999999987 4889999999876544 56788899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+++|.+++..... .+++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976542 178899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eecccccCCCCCChhhh-hcCCCCccceEeehhHhHHHHHhCCcCCCC
Q 044232 232 ISTRVAGTEGYLAPEYA-IRGQLTRKADIYSFGVLLLEIVSGRCNTNR 278 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~p~~~ 278 (415)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678889999998 666788899999999999999999988854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=232.84 Aligned_cols=251 Identities=18% Similarity=0.301 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeE-EEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGC-CVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 147 (415)
.+.|.+.+.||+|.||.+-+++++ +++.+++|.+...- ...++|.+|...--.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 477999999999999999999987 68889999987653 3457899999877666 58899998876 56677889999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCCCeEEeeecccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD--KDLTPKISDFGLAKLF 225 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~ 225 (415)
||++.|+|..-+... .+.+.....++.|+++|+.|+|++ ++||||||.+||||- +..++||+|||+.+..
T Consensus 102 E~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999888765 467788899999999999999999 999999999999993 3458999999999854
Q ss_pred CCCCcceecccccCCCCCChhhhhcC-----CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRG-----QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
... .....-+..|.|||+.... ...+.+|||.||++++.++||+.|+....... ...|-|..+..+..
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKN 246 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccC
Confidence 321 1122335569999987532 35678999999999999999999987432211 12233444444443
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+.+. -......+..+..+-+..+|++|=...+..+
T Consensus 247 ~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 247 PALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 322211 1122356778888999999999954444433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=238.17 Aligned_cols=261 Identities=24% Similarity=0.300 Sum_probs=195.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------C
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------D 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 141 (415)
..+|.-++.+|.|.- .|..|-+. .++.||+|.+... .....++..+|..++..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999998 66666554 6889999987654 233456778899999999999999999998643 3
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..|+|||+| ..+|...++- .++-.++..|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 579999999 5578887762 567789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhh---------------
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY--------------- 286 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~--------------- 286 (415)
|+.-... -..+....|..|.|||++.+-.+...+||||+||++.||++|+.-|.+..--..-.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9854332 34566778999999999998889999999999999999999998776543211100
Q ss_pred -HHHHHHHHHhhC------cchhhc-ccccC--CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 287 -LLEMAWKLYERG------KLVELV-DASLN--GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 287 -~~~~~~~~~~~~------~~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
+...+....... ...+.+ |.... .+.+........+++.+||-.+|++|-+++++|+.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 001111111100 001111 11111 11122234567789999999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=235.60 Aligned_cols=264 Identities=28% Similarity=0.405 Sum_probs=196.7
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCC
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGD 141 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 141 (415)
+.-..+.|..+++||.|.|++||++.+. .++.||+|.+.....- .+..+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999753 4678999998765433 5678899999999 6899999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeec
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFG 220 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 220 (415)
...+|+||++.....+++. .++...+..+++.++.||.++|.+ |||||||||+|+|.+.. ++-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999999998886 456788999999999999999999 99999999999999765 678999999
Q ss_pred cccccCCCC-------------cc------------------------------eecccccCCCCCChhhhhc-CCCCcc
Q 044232 221 LAKLFPANL-------------TH------------------------------ISTRVAGTEGYLAPEYAIR-GQLTRK 256 (415)
Q Consensus 221 la~~~~~~~-------------~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~ 256 (415)
+|....... .. ......||++|.|||++.. ...+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997220000 00 0012469999999999875 568999
Q ss_pred ceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH---------HHHhhCc--chh---------h------c--cccc
Q 044232 257 ADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW---------KLYERGK--LVE---------L------V--DASL 308 (415)
Q Consensus 257 ~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~---------~~~~~~~--~~~---------~------~--~~~~ 308 (415)
.||||.|||++-+++++.||....... ..+.+.+. -....|. +.+ . + ....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999987533211 11111110 0001111 000 0 0 0000
Q ss_pred CCCC--------CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDY--------SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~--------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+. ..-.+..+.+++.+|+..||.+|-|+++.|+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0000 0112347889999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=268.21 Aligned_cols=194 Identities=18% Similarity=0.189 Sum_probs=136.8
Q ss_pred cCC-cceeeeeeEE-------EeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 044232 125 IKH-ENLVELYGCC-------VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196 (415)
Q Consensus 125 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 196 (415)
++| +||++++++| ......++++|++ +++|.++|.... ..+++..++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445 5788888877 2334567788987 669999996532 2589999999999999999999999 99
Q ss_pred EecCCCCCCeeecCC-------------------CCeEEeeeccccccCCCCc---------------ceecccccCCCC
Q 044232 197 VHRDIKASNILLDKD-------------------LTPKISDFGLAKLFPANLT---------------HISTRVAGTEGY 242 (415)
Q Consensus 197 vH~Dlkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 242 (415)
+||||||+||||+.. +.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653211000 001124588899
Q ss_pred CChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHH
Q 044232 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK 322 (415)
Q Consensus 243 ~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (415)
||||++.+..++.++|||||||+||||++|..|+.... ...... ... ...+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~-~~~----~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL-RHR----VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH-HHh----hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999876543210 000111 000 00000 0111234567
Q ss_pred HHHHcCCcCCCCCCCHHHHHH
Q 044232 323 IALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 323 li~~cl~~~P~~RPs~~evl~ 343 (415)
++.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=209.10 Aligned_cols=166 Identities=23% Similarity=0.288 Sum_probs=125.7
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++..++. .+++..++.|+.||+.||.|||+. + ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999976532 699999999999999999999998 5 999999999999999 9999865432
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCC
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY 312 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (415)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+....+... ......... ... ... ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~-~~~--~~~-~~~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNGM-PAD--DPR-DRSN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHHh-ccC--Ccc-cccc
Confidence 12589999999999999999999999999999999999998865432211 111111110 000 000 0011
Q ss_pred CHHHHH--HHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 313 SVEEAH--RYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 313 ~~~~~~--~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
+..... .+.+++.+||+.+|.+||++.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 122233 68999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=222.96 Aligned_cols=260 Identities=23% Similarity=0.266 Sum_probs=196.4
Q ss_pred CCCCCCcccccCeEEEEEEEecCC--CEEEEEEccccchHhHHHHHHHHHHHhhcCC----cceeeeeeEE-EeCCeeEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKDG--TLAAIKVLSADSRQGVREFLTEINVIKDIKH----ENLVELYGCC-VEGDHRIL 145 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 145 (415)
+|.+.++||+|+||.||+|..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997643 5789998876533322356778999988863 5899999999 47778999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-----CCeEEeeec
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-----LTPKISDFG 220 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG 220 (415)
||+.+ |.+|.++..... ...++..+...|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999886665 34799999999999999999999999 99999999999999765 469999999
Q ss_pred ccc--ccCCCCcc----e---ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 221 LAK--LFPANLTH----I---STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 221 la~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
+++ .+...... . .....||..|+++.++.+...+++.|+||++.++.+|+.|..|+......... ...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHH
Confidence 999 43222111 1 22356999999999999999999999999999999999998777543322111 111
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
...... ..... .....+..+..+...+-..+..++|....+...|.....
T Consensus 250 ~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 250 EKDPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 111000 00000 122234556667777777899999999999988765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=221.86 Aligned_cols=167 Identities=20% Similarity=0.242 Sum_probs=131.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec--CCCEEEEEEcccc-----chHhHHHHHHHHHHHhhcCCcceee-eeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSAD-----SRQGVREFLTEINVIKDIKHENLVE-LYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 138 (415)
.+...++|.+.+.||+|+||+||+|.++ +++.||||++... .......|.+|+.+|+.++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 4556788999999999999999999865 5788899986533 1223456889999999999999985 4432
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeecCCCCeEEe
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDI-KASNILLDKDLTPKIS 217 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~ 217 (415)
...++||||++|++|.. +.. .. ...++.++++||.|||+. ||+|||| ||+|||++.++.+||+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence 45799999999999963 211 11 146788999999999999 9999999 9999999999999999
Q ss_pred eeccccccCCCCcce-------ecccccCCCCCChhhhhcC
Q 044232 218 DFGLAKLFPANLTHI-------STRVAGTEGYLAPEYAIRG 251 (415)
Q Consensus 218 DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 251 (415)
|||+++.+....... .....+++.|+|||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999765432111 1346688899999988643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-27 Score=206.93 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=194.0
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
....-+|.+...|..|+|++..+. +++|++... ....-++|..|.-.|+.+.||||+.++|.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 445568899999999999998555 455766543 23333679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe--eeccccccCCCC
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS--DFGLAKLFPANL 229 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfGla~~~~~~~ 229 (415)
.|+|+..++.... ...+..++.+++.++++|++|||+. .+-|.---|....++||++.+++|. |--.+..
T Consensus 271 ~gslynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred chHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 9999999987653 3567789999999999999999997 3334455789999999999988775 3222211
Q ss_pred cceecccccCCCCCChhhhhcCCC---CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQL---TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.....-.|.||+||.++..+. -+++|+|||++++|||.|...||..-.|.+ ...++.. +
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------cgmkial---------e 404 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------CGMKIAL---------E 404 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------hhhhhhh---------c
Confidence 112233678999999987654 368999999999999999988876655543 2222222 3
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.++...+...+..+.+|+.-|++.||.+||.+..|+-.|++.+
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4455566667788999999999999999999999999887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-24 Score=202.57 Aligned_cols=261 Identities=29% Similarity=0.411 Sum_probs=198.8
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccchH---hHHHHHHHHHHHhhcCCc-ceeeeeeEEEeCCeeEEEEee
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ---GVREFLTEINVIKDIKHE-NLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 149 (415)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999987 77899998766332 357899999999999988 799999999777778999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 228 (415)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+..+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2578889999999999999999999 999999999999999998 7999999999865443
Q ss_pred Ccc-----eecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 229 LTH-----ISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 229 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
... ......||..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 221 2456789999999999987 57899999999999999999999886554321 001111111111110
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000001111012223567889999999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=188.66 Aligned_cols=259 Identities=21% Similarity=0.284 Sum_probs=200.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEE-ecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC-cceeeeeeEEEeCCeeEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH-ENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 146 (415)
+...+|.++++||+|+||.+|.|. ..+|..||||+-+..... ..+.-|..+...+++ ..|..+.-+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 458999999998765433 356678999999975 5788888888889999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 223 (415)
|+.+ |-||.+++.-.. ..++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.|+|||+++
T Consensus 90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 889998876332 2688899999999999999999999 99999999999999643 469999999999
Q ss_pred ccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 224 LFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 224 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
.+.+..+. ......||.+|.+-..+.+...+...|+-|+|.||..+.-|..||.+-.+.......+.+.+.-..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 77543222 123467999999999888889999999999999999999999998876665554444433222111
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
-.+ ..+...+ |.++...+.-|-..--++-|...-+-+.+
T Consensus 243 ~~i-----e~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 243 TPI-----EVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCH-----HHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 111 1122223 45677778888888888889876555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=195.20 Aligned_cols=202 Identities=24% Similarity=0.370 Sum_probs=172.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..-.|++.++||+|.||.++.|+.- ++++||||.-...+.. -.+..|...++.| ..++|..+|.+..++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3457999999999999999999854 8999999987655332 4566788888887 5789999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-----CCeEEeeeccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-----LTPKISDFGLA 222 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGla 222 (415)
|.+ |-||.|+..-.+. .++..++..+|.|++.-++|+|++ .+|+|||||+|+||... ..+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 8899998876553 799999999999999999999999 99999999999999654 35899999999
Q ss_pred cccCCCCcce------ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCC
Q 044232 223 KLFPANLTHI------STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL 280 (415)
Q Consensus 223 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~ 280 (415)
+.+.+..+.. .....||.+||+-..+.+.+.+++.|+-|||-|+++.+-|..||.+-.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 9885543322 234679999999999999999999999999999999999988887643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=227.63 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=189.4
Q ss_pred CCCCcccccCeEEEEEEEec-CCCEEEEEEcc----c-cchHh-HHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 75 SPANKIGQGGFGSVYKGTLK-DGTLAAIKVLS----A-DSRQG-VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
...+.+|.|++|.|+..... .....+.|... . ..... ...+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988777643 33334444332 1 11111 122556777778889999998888877766666669
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|||++ +|..++...+ .+....+..++.|++.|++|||+. ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999998764 577888999999999999999999 999999999999999999999999999987754
Q ss_pred CCc---ceecccccCCCCCChhhhhcCCCCc-cceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 228 NLT---HISTRVAGTEGYLAPEYAIRGQLTR-KADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 228 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
... ......+|+..|+|||++.+..|.. ..||||.|+++..|++|+.||........++ .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccc
Confidence 433 4456688999999999999888865 6899999999999999999987655444322 000000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
-...-........+.....++.++|+.+|.+|-|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000011122345667788999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=191.60 Aligned_cols=173 Identities=15% Similarity=0.169 Sum_probs=135.5
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHh---HHH------HHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG---VRE------FLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
...++|+..+.||.|+||.||++.. ++..+|+|++....... ... +.+|+..+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 56679999997653222 122 5789999999999999999998664
Q ss_pred C--------CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 140 G--------DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 140 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
. ...+|||||++|.+|.++. .++. ....+++.+|..||+. |++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 3578999999999998773 2222 2455899999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh
Q 044232 212 LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS 271 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt 271 (415)
| ++|+|||........... ..+.....+..++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988754321110 113445556789999999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=186.30 Aligned_cols=139 Identities=19% Similarity=0.209 Sum_probs=109.0
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchH--h-------HH-----------------HHHHHHHHHhhcCCcce
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ--G-------VR-----------------EFLTEINVIKDIKHENL 130 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni 130 (415)
.+.||+|+||.||+|...+|+.||+|+++..... . .. ....|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999764211 0 01 22349999999988776
Q ss_pred eeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCCeeec
Q 044232 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL-HEEVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 131 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 209 (415)
.....+.. ...+|||||++++++........ .+++..+..++.|++.+|.+| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 22489999999887765533332 678899999999999999999 688 999999999999998
Q ss_pred CCCCeEEeeecccccc
Q 044232 210 KDLTPKISDFGLAKLF 225 (415)
Q Consensus 210 ~~~~~kl~DfGla~~~ 225 (415)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 578999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=178.50 Aligned_cols=140 Identities=19% Similarity=0.203 Sum_probs=111.2
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchH--------------------------hHHHHHHHHHHHhhcCCcce
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ--------------------------GVREFLTEINVIKDIKHENL 130 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 130 (415)
.+.||+|++|.||+|...+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999878999999998764210 01223578999999999987
Q ss_pred eeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeec
Q 044232 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 131 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 209 (415)
.....+... ..+|||||++|+++........ .++......++.|++.+|.+||+ . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 2489999999886544322222 56778899999999999999999 8 999999999999999
Q ss_pred CCCCeEEeeeccccccC
Q 044232 210 KDLTPKISDFGLAKLFP 226 (415)
Q Consensus 210 ~~~~~kl~DfGla~~~~ 226 (415)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=214.31 Aligned_cols=249 Identities=22% Similarity=0.252 Sum_probs=181.4
Q ss_pred CCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc-hHhHHHHHH---HHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-RQGVREFLT---EINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++...+.||++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.+ |++ ...++|||.+++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998887 8888876543 333344444 444 455699999999998888888899999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc--C
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--P 226 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~--~ 226 (415)
|+.+ +|+|.+..+. -+...+...|+.|++.||..+|.. ||+|||||.+||||+.-+-+.|+||..-+.. +
T Consensus 102 yvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9955 7999998775 577788899999999999999999 9999999999999999999999999876522 2
Q ss_pred CC----CcceecccccCCCCCChhhhhcC-----------CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 227 AN----LTHISTRVAGTEGYLAPEYAIRG-----------QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 227 ~~----~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
.+ ......+......|+|||.+... ..+++.||||+|||+.||++-..| +|+-..+..+-
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P-----lF~LSQL~aYr 248 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP-----LFTLSQLLAYR 248 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC-----cccHHHHHhHh
Confidence 21 11222233334579999987541 167899999999999999985333 33332222221
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
... .......+....+ ..+.+++..|++.||.+|-++++.++.-.
T Consensus 249 ~~~--~~~~e~~Le~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 249 SGN--ADDPEQLLEKIED--------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ccC--ccCHHHHHHhCcC--------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 100 0011111111111 24789999999999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-23 Score=200.72 Aligned_cols=225 Identities=24% Similarity=0.265 Sum_probs=181.6
Q ss_pred cccccCeEEEEEEE----ecCCCEEEEEEccccchH--hHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEeecc
Q 044232 79 KIGQGGFGSVYKGT----LKDGTLAAIKVLSADSRQ--GVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
.+|+|.||.|++++ .+.|..+|+|++++.... .......|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 235788999988765221 1114556888888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
||.|...+.... .+.+.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998887665 566777778888899999999999 999999999999999999999999999986543321
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
.+||..|||||++. ....++|.||||++++||+||..||.. +....+.. ....
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~-----------~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK-----------AELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh-----------hccC
Confidence 18999999999987 567899999999999999999888765 11111211 1234
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
.+.........++..++..+|.+|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 566667778888899999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=170.74 Aligned_cols=185 Identities=17% Similarity=0.106 Sum_probs=140.2
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEccccchH----hHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEee
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ----GVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.+...|++|+||+||.+.. .+..++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 6777887777654321 1225789999999995 5789999886 447999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeecCCCCeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDI-KASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
+.|.+|...+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 1135778899999999999 9999999 799999999999999999999865443
Q ss_pred Ccc----e--------ecccccCCCCCChhhhhcC-CCC-ccceEeehhHhHHHHHhCCcCCCC
Q 044232 229 LTH----I--------STRVAGTEGYLAPEYAIRG-QLT-RKADIYSFGVLLLEIVSGRCNTNR 278 (415)
Q Consensus 229 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvvl~elltg~~p~~~ 278 (415)
... . ......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+.-.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 0 1113368889999854332 333 567899999999999999877544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=191.35 Aligned_cols=217 Identities=27% Similarity=0.439 Sum_probs=162.4
Q ss_pred HhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCc-EecC
Q 044232 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI-VHRD 200 (415)
Q Consensus 122 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~D 200 (415)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.-...++.+|+.||+|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 46789999999999999999999999999999999999874 34789999999999999999999998 55 9999
Q ss_pred CCCCCeeecCCCCeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcC-------CCCccceEeehhHhHHHHHhC
Q 044232 201 IKASNILLDKDLTPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRG-------QLTRKADIYSFGVLLLEIVSG 272 (415)
Q Consensus 201 lkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvvl~elltg 272 (415)
+++.|.++|..+.+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999998764210 0111111223469999988753 147789999999999999999
Q ss_pred CcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 273 RCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 273 ~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
..||....-.... .+.+..+...+. ..+.+.+... .+.++.+..++..||..+|.+||++++|-..+.....
T Consensus 155 ~~~~~~~~~~~~~--~eii~~~~~~~~--~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP--DEIILRVKKGGS--NPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh--HHHHHHHHhcCC--CCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9998763322221 222222222111 1111111111 1344578899999999999999999999988865544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=180.34 Aligned_cols=232 Identities=20% Similarity=0.221 Sum_probs=150.5
Q ss_pred CCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcC----------CcceeeeeeEEE--
Q 044232 75 SPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIK----------HENLVELYGCCV-- 138 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~-- 138 (415)
...+.||.|+++.||.+.+. +++.+|+|+..... ....+.+.+|.-....+. |-.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999987 69999999875442 334566776665554432 222333333322
Q ss_pred -------eC---C-----eeEEEEeeccCCCHHHHhh---cCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 044232 139 -------EG---D-----HRILVYGYLENNSLAQTLL---GRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200 (415)
Q Consensus 139 -------~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 200 (415)
.. + +.+++|+-+ .++|.+++. ........+....++.+..|+++.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 11 1 236778877 668877754 2222222344556677789999999999999 999999
Q ss_pred CCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC--------CCCccceEeehhHhHHHHHhC
Q 044232 201 IKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG--------QLTRKADIYSFGVLLLEIVSG 272 (415)
Q Consensus 201 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGvvl~elltg 272 (415)
|+|+|++++.+|.++|+||+........ ... ...+..|.+||..... .++.+.|.|+||+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999887754322 111 3345779999977542 478899999999999999999
Q ss_pred CcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCC
Q 044232 273 RCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR 335 (415)
Q Consensus 273 ~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 335 (415)
+.|++...+...... .-.... +.++.+..||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999987644332110 111233 667889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=168.57 Aligned_cols=137 Identities=18% Similarity=0.249 Sum_probs=106.4
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-----CCcceeeeeeEEEeCC---e-eEE
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-----KHENLVELYGCCVEGD---H-RIL 145 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 145 (415)
.-.+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . +.+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 3234444 68888765444456789999999999 5799999999998864 3 347
Q ss_pred EEee--ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCeeecC----CCCeEEee
Q 044232 146 VYGY--LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL-AFLHEEVQPHIVHRDIKASNILLDK----DLTPKISD 218 (415)
Q Consensus 146 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D 218 (415)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 24444 35677888777 999999 9999999999999974 34899999
Q ss_pred ecccc
Q 044232 219 FGLAK 223 (415)
Q Consensus 219 fGla~ 223 (415)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=179.38 Aligned_cols=196 Identities=24% Similarity=0.288 Sum_probs=141.5
Q ss_pred CCcceeeeeeEEEe---------------------------CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHH
Q 044232 126 KHENLVELYGCCVE---------------------------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178 (415)
Q Consensus 126 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 178 (415)
+|||||++++.|.+ +..+|+||.-.+ .+|..++-.+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999987643 335789998884 48999987663 4566778889
Q ss_pred HHHHHHHHHHHhcCCCCcEecCCCCCCeee--cCCC--CeEEeeeccccccCCC-----CcceecccccCCCCCChhhhh
Q 044232 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILL--DKDL--TPKISDFGLAKLFPAN-----LTHISTRVAGTEGYLAPEYAI 249 (415)
Q Consensus 179 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~ 249 (415)
.|+++|+.|||.+ ||.|||+|++|||| |+|+ .+.|+|||.+--.... .........|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 4554 5788999988633221 111122345777799999876
Q ss_pred cCC------CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHH
Q 044232 250 RGQ------LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKI 323 (415)
Q Consensus 250 ~~~------~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 323 (415)
..+ --.|+|.|+.|.+.||+++...||.......- +. +.+ .+..-+..+..++..+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----~~--r~Y---------qe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----DT--RTY---------QESQLPALPSRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----ch--hhh---------hhhhCCCCcccCChHHHHH
Confidence 432 24689999999999999999999876321110 00 001 1122234455667889999
Q ss_pred HHHcCCcCCCCCCCHHHHHHHh
Q 044232 324 ALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 324 i~~cl~~~P~~RPs~~evl~~L 345 (415)
+...|+.||++||+..-..+.|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876555544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-22 Score=205.20 Aligned_cols=200 Identities=22% Similarity=0.265 Sum_probs=161.5
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCC
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK---HENLVELYGCCVEGD 141 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 141 (415)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-++..... |.=-.+++.+|+ -+-|..+...+.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44566778899999999999999999998889999999987765432 221233444444 344555666666778
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-------CCCCe
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-------KDLTP 214 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~ 214 (415)
..++|+||.+.|+|.+++...+ .++|..+..++.|++.-++.||.. +|||+||||+|.||. +...+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 8899999999999999998443 689999999999999999999999 999999999999994 23469
Q ss_pred EEeeeccccccCCC-CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc
Q 044232 215 KISDFGLAKLFPAN-LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274 (415)
Q Consensus 215 kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 274 (415)
+|+|||.+..+.-- ........++|-.+-.+|+..+..|++.+|.|.|+.+++-|+.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999998643211 1123455678899999999999999999999999999999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=168.64 Aligned_cols=141 Identities=16% Similarity=0.148 Sum_probs=111.0
Q ss_pred CCCCCCcccccCeEEEEEEE--ecCCCEEEEEEccccchH------------------------hHHHHHHHHHHHhhcC
Q 044232 73 NFSPANKIGQGGFGSVYKGT--LKDGTLAAIKVLSADSRQ------------------------GVREFLTEINVIKDIK 126 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 126 (415)
.|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 458999999998754210 1123567999999997
Q ss_pred Cc--ceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCC
Q 044232 127 HE--NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH-IVHRDIKA 203 (415)
Q Consensus 127 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp 203 (415)
+. .+.++++. ...++||||++|++|........ .+.......++.||+.+|.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 34444443 23589999999988876553322 455666789999999999999999 9 99999999
Q ss_pred CCeeecCCCCeEEeeecccccc
Q 044232 204 SNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 204 ~NIll~~~~~~kl~DfGla~~~ 225 (415)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998744
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=161.80 Aligned_cols=134 Identities=22% Similarity=0.304 Sum_probs=113.6
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccch--------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR--------QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
+.||+|++|.||+|.. +|..+++|+...... .....+.+|+.++..+.|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 566788887654311 1124577899999999999998888888778889999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
++|++|.+++.... + .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7789999999999999999 999999999999999 78999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-21 Score=194.04 Aligned_cols=208 Identities=24% Similarity=0.310 Sum_probs=149.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+|..++.|..|+||.||.++++ ..+.+|+|+-++. . +++ .++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilR--nilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILR--NILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhh--ccccccCCccee------------------
Confidence 468999999999999999999987 5778888543322 1 111 033333444444
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|+-...+...+ +++.. ++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk~~g----~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG----PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccCC----CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 45555555444 33332 37889999999 99999999999999999999999999997431110
Q ss_pred c--------------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 230 T--------------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 230 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
. ....+++||+.|+|||++....|+..+|+|++|+|+||.+-|..||.++.|.+-.. .++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhh
Confidence 0 11235789999999999999999999999999999999999999999988755211 011
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP 336 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 336 (415)
. |....++-....+.+..+++.+.|+.+|..|-
T Consensus 272 s--------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 S--------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 00111111233456788999999999999995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=158.33 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=111.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchH----------------------hHHHHHHHHHHHhhcC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ----------------------GVREFLTEINVIKDIK 126 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 126 (415)
.....|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333448888999999999999999888999999987543200 1123567899999998
Q ss_pred Ccc--eeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 127 HEN--LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 127 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
|++ ++..++. ...++||||++|++|...... .....++.+++.++.++|+. +++||||||+
T Consensus 92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~ 154 (198)
T cd05144 92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEF 154 (198)
T ss_pred HcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcc
Confidence 874 4444442 345899999999998765321 23467888999999999998 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCC
Q 044232 205 NILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++.++.++|+|||++..+..
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=180.12 Aligned_cols=140 Identities=21% Similarity=0.293 Sum_probs=113.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc-------chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD-------SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD 141 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 141 (415)
.....|...+.||+|+||.||+|.+.+...++.+.+... .....+++.+|+.++..++|++++....++....
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334556778999999999999998765443333222211 1112356889999999999999998888887777
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999998874 3467899999999999999 99999999999999 677999999999
Q ss_pred ccc
Q 044232 222 AKL 224 (415)
Q Consensus 222 a~~ 224 (415)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=155.97 Aligned_cols=130 Identities=25% Similarity=0.339 Sum_probs=106.7
Q ss_pred cccccCeEEEEEEEecCCCEEEEEEccccc--------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADS--------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.||+|+||.||+|.+ ++..|++|...... .....++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 56778888854321 112356778999999999887666666666677789999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|++|.+.+.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875432 1 7889999999999999 999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-20 Score=177.53 Aligned_cols=174 Identities=24% Similarity=0.329 Sum_probs=130.6
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
.++|.|++|...+|.++|..+... ...++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999765433 356788999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCC-----cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 222 AKLFPANL-----THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 222 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
........ ....+...||..||+||.+.+..|+.++||||||++|+||+.- |. .+++. .....-++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~--T~~er----~~t~~d~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FS--TQFER----IATLTDIR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hc--cHHHH----HHhhhhhh
Confidence 98665443 2334567799999999999999999999999999999999972 11 11111 11111222
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHH
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMST 340 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 340 (415)
.+.+. +....+++ +=..|+.+++...|.+||++.+
T Consensus 474 ~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 22222 11111222 2246888999999999994443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=144.89 Aligned_cols=137 Identities=19% Similarity=0.250 Sum_probs=98.5
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchH--hHHHH----------------------HHHHHHHhhcCCcc--e
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ--GVREF----------------------LTEINVIKDIKHEN--L 130 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 130 (415)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999888999999998754211 11111 24566666654432 4
Q ss_pred eeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeec
Q 044232 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 131 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 209 (415)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 24689999999965432111110 011 5678899999999999999 7 999999999999999
Q ss_pred CCCCeEEeeeccccccC
Q 044232 210 KDLTPKISDFGLAKLFP 226 (415)
Q Consensus 210 ~~~~~kl~DfGla~~~~ 226 (415)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-17 Score=137.85 Aligned_cols=135 Identities=19% Similarity=0.217 Sum_probs=114.4
Q ss_pred CCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 76 PANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH--ENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999865 6789999866543 3578889999999976 58999999888888899999999988
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
.+..+ +......++.+++.+|++||.....+++|+|++|+||+++.++.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999986444799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=144.10 Aligned_cols=134 Identities=18% Similarity=0.218 Sum_probs=103.4
Q ss_pred Cccc-ccCeEEEEEEEecCCCEEEEEEccccc-------------hHhHHHHHHHHHHHhhcCCcce--eeeeeEEEeCC
Q 044232 78 NKIG-QGGFGSVYKGTLKDGTLAAIKVLSADS-------------RQGVREFLTEINVIKDIKHENL--VELYGCCVEGD 141 (415)
Q Consensus 78 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 141 (415)
..|| .||.|+||.+... +..+++|...... ......+.+|+.++..+.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 8888999988775 5678888774321 1223467889999999998875 67777654332
Q ss_pred ----eeEEEEeeccC-CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 142 ----HRILVYGYLEN-NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 142 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
..++|||+++| .+|.+++... .++.. .+.+|+.+|.+||+. ||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6898887543 34433 356899999999999 9999999999999999999999
Q ss_pred eeeccccc
Q 044232 217 SDFGLAKL 224 (415)
Q Consensus 217 ~DfGla~~ 224 (415)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-18 Score=175.80 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=189.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec--CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADS--RQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 146 (415)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777888999999999888753 35567777765543 222334445777777776 99999999999999999999
Q ss_pred EeeccCCCHHHHhh-cCCCCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCeeecCCC-CeEEeeecccc
Q 044232 147 YGYLENNSLAQTLL-GRGHSSIQFNWQTRRNICIGVAKGLAFLH-EEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 223 (415)
.+|..++++.+.+. ... ...+......++.|+..++.|+| +. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999988883 221 13455677789999999999999 77 999999999999999999 99999999999
Q ss_pred ccCC--CCcceeccccc-CCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 224 LFPA--NLTHISTRVAG-TEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 224 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
.+.. .........+| ++.|+|||...+ .......|+||.|+++.-+++|..|+........ .
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------~ 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------R 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------c
Confidence 7765 33334455678 999999999887 4667889999999999999999988765433221 1
Q ss_pred chhhccccc--CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASL--NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......... .............++..+++..+|..|.+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111111111 11112233455677888899999999999888753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-15 Score=146.64 Aligned_cols=141 Identities=18% Similarity=0.255 Sum_probs=100.3
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHH----------------------------------------HHHH
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR----------------------------------------EFLT 117 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 117 (415)
+.||.|++|.||+|++++|+.||||+.++....... .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999999999999998764211110 2444
Q ss_pred HHHHHhhcC----CcceeeeeeEEE-eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHH-HHHHHHhc
Q 044232 118 EINVIKDIK----HENLVELYGCCV-EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK-GLAFLHEE 191 (415)
Q Consensus 118 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~ 191 (415)
|+..+.++. |.+-+.+-.++. ..+..+|||||++|++|.+....... .. ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555542 333333333332 23457999999999999887643211 11 23456666665 47788988
Q ss_pred CCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 192 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|++|+|++|.||+++.+++++++|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.7e-15 Score=134.13 Aligned_cols=203 Identities=20% Similarity=0.285 Sum_probs=143.2
Q ss_pred HHHHhhcCCcceeeeeeEEEeC-----CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCC
Q 044232 119 INVIKDIKHENLVELYGCCVEG-----DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193 (415)
Q Consensus 119 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 193 (415)
..-|-.+-|.|||+++.++.+. ....++.||+..|+|..+|++.......+....-.+|+.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445566799999999998653 357899999999999999998776667888888899999999999999995 7
Q ss_pred CCcEecCCCCCCeeecCCCCeEEeeeccccccCCC----CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHH
Q 044232 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN----LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEI 269 (415)
Q Consensus 194 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~el 269 (415)
|.|+|+++..+.|++..+|-+|+.--.-. ..... .........+-++|.|||.-...+.+-++|||+||...++|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999998888521111 00000 01111223467899999987777788899999999999999
Q ss_pred HhCCcC-CCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 270 VSGRCN-TNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 270 ltg~~p-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.-|..- .+...-..... .+.+ ........+ -..++..|++..|..||+|++++.
T Consensus 276 ailEiq~tnseS~~~~ee---~ia~------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEE---NIAN------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhh---hhhh------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 887643 22111111100 0000 000000001 124677899999999999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=145.92 Aligned_cols=146 Identities=15% Similarity=0.222 Sum_probs=96.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC-CCEEEEEEccccchHh----------------------------------HHH-
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQG----------------------------------VRE- 114 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~- 114 (415)
...|+. +.||+|++|.||+|++++ |+.||||+.++.-... .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999986 9999999997542110 111
Q ss_pred -----HHHHHHHHhhcC----CcceeeeeeEEEe-CCeeEEEEeeccCCCHHHH--hhcCCCCCCccCHHHHHHHHHHHH
Q 044232 115 -----FLTEINVIKDIK----HENLVELYGCCVE-GDHRILVYGYLENNSLAQT--LLGRGHSSIQFNWQTRRNICIGVA 182 (415)
Q Consensus 115 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~ 182 (415)
|.+|+..+.+++ +.+.+.+-.++.+ .+..+|||||++|+.+.+. +...+.....+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 233444443332 3333444444433 3467899999999999874 3222211112333333333333
Q ss_pred HHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEeeeccccccCC
Q 044232 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISDFGLAKLFPA 227 (415)
Q Consensus 183 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~ 227 (415)
+... |++|+|+||+||+++.++ +++++|||++..++.
T Consensus 276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3445 999999999999999988 999999999986644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.2e-14 Score=139.49 Aligned_cols=248 Identities=22% Similarity=0.237 Sum_probs=181.4
Q ss_pred HhcCCCCCCcccc--cCeEEEEEEEe--c-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCC
Q 044232 70 ATENFSPANKIGQ--GGFGSVYKGTL--K-DGTLAAIKVLSADS--RQGVREFLTEINVIKDI-KHENLVELYGCCVEGD 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 141 (415)
....|.+.+.+|. |.+|.||.+.. . ++..+|+|.-+... ......=.+|+....++ .|+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456778899999 99999999987 3 68889998743321 12222334566666666 5999999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEE
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK----GLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKI 216 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl 216 (415)
..++-+|++ +.+|..+...... .++....+.+..+..+ ||.++|+. +++|-|+||.||++..+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 999999988 5788888766543 3666777778888888 99999999 99999999999999999 78999
Q ss_pred eeeccccccCCCCc----ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCC--CChhhhhHHHH
Q 044232 217 SDFGLAKLFPANLT----HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRR--LPYEEQYLLEM 290 (415)
Q Consensus 217 ~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~--~p~~~~~~~~~ 290 (415)
+|||+...+....- ....+..|...|++||.. .+-++.+.|+|++|.++.+-.+|..+.... ..|.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~------- 336 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS------- 336 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-------
Confidence 99999987754431 112233577889999965 567799999999999999999987654432 1111
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+.+. +..++-......+...+.++++.+|..|++.+.+.+
T Consensus 337 ---~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ---QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111 111111112234555888999999999999888765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=117.98 Aligned_cols=130 Identities=18% Similarity=0.170 Sum_probs=96.0
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
++.|+.|.++.||+++.. +..+++|+....... ...+..|+.++..+.+.++ .+++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 667999997655321 2345679999998866554 4455443 3346899999999887
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV--QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
... . .....++.+++.+|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~----~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 011245678999999999982 11259999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-12 Score=111.78 Aligned_cols=136 Identities=19% Similarity=0.179 Sum_probs=99.0
Q ss_pred CCcccccCeEEEEEEEecC-------CCEEEEEEccccc----------------------hHhHHHH----HHHHHHHh
Q 044232 77 ANKIGQGGFGSVYKGTLKD-------GTLAAIKVLSADS----------------------RQGVREF----LTEINVIK 123 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~ 123 (415)
...||.|--+.||.|...+ +..+|||+.+... ....+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 4789999874210 0111222 37999999
Q ss_pred hcCC--cceeeeeeEEEeCCeeEEEEeeccCCCHHH-HhhcCCCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCcEec
Q 044232 124 DIKH--ENLVELYGCCVEGDHRILVYGYLENNSLAQ-TLLGRGHSSIQFNWQTRRNICIGVAKGLAFL-HEEVQPHIVHR 199 (415)
Q Consensus 124 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~ 199 (415)
++.. -++.+++++ ...+|||||+.++.+.. .+.+. .++......+..+++.+|..| |.. +++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8853 467777764 46789999997654422 22211 344456677889999999999 777 99999
Q ss_pred CCCCCCeeecCCCCeEEeeecccccc
Q 044232 200 DIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 200 Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||++.|||++ ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.1e-12 Score=126.02 Aligned_cols=170 Identities=18% Similarity=0.229 Sum_probs=127.4
Q ss_pred EEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCcc
Q 044232 91 GTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQF 169 (415)
Q Consensus 91 ~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l 169 (415)
|..+ ++.+|.|...............+-++-|+.++||||+++++.++..+..|||+|-+. -|..++...+
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------ 102 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------ 102 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------
Confidence 4433 688888888776655444556678899999999999999999999999999999884 3666665443
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhh
Q 044232 170 NWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249 (415)
Q Consensus 170 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 249 (415)
.......+.||+.||.+||+.| +++|++|..+.|+|+..|..||++|.++........ .......--.|..|+.+.
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 4566677899999999999765 999999999999999999999999998864432211 011111122366676543
Q ss_pred cCCCCccceEeehhHhHHHHHhCCc
Q 044232 250 RGQLTRKADIYSFGVLLLEIVSGRC 274 (415)
Q Consensus 250 ~~~~~~~~DvwSlGvvl~elltg~~ 274 (415)
... ...|.|.|||+++|++.|..
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCccc
Confidence 222 45799999999999999943
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-13 Score=130.48 Aligned_cols=258 Identities=21% Similarity=0.206 Sum_probs=180.4
Q ss_pred cCCcccchhh-HHHHhcCCCCCCcccccCeEEEEEEEec--CCCEEEEEEccccchHhHH--HHHHHHHHHhhc-CCcce
Q 044232 57 QDTNLYGYKD-LRVATENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADSRQGVR--EFLTEINVIKDI-KHENL 130 (415)
Q Consensus 57 ~~~~~~~~~~-~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~ni 130 (415)
...+.|.-.+ ......+|..+..||.|.|+.|++...+ ++..+++|.+.+....... .-+.|+-+...+ .|.++
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence 3344444444 3455778999999999999999998754 6788899987665322212 223466666555 68889
Q ss_pred eeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 044232 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK 210 (415)
Q Consensus 131 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 210 (415)
+..+..+....+.++=-|||+++++...+... ..+.+..++.+..|++.++.++|+. .++|+|+||+||++..
T Consensus 329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISN 401 (524)
T ss_pred CCCCCCccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeecc
Confidence 99888888878888999999999987766322 2567788899999999999999998 9999999999999988
Q ss_pred C-CCeEEeeeccccccCCCCcceecccccCCCCC--ChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhH
Q 044232 211 D-LTPKISDFGLAKLFPANLTHISTRVAGTEGYL--APEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYL 287 (415)
Q Consensus 211 ~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~ 287 (415)
+ +.-++.|||.+..+... .......-++. +|+......+..+.|++|||..+.+.++|..-......+
T Consensus 402 ~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----- 472 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----- 472 (524)
T ss_pred chhhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----
Confidence 6 78899999998642211 11122233344 455555668889999999999999999985422111110
Q ss_pred HHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHh
Q 044232 288 LEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345 (415)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 345 (415)
. ....+ .-+..+.. ...+..+...+...++..||.+.++....
T Consensus 473 ~-----~i~~~---------~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 473 L-----TIRSG---------DTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred e-----eeecc---------cccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 0 01111 11111222 25677788889999999999988876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.2e-12 Score=112.64 Aligned_cols=142 Identities=20% Similarity=0.298 Sum_probs=109.5
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccch-HhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCC---eeEEEEeecc
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR-QGVREFLTEINVIKDIKH--ENLVELYGCCVEGD---HRILVYGYLE 151 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 151 (415)
+.||.|..+.||++...+|..+++|+...... .....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887768899999765432 133567889999999975 34677777766542 5689999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV--------------------------------------- 192 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 192 (415)
|.++.+.+.. . .++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~-~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-P----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-C----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988765532 1 4666777788888888888888531
Q ss_pred --------------CCCcEecCCCCCCeeecC--CCCeEEeeeccccc
Q 044232 193 --------------QPHIVHRDIKASNILLDK--DLTPKISDFGLAKL 224 (415)
Q Consensus 193 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~ 224 (415)
...++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-12 Score=134.49 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=177.3
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
+...+.+.+.+-+-+|.++.++.++-. .|...+.|+...... ...+....+-.++-...+|.++...--+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 455678888899999999999988644 455555555433211 1122233343444444567777666665566788
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
+|+++|+.+++|...++..+ ..+..-.+.....+.++++|||+. .+.|+|++|.|+++..++..+++|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999998766 345555566677788999999998 79999999999999999999999998443
Q ss_pred ccCC------C------------------------CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCC
Q 044232 224 LFPA------N------------------------LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273 (415)
Q Consensus 224 ~~~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 273 (415)
.... . .........||+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2100 0 000112356899999999999999999999999999999999999
Q ss_pred cCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHH
Q 044232 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMS 339 (415)
Q Consensus 274 ~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 339 (415)
.||+...|... +++ +... ....+..+........+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~----------f~n--i~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI----------FEN--ILNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh----------hhc--cccC--CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99887665432 111 0000 0112233444556677888889999999997665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.2e-11 Score=101.07 Aligned_cols=131 Identities=23% Similarity=0.295 Sum_probs=100.3
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEc-ccc--c-----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVL-SAD--S-----RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..+++|+-+.+|.+.+.+.. +++|.= ++. . .-...+-.+|+.++.++.--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45889999999999775444 555543 221 1 11224567899999998766666666666677888999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.+++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888654 235666777788899999 999999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-10 Score=97.44 Aligned_cols=143 Identities=20% Similarity=0.296 Sum_probs=106.5
Q ss_pred CCCcccccCeEEEEEEEecCCCEEEEEE-cccc-------chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 76 PANKIGQGGFGSVYKGTLKDGTLAAIKV-LSAD-------SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+..|-+|+-+.|+++.+. |+.+.||. +.+. ..-...+..+|+.+|.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999986 55555553 3222 1223456778999999987666666666677777888999
Q ss_pred eeccC-CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEEeeecccc
Q 044232 148 GYLEN-NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKISDFGLAK 223 (415)
Q Consensus 148 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~ 223 (415)
||++| .++.+++...... .........++..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 3677887665432 222333367888899999999999 999999999999997665 45899999986
Q ss_pred c
Q 044232 224 L 224 (415)
Q Consensus 224 ~ 224 (415)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=109.84 Aligned_cols=170 Identities=19% Similarity=0.281 Sum_probs=129.7
Q ss_pred CeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEE----eCCeeEEEEeeccC-CCHHH
Q 044232 84 GFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV----EGDHRILVYGYLEN-NSLAQ 157 (415)
Q Consensus 84 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 157 (415)
.-.+.|++... +|..|++|+++.+..........-++.++++.|+|+|++.+++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999765 89999999995543333223334578899999999999999887 34578999999985 57887
Q ss_pred HhhcCCC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 158 TLLGRGH-----------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 158 ~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
+...... .....++..+|.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7654322 123577899999999999999999999 99999999999999999999999888776554
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 274 (415)
.+. .+| +.. -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~-------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP-------------TEP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-------------Ccc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 332 011 111 235678889999999999954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-10 Score=97.98 Aligned_cols=125 Identities=21% Similarity=0.252 Sum_probs=83.4
Q ss_pred EEEEEEecCCCEEEEEEccccc--------------------------hHhHHHHHHHHHHHhhcCCc--ceeeeeeEEE
Q 044232 87 SVYKGTLKDGTLAAIKVLSADS--------------------------RQGVREFLTEINVIKDIKHE--NLVELYGCCV 138 (415)
Q Consensus 87 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 138 (415)
.||.|...+|..+|+|+.+... ........+|+..|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999889999999864210 00113456799999999765 567776552
Q ss_pred eCCeeEEEEeecc--CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 139 EGDHRILVYGYLE--NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL-HEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 139 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
..+|||||++ |..+..+.. . .++......++.+++..+..+ |.. ||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-c-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4579999998 555543332 2 122345567777888866664 677 99999999999999988 999
Q ss_pred Eeeecccccc
Q 044232 216 ISDFGLAKLF 225 (415)
Q Consensus 216 l~DfGla~~~ 225 (415)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=98.57 Aligned_cols=134 Identities=20% Similarity=0.196 Sum_probs=99.4
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccc----------------------hHhHHHHHHHHHHHhhcCCc--c
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS----------------------RQGVREFLTEINVIKDIKHE--N 129 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 129 (415)
..+..+||-|--+.||.|....|.++|||.-+... ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999753211 01123456799999999655 6
Q ss_pred eeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 044232 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 130 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 209 (415)
+.+.+++ +.-.+|||+++|..|...-. .......++..|++-+.-+-.. |+||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777765 56689999999977754321 2233334455555555555565 999999999999999
Q ss_pred CCCCeEEeeecccc
Q 044232 210 KDLTPKISDFGLAK 223 (415)
Q Consensus 210 ~~~~~kl~DfGla~ 223 (415)
+||.+.++||-.+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-09 Score=98.30 Aligned_cols=133 Identities=17% Similarity=0.070 Sum_probs=95.2
Q ss_pred eEEEEEEEecCCCEEEEEEccccchH-hHH----------HHHHHHHHHhhcCCcc--eeeeeeEEEe-----CCeeEEE
Q 044232 85 FGSVYKGTLKDGTLAAIKVLSADSRQ-GVR----------EFLTEINVIKDIKHEN--LVELYGCCVE-----GDHRILV 146 (415)
Q Consensus 85 ~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv 146 (415)
...|++..+ +|+.+.||........ ..+ .+.+|...+.++...+ .++++++.+. ....++|
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344666655 5678899976443211 111 3678988888884333 3344555543 2357899
Q ss_pred EeeccCC-CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-------CCCeEEee
Q 044232 147 YGYLENN-SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-------DLTPKISD 218 (415)
Q Consensus 147 ~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~D 218 (415)
+|++++. +|.+++..... .+.+......++.+++..+.-||.. ||+|+|+++.|||++. ++.+.|+|
T Consensus 114 te~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 114 TEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 9999886 79888854321 1445667789999999999999999 9999999999999975 46899999
Q ss_pred ecccc
Q 044232 219 FGLAK 223 (415)
Q Consensus 219 fGla~ 223 (415)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.4e-09 Score=97.27 Aligned_cols=259 Identities=15% Similarity=0.162 Sum_probs=155.6
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeE----E---EeCCeeEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGC----C---VEGDHRIL 145 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~---~~~~~~~l 145 (415)
....+.||+|+-+.+|-.-.- +.. +.|+..........+. +..|.+. .||-+-.=+.+ . ..+....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 345678999999999974322 222 4477665543322222 2233333 45543331111 1 11223667
Q ss_pred EEeeccCCC-HHHHhhc--CCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 146 VYGYLENNS-LAQTLLG--RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 146 v~e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.|..+.+.. +..++.- +...-.-.+|...++.+..++.+.+-||+. |.+-+|++++|+||.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 888887652 2222221 111112478999999999999999999999 9999999999999999999999974332
Q ss_pred cccCCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhC-CcCCCCCCC---hhhhhHHHHHHH
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSG-RCNTNRRLP---YEEQYLLEMAWK 293 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg-~~p~~~~~p---~~~~~~~~~~~~ 293 (415)
... .+ ....-...|.+.|.+||.-. +-.-+...|-|.||+++++|+.| ++|+.+-.- .......+.
T Consensus 165 qi~-~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I--- 239 (637)
T COG4248 165 QIN-AN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI--- 239 (637)
T ss_pred eec-cC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh---
Confidence 221 11 12223356889999999654 23456789999999999999988 778764221 111111111
Q ss_pred HHhhCcchhhccccc-----CCCCC-HHHHHHHHHHHHHcCCc--CCCCCCCHHHHHHHhhc
Q 044232 294 LYERGKLVELVDASL-----NGDYS-VEEAHRYLKIALLCTQD--MPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~-----~~~~~-~~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~ 347 (415)
..+......+... ....+ .-.+..+..+..+|+.. ++.-||+++.++..|..
T Consensus 240 --a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 240 --AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred --hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 1111111111110 01111 23356777888889875 36789999998877643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=108.48 Aligned_cols=194 Identities=18% Similarity=0.266 Sum_probs=116.7
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhH------------------------------H----------HHHH
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV------------------------------R----------EFLT 117 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 117 (415)
+-|+.++-|.||+|++++|+.||||+.+++-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999999999999999875422111 1 1334
Q ss_pred HHHHHhhc----C-CcceeeeeeEEEeCCeeEEEEeeccCCCHHHHh--hcCCCCCCccCHHHHHHHHHHHHHH-HHHHH
Q 044232 118 EINVIKDI----K-HENLVELYGCCVEGDHRILVYGYLENNSLAQTL--LGRGHSSIQFNWQTRRNICIGVAKG-LAFLH 189 (415)
Q Consensus 118 E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH 189 (415)
|+..+.++ + .|++.-..=+.+-.+...|+|||++|-.+.+.. ...+ .+... ++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----IDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CCHHH---HHHHHHHHHHHHHH
Confidence 44444444 1 233222222223356778999999999888774 4332 33222 22222222 22333
Q ss_pred hcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCccee---------------cccccCCCCCChhhh------
Q 044232 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS---------------TRVAGTEGYLAPEYA------ 248 (415)
Q Consensus 190 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~---------------~~~~gt~~y~aPE~~------ 248 (415)
.. |++|.|.+|.||+++.+|++.+.|||+...++....... ....-..+|.+|+.-
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~r~~l~~~~~a~~~rD~~~v~~~~~~~G~~~~~~~~~~~~~ 359 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFRRYLAELLLAFLNRDYDRVAELHVELGYVPPDTDRDPLAA 359 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCHHHHHHHHHHHHHHHhhCHHHHHHHHHHhCCCCCccchHHHHH
Confidence 34 999999999999999999999999999986654322110 001122356666321
Q ss_pred -----hcCCCCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 249 -----IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 249 -----~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
....++....-.++|-++.++...-.-+.-..|.
T Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~p~ 398 (517)
T COG0661 360 AIRAVLEPIYGKPLEEISFGEILDKLFEVARRFPMRLPP 398 (517)
T ss_pred HHHHHHHhhhCCChhhccHHHHHHHHHHHHHhcCccCCH
Confidence 1112445556667777777776554333344443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.7e-08 Score=84.67 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=101.7
Q ss_pred ccccCeEEEEEEEecCCCEEEEEEcccc------chHhHHHHHHHHHHHhhcCCc--ceeeeeeEEEe----CCeeEEEE
Q 044232 80 IGQGGFGSVYKGTLKDGTLAAIKVLSAD------SRQGVREFLTEINVIKDIKHE--NLVELYGCCVE----GDHRILVY 147 (415)
Q Consensus 80 lG~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~ 147 (415)
-|+||-+.|+.....+. .+-+|.-... .+.....|.+|+..|..+..- .+.++...... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36789999999776544 5777765421 023456899999999988432 24555422222 12468999
Q ss_pred eeccC-CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC--eEEeeeccccc
Q 044232 148 GYLEN-NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT--PKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~ 224 (415)
|-++| -+|.+++...... +.+...+..++.+++..+.-||.. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 4888888654322 456777889999999999999999 9999999999999986677 99999987663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.2e-08 Score=88.35 Aligned_cols=106 Identities=22% Similarity=0.205 Sum_probs=83.1
Q ss_pred HHHHHHHHHHhhcCC--cceeeeeeEEEeC----CeeEEEEeeccCC-CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHH
Q 044232 113 REFLTEINVIKDIKH--ENLVELYGCCVEG----DHRILVYGYLENN-SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185 (415)
Q Consensus 113 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L 185 (415)
....+|...+..+.. -..++.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 456778888777743 2355566665542 2458999999884 7999887643 245567788999999999
Q ss_pred HHHHhcCCCCcEecCCCCCCeeecCCC---CeEEeeecccccc
Q 044232 186 AFLHEEVQPHIVHRDIKASNILLDKDL---TPKISDFGLAKLF 225 (415)
Q Consensus 186 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~ 225 (415)
.-||.. ||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999987743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.4e-09 Score=108.60 Aligned_cols=150 Identities=21% Similarity=0.248 Sum_probs=103.8
Q ss_pred HHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc--------eecccccCCCCCChhhhhcC
Q 044232 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH--------ISTRVAGTEGYLAPEYAIRG 251 (415)
Q Consensus 180 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~ 251 (415)
+++.||.|+|.. +++||+.|.|++|.++.++..||+.|+.+......... ......-...|.|||++...
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 355899999987 59999999999999999999999999988654332111 11112235679999999998
Q ss_pred CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcC
Q 044232 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDM 331 (415)
Q Consensus 252 ~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 331 (415)
..+.++|+||+||++|.+..|+.+.-....... . +......+....-.++...+.++.+=+.+++..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~--------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----S--------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcc----h--------hhhhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence 889999999999999999955443221111000 0 0001111111122334566778888888999999
Q ss_pred CCCCCCHHHHHH
Q 044232 332 PKRRPSMSTLVN 343 (415)
Q Consensus 332 P~~RPs~~evl~ 343 (415)
+.-||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998877754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-07 Score=85.31 Aligned_cols=139 Identities=15% Similarity=0.218 Sum_probs=85.5
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc--eeeeeeEEEeCCeeEEEEeeccCCC-
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN--LVELYGCCVEGDHRILVYGYLENNS- 154 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 154 (415)
..||+|..+.||+. . +..+++|........ ....+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~~~--~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGFDK--ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCCCCH--HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 2 445778887664322 34578999999886433 5778888888888899999999863
Q ss_pred HHHHh---------------------hcCCCCCCccCHHHHHHHHH----------HHHH-HHHHHHhc-CCCCcEecCC
Q 044232 155 LAQTL---------------------LGRGHSSIQFNWQTRRNICI----------GVAK-GLAFLHEE-VQPHIVHRDI 201 (415)
Q Consensus 155 L~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------~i~~-~L~~LH~~-~~~~ivH~Dl 201 (415)
+...+ +........++.. ...+-. .+.. ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1110011111100 000100 0111 11222211 1336789999
Q ss_pred CCCCeeecCCCCeEEeeecccc
Q 044232 202 KASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 202 kp~NIll~~~~~~kl~DfGla~ 223 (415)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-07 Score=82.63 Aligned_cols=138 Identities=17% Similarity=0.206 Sum_probs=92.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHH---------HHHHHHhhcC---CcceeeeeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFL---------TEINVIKDIK---HENLVELYGC 136 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~---h~niv~l~~~ 136 (415)
+...+|...+.+-......|.+-.. +|..+++|..+.......+.|. +++..+..+. -.....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888877777777665 4677899988766443333322 3333333332 2233333333
Q ss_pred EE-----eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 137 CV-----EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 137 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
.+ -....+|+|||++|..|.+... ++. .++..+.+++.-||.. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 22 2345678999999988866531 222 2445677889999999 99999999999999965
Q ss_pred CCeEEeeecccc
Q 044232 212 LTPKISDFGLAK 223 (415)
Q Consensus 212 ~~~kl~DfGla~ 223 (415)
.++++||+.-+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 59999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3e-07 Score=82.16 Aligned_cols=149 Identities=21% Similarity=0.241 Sum_probs=98.4
Q ss_pred hhHHHHhcCCCCC---CcccccCeEEEEEEEecCCCEEEEEEccccchHhH------------------------HHHHH
Q 044232 65 KDLRVATENFSPA---NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV------------------------REFLT 117 (415)
Q Consensus 65 ~~~~~~~~~~~~~---~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~ 117 (415)
..+.....+..+. ..|.+|--+.||+|...++..+|+|+.+....... .-...
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 3344444444443 35678888899999988899999999864321110 11235
Q ss_pred HHHHHhhcC--CcceeeeeeEEEeCCeeEEEEeeccCCCH-HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 044232 118 EINVIKDIK--HENLVELYGCCVEGDHRILVYGYLENNSL-AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194 (415)
Q Consensus 118 E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 194 (415)
|+.-|.++. +-.+.+.+++. .-.|||||+....+ .-.|. ..++.......+..++++.+.-|-.. .
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~--a 186 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE--A 186 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh--c
Confidence 777777663 34455555543 35799999965411 11111 11233335677778888888888763 2
Q ss_pred CcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 195 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
++||+||+.-|||+. ++.+.|+|||.|...
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 999999999999999 889999999988643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-07 Score=92.62 Aligned_cols=140 Identities=19% Similarity=0.272 Sum_probs=89.8
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhH-------------------------------H------HHHHHHH
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV-------------------------------R------EFLTEIN 120 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~E~~ 120 (415)
+.||.-+.|.||+|++++|+.||||+-++.-.... + +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 68999999999999999999999999865422110 1 1334443
Q ss_pred HHhhc----CCcc---eeeeeeEEEe-CCeeEEEEeeccCCCHHHH--hhcCCCCCCccCHHHHHHHHHHHHHHHH-HHH
Q 044232 121 VIKDI----KHEN---LVELYGCCVE-GDHRILVYGYLENNSLAQT--LLGRGHSSIQFNWQTRRNICIGVAKGLA-FLH 189 (415)
Q Consensus 121 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH 189 (415)
-..+. .|-+ -|.+=.++.+ .....|+||||+|..+.+. |...+ ++... ++..+.++.. .|-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~---i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHD---ILNKLVEAYLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHH---HHHHHHHHHHHHHH
Confidence 33322 3444 1222223322 3467999999999877654 44443 44443 3333333322 222
Q ss_pred hcCCCCcEecCCCCCCeeec----CCCCeEEeeeccccccCCC
Q 044232 190 EEVQPHIVHRDIKASNILLD----KDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 190 ~~~~~~ivH~Dlkp~NIll~----~~~~~kl~DfGla~~~~~~ 228 (415)
.. |++|+|=.|.||+++ .++.+.+.|||+.......
T Consensus 319 ~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22 999999999999998 3678999999999866543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.7e-09 Score=103.40 Aligned_cols=186 Identities=19% Similarity=0.136 Sum_probs=138.2
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCCeeEEEEeeccC
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN-LVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+...+.+++|++++++|.+....+....+++... ....-++++|.+++||| .+..++-+..++..+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 4445678999999999988654444446666554 22334889999999999 77777878888889999999987
Q ss_pred C-CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 153 N-SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 153 g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+ +..... ......+...+...++..-+++|++||+. .=+|+| ||+..+ +..+.+||+....+....
T Consensus 319 ~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 319 GRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 7 222111 11122344445556667777899999987 558888 777665 689999999998775543
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTN 277 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~ 277 (415)
......+|+.++|||+.....+..+.|+|++|+-..++.-|-.|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3455679999999999999999999999999998888887766543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.1e-07 Score=81.76 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=85.0
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeeeeEEEe---CCeeEEEEeecc
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELYGCCVE---GDHRILVYGYLE 151 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 151 (415)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999877 58899987665 3445677888888888533 35666664433 335689999999
Q ss_pred CCCHHH----------------Hh---hcCCCCCCccCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 044232 152 NNSLAQ----------------TL---LGRGHSSIQFNWQT---------RRNI------------CIGVAK-GLAFLHE 190 (415)
Q Consensus 152 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~ 190 (415)
|..+.. .+ +........+.+.. .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 11100111111110 0000 011222 2333332
Q ss_pred c----CCCCcEecCCCCCCeeec-CCCCeEEeeecccc
Q 044232 191 E----VQPHIVHRDIKASNILLD-KDLTPKISDFGLAK 223 (415)
Q Consensus 191 ~----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~ 223 (415)
. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234799999999999999 66677899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-06 Score=78.65 Aligned_cols=140 Identities=15% Similarity=0.115 Sum_probs=85.3
Q ss_pred ccccCe-EEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEeeccCCCHHH
Q 044232 80 IGQGGF-GSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYLENNSLAQ 157 (415)
Q Consensus 80 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 157 (415)
|-.|.. ..||+.... +..+.+|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998765 4678888876543 234567888888873 3446678887776667899999999987764
Q ss_pred Hh-------------------hcCCCCCCccCHH--HHHHHHH--------------------HHHHHHHHHHhc----C
Q 044232 158 TL-------------------LGRGHSSIQFNWQ--TRRNICI--------------------GVAKGLAFLHEE----V 192 (415)
Q Consensus 158 ~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~L~~LH~~----~ 192 (415)
.. +.......++... ....... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1111100011100 0000000 011112222111 1
Q ss_pred CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 193 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
.+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3468999999999999998778999998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-05 Score=71.00 Aligned_cols=128 Identities=22% Similarity=0.298 Sum_probs=91.5
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccc----------------hHhHHHHHHHHHHHhhcC------Ccceeeee
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS----------------RQGVREFLTEINVIKDIK------HENLVELY 134 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 134 (415)
...||+|+.-.||. +.+.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999997 4444556788887655 122355667777666665 88999999
Q ss_pred eEEEeCCeeEEEEeeccCC------CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 044232 135 GCCVEGDHRILVYGYLENN------SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208 (415)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 208 (415)
|+.+++-...+|+|.+.+. +|.+++... .++. . +...+-+-..||-+. .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 9999999999999987432 577888544 2443 2 223334445677777 89999999999999
Q ss_pred cCCC----CeEEee
Q 044232 209 DKDL----TPKISD 218 (415)
Q Consensus 209 ~~~~----~~kl~D 218 (415)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.9e-06 Score=75.58 Aligned_cols=105 Identities=20% Similarity=0.218 Sum_probs=81.9
Q ss_pred HHHHHHHhhcCC-cceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 044232 116 LTEINVIKDIKH-ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194 (415)
Q Consensus 116 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 194 (415)
.+|.-+++.+++ +++++++|+|- .++|.||...+++........ .-...+|..+.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888876 69999999993 467999998776643210000 001568999999999999999999986444
Q ss_pred CcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 195 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
.+.-.|++++|+-++++|++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6777999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.3e-06 Score=70.88 Aligned_cols=129 Identities=21% Similarity=0.293 Sum_probs=89.6
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceee-eeeEEEeCCeeEEEEeeccCC
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE-LYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 153 (415)
...+.||+|.+|.||+|.+.++ .+|+|+-+.+++. ..+..|+++|..+.-.++-+ ++.+.. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 3457899999999999999754 7899988776554 56788999999987665543 444432 34559999998
Q ss_pred CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC-CCCeeecCCCCeEEeeeccccc
Q 044232 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK-ASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 154 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfGla~~ 224 (415)
.|.+.-... ....+ ..+++.---|-.. ||-|..|. |..++|..++.+.|+||..|..
T Consensus 98 ~L~~~~~~~-------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887655321 12222 2344553334444 99999996 5555555666999999998873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.3e-06 Score=89.27 Aligned_cols=148 Identities=17% Similarity=0.295 Sum_probs=91.3
Q ss_pred CCcccccCeEEEEEEEecCC---CEEEEEEccccc-hHhHHHHHHHHHHHhhcC-Ccce--eeeeeEEEeC---CeeEEE
Q 044232 77 ANKIGQGGFGSVYKGTLKDG---TLAAIKVLSADS-RQGVREFLTEINVIKDIK-HENL--VELYGCCVEG---DHRILV 146 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 146 (415)
++.|+.|.++.+|+....++ ..+++|+..... ......+.+|+.+|+.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999877643 356777764432 122346778999999995 6664 7888888764 357899
Q ss_pred EeeccCCCHHH--------------------H---hhcCCCCC-------CccC--HHHHHHHHH---------------
Q 044232 147 YGYLENNSLAQ--------------------T---LLGRGHSS-------IQFN--WQTRRNICI--------------- 179 (415)
Q Consensus 147 ~e~~~~gsL~~--------------------~---l~~~~~~~-------~~l~--~~~~~~i~~--------------- 179 (415)
|||++|..+.+ . |+...... .+.. ..++..|..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998865321 1 11111000 0001 111211111
Q ss_pred HHHHHHHHHHhcC--------CCCcEecCCCCCCeeecCC-CC-eEEeeeccccc
Q 044232 180 GVAKGLAFLHEEV--------QPHIVHRDIKASNILLDKD-LT-PKISDFGLAKL 224 (415)
Q Consensus 180 ~i~~~L~~LH~~~--------~~~ivH~Dlkp~NIll~~~-~~-~kl~DfGla~~ 224 (415)
.+...+.+|..+. ++.++|+|+++.|||++.+ +. +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 1233456664432 1359999999999999853 33 57999998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.5e-06 Score=74.68 Aligned_cols=74 Identities=18% Similarity=0.243 Sum_probs=46.7
Q ss_pred CCcccccCeE-EEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc---ceeeeeeEEEeC---CeeEEEEee
Q 044232 77 ANKIGQGGFG-SVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE---NLVELYGCCVEG---DHRILVYGY 149 (415)
Q Consensus 77 ~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~ 149 (415)
++.|+.|+.. .||+. +..+++|+.+... ....+.+|++++..+... -+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4567877776 48875 2346778765432 234677899999887532 344455544332 234889999
Q ss_pred ccCCCHH
Q 044232 150 LENNSLA 156 (415)
Q Consensus 150 ~~~gsL~ 156 (415)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=75.34 Aligned_cols=78 Identities=13% Similarity=0.106 Sum_probs=57.2
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC---cceeeeeeEEEeC---CeeEEEEe
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH---ENLVELYGCCVEG---DHRILVYG 148 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e 148 (415)
.-.+.||.|..+.||.....+++ +++|..+.... ...+..|+..|+.+.- -.+.+++++|..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34567999999999998766564 66677543111 2467789999988843 4688888887643 56899999
Q ss_pred eccCCCH
Q 044232 149 YLENNSL 155 (415)
Q Consensus 149 ~~~~gsL 155 (415)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.1e-05 Score=74.52 Aligned_cols=140 Identities=11% Similarity=0.088 Sum_probs=79.7
Q ss_pred cccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeeccCCCHHH
Q 044232 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYLENNSLAQ 157 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 157 (415)
.+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ .+++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 466788889998874 466788887654422211134678888888854333 34444432 368999999876532
Q ss_pred H-----------------hhcCCCCCCccCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCcEecCCCCCC
Q 044232 158 T-----------------LLGRGHSSIQFNWQ-TRRNICIGV---------AKGLAFLHEE-----VQPHIVHRDIKASN 205 (415)
Q Consensus 158 ~-----------------l~~~~~~~~~l~~~-~~~~i~~~i---------~~~L~~LH~~-----~~~~ivH~Dlkp~N 205 (415)
. ++.......+++.. ....+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12111111122211 111111111 1112222111 13368999999999
Q ss_pred eeecCCCCeEEeeeccccc
Q 044232 206 ILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 206 Ill~~~~~~kl~DfGla~~ 224 (415)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999887 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.3e-05 Score=66.35 Aligned_cols=125 Identities=23% Similarity=0.346 Sum_probs=89.4
Q ss_pred cCCCCCCcccccCe-EEEEEEEecCCCEEEEEEccc---cch------------------HhHHHHHHHHHHHhhcC---
Q 044232 72 ENFSPANKIGQGGF-GSVYKGTLKDGTLAAIKVLSA---DSR------------------QGVREFLTEINVIKDIK--- 126 (415)
Q Consensus 72 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 126 (415)
.+++.++.||.|.- |.||+++.. |+.+|+|++.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999985 66899999321 100 11235777888777774
Q ss_pred Ccce--eeeeeEEEeC------------------CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHH
Q 044232 127 HENL--VELYGCCVEG------------------DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186 (415)
Q Consensus 127 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~ 186 (415)
+.++ |+.+|+..-. ....||.||++... .+.. .-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 4456 9999997422 12367888876643 1122 23445777788
Q ss_pred HHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 187 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999985 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.9e-05 Score=70.70 Aligned_cols=142 Identities=16% Similarity=0.211 Sum_probs=82.4
Q ss_pred CCcccccCeEEEEEEEecC--CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCCeeEEEEeeccCC
Q 044232 77 ANKIGQGGFGSVYKGTLKD--GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN-LVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
++.|..|-...+|+....+ +..+++|+........ -...+|+.++..+...+ .+++++.+. -.+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3568888899999998764 6778899876542221 22236888888885333 444544432 24899999987
Q ss_pred CHHHH-----------------hhcCCCCC--------CccCHHHHHHHHHH----------------------HHHHHH
Q 044232 154 SLAQT-----------------LLGRGHSS--------IQFNWQTRRNICIG----------------------VAKGLA 186 (415)
Q Consensus 154 sL~~~-----------------l~~~~~~~--------~~l~~~~~~~i~~~----------------------i~~~L~ 186 (415)
++... ++...... ....+..+..+... +...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 11111100 01112222222111 111111
Q ss_pred HH----Hhc-CCCCcEecCCCCCCeeecC-CCCeEEeeecccc
Q 044232 187 FL----HEE-VQPHIVHRDIKASNILLDK-DLTPKISDFGLAK 223 (415)
Q Consensus 187 ~L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~ 223 (415)
.| -.. ....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 111 1336999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00023 Score=69.51 Aligned_cols=75 Identities=15% Similarity=0.212 Sum_probs=54.4
Q ss_pred CcccccCeEEEEEEEecCC-CEEEEEEcccc-----c--hHhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCCeeEEE
Q 044232 78 NKIGQGGFGSVYKGTLKDG-TLAAIKVLSAD-----S--RQGVREFLTEINVIKDIK---HENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 146 (415)
+.||.|.++.||++...+| +.++||.-... . .....++..|.+.|..+. -.++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 47999985421 1 123456677888888762 2457777776 44567899
Q ss_pred EeeccCCC
Q 044232 147 YGYLENNS 154 (415)
Q Consensus 147 ~e~~~~gs 154 (415)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.3e-05 Score=83.32 Aligned_cols=196 Identities=23% Similarity=0.255 Sum_probs=137.4
Q ss_pred HHHHHHHhhcCCcceeeeeeEEEeCCeeE----EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc
Q 044232 116 LTEINVIKDIKHENLVELYGCCVEGDHRI----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191 (415)
Q Consensus 116 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 191 (415)
.-|...+.+..|+|++.++.+........ +..+++...++...+..-+ ..+..+.+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34677778889999999999876544332 4457888888888887665 678889999999999999999998
Q ss_pred CCCCcEecCCCCC---CeeecCCCCeEEe--eeccccccCCCCcceecccccCCCCCChhhhhcCCCC--ccceEeehhH
Q 044232 192 VQPHIVHRDIKAS---NILLDKDLTPKIS--DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT--RKADIYSFGV 264 (415)
Q Consensus 192 ~~~~ivH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~DvwSlGv 264 (415)
...|.-|..+ +--++.++.+.++ ||+.+..++..... .....+..+.|||......+. ...|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 6666655555 5566777777777 99888766543222 122235568888877665544 4479999999
Q ss_pred hHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 265 LLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 265 vl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.+..+..|..+..... ....+.+. .....+......|+..++++|++..+++..
T Consensus 381 l~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999998854322100 00001110 111146677889999999999999999875
Q ss_pred hh
Q 044232 345 LI 346 (415)
Q Consensus 345 L~ 346 (415)
..
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 53
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00013 Score=68.97 Aligned_cols=143 Identities=16% Similarity=0.152 Sum_probs=84.7
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeeeeE------EEeCCeeEEEEe
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELYGC------CVEGDHRILVYG 148 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 148 (415)
.+.|..|....+|+....++ .+++|+..... ......|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 46788888899999876544 57888876522 23455677777777432 24444432 123456689999
Q ss_pred eccCCCHHH----H----------hhcC----CCC---CCccCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 044232 149 YLENNSLAQ----T----------LLGR----GHS---SIQFNWQTRR----------NICIGVAKGLAFLHE----EVQ 193 (415)
Q Consensus 149 ~~~~gsL~~----~----------l~~~----~~~---~~~l~~~~~~----------~i~~~i~~~L~~LH~----~~~ 193 (415)
|++|..+.. . ++.. ... .....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876531 0 1110 000 0011221110 011113334445443 123
Q ss_pred CCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 194 PHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 194 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=9.8e-05 Score=69.98 Aligned_cols=141 Identities=23% Similarity=0.251 Sum_probs=84.1
Q ss_pred CcccccCeEEEEEEEecC-------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKD-------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN-LVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 149 (415)
+.|..|-...+|+....+ +..+++|+....... .....+|..++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456778888999988654 578899997654322 234456888888875333 3455555532 358999
Q ss_pred ccCCCHHHH-----------------hhcCCCC-------CCccCHHHHHHH--------------------------HH
Q 044232 150 LENNSLAQT-----------------LLGRGHS-------SIQFNWQTRRNI--------------------------CI 179 (415)
Q Consensus 150 ~~~gsL~~~-----------------l~~~~~~-------~~~l~~~~~~~i--------------------------~~ 179 (415)
++|..+... ++..... ..+.-+.....+ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1111111 001111111111 11
Q ss_pred HHHHHHHHHHh------cCCCCcEecCCCCCCeeecCC----CCeEEeeecccc
Q 044232 180 GVAKGLAFLHE------EVQPHIVHRDIKASNILLDKD----LTPKISDFGLAK 223 (415)
Q Consensus 180 ~i~~~L~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~ 223 (415)
.+...+..|-. .....++|+|+.+.|||++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 134578999999999999985 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00052 Score=65.58 Aligned_cols=143 Identities=16% Similarity=0.194 Sum_probs=77.6
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeeee------EEEeCCeeEEEEe
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELYG------CCVEGDHRILVYG 148 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e 148 (415)
.+.|+.|....+|+....+| .+++|+...... .....|+.++..|... .+.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677888889999887666 578888752222 2233355555555211 1333332 1223456789999
Q ss_pred eccCCCHH-----------HHh---hcCCC-------CCCccCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 044232 149 YLENNSLA-----------QTL---LGRGH-------SSIQFNW-QTRRN------------ICIG-VAKGLAFLHEE-- 191 (415)
Q Consensus 149 ~~~~gsL~-----------~~l---~~~~~-------~~~~l~~-~~~~~------------i~~~-i~~~L~~LH~~-- 191 (415)
|++|..+. +.+ +.... ....+.| ..... .+.+ +...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99987531 111 11100 0001111 11111 1111 11122333211
Q ss_pred --CCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 192 --VQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 192 --~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
...+++|+|+.|.||+++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24489999999999999977666899999886
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5.3e-05 Score=70.38 Aligned_cols=136 Identities=15% Similarity=0.136 Sum_probs=95.0
Q ss_pred CCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc-----------------hHh-----HHHHHHHHHHHhhcCC-c-
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-----------------RQG-----VREFLTEINVIKDIKH-E- 128 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~E~~~l~~l~h-~- 128 (415)
-+.+.++||-|.-+.||.+....|++.++|+-+... ... .-...+|++.|+.|.- -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367789999999999999999999999998643210 000 1124468888888842 2
Q ss_pred ceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 044232 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208 (415)
Q Consensus 129 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 208 (415)
-+.+.+++ +..++|||++.|-.|...-+-. +.. .+...+..-+--|-.+ |+||+|..--||+|
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecC-------ChH---HHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 35555554 4568899999888776543211 122 2333344445556666 99999999999999
Q ss_pred cCCCCeEEeeecccccc
Q 044232 209 DKDLTPKISDFGLAKLF 225 (415)
Q Consensus 209 ~~~~~~kl~DfGla~~~ 225 (415)
++++.++++||-.+...
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00072 Score=64.26 Aligned_cols=144 Identities=16% Similarity=0.211 Sum_probs=81.9
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeeeeEE------EeCCeeEEEEe
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELYGCC------VEGDHRILVYG 148 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e 148 (415)
++.++.|....+|+....+| .+++|+...... ......|++++..|... .+.+++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677888889999876555 467787655321 13344566777666322 234444321 22456789999
Q ss_pred eccCCCHH-----------HH---hhcCCC----CC----CccCHHHHH------------HHHHHHHHHHHHHHh----
Q 044232 149 YLENNSLA-----------QT---LLGRGH----SS----IQFNWQTRR------------NICIGVAKGLAFLHE---- 190 (415)
Q Consensus 149 ~~~~gsL~-----------~~---l~~~~~----~~----~~l~~~~~~------------~i~~~i~~~L~~LH~---- 190 (415)
|++|..+. .. ++.... .. ..-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99886532 00 111100 00 001111110 001123334555532
Q ss_pred cCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 191 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
....+++|+|+++.||+++.++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00064 Score=64.41 Aligned_cols=140 Identities=21% Similarity=0.244 Sum_probs=95.7
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEcccc-------------------------chHhHH-HHHHHHHHHhhcCCc
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD-------------------------SRQGVR-EFLTEINVIKDIKHE 128 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------------------------~~~~~~-~~~~E~~~l~~l~h~ 128 (415)
.+...|..|--+.||.|...+|..+|||+.+.. .+...+ ....|+.-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345688999999999999999999999987421 111111 233577777777544
Q ss_pred ceeeeeeEEEeCCeeEEEEeeccCCCHH-HHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 044232 129 NLVELYGCCVEGDHRILVYGYLENNSLA-QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207 (415)
Q Consensus 129 niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 207 (415)
.|.-.--+.. ....|||+|+.+..-. -.|. ...++...+..+-.+++.-|.-|...| ++||.||.--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 4322111111 1346899999532211 1122 125667778888889999999998776 8999999999999
Q ss_pred ecCCCCeEEeeeccccc
Q 044232 208 LDKDLTPKISDFGLAKL 224 (415)
Q Consensus 208 l~~~~~~kl~DfGla~~ 224 (415)
+- +|.+.|+|.+.+..
T Consensus 298 yh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSVE 313 (520)
T ss_pred EE-CCEEEEEEcccccc
Confidence 84 56899999887753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00085 Score=62.67 Aligned_cols=31 Identities=32% Similarity=0.550 Sum_probs=26.0
Q ss_pred CCcEecCCCCCCeeecCCCC-eEEeeeccccc
Q 044232 194 PHIVHRDIKASNILLDKDLT-PKISDFGLAKL 224 (415)
Q Consensus 194 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~ 224 (415)
+.++|+|++|.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997565 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00068 Score=65.45 Aligned_cols=142 Identities=15% Similarity=0.205 Sum_probs=83.5
Q ss_pred CcccccCeEEEEEEEecC-----CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeecc
Q 044232 78 NKIGQGGFGSVYKGTLKD-----GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 151 (415)
..|-.|-...+|++...+ ++.|++|+.......... -.+|..++..+..-++ .++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456668888999987542 367899988665433222 2568888888854433 3455655332 5899998
Q ss_pred CCCHHHH-----------------hhcCCCC--CCccCHHHHHHHHHHH-----------------HHHHHHHH----h-
Q 044232 152 NNSLAQT-----------------LLGRGHS--SIQFNWQTRRNICIGV-----------------AKGLAFLH----E- 190 (415)
Q Consensus 152 ~gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~i-----------------~~~L~~LH----~- 190 (415)
+.+|... ++..... .....+..+..+..++ ...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 1111110 1112233333333221 11122222 1
Q ss_pred cCCCCcEecCCCCCCeeecC-CCCeEEeeeccccc
Q 044232 191 EVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKL 224 (415)
Q Consensus 191 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~ 224 (415)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11336899999999999986 46899999988763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00074 Score=63.24 Aligned_cols=73 Identities=19% Similarity=0.238 Sum_probs=47.5
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc---CCcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI---KHENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
.+.++.|....+|+.. .+++.+.||+-.... ...|..|+.-|+.| .--.+++++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678999999999977 567788999876322 24567788888777 3446889999988888889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0015 Score=61.78 Aligned_cols=139 Identities=22% Similarity=0.312 Sum_probs=84.1
Q ss_pred CCCcccccCeEEEEEEEecCCCEEEEEEccc--cchHhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCC--eeEEEEee
Q 044232 76 PANKIGQGGFGSVYKGTLKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKH--ENLVELYGCCVEGD--HRILVYGY 149 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~ 149 (415)
+++.+-.|....+|..... ++.+++. ... ..........+|+.+++.+.- --+...+++|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444544444455555444 6677777 321 223334555678888877743 24555677777665 66999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHH-HHHHHHHHHH---------------------------------------
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICI-GVAKGLAFLH--------------------------------------- 189 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~-~i~~~L~~LH--------------------------------------- 189 (415)
++|..+.+.+.... .. .+.+. .++..|+-||
T Consensus 107 veGe~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 107 VEGEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred ecceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 98854433221110 00 11111 3444444444
Q ss_pred -----------hc-----CCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 190 -----------EE-----VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 190 -----------~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
.+ .++.++|+|+++.||+++.++.+-+.||+++..-
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 1346899999999999999988999999998753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=9.6e-06 Score=88.02 Aligned_cols=159 Identities=13% Similarity=0.027 Sum_probs=116.6
Q ss_pred HHHHHHHHhhcCCcceeeeeeEEEe--CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC
Q 044232 115 FLTEINVIKDIKHENLVELYGCCVE--GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192 (415)
Q Consensus 115 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 192 (415)
...|...++...|+++.....-... ....+.+++|+.+|.+...|.........+...-+.....+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556666789988877665543 34678899999999999999766544434444444333334356666666553
Q ss_pred C--CCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHH
Q 044232 193 Q--PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIV 270 (415)
Q Consensus 193 ~--~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 270 (415)
. .-.+|++||+-|.+|..+.++|++++|+.+..... ....+...+++.|++|++...-.++.++|+|..|+-+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2 23689999999999999999999999999844332 23334556788899999998889999999999999999998
Q ss_pred hCCc
Q 044232 271 SGRC 274 (415)
Q Consensus 271 tg~~ 274 (415)
-|..
T Consensus 1435 ~~n~ 1438 (2724)
T KOG1826|consen 1435 DGNA 1438 (2724)
T ss_pred cccH
Confidence 7743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0038 Score=60.93 Aligned_cols=73 Identities=18% Similarity=0.199 Sum_probs=50.2
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccch-------HhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCCeeEEE
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR-------QGVREFLTEINVIKDIK---HENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 146 (415)
.+.||.|....||+.... +..++||.-..... -...+-..|+..|..+. -.++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467999999999998864 44588887652110 12233444677776653 247888888877 446789
Q ss_pred EeeccC
Q 044232 147 YGYLEN 152 (415)
Q Consensus 147 ~e~~~~ 152 (415)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0017 Score=57.44 Aligned_cols=118 Identities=20% Similarity=0.164 Sum_probs=74.3
Q ss_pred cCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcC
Q 044232 83 GGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGR 162 (415)
Q Consensus 83 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 162 (415)
|+.++.-.++.+-|..+..|+...+..-...-|.++..++.++. .|+++..- ++-.+.++.|+|..-..
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 34455555554445444444433332223355778889988875 57777632 44467799999843211
Q ss_pred CCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 163 GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 163 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
. . ..++..=+.+|.-.|+. ..+.+|+|-.|+|||-|..|.+||.|-+..
T Consensus 142 -------~--~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------N--F-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------c--h-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 0 11111124667788965 348999999999999999999999997654
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0055 Score=58.79 Aligned_cols=80 Identities=13% Similarity=0.155 Sum_probs=50.8
Q ss_pred CcccccCeEEEEEEEecCC-CEEEEEEccc-------cchHhHHHHHHHHHHHhhcC--Cc-ceeeeeeEEEeCCeeEEE
Q 044232 78 NKIGQGGFGSVYKGTLKDG-TLAAIKVLSA-------DSRQGVREFLTEINVIKDIK--HE-NLVELYGCCVEGDHRILV 146 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 146 (415)
+.||.|....||++...+| +.|+||.-.. .-+....+..-|...|+... -| .+++++.+ +.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3589999999999997654 5788886432 11223345556777776653 24 45555543 44566799
Q ss_pred EeeccCCC-HHHHh
Q 044232 147 YGYLENNS-LAQTL 159 (415)
Q Consensus 147 ~e~~~~gs-L~~~l 159 (415)
||+++... |.+.|
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 99996543 43444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.006 Score=58.03 Aligned_cols=32 Identities=22% Similarity=0.317 Sum_probs=28.7
Q ss_pred CCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 193 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+.+++|+|+.++|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0029 Score=60.76 Aligned_cols=142 Identities=15% Similarity=0.231 Sum_probs=81.0
Q ss_pred CcccccCeEEEEEEEecC----CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLKD----GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 152 (415)
+.|..|-...+|+....+ +..|++|+........ -.-.+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 456668888899987543 2378899876543322 223468888888865444 3556555322 58999977
Q ss_pred CCHHH-----------------HhhcCCCC--CCccCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 044232 153 NSLAQ-----------------TLLGRGHS--SIQFNWQTRRNICIGV----------------------AKGLAFLHE- 190 (415)
Q Consensus 153 gsL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~~i----------------------~~~L~~LH~- 190 (415)
..|.. .++..... ..+-.|..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76521 11111111 0111233333332221 111222211
Q ss_pred ---c-CCCCcEecCCCCCCeeecC-CCCeEEeeeccccc
Q 044232 191 ---E-VQPHIVHRDIKASNILLDK-DLTPKISDFGLAKL 224 (415)
Q Consensus 191 ---~-~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~ 224 (415)
. ....+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1224799999999999975 57899999988853
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0021 Score=63.50 Aligned_cols=50 Identities=20% Similarity=0.260 Sum_probs=39.4
Q ss_pred HHHHHHHHHHhhcCCcceeeeeeEEEeCC-eeEEEEeeccCCCHHHHhhcCC
Q 044232 113 REFLTEINVIKDIKHENLVELYGCCVEGD-HRILVYGYLENNSLAQTLLGRG 163 (415)
Q Consensus 113 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~ 163 (415)
...+-..++++.+.|+|+...+++-.... ...+|+|++ +.||++.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 34556678899999999999999876543 467889998 779999887654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0083 Score=57.27 Aligned_cols=142 Identities=20% Similarity=0.341 Sum_probs=83.0
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC---cc---eeeeeeE----EEeCCeeEEEE
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH---EN---LVELYGC----CVEGDHRILVY 147 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~l~~~----~~~~~~~~lv~ 147 (415)
..|.+ .-..+|+....+|.. ++|+.+.. ....+...|...+..+.- += +..+-|- .......+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34555 567899998887776 89998876 222445557777777731 11 2222221 11223678899
Q ss_pred eeccCCCHHH-H--------------hh----c----CCCCCCccCHHH-------------HHHHHHHHHHHHHHHHhc
Q 044232 148 GYLENNSLAQ-T--------------LL----G----RGHSSIQFNWQT-------------RRNICIGVAKGLAFLHEE 191 (415)
Q Consensus 148 e~~~~gsL~~-~--------------l~----~----~~~~~~~l~~~~-------------~~~i~~~i~~~L~~LH~~ 191 (415)
+|++|..+.. . |+ . +........|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988772 1 01 0 011111223320 001223344444444433
Q ss_pred C----CCC---cEecCCCCCCeeecCCCC-eEEeeecccc
Q 044232 192 V----QPH---IVHRDIKASNILLDKDLT-PKISDFGLAK 223 (415)
Q Consensus 192 ~----~~~---ivH~Dlkp~NIll~~~~~-~kl~DfGla~ 223 (415)
. ... +||+|+.|.||+++.+.. +.++|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 223 899999999999999985 8999999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.037 Score=52.50 Aligned_cols=29 Identities=28% Similarity=0.356 Sum_probs=25.6
Q ss_pred CCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 194 PHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 194 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999988 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.062 Score=51.47 Aligned_cols=71 Identities=14% Similarity=0.120 Sum_probs=43.7
Q ss_pred cCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeee---e--EEEeCCeeEEEEeeccCCC
Q 044232 83 GGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELY---G--CCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 83 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gs 154 (415)
+.-..||+....++..+++|+.+... ........|+..+..+... .++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 44578999988888889999886432 1224455677777666321 122211 2 1223456788999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.02 Score=55.68 Aligned_cols=81 Identities=15% Similarity=0.189 Sum_probs=52.5
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccc------cchHhHHHHHHHHHHHhhcC--Cc-ceeeeeeEEEeCCeeEEE
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSA------DSRQGVREFLTEINVIKDIK--HE-NLVELYGCCVEGDHRILV 146 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 146 (415)
.+.||.|.-..||++... +++.|+||.-.. +-.-...+..-|...|+... -| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 467999999999999975 356788886422 11233455666888887663 34 45556554 44567789
Q ss_pred EeeccCCC-HHHHh
Q 044232 147 YGYLENNS-LAQTL 159 (415)
Q Consensus 147 ~e~~~~gs-L~~~l 159 (415)
||+++... |.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 99986543 44443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0054 Score=54.79 Aligned_cols=29 Identities=38% Similarity=0.565 Sum_probs=21.0
Q ss_pred CcEecCCCCCCeee-cCCCCeEEeeecccc
Q 044232 195 HIVHRDIKASNILL-DKDLTPKISDFGLAK 223 (415)
Q Consensus 195 ~ivH~Dlkp~NIll-~~~~~~kl~DfGla~ 223 (415)
.+.|.|+.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.069 Score=47.76 Aligned_cols=76 Identities=14% Similarity=0.206 Sum_probs=52.9
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK---HENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
.+.+..|.--..|...+ +...+.+|+-.. .....|..|+.-|..|. .-++.+++.+..+.++.|+|+||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555555443 456788886533 34466788887777663 456888888888999999999999987
Q ss_pred CHH
Q 044232 154 SLA 156 (415)
Q Consensus 154 sL~ 156 (415)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.055 Score=59.76 Aligned_cols=143 Identities=18% Similarity=0.276 Sum_probs=79.6
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC-------Ccceeeee-e----EEEe-CC--e
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-------HENLVELY-G----CCVE-GD--H 142 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~-~~--~ 142 (415)
+.|+ |..-.+|+....+|..+++|+.+..... .....|.++|..|. -|.+++-. | .... .. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 4568889988878888999999865322 23334555665442 23333322 1 1111 12 4
Q ss_pred eEEEEeeccCCCHHHHh---------------------hcCCC--CCCccCHHH-----------------HHHHHHHHH
Q 044232 143 RILVYGYLENNSLAQTL---------------------LGRGH--SSIQFNWQT-----------------RRNICIGVA 182 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l---------------------~~~~~--~~~~l~~~~-----------------~~~i~~~i~ 182 (415)
.+-+++|++|..+.+.. ..... ....+.|.. .+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 67789999998776510 00110 011222321 122222333
Q ss_pred HHHHH----HHhcCCCCcEecCCCCCCeeecCCC--CeE-Eeeecccc
Q 044232 183 KGLAF----LHEEVQPHIVHRDIKASNILLDKDL--TPK-ISDFGLAK 223 (415)
Q Consensus 183 ~~L~~----LH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~DfGla~ 223 (415)
....- .-.....++||+|+.+.|||++.++ ++. |+|||.+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 32221 1122344799999999999999875 555 99999886
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.016 Score=55.10 Aligned_cols=103 Identities=17% Similarity=0.152 Sum_probs=69.1
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...|++|++- |+.|.-.- ...+.+...++.+.+.-+.-+..+. ..-|||+.-.||||+ +|+|-|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 3556777765 55553221 3457888999999888888887764 789999999999999 9999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeeh
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSF 262 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 262 (415)
+++.-... ... .....--|-.+.| .-+..-|||-+
T Consensus 367 lsRl~~~q-~~i-----sy~rldhp~lF~G-~dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQ-GII-----SYNRLDHPDLFNG-VDDYQFEIYRL 401 (488)
T ss_pred eeecccCC-cee-----eccccCchhhhcC-ccceeeeHHHH
Confidence 99943222 111 1122334555543 33555566653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.044 Score=53.59 Aligned_cols=75 Identities=23% Similarity=0.275 Sum_probs=45.7
Q ss_pred CCcccccCeEEEEEEEecCC--C-----EEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEe
Q 044232 77 ANKIGQGGFGSVYKGTLKDG--T-----LAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYG 148 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 148 (415)
++.|..|-.+.+|++...++ . .|.+.......... -.-.+|+.+++.+...++ .++++.+. -++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 34666788899999976532 1 24444432221111 122458999999865544 45566553 258999
Q ss_pred eccCCCHH
Q 044232 149 YLENNSLA 156 (415)
Q Consensus 149 ~~~~gsL~ 156 (415)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99988764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.026 Score=54.50 Aligned_cols=61 Identities=16% Similarity=0.123 Sum_probs=44.2
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD 209 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 209 (415)
...|+-+|.+|-++..++.... .++....+++.-.+.||..+---. +++|.|+.|.||++-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 4567778899999999887653 345566667666666665443321 899999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 415 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-61 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-27 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-26 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-179
Identities = 125/300 (41%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 59 TNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGV-REFLT 117
+ ++L+VA++NFS N +G+GGFG VYKG L DGTL A+K L + QG +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 118 EINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI 177
E+ +I H NL+ L G C+ R+LVY Y+ N S+A L R S +W R+ I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
+G A+GLA+LH+ P I+HRD+KA+NILLD++ + DFGLAKL TH++T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 238 GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ--YLLEMAWKLY 295
GT G++APEY G+ + K D++ +GV+LLE+++G+ + + LL+ L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEE 355
+ KL LVD L G+Y EE + +++ALLCTQ P RP MS +V ML G+ + E
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 438 bits (1130), Expect = e-154
Identities = 118/294 (40%), Positives = 171/294 (58%), Gaps = 4/294 (1%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIK 123
DL AT NF IG G FG VYKG L+DG A+K + +S QG+ EF TEI +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+H +LV L G C E + IL+Y Y+EN +L + L G ++ +W+ R ICIG A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP-ANLTHISTRVAGTEGY 242
GL +LH I+HRD+K+ NILLD++ PKI+DFG++K + TH+ST V GT GY
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
+ PEY I+G+LT K+D+YSFGV+L E++ R + LP E L E A + + G+L +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEI 356
+VD +L E ++ A+ C + RPSM ++ L + + + I
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-147
Identities = 110/305 (36%), Positives = 164/305 (53%), Gaps = 23/305 (7%)
Query: 55 EIQDTNL--YGYKDLRVATENFSP------ANKIGQGGFGSVYKGTLKDGTLAAIKVLSA 106
E+ DT + + +L+ T NF NK+G+GGFG VYKG + + T A+K L+A
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 107 ----DSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGR 162
+ + ++F EI V+ +HENLVEL G +GD LVY Y+ N SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 163 GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222
+ +W R I G A G+ FLHE H +HRDIK++NILLD+ T KISDFGLA
Sbjct: 125 -DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 223 KLFPAN-LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281
+ T +++R+ GT Y+APE +RG++T K+DIYSFGV+LLEI++G +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 282 YEEQYLLEMAWKLY-ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMST 340
Q LL++ ++ E + + +D + D +A C + +RP +
Sbjct: 240 --PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 341 LVNML 345
+ +L
Sbjct: 297 VQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 2e-84
Identities = 72/306 (23%), Positives = 121/306 (39%), Gaps = 30/306 (9%)
Query: 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVI 122
G ++L + +G FG V+K L A+K+ +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYSL 72
Query: 123 KDIKHENLVELYGCCVEGDH----RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
+KHEN+++ G G L+ + E SL+ L +W +I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIA 127
Query: 179 IGVAKGLAFLHEEVQ-------PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231
+A+GLA+LHE++ P I HRDIK+ N+LL +LT I+DFGLA F A +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 232 I-STRVAGTEGYLAPEYA-----IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
+ GT Y+APE + + D+Y+ G++L E+ S + +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 286 YLLEMAWKLYERGKLVELVDA-----SLNGDYSVEEAHRYL-KIALLCTQDMPKRRPSMS 339
E + + E+V L + L + C + R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 340 TLVNML 345
+ +
Sbjct: 308 CVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 5e-69
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 43/317 (13%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIK 123
+ + +N IG+G +G+VYKG+L D A+KV S +RQ I +
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYRVP 62
Query: 124 DIKHENLVELYGCCVEGD-----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
++H+N+ +LV Y N SL + L +W + +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLA 117
Query: 179 IGVAKGLAFLHEEV------QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN---- 228
V +GLA+LH E+ +P I HRD+ + N+L+ D T ISDFGL+ N
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 229 ---LTHISTRVAGTEGYLAPEYA-------IRGQLTRKADIYSFGVLLLEIVSGRCNTNR 278
+ + GT Y+APE ++ D+Y+ G++ EI RC
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLF 236
Query: 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNGDY---------SVEEAHRYL-KIALLCT 328
+Y + ++ ++ A R L + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 329 QDMPKRRPSMSTLVNML 345
+ R + +
Sbjct: 297 DQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-60
Identities = 81/274 (29%), Positives = 142/274 (51%), Gaps = 29/274 (10%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYG 135
KIG G FG+V++ G+ A+K+L + V EFL E+ ++K ++H N+V G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
+ + +V YL SL + LL + + Q + + R ++ VAKG+ +LH P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-T 254
IVHR++K+ N+L+DK T K+ DFGL++ A+ S AGT ++APE +R +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPE-VLRDEPSN 217
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL---VDASLNGD 311
K+D+YSFGV+L E+ + + P+ ++ + + K +E+ ++ +
Sbjct: 218 EKSDVYSFGVILWELATL------QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--- 268
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
I C + P +RPS +T++++L
Sbjct: 269 ---------AAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-58
Identities = 62/279 (22%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYG 135
K+ + G ++KG + G +KVL S + R+F E ++ H N++ + G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 136 CCVE--GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
C H L+ ++ SL L ++ + + +A+G+AFLH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTL-E 131
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ- 252
P I + + ++++D+D+T +IS + F S ++APE A++ +
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKP 184
Query: 253 ---LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL---VDA 306
R AD++SF VLL E+V+ R +P+ + +E+ K+ G + +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVT------REVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ K+ +C + P +RP +V +L
Sbjct: 239 HVS------------KLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-58
Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 38/281 (13%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVL----SADSRQGVREFLTEINVIKDIKHENLVEL 133
IG GGFG VY+ G A+K D Q + E + +KH N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C++ + LV + L + L G+ + N + +A+G+ +LH+E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 194 PHIVHRDIKASNILLDKDLTP--------KISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
I+HRD+K+SNIL+ + + KI+DFGLA+ + AG ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAP 183
Query: 246 EYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
E IR + ++ +D++S+GVLL E+++G +P+ L +A+ + + +
Sbjct: 184 E-VIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ E + K+ C P RPS + +++ L
Sbjct: 237 S-------TCPEP--FAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-58
Identities = 78/316 (24%), Positives = 136/316 (43%), Gaps = 60/316 (18%)
Query: 56 IQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQG--- 111
+ + + +A +IG+GGFG V+KG L D ++ AIK L +G
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 112 ----VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSI 167
+EF E+ ++ ++ H N+V+LYG +V ++ L LL + H
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--- 117
Query: 168 QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-----DLTPKISDFGLA 222
W + + + +A G+ ++ + P IVHRD+++ NI L + K++DFGL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQL---TRKADIYSFGVLLLEIVSGRCNTNRR 279
+ H + + G ++APE I + T KAD YSF ++L I++G
Sbjct: 177 QQS----VHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTG------E 225
Query: 280 LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHR----------YLKIALLCTQ 329
P++E ++ + + ++ EE R + LC
Sbjct: 226 GPFDEYSYGKIKF--------INMI---------REEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 330 DMPKRRPSMSTLVNML 345
PK+RP S +V L
Sbjct: 269 GDPKKRPHFSYIVKEL 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 78 NKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGC 136
+G+G FG K T ++ G + +K L + R FL E+ V++ ++H N+++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
+ + Y++ +L + Q+ W R + +A G+A+LH +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-------------ISTRVAGTEGYL 243
+HRD+ + N L+ ++ ++DFGLA+L T V G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 244 APEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL-- 300
APE I G+ K D++SFG++L EI+ R + M + L RG L
Sbjct: 190 APE-MINGRSYDEKVDVFSFGIVLCEIIG------RVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 301 --VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
S I + C P++RPS L + L
Sbjct: 243 YCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-57
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 35/274 (12%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
+G+G FG V K + AIK + ++S + + F+ E+ + + H N+V+LYG C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ + LV Y E SL +L + + C+ ++G+A+LH ++
Sbjct: 71 L--NPVCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 198 HRDIKASNILLDKDLT-PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TR 255
HRD+K N+LL T KI DFG A ++ T G+ ++APE G +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE-VFEGSNYSE 182
Query: 256 KADIYSFGVLLLEIVSGRCNTNRRLPYEE--QYLLEMAWKLYE--RGKLVELVDASLNGD 311
K D++S+G++L E+++ RR P++E + W ++ R L++ + +
Sbjct: 183 KCDVFSWGIILWEVIT------RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE-- 234
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ C P +RPSM +V ++
Sbjct: 235 ----------SLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVL--SADSRQGVREFLTEINVIKDIKHENLVELYG 135
IG+G FG VY G G +A I+++ D+ ++ F E+ + +HEN+V G
Sbjct: 39 ELIGKGRFGQVYHGRWH-GEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
C+ H ++ + +L + I + R I + KG+ +LH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKL----FPANLTHISTRVAGTEGYLAPEYAIRG 251
I+H+D+K+ N+ D I+DFGL + G +LAPE IR
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI-IRQ 208
Query: 252 QL----------TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
++ +D+++ G + E+ + P++ Q + W++ G
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAR------EWPFKTQPAEAIIWQM-GTGMKP 261
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
L + + S I L C + RP+ + L++ML
Sbjct: 262 NLSQIGMGKEIS--------DILLFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-55
Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYG 135
+IG G FG+VYKG G +A +K+L+ + Q ++ F E+ V++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKWH-GDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH 195
I V + E +SL L +F + +I A+G+ +LH
Sbjct: 88 YSTAPQLAI-VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 196 IVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPEYAIRGQL- 253
I+HRD+K++NI L +D T KI DFGLA + +H +++G+ ++APE IR Q
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDS 199
Query: 254 ---TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL-VELVDASLN 309
+ ++D+Y+FG++L E+++G +LPY + ++ RG L +L N
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
R ++ C + RPS ++ +
Sbjct: 254 CP------KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 36/294 (12%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSA-DSRQGVREFLTEINVIKDIKHENLVELYGC 136
+IG+G +G V+ G + G A+KV + RE TEI ++HEN++
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99
Query: 137 CVEGDHRI----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
++G L+ Y EN SL L S + ++ + GL LH E+
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 193 -----QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI---STRVAGTEGYLA 244
+P I HRD+K+ NIL+ K+ T I+D GLA F ++ + GT+ Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 245 PEYAIRGQL-------TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
PE + L AD+YSFG++L E+ RC + + + ++
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 298 GKLVELVDA-----SLNGDYSVEEAHRYL-KIALLCTQDMPKRRPSMSTLVNML 345
+ E+V S +S +E R + K+ C P R + + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-53
Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 35/243 (14%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSA-DSRQGVREFLTEINVIKDIK 126
R + + +G+G +G V++G+ + G A+K+ S+ D + RE TE+ ++
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLR 60
Query: 127 HENLVELYGCCVEGDHRI----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
HEN++ + H L+ Y E SL L + + + + I + +A
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTT---LDTVSCLRIVLSIA 115
Query: 183 KGLAFLHEEV-----QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI---ST 234
GLA LH E+ +P I HRD+K+ NIL+ K+ I+D GLA + + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 235 RVAGTEGYLAPEYAIRGQL-------TRKADIYSFGVLLLEIVSGRCNTNR-----RLPY 282
GT+ Y+APE + + ++ DI++FG++L E+ R +N + P+
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPF 233
Query: 283 EEQ 285
+
Sbjct: 234 YDV 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 36/294 (12%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSA-DSRQGVREFLTEINVIKDIKHENLVELYGC 136
IG+G FG V++G + G A+K+ S+ + R RE EI ++HEN++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104
Query: 137 CVEGDHRI----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ + LV Y E+ SL L ++ + + + A GLA LH E+
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYT---VTVEGMIKLALSTASGLAHLHMEI 159
Query: 193 Q-----PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI---STRVAGTEGYLA 244
P I HRD+K+ NIL+ K+ T I+D GLA + I GT+ Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 245 PEYAIRGQL-------TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
PE + + ++ADIY+ G++ EI Y+ Y ++
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSV 277
Query: 298 GKLVELVDAS------LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ ++V N S E KI C R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 45/292 (15%)
Query: 78 NKIGQGGFGSVYKGTLK-----DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
++G+G FGSV G + A+K L + + +R+F EI ++K ++H+N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 133 LYGCCVEGDHR--ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G C R L+ YL SL L + + + KG+ +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT 132
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLA 244
+ +HRD+ NIL++ + KI DFGL K+ P + + G A
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----A 185
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
PE + + +D++SFGV+L E+ + + +++ + + + L+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 305 DASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ ++ R Y I C + +RPS L +
Sbjct: 243 EL-------LKNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRV 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 30/280 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLA-AIKVLSAD-SRQGVREFLTEINVIKDIKHEN 129
E+ +IG+G FG V+ G L+ A+K +FL E ++K H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V L G C + +V ++ L G + +T + A G+ +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE 230
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY----LAP 245
+ +HRD+ A N L+ + KISDFG+++ + G AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAP 284
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
E G+ + ++D++SFG+LL E + PY + + + G+L
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETF-----SLGASPYPNLSNQQTREFVEKGGRLPCPEL 339
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ ++ C P +RPS ST+ L
Sbjct: 340 CP-------DAVF---RLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 78 NKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
++G+G FGSV G + A+K L + + +R+F EI ++K ++H+N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 133 LYGCCVEGDHR--ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G C R L+ YL SL L + + + KG+ +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT 163
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----AP 245
+ +HRD+ NIL++ + KI DFGL K+ P + + G AP
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY---KVKEPGESPIFWYAP 217
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
E + + +D++SFGV+L E+ + + +++ + + + L++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 306 ASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
++ R Y I C + +RPS L +
Sbjct: 275 L-------LKNNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRV 317
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 79/353 (22%), Positives = 132/353 (37%), Gaps = 66/353 (18%)
Query: 9 YYCSQYHKLQPSPFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLR 68
+ + L+ H T ++ + + +
Sbjct: 138 LSIDEEVYFE--------NLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA 189
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE 128
+ + IG+G FG V G + G A+K + D+ + FL E +V+ ++H
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 129 NLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
NLV+L G VE + +V Y+ SL L RG S + + + V + + +
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEY 304
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLA 244
L + VHRD+ A N+L+ +D K+SDFGL K S+ + + A
Sbjct: 305 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA 354
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303
PE + + K+D++SFG+LL EI S GR PY + K ++
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRV------PYPR-----IPLK--------DV 395
Query: 304 VDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
V VE+ ++ Y + C RP+ L L
Sbjct: 396 VPR-------VEKGYKMDAPDGCPPAVY-DVMKNCWHLDAATRPTFLQLREQL 440
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 75/293 (25%), Positives = 118/293 (40%), Gaps = 48/293 (16%)
Query: 78 NKIGQGGFGSVYKGTLK-----DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
+++G+G FGSV G L A+K L R+F EI ++K + + +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 133 LYGCCVEGDHR--ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
G + LV YL + L L + H + + + + KG+ +L
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRA-RLDASRLLLYSSQICKGMEYLGS 145
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----AP 245
VHRD+ A NIL++ + KI+DFGLAKL P + V G AP
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYVVREPGQSPIFWYAP 199
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE-EQYLLEMAWKLYERGKLVEL 303
E +R++D++SFGV+L E+ + L M + L L
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYC------DKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 304 VDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
++ +EE R + ++ LC P+ RPS S L L
Sbjct: 254 LEL-------LEEGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQL 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 47/293 (16%)
Query: 78 NKIGQGGFGSVYKGTLK-----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLV 131
+G+G FG V G A+K L + + + EI +++++ HEN+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 132 ELYGCCVEGDHR--ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+ G C E L+ +L + SL + L + + N + + + + KG+ +L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLG 143
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYL 243
VHRD+ A N+L++ + KI DFGL K + + + +
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303
APE ++ + +D++SFGV L E+++ C L+M + + + L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT-YC---DSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 304 VDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
V+ ++E R Y ++ C + P R S L+
Sbjct: 253 VNT-------LKEGKRLPCPPNCPDEVY-QLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 78/337 (23%), Positives = 130/337 (38%), Gaps = 60/337 (17%)
Query: 33 HHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT 92
HH + + D + L +G+G FG V
Sbjct: 5 HHHHHHHHGALEVLFQGPGDPTVFHKRYL-------------KKIRDLGEGHFGKVSLYC 51
Query: 93 LKD-----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR--I 144
G + A+K L AD Q + EI++++ + HE++++ GCC +
Sbjct: 52 YDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111
Query: 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204
LV Y+ SL L HS + +G+A+LH + H +HRD+ A
Sbjct: 112 LVMEYVPLGSLRDYL--PRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAAR 163
Query: 205 NILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRGQLTRKADI 259
N+LLD D KI DFGLAK P +G APE + +D+
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 220
Query: 260 YSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHR 319
+SFGV L E+++ C++++ P + L+ +A + ++ L + +E R
Sbjct: 221 WSFGVTLYELLT-HCDSSQSPPTKFLELIGIA---QGQMTVLRLTEL-------LERGER 269
Query: 320 -----------YLKIALLCTQDMPKRRPSMSTLVNML 345
Y + C + RP+ L+ +L
Sbjct: 270 LPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPIL 305
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 72/317 (22%), Positives = 132/317 (41%), Gaps = 22/317 (6%)
Query: 30 LLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVY 89
L+ HH T + Y + + + +K+G G +G VY
Sbjct: 178 LVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVY 237
Query: 90 KGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148
+G K A+K L D+ + V EFL E V+K+IKH NLV+L G C ++
Sbjct: 238 EGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296
Query: 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208
++ +L L R + + + + ++ + +L ++ + +HR++ A N L+
Sbjct: 297 FMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLV 351
Query: 209 DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLE 268
++ K++DFGL++L + + APE + + K+D+++FGVLL E
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 269 IVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCT 328
I T PY L ++ L + ++ E+ + ++ C
Sbjct: 412 IA-----TYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-------EKVY---ELMRACW 456
Query: 329 QDMPKRRPSMSTLVNML 345
Q P RPS + +
Sbjct: 457 QWNPSDRPSFAEIHQAF 473
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 67/271 (24%), Positives = 106/271 (39%), Gaps = 31/271 (11%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYG 135
+IG+G F +VYKG + A L ++ + F E ++K ++H N+V Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 136 CCVEGDHR----ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LV + + +L L + R+ C + KGL FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 192 VQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
P I+HRD+K NI + + KI D GLA L A+ V GT ++APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YE 203
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ D+Y+FG+ +LE+ + PY E ++ G D
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQIYRRVTSGVKPASFDKVAI- 256
Query: 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
E ++ C + R S+ L
Sbjct: 257 ----PEVKEIIE---GCIRQNKDERYSIKDL 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 52/289 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
++ + ++G G FG V G + AIK++ S EF+ E V+ ++ HE LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LYG C + ++ Y+ N L L H +F Q +C V + + +L +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK 139
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYA 248
+HRD+ A N L++ K+SDFGL++ + T G++ + PE
Sbjct: 140 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVL 193
Query: 249 IRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ + + K+DI++FGVL+ EI S G+ PYE E +
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKM------PYERF-------------TNSETAEH- 233
Query: 308 LNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ + R Y I C + RP+ L++ +
Sbjct: 234 ------IAQGLRLYRPHLASEKVY-TIMYSCWHEKADERPTFKILLSNI 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 52/283 (18%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
+IG G FG V+ G + AIK + + +F+ E V+ + H LV+LYG C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+E LV ++E+ L+ L + F +T +C+ V +G+A+L E ++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQLT 254
HRD+ A N L+ ++ K+SDFG+ + + T GT+ + +PE + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 255 RKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313
K+D++SFGVL+ E+ S G+ PYE + E+V+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI------PYENR-------------SNSEVVED------- 217
Query: 314 VEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ R Y +I C ++ P+ RP+ S L+ L
Sbjct: 218 ISTGFRLYKPRLASTHVY-QIMNHCWRERPEDRPAFSRLLRQL 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 52/282 (18%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
++G G FG V G K A+K++ S EF E + + H LV+ YG C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
+ +V Y+ N L L G +C V +G+AFL +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE---GYLAPEYAIRGQLTR 255
RD+ A N L+D+DL K+SDFG+ + + GT+ + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 256 KADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
K+D+++FG+L+ E+ S G+ PY+ E+V V
Sbjct: 185 KSDVWAFGILMWEVFSLGKM------PYDLY-------------TNSEVVLK-------V 218
Query: 315 EEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ HR Y +I C ++P++RP+ L++ +
Sbjct: 219 SQGHRLYRPHLASDTIY-QIMYSCWHELPEKRPTFQQLLSSI 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 83/285 (29%), Positives = 131/285 (45%), Gaps = 56/285 (19%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
++G G FG V+ G T A+K L S FL E N++K ++H+ LV LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ + ++ Y+EN SL L + S I+ ++ +A+G+AF+ E + +
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRGQ 252
HRD++A+NIL+ L+ KI+DFGLA+L N T G APE G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREG--AKFPIKWTAPEAINYGT 186
Query: 253 LTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
T K+D++SFG+LL EIV+ GR PY E++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI------PYPGM-------------TNPEVIQN----- 222
Query: 312 YSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+E +R Y ++ LC ++ P+ RP+ L ++L
Sbjct: 223 --LERGYRMVRPDNCPEELY-QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 56/286 (19%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLA-AIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGC 136
+K+G G +G VY+G K +L A+K L D+ + V EFL E V+K+IKH NLV+L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
C ++ ++ +L L R + + + + ++ + +L ++ +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRG 251
+HRD+ A N L+ ++ K++DFGL++L + T A APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYN 187
Query: 252 QLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ + K+D+++FGVLL EI + G P Y L ++ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS------P-------------YPGIDLSQVYEL---- 224
Query: 311 DYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+E+ +R Y ++ C Q P RPS + +
Sbjct: 225 ---LEKDYRMERPEGCPEKVY-ELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 73/316 (23%), Positives = 123/316 (38%), Gaps = 76/316 (24%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENL 130
++GQG FG VY+G K T AIK ++ S + EFL E +V+K+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------NICIGVAKG 184
V L G +G +++ + L L + + +A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL- 243
+A+L+ VHRD+ A N ++ +D T KI DFG+ + ++ G +G L
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203
Query: 244 ----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298
+PE G T +D++SFGV+L EI + PY+
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQ--------------- 242
Query: 299 KLVELVDASLNGDYSVEEAHRYLK-----------------IALLCTQDMPKRRPSMSTL 341
S E+ R++ + +C Q PK RPS +
Sbjct: 243 ------------GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 342 VNMLIGEIDVNKEEIS 357
++ + E++ E+S
Sbjct: 291 ISSIKEEMEPGFREVS 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 68/291 (23%), Positives = 109/291 (37%), Gaps = 61/291 (20%)
Query: 78 NKIGQGGFGSVYKGTLKDG-----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLV 131
+G G FG+VYKG AIK L S + +E L E V+ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G C+ L+ + L + Q N C+ +AKG+ +L +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APE 246
+VHRD+ A N+L+ KI+DFGLAKL A G + A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ T ++D++S+GV + E+++ G PY+ E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGI-------------PASEISS 230
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDM-----------PKRRPSMSTLVNML 345
+E+ R L +CT D+ RP L+
Sbjct: 231 I-------LEKGER-LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-41
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 62/286 (21%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
IG+G FG V G + G A+K + D+ + FL E +V+ ++H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 138 VEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
VE + +V Y+ SL L RG S + + + V + + +L +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---NF 138
Query: 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRG 251
VHRD+ A N+L+ +D K+SDFGL K G L APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREK 189
Query: 252 QLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ + K+D++SFG+LL EI S GR PY + K ++V
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV------PYP-----RIPLK--------DVVPR---- 226
Query: 311 DYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
VE+ ++ Y ++ C RPS L L
Sbjct: 227 ---VEKGYKMDAPDGCPPAVY-EVMKNCWHLDAAMRPSFLQLREQL 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 69/324 (21%), Positives = 126/324 (38%), Gaps = 75/324 (23%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
++G+G FG V+ + L A+K L S ++F E ++ ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN-----------ICIG 180
+G C EG ++V+ Y+ + L + L G + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
VA G+ +L H VHRD+ N L+ + L KI DFG+++ ++ G
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGR 219
Query: 241 GYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKL 294
L PE + + T ++D++SFGV+L EI + G+ P+ +++
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWY-----QLSNT- 267
Query: 295 YERGKLVELVDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVN 343
E +D + + Y I C Q P++R S+ +
Sbjct: 268 -------EAIDC-------ITQGRELERPRACPPEVY-AIMRGCWQREPQQRHSIKDVHA 312
Query: 344 MLIGEIDVNKEEISKPGLLSDLLG 367
L + P + D+LG
Sbjct: 313 RL-------QALAQAPPVYLDVLG 329
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 77/338 (22%), Positives = 123/338 (36%), Gaps = 41/338 (12%)
Query: 14 YHKLQPSPFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVAT-- 71
+H S + T L + + + + R E +E + GY R +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSP------GYDPSRPESFF 55
Query: 72 -ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDI-K 126
++F +++G G +G V+K K DG L A+K + R + L E+ + + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H V L EG L SL Q G S LA
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGAS---LPEAQVWGYLRDTLLALA 171
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
LH + +VH D+K +NI L K+ DFGL + G Y+APE
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE 226
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
++G AD++S G+ +LE+ N LP+ + W+ +G L
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVA-----CNMELPHGGE-----GWQQLRQGYLPP---- 271
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344
S E L + + PK R + L+ +
Sbjct: 272 EFTAGLS-SELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-41
Identities = 64/283 (22%), Positives = 118/283 (41%), Gaps = 33/283 (11%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIK---VLSADSRQGVREFLTEINVIKDIKH 127
NF KIG+G F VY+ L DG A+K + + + + EI+++K + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
N+++ Y +E + +V + L++ + +T + + L
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
+H ++HRDIK +N+ + K+ D GL + F + T + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE- 206
Query: 248 AIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
I K+DI+S G LL E+ + + P+ + L L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAAL------QSPFYGDKM-----------NLYSLCKK 249
Query: 307 SLNGDYSVEEAHRY---LK--IALLCTQDMPKRRPSMSTLVNM 344
DY + Y L+ + + D P++RP ++ + ++
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPD-PEKRPDVTYVYDV 291
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 66/309 (21%), Positives = 123/309 (39%), Gaps = 81/309 (26%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
++G+G FG V+ + L A+K L + ++F E ++ +++HE++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------------NICI 179
+ YG C +GD I+V+ Y+++ L + L G ++ R +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
+A G+ +L + H VHRD+ N L+ +L KI DFG+++ ++ G
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGG 193
Query: 240 EGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293
L PE + + T ++D++SFGV+L EI + G+ P+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------PWF---------- 237
Query: 294 LYERGKLVELVDASLNGDYSVEEAHRYLK-----------------IALLCTQDMPKRRP 336
S E + + L C Q P++R
Sbjct: 238 -----------------QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRL 280
Query: 337 SMSTLVNML 345
++ + +L
Sbjct: 281 NIKEIYKIL 289
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 52/283 (18%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
K+G G FG V+ T T A+K + S V FL E NV+K ++H+ LV+L+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ + ++ ++ SL L + + + +A+G+AF+ + + +
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG---YLAPEYAIRGQLT 254
HRD++A+NIL+ L KI+DFGLA++ N T G + + APE G T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 255 RKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313
K+D++SFG+LL+EIV+ GR PY M E++ A
Sbjct: 364 IKSDVWSFGILLMEIVTYGRI------PYP-----GM--------SNPEVIRA------- 397
Query: 314 VEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+E +R Y I + C ++ P+ RP+ + ++L
Sbjct: 398 LERGYRMPRPENCPEELY-NIMMRCWKNRPEERPTFEYIQSVL 439
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 82/279 (29%), Positives = 128/279 (45%), Gaps = 44/279 (15%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
K+GQG FG V+ GT T AIK L + FL E V+K ++HE LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
E + +V Y+ SL L +G + ++ +A G+A++ + V
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA 257
HRD++A+NIL+ ++L K++DFGLA+L N + APE A+ G+ T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 258 DIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEA 317
D++SFG+LL E+ T R+PY M + E++D VE
Sbjct: 363 DVWSFGILLTELT-----TKGRVPYPG-----MVNR--------EVLDQ-------VERG 397
Query: 318 HR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+R + + C + P+ RP+ L L
Sbjct: 398 YRMPCPPECPESLH-DLMCQCWRKEPEERPTFEYLQAFL 435
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 2e-40
Identities = 82/279 (29%), Positives = 128/279 (45%), Gaps = 44/279 (15%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
K+GQG FG V+ GT T AIK L + FL E V+K ++HE LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
E + +V Y+ SL L +G + ++ +A G+A++ + V
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA 257
HRD++A+NIL+ ++L K++DFGLA+L N + APE A+ G+ T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 258 DIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEA 317
D++SFG+LL E+ T R+PY M + E++D VE
Sbjct: 446 DVWSFGILLTELT-----TKGRVPYPG-----MVNR--------EVLDQ-------VERG 480
Query: 318 HR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+R + + C + P+ RP+ L L
Sbjct: 481 YRMPCPPECPESLH-DLMCQCWRKEPEERPTFEYLQAFL 518
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
+G+G +G VY G L + AIK + + + EI + K +KH+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198
E + + SL+ LL ++ N QT + +GL +LH+ IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 199 RDIKASNILLD-KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL---T 254
RDIK N+L++ KISDFG +K T GT Y+APE I
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-IIDKGPRGYG 203
Query: 255 RKADIYSFGVLLLEIVSGR 273
+ ADI+S G ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 77/344 (22%), Positives = 137/344 (39%), Gaps = 68/344 (19%)
Query: 30 LLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLR-VATENFSPANKIGQGGFGSV 88
+ +H + + D N K + + IG G FG V
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEV 60
Query: 89 YKGTLKDGTLA-----AIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142
YKG LK + AIK L A + + +FL E ++ H N++ L G +
Sbjct: 61 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK 202
+++ Y+EN +L + L + +F+ + G+A G+ +L + VHRD+
Sbjct: 121 MMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLA 174
Query: 203 ASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPEYAIRGQLTRK 256
A NIL++ +L K+SDFGL+++ + T G T APE + T
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSA 230
Query: 257 ADIYSFGVLLLEIVS-GRCNTNRRLPYEE---QYLLEMAWKLYERGKLVELVDASLNGDY 312
+D++SFG+++ E+++ G PY E +++
Sbjct: 231 SDVWSFGIVMWEVMTYGER------PYWELSNHEVMKA---------------------- 262
Query: 313 SVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ + R Y ++ + C Q RRP + +V++L
Sbjct: 263 -INDGFRLPTPMDCPSAIY-QLMMQCWQQERARRPKFADIVSIL 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 68/307 (22%), Positives = 111/307 (36%), Gaps = 76/307 (24%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENL 130
++G+ FG VYKG L AIK L EF E + ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------------NIC 178
V L G + +++ Y + L + L+ R S + R ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG 238
+A G+ +L H+VH+D+ N+L+ L KISD GL + +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLL 187
Query: 239 TEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE---QYLLE 289
L APE + G+ + +DI+S+GV+L E+ S G PY Q ++E
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ------PYCGYSNQDVVE 241
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSM 338
M + Y + + C + P RRP
Sbjct: 242 M-----------------------IRNRQVLPCPDDCPAWVY-ALMIECWNEFPSRRPRF 277
Query: 339 STLVNML 345
+ + L
Sbjct: 278 KDIHSRL 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 70/299 (23%), Positives = 110/299 (36%), Gaps = 61/299 (20%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADSRQGVREFLTEINVIK 123
E+ +GQG F ++KG ++ T +KVL R F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H++LV YG CV GD ILV +++ SL T L + + I W+ + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINILWKL--EVAKQLAA 124
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTP--------KISDFGLAKLFPANLTHISTR 235
+ FL E ++H ++ A NILL ++ K+SD G++
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----------- 170
Query: 236 VAGTEGY------LAPEYAI--RGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQY 286
V + + PE I L D +SFG L EI S G P
Sbjct: 171 VLPKDILQERIPWVPPE-CIENPKNLNLATDKWSFGTTLWEICSGGDK------PLSALD 223
Query: 287 LLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+R +L A L + + C P RPS ++ L
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAEL---AN---------LINNCMDYEPDHRPSFRAIIRDL 270
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
IG+G FG VY GTL D A+K L+ V +FLTE ++KD H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 133 LYGCCVEGDHRIL-VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G C+ + L V Y+++ L + H + + VAKG+ +L +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL------AP 245
VHRD+ A N +LD+ T K++DFGLA+ V G A
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMAL 201
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
E + T K+D++SFGVLL E+++ G PY + ++ L + +L++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRLLQPE 255
Query: 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ + + L C + RPS S LV+ +
Sbjct: 256 YCP-------DPLYE---VMLKCWHPKAEMRPSFSELVSRI 286
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 38/278 (13%)
Query: 79 KIGQGGFGSVYKGTLKDG---TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
++G G FGSV +G + AIKVL + E + E ++ + + +V L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G C + + +LV L + L+G+ + + V+ G+ +L E+
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPEYA 248
+ VHRD+ A N+LL KISDFGL+K A+ ++ + R AG APE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 249 IRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ + ++D++S+GV + E +S G+ PY++ E+ + E+GK +E
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK------PYKKMKGPEVMAFI-EQGKRMECPPEC 238
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
Y+ + C + RP T+ +
Sbjct: 239 PPELYA---------LMSDCWIYKWEDRPDFLTVEQRM 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 61/305 (20%), Positives = 118/305 (38%), Gaps = 49/305 (16%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIK 123
+ + +++ K+G+GGF V L DG A+K + +Q E E ++ +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 124 DIKHENLVELYGCCVE---GDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
H N++ L C+ H L+ + + +L + + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA-- 237
G+ +GL +H HRD+K +NILL + P + D G ++ +
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 238 ------GTEGYLAPE------YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
T Y APE + + + + D++S G +L ++ G PY+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFG------EGPYDMV 249
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRY---LK--IALLCTQDMPKRRPSMST 340
+++G V L + S+ ++ R+ L + + T D P +RP +
Sbjct: 250 ---------FQKGDSVALA---VQNQLSIPQSPRHSSALWQLLNSMMTVD-PHQRPHIPL 296
Query: 341 LVNML 345
L++ L
Sbjct: 297 LLSQL 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 73/287 (25%), Positives = 111/287 (38%), Gaps = 42/287 (14%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENL 130
+G G FG VY+G + A+K L S Q +FL E +I H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR---NICIGVAKGLAF 187
V G ++ R ++ + L L Q + ++ +A G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 188 LHEEVQPHIVHRDIKASNILLDK---DLTPKISDFGLAKLFPANLTHISTRVAGTEGYL- 243
L E H +HRDI A N LL KI DFG+A+ ++ S G L
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLP 208
Query: 244 ----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298
PE + G T K D +SFGVLL EI S G PY + E+ + G
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------PYPSKSNQEVLEFVTSGG 262
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ + +R I C Q P+ RP+ + ++ +
Sbjct: 263 RMDPPKNCP-------GPVYR---IMTQCWQHQPEDRPNFAIILERI 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 67/301 (22%), Positives = 114/301 (37%), Gaps = 50/301 (16%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+F +GQG FG V K D AIK + + + L+E+ ++ + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 130 LVELYGCCVEGDHRI-------------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN 176
+V Y +E + + + Y EN +L + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN---QQRDEYWR 120
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--- 233
+ + + L+++H + I+HRD+K NI +D+ KI DFGLAK +L +
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 234 ----------TRVAGTEGYLAPE-YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282
T GT Y+A E G K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FS 229
Query: 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342
+ + KL + + + E + + I LL D P +RP TL+
Sbjct: 230 TGMERVNILKKLR-SVSIEF--PPDFDDNKMKVE--KKI-IRLLIDHD-PNKRPGARTLL 282
Query: 343 N 343
N
Sbjct: 283 N 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 72/361 (19%), Positives = 125/361 (34%), Gaps = 90/361 (24%)
Query: 35 LRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK 94
L + R+ N + L N IG+G FG V++
Sbjct: 10 LTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAP 69
Query: 95 DG------TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147
T+ A+K+L + S +F E ++ + + N+V+L G C G L++
Sbjct: 70 GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129
Query: 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRN--------------------ICIGVAKGLAF 187
Y+ L + L ++ + + I VA G+A+
Sbjct: 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL---- 243
L E VHRD+ N L+ +++ KI+DFGL++ N+ A +
Sbjct: 190 LSER---KFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYKADGNDAIPIRW 242
Query: 244 -APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
PE + T ++D++++GV+L EI S G PY
Sbjct: 243 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------PY------------------- 277
Query: 302 ELVDASLNGDYSVEEAHRYLK-----------------IALLCTQDMPKRRPSMSTLVNM 344
+ EE Y++ + LC +P RPS ++ +
Sbjct: 278 --------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
Query: 345 L 345
L
Sbjct: 330 L 330
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 60/291 (20%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVE 132
IG G G V G L+ AIK L A + R +FL+E +++ H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L G G ++V Y+EN SL L QF + GV G+ +L +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPE 246
VHRD+ A N+L+D +L K+SDFGL+++ + T G T APE
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APE 224
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ +D++SFGV++ E+++ G PY M +++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER------PYW-----NM--------TNRDVIS 265
Query: 306 ASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+ VEE +R + ++ L C +RP S +V++L
Sbjct: 266 S-------VEEGYRLPAPMGCPHALH-QLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 51/306 (16%)
Query: 78 NKIGQGGFGSVYKGTLKD--------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KH 127
+G+G FG V A+K+L D + + + + ++E+ ++K I KH
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN----------- 176
+N++ L G C + ++ Y +L + L R +++++ R
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 177 -ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
+A+G+ +L + +HRD+ A N+L+ ++ KI+DFGLA+ ++ +I
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259
Query: 236 VAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289
T G L APE T ++D++SFGVL+ EI + G PY +E
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PY-PGIPVE 312
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349
+KL + G ++ N Y + C +P +RP+ LV L +
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIL 363
Query: 350 DVNKEE 355
+ E
Sbjct: 364 TLTTNE 369
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 72/291 (24%), Positives = 116/291 (39%), Gaps = 61/291 (20%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLA-----AIKVLSADS-RQGVREFLTEINVIKDIKHENLV 131
+G G FG+V+KG + IKV+ S RQ + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G C G LV YL SL + Q N + +AKG+ +L E
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APE 246
+VHR++ A N+LL +++DFG+A L P + ++ +E A E
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQLLYSEAKTPIKWMALE 187
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
G+ T ++D++S+GV + E+++ G PY +L E+ D
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE------PYAGL-------------RLAEVPD 228
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDM-----------PKRRPSMSTLVNML 345
+E+ R L +CT D+ RP+ L N
Sbjct: 229 L-------LEKGER-LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 67/291 (23%), Positives = 109/291 (37%), Gaps = 61/291 (20%)
Query: 78 NKIGQGGFGSVYKGTLKDG-----TLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLV 131
+G G FG+VYKG AIK L + + +E L E V+ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G C+ L+ + L + Q N C+ +AKG+ +L +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APE 246
+VHRD+ A N+L+ KI+DFGLAKL A G + A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ T ++D++S+GV + E+++ G PY+ E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGI-------------PASEISS 230
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDM-----------PKRRPSMSTLVNML 345
+E+ R L +CT D+ RP L+
Sbjct: 231 I-------LEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 73/294 (24%), Positives = 116/294 (39%), Gaps = 56/294 (19%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLV 131
+G+G FGSV +G LK A+K + D S++ + EFL+E +KD H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 132 ELYGCCVEGDHRILVYGYL-----ENNSLAQTLLGRGHSSIQFNWQTRR--NICIGVAKG 184
L G C+E + + + + L LL + + + + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL- 243
+ +L + +HRD+ A N +L D+T ++DFGL+K + G +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMP 212
Query: 244 ----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298
A E T K+D+++FGV + EI + G PY EM L
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT------PYPGVQNHEMYDYLLHGH 266
Query: 299 KL-------VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+L EL Y I C + P RP+ S L L
Sbjct: 267 RLKQPEDCLDEL--------YE---------IMYSCWRTDPLDRPTFSVLRLQL 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 68/298 (22%), Positives = 107/298 (35%), Gaps = 53/298 (17%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV--LSADSRQGVREFLTEINVIKDI-K 126
T F KIG G FGSV+K DG + AIK + L E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H ++V + E DH ++ Y SLA + F +++ + V +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 187 FLHEEVQPHIVHRDIKASNILLDKD-------------------LTPKISDFGLAKLFPA 227
++H +VH DIK SNI + + + KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183
Query: 228 NLTHISTRVAGTEGYLAPEYAIRGQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
++ G +LA E ++ KADI++ + ++ LP
Sbjct: 184 -ISSPQVEE-GDSRFLANE-VLQENYTHLPKADIFALALTVVCAA-----GAEPLPRNGD 235
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
W +G+L + S +E LK + P+RRPS LV
Sbjct: 236 -----QWHEIRQGRL-----PRIPQVLS-QEFTELLK---VMIHPDPERRPSAMALVK 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-39
Identities = 69/296 (23%), Positives = 129/296 (43%), Gaps = 51/296 (17%)
Query: 78 NKIGQGGFGSVYKGTLKD--------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KH 127
+G+G FG V A+K+L D + + + + ++E+ ++K I KH
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN----------- 176
+N++ L G C + ++ Y +L + L R +++++ R
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 177 -ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
+A+G+ +L + +HRD+ A N+L+ ++ KI+DFGLA+ ++ +I
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213
Query: 236 VAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289
T G L APE T ++D++SFGVL+ EI + G PY + E
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIPVEE 267
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ L E ++ + + + E + + C +P +RP+ LV L
Sbjct: 268 LFKLLKEGHRMDKPANCT-------NELYM---MMRDCWHAVPSQRPTFKQLVEDL 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 82/380 (21%), Positives = 128/380 (33%), Gaps = 84/380 (22%)
Query: 8 LYYCSQYHKLQPSP-----FLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLY 62
Y+ +H F + S L + + ++T + N +
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCF--AGKTS 60
Query: 63 GYKDLR-VATENFSPANKIGQGGFGSVYKGTLKDG------TLAAIKVLSAD-SRQGVRE 114
DL+ V +N + +G G FG VY+G + A+K L S Q +
Sbjct: 61 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 115 FLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR 174
FL E +I H+N+V G ++ R ++ + L L Q +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 175 R---NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFGLAKLFPAN 228
++ +A G +L E H +HRDI A N LL KI DFG+A+ +
Sbjct: 181 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----D 233
Query: 229 LTHISTRVAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282
+ G L PE + G T K D +SFGVLL EI S G PY
Sbjct: 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------PY 287
Query: 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK-----------------IAL 325
S +E ++ I
Sbjct: 288 ---------------------------PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMT 320
Query: 326 LCTQDMPKRRPSMSTLVNML 345
C Q P+ RP+ + ++ +
Sbjct: 321 QCWQHQPEDRPNFAIILERI 340
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 51/293 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+F IG GGFG V+K DG IK + ++ + RE + + + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 131 VELYGCCVEGDHRI----------------LVYGYLENNSLAQTLLGRGHSSIQFNWQTR 174
V GC D+ + + + +L Q + + +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234
+ + KG+ ++H + +++RD+K SNI L KI DFGL + T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
R GT Y++PE ++ D+Y+ G++L E LL +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLIL---------------AE---LLHVCDTA 221
Query: 295 YERGKLVELV-DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+E K + D ++ + +E + L + L ++ P+ RP+ S ++ L
Sbjct: 222 FETSKFFTDLRDGIISDIFDKKE--KTL-LQKLLSKK-PEDRPNTSEILRTLT 270
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 88/341 (25%), Positives = 145/341 (42%), Gaps = 73/341 (21%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLA----AIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
+G G FG V G LK + AIK L + + R+FL E +++ H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L G + ++V Y+EN SL L R H + QF + G+A G+ +L +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDA-QFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPE 246
VHRD+ A NIL++ +L K+SDFGL ++ + T G T +PE
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPE 220
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ T +D++S+G++L E++S G PY EM +++
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER------PYW-----EM--------SNQDVIK 261
Query: 306 ASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKE 354
A V+E +R Y ++ L C Q RP +V++L +
Sbjct: 262 A-------VDEGYRLPPPMDCPAALY-QLMLDCWQKDRNNRPKFEQIVSIL-------DK 306
Query: 355 EISKPGLLSDLLGLRVDKGEKDKASAVSGDSSKLDHSSFSS 395
I PG L++ + S + D S +D ++F +
Sbjct: 307 LIRNPGS------LKIITSAAARPSNLLLDQSNVDITTFRT 341
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 31/279 (11%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHE 128
E + KIG+G FG +DG IK +S S + E E+ V+ ++KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N+V+ E +V Y E L + + + F + + + L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H+ I+HRDIK+ NI L KD T ++ DFG+A++ + + + GT YL+PE
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE-I 196
Query: 249 IRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ K+DI++ G +L E+ + + +E + + K+ G
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTL------KHAFEAGSMKNLVLKI-ISGSF-----PP 244
Query: 308 LNGDYSVEEAHRYLK--IALLCTQDMPKRRPSMSTLVNM 344
++ YS + L+ ++ L ++ P+ RPS+++++
Sbjct: 245 VSLHYSYD-----LRSLVSQLFKRN-PRDRPSVNSILEK 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 40/279 (14%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA---AIKVLSAD--SRQGVREFLTEINVIKDIKHENLVEL 133
++G G FG+V KG + + A+K+L + E L E NV++ + + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G C E + +LV E L + L + + ++ + V+ G+ +L E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNII--ELVHQVSMGMKYLEES-- 136
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPEY 247
+ VHRD+ A N+LL KISDFGL+K A+ + + G APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191
Query: 248 AIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
+ + K+D++SFGVL+ E S G+ PY E+ L E+G+ +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK------PYRGMKGSEVTAML-EKGERMGCPAG 244
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
Y + LC + RP + + L
Sbjct: 245 CPREMYD---------LMNLCWTYDVENRPGFAAVELRL 274
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 36/280 (12%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVE 132
IG+G FG VY G D AIK LS Q V FL E +++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 133 LYGCCVEGDHRIL-VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L G + + + Y+ + L Q + + + + VA+G+ +L E+
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APE 246
VHRD+ A N +LD+ T K++DFGLA+ + L A E
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRHARLPVKWTALE 198
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ T K+D++SFGVLL E+++ G PY ++ +G+ + +
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP------PYRHIDPFDL-THFLAQGRRLPQPE 251
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ Y + C + P RP+ LV +
Sbjct: 252 YCPDSLYQ---------VMQQCWEADPAVRPTFRVLVGEV 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 59/253 (23%), Positives = 107/253 (42%), Gaps = 28/253 (11%)
Query: 32 LHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATEN----FSPANKIGQGGFGS 87
+HH + + + + V + KIG+G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 88 VYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146
V G A+K++ +Q E+ +++D +H N+VE+Y + G+ ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 147 YGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIK 202
+L+ +L Q L + +C V + LA+LH + ++HRDIK
Sbjct: 121 MEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 203 ASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAPEYAIRGQLTRKADI 259
+ +ILL D K+SDFG A ++ + + GT ++APE R + DI
Sbjct: 169 SDSILLTLDGRVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 260 YSFGVLLLEIVSG 272
+S G++++E+V G
Sbjct: 225 WSLGIMVIEMVDG 237
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 50/307 (16%)
Query: 78 NKIGQGGFGSVYKGTLKD------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHEN 129
+G G FG V + T A+K+L ++E+ V+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN------------- 176
+V L G C G +++ Y L L + S I
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 177 -ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
VAKG+AFL + + +HRD+ A NILL KI DFGLA+ ++ + S
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNY 201
Query: 236 VAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289
V L APE T ++D++S+G+ L E+ S G PY +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------PYPGMPVDS 255
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349
+K+ + G + + + Y I C P +RP+ +V ++ +I
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMY---------DIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 350 DVNKEEI 356
+ I
Sbjct: 307 SESTNHI 313
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 78 NKIGQGGFGSVYKGTLKDG----TLAAIKVL--SADSRQGVREFLTEINVIKDIKHENLV 131
+G+G FGSV + LK A+K+L + + EFL E +K+ H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 132 ELYGCCVEGDHRILVYG------YLENNSLAQTLLGRGHSSIQFNWQTRR--NICIGVAK 183
+L G + + + ++++ L LL FN + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
G+ +L + +HRD+ A N +L +D+T ++DFGL++ + G L
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKL 201
Query: 244 -----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYER 297
A E T +D+++FGV + EI++ G+ PY E+ L
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT------PYAGIENAEIYNYL-IG 254
Query: 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
G ++ + Y + C PK+RPS + L L
Sbjct: 255 GNRLKQPPECMEEVYD---------LMYQCWSADPKQRPSFTCLRMEL 293
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 31/220 (14%)
Query: 79 KIGQGGFGSVYKGTLK----DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLV 131
K+G G FG V +G A+K L D + + +F+ E+N + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
LYG + +V SL L F T + VA+G+ +L +
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK 140
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAP 245
+HRD+ A N+LL KI DFGL + P N H + AP
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----AP 193
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284
E + +D + FGV L E+ + G+ P+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIG 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 75/304 (24%), Positives = 119/304 (39%), Gaps = 75/304 (24%)
Query: 78 NKIGQGGFGSVYKGTLKDG---TLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVE 132
+ IG+G FG V K +K AAIK + S+ R+F E+ V+ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN--------------IC 178
L G C + L Y + +L L R ++ +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG 238
VA+G+ +L ++ +HRD+ A NIL+ ++ KI+DFGL++ V
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 239 TEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAW 292
T G L A E T +D++S+GVLL EIVS G PY M
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------PYC-----GMTC 247
Query: 293 KLYERGKLVELVDASLNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTL 341
EL + + + +R Y + C ++ P RPS + +
Sbjct: 248 A--------ELYEK-------LPQGYRLEKPLNCDDEVY-DLMRQCWREKPYERPSFAQI 291
Query: 342 VNML 345
+ L
Sbjct: 292 LVSL 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+ ++ KIGQG G+VY + G AI+ ++ + + EI V+++ K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
+V + GD +V YL SL +T + G + +C + L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQAL 129
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGY 242
FLH ++HRDIK+ NILL D + K++DFG A +T ++ + GT +
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYW 182
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
+APE R K DI+S G++ +E++ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 41/328 (12%)
Query: 35 LRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPAN-----KIGQGGFGSVY 89
L +K S + N ++ N + ++ S IG+G FG VY
Sbjct: 47 LYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY 106
Query: 90 KGTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144
GTL D A+K L+ V +FLTE ++KD H N++ L G C+ +
Sbjct: 107 HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 145 L-VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKA 203
L V Y+++ L + H + + VAKG+ FL + VHRD+ A
Sbjct: 167 LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAA 220
Query: 204 SNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRGQLTRKAD 258
N +LD+ T K++DFGLA+ T L A E + T K+D
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 259 IYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEA 317
++SFGVLL E+++ G PY + ++ L + +L++ +
Sbjct: 279 VWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRLLQPEYCP-------DPL 325
Query: 318 HRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ + L C + RPS S LV+ +
Sbjct: 326 YE---VMLKCWHPKAEMRPSFSELVSRI 350
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-38
Identities = 58/244 (23%), Positives = 97/244 (39%), Gaps = 21/244 (8%)
Query: 37 RKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKD 95
+ E NE V + Y + R + ++G+G FG V++ +
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 96 GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155
G A+K + + + + E+ + +V LYG EG + LE SL
Sbjct: 83 GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP- 214
Q + G +GL +LH I+H D+KA N+LL D +
Sbjct: 138 GQLIKQMGC----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 215 KISDFGLAKLFPANLTHISTR----VAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEI 269
+ DFG A + S + GTE ++APE + G+ K DI+S ++L +
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHM 249
Query: 270 VSGR 273
++G
Sbjct: 250 LNGC 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 78/347 (22%), Positives = 142/347 (40%), Gaps = 51/347 (14%)
Query: 27 TSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFG 86
HH T + ++ + + L + + +G+G FG
Sbjct: 24 GMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFG 83
Query: 87 SVYKGTLKD--------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGC 136
V T A+K+L +D + + + + ++E+ ++K I KH+N++ L G
Sbjct: 84 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN------------ICIGVAKG 184
C + ++ Y +L + L R +++++ N VA+G
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL- 243
+ +L + +HRD+ A N+L+ +D KI+DFGLA+ ++ HI T G L
Sbjct: 204 MEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLP 256
Query: 244 ----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298
APE T ++D++SFGVLL EI + G PY + E+ L E
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPVEELFKLLKEGH 310
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ + + + E + + C +P +RP+ LV L
Sbjct: 311 RMDKPSNCT-------NELYM---MMRDCWHAVPSQRPTFKQLVEDL 347
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 73/318 (22%), Positives = 119/318 (37%), Gaps = 90/318 (28%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENL 130
+G+G FG V K T T A+K+L + S +R+ L+E NV+K + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN-------------- 176
++LYG C + +L+ Y + SL L +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 177 ------ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
+++G+ +L E +VHRD+ A NIL+ + KISDFGL++ ++
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR----DVY 201
Query: 231 HISTRVAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284
+ V ++G + A E T ++D++SFGVLL EIV+ G PY
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------PYP- 254
Query: 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK-----------------IALLC 327
E LK + L C
Sbjct: 255 --------------------------GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQC 288
Query: 328 TQDMPKRRPSMSTLVNML 345
+ P +RP + + L
Sbjct: 289 WKQEPDKRPVFADISKDL 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 30/283 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHE 128
E++ IG G +G K DG + K L + + ++E+N+++++KH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 129 NLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
N+V Y ++ + L V Y E LA + + + + + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 187 FLHE--EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
H + ++HRD+K +N+ LD K+ DFGLA++ + + T V GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 245 PEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303
PE + K+DI+S G LL E+ + P+ E+A K+ GK
Sbjct: 185 PE-QMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKELAGKI-REGKF--- 233
Query: 304 VDASLNGDYSVEEAHRYLK--IALLCTQDMPKRRPSMSTLVNM 344
+ YS E L I + RPS+ ++
Sbjct: 234 --RRIPYRYSDE-----LNEIITRMLNLK-DYHRPSVEEILEN 268
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 75/295 (25%), Positives = 115/295 (38%), Gaps = 49/295 (16%)
Query: 78 NKIGQGGFGSVYKGTLKD------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHEN 129
+G+G FG V + A+K+L + R ++E+ ++ I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 130 LVELYGCCVEGDHRILV------YG----YLENNSLAQTLLGRGHSSIQFNWQTRRN--- 176
+V L G C + ++V +G YL + + ++ T +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRV 236
VAKG+ FL +HRD+ A NILL + KI DFGLA+ ++ V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205
Query: 237 AGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEM 290
+ L APE T ++D++SFGVLL EI S G PY + E
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDEE 259
Query: 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ + G + D + Y L C P +RP+ S LV L
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 76/355 (21%), Positives = 129/355 (36%), Gaps = 77/355 (21%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLR---------VATENFSPANKIGQGGFGSVYKGTLKD 95
+ +V + E + N Y + D N +G G FG V + T
Sbjct: 10 PKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFG 69
Query: 96 ------GTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147
A+K+L + ++E+ ++ + +HEN+V L G C G +++
Sbjct: 70 LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129
Query: 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRN----------ICIGVAKGLAFLHEEVQPHIV 197
Y L L + N VA+G+AFL + + +
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCI 186
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYAIRGQ 252
HRD+ A N+LL KI DFGLA+ ++ + S + L APE
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCV 242
Query: 253 LTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
T ++D++S+G+LL EI S G PY + + K Y+
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLN------PY---PGILVNSKFYKL-------------- 279
Query: 312 YSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEE 355
V++ ++ Y I C P RP+ + + L + ++ E
Sbjct: 280 --VKDGYQMAQPAFAPKNIY-SIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 3e-37
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 38/278 (13%)
Query: 79 KIGQGGFGSVYKGTLKDG---TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELY 134
++G G FGSV +G + AIKVL + E + E ++ + + +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
G C + + +LV L + L+G+ + + V+ G+ +L E+
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG------TEGYLAPEYA 248
+ VHR++ A N+LL KISDFGL+K A+ ++ + R AG APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 249 IRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ + ++D++S+GV + E +S G+ PY++ E+ + E+GK +E
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK------PYKKMKGPEVMAFI-EQGKRMECPPEC 564
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
Y+ + C + RP T+ +
Sbjct: 565 PPELYA---------LMSDCWIYKWEDRPDFLTVEQRM 593
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 65/289 (22%), Positives = 106/289 (36%), Gaps = 61/289 (21%)
Query: 79 KIGQGGFGSVYKGTLKDG----TLAAIKVLSADSRQGVR-EFLTEINVIKDIKHENLVEL 133
IG+G FG V++G AIK + VR +FL E ++ H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G E I + L L R + + + ++ LA+L +
Sbjct: 82 IGVITENPVWI-IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK-- 135
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL-----APEYA 248
VHRDI A N+L+ + K+ DFGL++ + ++G L APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESI 189
Query: 249 IRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ T +D++ FGV + EI+ G P++ K +++
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK------PFQGV-------------KNNDVIGR- 229
Query: 308 LNGDYSVEEAHR-----------YLKIALLCTQDMPKRRPSMSTLVNML 345
+E R Y + C P RRP + L L
Sbjct: 230 ------IENGERLPMPPNCPPTLY-SLMTKCWAYDPSRRPRFTELKAQL 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 78/358 (21%), Positives = 132/358 (36%), Gaps = 50/358 (13%)
Query: 10 YCSQYHKLQPSPFL-------FYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTN-- 60
YC + S + L S L + ++ S T V +D +EI D
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376
Query: 61 --LYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDG----TLAAIKVLSADSRQGVR- 113
+ +D + E IG+G FG V++G AIK + VR
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 114 EFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQT 173
+FL E ++ H ++V+L G E + ++ L L R + +
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF---SLDLAS 492
Query: 174 RRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS 233
++ LA+L + VHRDI A N+L+ + K+ DFGL++ S
Sbjct: 493 LILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDS 544
Query: 234 TRVAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYL 287
T ++G L APE + T +D++ FGV + EI+ G P++
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK------PFQGVKN 598
Query: 288 LEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ ++ +L + + + C P RRP + L L
Sbjct: 599 NDVIGRIENGERLPMPPNCP-------PTLYS---LMTKCWAYDPSRRPRFTELKAQL 646
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
E + ++G G FG VYK + G LAA KV+ S + + +++ EI ++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVAKGL 185
+V+L G ++ + ++ +L IQ +C + + L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEAL 130
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGY 242
FLH + I+HRD+KA N+L+ + +++DFG++ A + GT +
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYW 183
Query: 243 LAPEYAIRGQLTR-----KADIYSFGVLLLEIVSG 272
+APE + + KADI+S G+ L+E+
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 62/324 (19%), Positives = 126/324 (38%), Gaps = 58/324 (17%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKV- 103
H + ++ NLY ++ + V +S +IG GG V++ + + AIK
Sbjct: 2 HHHHHHSSGVDLGTENLY-FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 104 -LSADSRQGVREFLTEINVIKDIKHENL--VELYGCCVEGDHRILVYGYLE--NNSLAQT 158
L Q + + EI + ++ + + LY + + +Y +E N L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSW 117
Query: 159 LLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISD 218
L + + R++ + + + +H+ IVH D+K +N L+ K+ D
Sbjct: 118 LKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLID 169
Query: 219 FGLAKLFPANLTHISTR-VAGTEGYLAPE-----------YAIRGQLTRKADIYSFGVLL 266
FG+A + T + GT Y+ PE + +++ K+D++S G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 267 LEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVE-------EAHR 319
+ G + P+ + + + A ++ ++ +E +
Sbjct: 230 YYMTYG------KTPF------------QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 320 YLKIALLCTQDMPKRRPSMSTLVN 343
LK C + PK+R S+ L+
Sbjct: 272 VLK---CCLKRDPKQRISIPELLA 292
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 64/298 (21%), Positives = 114/298 (38%), Gaps = 49/298 (16%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHEN 129
+F P +G+GGFG V++ K D AIK + +R+ RE + E+ + ++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 130 LVELYGCCVEGD---------HRILVY---GYLENNSLAQTLLGRGHSSIQFNWQTRRNI 177
+V + +E + ++ +Y +L + + + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHI 123
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-----------P 226
+ +A+ + FLH + ++HRD+K SNI D K+ DFGL P
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 227 ANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
T GT+ Y++PE I G + K DI+S G++L E++ P+ Q
Sbjct: 181 MPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY---------PFSTQ 230
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
K L + ++ +L P RP ++
Sbjct: 231 MERVRTLTDVRNLKF-----PPLFTQKY-PCEYVMVQ-DMLSPS--PMERPEAINIIE 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 53/285 (18%)
Query: 79 KIGQGGFGSVYKGTLKDG----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVEL 133
+G+G FG VY+G + A+K D + +F++E ++K++ H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
G E + ++ L L + T + + K +A+L
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY----------- 242
+ VHRDI NIL+ K+ DFGL+ R E Y
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLS------------RYIEDEDYYKASVTRLPIK 179
Query: 243 -LAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
++PE + T +D++ F V + EI+S G+ P+ ++ L E+G
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ------PFFWLENKDVIGVL-EKGDR 232
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ D Y+ + C P RP + LV L
Sbjct: 233 LPKPDLCPPVLYT---------LMTRCWDYDPSDRPRFTELVCSL 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
E F K+G+G +GSVYK + G + AIK + +S ++E + EI++++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVAKGL 185
+V+ YG + +V Y S++ + R I I KGL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTLKGL 138
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGY 242
+LH +HRDIKA NILL+ + K++DFG+A LT + V GT +
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFW 191
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
+APE ADI+S G+ +E+ G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHE 128
E F+ KIG+G FG V+KG + + AIK++ + + + + EI V+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
+ + YG ++ ++ YL S L Q I + KGL +L
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI-----ATILREILKGLDYL 135
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAP 245
H E +HRDIKA+N+LL + K++DFG+A LT + GT ++AP
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAP 188
Query: 246 EYAIRGQLTRKADIYSFGVLLLEIVSG 272
E + KADI+S G+ +E+ G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 57/302 (18%)
Query: 78 NKIGQGGFGSVYKGTLKDG------TLAAIKVL--SADSRQGVREFLTEINVIKDI-KHE 128
+G G FG V T A+K+L ADS + ++E+ ++ + HE
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHE 109
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRN------------ 176
N+V L G C L++ Y L L + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 177 -------ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229
VAKG+ FL + VHRD+ A N+L+ KI DFGLA+ ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR----DI 222
Query: 230 THISTRVAGTEGYL-----APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE 283
S V L APE G T K+D++S+G+LL EI S G PY
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PYP 276
Query: 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ +KL + G ++ + Y I C ++RPS L +
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYI---------IMQSCWAFDSRKRPSFPNLTS 327
Query: 344 ML 345
L
Sbjct: 328 FL 329
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 58/302 (19%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKD 124
+ V +S +IG GG V++ + + AIK L Q + + EI +
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 125 IKH--ENLVELYGCCVEGDHRILVYGYLE--NNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ + ++ LY + + +Y +E N L L + + R++
Sbjct: 64 LQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKN 116
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR-VAGT 239
+ + + +H+ IVH D+K +N L+ K+ DFG+A + T + GT
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 240 EGYLAPE-----------YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288
Y+ PE + +++ K+D++S G +L + G + P+
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTPF------ 220
Query: 289 EMAWKLYERGKLVELVDASLNGDYSVE-------EAHRYLKIALLCTQDMPKRRPSMSTL 341
+ + + A ++ ++ +E + LK C + PK+R S+ L
Sbjct: 221 ------QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
Query: 342 VN 343
+
Sbjct: 272 LA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 51/279 (18%), Positives = 106/279 (37%), Gaps = 33/279 (11%)
Query: 13 QYHKLQPSPFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATE 72
+H S + + + +R + + ++D N + + V
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSAN----ECISVKGR 56
Query: 73 NFSPANKIGQGGFGSVYKGTLKDGTLAAIKV--LSADSRQGVREFLTEINVIKDIKHENL 130
+S +IG GG V++ + + AIK L Q + + EI + ++ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 131 --VELYGCCVEGDHRILVYGYLE--NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
+ LY + + +Y +E N L L + + R++ + + +
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVH 169
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR-VAGTEGYLAP 245
+H+ IVH D+K +N L+ K+ DFG+A + T + G Y+ P
Sbjct: 170 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 246 E-----------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
E + +++ K+D++S G +L + G+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA---AIKVLS---ADSRQGVREFLTEINVIKDIKHENLVE 132
K+G GG +VY +D L AIK + + + ++ F E++ + H+N+V
Sbjct: 18 KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ E D LV Y+E +L++ + G + T N + G+ H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDM- 130
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAIRG 251
IVHRDIK NIL+D + T KI DFG+AK L +LT + V GT Y +PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGE 187
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
DIYS G++L E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREF-LTEINVI 122
K + ++F +++G G G V+K + K G + A K++ + + +R + E+ V+
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 123 KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
+ +V YG + +++ SL Q L G + Q + I V
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVI 141
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEG 241
KGL +L E+ I+HRD+K SNIL++ K+ DFG++ L ++ GT
Sbjct: 142 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 195
Query: 242 YLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
Y++PE ++G + ++DI+S G+ L+E+ GR
Sbjct: 196 YMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 63/299 (21%), Positives = 109/299 (36%), Gaps = 38/299 (12%)
Query: 54 SEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVR 113
S QD + V +F P + +G G G++ + D A+K + +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65
Query: 114 EFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLE--NNSLAQTLLGRGHSSIQFN 170
E+ ++++ +H N++ + + + + +E +L + + + +
Sbjct: 66 R---EVQLLRESDEHPNVIRYFCTEKDRQFQYIA---IELCAATLQEYVEQKDFA---HL 116
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL-----DKDLTPKISDFGLAKLF 225
+ GLA LH +IVHRD+K NIL+ + ISDFGL K
Sbjct: 117 GLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 226 PANLTHISTR--VAGTEGYLAPEY---AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL 280
S R V GTEG++APE + T DI+S G + ++S
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-----GSH 228
Query: 281 PYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMS 339
P+ + + L A I + D P++RPS
Sbjct: 229 PFGKSLQRQA----NILLGACSLDCLHPEKHED-VIAREL--IEKMIAMD-PQKRPSAK 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 30/236 (12%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYGC 136
+GQG +V++G K G L AIKV + S + E V+K + H+N+V+L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 137 --CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
H++L+ + SL L ++ + V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 195 HIVHRDIKASNILL----DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
IVHR+IK NI+ D K++DFG A+ + + GTE YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDM-YE 188
Query: 251 GQLTR---------KADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
+ R D++S GV +G LP+ ++ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATG------SLPFRPFEGPRRNKEVMYK 238
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG---VREFLTEINVIKDIK 126
+ FS +IG G FG+VY +++ + AIK +S +Q ++ + E+ ++ ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVA 182
H N ++ GC + LV Y S + L I + G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA-------VTHGAL 164
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
+GLA+LH +++HRD+KA NILL + K+ DFG A + + ++ V GT +
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV-GTPYW 216
Query: 243 LAPE---YAIRGQLTRKADIYSFGVLLLEIVSG 272
+APE GQ K D++S G+ +E+
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 14/213 (6%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHEN 129
+++ IG G V AIK ++ + Q + E L EI + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLA----QTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
+V Y V D LV L S+ + H S + T I V +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL-AKLF-PANLTHISTR--VAGTEG 241
+LH+ +HRD+KA NILL +D + +I+DFG+ A L ++T R GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 242 YLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
++APE + + KADI+SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYGC 136
+GQG +V++G K G L AIKV + S + E V+K + H+N+V+L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 137 --CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
H++L+ + SL L ++ + V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 195 HIVHRDIKASNILL----DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE---- 246
IVHR+IK NI+ D K++DFG A+ + + GTE YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYER 189
Query: 247 ----YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ + D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 40/243 (16%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLT-----------------EINV 121
+ QG F + KD A+K + R+F E+ +
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNI 177
I DIK+E + G D ++Y Y+EN+S+ + + Q + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA 237
V +++H + +I HRD+K SNIL+DK+ K+SDFG ++ S
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 238 GTEGYLAPEYAIRGQLT---RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
GT ++ PE + + K DI+S G+ L + +P+ + L +L
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYN------VVPFSLKISLV---EL 261
Query: 295 YER 297
+
Sbjct: 262 FNN 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 41/274 (14%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADS--RQGVRE-FLTEINVIKDIKHENLVELYG 135
+G+GGF ++ + + A K++ + RE EI++ + + H+++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 136 CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
E + + +V SL + R R + G +LH
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
++HRD+K N+ L++DL KI DFGLA + + GT Y+APE + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
+ D++S G ++ ++ G + P+E L E Y R K +YS+
Sbjct: 220 FEVDVWSIGCIMYTLLVG------KPPFETSCLKET----YLRIK---------KNEYSI 260
Query: 315 -----EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
A ++ +L T P RP+++ L+N
Sbjct: 261 PKHINPVAASLIQ-KMLQTD--PTARPTINELLN 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 41/274 (14%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADS--RQGVRE-FLTEINVIKDIKHENLVELYG 135
+G+GGF ++ + + A K++ + RE EI++ + + H+++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 136 CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
E + + +V SL + R R + G +LH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
++HRD+K N+ L++DL KI DFGLA + + GT Y+APE + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSV 314
+ D++S G ++ ++ G + P+E L E Y R K +YS+
Sbjct: 194 FEVDVWSIGCIMYTLLVG------KPPFETSCLKET----YLRIK---------KNEYSI 234
Query: 315 -----EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
A ++ +L T P RP+++ L+N
Sbjct: 235 PKHINPVAASLIQ-KMLQTD--PTARPTINELLN 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 26/220 (11%)
Query: 71 TENFSPANKIGQG--GFGSVYKGT-LKDGTLAAIKV--LSADSRQGVREFLTEINVIKDI 125
+ IG+G +V G ++ L A S + V E++V K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
H N+V + + +V ++ S + H N I GV K L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKAL 141
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR---------- 235
++H VHR +KAS+IL+ D +S ++ R
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN----LSMISHGQRQRVVHDFPKY 194
Query: 236 VAGTEGYLAPEYAIRGQL--TRKADIYSFGVLLLEIVSGR 273
+L+PE + K+DIYS G+ E+ +G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVI 122
+ E+ +IG+G +GSV K K G + A+K + + + ++ L +++V+
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 123 -KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
+ +V+ YG + + + + I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--TRVAGT 239
K L L E + I+HRDIK SNILLD+ K+ DFG++ L TR AG
Sbjct: 135 VKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGC 188
Query: 240 EGYLAPEYAIRGQLTR-----KADIYSFGVLLLEIVSGR 273
Y+APE I +R ++D++S G+ L E+ +GR
Sbjct: 189 RPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 61/317 (19%), Positives = 112/317 (35%), Gaps = 54/317 (17%)
Query: 57 QDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREF 115
+D + + + + + + +GGF VY+ + G A+K L ++ + R
Sbjct: 13 RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 116 LTEINVIKDIK-HENLVELYGCCV-------EGDHRILVYGYLENNSLAQTLLGRGHSSI 167
+ E+ +K + H N+V+ G L+ L L + L
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG- 131
Query: 168 QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227
+ T I + + +H + +P I+HRD+K N+LL T K+ DFG A
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 228 NLTHISTRVA-----------GTEGYLAPE---YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ + T Y PE + K DI++ G +L +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR- 249
Query: 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK-----IALLCT 328
+ P+E+ L +NG YS+ I +
Sbjct: 250 -----QHPFEDGAKL-----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 329 QDMPKRRPSMSTLVNML 345
+ P+ R S++ +V+ L
Sbjct: 288 VN-PEERLSIAEVVHQL 303
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADS--RQGVRE-FLTEINVIKDIKHENLVELYG 135
+G+G F VY+ + G AIK++ + + G+ + E+ + +KH +++ELY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 136 CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
E + + LV N + + L R F+ R+ + G+ +LH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSH--- 131
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
I+HRD+ SN+LL +++ KI+DFGLA T + GT Y++PE A R
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190
Query: 255 RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
++D++S G + ++ G R P++ +
Sbjct: 191 LESDVWSLGCMFYTLLIG------RPPFDTDTVKNT 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVI-K 123
+ V ++ P ++G+G +G V K G + A+K + A ++ L ++++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ V YG + + + SL + I + + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--VAGTEG 241
L LH ++ ++HRD+K SN+L++ K+ DFG++ L + AG +
Sbjct: 121 ALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAGCKP 174
Query: 242 YLAPEYAIRGQLTR-----KADIYSFGVLLLEIVSGR 273
Y+APE I +L + K+DI+S G+ ++E+ R
Sbjct: 175 YMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 62/232 (26%), Positives = 90/232 (38%), Gaps = 25/232 (10%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELY-- 134
++G GGFG V + +D G AIK + RE EI ++K + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 135 ----GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
D +L Y E L + L + R + ++ L +LHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHE 139
Query: 191 EVQPHIVHRDIKASNILLD---KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
I+HRD+K NI+L + L KI D G AK + V GT YLAPE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPE- 193
Query: 248 AIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
+ + T D +SFG L E ++G P+ +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG------FRPFLPNWQPVQWHGKVREK 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 29/239 (12%)
Query: 50 NEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADS 108
+ + + +L +D F +G G +G VYKG +K G LAAIKV+
Sbjct: 5 DSPARSLDEIDLSALRD---PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 109 RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRI------LVYGYLENNSLAQTLLG 161
E EIN++K H N+ YG ++ + LV + S+ T L
Sbjct: 62 -DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV--TDLI 118
Query: 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221
+ + IC + +GL+ LH+ ++HRDIK N+LL ++ K+ DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 222 AKLFPANLTHISTR---VAGTEGYLAPEYAIRGQLTR-----KADIYSFGVLLLEIVSG 272
+ A L R GT ++APE + K+D++S G+ +E+ G
Sbjct: 176 S----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-31
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 26/235 (11%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD--SRQGVRE-FLTEINVIK 123
+ A E+F +G+G FG+VY K + A+KVL + GV E+ +
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 124 DIKHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
++H N++ LYG R+ L+ Y ++ + L F+ Q +A
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELA 119
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
L++ H + ++HRDIK N+LL KI+DFG + P++ + GT Y
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDY 173
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
L PE K D++S GVL E + G + P+E E Y+R
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQET----YKR 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLS---ADSRQGVREFLTEINVIKDIKHENLVEL 133
+G+G FG V K G A+KV+S + L E+ ++K + H N+++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
Y + + LV L ++ R F+ I V G+ ++H+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKN-- 145
Query: 194 PHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
IVHRD+K N+LL KD +I DFGL+ F A+ GT Y+APE +
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLH 201
Query: 251 GQLTRKADIYSFGVLLLEIVSGR 273
G K D++S GV+L ++SG
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGC 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-30
Identities = 39/269 (14%), Positives = 81/269 (30%), Gaps = 29/269 (10%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQGVREFLTE 118
+ ++ ++ + +G+G F VY+ T D +KV +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 119 INVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTL-LGRGHSSIQFNWQTRRNI 177
+ +K ++ Y + + +LV +L + L + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP-----------KISDFGLA---K 223
+ + + +H+ I+H DIK N +L + D G + K
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
LFP + T G+ E + D + + ++ G + E
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 284 EQYLLEMAWKLYERGKLV-ELVDASLNGD 311
E ++ + E LN
Sbjct: 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIP 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 42/205 (20%), Positives = 87/205 (42%), Gaps = 13/205 (6%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKD 124
+ + IG+G F V + ++ G A+K+ ++ + E ++
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+KH ++VEL +V+ +++ L ++ R + ++ + + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 185 LAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
L + H+ +I+HRD+K +LL + K+ FG+A + RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLL 266
++APE R + D++ GV+L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA---AIKVLS---ADSRQGVREFLTEINVIKDIKHENLVE 132
+G GG V+ +D A+KVL A F E + H +V
Sbjct: 19 ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 133 LY--GCCVEGDHRI--LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
+Y G + +V Y++ +L + G + + + L F
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 132
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI--STRVAGTEGYLAPE 246
H+ I+HRD+K +NI++ K+ DFG+A+ + + + V GT YL+PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGR 273
A + ++D+YS G +L E+++G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVL--SADSRQGVREFLTEINVIKDIKHENLVELY 134
K+G G +G V K AIK++ ++ S + L E+ V+K + H N+++LY
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
+ + LV + L ++ R FN I V G+ +LH+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKH--- 155
Query: 195 HIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+IVHRD+K N+LL +KD KI DFGL+ +F GT Y+APE +R
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRK 212
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
+ K D++S GV+L +++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAGY 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 14/192 (7%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
IG+G +G V K A K + + V F EI ++K + H N++ LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ LV L + ++ + F I V +A+ H+ ++
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 198 HRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
HRD+K N L D K+ DFGLA F + GT Y++P+ + G
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VLEGLYG 185
Query: 255 RKADIYSFGVLL 266
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 47/202 (23%), Positives = 76/202 (37%), Gaps = 17/202 (8%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA---AIKVLS---ADSRQGVREFLTEINVIKDIKHENLVE 132
+G+GG G VY+ D A+K++S + E ++ ++V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
++ + + LA L +G + I + L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP----RAVAIVRQIGSALDAAHAA- 153
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAIRG 251
HRD+K NIL+ D + DFG+A LT + GT Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSES 210
Query: 252 QLTRKADIYSFGVLLLEIVSGR 273
T +ADIY+ +L E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD--SRQGVREFL-TEINVIKDIKHENLVELYG 135
+G+G FG+VY K + A+KVL ++GV L EI + ++H N++ +Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 136 CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
RI L+ + L + L G F+ Q +A L + HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHER--- 133
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL- 253
++HRDIK N+L+ KI+DFG + P+ T + GT YL PE I G+
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGKTH 189
Query: 254 TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
K D++ GVL E + G P++ E + R
Sbjct: 190 DEKVDLWCAGVLCYEFLVG------MPPFDSPSHTET----HRR 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 42/223 (18%), Positives = 79/223 (35%), Gaps = 34/223 (15%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA----AIKVL-SADSRQGVREFLTEINVIKDIKHENLVEL 133
I GG G +Y D + +K L + + + E + ++ H ++V++
Sbjct: 87 CIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 134 YGCCVEGDHRILVYGYL-----ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
+ D GY+ SL ++ + + + L++L
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYL 198
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H +V+ D+K NI+L ++ K+ D G + + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIV 249
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291
R T DIY+ G L + +Y+ +
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLD------LPTRNGRYVDGLP 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 33/256 (12%), Positives = 76/256 (29%), Gaps = 47/256 (18%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSAD---SRQGVREFLTEINVIK------------ 123
+GQ + + T + G + V +++ E+ ++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 124 ----------DIKHENLVELYGCCVEGDHRILVYGYL-------ENNSLAQTLLGRGHSS 166
+K ++ ++ ++ + + + LL +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 167 IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226
R + + V + LA LH +VH ++ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 227 ANLTHISTRVAGTEGYLAPEYAIRGQ-----LTRKADIYSFGVLLLEIVSGRCNTNRRLP 281
A+ R A GQ +T D ++ G+ + I LP
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA------DLP 316
Query: 282 YEEQYLLEMAWKLYER 297
+ L + ++
Sbjct: 317 NTDDAALGGSEWIFRS 332
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 58 DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVRE 114
NLY E ++ +G+G FG V K + A+KV++ +
Sbjct: 11 RENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 115 FLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR 174
L E+ ++K + H N+++L+ + +V L ++ R F+
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDA 123
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTH 231
I V G+ ++H+ +IVHRD+K NILL +KD KI DFGL+ F N
Sbjct: 124 ARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178
Query: 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
GT Y+APE +RG K D++S GV+L ++SG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 36/262 (13%), Positives = 80/262 (30%), Gaps = 58/262 (22%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE------------------------ 114
+GQ + + T + G + V R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 115 ----FLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL----ENNSLAQTLLGRGHSS 166
F+ +++KD + + ++ + + + Y + + LL +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 167 IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226
R + + V + LA LH +VH ++ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 227 ANLTHISTRVAGTEGYLAPEYAI-----------RGQLTRKADIYSFGVLLLEIVSGRCN 275
A + + + G+ PE R +T D ++ G+++ I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA--- 309
Query: 276 TNRRLPYEEQYLLEMAWKLYER 297
LP + L + ++
Sbjct: 310 ---DLPITKDAALGGSEWIFRS 328
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVI 122
+ + + ++G G G V+K + G + A+K + + + L +++V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 123 -KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
K +V+ +G + + + + +G + + + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAI 133
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--TRVAGT 239
K L +L E+ ++HRD+K SNILLD+ K+ DFG++ L R AG
Sbjct: 134 VKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAGC 187
Query: 240 EGYLAPE-----YAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y+APE + +AD++S G+ L+E+ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLS-ADSRQGVREFLTEINVIKDIKHENLVELYGC 136
K+G G FG V+ + G IK ++ S+ + + EI V+K + H N+++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196
+ + +V E L + ++ + + + LA+ H + H+
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 197 VHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL 253
VH+D+K NIL KI DFGLA+LF ++ ST AGT Y+APE + +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VFKRDV 202
Query: 254 TRKADIYSFGVLL 266
T K DI+S GV++
Sbjct: 203 TFKCDIWSAGVVM 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 30/292 (10%), Positives = 68/292 (23%), Gaps = 49/292 (16%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVL---SADSRQGVREFLTEINVIKDIKHENLVELYG 135
+ G V+ + A+KV + +SR + + E+ E
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 136 CC----------VEGDHRILVYGYLENNS----------LAQTLLGRGHSSIQ------- 168
V+ +++ A L S++
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 169 -FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227
+ + + A L + +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 228 NLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
+ Y E+ T + + G+ + + LP+
Sbjct: 247 R----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL------FLPFGLV 296
Query: 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337
++ + + + + L L +RR
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLL 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLS-------------ADSRQGVREFLTEINVIK 123
K+G G +G V K + AIKV+ + + E EI+++K
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H N+++L+ + + LV + E L + ++ R F+ NI +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILS 157
Query: 184 GLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
G+ +LH+ +IVHRDIK NILL + L KI DFGL+ F + + GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTA 212
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y+APE ++ + K D++S GV++ ++ G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQG--VREFLTEINVIKDIKH 127
E ++ +G+G FG V K + A+KV++ S + L E+ ++K + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
N+++L+ + +V L ++ R F+ I V G+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITY 136
Query: 188 LHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
+H+ +IVHRD+K NILL +KD KI DFGL+ F N GT Y+A
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIA 191
Query: 245 PEYAIRGQLTRKADIYSFGVLL 266
PE +RG K D++S GV+L
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVIL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 38/228 (16%)
Query: 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVE 132
+G G G+V G A+K + D EI ++ + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73
Query: 133 LYGCCVEGDHRILVYGYLE--NNSLAQTLLGRGHSSIQFNWQTR---RNICIGVAKGLAF 187
Y + LE N +L + + S Q ++ +A G+A
Sbjct: 74 YYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 188 LHEEVQPHIVHRDIKASNILLD-------------KDLTPKISDFGLAKLFPANLTHIST 234
LH I+HRD+K NIL+ ++L ISDFGL K + + T
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 235 R---VAGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSG 272
+GT G+ APE + +LTR DI+S G + I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKD 124
++N+ ++G+G F V + K G A K+ LSA Q + E + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++H N+V L+ E LV+ + L + ++ R ++ + + +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILES 117
Query: 185 LAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+A+ H IVHR++K N+LL K K++DFGLA + AGT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPG 172
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLL 266
YL+PE + ++ DI++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 55/192 (28%), Positives = 85/192 (44%), Gaps = 14/192 (7%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
+G G F V+ + G L A+K + EI V+K IKHEN+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
H LV + L +L RG + + + V + +LHE IV
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 198 HRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
HRD+K N+L +++ I+DFGL+K+ + + GT GY+APE + +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKPYS 185
Query: 255 RKADIYSFGVLL 266
+ D +S GV+
Sbjct: 186 KAVDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS--------ADSRQGVRE-FLTEIN 120
EN+ P +G+G V + K A+K++ A+ Q +RE L E++
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 121 VIKDIK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
+++ + H N+++L LV+ ++ L L + + + R I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMR 131
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
+ + + LH+ +IVHRD+K NILLD D+ K++DFG + V GT
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGT 186
Query: 240 EGYLAPE------YAIRGQLTRKADIYSFGVLL 266
YLAPE ++ D++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 11/197 (5%)
Query: 73 NFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
S +G G FG V+K G A K++ + E EI+V+ + H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LY + +LV Y++ L ++ ++ + +G+ +H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN---LTELDTILFMKQICEGIRHMHQM 206
Query: 192 VQPHIVHRDIKASNILL-DKDLTP-KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
+I+H D+K NIL ++D KI DFGLA+ + + GT +LAPE
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNF-GTPEFLAPEVVN 261
Query: 250 RGQLTRKADIYSFGVLL 266
++ D++S GV+
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 16/242 (6%)
Query: 33 HHLRRKRASSATHRVEVNEDVSEIQDT-NLYGYKDLRVATENFSP----ANKIGQGGFGS 87
HH + ++N+ +D Y + + V + ++G G FG
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 88 VYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146
V++ K G + K ++ EI+++ + H L+ L+ + +L+
Sbjct: 67 VHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206
+L L + + + N +GL +HE IVH DIK NI
Sbjct: 127 LEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENI 180
Query: 207 LL-DKDLTP-KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGV 264
+ K + KI DFGLA + I T + APE R + D+++ GV
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 265 LL 266
L
Sbjct: 239 LG 240
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 56 IQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVRE 114
++D+ Y + DL + + +G+G F K K A+K++S ++
Sbjct: 1 MKDSPFYQHYDLDLKDK------PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK 54
Query: 115 FLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQT 173
EI +K + H N+V+L+ + H LV L L + + + H F+
Sbjct: 55 ---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH----FSETE 107
Query: 174 RRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLT 230
I + ++ +H+ +VHRD+K N+L + +L KI DFG A+L P +
Sbjct: 108 ASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLL 266
+ T T Y APE + D++S GV+L
Sbjct: 165 PLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 61 LYGYKDLRVATENFSPAN---------KIGQGGFGSVYKGTLKD-GTLAAIKVLS----- 105
++ + DL V ++ P +G G G V + AI+++S
Sbjct: 115 VFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFA 174
Query: 106 ---ADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGR 162
A TEI ++K + H ++++ D+ +V +E L ++G
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN 233
Query: 163 GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDF 219
T + + + +LHE I+HRD+K N+LL ++D KI+DF
Sbjct: 234 KR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 220 GLAKLFPANLTHISTRVAGTEGYLAPE---YAIRGQLTRKADIYSFGVLL 266
G +K+ + + T GT YLAPE R D +S GV+L
Sbjct: 287 GHSKILGET-SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKD 124
++N+ ++G+G F V + K G A K+ LSA Q + E + +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 84
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++H N+V L+ E LV+ + L + ++ R ++ + + +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILES 140
Query: 185 LAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+A+ H IVHR++K N+LL K K++DFGLA + AGT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPG 195
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLL 266
YL+PE + ++ DI++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKD 124
TE + ++G+G F V + G A + LSA Q + E + +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+KH N+V L+ E H L++ + L + ++ R + ++ + + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEA 122
Query: 185 LAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+ H+ +VHR++K N+LL K K++DFGLA GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLL 266
YL+PE + + D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 57/253 (22%), Positives = 84/253 (33%), Gaps = 54/253 (21%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-----LSADSRQGVREFLTEINVIKD 124
+ + IGQG +G V + AIK+ + + + V TE+ ++K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR---------- 174
+ H N+ LY + + LV L L S
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 175 --------------------------RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208
NI + L +LH + I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 209 --DKDLTPKISDFGLAKLFPANLTHISTR---VAGTEGYLAPEYAIRGQL---TRKADIY 260
+K K+ DFGL+K F AGT ++APE + K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAW 260
Query: 261 SFGVLLLEIVSGR 273
S GVLL ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKV-------LSADSRQGVREFL-TEINV 121
+ + P + IG+G V + + G A+K+ LS + + VRE E ++
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 122 IKDIK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ + H +++ L LV+ + L L + + + R+I
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRS 208
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
+ + ++FLH +IVHRD+K NILLD ++ ++SDFG + + GT
Sbjct: 209 LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTP 263
Query: 241 GYLAPE------YAIRGQLTRKADIYSFGVLL 266
GYLAPE ++ D+++ GV+L
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVI-KDIKHE 128
T+ + IG G + + K A+K++ S++ E EI ++ + +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHP 76
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N++ L +G + +V ++ L +L + F+ + + + K + +L
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYL 132
Query: 189 HEEVQPHIVHRDIKASNILL---DKDLTP-KISDFGLAKLFPANLTHISTRVAGTEGYLA 244
H + +VHRD+K SNIL + +I DFG AK A + T T ++A
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVA 188
Query: 245 PEYAIRGQLTRKADIYSFGVLL 266
PE R DI+S GVLL
Sbjct: 189 PEVLERQGYDAACDIWSLGVLL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 11/226 (4%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIK 123
+ + F +G+GGFG V+ +K G L A K L+ R+G + + E ++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ +V L LV + + + + F +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL LH+ +I++RD+K N+LLD D +ISD GLA A T GT G++
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFM 356
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGRC---NTNRRLPYEEQY 286
APE + + D ++ GV L E+++ R ++ +E
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS--------ADSRQGVREFLTEINV 121
+ + + +G G G V + AIK++S A TEI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
+K + H ++++ D+ +V +E L ++G T + +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQM 123
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAG 238
+ +LHE I+HRD+K N+LL ++D KI+DFG +K+ + + G
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 178
Query: 239 TEGYLAPE---YAIRGQLTRKADIYSFGVLL 266
T YLAPE R D +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-RQGV-----REFLTEINVIKDI 125
E + K+G+G +G VYK G + A+K + D+ +G+ RE I+++K++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKEL 76
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
H N+V L LV+ ++E + L + L + + + +G+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGV 132
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
A H+ I+HRD+K N+L++ D K++DFGLA+ F + + V T Y AP
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 246 E-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ Y + DI+S G + E+++G+
Sbjct: 189 DVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 70 ATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGV-----REFLTEINVIK 123
++ F K+G G + +VYKG G A+K + DS +G RE I+++K
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTL--LGRGHSSIQFNWQTRRNICIGV 181
++KHEN+V LY + LV+ +++N+ L + + G++ + +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+GLAF HE I+HRD+K N+L++K K+ DFGLA+ F + S+ V T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 242 YLAPE-------Y--AIRGQLTRKADIYSFGVLLLEIVSGR 273
Y AP+ Y +I DI+S G +L E+++G+
Sbjct: 174 YRAPDVLMGSRTYSTSI--------DIWSCGCILAEMITGK 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 49/238 (20%), Positives = 87/238 (36%), Gaps = 15/238 (6%)
Query: 36 RRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSP----ANKIGQGGFGSVYKG 91
+ + V N D Y + + + ++ ++G G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 92 TLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150
T + G A K + EI + ++H LV L+ + + +++Y ++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL-- 208
L + + + + V KGL +HE + VH D+K NI+
Sbjct: 237 SGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTT 290
Query: 209 DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLL 266
+ K+ DFGL GT + APE A + D++S GVL
Sbjct: 291 KRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 76/284 (26%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 11 CSQYHKLQPSPFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDL--- 67
C+Q + P LF + L +L + + I +K L
Sbjct: 129 CTQRLEQGPCKDLFQELTRLTHEYLSVA---------PFADYLDSIYFNRFLQWKWLERQ 179
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIK 123
V F +G+GGFG V ++ G + A K L R+G L E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ +V L D LV + L + G + F +
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICC 297
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
GL LH E IV+RD+K NILLD +ISD GLA P T I RV GT GY+
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 352
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGRC---NTNRRLPYEE 284
APE + T D ++ G LL E+++G+ +++ EE
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 15/192 (7%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
++G+G VY+ K A+KVL + TEI V+ + H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
LV + L ++ +G+ ++ + + + + +A+LHE IV
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHEN---GIV 170
Query: 198 HRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT 254
HRD+K N+L D KI+DFGL+K+ + V GT GY APE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYG 228
Query: 255 RKADIYSFGVLL 266
+ D++S G++
Sbjct: 229 PEVDMWSVGIIT 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIK-VLSADSRQGVREF-LTEINVIKDIKHE 128
E + KIG+G +G V+K +D G + AIK L ++ +++ L EI ++K +KH
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
NLV L LV+ Y ++ + L ++I + + F
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE-- 246
H+ + +HRD+K NIL+ K K+ DFG A+L + VA T Y +PE
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELL 174
Query: 247 -----Y--AIRGQLTRKADIYSFGVLLLEIVSGR 273
Y + D+++ G + E++SG
Sbjct: 175 VGDTQYGPPV--------DVWAIGCVFAELLSGV 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGV-REFLTEINVIKDIKHEN 129
E + +K+G+G + +VYKG K L A+K + + +G + E++++KD+KH N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V L+ LV+ YL+ + L Q L N + + +GLA+ H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE--- 246
+ ++HRD+K N+L+++ K++DFGLA+ V T Y P+
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 247 ----YAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y + + D++ G + E+ +GR
Sbjct: 174 GSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-RQGV-----REFLTEINVIKDI 125
E + KIG+G +G VYK G A+K + + +G+ RE I+++K++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKEL 57
Query: 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
KH N+V+LY +LV+ +L+ + L + L T ++ + + G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 186 AFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAP 245
A+ H+ ++HRD+K N+L++++ KI+DFGLA+ F + + + T Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 246 E-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ Y + DI+S G + E+V+G
Sbjct: 170 DVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 71/276 (25%), Positives = 110/276 (39%), Gaps = 41/276 (14%)
Query: 6 FQLYYCSQYHKLQPSPFLFYLTSALLLHHLRRKRASSATHRVEVNEDVSEIQDTNLYGYK 65
FQ Y L+ F ++ S + K VE+N ++ + D ++
Sbjct: 146 FQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKN-------VELNIHLT-MNDFSV---- 193
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINV 121
R+ IG+GGFG VY D G + A+K L +QG L E +
Sbjct: 194 -HRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 122 IKDIKHEN---LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
+ + + +V + D + + L L G F+ R
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYA 298
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAG 238
+ GL +H +V+RD+K +NILLD+ +ISD GLA F H V G
Sbjct: 299 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-G 352
Query: 239 TEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
T GY+APE +G AD +S G +L +++ G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 44/207 (21%), Positives = 80/207 (38%), Gaps = 20/207 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS------ADSRQGVREFLTEINVIK 123
+ + ++G G F V K K G A K + + E E+++++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H N++ L+ +L+ + L L + + + + +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILD 126
Query: 184 GLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
G+ +LH + I H D+K NI+L K+ DFGLA + GT
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGT 181
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLL 266
++APE L +AD++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIK-VLSADSRQGVREF-LTEINVIKDIKHE 128
E + +G+G +G V K KD G + AIK L +D + V++ + EI ++K ++HE
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
NLV L C + LV+ ++++ + L ++Q + + G+ F
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE-- 246
H +I+HRDIK NIL+ + K+ DFG A+ A VA T Y APE
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELL 196
Query: 247 -----Y--AIRGQLTRKADIYSFGVLLLEIVSGR 273
Y A+ D+++ G L+ E+ G
Sbjct: 197 VGDVKYGKAV--------DVWAIGCLVTEMFMGE 222
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 20/207 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVL------SADSRQGVREFLTEINVIK 123
+++ ++G G F V K K G A K + S+ E E+N+++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+I+H N++ L+ +L+ + L L + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILD 119
Query: 184 GLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
G+ +LH + I H D+K NI+L + K+ DFG+A A GT
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF-GT 174
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLL 266
++APE L +AD++S GV+
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 65/275 (23%), Positives = 103/275 (37%), Gaps = 50/275 (18%)
Query: 34 HLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT- 92
H +S R +++ T L K+ + +G GGFGSVY G
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64
Query: 93 LKDGTLAAIKVLS-------ADSRQGVREFLTEINVIKDIKHE--NLVELYGCCVEGDHR 143
+ D AIK + + G R + E+ ++K + ++ L D
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 144 ILV----------YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+L+ + ++ Q L R F WQ V + + H
Sbjct: 124 VLILERPEPVQDLFDFITERGALQEELAR-----SFFWQ--------VLEAVRHCH---N 167
Query: 194 PHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
++HRDIK NIL+D + K+ DFG L + GT Y PE+ IR
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEW-IRYH 223
Query: 253 L--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
R A ++S G+LL ++V G +P+E
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG------DIPFEHD 252
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 20/207 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS------ADSRQGVREFLTEINVIK 123
+ + ++G G F V K K G A K + + E E+++++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H N++ L+ +L+ + L L + + + + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILD 126
Query: 184 GLAFLHEEVQPHIVHRDIKASNILL-DKDLTP---KISDFGLAKLFPANLTHISTRVAGT 239
G+ +LH + I H D+K NI+L DK++ K+ DFGLA + GT
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGT 181
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLL 266
++APE L +AD++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 49/204 (24%), Positives = 75/204 (36%), Gaps = 25/204 (12%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCC 137
+G+G V A+K++ E+ ++ + H N++EL
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
E D LV+ + S+ + R H FN + VA L FLH I
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHN---KGIA 133
Query: 198 HRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTR------VAGTEGYLAPEYA 248
HRD+K NIL ++ KI DF L N G+ Y+APE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-V 192
Query: 249 IRGQLTR------KADIYSFGVLL 266
+ + D++S GV+L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 69/254 (27%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLT--------------------- 117
IG+G +G V D T A+KVLS F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 118 -----EINVIKDIKHENLVELYGCCV----EGDHRILVYGYLENNSLAQTLLGRGHSSIQ 168
EI ++K + H N+V+L V DH +V+ + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 169 FNWQTR--------RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220
T R + KG+ +LH + I+HRDIK SN+L+ +D KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLT----RKADIYSFGVLLLEIVSGRCNT 276
++ F + +S GT ++APE ++ + D+++ GV L V G
Sbjct: 183 VSNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFG---- 236
Query: 277 NRRLPYEEQYLLEM 290
+ P+ ++ ++ +
Sbjct: 237 --QCPFMDERIMCL 248
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 70 ATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADS-RQGVREF----LTEINVIK 123
AT + P +IG G +G+VYK G A+K + + G + E+ +++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 124 DIK---HENLVELYGCCVEGDHRI-----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRR 175
++ H N+V L C LV+ +++ + L L +T +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIK 123
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--PANLTHIS 233
++ +GL FLH IVHRD+K NIL+ T K++DFGLA+++ LT
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP-- 178
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
V T Y APE ++ D++S G + E+ +
Sbjct: 179 -VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 20/199 (10%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVL------SADSRQGVREFLTEINVIKDIKHENLV 131
++G G F V K K G A K + S+ + E++++K+I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L+ IL+ + L L + + + G+ +LH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSL 133
Query: 192 VQPHIVHRDIKASNILL----DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
I H D+K NI+L KI DFGLA + + GT ++APE
Sbjct: 134 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 248 AIRGQLTRKADIYSFGVLL 266
L +AD++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADS-RQGV-----REFLTEINVIKD 124
+ + K+G+G +G VYK AIK + + +GV RE ++++K+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKE 89
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
++H N++EL L++ Y EN+ L + + + + + ++ + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLING 144
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTP-----KISDFGLAKLFPANLTHISTRVAGT 239
+ F H +HRD+K N+LL KI DFGLA+ F + + + T
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 240 EGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y PE Y + DI+S + E++
Sbjct: 201 LWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 20/190 (10%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE-----FLTEI 119
D++ + + + +G+G F +VYK + AIK + R ++ L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 120 NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
+++++ H N++ L + LV+ ++E + L + +S+ + +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYML 119
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--PAN-LTHISTRV 236
+GL +LH+ I+HRD+K +N+LLD++ K++DFGLAK F P TH +V
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QV 173
Query: 237 AGTEGYLAPE 246
T Y APE
Sbjct: 174 V-TRWYRAPE 182
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 46/182 (25%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADS-RQGV-----REFLTEINVIKD 124
+ + KIG+G +G+V+K + + A+K + D +GV RE I ++K+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKE 57
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+KH+N+V L+ LV+ + + + L + + + + ++ + KG
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKG 113
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
L F H +++HRD+K N+L++++ K+++FGLA+ F + S V T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRP 169
Query: 245 PE 246
P+
Sbjct: 170 PD 171
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 79 KIGQGGFGSVYKGTLKD---GTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVEL 133
K+G+G +G VYK KD A+K + S RE I +++++KH N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 83
Query: 134 YGCCVE-GDHRI-LVYGYLENNSLAQTL-----LGRGHSSIQFNWQTRRNICIGVAKGLA 186
+ D ++ L++ Y E++ L + +Q +++ + G+
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTP----KISDFGLAKLF--PAN-LTHISTRVAGT 239
+LH ++HRD+K +NIL+ + KI+D G A+LF P L + V T
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 240 EGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y APE Y T+ DI++ G + E+++
Sbjct: 199 FWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 56/231 (24%), Positives = 83/231 (35%), Gaps = 52/231 (22%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLS-------ADSRQGVREFLTEINVIK----DIKH 127
+G+GGFG+V+ G L D AIKV+ + V L E+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 128 ENLVELYGCCVEGDHRILV----------YGYLENNSLAQTLLGRGHSSIQFNWQTRRNI 177
++ L + +LV + Y+ R F Q
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-----CFFGQ----- 147
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHISTRV 236
V + H +VHRDIK NIL+D K+ DFG L
Sbjct: 148 ---VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198
Query: 237 AGTEGYLAPEYAIRGQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
GT Y PE+ I A ++S G+LL ++V G +P+E
Sbjct: 199 DGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCG------DIPFERD 242
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADS-RQGVREFLT---EINVIKDIK 126
+ KIGQG FG V+K K G A+K + ++ ++G +T EI +++ +K
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLK 74
Query: 127 HENLVELYGCCVEGDHRI--------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
HEN+V L C LV+ + E++ LA L + ++F + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVM 130
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-------PANLTH 231
+ GL ++H I+HRD+KA+N+L+ +D K++DFGLA+ F P T+
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 232 ISTRVAGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
RV T Y PE Y D++ G ++ E+ +
Sbjct: 188 ---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 39/199 (19%), Positives = 77/199 (38%), Gaps = 12/199 (6%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
E + A +G+G FG V++ K + EI+++ +H N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
++ L+ + ++++ ++ + + + N + + V + L FLH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH 119
Query: 190 EEVQPHIVHRDIKASNILL--DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
+I H DI+ NI+ + T KI +FG A+ + Y APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLF-TAPEYYAPEV 174
Query: 248 AIRGQLTRKADIYSFGVLL 266
++ D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYGCC 137
+G+G +G V A+K++ E + EI + K + HEN+V+ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
EG+ + L Y L + + +F Q + G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-----GVVYLH---G 123
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT--HISTRVAGTEGYLAPEYAIRG 251
I HRDIK N+LLD+ KISDFGLA +F N ++ GT Y+APE ++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKR 181
Query: 252 QL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
+ D++S G++L +++G LP+++
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG------ELPWDQP 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 40/247 (16%)
Query: 46 RVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLS 105
++ +D +++ K ++ IG G FG V++ L + AIK +
Sbjct: 14 KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL 73
Query: 106 ADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI------LVYGYLENNSLAQTL 159
D R R E+ +++ +KH N+V+L + LV Y+ +T+
Sbjct: 74 QDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETV 124
Query: 160 LGRGHSSIQFNWQTRRNICIGVAK--------GLAFLHEEVQPHIVHRDIKASNILLDKD 211
+ + + + ++ + + + K LA++H I HRDIK N+LLD
Sbjct: 125 ----YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPP 177
Query: 212 LTP-KISDFGLAKLF---PANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLL 266
K+ DFG AK+ N+++I +R Y APE T DI+S G ++
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 267 LEIVSGR 273
E++ G+
Sbjct: 233 AELMQGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGC 136
IG+G F V + G AIK++ + +++ E+ ++K + H N+V+L+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 137 CVEGDHRILVYGYLENNSLAQTLLGRGH----SSIQFNWQTRRNICIGVAKGLAFLHEEV 192
L+ Y + L+ G + Q + + + H++
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------IVSAVQYCHQK- 133
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
IVHRD+KA N+LLD D+ KI+DFG + F + G Y APE +G+
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-LFQGK 188
Query: 253 L--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
+ D++S GV+L +VSG LP++ Q L E+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKEL 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINV 121
G R +++ IG G FG VY+ L D G L AIK + D R RE + +
Sbjct: 45 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQI 100
Query: 122 IKDIKHENLVELYGC-CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ + H N+V L G+ + VY L + + +T+ + + + ++ + +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV----YRVARHYSRAKQTLPVI 156
Query: 181 VAK--------GLAFLHEEVQPHIVHRDIKASNILLDKDLTP-KISDFGLAKLF---PAN 228
K LA++H I HRDIK N+LLD D K+ DFG AK N
Sbjct: 157 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 229 LTHISTRVAGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+++I +R Y APE Y T D++S G +L E++ G+
Sbjct: 214 VSYICSRY-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 47/195 (24%), Positives = 79/195 (40%), Gaps = 14/195 (7%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVL--SADSRQGVREFLTEINVIKDIKH-ENLVELY 134
++G+G F V + K G A K L + E L EI V++ K ++ L+
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
IL+ Y + L + + + +G+ +LH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQN--- 150
Query: 195 HIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+IVH D+K NILL KI DFG+++ + + GT YLAPE
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIM-GTPEYLAPEILNYD 208
Query: 252 QLTRKADIYSFGVLL 266
+T D+++ G++
Sbjct: 209 PITTATDMWNIGIIA 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYGCC 137
+G+G +G V A+K++ E + EI + K + HEN+V+ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
EG+ + L Y L + + +F Q + G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-----GVVYLH---G 123
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT--HISTRVAGTEGYLAPEYAIRG 251
I HRDIK N+LLD+ KISDFGLA +F N ++ GT Y+APE ++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKR 181
Query: 252 QL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285
+ D++S G++L +++G LP+++
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG------ELPWDQP 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGC 136
+G G G V + + G A+K+L R+ E++ ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQ---EVDHHWQASGGPHIVCILDV 90
Query: 137 CVEGDHRI----LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
H ++ +E L + RG + F + I + + FLH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--FTEREAAEIMRDIGTAIQFLHSH- 147
Query: 193 QPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
+I HRD+K N+L +KD K++DFG AK N + T T Y+APE
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLG 202
Query: 250 RGQLTRKADIYSFGVLL 266
+ + D++S GV++
Sbjct: 203 PEKYDKSCDMWSLGVIM 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 72 ENFSPANKIGQGGFGSVYKG--TLKDGTLAAIKVLSADS-RQGV-----REFLTEINVIK 123
+ + +IG+G +G V+K G A+K + + +G+ RE + V++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLR 66
Query: 124 DIK---HENLVELYGCCV----EGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRR 175
++ H N+V L+ C + + ++ LV+ +++ + L L +T +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGVPTETIK 123
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF--PANLTHIS 233
++ + +GL FLH +VHRD+K NIL+ K++DFGLA+++ LT
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
V T Y APE ++ D++S G + E+ +
Sbjct: 179 -VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 39/254 (15%)
Query: 105 SADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH 164
S + +I + +N V + + +L + R
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRC 156
Query: 165 SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK- 223
S +I I +A+ + FLH + ++HRD+K SNI D K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 224 ----------LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
L P T GT+ Y++PE + K DI+S G++L E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS- 272
Query: 274 CNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALL---CTQD 330
+T ER +++ V N + + +Y + ++
Sbjct: 273 FSTQ-----------------MERVRIITDVR---NLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 331 MPKRRPSMSTLVNM 344
P RP + ++
Sbjct: 313 SPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 20/73 (27%), Positives = 36/73 (49%), Gaps = 2/73 (2%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHEN 129
+F P +G+GGFG V++ K D AIK + +R+ RE + E+ + ++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 130 LVELYGCCVEGDH 142
+V + +E
Sbjct: 66 IVRYFNAWLETPP 78
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 34/229 (14%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLT-EINVIKDIKHENLVELYGCC 137
IG G FG L A+K + + + E + EI + ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 138 VEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+ H ++ Y L + + G + F Q + GV ++ H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ----LLSGV----SYCHSM-- 135
Query: 194 PHIVHRDIKASNILLDKDLTP--KISDFGLAKLF-PANLTHISTRVAGTEGYLAPEYAIR 250
I HRD+K N LLD P KI DFG +K + + V GT Y+APE +
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE-VLL 190
Query: 251 GQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
Q + AD++S GV L ++ G P+E+ K +R
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVG------AYPFEDPEEPRDYRKTIQR 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVL------SADSRQGVREFLTEINVIKDIKHENLVE 132
+G G FG V G G A+K+L S D ++ EI +K +H ++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIK 75
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFL 188
LY +V Y+ L + G + + Q + + +
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ--------ILSAVDYC 127
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPEY 247
H + +VHRD+K N+LLD + KI+DFGL+ + S G+ Y APE
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE- 180
Query: 248 AIRGQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
I G+L + DI+S GV+L ++ G LP++++++ +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCG------TLPFDDEHVPTL 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 46/233 (19%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLT----EINVIKDIKHENLVELY 134
+G+G +G V + + A+K+L + + EI +++ ++H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 135 G-CCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK--------G 184
E ++ +V Y G + + + + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVC----------GMQEM-LDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF----PANLTHISTRVAGTE 240
L +LH IVH+DIK N+LL T KIS G+A+ + S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSP 175
Query: 241 GYLAPEYAIRGQLT---RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
+ PE G T K DI+S GV L I +G P+E + ++
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG------LYPFEGDNIYKL 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 32/249 (12%)
Query: 41 SSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLA 99
A + + ++ + +DLR+ E++ IG+G FG V K +
Sbjct: 38 FPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 97
Query: 100 AIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLA 156
A+K+LS R F E +++ +V+L+ + + +V Y+ L
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 157 QTLLGRGHSSIQFNWQTRRNICIGVAK--------GLAFLHEEVQPHIVHRDIKASNILL 208
N + ++ A+ L +H +HRD+K N+LL
Sbjct: 157 ------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 201
Query: 209 DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE----YAIRGQLTRKADIYSFGV 264
DK K++DFG GT Y++PE G R+ D +S GV
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261
Query: 265 LLLEIVSGR 273
L E++ G
Sbjct: 262 FLYEMLVGD 270
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 14/212 (6%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADS---RQGVREFLTEINVIK 123
+ E+F +G+G F +V AIK+L V E +V+
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H V+LY + + Y +N L + + S F+ R +
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRFYTAEIVS 141
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR-VAGTEGY 242
L +LH + I+HRD+K NILL++D+ +I+DFG AK+ GT Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 243 LAPEYAIRGQLTRKA-DIYSFGVLLLEIVSGR 273
++PE + + K+ D+++ G ++ ++V+G
Sbjct: 199 VSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+ F GQG FG+V G K G AIK + D R RE L + + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 130 LVELYGC--CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK---- 183
+V+L + R +Y + + TL H + ++ + + K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL----HRCCRNYYRRQVAPPPILIKVFLF 136
Query: 184 ----GLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFGLAKLF---PANLTHIS 233
+ LH ++ HRDIK N+L+++ L K+ DFG AK N+ +I
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 234 TRVAGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+R Y APE Y T DI+S G + E++ G
Sbjct: 194 SRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYG 135
IG+G FG V D + A+K ++ R VR E+ +++ ++H LV L+
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQF-NWQTRRNIC-IGVAKGLAFLHEEVQ 193
+ + +V L L + L + ++ F + IC + +A L +L +
Sbjct: 83 SFQDEEDMFMVVDLLLGGDL-RYHLQQ---NVHFKEETVKLFICELVMA--LDYLQNQ-- 134
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE-YAIRGQ 252
I+HRD+K NILLD+ I+DF +A + P + +AGT+ Y+APE ++ R
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 253 L--TRKADIYSFGVLLLEIVSGR 273
+ D +S GV E++ GR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 11/228 (4%)
Query: 51 EDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD-- 107
++ + RV F +G+G FG V K G A+K+L +
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI 186
Query: 108 -SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSS 166
++ V LTE V+++ +H L L D V Y L L
Sbjct: 187 VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRE 242
Query: 167 IQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226
F+ R + L +LH E +V+RD+K N++LDKD KI+DFGL K
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274
+ + T GT YLAPE R D + GV++ E++ GR
Sbjct: 301 KDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 43/197 (21%), Positives = 80/197 (40%), Gaps = 21/197 (10%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYG- 135
+G G G V + K A+K+L R E+ + + ++V +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHIVRIVDV 123
Query: 136 ---CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
++V L+ L + RG + F + I + + + +LH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI- 180
Query: 193 QPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
+I HRD+K N+L + K++DFG AK ++ ++T T Y+APE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPC-YTPYYVAPEVLG 236
Query: 250 RGQLTRKADIYSFGVLL 266
+ + D++S GV++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 15/242 (6%)
Query: 41 SSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLA 99
+S R + + E K +R+ E+F IG+G FG V LK+ +
Sbjct: 43 NSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVF 102
Query: 100 AIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLA 156
A+K+L+ R F E +V+ + + + L+ + ++ LV Y L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 157 QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216
TLL + + + R + + +H+ H VHRDIK NIL+D + ++
Sbjct: 163 -TLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 216
Query: 217 SDFGLAKLFPANLTHISTRVAGTEGYLAPE-----YAIRGQLTRKADIYSFGVLLLEIVS 271
+DFG + T S+ GT Y++PE +G+ + D +S GV + E++
Sbjct: 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 272 GR 273
G
Sbjct: 277 GE 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 52/229 (22%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLS---------ADSRQGVREFLTEINVIKDIKHEN 129
+G G FG V+ + +K + + + + L EI ++ ++H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 130 LVELYGCCVEGDHRI-LV----------YGYLENNSLAQTLLGRGHSSIQFNWQTRRNIC 178
++++ E LV + +++ + L Q
Sbjct: 91 IIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS-----YIFRQ------ 138
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVA 237
+ + +L + I+HRDIK NI++ +D T K+ DFG A L +
Sbjct: 139 --LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---C 190
Query: 238 GTEGYLAPEYAIRGQLTR--KADIYSFGVLLLEIVSGRCNTNRRLPYEE 284
GT Y APE + G R + +++S GV L +V P+ E
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE------ENPFCE 232
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEIN 120
K++R+ ++F IG+G F V +K G + A+K+++ R V F E +
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 121 VIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
V+ + + +L+ + ++ LV Y L TLL + + + R
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSK--FGERIPAEMARFYLAE 170
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
+ + +H VHRDIK NILLD+ +++DFG A+ T S GT
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 241 GYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
YL+PE G + D ++ GV E+ G+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVL------SADSRQGVREFLTEINVIKDIKHENLVE 132
+G G FG V G G A+K+L S D +R EI +K +H ++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIK 80
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFL 188
LY +V Y+ L + G S + Q + G+ +
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ--------ILSGVDYC 132
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPEY 247
H + +VHRD+K N+LLD + KI+DFGL+ + S G+ Y APE
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE- 185
Query: 248 AIRGQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
I G+L + DI+S GV+L ++ G LP+++ ++ +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCG------TLPFDDDHVPTL 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 13/240 (5%)
Query: 39 RASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GT 97
RA E + R+ +F+ +G+G FG V K
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 98 LAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLENN 153
L A+K+L D V + E V+ K L +L+ C D V Y+
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 154 SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213
L + +F +A GL FL + I++RD+K N++LD +
Sbjct: 428 DLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480
Query: 214 PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
KI+DFG+ K + T GT Y+APE + D ++FGVLL E+++G+
Sbjct: 481 IKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVL------SADSRQGVREFLTEINVIKDIKHENLVE 132
+G+G FG V T K A+K + +D V EI+ +K ++H ++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIK 73
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG----HSSIQFNWQTRRNICIGVAKGLAFL 188
LY ++V Y L ++ + +F Q + + +
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ--------IICAIEYC 124
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGYLAPEY 247
H + IVHRD+K N+LLD +L KI+DFGL+ + N S G+ Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE- 177
Query: 248 AIRGQL--TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290
I G+L + D++S G++L ++ G RLP++++++ +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVG------RLPFDDEFIPNL 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 22/201 (10%), Positives = 47/201 (23%), Gaps = 45/201 (22%)
Query: 79 KIGQGGFGSVYKGTLKDGTLA---AIKVLSAD---SRQGVREFLTEINVIKDIKHENLVE 132
G ++ D L A+ + ++E L+ + I +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ ++V ++ SL + + S + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQE-VADTSPSPVG-----AIRAMQSLAAAADAAHRA- 148
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+ S + + D G L +
Sbjct: 149 --GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 253 LTRKADIYSFGVLLLEIVSGR 273
+ DI G L ++ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 49 VNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVY---KGTLKD-GTLAAIKVL 104
+ + EI T+ + F +GQG FG V+ K + D L A+KVL
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 105 SADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161
+ R V E +++ ++ H +V+L+ L+ +L L L
Sbjct: 61 KKATLKVRDRV-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221
F + + +A L LH I++RD+K NILLD++ K++DFGL
Sbjct: 120 EVM----FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
+K + + GT Y+APE R T+ AD +SFGVL+ E+++G
Sbjct: 173 SKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIK 123
+V +F +G+G FG V K G A+K+L + ++ V +TE V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ +H L L D V Y L L F + R +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVS 116
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEG 241
L +LH +V+RDIK N++LDKD KI+DFGL K + T GT
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPE 170
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274
YLAPE R D + GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 68 RVATENFSPANKIGQGGFGSVY---KGTLKD-GTLAAIKVLSADS----RQGVREFLTEI 119
++ E F +G+GG+G V+ K T + G + A+KVL + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 120 NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
N+++++KH +V+L G L+ YL L L G F T
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI----FMEDTACFYLA 128
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGT 239
++ L LH++ I++RD+K NI+L+ K++DFGL K + T T GT
Sbjct: 129 EISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGT 184
Query: 240 EGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
Y+APE +R R D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELY 134
+G+G FG V +K+ G L A+KVL D V +TE ++ H L +L+
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
C D V ++ L + S +F+ R + L FLH++
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDK--- 143
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
I++RD+K N+LLD + K++DFG+ K + T +T GT Y+APE ++
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYIAPE-ILQEM 199
Query: 253 L-TRKADIYSFGVLLLEIVSGR 273
L D ++ GVLL E++ G
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGH 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 71/343 (20%), Positives = 114/343 (33%), Gaps = 95/343 (27%)
Query: 78 NKIGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQG-VREFLTEINVIKDI-KHEN 129
+G+G FG V + A+K+L + R ++E+ ++ I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 130 LVELYGCCVEGDHRILV------YG----YLENN---------------------SLAQT 158
+V L G C + ++V +G YL +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 159 LLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---------- 208
L R SI + + + + K L+ + EE P +++D L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVE-EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 209 --------------------DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL----- 243
+ KI DFGLA+ ++ V + L
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWM 262
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
APE T ++D++SFGVLL EI S G PY + E + + G +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDEEFCRRLKEGTRMR 316
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
D + Y L C P +RP+ S LV L
Sbjct: 317 APDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL 350
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 53/241 (21%), Positives = 100/241 (41%), Gaps = 18/241 (7%)
Query: 40 ASSATHRVEVNEDVSEIQDTNLYGYKDL---RVATENFSPANKIGQGGFGSVYKGTLKD- 95
A + + V E +++ ++ L ++ + F +G G FG V K+
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65
Query: 96 GTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152
G A+K+L + + L E +++ + LV+L + + +V Y+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212
+ L G F+ R + +LH +++RD+K N+L+D+
Sbjct: 126 GEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQG 178
Query: 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSG 272
+++DFG AK T T + GT LAPE + + D ++ GVL+ E+ +G
Sbjct: 179 YIQVTDFGFAKRVKGR-TW--T-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 273 R 273
Sbjct: 235 Y 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELY 134
+G+G FG V K L A+K+L D V + E V+ K L +L+
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
C D V Y+ L + +F +A GL FL +
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK--- 140
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
I++RD+K N++LD + KI+DFG+ K ++ T T GT Y+APE
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIAPEIIAYQP 197
Query: 253 LTRKADIYSFGVLLLEIVSGR 273
+ D ++FGVLL E+++G+
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINV-IKDIKHENLVELY 134
+G+G FG V+ K AIK L D V + E V +H L ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
++ V YL L + S +F+ + GL FLH +
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK--- 137
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
IV+RD+K NILLDKD KI+DFG+ K + T +T GT Y+APE + +
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPDYIAPEILLGQK 194
Query: 253 LTRKADIYSFGVLLLEIVSGRC 274
D +SFGVLL E++ G+
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQS 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 39/230 (16%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIK 123
L V NF KIG G FG + G L AIK+ SR E K
Sbjct: 3 GVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYK 59
Query: 124 DIKH-ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------- 175
+ + + ++Y G + +V LLG + F+ R
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMV----------LELLGPSLEDL-FDLCDRTFSLKTVL 108
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK-----ISDFGLAKLF--PAN 228
I I + + ++H + ++++RD+K N L+ + I DF LAK + P
Sbjct: 109 MIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 229 LTHISTR----VAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
HI R + GT Y G + +R+ D+ + G + + + G
Sbjct: 166 KKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELY 134
IG+G + V LK + A+KV+ + + + TE +V + H LV L+
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
C V Y+ L + + + R ++ L +LHE
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER--- 129
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
I++RD+K N+LLD + K++D+G+ K L P + T T GT Y+APE +RG+
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYIAPE-ILRGE 185
Query: 253 L-TRKADIYSFGVLLLEIVSGRC 274
D ++ GVL+ E+++GR
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRS 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 19/232 (8%)
Query: 51 EDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD-- 107
E+ E +T G + ++F IG+G + V LK + A++V+ +
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90
Query: 108 -SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS 165
+ + TE +V + H LV L+ C V Y+ L +
Sbjct: 91 NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QR 146
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK-- 223
+ + R ++ L +LHE I++RD+K N+LLD + K++D+G+ K
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203
Query: 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRC 274
L P + T GT Y+APE +RG+ D ++ GVL+ E+++GR
Sbjct: 204 LRPGDTTST---FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 63 GYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINV 121
G +LRV + KIG G FG +Y GT + G AIK+ ++ E +
Sbjct: 1 GSMELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKI 57
Query: 122 IKDIKH-ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR----- 175
K ++ + + C EGD+ ++V LLG + FN+ +R+
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMV----------MELLGPSLEDL-FNFCSRKFSLKT 106
Query: 176 --NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK---ISDFGLAKLF--PAN 228
+ + + ++H + + +HRD+K N L+ I DFGLAK +
Sbjct: 107 VLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
Query: 229 LTHISTR----VAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
HI R + GT Y A G + +R+ D+ S G +L+ G
Sbjct: 164 HQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 67/254 (26%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKH 127
+++ +S +G G FG V + + G A+K + D R RE ++++K + H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDH 59
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRG------------------------ 163
N+++L ++ G
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 164 -----HSSIQFNWQTRRNICIG--------VAKGLAFLHEEVQPHIVHRDIKASNILLD- 209
H ++ ++ R+I + + + + F+H I HRDIK N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNS 176
Query: 210 KDLTPKISDFGLAKLF---PANLTHISTRVAGTEGYLAPE-------YAIRGQLTRKADI 259
KD T K+ DFG AK ++ +I +R Y APE Y T D+
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY------TPSIDL 225
Query: 260 YSFGVLLLEIVSGR 273
+S G + E++ G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 46/249 (18%), Positives = 104/249 (41%), Gaps = 54/249 (21%)
Query: 49 VNEDVSEIQDTNLYGYKDLRVA---TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVL 104
V DV+ + + Y+ V +++ K+G+G + V++ + + +K+L
Sbjct: 10 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 69
Query: 105 SADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHR--ILVYGYLENNSLAQTL-- 159
++ + EI ++++++ N++ L + R LV+ ++ N Q
Sbjct: 70 KPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 126
Query: 160 LGRGHSSIQ-FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPK 215
L I+ + ++ + L + H I+HRD+K N+++D + L +
Sbjct: 127 LTDYD--IRFYMYEILK--------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKL--R 171
Query: 216 ISDFGLAKLFPAN--LTHISTRVAGTEGYLAPE---------YAIRGQLTRKADIYSFGV 264
+ D+GLA+ + RVA + + PE Y++ D++S G
Sbjct: 172 LIDWGLAEFYHPGQEYNV---RVA-SRYFKGPELLVDYQMYDYSL--------DMWSLGC 219
Query: 265 LLLEIVSGR 273
+L ++ +
Sbjct: 220 MLASMIFRK 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 47/256 (18%)
Query: 33 HHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT 92
+++ + + + + VEV + + + + IG G G V
Sbjct: 37 YNMSKSKVDNQFYSVEVGDSTFTV--------------LKRYQNLKPIGSGAQGIVCAAY 82
Query: 93 -LKDGTLAAIKVLS------ADSRQGVREFLTEINVIKDIKHENLVELY-----GCCVEG 140
AIK LS +++ RE + ++K + H+N++ L +E
Sbjct: 83 DAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 141 DHRI-LVYGYLEN--NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIV 197
+ LV ++ + Q L S +Q G+ LH I+
Sbjct: 139 FQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLC--------GIKHLHSA---GII 186
Query: 198 HRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKA 257
HRD+K SNI++ D T KI DFGLA+ + + T T Y APE +
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 258 DIYSFGVLLLEIVSGR 273
DI+S G ++ E+V +
Sbjct: 245 DIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 56/248 (22%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV 103
++ +VN+ E+ + + +G G +GSV + G AIK
Sbjct: 11 YKQDVNKTAWEL--------------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK 56
Query: 104 LS------ADSRQGVREFLTEINVIKDIKHENLVELY-----GCCVEGDHRI-LVYGYLE 151
LS +++ RE + ++K ++HEN++ L + + LV +++
Sbjct: 57 LSRPFQSEIFAKRAYRE----LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ 112
Query: 152 ---NNSLAQTLLGRGHSSIQ-FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207
+ IQ +Q + GL ++H +VHRD+K N+
Sbjct: 113 TDLQKIMGLKFS---EEKIQYLVYQMLK--------GLKYIHSA---GVVHRDLKPGNLA 158
Query: 208 LDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVL 265
+++D KI DFGLA+ A +T + TR Y APE + + DI+S G +
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 266 LLEIVSGR 273
+ E+++G+
Sbjct: 214 MAEMLTGK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINVIK 123
+ + ++F +G G FG V+ + G A+KVL + + V E ++
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H ++ ++G + ++ Y+E L +LL + S +F + V
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF-SLLRK---SQRFPNPVAKFYAAEVCL 117
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
L +LH + I++RD+K NILLDK+ KI+DFG AK P ++T+ T + GT Y+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY--T-LCGTPDYI 170
Query: 244 APEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
APE + + + D +SFG+L+ E+++G
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 80 IGQGGFGSVYKGTLKD-GTLAAIKVLSAD---SRQGVREFLTEINV-IKDIKHENLVELY 134
IG+G FG V K A+KVL ++ + ++E NV +K++KH LV L+
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQP 194
D V Y+ L L F R +A L +LH
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL--- 158
Query: 195 HIVHRDIKASNILLDKDLTPKISDFGLAK--LFPANLTHISTRVAGTEGYLAPEYAIRGQ 252
+IV+RD+K NILLD ++DFGL K + + T ST GT YLAPE + Q
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPE-VLHKQ 214
Query: 253 L-TRKADIYSFGVLLLEIVSGR 273
R D + G +L E++ G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGL 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 36/287 (12%)
Query: 33 HHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVAT----------ENFSPANKIGQ 82
HH + S+ + D + + L +LR A ENF +G
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64
Query: 83 GGFGSVY---KGTLKD-GTLAAIKVLSADS----RQGVREFLTEINVIKDIKHEN-LVEL 133
G +G V+ K + D G L A+KVL + + TE V++ I+ LV L
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 134 YGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
+ L+ Y+ L L R F + + L LH+
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL-- 178
Query: 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL 253
I++RDIK NILLD + ++DFGL+K F A+ T + GT Y+AP+ +RG
Sbjct: 179 -GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD-IVRGGD 236
Query: 254 ---TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
+ D +S GVL+ E+++G P+ ++ R
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTG------ASPFTVDGEKNSQAEISRR 277
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 65 KDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIK 123
++ V ++ +IG+G FG +++GT L + AIK S + E K
Sbjct: 4 QNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYK 60
Query: 124 DIKH-ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR------- 175
+ + +Y EG H +LV LLG + + R+
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLV----------IDLLGPSLEDL-LDLCGRKFSVKTVA 109
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK-----ISDFGLAKLF--PAN 228
+ + +HE+ +V+RDIK N L+ + + + DFG+ K + P
Sbjct: 110 MAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 229 LTHISTR----VAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
HI R ++GT Y G + +R+ D+ + G + + + G
Sbjct: 167 KQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 60/253 (23%), Positives = 99/253 (39%), Gaps = 49/253 (19%)
Query: 37 RKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKD 95
R + + + VE+ + + + + IG G G V
Sbjct: 4 RSKRDNNFYSVEIGDSTFTV--------------LKRYQNLKPIGSGAQGIVCAAYDAIL 49
Query: 96 GTLAAIKVLS------ADSRQGVREFLTEINVIKDIKHENLVELY-----GCCVEGDHRI 144
AIK LS +++ RE + ++K + H+N++ L +E +
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105
Query: 145 -LVYGYLENNSLAQTL---LGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200
+V ++ N L Q + L S +Q G+ LH I+HRD
Sbjct: 106 YIVMELMDAN-LCQVIQMELDHERMSY-LLYQMLC--------GIKHLHSA---GIIHRD 152
Query: 201 IKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIY 260
+K SNI++ D T KI DFGLA+ A + + T T Y APE + DI+
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 261 SFGVLLLEIVSGR 273
S G ++ E++ G
Sbjct: 211 SVGCIMGEMIKGG 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 47/256 (18%)
Query: 33 HHLRRKRASSATHRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT 92
HH + +R E+N+ + E+ + Y++L +G G +GSV
Sbjct: 4 HHHHHSQERPTFYRQELNKTIWEVPER----YQNLSP----------VGSGAYGSVCAAF 49
Query: 93 -LKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKHENLVELY-----GCCVEGDHRI 144
K G A+K LS S + E+ ++K +KHEN++ L +E + +
Sbjct: 50 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 145 -LVYGYLE---NNSLAQTLLGRGHSSIQ-FNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199
LV + NN + L H +Q +Q R GL ++H I+HR
Sbjct: 110 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILR--------GLKYIH---SADIIHR 156
Query: 200 DIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQL-TRKA 257
D+K SN+ +++D KI DFGLA+ +T +++TR Y APE + +
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTV 211
Query: 258 DIYSFGVLLLEIVSGR 273
DI+S G ++ E+++GR
Sbjct: 212 DIWSVGCIMAELLTGR 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 44/229 (19%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIK--VLSADSRQGVREF---------LTEI 119
++ I G +G+V G +G AIK + + V L EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 120 NVIKDIKHENLVELYGC----CVEGDHRI-LVYGYLENN-----SLAQTLLGRGHSSIQ- 168
++ H N++ L H++ LV + + + ++ H IQ
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH--IQY 138
Query: 169 FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228
F + GL LHE +VHRD+ NILL + I DF LA+ A+
Sbjct: 139 FMYHILL--------GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 229 --LT-HISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFGVLLLEIVSGR 273
T +++ R Y APE + T+ D++S G ++ E+ + +
Sbjct: 188 ANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKD 124
+ RV F KIG G FG +Y GT ++ AIK+ + ++ + E + +
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRI 58
Query: 125 IK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR-------N 176
++ + + VEGD+ +LV LLG + FN+ +R+
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLV----------MDLLGPSLEDL-FNFCSRKLSLKTVLM 107
Query: 177 ICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK---ISDFGLAKLF--PANLTH 231
+ + + F+H + +HRDIK N L+ I DFGLAK + + H
Sbjct: 108 LADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
Query: 232 ISTR----VAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGR 273
I R + GT Y A G + +R+ D+ S G +L+ + G
Sbjct: 165 IPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 2e-15
Identities = 38/199 (19%), Positives = 64/199 (32%), Gaps = 45/199 (22%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--------RQGVREFLTEIN 120
+ TE KIG+G FG V++ T AIK+++ + ++ E L EI
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 121 VIK---------DIKHENLVELYGC-CVEGD-HRILVYGYL----ENNSLAQTLLGRGHS 165
+ K + E + L CV+G +L+ + S
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 166 SI-------------------QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206
+ + T ++I + LA + HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 207 LLDKDLTPKISDFGLAKLF 225
LL K K+ K
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 50/241 (20%), Positives = 97/241 (40%), Gaps = 42/241 (17%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK----------- 126
K+G G F +V+ + + T A+K++ D EI +++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 127 HENLVELYGC----CVEGDHRILVYGYLENN--SLAQTLLGRGHSSIQFNWQTRRNICIG 180
++++L G H ++V+ L N +L + RG + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-----IPLIYVKQISKQ 139
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLD------KDLTPKISDFGLAKLFPANLT-HIS 233
+ GL ++H I+H DIK N+L++ + KI+D G A + + T I
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR----CNTNRRLPYEEQYLLE 289
TR Y +PE + ADI+S L+ E+++G + ++ ++ +
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 290 M 290
+
Sbjct: 253 I 253
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 37/230 (16%), Positives = 80/230 (34%), Gaps = 46/230 (20%)
Query: 78 NKIGQGGFGSVYKGT---------LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE 128
+ + G +Y+ ++K+ + D + E K ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-RLFNEQNFFQRAAKPLQVN 106
Query: 129 NLVELYGCCVEGDHRILVYGYLEN--NSLAQTLLGRGHSSIQ--FNWQTRRNICIGVAKG 184
+LY + + +G ++ L LGR S+Q + + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR---SLQSALDVSPKHVLSERSVLQ 163
Query: 185 LA--------FLHEEVQPHIVHRDIKASNILLDKDLTPKI--SDFGLAKLFPANLTHIST 234
+A FLHE VH ++ A NI +D + ++ + +G A + + H++
Sbjct: 164 VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 235 R------VAGTEGYLAPEYA-IRGQL----TRKADIYSFGVLLLEIVSGR 273
G E+ + +R++D+ S G +L+ + G
Sbjct: 221 VEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 19/154 (12%)
Query: 79 KIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGC 136
+G G G V + K A+K+L R E+ + + ++V +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHIVRIVDV 79
Query: 137 C----VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
++V L+ L + RG + F + I + + + +LH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI- 136
Query: 193 QPHIVHRDIKASNILL---DKDLTPKISDFGLAK 223
+I HRD+K N+L + K++DFG AK
Sbjct: 137 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA--DSRQGVREFLTEINVIKDIKH 127
+ +G G +G+V + G AIK L S + E+ ++K ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 128 ENLVELYGC-CVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
EN++ L + Y + T LG+ + + + + KG
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMP---FMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYL 243
L ++H I+HRD+K N+ +++D KI DFGLA+ + +T ++ TR Y
Sbjct: 141 LRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YR 192
Query: 244 APEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
APE + T+ DI+S G ++ E+++G+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA-DSRQGVREFLTEINVIKDIKHE 128
++ + IG+G +G V + AIK +S + + + L EI ++ +HE
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 129 NLVELYGC----CVEGDHRI-LVYGYLENNSLAQTL----LGRGHSSIQ-FNWQTRRNIC 178
N++ + +E + +V +E + L + L L H I F +Q R
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDH--ICYFLYQILR--- 139
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--TRV 236
GL ++H +++HRD+K SN+LL+ KI DFGLA++ + H T
Sbjct: 140 -----GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 237 AGTEGYLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
T Y APE Y T+ DI+S G +L E++S R
Sbjct: 192 VATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+ +G GG G V+ AIK + Q V+ L EI +I+ + H+N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 130 LVELY--------------GCCVEGDHRILVYGYLE---NNSLAQTLLGRGHSSIQ-FNW 171
+V+++ G E + +V Y+E N L Q L H + F +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH--ARLFMY 127
Query: 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLF---PA 227
Q R GL ++H +++HRD+K +N+ ++ +DL KI DFGLA++ +
Sbjct: 128 QLLR--------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 228 NLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
+ H+S + T+ Y +P + T+ D+++ G + E+++G+
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 54/234 (23%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSA-----DSRQGVREFLTEINVIKD 124
+ +F + +G+G +G V T G + AIK + + + +RE I ++K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKH 65
Query: 125 IKHENLVELYGC----CVEGDHRI-LVYGYLE---NNSLAQTLLGRGHSSIQ-FNWQTRR 175
KHEN++ ++ E + + ++ ++ + ++ +L H IQ F +QT R
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH--IQYFIYQTLR 123
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
+ LH +++HRD+K SN+L++ + K+ DFGLA++ + S
Sbjct: 124 --------AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 236 VAGTEG---------YLAPE-------YAIRGQLTRKADIYSFGVLLLEIVSGR 273
G Y APE Y +R D++S G +L E+ R
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 43/228 (18%), Positives = 78/228 (34%), Gaps = 44/228 (19%)
Query: 79 KIGQGGFGSVYKGTLKDGT------LAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE 132
IGQGGFG +Y + +KV +D+ E K + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 133 LYGCCVEGDHRILVYGYLEN-----NSLAQTLLGRGHSSIQ--FNWQTRR-------NIC 178
G + G + + G +Q + +R +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS---DLQKIYEANAKRFSRKTVLQLS 158
Query: 179 IGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI--SDFGLAKLF--PANLTHIST 234
+ + L ++HE VH DIKASN+LL+ ++ D+GLA + +
Sbjct: 159 LRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 235 R----VAGTEGYLAPEYA-IRGQL----TRKADIYSFGVLLLEIVSGR 273
GT E+ I +R+ D+ G +++ ++G
Sbjct: 216 DPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 78/279 (27%)
Query: 79 KIGQGGFGSVYKG-TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK--------HEN 129
K+G G F +V+ ++ A+KV+ + L EI ++K ++ E
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 130 LVELYGC----CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
+V+L V G H +V+ L ++ L + + I V +GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 186 AFLHEEVQPHIVHRDIKASNILL------------------------------------- 208
+LH + I+H DIK NILL
Sbjct: 160 DYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 209 ------------DKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTR 255
+ L KI+D G A + T I TR Y + E I
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 256 KADIYSFGVLLLEIVSGR----CNTNRRLPYEEQYLLEM 290
ADI+S + E+ +G ++ +E ++ +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVL---SADSRQGVREFLTEINVIKDIKHE------N 129
IG+G FG V K K A+K++ RQ EI +++ ++ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
++ + +H + + L N L + + + + F+ R + + L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN-LYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 190 EEVQPHIVHRDIKASNILLDKDLTP--KISDFGLAKLFPANL-THISTRVAGTEGYLAPE 246
+ I+H D+K NILL + K+ DFG + + T+I +R Y APE
Sbjct: 218 KN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPE 269
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ + D++S G +L E+++G
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 40/173 (23%), Positives = 61/173 (35%), Gaps = 25/173 (14%)
Query: 79 KIGQGGFGSVYKG----TLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELY 134
KIG GGFG +Y + +KV ++ E V K + +E
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 135 GCCVEGDHRILVYGYLEN-----NSLAQTLLGRGHSSIQ--------FNWQTRRNICIGV 181
G G E + LG +Q F T + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI---DLQKISGQNGTFKKSTVLQLGIRM 160
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI--SDFGLAKLFPANLTHI 232
L ++HE VH DIKA+N+LL ++ +D+GL+ + N H
Sbjct: 161 LDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 35/170 (20%), Positives = 74/170 (43%), Gaps = 36/170 (21%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS------ADSRQGVREFLTEINVIK 123
+ + + IG G +G V + + + AIK + D ++ +RE I ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILN 107
Query: 124 DIKHENLVELYGCCV----EGDHRI-LVYGYLENNSLAQTL-----LGRGHSSIQ-FNWQ 172
+ H+++V++ + E + +V +++ + L H I+ +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLFRTPVYLTELH--IKTLLYN 164
Query: 173 TRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222
G+ ++H I+HRD+K +N L+++D + K+ DFGLA
Sbjct: 165 LLV--------GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS------ADSRQGVRE--FLTEINV 121
+ K+G+G +G V+K + G + A+K + D+++ RE LTE++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS- 66
Query: 122 IKDIKHENLVELYGCCV-EGDHRI-LVYGYLE---NNSLAQTLLGRGHSSIQ-FNWQTRR 175
HEN+V L + D + LV+ Y+E + + +L H Q +Q +
Sbjct: 67 ----GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH--KQYVVYQLIK 120
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR 235
+ +LH ++HRD+K SNILL+ + K++DFGL++ F +
Sbjct: 121 --------VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 236 VAGTEGYLAPEYAIRGQLT 254
+ LT
Sbjct: 170 PLSINENTENFDDDQPILT 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 37/203 (18%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS------ADSRQGVREFLTEINVIK 123
+N+ + IG+G +G VY AIK ++ D ++ +RE I ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILN 80
Query: 124 DIKHENLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQ---------FNWQ 172
+K + ++ LY + D +Y LE +A + L + + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLE---IADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 173 TRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA-KLFPANLTH 231
G F+HE I+HRD+K +N LL++D + K+ DFGLA + T+
Sbjct: 138 LLL--------GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 232 ISTRVAGTEGYLAPEYAIRGQLT 254
I + E ++ QLT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLT 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 6e-12
Identities = 63/360 (17%), Positives = 116/360 (32%), Gaps = 101/360 (28%)
Query: 64 YKDLRVATENFSPANKI---GQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEI- 119
Y LR A PA + G G G K + A+ V + Q +F +I
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDF--KIF 185
Query: 120 --NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNI 177
N+ E ++E +L Q LL + I NW +R +
Sbjct: 186 WLNLKNCNSPETVLE-----------ML-----------QKLLYQ----IDPNWTSRSDH 219
Query: 178 CIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL---THIST 234
+ + + E++ + + + ++L + + + F NL ++T
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-N----VQNAKAWNAF--NLSCKILLTT 272
Query: 235 R--------VAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ- 285
R A T +++ ++ LT LLL+ + R LP E
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMT-LTPD---EVKS-LLLKYLDCRPQD---LPREVLT 324
Query: 286 ---YLLEMA-------------WKLYERGKLVELVDASLNGDYSVEEAHRYLKIA----- 324
L + WK KL ++++SLN E + +++
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS 384
Query: 325 ------LLCT--QDMPKRRPS--MSTLVNMLIGEIDVNKEEISKPGLLSDLLGLRVDKGE 374
LL D+ K ++ L + E + IS P + +L ++
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 26/209 (12%)
Query: 78 NKIGQGGFGSVYKGT-LKDGTLAAIKVL---SADSRQGVREFLTEINVIKDIKHE----- 128
+ IG+G FG V K + AIK++ A Q E+ +++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 129 -NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
+V L + +H LV+ L N L L R + + R + L F
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTP--KISDFGLAKLFPANL-THISTRVAGTEGYLA 244
L + I+H D+K NILL KI DFG + + +I +R Y +
Sbjct: 173 LATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRS 226
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
PE + D++S G +L+E+ +G
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 62/233 (26%)
Query: 79 KIGQGGFGSVYKG--TLKDGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHE----- 128
+G+G FG V + + + A+K++ + EINV+K IK +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 129 -NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
V + H + + L N + L + ++ + R++ + L F
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKN-TFEFL--KENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTP-------------------KISDFGLAKLFPAN 228
LHE + H D+K NIL +++DFG A +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 229 L-THISTRVAGTEGYLAPE--------YAIRGQLTRKADIYSFGVLLLEIVSG 272
T ++TR Y PE D++S G +L E G
Sbjct: 196 HTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 54/245 (22%), Positives = 90/245 (36%), Gaps = 82/245 (33%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHE-----N 129
K+G G FG V + + A+KV+ + E +++K I+++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 130 LVELYGCCVEGDHRILV--------YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
+V+ +G + DH L+ Y + N+ G F+ + + CI +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY------NG-----FHIEDIKLYCIEI 146
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP-------------------------KI 216
K L +L + + H D+K NILLD K+
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 217 SDFGLAKLFPANL-THISTRVAGTEGYLAPE--------YAIRGQLTRKADIYSFGVLLL 267
DFG A + I+TR Y APE + D++SFG +L
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSS--------DMWSFGCVLA 250
Query: 268 EIVSG 272
E+ +G
Sbjct: 251 ELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 48/241 (19%), Positives = 77/241 (31%), Gaps = 78/241 (32%)
Query: 79 KIGQGGFGSVYKG--TLKDGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHE----- 128
+G+G FG V + G A+K++ R +EI V++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 129 -NLVELYGCCVEGDHRILV--------YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
V++ H +V Y +++ N F R +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF------LP-----FRLDHIRKMAY 125
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP-------------------KISDFG 220
+ K + FLH + H D+K NIL + K+ DFG
Sbjct: 126 QICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 221 LAKLFPANL-THISTRVAGTEGYLAPE--------YAIRGQLTRKADIYSFGVLLLEIVS 271
A + T +STR Y APE D++S G +L+E
Sbjct: 183 SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPC--------DVWSIGCILIEYYL 229
Query: 272 G 272
G
Sbjct: 230 G 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.69 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.68 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.62 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=448.80 Aligned_cols=259 Identities=25% Similarity=0.466 Sum_probs=216.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 366888899999999999999864 47789999998877777788999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCC---------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 145 LVYGYLENNSLAQTLLGRG---------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
||||||++|+|.++|...+ .....++|..++.|+.||+.||+|||++ +|+||||||+||||+.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997643 2234799999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHH
Q 044232 216 ISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 216 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~ 293 (415)
|+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||....+. +....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 999999986644322 22334579999999999999999999999999999999998 88887654322 22222
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
+ ..+.. ...+..++.++.+|+.+||+.||++||||.+|++.|++.
T Consensus 243 i-~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 I-TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp H-HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2 22221 223445667899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=448.69 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=211.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456778899999999999999864 47889999998877777788999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCC-----------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC
Q 044232 145 LVYGYLENNSLAQTLLGRGHS-----------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT 213 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 213 (415)
||||||++|+|.+++...... ..+++|..++.|+.||+.||+|||++ +|+||||||+||||+.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999999765321 23689999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHH
Q 044232 214 PKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~ 291 (415)
+||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||....+. +..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAI 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 9999999998664332 223345679999999999999999999999999999999999 88887654322 222
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+ ..+. ....+..++.++.+|+.+||+.||++||||.||++.|+...
T Consensus 271 ~~i-~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCI-TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHH-HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHH-HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 222 2221 12334456678999999999999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=446.11 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=213.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++++.++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999863 46789999997653 334578999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 044232 145 LVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 212 (415)
||||||++|+|.++|..+... ...++|..+..|+.|||.||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999754321 23689999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHH
Q 044232 213 TPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~ 290 (415)
.+||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.+..+ .+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence 99999999998664322 223445679999999999999999999999999999999998 7777765432 222
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
... ...+. ....+..++.++.+|+.+||+.||++||||.||++.|+....
T Consensus 257 ~~~-i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 257 VEM-IRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHH-HHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222 22222 122344567889999999999999999999999999986543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=441.73 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=208.7
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
|++..+++++.++||+|+||+||+|++++ .||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 45566788899999999999999998754 5899998753 34556789999999999999999999998865 5689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
||||||+||+|.++|..... .++|..+..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 99999999999999976532 699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-cceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 225 FPANL-THISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 225 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
..... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....+.. ........+..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~ 255 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA 255 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC
Confidence 64322 233455789999999999964 468999999999999999999999987644322 12222222211
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
. + .....+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus 256 ~----p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 256 S----P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp C----C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred C----C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1 1122344566789999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=445.94 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|+++++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999976 7999999999754 34455789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
||+||+|.++|...+.. .+++..++.|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999765422 578999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+. +....... +..
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~~~-------- 242 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIIS-GSF-------- 242 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCC--------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-CCC--------
Confidence 12234567999999999999999999999999999999999999998765332 22222222 211
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334577899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=441.21 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=211.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 79999999997665444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
+||+|.+++... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999754 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+.+ ....+.. +.. ...
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~-~~~-------~~~ 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRD-NLP-------PRL 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH-SSC-------CCC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-CCC-------CCC
Confidence 23456789999999999999999999999999999999999999987654322 1111211 110 111
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122344578899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=432.62 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=211.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++++.||+|+||+||+|+.+ +|+.||+|++.+.. ....+.+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 79999999997542 234567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|||+||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998765 799999999999999999999999 999999999999999999999999999997754
Q ss_pred CC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +...+... +..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~-~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIK-LEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-TCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CCC------
Confidence 32 23345678999999999999999999999999999999999999998764322 12222222 211
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLV 342 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 342 (415)
.++...+.++.+|+.+||+.||++|||++|++
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12233456788999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=423.70 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=200.1
Q ss_pred CCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCeeEEEE
Q 044232 75 SPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE----GDHRILVY 147 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 147 (415)
++.++||+|+||+||+|.+. ++..||+|++... .....+.|.+|+.+|++++|||||++++++.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999976 6899999998654 34445789999999999999999999999875 34689999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecC-CCCeEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLDK-DLTPKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfGla~~ 224 (415)
|||+||+|.+++...+ .+++..+..|+.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998765 789999999999999999999998 6 999999999999985 79999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....... .+......+.....+
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASF 251 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGG
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCCC
Confidence 4432 2345789999999998864 69999999999999999999999986543322 112222222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 252 --------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122356889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=442.58 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=212.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.+.|+++++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999986 7999999999766544556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
|+||+|.+++... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999754 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+.. ....+.. +.. . .
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~-~~~-----~--~ 366 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRD-NLP-----P--R 366 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH-SCC-----C--C
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-CCC-----C--C
Confidence 23456789999999999999999999999999999999999999987654332 1121211 111 0 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112234567899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=432.90 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=209.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788889999999999999986 799999999976432 24699999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccccCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLFPAN 228 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 228 (415)
|+||+|.+++...+ .+++..+..|+.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998765 799999999999999999999999 999999999999999998 6999999999876543
Q ss_pred Ccc----eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 229 LTH----ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 229 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....+.... ..+.......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~--- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPI--- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGG---
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCc---
Confidence 211 223467999999999999999999999999999999999999999765543321 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+...+..+.+++.+||+.||.+|||+.||++.|...+
T Consensus 276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1223345577899999999999999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=438.23 Aligned_cols=270 Identities=25% Similarity=0.357 Sum_probs=221.4
Q ss_pred cchhhHHHHhcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccc-hHhHHHHHHHHHHHhhcCC-cceeee
Q 044232 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADS-RQGVREFLTEINVIKDIKH-ENLVEL 133 (415)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l 133 (415)
+....|++..++|++.+.||+|+||+||+|.+.. ++.||||.+.... ....+.|.+|+.+|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445677888999999999999999999998652 3579999997653 3445689999999999965 899999
Q ss_pred eeEEEeC-CeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 044232 134 YGCCVEG-DHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200 (415)
Q Consensus 134 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 200 (415)
+|+|.+. +.++||||||++|+|.++|..... ....+++..+..|+.|||.||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 578999999999999999976431 123589999999999999999999999 999999
Q ss_pred CCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCC
Q 044232 201 IKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNR 278 (415)
Q Consensus 201 lkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~ 278 (415)
|||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654332 33455779999999999999999999999999999999998 8888865
Q ss_pred CCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..... .+......+. ....+..++.++.+++.+||+.||++||||.||++.|...+
T Consensus 291 ~~~~~------~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 43322 1222233332 22333445678999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-57 Score=416.99 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=194.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.+|+.++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999976 79999999997542 233467899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+ +|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 789999998765 799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...... ...... ..+..
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i-~~~~~------ 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNI-SNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHTCC------
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCC------
Confidence 2 23345789999999999988775 58999999999999999999998754321 111222 22211
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.++...+.++.+|+.+||+.||++|||++|+++
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122234567889999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=422.12 Aligned_cols=266 Identities=27% Similarity=0.353 Sum_probs=202.7
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----eeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----HRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 147 (415)
++|.+.++||+|+||+||+|++ +|+.||||++....... ..+..|+..+.+++|||||+++|+|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577788999999999999998 57899999997654322 23345677778899999999999998654 579999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-----QPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
|||++|+|.+++... +++|..+.+++.|++.||+|||+++ +++|+||||||+||||+.++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999865 5899999999999999999999762 458999999999999999999999999999
Q ss_pred cccCCCCcc---eecccccCCCCCChhhhhcC------CCCccceEeehhHhHHHHHhCCcCCCCC----CChhhhh---
Q 044232 223 KLFPANLTH---ISTRVAGTEGYLAPEYAIRG------QLTRKADIYSFGVLLLEIVSGRCNTNRR----LPYEEQY--- 286 (415)
Q Consensus 223 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~p~~~~----~p~~~~~--- 286 (415)
+........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|+... .|+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543222 22346799999999998764 3678999999999999999998876532 2333211
Q ss_pred -HHHHHHHHHhhCcchhhcccccCC-CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 287 -LLEMAWKLYERGKLVELVDASLNG-DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 287 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+........+.. ++.+.. ..+.+++..+.+|+.+||+.||++||||.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111111111 111111 11235677899999999999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=424.06 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++|++++.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999863 47899999997542 1222467889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||||+||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998765 789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..+.+ ....... +.
T Consensus 177 ~~~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~------ 242 (304)
T 3ubd_A 177 IDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILK-AK------ 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC------
T ss_pred cCC-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHc-CC------
Confidence 432 223445789999999999999999999999999999999999999987654322 2222221 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH-----HHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM-----STLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 343 (415)
..++...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 243 ----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12233345778999999999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=412.70 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=190.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC--------
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD-------- 141 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 141 (415)
++|++++.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999976 79999999987653 334567899999999999999999999987544
Q ss_pred ----eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 142 ----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 142 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
.+|||||||++|+|.+++...... ....+..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 379999999999999999876432 2345677899999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcc-----------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhh
Q 044232 218 DFGLAKLFPANLTH-----------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY 286 (415)
Q Consensus 218 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~ 286 (415)
|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence 99999876443211 1234579999999999999999999999999999999996 44321 11
Q ss_pred HHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 287 LLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... ......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~-~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLT-DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH-HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 111111111 11223355678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=405.81 Aligned_cols=262 Identities=20% Similarity=0.303 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe------CC
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE------GD 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 141 (415)
.++|++++.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999976 7999999999754 33445678899999999999999999999764 35
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
.+|||||||+ |+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 67999997665 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC---cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 222 AKLFPANL---THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 222 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
|+.+.... .......+||+.|||||++.+. .++.++||||+|||+|||++|+.||.+........ .+......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~---~I~~~~g~ 281 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ---LIMMVLGT 281 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH---HHHHHHCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhcCC
Confidence 98764321 2234567899999999998875 57999999999999999999999997654333211 11111110
Q ss_pred Ccc-----------hhhcccc-cCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 GKL-----------VELVDAS-LNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ~~~-----------~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ...+... .....+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000 000011 112467889999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=394.17 Aligned_cols=285 Identities=41% Similarity=0.678 Sum_probs=249.3
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
...++...+++|++.+.||+|+||.||+|.+++++.||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445557789999999999999999999988899999999887766666789999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999977655555799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 223 KLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 223 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........+.......+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654321 222344568999999999999999999999999999999999999998877777666666666666666677
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
..+++..........+..+.+++.+||+.||++|||+.||++.|...+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 7777777777888999999999999999999999999999999986654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=393.82 Aligned_cols=294 Identities=42% Similarity=0.739 Sum_probs=249.7
Q ss_pred ccCCcccchhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchH-hHHHHHHHHHHHhhcCCcceeeee
Q 044232 56 IQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQ-GVREFLTEINVIKDIKHENLVELY 134 (415)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~ 134 (415)
......+++.++....++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3445668889999999999999999999999999999888999999999765322 223688999999999999999999
Q ss_pred eEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 135 GCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
+++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998876655679999999999999999999999877799999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCC--ChhhhhHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL--PYEEQYLLEMAW 292 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~--p~~~~~~~~~~~ 292 (415)
||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........++..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998776554555556679999999999999999999999999999999999999985211 111223344444
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
............+......++...+..+.+++.+||+.+|.+|||+.+|++.|.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 444555666677777777888899999999999999999999999999999998643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=397.52 Aligned_cols=199 Identities=30% Similarity=0.438 Sum_probs=171.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 144 (415)
..++|++.++||+|+||+||+|+.+ +++.||+|++..... ..++.+|+++|+.+ +||||+++++++.+.++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999854 467899999866533 25678899999988 6999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeecccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAK 223 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~ 223 (415)
|||||+++|+|.+++. .+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999983 588999999999999999999999 99999999999999877 799999999998
Q ss_pred ccCCCCc---------------------------ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcC
Q 044232 224 LFPANLT---------------------------HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCN 275 (415)
Q Consensus 224 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p 275 (415)
....... ......+||+.|+|||++.+. .++.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6533211 112345799999999999875 589999999999999999999999
Q ss_pred CCCCC
Q 044232 276 TNRRL 280 (415)
Q Consensus 276 ~~~~~ 280 (415)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 86543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=416.03 Aligned_cols=249 Identities=23% Similarity=0.296 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++++.||+|+||+||+|+.+ +|+.||+|++.+.. .........++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999986 79999999996542 11122233456777788999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
|||||||+||+|.++|...+ .+++..++.++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998765 799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
.+... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ ......... .
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~-~---- 409 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-M---- 409 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHH-C----
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcC-C----
Confidence 76543 2345789999999999975 5799999999999999999999999975332221 111111111 1
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
...++...+.++.+|+.+||+.||.+|++ +.||++
T Consensus 410 ------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11223344577899999999999999998 688765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=416.85 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=212.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 7999999999877666667889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--CCeEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD--LTPKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~ 227 (415)
|+||+|.++|..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999965432 689999999999999999999999 99999999999999854 8999999999998754
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..+.+ ....+.. +.. .
T Consensus 310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~-~~~------~ 374 (573)
T 3uto_A 310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKS-CDW------N 374 (573)
T ss_dssp T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHT-TCC------C
T ss_pred C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHh-CCC------C
Confidence 3 23345689999999999999999999999999999999999999987654322 1122211 111 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111223467889999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=372.55 Aligned_cols=259 Identities=25% Similarity=0.449 Sum_probs=213.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367888999999999999999976 6999999998777777778899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999987432 689999999999999999999999 99999999999999999999999999998664332
Q ss_pred cce-------------ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 230 THI-------------STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 230 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
... .....||+.|+|||++.+..++.++|||||||++|||++|..|+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------- 235 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------- 235 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------
Confidence 211 114579999999999999999999999999999999999998876544432111000
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+. ..+..++..+.+++.+||+.||++|||+.++++.|....
T Consensus 236 ---~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 ---VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0001111 112233456889999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.80 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=211.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999965 7999999998766555557788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999765 588999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+... .......+. ..
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~--------~~ 235 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--------PE 235 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS--------CC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC--------CC
Confidence 2 23456799999999999999999999999999999999999999876543321 111222111 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123344567899999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=373.49 Aligned_cols=267 Identities=30% Similarity=0.464 Sum_probs=208.8
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..+.+..++|++.+.||+|+||.||+|+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445668899999999999999999987 57889999987653 4455688999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCCeEEeeec
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999986531 12489999999999999999999999 8 9999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. .........
T Consensus 185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~-- 255 (309)
T 3p86_A 185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKC-- 255 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSC--
T ss_pred CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC--
Confidence 998543321 22334679999999999999999999999999999999999999887543322 111111111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.....+...+..+.+++.+||+.+|.+|||+.+|++.|...+...
T Consensus 256 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 -------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 112233344577899999999999999999999999998776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=369.06 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=209.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999975 8999999998764 3445567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997765 689999999999999999999999 999999999999999999999999999986654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCC-ccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLT-RKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...... ....... .+..
T Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~------ 231 (328)
T 3fe3_A 167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVL-RGKY------ 231 (328)
T ss_dssp S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC------
T ss_pred C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------
Confidence 3 223456799999999999888765 8999999999999999999998764322 1111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1222345678899999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=361.46 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=215.1
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..++|++.+.||+|+||.||+|..+++..||+|++...... .+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 45789999999999999999999988888999999765433 36788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++...+. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999976532 589999999999999999999999 99999999999999999999999999998765544
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ........ +.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-~~--------- 222 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQ-GH--------- 222 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT-TC---------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHc-CC---------
Confidence 333444557788999999999999999999999999999999 88887643322 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
....+...+..+.+++.+||+.+|.+|||+.++++.|......
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1111222346789999999999999999999999999877554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=363.99 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=211.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 578999999999999999999976 7899999998543 344557889999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++...+ ++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ......... .... ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~-~~~~-~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS-VPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC-CCCH-HH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc-CCCc-ch
Confidence 443333445679999999999999999999999999999999999999987654322 111122111 1100 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-CHHHHHHHhhcCCCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRP-SMSTLVNMLIGEIDV 351 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~ 351 (415)
......+..+.+++.+||+.||.+|| ++.++.+.|...+..
T Consensus 235 ----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 ----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11223356789999999999999998 899999999876643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=362.35 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=214.3
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
+..++|++.+.||+|+||.||+|.+.++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 345778999999999999999999988889999999765433 3678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976532 589999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....+.. ....... +
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~-~--------- 223 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDIST-G--------- 223 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHT-T---------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhc-C---------
Confidence 3333344567788999999999999999999999999999999 888876543221 1111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 224 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111222233567899999999999999999999999997643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=374.84 Aligned_cols=261 Identities=25% Similarity=0.423 Sum_probs=214.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVE 139 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 139 (415)
..++|++.+.||+|+||.||+|++. ++..||+|++... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999853 3557999999765 334557899999999999 89999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 207 (415)
.+..++||||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 99999999999999999999875421 23588999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhh
Q 044232 208 LDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQ 285 (415)
Q Consensus 208 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~ 285 (415)
|+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 99999999999999986643322 22233557889999999999999999999999999999999 8888765432211
Q ss_pred hHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
......+ .....+..++.++.+++.+||+.+|.+||++.||++.|...+
T Consensus 315 ------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 ------FKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ------HHHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111211 122233445678999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=367.33 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=211.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567889999999999999999975 3456999999765 3445568999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999975532 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ..... ..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~-~~~--- 270 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSV-EEG--- 270 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHH-HTT---
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHH-HcC---
Confidence 6543221 2223446788999999999999999999999999999999 888876533221 11111 111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.....+..++..+.+++.+||+.+|.+||++.+|++.|...+.
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122333456789999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=362.01 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=213.6
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..+++..++|++.+.||+|+||.||+|.+.++..||+|++...... .+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 3445567889999999999999999999988889999999765433 367889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++++|.+++..... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EEEeccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999976322 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...... .+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~-~~----- 237 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIA-QG----- 237 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHH-TT-----
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHh-cc-----
Confidence 65433233334557788999999999999999999999999999998 888876543221 111111 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+..+.+++.+||+.+|.+|||+.++++.|...+
T Consensus 238 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 238 ----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111122233467899999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=387.40 Aligned_cols=266 Identities=28% Similarity=0.430 Sum_probs=218.5
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
....+++..++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+.+|+.++||||+++++++. .+.
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34556677889999999999999999999998888999999976543 3578999999999999999999999986 567
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred cEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 8999999999999999975421 2578889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
+..............+|+.|+|||++..+.++.++|||||||++|||++ |+.||...... +....+ ..+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i-~~~--- 401 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRAL-ERG--- 401 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHH-HHT---
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcC---
Confidence 8764432222233456788999999999999999999999999999999 88887653321 121111 122
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.....+..++..+.+|+.+||+.||++|||+.+|++.|......
T Consensus 402 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11122334567899999999999999999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=361.63 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=214.3
Q ss_pred cccchhhHHHHhcC----------CCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc
Q 044232 60 NLYGYKDLRVATEN----------FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE 128 (415)
Q Consensus 60 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 128 (415)
..+++++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34566666655543 666779999999999999987 7999999999876555567889999999999999
Q ss_pred ceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 044232 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208 (415)
Q Consensus 129 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 208 (415)
||+++++++...+..++||||+++++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH
Q 044232 209 DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288 (415)
Q Consensus 209 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~ 288 (415)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----- 248 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----- 248 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999999987654322 2345679999999999999999999999999999999999999987543322
Q ss_pred HHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 289 EMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... ...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 249 -~~~~~~-~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 -AMKRLR-DSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHH-HSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHh-cCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 111100 0112233467889999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=367.46 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=209.1
Q ss_pred HhcCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 142 (415)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 347789999999999999999984 2688999999988777777889999999999999999999999865 356
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 8999999999999999987542 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCCh---------hhhhHHHHH
Q 044232 223 KLFPANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY---------EEQYLLEMA 291 (415)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~---------~~~~~~~~~ 291 (415)
........ .......+++.|+|||++.+..++.++||||||+++|||++|..|+...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87644322 1223345777899999999999999999999999999999998876532100 000000011
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.. .+........+..++.++.+++.+||+.+|++|||+.||++.|...
T Consensus 242 ~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 242 IE---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HH---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 1111222233445567899999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=365.88 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=208.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++++.||+|+||+||+|+.+ +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999976 79999999997642 23446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|..++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997654 689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +.
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~------- 221 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EE------- 221 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CC-------
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc-CC-------
Confidence 22 22334567999999999999999999999999999999999999998754321 11111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNM 344 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 344 (415)
..++...+.++.+++.+||+.||.+|| ++.||++.
T Consensus 222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112333456789999999999999999 89999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=387.57 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=220.2
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
..+++..++|++.+.||+|+||.||+|.++ ++..||||++..... ..+.|.+|+.+|++++||||++++++|.+.+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 445566788999999999999999999987 488999999976543 347899999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999986542 2588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............+++.|+|||++.+..++.++|||||||++|||++ |+.|+........ ......
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~----- 434 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEK----- 434 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHT-----
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHc-----
Confidence 765443333334456788999999999999999999999999999999 8888765432211 111121
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
......+..++..+.+|+.+||+.+|.+||++.+|++.|+..+.
T Consensus 435 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12223344556789999999999999999999999999987754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=379.09 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=213.3
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.+.+..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......|.+|+.+++.++||||+++++++.+.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34455678999999999999999999987 78999999987653 33445788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 999999999999999976432 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccee-cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 224 LFPANLTHIS-TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
.......... ....+++.|+|||++.++.++.++|||||||++|||++ |..|+...... +. ......+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~~-- 332 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QT-REFVEKGG-- 332 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HH-HHHHHTTC--
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHHcCC--
Confidence 6543221111 12235778999999999999999999999999999998 87777543221 11 11222221
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
....+..++..+.+|+.+||+.||++|||+.+|++.|...
T Consensus 333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1222334567899999999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=373.61 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=202.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..++|++.+.||+|+||.||+|++. ++..||||++... .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3568999999999999999999865 4778999999765 3445568999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999976532 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +... ....+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~-~i~~~--- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIK-AVDEG--- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHH-HHHTT---
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHcC---
Confidence 65432211 122345778999999999999999999999999999998 88887653221 1111 11111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.....+..++..+.+++.+||+.+|.+||++.+|++.|...+.
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1122233456789999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=353.78 Aligned_cols=282 Identities=36% Similarity=0.601 Sum_probs=227.2
Q ss_pred CCcccchhhHHHHhcCCCCC------CcccccCeEEEEEEEecCCCEEEEEEcccc----chHhHHHHHHHHHHHhhcCC
Q 044232 58 DTNLYGYKDLRVATENFSPA------NKIGQGGFGSVYKGTLKDGTLAAIKVLSAD----SRQGVREFLTEINVIKDIKH 127 (415)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 127 (415)
+...|.+.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34567888899999888877 8999999999999987 5788999998653 23345678999999999999
Q ss_pred cceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 044232 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207 (415)
Q Consensus 128 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 207 (415)
|||+++++++.+.+..++||||+++++|.+++..... ...+++..+..++.||+.||.|||++ +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875432 22689999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhh
Q 044232 208 LDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY 286 (415)
Q Consensus 208 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~ 286 (415)
++.++.+||+|||++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 99999999999999986644322 22334679999999998764 5889999999999999999999998764332211
Q ss_pred HHHHHHHHHhh-CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 287 LLEMAWKLYER-GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 287 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+....... ..+...++... ...+...+..+.+++.+||+.+|.+||++.+|++.|...
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111 12233333333 345677889999999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.84 Aligned_cols=262 Identities=22% Similarity=0.266 Sum_probs=212.7
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
+.+++...++|++.+.||+|+||+||+|+.+ +++.||+|++..... .....+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455667789999999999999999999987 588999999975321 122347889999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999986422 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
|+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||....+.+ ....+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhh
Confidence 999876555444455578999999999987 4578999999999999999999999987654322 11112
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHH
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 343 (415)
........ .+......+.++.+|+.+||+.+|++ ||+++|+++
T Consensus 294 ~~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11100000 01111123467889999999988888 999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=371.21 Aligned_cols=271 Identities=25% Similarity=0.362 Sum_probs=218.3
Q ss_pred ccchhhHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceee
Q 044232 61 LYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVE 132 (415)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~ 132 (415)
.+....+++..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3445667778899999999999999999999842 46789999997653 34456799999999999 7899999
Q ss_pred eeeEEEeCC-eeEEEEeeccCCCHHHHhhcCCCC----------------------------------------------
Q 044232 133 LYGCCVEGD-HRILVYGYLENNSLAQTLLGRGHS---------------------------------------------- 165 (415)
Q Consensus 133 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 165 (415)
+++++.+.+ ..++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 489999999999999999865421
Q ss_pred ----------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 166 ----------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 166 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998654332
Q ss_pred -cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 230 -THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 230 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||........ .......+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~-------- 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGT-------- 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTC--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCC--------
Confidence 223345678999999999999999999999999999999998 9888876443221 111222221
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+.++.+++.+||+.+|.+|||+.||++.|...+
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11222334567899999999999999999999999997643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=383.50 Aligned_cols=266 Identities=30% Similarity=0.461 Sum_probs=212.6
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
...+++..++|++.+.||+|+||.||+|.++++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3455667788999999999999999999998878899999986543 34678999999999999999999999876 678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 999999999999999975321 1588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............+++.|+|||++.++.++.++|||||||++|||++ |+.|+....+. +.... ...+
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~-i~~~---- 397 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERG---- 397 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTT----
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcC----
Confidence 765432222334457889999999999999999999999999999999 88777654322 11111 1222
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.....+..++..+.+++.+||+.+|++|||+.+|++.|.......
T Consensus 398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 112233445678999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=359.49 Aligned_cols=263 Identities=24% Similarity=0.401 Sum_probs=220.4
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
+.+++..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 345566788999999999999999999987 588999999976543 347789999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999986543 2689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............+|+.|+|||++.+..++.++||||||+++|+|++ |..|+........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~----- 227 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEK----- 227 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHT-----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhc-----
Confidence 776554444455667889999999999999999999999999999999 8888765433221 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
......+...+..+.+++.+||+.||.+||++.++++.|....
T Consensus 228 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 228 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1122233344578999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=363.11 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=204.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999977 799999999865432 233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999987654 689999999999999999999999 9999999999999999999999999999865322
Q ss_pred C-cceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 229 L-THISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 229 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... . ......
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~-----~~~~~~------- 225 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S-----DWKEKK------- 225 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-H-----HHHTTC-------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-H-----HHhccc-------
Confidence 2 222345679999999999987765 789999999999999999999987644322110 0 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001111233567889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=368.05 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=203.8
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
...++|++.+.||+|+||+||+|+.+ +++.||+|++... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44588999999999999999999976 6899999999764 223446678899999988 799999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999998765 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+. +....+.. +.
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~---- 240 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN-DE---- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CC----
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CC----
Confidence 54322 22344567999999999999999999999999999999999999998764332 12222221 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH------HHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM------STLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 343 (415)
..++...+..+.+++.+||+.||.+||++ .++++
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11223345678899999999999999998 77775
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.22 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=207.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH------hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ------GVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999987 7999999998765321 246788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEeee
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISDF 219 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 219 (415)
++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997654 689999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ...... .+.
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~-~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT-AVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcC
Confidence 9998765432 2345679999999999999999999999999999999999999987643221 111111 111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ++... ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 1122467889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=367.46 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=201.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKH--ENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|...+++.||+|++... .....+.+.+|+.+|..++| |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45679999999999999999999888999999998754 34455788999999999987 999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 56889999998765 689999999999999999999999 999999999999997 678999999999876
Q ss_pred CCCCcc-eecccccCCCCCChhhhhc-----------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 226 PANLTH-ISTRVAGTEGYLAPEYAIR-----------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 226 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHH
Confidence 443221 2335679999999999875 678999999999999999999999986533211 11111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.++......++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 233 ---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 112222222333334678899999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=366.86 Aligned_cols=270 Identities=26% Similarity=0.375 Sum_probs=208.8
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----eeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----HRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 144 (415)
...++|++.+.||+|+||.||+|++. ++.||||++...... ...+..|+.++++++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578999999999999999999876 788999999765433 345667999999999999999999998744 479
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC-------CCCcEecCCCCCCeeecCCCCeEEe
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-------QPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ +++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999764 5899999999999999999999751 2389999999999999999999999
Q ss_pred eeccccccCCCCc-ceecccccCCCCCChhhhhcC-----CCCccceEeehhHhHHHHHhCCcCCCCCCC-----hhhh-
Q 044232 218 DFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRG-----QLTRKADIYSFGVLLLEIVSGRCNTNRRLP-----YEEQ- 285 (415)
Q Consensus 218 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~p~~~~~p-----~~~~- 285 (415)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... +...
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654322 223346799999999998863 456789999999999999999999876432 2110
Q ss_pred ---hHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 286 ---YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 286 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..................+... ......+..+.+|+.+||+.||++|||+.+|++.|...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001111111111111000000 01234567799999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=373.23 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=211.2
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
.+++...++|++.+.||+|+||+||+|+.+ +++.||+|++..... .....+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445556789999999999999999999987 689999999865321 1223577899999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+..++||||++||+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999764 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCC----CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ----LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....+.. ....+..
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHh
Confidence 99876554433445678999999999998765 7899999999999999999999987654322 1111111
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCC--CCCHHHHHHH
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKR--RPSMSTLVNM 344 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 344 (415)
.... +.... ....+.++.+|+.+||+.+|.+ ||++.||++.
T Consensus 288 ~~~~---~~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNS---LTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHH---CCCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccc---ccCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1000 00000 1123467889999999999988 9999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=352.88 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=213.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3577999999999999999999974 7899999998654322 4577899999999 8999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC-----eEEeeeccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT-----PKISDFGLA 222 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla 222 (415)
||+ +++|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 9999999986542 589999999999999999999999 9999999999999987776 999999999
Q ss_pred cccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 223 KLFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 223 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876543221 23456799999999999999999999999999999999999999987554333222222221111
Q ss_pred hCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 297 RGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....... .. ..+..+.+++.+||+.+|.+||++.+|++.|.....
T Consensus 239 ~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 239 STPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CccHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1111111 11 234678999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=370.11 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=216.7
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
+++..++|.+.+.||+|+||.||+|+.. .+..||+|++... .......+.+|+.+++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 4456688999999999999999999863 2357999999765 344557889999999999 99999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+.+.+..++||||+++|+|.+++...... ...+++..++.|+.||+.||+|||++ +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 99999999999999999999999876421 13589999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
||||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|+......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986643321 22334567889999999999999999999999999999999 88887643221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
+. ......+. ....+..++.++.+++.+||+.+|++||++.||++.|...+.
T Consensus 301 ------~~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 ------EL-FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ------HH-HHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HH-HHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11222221 112233445779999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=361.07 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=216.2
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
++...++|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3445678999999999999999999862 4578999999765 34455788999999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCC--------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGH--------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 199 (415)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999987543 123488999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCC
Q 044232 200 DIKASNILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTN 277 (415)
Q Consensus 200 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~ 277 (415)
||||+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999866443221 2233457889999999999999999999999999999999 988887
Q ss_pred CCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 278 RRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 278 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+... ......+. ....+...+..+.+++.+||+.||.+||++.+|++.|.+.+
T Consensus 255 ~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 255 GIPPERL-------FNLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCCGGGH-------HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHH-------HHHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6543221 11122211 12223344577999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=365.85 Aligned_cols=265 Identities=24% Similarity=0.402 Sum_probs=215.2
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445688999999999999999999975 34789999998653 34456799999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCC--------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHS--------------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 200 (415)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 9999999999999999999875321 13689999999999999999999999 999999
Q ss_pred CCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCC
Q 044232 201 IKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNR 278 (415)
Q Consensus 201 lkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~ 278 (415)
|||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986533211 22234567899999999999999999999999999999999 8888765
Q ss_pred CCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.... +... ....+.. ...+...+..+.+++.+||+.+|.+||++.+|++.|.+....
T Consensus 280 ~~~~------~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHE------EVIY-YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHH------HHHH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChH------HHHH-HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 3321 1111 1222211 122334456799999999999999999999999999887653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=365.79 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=215.0
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEE
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCC 137 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 137 (415)
++++..++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45566789999999999999999999862 45689999997642 23446788999999999 999999999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCCCC-------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRGHS-------------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVH 198 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 198 (415)
...+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999865421 12478999999999999999999999 9999
Q ss_pred cCCCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCC
Q 044232 199 RDIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNT 276 (415)
Q Consensus 199 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~ 276 (415)
|||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986543322 22344567889999999999999999999999999999998 98888
Q ss_pred CCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 277 NRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 277 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
........ .......+ .....+...+..+.+|+.+||+.||.+||++.+|++.|...+..
T Consensus 276 ~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 76433221 11122221 11222333457899999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.61 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=207.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999986 79999999997642 22346778899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~------- 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-E------- 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-C-------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-C-------
Confidence 32 23567999999999999999999999999999999999999998754321 112222221 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
..++...+.++.+++.+||+.||.+|| ++.+|++
T Consensus 220 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112223446788999999999999999 8899885
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=367.15 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=206.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
+..++|++++.||+|+||+||+|+.+ +++.||+|+++... ......+.+|..++.++ +||||+++++++.+.+..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34578999999999999999999987 68899999997652 22334577899999887 899999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|..++...+ .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence 99999999999999998765 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhh--hhHHHHHHHHHhhCcch
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE--QYLLEMAWKLYERGKLV 301 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~--~~~~~~~~~~~~~~~~~ 301 (415)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............+.
T Consensus 202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 202 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 278 (396)
T ss_dssp CCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred ecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence 53222 2234557899999999999999999999999999999999999999964322111 111111122222111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH------HHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM------STLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 343 (415)
..++...+.++.+|+.+||+.||.+||++ .||++
T Consensus 279 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 279 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 12233345678899999999999999985 56655
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=355.93 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=199.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
+..++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345789999999999999999998752 457999998764 3344567899999999999999999999984 5678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999976532 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. ....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------~~-~i~~~~--- 234 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IG-RIENGE--- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HH-HHHTTC---
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------HH-HHHcCC---
Confidence 765443333344557889999999999999999999999999999996 8888875433221 11 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|...+
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11223344577899999999999999999999999997653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.81 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=206.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH------hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ------GVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 6899999998764321 346788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEeee
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISDF 219 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 219 (415)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997654 689999999999999999999999 999999999999999887 8999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~- 233 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVN- 233 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHTC-
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHhcC-
Confidence 9998764332 2334679999999999999999999999999999999999999987543221 111111110
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000000122467889999999999999999999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=370.93 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=207.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999876 78999999987653 33446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCCeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 223 (415)
|||+++|+|.+.+...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998765 689999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +... ....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~-~i~~~~~~-- 231 (444)
T 3soa_A 162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQ-QIKAGAYD-- 231 (444)
T ss_dssp CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-HHHHTCCC--
T ss_pred EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHH-HHHhCCCC--
Confidence 665432 2234567999999999999999999999999999999999999998654321 1111 11222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 232 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 ----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011111233567889999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=369.58 Aligned_cols=261 Identities=26% Similarity=0.368 Sum_probs=210.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..++|++.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.+++.++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3577999999999999999999853 4678999999754 34445678899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEE
Q 044232 143 RILVYGYLENNSLAQTLLGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKI 216 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 216 (415)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999986542 123589999999999999999999999 999999999999999555 5999
Q ss_pred eeeccccccCCC-CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHH
Q 044232 217 SDFGLAKLFPAN-LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 217 ~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||...... +.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFV 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 999999854221 1122334568999999999999999999999999999999998 88887654321 111111
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+. ....+..++..+.+|+.+||+.+|.+||++.+|++.|....
T Consensus 300 -~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 -TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 11223344567899999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.60 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999976 688999999876543 346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCCeEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK--DLTPKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 227 (415)
+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999997543 2689999999999999999999999 9999999999999987 78999999999987654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... .. .+..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~-~~--~~~~ 225 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAE-YT--FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-CC--CCHH
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCC-CC--CChh
Confidence 32 234467899999999999888999999999999999999999998764322 1112222111 10 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ...+.++.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 122467889999999999999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=353.35 Aligned_cols=271 Identities=22% Similarity=0.281 Sum_probs=215.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC--eeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD--HRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999987 68999999997643 233567889999999999999999999998765 78999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCCeEEeeeccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLA 222 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 222 (415)
|||+++++|.+++...... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999865421 2389999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhh--------cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAI--------RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHH
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHH
Confidence 8765432 223456999999999986 46789999999999999999999999865332221 12222222
Q ss_pred HhhCcchh---h-------c----ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 295 YERGKLVE---L-------V----DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 295 ~~~~~~~~---~-------~----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
........ . + +.......+...+..+.+++.+||+.||++|||++|+++...+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22211000 0 0 001122456778889999999999999999999999999887543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=376.58 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=210.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-eeEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD-HRIL 145 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 145 (415)
+.+..++|++.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4455678999999999999999999986 6789999997654 3467999999999999999999999987765 7899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++...+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999999999876422 478999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
... .....+++.|+|||++.+..++.++|||||||++|||++ |+.|+......+. . .....+
T Consensus 340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~-~~i~~~------ 402 (450)
T 1k9a_A 340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------V-PRVEKG------ 402 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH------H-HHHHTT------
T ss_pred ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------H-HHHHcC------
Confidence 322 122357889999999999999999999999999999998 9888865433221 1 111222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+..++..+.+|+.+||+.+|.+|||+.+|++.|....
T Consensus 403 ---~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 403 ---YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 122334455678999999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=356.82 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 477999999999999999999998899999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++ +|.+.+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 78888875532 589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh----
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL---- 303 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 303 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...............
T Consensus 173 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 V-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGT
T ss_pred c-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhh
Confidence 2 22334568999999999876 56899999999999999999999999765443321 111111111100000
Q ss_pred -----ccccc--CCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 -----VDASL--NGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 -----~~~~~--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+... .... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 0000 1112357889999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.01 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=207.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 477999999999999999999976 68999999986542 23446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++||+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999998754 689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .....
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~----- 235 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFETT----- 235 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHHC-----
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhhc-----
Confidence 33 23345679999999999874 458999999999999999999999997544332211111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-HHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-MSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 343 (415)
...++...+..+.+|+.+||+.||.+||+ +.+|++
T Consensus 236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11233344577899999999999999998 777764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=364.29 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=210.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999976 7899999999877655556889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCCeEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK--DLTPKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 227 (415)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997543 2689999999999999999999999 9999999999999974 47899999999987654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ... .
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~-~~~------~ 268 (387)
T 1kob_A 204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKR-CDW------E 268 (387)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHH-CCC------C
T ss_pred Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC------C
Confidence 32 2234579999999999999999999999999999999999999987643221 1111111 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111222345678999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=361.71 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=203.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367889999999999999999965 444 36888876542 344578999999999999999999999998755 78
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|+||+++|+|.+++..... .+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987542 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
...... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ......+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~---- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKG---- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTT----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcC----
Confidence 654322 22233457889999999999999999999999999999999 9988876433221 1111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+..++..+.+++.+||+.+|.+||++.+|++.|....
T Consensus 236 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112223345567999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.36 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=202.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhh--cCCcceeeeeeEEEeC----Cee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD--IKHENLVELYGCCVEG----DHR 143 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 143 (415)
..++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999988 688899999876432 445567777666 7999999999997643 468
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH--------EEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
++||||+++|+|.+++... .+++..+..++.||+.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 9999999999999999543 6899999999999999999999 77 999999999999999999999
Q ss_pred EeeeccccccCCCCcce---ecccccCCCCCChhhhhcC------CCCccceEeehhHhHHHHHhC----------CcCC
Q 044232 216 ISDFGLAKLFPANLTHI---STRVAGTEGYLAPEYAIRG------QLTRKADIYSFGVLLLEIVSG----------RCNT 276 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg----------~~p~ 276 (415)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998664432221 2334799999999999876 455799999999999999999 6666
Q ss_pred CCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 277 NRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 277 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+..... ............... ......+...+..+.+++.+||+.||.+|||+.+|++.|.+
T Consensus 234 ~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 234 YDVVPNDPSF--EDMRKVVCVDQQRPN---IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTSCSSCCH--HHHHHHHTTSCCCCC---CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCCCcch--hhhhHHHhccCCCCC---CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 5433322211 111111111100000 00111234577889999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=360.28 Aligned_cols=256 Identities=18% Similarity=0.297 Sum_probs=206.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-----HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-----QGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999976 799999999864321 1346788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC---eEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT---PKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG 220 (415)
++||||+++++|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988865433333589999999999999999999999 9999999999999987654 9999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... . ...... ..+..
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~i-~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEGI-IKGKY 249 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHHH-HHTCC
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHHH-HcCCC
Confidence 998765432 22344679999999999999999999999999999999999999987531 1 111111 11111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ..... ...+..+.+|+.+||+.||++||++.++++
T Consensus 250 ~~--~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 112467889999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.88 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=212.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
..++|++.+.||+|+||.||+|...++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 34678899999999999999999988889999999765433 36788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++++|.+++..... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999976532 588999999999999999999999 99999999999999999999999999998664332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...... ..+ .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i-~~~---------~ 222 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDI-STG---------F 222 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHH-HTT---------C
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHH-hcC---------C
Confidence 222334557788999999999999999999999999999999 88777654321 111111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122233567899999999999999999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=359.33 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=206.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 145 (415)
.++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367889999999999999999986 6899999999764 334456788999999988 89999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999998654 689999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhh--hhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEE--QYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~--~~~~~~~~~~~~~~~~~~~ 303 (415)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............+.
T Consensus 161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 322 1233456899999999999999999999999999999999999999864221110 011111111222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH------HHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM------STLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 343 (415)
..++...+..+.+++.+||+.||.+||++ .++++
T Consensus 236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11233345678899999999999999995 56664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=361.97 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=208.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999976 7899999999754 334456788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~ 223 (415)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999997654 689999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... ....+...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~-~i~~~~~~-- 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYA-QIKAGAYD-- 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHTCCC--
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHhCCCC--
Confidence 665332 233467999999999999999999999999999999999999998654321 1111 11222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.........+.++.+|+.+||+.||.+||++.++++.
T Consensus 249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001112335678999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=358.22 Aligned_cols=260 Identities=19% Similarity=0.232 Sum_probs=210.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467999999999999999999975 7899999998755322 4578899999999 99999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC-----eEEeeecccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT-----PKISDFGLAK 223 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~ 223 (415)
|+ +++|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 9999999986522 689999999999999999999999 9999999999999999887 9999999998
Q ss_pred ccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 224 LFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 224 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76433221 124567999999999999999999999999999999999999999875433322222211111110
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
... ..... ..+ ++.+++..||+.+|.+||++.+|++.|....
T Consensus 239 ~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 TPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 00011 123 7999999999999999999999999887554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=364.17 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDH 142 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 142 (415)
....++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999986 68999999997642 23345677899999877 99999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||++||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998754 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....... +.
T Consensus 166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~-~~--- 234 (345)
T 1xjd_A 166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRM-DN--- 234 (345)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC---
T ss_pred hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHh-CC---
Confidence 854322 122445689999999999999999999999999999999999999987643221 1111111 11
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHH-HHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMS-TLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 343 (415)
..++...+.++.+++.+||+.||.+||++. +|++
T Consensus 235 -------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 122233456788999999999999999997 6653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.72 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=199.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC-------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD------- 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 141 (415)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999987 79999999987543 334567899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeeccCCCHHHHhhcCCCCCCccCH
Q 044232 142 --------------------------------------------------HRILVYGYLENNSLAQTLLGRGHSSIQFNW 171 (415)
Q Consensus 142 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 171 (415)
..++||||+++++|.+++...... ....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhh
Confidence 379999999999999999876532 24567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc-----------ceecccccCC
Q 044232 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-----------HISTRVAGTE 240 (415)
Q Consensus 172 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 240 (415)
..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 999999999999999999999999999987654321 1223456999
Q ss_pred CCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHH
Q 044232 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRY 320 (415)
Q Consensus 241 ~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 320 (415)
.|+|||++.+..++.++|||||||++|||++|..| +.... .. ......... +......+..+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~------~~~~~--~~-~~~~~~~~~---------~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QMERV--RI-ITDVRNLKF---------PLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCC------HHHHH--HH-HHHHHTTCC---------CHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCC------hhHHH--HH-HHHhhccCC---------CcccccCChhH
Confidence 99999999999999999999999999999998543 22111 11 111111111 11112344677
Q ss_pred HHHHHHcCCcCCCCCCCHHHHHH
Q 044232 321 LKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 321 ~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+++.+||+.||.+||++.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 89999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=355.83 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=216.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEe------cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
++...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 445568899999999999999999985 256789999997653 33456789999999999 9999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCC--------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHS--------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 999999999999999999999865421 22589999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876543222 2334567889999999999999999999999999999999 88888654332
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.. .......+ .....+...+..+.+++.+||+.||.+||++.++++.|.+.+
T Consensus 255 ~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 SK------FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HH------HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hH------HHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 21 11111211 111122334577899999999999999999999999998655
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.76 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=207.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67889999999999999999986 79999999986542 234467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....+. .+..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~-~~~~------- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV-SGKV------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC-------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHH-cCCC-------
Confidence 2 234679999999999999999999999999999999999999987643321 111121 1211
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
.++...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122334567899999999999999998 888876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=353.21 Aligned_cols=262 Identities=31% Similarity=0.485 Sum_probs=214.1
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++++..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 345566788999999999999999999988888999999976543 3467889999999999999999999986 45689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999996532 12588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... +..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~-~~~----- 226 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNL-ERG----- 226 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH-HTT-----
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHH-hcc-----
Confidence 65443333344567889999999998999999999999999999999 88777653321 111111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+..+.+++.+||+.+|++|||+.++++.|....
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 111222334577899999999999999999999999997654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.71 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=197.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccch----HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR----QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999975 78899999876432 2346788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC---cEecCCCCCCeeecC--------CCCeE
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH---IVHRDIKASNILLDK--------DLTPK 215 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~k 215 (415)
|||+++++|.+++... .+++..+..++.|++.||.|||++ + |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998643 689999999999999999999999 7 999999999999986 77899
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ......
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~ 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVA 227 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHH
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhh
Confidence 99999998654322 224568999999999999999999999999999999999998886543221 111111
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.. ......+...+..+.+++.+||+.+|.+|||+.|+++.|..
T Consensus 228 ~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MN---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cC---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 11122333445779999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=351.65 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=203.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999986 68999999987542 3344678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++ +|.+.+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 56555554322 689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecccccCCCCCChhhhhcCC-CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch------
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV------ 301 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~------ 301 (415)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.|+........ ...............
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGG
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhc
Confidence 2 2234457899999999998765 89999999999999999999888644322221 111111111111000
Q ss_pred hhccc---------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDA---------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+. ..........+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0001112234567889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=348.86 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=201.3
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999998899999999865432 2236788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++ +|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 89998876432 688999999999999999999999 99999999999999999999999999998764322
Q ss_pred cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh------
Q 044232 230 THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE------ 302 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~------ 302 (415)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...............
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhc
Confidence 222345689999999998764 589999999999999999999999875432211 111111111110000
Q ss_pred --hcccccC-------CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 --LVDASLN-------GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 --~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..++... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0111223567889999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.65 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=204.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999975 79999999986542 12235688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+ +|+|.+++...+ .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999887665 689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+.
T Consensus 160 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~ 221 (336)
T 3h4j_B 160 DG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN 221 (336)
T ss_dssp TS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC
T ss_pred CC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence 43 22345679999999999987765 7899999999999999999999875432110 01111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 11223334577899999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=371.48 Aligned_cols=262 Identities=23% Similarity=0.252 Sum_probs=211.2
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEE
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCV 138 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 138 (415)
..++.+...++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.. ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555666789999999999999999999986 79999999997542 122345788999999999999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEee
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISD 218 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 218 (415)
+.+.+++||||++||+|.+++...+. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999976432 689999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhh-------cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAI-------RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||....+.+ ..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HH
Confidence 9999877554443444568999999999987 3568999999999999999999999987643322 11
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCC---CCHHHHHH
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR---PSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~evl~ 343 (415)
..+...... . ..+..+...+.++.+|+.+||+ +|.+| |+++||++
T Consensus 280 ~~i~~~~~~--~----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYKEH--L----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHHHH--C----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcccC--c----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111110000 0 0011112335678999999999 99998 68999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.36 Aligned_cols=266 Identities=25% Similarity=0.399 Sum_probs=199.0
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEecC-C---CEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLKD-G---TLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
++.+..++|++.+.||+|+||.||+|.+.. + ..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344556789999999999999999998763 3 27999999765 33455789999999999999999999999987
Q ss_pred CCee------EEEEeeccCCCHHHHhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 140 GDHR------ILVYGYLENNSLAQTLLGRG--HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 140 ~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
.... ++||||+++|+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 99999999999999986542 2223589999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHH
Q 044232 212 LTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~ 289 (415)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----- 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI----- 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-----
Confidence 9999999999986543321 22233456888999999999999999999999999999999 8888775443221
Q ss_pred HHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
...... +. ....+...+..+.+++.+||+.||.+|||+.++++.|...+.
T Consensus 249 -~~~~~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 -YNYLIG-GN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp -HHHHHT-TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHhc-CC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 11 112233445779999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=348.71 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=205.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-------hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-------GVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 477899999999999999999975 7999999998654221 1167889999999999999999999987654
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCC-----eE
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLDKDLT-----PK 215 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 215 (415)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999998876542 689999999999999999999999 8 999999999999988776 99
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhh--cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI--RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
|+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ....
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINM 241 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHH
Confidence 999999974432 234567999999999984 456789999999999999999999998754432211 1111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.... ......+...+..+.+++.+||+.||.+||++.+|++.|.+
T Consensus 242 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred Hhcc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 12223344456789999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=354.51 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=197.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--------------------------HhHHHHHHHHHHHh
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--------------------------QGVREFLTEINVIK 123 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 123 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999976 789999999865421 11346889999999
Q ss_pred hcCCcceeeeeeEEEe--CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 044232 124 DIKHENLVELYGCCVE--GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDI 201 (415)
Q Consensus 124 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 201 (415)
.++||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.||+.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56899999999999998765322 689999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCC---CCccceEeehhHhHHHHHhCCcCCCC
Q 044232 202 KASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQ---LTRKADIYSFGVLLLEIVSGRCNTNR 278 (415)
Q Consensus 202 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~p~~~ 278 (415)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998765432 2234567999999999987665 47889999999999999999999865
Q ss_pred CCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ...... ..... ........+..+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~------~~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM------CLHSKI-KSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH------HHHHHH-HHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH------HHHHHH-hcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4221 111111 11111 00111123467899999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=358.76 Aligned_cols=275 Identities=24% Similarity=0.322 Sum_probs=213.7
Q ss_pred CCcccchhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-----Cccee
Q 044232 58 DTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-----HENLV 131 (415)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 131 (415)
+...+++++.....++|++.++||+|+||.||+|+.. +++.||+|++... ......+..|+.+++.+. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445677777788899999999999999999999985 7899999999754 333466778999999986 99999
Q ss_pred eeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-
Q 044232 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK- 210 (415)
Q Consensus 132 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 210 (415)
++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 99999999876532 588999999999999999999999 9999999999999975
Q ss_pred ------------------------CCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhH
Q 044232 211 ------------------------DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLL 266 (415)
Q Consensus 211 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl 266 (415)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999864432 2356789999999999999999999999999999
Q ss_pred HHHHhCCcCCCCCCChhhhhHHHHHH--------HHHhhCcchhhcccc-----cC-CCCC---------------HHHH
Q 044232 267 LEIVSGRCNTNRRLPYEEQYLLEMAW--------KLYERGKLVELVDAS-----LN-GDYS---------------VEEA 317 (415)
Q Consensus 267 ~elltg~~p~~~~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~-----~~-~~~~---------------~~~~ 317 (415)
|+|++|+.||................ ...........++.. .. .... ....
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 99999999987644322211111000 000000000000000 00 0000 0012
Q ss_pred HHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 318 HRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 318 ~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+.+|+.+||+.||.+|||+.|+++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 56789999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=385.44 Aligned_cols=266 Identities=30% Similarity=0.461 Sum_probs=217.4
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
...+++..++|++.++||+|+||.||+|.++++..||||+++.... ..+.|.+|+.+|++++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4556667788999999999999999999998878899999986543 34679999999999999999999999876 678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
+|||||+++|+|.+++..... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 999999999999999975321 1588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............++..|+|||++.++.++.++|||||||++|||++ |+.||...... +.... ...+
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~-i~~~---- 480 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERG---- 480 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHH-HHTT----
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcC----
Confidence 664322222233456788999999999999999999999999999999 88777653321 11111 1222
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.....+..++..+.+|+.+||+.+|++||++.+|++.|.......
T Consensus 481 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111223345678999999999999999999999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=360.20 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=207.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
...++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999987 58899999997642 23446678899999988 899999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||++||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998755 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+. +....+.. +.
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~---- 237 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME-HN---- 237 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CC----
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-CC----
Confidence 54322 22334567999999999999999999999999999999999999998754321 12222222 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+.++.+|+.+||+.||.+||+ +.+|++
T Consensus 238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1223344577899999999999999995 577765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=355.43 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=196.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 144 (415)
...++|++.++||+|+||+||+|... +++.||||++... .......+..|+..+..+ +||||+++++++.+++..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 44578999999999999999999987 7999999998654 233334555666666655 9999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+ +++|.+++...+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 134 lv~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 7799998876542 689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .. +.....+....
T Consensus 207 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~-----~~~~~~~~~~~-- 271 (311)
T 3p1a_A 207 LGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG-----WQQLRQGYLPP-- 271 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH-----HHHHTTTCCCH--
T ss_pred cccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH-----HHHHhccCCCc--
Confidence 5432 22344569999999998875 7999999999999999999997654331 11 11122221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 272 ------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111123467899999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.93 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=209.2
Q ss_pred CCCCCcccccCeEEEEEEEec-----CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLK-----DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRIL 145 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 145 (415)
|++++.||+|+||.||++.++ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998653 58889999998653 34456789999999999999999999999874 67899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++... .+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999765 488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.|+....... .....+.............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 54322 12334567888999999999999999999999999999999988865321100 0000000000000011122
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
+........+...+..+.+|+.+||+.+|.+|||+.++++.|....
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222233334455678999999999999999999999999997653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=346.84 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=207.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--CeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG--DHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 146 (415)
.++|++.+.||+|+||.||+|+++ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467889999999999999999985 788999998765 344556799999999999999999999999877 788999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+. + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986542 2589999999999999999999998 7 99999999999999999999999988764
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCc---cceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTR---KADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... .........+
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~--- 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEG--- 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSC---
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcC---
Confidence 322 2346899999999998765444 899999999999999999888654322 1122222221
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+..+.+++.+||+.||++|||+.++++.|....
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 ------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 122233345577999999999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=354.90 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=197.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEe----cCCCEEEEEEccccc----hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL----KDGTLAAIKVLSADS----RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 478999999997642 2234567889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999998654 688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... .
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-~--- 237 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKC-K--- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-C---
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-C---
Confidence 7543221 2234567999999999999999999999999999999999999998754321 111222211 1
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 238 -------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112223456789999999999999999 7788876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=362.48 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=195.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999987 7999999999765332 25678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC--eEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT--PKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~~~ 227 (415)
+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999997655 689999999999999999999999 9999999999999987765 99999999974322
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCcc-ceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRK-ADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ...........
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~--------- 237 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV--------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------
Confidence 2 22334579999999999988877655 8999999999999999999876433221 11111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1110111123467889999999999999999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=354.85 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=191.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999976 689999999876532 233578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 149 YLENNSLAQTLLGRG--HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|++ |+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999886542 2223588999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc---chh
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK---LVE 302 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~---~~~ 302 (415)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+........ ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 3322 2234568999999999876 4689999999999999999999999876443221 111111111000 000
Q ss_pred h-----ccccc------------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 L-----VDASL------------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ..... ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000 00001123467899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=351.96 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=206.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CC-------CEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DG-------TLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467889999999999999999865 33 4799999987766667889999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC--------e
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT--------P 214 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 214 (415)
.++||||+++|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999987542 488999999999999999999999 9999999999999998887 9
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........ ....
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQF 230 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHH
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----HHHH
Confidence 99999999754321 23458899999999987 7799999999999999999997655443322211 1111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
..... ..+...+.++.+++.+||+.||.+|||+.++++.|...+.
T Consensus 231 ~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 1111123458899999999999999999999999987764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.54 Aligned_cols=263 Identities=22% Similarity=0.382 Sum_probs=208.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC--Ce
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG--DH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 142 (415)
.+.|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 368899999997553 33446788999999999999999999999876 67
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999965432 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCC--------ChhhhhHHHHHH
Q 044232 223 KLFPANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL--------PYEEQYLLEMAW 292 (415)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~--------p~~~~~~~~~~~ 292 (415)
........ .......||..|+|||++.+..++.++||||||+++|+|++|+.|+.... ++..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87654432 22334568888999999999999999999999999999999987743211 111111111111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..... ......+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus 254 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111 112223344567899999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=356.06 Aligned_cols=273 Identities=25% Similarity=0.387 Sum_probs=219.2
Q ss_pred cccchhhHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceee
Q 044232 60 NLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
..+...++++..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 33445667777899999999999999999999764 36789999997653 334467899999999999999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCCHHHHhhcCC------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 044232 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRG------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206 (415)
Q Consensus 133 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 206 (415)
+++++.+.+..++||||+++|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 9999999999999999999999999987532 1112578999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~ 284 (415)
+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |+.|+.....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 246 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence 999999999999999986533221 12233457889999999999999999999999999999999 7777654322
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
..... ....+.. ...+...+..+.+++.+||+.+|.+||++.++++.|...+..
T Consensus 247 ---~~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 ---EQVLR-FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ---HHHHH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---HHHHH-HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11111 1111211 112234457789999999999999999999999999877653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.50 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=199.5
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
+..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999976 7999999999754 2334456788999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999997765 68999999999999999999998 7 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +.
T Consensus 298 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~-~~---- 365 (446)
T 4ejn_A 298 EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-EE---- 365 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC----
T ss_pred eccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHh-CC----
Confidence 54332 223345679999999999999999999999999999999999999986543211 1111111 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
..++...+.++.+|+.+||+.||.+|| +++|+++
T Consensus 366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112233457789999999999999999 9999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=359.42 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=214.7
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CC-----CEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DG-----TLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
..++...++|++.+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345667789999999999999999999875 22 479999997653 34456789999999999 89999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCC----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGH----------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNI 206 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 206 (415)
+.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 9999999999999999999999875321 122578999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEE 284 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~ 284 (415)
|++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..|+........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986543322 22334567889999999999999999999999999999998 8888765433221
Q ss_pred hhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 285 QYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.......+ .....+...+..+.+++.+||+.+|.+||++.+|++.|...
T Consensus 276 ------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ------FYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11122221 11112223356789999999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=362.70 Aligned_cols=268 Identities=19% Similarity=0.292 Sum_probs=207.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecC------CCEEEEEEccccchHhH-----------HHHHHHHHHHhhcCCcceee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQGV-----------REFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 132 (415)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998764 47899999876542211 12345666777889999999
Q ss_pred eeeEEEeC----CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 044232 133 LYGCCVEG----DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL 208 (415)
Q Consensus 133 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 208 (415)
+++++... ...+|||||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99999764 4589999999 9999999987532 689999999999999999999999 99999999999999
Q ss_pred c--CCCCeEEeeeccccccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCC
Q 044232 209 D--KDLTPKISDFGLAKLFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL 280 (415)
Q Consensus 209 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~ 280 (415)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999866432211 1133459999999999999999999999999999999999999987533
Q ss_pred ChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 281 PYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 281 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.... ......... ...+..+++..+.. ...+.++.+++..||+.+|.+||++.+|++.|...+.
T Consensus 266 ~~~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPK--YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHH--HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHH--HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2221 111111111 12233333333321 1234678999999999999999999999999877654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=356.93 Aligned_cols=265 Identities=24% Similarity=0.414 Sum_probs=214.4
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec--------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3445688999999999999999999863 4678999999765 334557789999999999 89999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+.+.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 99999999999999999999999865421 12488999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.|+......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999986654322 12233457889999999999999999999999999999999 88887653221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
+... ....+. ....+...+..+.+++.+||+.+|.+||++.+|++.|.+.+.
T Consensus 267 ------~~~~-~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ------ELFK-LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ------HHHH-HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHH-HHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 112221 112233445778999999999999999999999999987653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.75 Aligned_cols=268 Identities=21% Similarity=0.247 Sum_probs=206.1
Q ss_pred hcCCCCCCccccc--CeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPANKIGQG--GFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|++.+.||+| +||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999987 79999999997652 4455678889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999875322 689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC------cceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--HHHHH
Q 044232 226 PANL------THISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--AWKLY 295 (415)
Q Consensus 226 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--~~~~~ 295 (415)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 111223478999999999987 5799999999999999999999999976443322110000 00000
Q ss_pred hhC------------------cchhhc---------ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERG------------------KLVELV---------DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~------------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... .....+ ........+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 000000 000001122334567899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=357.78 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=193.2
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34678999999999999999999987 68899999997653 2356788999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 224 (415)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999997654 689999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~---- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEY---- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCC----
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCC----
Confidence 5432 223346799999999999999999999999999999999999999865433211 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 269 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 --YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111112234567889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=363.10 Aligned_cols=252 Identities=20% Similarity=0.336 Sum_probs=201.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcC--CcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIK--HENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|...+++.||||++... .......+.+|+.+|..++ ||||+++++++...+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34669999999999999999999888999999998654 3445578999999999996 5999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+
T Consensus 134 v~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 56889999998765 688899999999999999999999 999999999999995 589999999999876
Q ss_pred CCCCc-ceecccccCCCCCChhhhhc-----------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 226 PANLT-HISTRVAGTEGYLAPEYAIR-----------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 226 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH
Confidence 43322 12345679999999999875 468999999999999999999999986543211 11111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.. +......++...+..+.+|+.+||+.||.+||++.|+++.
T Consensus 280 ~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 II---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hh---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1111122222234678899999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.57 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=203.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3477999999999999999999876 68899999986542 2234568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997764 689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~------- 222 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRI-SRV------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HHT-------
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHH-HhC-------
Confidence 332 2234578999999999999999999999999999999999999887543221 11111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 223 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11222334567889999999999999999999997
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=350.19 Aligned_cols=262 Identities=26% Similarity=0.447 Sum_probs=200.9
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++..++|++.+.||+|+||.||+|+... .||+|++... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 4456789999999999999999998653 5999998754 344557899999999999999999999965 5567899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999996543 2689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC-CcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 226 PAN-LTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 226 ~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
... .........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... ........+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccC
Confidence 432 122234467999999999986 5678899999999999999999999987644322 122222222221
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..+ ......++..+.+++.+||+.+|.+||++.+|++.|....
T Consensus 245 ~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 1122344578999999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.32 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=204.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCE----EEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTL----AAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|++.+.||+|+||.||+|.+. ++.. ||+|.+.... ......+.+|+.++..++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 367888999999999999999975 4443 7888775432 223346778999999999999999999986 45689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997652 2688999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
...... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||........ ......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~--- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGE--- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTC---
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCC---
Confidence 654332 22344567889999999999999999999999999999999 9988876443221 11122221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+..++..+.+++.+||+.+|.+||++.++++.|.....
T Consensus 235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111222234467899999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=346.96 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=202.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999986 69999999886543 3334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887654 689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHhhCc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYERGK 299 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~~~~ 299 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............... ...+....
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 22334578999999999876 67899999999999999999999998765443322111110 00111111
Q ss_pred chhhcc-cccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVD-ASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... +......+ ...+..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00000000 123466889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.94 Aligned_cols=271 Identities=26% Similarity=0.357 Sum_probs=214.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEE--eCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV--EGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 143 (415)
.++|++.+.||+|+||.||+|++ .++..||+|++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36788999999999999999984 368899999998877777778999999999999999999999987 45678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999976432 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH--HHHhhCc
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW--KLYERGK 299 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~--~~~~~~~ 299 (415)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.|+....... ...... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSR 252 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHH
Confidence 76543222 2233568888999999999999999999999999999999988765321100 000000 0000000
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+........+...+..+.+++.+||+.||.+|||+.+|++.|.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111112222233344556789999999999999999999999999987754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=354.18 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=199.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe----
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH---- 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 142 (415)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 478999999999999999999975 7899999999765 33445678899999999999999999999876543
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++++|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999998665 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 223 KLFPANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 223 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 86643322 22234568999999999999999999999999999999999999987654322 22222222211
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH-Hhh
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN-MLI 346 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~-~L~ 346 (415)
... .... ..+.++.+++.+||+.||.+||++.+++. .|.
T Consensus 238 ~~~---~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 238 PPS---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CHH---HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Ccc---cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 100 0011 13467889999999999999997766654 443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=348.76 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=206.4
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
+..++|++.+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345789999999999999999998642 346999999765 34455789999999999999999999999865 457
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 899999999999999976532 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .. ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~----~~~~~~--- 231 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG----VLEKGD--- 231 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH----HHHHTC---
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH----HHhcCC---
Confidence 765433333344567889999999999999999999999999999998 9988865433221 11 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11122234567899999999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=356.66 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=181.3
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEeeccCCC
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 154 (415)
.+.||+|+||.||+|..+ +++.||+|++.... ...+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 78999999996542 356778999999997 9999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeEEeeeccccccCCCCcc
Q 044232 155 LAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 155 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~ 231 (415)
|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 93 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~ 164 (325)
T 3kn6_A 93 LFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQ 164 (325)
T ss_dssp HHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CC
Confidence 999998765 689999999999999999999999 999999999999998766 8999999999865433 22
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 2344568999999999999999999999999999999999999987643321111111111112221110 0000
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+.++.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01123577899999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.65 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=209.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEE-EeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC-VEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+|+.+++.++|++++..++.+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 478999999999999999999974 7999999998765432 4678899999999998866666655 56778899999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeecccccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLF 225 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 225 (415)
|+ +++|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999975432 689999999999999999999999 99999999999999 48889999999999876
Q ss_pred CCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 226 PANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 226 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543221 12446799999999999999999999999999999999999999986443332222222111111111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.. ..... .+..+.+++.+||+.+|.+||++.+|++.|.......
T Consensus 239 ~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hH-----HHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 10 11112 2467899999999999999999999999998765433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=352.89 Aligned_cols=270 Identities=25% Similarity=0.369 Sum_probs=217.1
Q ss_pred cchhhHHHHhcCCCCCCcccccCeEEEEEEEe------cCCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeee
Q 044232 62 YGYKDLRVATENFSPANKIGQGGFGSVYKGTL------KDGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVEL 133 (415)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 133 (415)
+....+....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666778999999999999999999984 246889999997653 33456789999999999 79999999
Q ss_pred eeEEEeCC-eeEEEEeeccCCCHHHHhhcCCCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 044232 134 YGCCVEGD-HRILVYGYLENNSLAQTLLGRGHS------------SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRD 200 (415)
Q Consensus 134 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 200 (415)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.||+.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 589999999999999999876431 11388999999999999999999999 999999
Q ss_pred CCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCC
Q 044232 201 IKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNR 278 (415)
Q Consensus 201 lkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~ 278 (415)
|||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986643322 23344568899999999999999999999999999999998 9888865
Q ss_pred CCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 279 RLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...... .......+.. ...+...+..+.+++.+||+.+|.+||++.+|++.|...+
T Consensus 254 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHH------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHH------HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 433221 1112222211 1122233567899999999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=357.03 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=202.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCE----EEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTL----AAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999965 4443 577777543 3334578899999999999999999999998765 78
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+|++|+++|+|.+++..... .+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987543 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 225 FPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 225 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ......+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~---- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKG---- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTT----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcC----
Confidence 643322 22233456888999999999999999999999999999999 9988876433221 1111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.....+...+.++.+++.+||+.+|.+||++.|+++.|.....
T Consensus 236 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 -----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1122233445678999999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=345.69 Aligned_cols=264 Identities=21% Similarity=0.288 Sum_probs=206.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEE-EeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC-VEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 147 (415)
..++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+|+.+++.++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999974 7899999987654322 3577899999999988877766665 6677889999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 224 (415)
||+ +++|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999975432 689999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCc------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 225 FPANLT------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 225 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654322 12234679999999999999999999999999999999999999998654433222222221111111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
... ..... .+..+.+++.+||+.+|++||++.+|++.|......
T Consensus 238 ~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 238 PIE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CHH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhh-----hhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 110 01111 246789999999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=354.09 Aligned_cols=266 Identities=19% Similarity=0.262 Sum_probs=208.5
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCe
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE----GDH 142 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 142 (415)
.+..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345678999999999999999999975 799999999977766667889999999999999999999999873 347
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999976433334789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcc--------eecccccCCCCCChhhhhcCC---CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 223 KLFPANLTH--------ISTRVAGTEGYLAPEYAIRGQ---LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 223 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~---- 256 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV---- 256 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH----
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh----
Confidence 754321110 012345799999999987553 68999999999999999999887642100000 00
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
..... ...........+..+.+++.+||+.||.+||++.+|++.|.....
T Consensus 257 ~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 257 ALAVQ---------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hHHhh---------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00011 111111122345679999999999999999999999999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=347.85 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=209.6
Q ss_pred hcCCCCCC-cccccCeEEEEEEEec---CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 71 TENFSPAN-KIGQGGFGSVYKGTLK---DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
.++|.+.+ .||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 8999999999999854 5778999999875 344567899999999999999999999999 5567899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997543 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 226 PANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 226 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
....... .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||........ . .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~-~~i~~~~--- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M-AFIEQGK--- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------H-HHHHTTC---
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH------H-HHHhcCC---
Confidence 4432221 223456889999999998899999999999999999998 9988876443221 1 1112221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus 231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12233445678999999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.10 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=199.2
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999976 7999999999887666667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee--cCCCCeEEeeeccccccCCCCccee
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL--DKDLTPKISDFGLAKLFPANLTHIS 233 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 233 (415)
.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 99887543 2689999999999999999999999 99999999999999 567899999999998765432 22
Q ss_pred cccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC
Q 044232 234 TRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS 313 (415)
Q Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (415)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........... ......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~-------~~~~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD-------LEDEEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC-------SCSGGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC-------CChhhh
Confidence 3456999999999999899999999999999999999999998764322 122222221100 000011
Q ss_pred HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 314 VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+.++.+|+.+||+.||.+||++.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 123467899999999999999999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=343.36 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=207.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999976 6899999998654 3344567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC---eEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT---PKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 224 (415)
||+++++|.+.+.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887764 689999999999999999999999 9999999999999987655 99999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ..+...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~-~~~~~~--- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQI-KAGAYD--- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCC---
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHH-Hhcccc---
Confidence 54332 2234679999999999999999999999999999999999999986543221 11111 111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+..+.+++.+||+.+|.+|||+.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001111233467889999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=360.48 Aligned_cols=246 Identities=26% Similarity=0.338 Sum_probs=196.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHH-HhhcCCcceeeeeeEEEeCCeeE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINV-IKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
..++|++++.||+|+||.||+|+.+ +++.||+|++.... ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3477999999999999999999987 68999999997653 2233456677776 57789999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++.
T Consensus 116 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999999998754 688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+... .
T Consensus 189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-~----- 255 (373)
T 2r5t_A 189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK-P----- 255 (373)
T ss_dssp GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHS-C-----
T ss_pred cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc-c-----
Confidence 4322 22344568999999999999999999999999999999999999998754321 122222221 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMST 340 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 340 (415)
..++...+..+.+|+.+||+.||.+||++.+
T Consensus 256 -----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1122234467889999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=356.35 Aligned_cols=261 Identities=23% Similarity=0.234 Sum_probs=204.2
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-----chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-----SRQGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
+....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556788999999999999999999976 7889999998654 234456889999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCC------------------------------------CCCccCHHHHHHHHHHHHHH
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGH------------------------------------SSIQFNWQTRRNICIGVAKG 184 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i~~~ 184 (415)
+..++||||+++|+|.+++..... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 01234677888999999999
Q ss_pred HHHHHhcCCCCcEecCCCCCCeeecCCC--CeEEeeeccccccCCC---CcceecccccCCCCCChhhhhc--CCCCccc
Q 044232 185 LAFLHEEVQPHIVHRDIKASNILLDKDL--TPKISDFGLAKLFPAN---LTHISTRVAGTEGYLAPEYAIR--GQLTRKA 257 (415)
Q Consensus 185 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 257 (415)
|+|||+. +|+||||||+|||++.++ .+||+|||++..+... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 8999999999865322 1112345679999999999875 6789999
Q ss_pred eEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC
Q 044232 258 DIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337 (415)
Q Consensus 258 DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 337 (415)
|||||||++|||++|+.||...... +............. .......+..+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999988654322 22222222211110 0011123467889999999999999999
Q ss_pred HHHHHH
Q 044232 338 MSTLVN 343 (415)
Q Consensus 338 ~~evl~ 343 (415)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=348.74 Aligned_cols=262 Identities=21% Similarity=0.348 Sum_probs=200.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999975 7999999998753 344557789999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++.........+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999875332233689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... .........
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~---- 257 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-KIEQCDYPP---- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHH-HHHTTCSCC----
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHH-HhhcccCCC----
Confidence 332 12234568999999999999999999999999999999999999886532211 11111 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
......+.++.+++.+||+.||.+||++.+|++.|....
T Consensus 258 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111233467899999999999999999999999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=340.57 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=206.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999987 5789999998776555567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeeccccccC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~ 226 (415)
+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987765 689999999999999999999999 99999999999999 788999999999998764
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ..... ..+..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~------ 224 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKI-REGTF------ 224 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCCC------
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HhCCC------
Confidence 432 2334569999999998765 48999999999999999999999987543211 11111 11111
Q ss_pred ccCCCCCH----HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSV----EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+. ..+..+.+++.+||+.||.+||++.++++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 ----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 23467889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.37 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=200.9
Q ss_pred hcCCCCC-CcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPA-NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.+.|++. +.||+|+||.||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999965 7999999999776555567888999999885 7999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC---eEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT---PKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 224 (415)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999998764 689999999999999999999999 9999999999999998876 99999999976
Q ss_pred cCCCCc------ceecccccCCCCCChhhhhc-----CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhh--------
Q 044232 225 FPANLT------HISTRVAGTEGYLAPEYAIR-----GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ-------- 285 (415)
Q Consensus 225 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~-------- 285 (415)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223569999999999875 56889999999999999999999999765432100
Q ss_pred hHHHHHHHHHhhCcchhhcccccCCCCCH----HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 286 YLLEMAWKLYERGKLVELVDASLNGDYSV----EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............+.. ..+. ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000111111222211 1111 13467899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=348.27 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=207.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH------hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ------GVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999986 6899999998764321 34678899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEee
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISD 218 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 218 (415)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999997654 689999999999999999999999 999999999999999888 799999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ ...... ..
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~ 233 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT-SV 233 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TT
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hc
Confidence 99998765432 2234569999999999999999999999999999999999999987543221 111111 11
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ..+.... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY--DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 10 0000000 122466889999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.28 Aligned_cols=255 Identities=26% Similarity=0.464 Sum_probs=199.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
.++|++.+.||+|+||.||+|++. ++.||+|++.... ..+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999875 6789999997543 3467899999999999999999999887 3489999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC-eEEeeeccccccCCCC
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT-PKISDFGLAKLFPANL 229 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~ 229 (415)
++|+|.+++..... ...+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999986542 124678899999999999999999932229999999999999998886 799999999755332
Q ss_pred cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.... +. .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~---------~ 222 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GT---------R 222 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TC---------C
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CC---------C
Confidence 223468999999999999999999999999999999999999986532211 111121111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.......+..+.+++.+||+.+|.+|||+.++++.|....
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1122234567889999999999999999999999997654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=346.98 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=207.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRIL 145 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 145 (415)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999986 7899999998754 33445678999999999999999999998864 568899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCCeeecCCCCeEEeeec
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH-----IVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976543334589999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +... ....+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAG-KIREGKF 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHTCC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHH-HHhhccc
Confidence 998764332 1223456899999999999999999999999999999999999888754321 1111 1222221
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
...+...+.++.+++.+||+.+|.+||++.||++.+.
T Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1222334577899999999999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.16 Aligned_cols=264 Identities=23% Similarity=0.351 Sum_probs=194.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCC--e
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIK-HENLVELYGCCVEGD--H 142 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 142 (415)
...++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45688999999999999999999976 7999999998643 3445567889999999997 999999999997544 7
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 6899998764 588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC--------------------CcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 223 KLFPAN--------------------LTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 223 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
+.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 0112234679999999999886 6799999999999999999999999876543
Q ss_pred hhhhhHHHHHHHHHhhCcchhh-----------c----------ccccCCC------------CCHHHHHHHHHHHHHcC
Q 044232 282 YEEQYLLEMAWKLYERGKLVEL-----------V----------DASLNGD------------YSVEEAHRYLKIALLCT 328 (415)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~------------~~~~~~~~l~~li~~cl 328 (415)
.... ..+...........+ + ....... .....+.++.+|+.+||
T Consensus 237 ~~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 2211 111111110000000 0 0000000 00122467889999999
Q ss_pred CcCCCCCCCHHHHHHH
Q 044232 329 QDMPKRRPSMSTLVNM 344 (415)
Q Consensus 329 ~~~P~~RPs~~evl~~ 344 (415)
+.||++|||+.|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=366.05 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=209.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999986 799999999975422 2346788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999997654 689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ..... ..+..
T Consensus 168 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i-~~~~~----- 233 (476)
T 2y94_A 168 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKI-CDGIF----- 233 (476)
T ss_dssp TT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHH-HTTCC-----
T ss_pred cc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHH-hcCCc-----
Confidence 43 22345679999999999988765 789999999999999999999987643321 11111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH--Hhhc
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN--MLIG 347 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 347 (415)
..+...+..+.+|+.+||+.||.+|||+.++++ .+..
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 112223467889999999999999999999997 4544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.00 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-----HhHHHHHHHHHHHhhc---CCcceeeeeeEEEe
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-----QGVREFLTEINVIKDI---KHENLVELYGCCVE 139 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 139 (415)
...++|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45689999999999999999999975 799999999874321 1123556677777766 49999999999987
Q ss_pred CC-----eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 140 GD-----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 140 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
.. ..++||||+. ++|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 5799999996 5999999876532 489999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence 99999999866433 223456799999999999999999999999999999999999999876543221 1111111
Q ss_pred HhhCcchhhc------ccccC--CC-----CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 295 YERGKLVELV------DASLN--GD-----YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~------~~~~~--~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... ..... .. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1110000000 00000 00 01123467889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=356.07 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=202.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.+.|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355888999999999999999975 7899999998754 233446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+. |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 67888876433 2689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
.. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ........... .
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~-~-- 271 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-P-- 271 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-C--
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC-C--
Confidence 32 3457999999999985 567899999999999999999999887654322 12222222211 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. ..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 272 ---~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ---A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 1112334678899999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=357.10 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=210.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEe-----cCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC--ee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTL-----KDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD--HR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 143 (415)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46688999999999999999984 368899999998776666778999999999999999999999987644 78
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999987642 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC-hh--------hhhHHHHHH
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP-YE--------EQYLLEMAW 292 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p-~~--------~~~~~~~~~ 292 (415)
........ ......++..|+|||++.+..++.++||||||+++|||++|..|+..... +. .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543221 12234577789999999999999999999999999999999877643100 00 000000111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
..+........+..++..+.+++.+||+.||.+||++.+|++.|...
T Consensus 274 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 274 ---------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111112223344567899999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=369.88 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=210.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999986 79999999997642 22346788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++||+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987654445799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... +
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~-~-------- 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE-Q-------- 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH-C--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh-c--------
Confidence 4322 23345799999999999999999999999999999999999999976532211 1111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH-----HHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM-----STLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 343 (415)
...++...+..+.+|+.+||+.||.+||++ .+|++
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 112233445778899999999999999975 66664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.21 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999976 68999999987653 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeecccccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLF 225 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 225 (415)
|+++|+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865422223689999999999999999999999 99999999999999 55678999999999865
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... .......||+.|+|||++. +.++.++|||||||++|+|++|+.||....... ...........
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~----- 243 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPN----- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC-----
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcc-----
Confidence 432 2234567899999999875 578999999999999999999999987543211 11111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 244 --~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 --YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000112467889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.14 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=203.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..++|++.+.||+|+||.||+|..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4577999999999999999999986 6899999999765322 34688888888 7999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----CCeEEeeecccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD----LTPKISDFGLAK 223 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~ 223 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999998665 689999999999999999999999 99999999999998543 359999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.. .....+..
T Consensus 169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~-~~i~~~~~--- 240 (342)
T 2qr7_A 169 QLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEIL-ARIGSGKF--- 240 (342)
T ss_dssp ECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHH-HHHHHCCC---
T ss_pred cCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHH-HHHccCCc---
Confidence 764432 223456789999999999888899999999999999999999999875322111 1111 12222221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+....+..+.+|+.+||+.||++||++.++++
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111222334577899999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=344.40 Aligned_cols=261 Identities=18% Similarity=0.196 Sum_probs=202.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999976 78899999987652 33446788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998754 689999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
...........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~---- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R---- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C----
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C----
Confidence 43333334567899999999999999999999999999999999999888653211 11111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-CHHHHHHHhhcCCCCC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRP-SMSTLVNMLIGEIDVN 352 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 352 (415)
....+...+..+.+++.+||+.||++|| ++.++++.|...+...
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0011223346788999999999999999 9999999998776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.80 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=202.7
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCV 138 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 138 (415)
.++.+..++|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444556788999999999999999999864 2458999998754 3445577899999999999999999999998
Q ss_pred eCC-----eeEEEEeeccCCCHHHHhhcCC--CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 139 EGD-----HRILVYGYLENNSLAQTLLGRG--HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 139 ~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
+.+ ..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 655 3599999999999999985432 2233689999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHH
Q 044232 212 LTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~ 289 (415)
+.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..|+........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----- 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----- 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----
Confidence 9999999999986543321 12233457889999999999999999999999999999999 7777765433221
Q ss_pred HHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.. ....+. ....+...+..+.+++.+||+.+|.+||++.+|++.|...+
T Consensus 259 -~~-~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 259 -YD-YLLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -HH-HHHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH-HHHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111111 11222334567999999999999999999999999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=379.82 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=203.6
Q ss_pred cCCCCCC-cccccCeEEEEEEEec---CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPAN-KIGQGGFGSVYKGTLK---DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
+++.+.+ .||+|+||.||+|.++ ++..||||+++... ....+.|.+|+.+|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3344444 7999999999999864 45679999997653 3355789999999999999999999999976 568999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997543 2689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ . ...+..+.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~-~~~i~~~~---- 556 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------V-MAFIEQGK---- 556 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------H-HHHHHTTC----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------H-HHHHHcCC----
Confidence 332211 122345689999999999999999999999999999998 998887654322 1 11222221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+..++..+.+|+.+||+.+|++||++.+|++.|....
T Consensus 557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22233455678999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=350.78 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC-----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD-----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
.++|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4667788999999999999998652 235999999765 3344567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999976532 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +... ....+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~-~~~~~--- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMK-AINDG--- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-HHHTT---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHH-HHHCC---
Confidence 6433211 1222346788999999999999999999999999999999 98887643221 1111 11111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.....+...+..+.+++.+||+.+|.+||++.+|++.|...+.
T Consensus 267 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 267 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112233445778999999999999999999999999976653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=348.48 Aligned_cols=265 Identities=25% Similarity=0.414 Sum_probs=203.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhh--cCCcceeeeeeEEEeC----
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD--IKHENLVELYGCCVEG---- 140 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---- 140 (415)
.....++|++.+.||+|+||.||+|+.. ++.||+|++..... ..+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445688999999999999999999886 88999999865432 334455555554 4999999999999887
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeecCCCCeE
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-----QPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+++ +++|+||||||+|||++.++.+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999765 5899999999999999999999752 33899999999999999999999
Q ss_pred EeeeccccccCCCCcce---ecccccCCCCCChhhhhcCCCCcc------ceEeehhHhHHHHHhCCc----------CC
Q 044232 216 ISDFGLAKLFPANLTHI---STRVAGTEGYLAPEYAIRGQLTRK------ADIYSFGVLLLEIVSGRC----------NT 276 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvvl~elltg~~----------p~ 276 (415)
|+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||++|.. |+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997664332221 224579999999999988766665 999999999999999944 44
Q ss_pred CCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 277 NRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 277 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+.... ........... ......+ ..++..+.+++.+||+.||.+|||+.+|++.|.....
T Consensus 263 ~~~~~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPSDPS--YEDMREIVCIK--------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCSSCC--HHHHHHHHTTS--------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCCCCc--hhhhHHHHhhh--------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 332221111 11111111111 1112222 3678889999999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.88 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=206.8
Q ss_pred HhcCCCCCC-cccccCeEEEEEEEec---CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 70 ATENFSPAN-KIGQGGFGSVYKGTLK---DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 70 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
..++|++.+ .||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788777 9999999999999643 47889999997653 23356789999999999999999999999 56778
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999998764 688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcce--ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 224 LFPANLTHI--STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 224 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... .......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~- 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE- 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC-
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-
Confidence 765433221 222446788999999999899999999999999999999 988876543211 111222221
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+...+..+.+++.+||+.||.+||++.+|++.|....
T Consensus 238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12223345578999999999999999999999999997654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=351.42 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=200.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccchH-----------hHHHHHHHHHHHhhcCCcceeeeee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADSRQ-----------GVREFLTEINVIKDIKHENLVELYG 135 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 135 (415)
.++|++.+.||+|+||.||+|... ++..||+|+....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5778999998765321 1123667889999999999999999
Q ss_pred EEEe----CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 136 CCVE----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 136 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999998665 789999999999999999999999 99999999999999988
Q ss_pred C--CeEEeeeccccccCCCCc------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 212 L--TPKISDFGLAKLFPANLT------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 212 ~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
+ .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999986643211 11234579999999999999999999999999999999999999985432211
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.. ........... ....+..... ....+.++.+++.+||+.+|++||++.+|++.|...
T Consensus 268 ~~--~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VA--VQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HH--HHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HH--HHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11 11111111111 1111111110 012346789999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=355.56 Aligned_cols=243 Identities=21% Similarity=0.317 Sum_probs=203.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--------QGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999975 789999999876421 1224567899999999999999999999999
Q ss_pred CeeEEEEeeccCC-CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 141 DHRILVYGYLENN-SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 141 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999998765 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9998765432 2334679999999999988776 8899999999999999999998864111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
...... ..+...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 236 ----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111 1111234678999999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=356.82 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=207.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEe----cCCCEEEEEEccccc----hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTL----KDGTLAAIKVLSADS----RQGVREFLTEINVIKDI-KHENLVELYGCCVEG 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 140 (415)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999987 368999999987532 12234567799999999 699999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 99999999999999999998764 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
+++.+............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~- 281 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS- 281 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc-
Confidence 9987644333334456799999999999863 5789999999999999999999998754322211 1111111111
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHHHh
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVNML 345 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L 345 (415)
...++...+..+.+|+.+||+.||.+|| ++.++++..
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1223334456788999999999999999 999998744
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=371.27 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=210.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|+.+|..++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4577999999999999999999986 79999999986542 2234568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||++||+|.+++...+. ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976542 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~------- 404 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEV------- 404 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHC-------
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcc-------
Confidence 5432 2334579999999999999899999999999999999999999997654321111 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...++...+.++.+|+.+||+.||.+|| ++.||++
T Consensus 405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1122333457789999999999999999 7888876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=350.37 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=206.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCE--EEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTL--AAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 146 (415)
++|++.+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999976 5654 499988754 233445788999999999 999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCC------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 147 YGYLENNSLAQTLLGRG------------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997654 2233689999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... ...
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE- 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH-
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH-
Confidence 9999999974321 111233457889999999999899999999999999999998 988886543211 111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.... ......+...+..+.+++.+||+.+|.+||++.++++.|...+.
T Consensus 253 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11122233445779999999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=348.85 Aligned_cols=261 Identities=19% Similarity=0.249 Sum_probs=208.1
Q ss_pred chhhHHHHhcCCCCC-CcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhc-CCcceeeeeeEE
Q 044232 63 GYKDLRVATENFSPA-NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDI-KHENLVELYGCC 137 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 137 (415)
.++..+...++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..+ .||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345566677888887 88999999999999976 69999999987642 22346788999999999 569999999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCe
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTP 214 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 214 (415)
.+.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999865422 2689999999999999999999999 9999999999999988 7899
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i 245 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNI 245 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHH
Confidence 999999998764322 2234579999999999999999999999999999999999999986543221 11111
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ...........+..+.+++.+||+.||.+|||++++++
T Consensus 246 ~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 SQVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Hhcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1110 01111222234567889999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=342.58 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=204.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-C---CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee-EEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-D---GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR-ILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 146 (415)
.|...+.||+|+||.||+|.+. + +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999864 2 237999998764 334557889999999999999999999999876655 999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976432 688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC---cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANL---THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+........ .. .....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~~-~~~~~~----- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LT-HFLAQG----- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----HH-HHHHTT-----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----HH-HHhhcC-----
Confidence 321 1122345678899999999999999999999999999999997665443222111 11 111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+...+..+.+++.+||+.+|.+|||+.++++.|...+
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111222334567899999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.39 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=196.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999976 789999999976532 2345678899999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-----CCCCeEEeeecc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-----KDLTPKISDFGL 221 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DfGl 221 (415)
|||++ |+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 59999998765 689999999999999999999999 999999999999994 455699999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ...........
T Consensus 184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF---KIFEVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCT
T ss_pred ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH---HHHHHhCCCch
Confidence 98764332 223345689999999999874 58999999999999999999999987654322111 11111110000
Q ss_pred hhhc--------cccc---CCC-----CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELV--------DASL---NGD-----YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~--------~~~~---~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... .... ... .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0000 000 00113467889999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=340.69 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=185.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch---HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR---QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57899999999999999999975 799999999865422 22467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999997653 2689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ... ....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~-----~~~~- 227 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNK-----VVLA- 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS-
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHH-----Hhhc-
Confidence 221 22345689999999999988999999999999999999999999875433211 000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+.++.+++.+||+.||++||++.++++
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01122334567889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=341.96 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=207.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999987 6889999998654 234456788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987654 689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ ..... ..+.
T Consensus 167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~------- 231 (294)
T 2rku_A 167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRI-KKNE------- 231 (294)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HTTC-------
T ss_pred cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hhcc-------
Confidence 322 22334568999999999998899999999999999999999999886543211 11111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.||++||++.|+++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122233467889999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.85 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=195.3
Q ss_pred CCCCCCcccccCeEEEEEEEec--C--CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCeeEEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK--D--GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE-GDHRILV 146 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 146 (415)
.|++.+.||+|+||.||+|.+. + +..||+|.+... .....+.|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 2 236899998654 33455789999999999999999999998754 5578999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999976542 578999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCc---ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 227 ANLT---HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 227 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..|+......... . ....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~------~-~~~~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------V-YLLQGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH------H-HHHTTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH------H-HHHcCC---
Confidence 3221 11233457889999999999999999999999999999999 55565544332211 1 111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+..++..+.+++.+||+.+|++||++.+|++.|...+
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122334567999999999999999999999999998655
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=362.58 Aligned_cols=194 Identities=22% Similarity=0.381 Sum_probs=156.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Ce
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 142 (415)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999976 7899999998653 344557889999999999999999999998543 57
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 578999997654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--------------------------ceecccccCCCCCChhhh-hcCCCCccceEeehhHhHHHHHhC
Q 044232 223 KLFPANLT--------------------------HISTRVAGTEGYLAPEYA-IRGQLTRKADIYSFGVLLLEIVSG 272 (415)
Q Consensus 223 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg 272 (415)
+....... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87642211 123446789999999986 456799999999999999999994
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=358.36 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=216.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC--eeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGD--HRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 146 (415)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999987 69999999997643 233467789999999999999999999998765 78999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCCeEEeeeccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL----DKDLTPKISDFGLA 222 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 222 (415)
|||+++|+|.+++...... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999765321 2389999999999999999999999 99999999999999 77888999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhc--------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIR--------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 164 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (396)
T ss_dssp EECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHH
T ss_pred eEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHH
Confidence 876443 22334679999999999875 5678899999999999999999999864322111 11222223
Q ss_pred HhhCcchhhc---------------ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 295 YERGKLVELV---------------DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 295 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
.... ....+ +.......+...+..+.+++.+||+.||++||++.++++.+...+..
T Consensus 240 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2221 11110 00112244577888999999999999999999999999998776654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.48 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=194.2
Q ss_pred hcCCCCC-CcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHh-hcCCcceeeeeeEEEe----CCee
Q 044232 71 TENFSPA-NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIK-DIKHENLVELYGCCVE----GDHR 143 (415)
Q Consensus 71 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 143 (415)
.++|.+. +.||+|+||+||+|..+ +++.||||++... ..+.+|+.++. ..+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567666 68999999999999976 7899999999643 34567888874 4589999999999875 5678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 220 (415)
++||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999986542 2689999999999999999999999 9999999999999997 7899999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......+..
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY 284 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCC
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcc
Confidence 99865432 223456789999999999999999999999999999999999999976543221100 0011111111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. .........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0001112345678999999999999999999999983
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=340.65 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=206.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999986 78999999986543 3344678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999986543 689999999999999999999999 9999999999999999999999999999865332
Q ss_pred C-cceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 229 L-THISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 229 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... . ..+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-----~~~~~~~~------ 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT------ 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H-----HHHHTTCT------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHhhhccc------
Confidence 1 122344678999999999987665 78999999999999999999998764432211 0 01111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111233467889999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=342.89 Aligned_cols=258 Identities=29% Similarity=0.408 Sum_probs=203.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEE-eCCeeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCV-EGDHRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 144 (415)
..+|++.+.||+|+||.||+|.+.+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998642 235899998764 3445578899999999999999999999865 456789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999976432 578999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc---ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc-CCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 225 FPANLT---HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC-NTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 225 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|.. |+........ .... ..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------~~~~-~~~~- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYL-LQGR- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH------HHHH-HTTC-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHH-hcCC-
Confidence 543221 12234567889999999999999999999999999999999554 4443322221 1111 1111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|...+.
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111122335679999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=348.94 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=208.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999986 6889999998754 334556788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987654 689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...... .+..
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~-~~~~------ 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIK-KNEY------ 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-HTCC------
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHh-cCCC------
Confidence 332 22334578999999999999999999999999999999999999886543211 111111 1110
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+++.+||+.||++||++.|+++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233467889999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=354.09 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=206.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEecC---------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceee---------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKD---------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVE--------- 132 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 132 (415)
.++|++.+.||+|+||.||+|.... ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 788999998754 35778999999999999988
Q ss_pred ------eeeEEEe-CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 044232 133 ------LYGCCVE-GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASN 205 (415)
Q Consensus 133 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 205 (415)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67899999999 999999998652 12689999999999999999999999 99999999999
Q ss_pred eeecCCC--CeEEeeeccccccCCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCC
Q 044232 206 ILLDKDL--TPKISDFGLAKLFPANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTN 277 (415)
Q Consensus 206 Ill~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~ 277 (415)
||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999865432111 1233579999999999999999999999999999999999999887
Q ss_pred CCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCC
Q 044232 278 RRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDV 351 (415)
Q Consensus 278 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 351 (415)
...+.... .......... ....+.+... .....+..+.+++.+||+.||.+||++.+|++.|...+..
T Consensus 270 ~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 270 NCLPNTED-IMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GGTTCHHH-HHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCcCHHH-HHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 64422211 1111111111 1111111110 0112246789999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=353.58 Aligned_cols=264 Identities=24% Similarity=0.368 Sum_probs=205.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999987 7899999999765 34445678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++...+ .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999998765 6889999999999999999999831 899999999999999999999999999975422
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH---------HHH-----
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA---------WKL----- 294 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~---------~~~----- 294 (415)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1223457899999999999999999999999999999999999998754322111000000 000
Q ss_pred ---------HhhCcchhhcc----cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 295 ---------YERGKLVELVD----ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 295 ---------~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........++ ...........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000 00011111223567899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=353.03 Aligned_cols=265 Identities=24% Similarity=0.419 Sum_probs=202.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999986 68999999986542 334456889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988876554 689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--------HHHHHhhC
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--------AWKLYERG 298 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--------~~~~~~~~ 298 (415)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............. ....+...
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 32 223345689999999998875 789999999999999999999999876543322111100 01111111
Q ss_pred cchh-hcccccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLVE-LVDASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ...+......+ ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1100 00001111111 123577999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.50 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 366889999999999999999875 78999999987553 3345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998643 689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....+.. ..... ..+.
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~--------- 235 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLI-PKNN--------- 235 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSC---------
T ss_pred c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHh-hcCC---------
Confidence 2 12334578999999999999999999999999999999999998886543321 11111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111222334678999999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.88 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=200.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE----GDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 144 (415)
+.|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44777889999999999999976 6889999998754 34455778999999999999999999999875 35689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeec-CCCCeEEeeecc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLD-KDLTPKISDFGL 221 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl 221 (415)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999998754 688999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
+...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||........ .......+...
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~ 248 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP 248 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCc
Confidence 9755433 223456899999999876 5689999999999999999999999865433221 11122222111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. .+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 249 ~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 AS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11122356899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.54 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=196.7
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHh-HHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 78999999987653221 12455799999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
++ |+|.+++...+. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 589998876542 588999999999999999999999 9999999999999999999999999999865432
Q ss_pred cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc---hhhcc
Q 044232 230 THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL---VELVD 305 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 305 (415)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+......... .....
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhc
Confidence 222334568999999999876 5789999999999999999999999876543221 1111111111100 00000
Q ss_pred c---------ccCCC----CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 A---------SLNGD----YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~---------~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ..... .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 00000 01123467889999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.81 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=200.5
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-CeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG-DHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 147 (415)
+..++|++.+.||+|+||.||+|..+ |+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999875 7889999997654 346788999999999999999999997654 4789999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999976531 1378899999999999999999999 999999999999999999999999999975433
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. .....+++.|+|||++.+..++.++||||||+++|+|++ |+.|+........ ......+
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~-------- 230 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKG-------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTT--------
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcC--------
Confidence 2 223457889999999999999999999999999999998 9888765432111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus 231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11222334457899999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=339.78 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=206.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999976 68899999986542 12245788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++++|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998764 689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....... .
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~-~-------- 227 (284)
T 2vgo_A 166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVN-V-------- 227 (284)
T ss_dssp SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT-T--------
T ss_pred cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhc-c--------
Confidence 32 1234578999999999999999999999999999999999999886543211 1111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...++...+..+.+++.+||+.+|.+||++.++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11122334567889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=342.06 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=201.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3577999999999999999999987 7999999998764 233446788999999999 99999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--------------
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-------------- 211 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 211 (415)
||||+++++|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976532223689999999999999999999999 99999999999999844
Q ss_pred -----CCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhh
Q 044232 212 -----LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ 285 (415)
Q Consensus 212 -----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~ 285 (415)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 47999999999866442 223589999999999866 667899999999999999999766432211
Q ss_pred hHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 286 YLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.....+.. ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ------WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111222211 1222234567899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=343.16 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
..++|.+.+.||+|+||.||+|+.. +|+.||+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999976 799999999987654445678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeecccccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLF 225 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 225 (415)
|+++++|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999997654 688999999999999999999999 99999999999999 78899999999999754
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... ....+..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~i~~~~~----- 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFE-KIKEGYY----- 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHCCC-----
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHH-HHHcCCC-----
Confidence 322 2234568999999999999999999999999999999999999886543211 111 1112211
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+..+.+++.+||+.||.+||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122234577899999999999999999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.29 Aligned_cols=259 Identities=23% Similarity=0.268 Sum_probs=197.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------C
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------D 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 141 (415)
.++|++++.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999876 7899999999764 344557788999999999999999999999654 3
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||++++ |.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 579999999764 6666632 478999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC---
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG--- 298 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~--- 298 (415)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... ..+.......
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~---~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---NKVIEQLGTPCPE 285 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHH
Confidence 9865432 2234567999999999999999999999999999999999999998765432211 1111110000
Q ss_pred ----------------------cchhhcccccCCCC---CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 299 ----------------------KLVELVDASLNGDY---SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 299 ----------------------~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.....+........ ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 11225678999999999999999999999973
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=347.56 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=206.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
..++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4578999999999999999999842 5778999999754 34455678999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCC---CCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEE
Q 044232 143 RILVYGYLENNSLAQTLLGRGHS---SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKI 216 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 216 (415)
.++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999876422 13588999999999999999999999 9999999999999984 446999
Q ss_pred eeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHH
Q 044232 217 SDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 217 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~-~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLE-F 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH-H
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHH-H
Confidence 9999998553221 122334567899999999999999999999999999999998 88777654221 1111 1
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+. ....+...+..+.+++.+||+.+|.+||++.+|++.|....
T Consensus 258 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111 11222334567899999999999999999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.18 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=209.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCC-cceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKH-ENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.++||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999975 7999999988655332 357789999999987 566667677778889999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeecccccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLAKLF 225 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 225 (415)
|+ +++|.+++..... .+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999975432 689999999999999999999999 99999999999999 68899999999999876
Q ss_pred CCCCcc------eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 226 PANLTH------ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 226 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
...... ......||+.|+|||++.+..++.++||||||||+|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543221 12356799999999999999999999999999999999999999987554333332222222111111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+. .. .+.++.+|+..||+.+|++||++.+|++.|...+
T Consensus 237 ~~~l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 237 IEALC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111 11 2467899999999999999999999999887654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=376.24 Aligned_cols=247 Identities=27% Similarity=0.380 Sum_probs=200.2
Q ss_pred CcccccCeEEEEEEEec---CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK---DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
++||+|+||.||+|.+. +++.||||+++... ....+++.+|+.+|.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997653 3345789999999999999999999999964 568899999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc--
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT-- 230 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-- 230 (415)
|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997664 689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .......+. .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~---------~ 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------R 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 22233456789999999999999999999999999999998 988886543221 111222221 2
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
...+..++.++.+|+..||+.||++||++.+|++.|...
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223344567899999999999999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.70 Aligned_cols=267 Identities=26% Similarity=0.355 Sum_probs=209.1
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhh--cCCcceeeeeeEEEeCC-
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKD--IKHENLVELYGCCVEGD- 141 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 141 (415)
.......++|++.+.||+|+||.||+|+. +++.||+|++.... ...+.+|++++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33455678999999999999999999998 48899999996543 3567788888887 79999999999998776
Q ss_pred ---eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeecC
Q 044232 142 ---HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH--------EEVQPHIVHRDIKASNILLDK 210 (415)
Q Consensus 142 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~ 210 (415)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 789999999999999999764 5899999999999999999999 77 9999999999999999
Q ss_pred CCCeEEeeeccccccCCCCcc---eecccccCCCCCChhhhhcCC------CCccceEeehhHhHHHHHhC---------
Q 044232 211 DLTPKISDFGLAKLFPANLTH---ISTRVAGTEGYLAPEYAIRGQ------LTRKADIYSFGVLLLEIVSG--------- 272 (415)
Q Consensus 211 ~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltg--------- 272 (415)
++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876543322 224457999999999987652 34789999999999999999
Q ss_pred -CcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC-CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 273 -RCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD-YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 273 -~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
..||....+... .... .......... .+..... ....++..+.+|+.+||+.||++||++.+|++.|....
T Consensus 263 ~~~p~~~~~~~~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-SVEE-MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSC-CHHH-HHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCcc-cHHH-HHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 555544332211 1111 1111111111 1111100 12467788999999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=339.12 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=202.3
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++|.....||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44555669999999999999975 78899999998766555678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCCeEEeeeccccccCCCC
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~ 229 (415)
++++|.+++..... ...+++..+..++.||+.||.|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999976532 23567889999999999999999999 9999999999999987 8999999999998664321
Q ss_pred cceecccccCCCCCChhhhhcCC--CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 230 THISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ........ .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~---------~ 242 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGMF---------K 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHHH---------C
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhccc---------c
Confidence 2233457899999999987654 88999999999999999999988754322111 01111000 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+...+..+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112233344577899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.35 Aligned_cols=260 Identities=19% Similarity=0.253 Sum_probs=192.1
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEE-----
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCV----- 138 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----- 138 (415)
.+.+...+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++.++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34445678999999999999999999976 78999999997776666778999999999996 999999999994
Q ss_pred ---eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCC
Q 044232 139 ---EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLDKDLT 213 (415)
Q Consensus 139 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 213 (415)
.....++||||+. |+|.+++..... ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence 3345799999995 789988865221 12689999999999999999999998 8 999999999999999999
Q ss_pred eEEeeeccccccCCCCcc-----------eecccccCCCCCChhhh---hcCCCCccceEeehhHhHHHHHhCCcCCCCC
Q 044232 214 PKISDFGLAKLFPANLTH-----------ISTRVAGTEGYLAPEYA---IRGQLTRKADIYSFGVLLLEIVSGRCNTNRR 279 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~p~~~~ 279 (415)
+||+|||++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876433211 11134589999999998 5667899999999999999999999887643
Q ss_pred CChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 280 LPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.... ... ...........+..+.+|+.+||+.+|.+||++.|+++.|....
T Consensus 257 ~~~~----------~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 257 AKLR----------IVN---------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHH----------hhc---------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2211 000 01111111122345789999999999999999999999997654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=337.24 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=203.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR------QGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999987 799999999875421 1346788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEeee
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISDF 219 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 219 (415)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997654 689999999999999999999999 999999999999998887 8999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ....
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNI-SAVN 227 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HTTC
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHh-Hhcc
Confidence 9998654322 2234568999999999999999999999999999999999999887543221 11111 1111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ..... ....+..+.+++.+||+.||.+||++.++++
T Consensus 228 ~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 00000 0122467889999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=345.18 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=189.9
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
+.+..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455688999999999999999999975 78999999987543 234467889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcC----CCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 145 LVYGYLENNSLAQTLLGR----GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+||||+++++|.+++... ......+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998641 11123689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc----ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHH
Q 044232 221 LAKLFPANLT----HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 221 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh
Confidence 9986643211 12234568999999999876 57899999999999999999999998765443221 1111
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. +..................+..+.+++.+||+.||.+||++.++++
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 Q-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp T-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 1111111111111112233467889999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.76 Aligned_cols=269 Identities=26% Similarity=0.361 Sum_probs=198.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHH--HHHHhhcCCcceeeeeeEEEe-----CCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTE--INVIKDIKHENLVELYGCCVE-----GDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~-----~~~~ 143 (415)
.++|++.+.||+|+||.||+|+. +++.||+|++..... ..+..| +..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999977 578999999976543 233344 444556899999999986543 2367
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeecCCCCeEEe
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV------QPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
++||||+++|+|.+++... ..++..+..++.||+.||.|||+.+ +++|+||||||+||||+.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999765 3588999999999999999999862 3389999999999999999999999
Q ss_pred eeccccccCCCC-------cceecccccCCCCCChhhhhc-------CCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 218 DFGLAKLFPANL-------THISTRVAGTEGYLAPEYAIR-------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 218 DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
|||++..+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998664321 112234569999999999876 356779999999999999999987764322211
Q ss_pred h---hh--------HHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 284 E---QY--------LLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 284 ~---~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
. .. .................+.. ........+..+.+|+.+||+.||++|||+.|+++.|...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0 00 00011111111111000000 011123467789999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=349.54 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=199.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH-----hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ-----GVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999976 6899999999754221 124678899999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 8988887543 2688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|..|+........ ...............
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhh
Confidence 764332 223446789999999998764 589999999999999999999988766433221 111111111100000
Q ss_pred hcc---------cccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 303 LVD---------ASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 303 ~~~---------~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..+ ....+..+ ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00000111 2234779999999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=360.69 Aligned_cols=243 Identities=14% Similarity=0.130 Sum_probs=191.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHH---HHHhhcCCcceeeee-------eE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEI---NVIKDIKHENLVELY-------GC 136 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 136 (415)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 577889999999999999999975 7999999998743 334557888999 455566899999998 66
Q ss_pred EEeCC-----------------eeEEEEeeccCCCHHHHhhcCCC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 044232 137 CVEGD-----------------HRILVYGYLENNSLAQTLLGRGH---SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196 (415)
Q Consensus 137 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 196 (415)
+.+.+ ..++||||+ +|+|.+++...+. ....+++..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66543 278999999 6899999976431 112345688889999999999999999 99
Q ss_pred EecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC-----------CCCccceEeehhHh
Q 044232 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-----------QLTRKADIYSFGVL 265 (415)
Q Consensus 197 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvv 265 (415)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3345567 999999999887 89999999999999
Q ss_pred HHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 266 LLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 266 l~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+|||++|+.||....... ........ .. ..+.++.+|+.+||+.||.+||++.++++
T Consensus 303 l~elltg~~Pf~~~~~~~---------------~~~~~~~~--~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG---------------GSEWIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C---------------CSGGGGSS--CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc---------------chhhhhhh--cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999886533211 11111110 11 22467889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=355.72 Aligned_cols=198 Identities=26% Similarity=0.406 Sum_probs=168.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Ce
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 142 (415)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999976 6889999999753 344557889999999999999999999999766 57
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||++ |+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999985 69999997654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc---------------------ceecccccCCCCCChhhh-hcCCCCccceEeehhHhHHHHHhCCcCC
Q 044232 223 KLFPANLT---------------------HISTRVAGTEGYLAPEYA-IRGQLTRKADIYSFGVLLLEIVSGRCNT 276 (415)
Q Consensus 223 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~p~ 276 (415)
+....... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87643221 123556799999999986 4567999999999999999999865544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=340.74 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=204.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--------
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE-------- 139 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 139 (415)
...++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34577999999999999999999987 79999999997654 245679999999999999999999864
Q ss_pred --------CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 140 --------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 140 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
....++||||+++++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 4458999999999999999976432 2688999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 212 LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
+.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+. ... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~------~~~---~~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF------ETS---KF 227 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH------HHH---HH
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch------hHH---HH
Confidence 999999999998765432 2234568999999999999999999999999999999999975532 111 11
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
......+. ... ..+..+.+++.+||+.||.+||++.|+++.|....
T Consensus 228 ~~~~~~~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 228 FTDLRDGI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHTTC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHhhccc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111111 111 23356889999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=347.20 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=206.8
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--------hHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--------RQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
.....++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999986 79999999986543 12245678899999999 89999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
+...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998654 689999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCcceecccccCCCCCChhhhhcC------CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH
Q 044232 217 SDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG------QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 217 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~ 290 (415)
+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------M 313 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------H
Confidence 9999998765432 23456799999999998643 58899999999999999999999986543221 1
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ...+..... .+ ... ..+..+.+++.+||+.||.+||++.++++
T Consensus 314 ~~~-i~~~~~~~~-~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRM-IMEGQYQFS-SP-EWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH-HHHTCCCCC-HH-HHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH-HHhCCCCCC-Cc-ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111111000 00 000 12356889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.40 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=205.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3477999999999999999999986 79999999986532 22346788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCCeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 223 (415)
|||+++|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999987765 689999999999999999999999 999999999999995 55689999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.+ ..... ..+....
T Consensus 173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~~- 241 (486)
T 3mwu_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRV-ETGKYAF- 241 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCCS-
T ss_pred ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCCCC-
Confidence 66443 22344579999999998865 59999999999999999999999987654322 11212 1221110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........+..+.+++.+||+.+|.+|||+.++++
T Consensus 242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111233567899999999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=344.14 Aligned_cols=253 Identities=23% Similarity=0.405 Sum_probs=201.7
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999987 689999999987766666789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+++++|.+++..... .+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998876432 589999999999999999999999 9999999999999999999999999997643211
Q ss_pred CcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 229 LTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
........||+.|+|||++. +..++.++||||||+++|+|++|+.|+....+.. .......... ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~- 241 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP-PT- 241 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-CC-
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC-cc-
Confidence 11123456899999999984 5678999999999999999999998887543321 1122221111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 242 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 ------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112334567899999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=352.19 Aligned_cols=258 Identities=15% Similarity=0.174 Sum_probs=206.0
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEE------ecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC---Ccceeeeee
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGT------LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK---HENLVELYG 135 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~ 135 (415)
.+++...++|++.+.||+|+||.||+|. ..+++.||+|++..... .++..|+.++..++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4445567889999999999999999994 34688999999977644 35666777777775 999999999
Q ss_pred EEEeCCeeEEEEeeccCCCHHHHhhcCCC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC----
Q 044232 136 CCVEGDHRILVYGYLENNSLAQTLLGRGH-SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---- 210 (415)
Q Consensus 136 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 210 (415)
++...+..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||++ +|+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 99999999999999999999999975321 123699999999999999999999999 9999999999999998
Q ss_pred -------CCCeEEeeeccccccCC-CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 211 -------DLTPKISDFGLAKLFPA-NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 211 -------~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999975432 2233445577999999999999999999999999999999999999887532211
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCC-CCHHHHHHHhhcCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR-PSMSTLVNMLIGEI 349 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~~ 349 (415)
. ..+..... .+ .....+.+++..|++.+|.+| |++.++.+.|...+
T Consensus 292 ~------------------~~~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 292 E------------------CKPEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp E------------------EEECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred c------------------eeechhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 00111111 11 124567789999999999999 67888888776654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=351.63 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=206.5
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC--------CcceeeeeeEEE-
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK--------HENLVELYGCCV- 138 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 138 (415)
...++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34588999999999999999999875 6889999999754 334467889999999985 888999999987
Q ss_pred ---eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---
Q 044232 139 ---EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL--- 212 (415)
Q Consensus 139 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 212 (415)
+....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 556899999999 6677776665432 26899999999999999999999863 899999999999999775
Q ss_pred ----------------------------------------------CeEEeeeccccccCCCCcceecccccCCCCCChh
Q 044232 213 ----------------------------------------------TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246 (415)
Q Consensus 213 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 246 (415)
.+||+|||++...... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 8999999999865432 23457899999999
Q ss_pred hhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhh---hHHHHHHHHHhh--------Ccc-hhhcccc-------
Q 044232 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQ---YLLEMAWKLYER--------GKL-VELVDAS------- 307 (415)
Q Consensus 247 ~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~---~~~~~~~~~~~~--------~~~-~~~~~~~------- 307 (415)
++.+..++.++|||||||++|||++|+.||......... ............ +.. ...+...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999765433211 111111111110 000 0000000
Q ss_pred ------------cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 ------------LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 011345677889999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=340.00 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=202.1
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
...++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999986 699999999976532 367889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999987432 2689999999999999999999999 999999999999999999999999999986644
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+... ...... ....
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~------ 243 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPT-NPPP------ 243 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCC------
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc-CCCc------
Confidence 322 23345689999999999998999999999999999999999988865433221 111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+...+..+.+++.+||+.||.+||++.++++
T Consensus 244 -~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 -TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112233567899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.42 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=197.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999975 7999999998653 3344567889999999999999999999997653
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999998763 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....... ..+...... ..
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~-~~ 246 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGT-PP 246 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCC-CC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCC-CC
Confidence 9865432 334678999999999887 68999999999999999999999998765432211 111111000 00
Q ss_pred hhh---------------cccc---cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VEL---------------VDAS---LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~---------------~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+. +... .........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000 000111233567889999999999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=363.96 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=207.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999987 79999999986542 2345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCCeEEeeeccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL---DKDLTPKISDFGLA 222 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla 222 (415)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999997665 689999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.. ..... ..+....
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKV-EKGKYTF 246 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCCCCC
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCCCC
Confidence 8765432 2344579999999998865 79999999999999999999999987654322 11112 2221110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00111234567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=362.78 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=201.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++++.||+|+||.||+|+.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999986 78999999987642 22346788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEeeecccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISDFGLAK 223 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 223 (415)
|||+++|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999887665 689999999999999999999999 99999999999999764 459999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......||+.|+|||++. +.++.++|||||||++|+|++|+.||....+.+ ..... ..+...
T Consensus 188 ~~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~-- 255 (494)
T 3lij_A 188 VFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKV-EKGKYT-- 255 (494)
T ss_dssp ECBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCC--
T ss_pred ECCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCCC--
Confidence 76543 2234567999999999875 569999999999999999999999987644321 11112 222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.... ....+..+.+|+.+||+.+|.+|||+.++++
T Consensus 256 ~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 1123467889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=356.56 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=194.7
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--------hHhHHHHHHHHHHHhhcCCcceeeeeeEEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--------RQGVREFLTEINVIKDIKHENLVELYGCCV 138 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 138 (415)
....++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999976 68999999987542 112235788999999999999999999975
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---CeE
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL---TPK 215 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 215 (415)
.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 456899999999999999887654 689999999999999999999999 999999999999997544 599
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~---- 354 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK---- 354 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----
Confidence 9999999876432 22345679999999999853 6788999999999999999999999875432211 11
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+..... +.. ....+..+.+++.+||+.||.+||++.|+++
T Consensus 355 ~~i~~~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 DQITSGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHTTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCC--chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111111000 000 0123467899999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=346.88 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=201.1
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe--
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVE-- 139 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 139 (415)
...+....++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344456788999999999999999999975 7899999998765332 36788999999999 89999999999987
Q ss_pred ----CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeE
Q 044232 140 ----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPK 215 (415)
Q Consensus 140 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 215 (415)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 468899999999999999998653 12688999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM 290 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~ 290 (415)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||....+...
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------ 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 242 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------
Confidence 99999998654321 1223456899999999987 56789999999999999999999988865433221
Q ss_pred HHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 291 AWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... ..... ......+..+.+++.+||+.||.+||++.++++
T Consensus 243 ~~~~~~-~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPR-NPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHH-SCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhc-Ccccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 11111 111223467899999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=375.28 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=208.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 143 (415)
...++|++++.||+|+||.||+|+.+ +++.||||++.... ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999976 68899999997542 23345678899999987 799999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
+|||||+++|+|.+++...+ .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998765 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+. +....+...
T Consensus 491 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~------ 557 (674)
T 3pfq_A 491 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH------ 557 (674)
T ss_dssp ECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSS------
T ss_pred ccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC------
Confidence 64332 22344578999999999999999999999999999999999999998764321 122222211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH-----HHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM-----STLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 343 (415)
...++...+.++.+|+.+||+.||.+||++ +||++
T Consensus 558 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 112333455788999999999999999997 77765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=334.39 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=198.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999987 79999999986542 2234578899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997764 688999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ... .....+..
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~---- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLF-KKIRGGVF---- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCC----
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH-HHhhcCcc----
Confidence 4321 2234568999999999987765 68999999999999999999888653221 111 11111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112223467889999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=341.71 Aligned_cols=256 Identities=20% Similarity=0.319 Sum_probs=189.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
+..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999975 78999999997652 2222344455566888999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||++ |+|.+++.........+++..+..++.||+.||+|||+++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 5888877653222337899999999999999999999852 8999999999999999999999999999865
Q ss_pred CCCCcceecccccCCCCCChhhh----hcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 226 PANLTHISTRVAGTEGYLAPEYA----IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... ...........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC--
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC--
Confidence 4432 22334689999999996 45678999999999999999999999986532211 11111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........+..+.+++.+||+.+|++|||+.|+++
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111233567899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.64 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=200.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEe--------C
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVE--------G 140 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 140 (415)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 67999999999999999999985 799999999865432 223567889999999999999999999987 4
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+..++||||+++ +|.+.+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 77777765432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC---cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 221 LAKLFPANL---THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 221 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
++..+.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhC
Confidence 998764321 122344678999999999876 46899999999999999999999998765432221 11111111
Q ss_pred hCcchhhccc------------ccCCCCCHH-------HHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKLVELVDA------------SLNGDYSVE-------EAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~~~~~~~------------~~~~~~~~~-------~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ....... ......... .+..+.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SI-TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CC-CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 10 0000000 000000000 1356889999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=332.88 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=200.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc----hHhHHHHHHHHHHHhhcCCcceeeeeeEEE--eCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS----RQGVREFLTEINVIKDIKHENLVELYGCCV--EGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 143 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999976 78999999997642 234467899999999999999999999984 45578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||++++ |.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 2689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC-CcceecccccCCCCCChhhhhcCC--CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 224 LFPAN-LTHISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 224 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
..... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LFE-NIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH-HHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHH-HHhcCCC
Confidence 76432 222334566899999999987654 3789999999999999999999987543221 111 1122211
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122234567889999999999999999999997
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.24 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=203.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-------------HhHHHHHHHHHHHhhcCCcceeeeee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-------------QGVREFLTEINVIKDIKHENLVELYG 135 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 135 (415)
..++|+++++||+|+||+||+|..+ ++..||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999976 688999999875421 23467889999999999999999999
Q ss_pred EEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---
Q 044232 136 CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL--- 212 (415)
Q Consensus 136 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 212 (415)
++.+....++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999997765 689999999999999999999999 999999999999998776
Q ss_pred CeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||....+.+ ...
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 69999999998765432 234467999999999876 568999999999999999999999987643321 111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ..+.... +.... ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~i-~~~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KV-EKGKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HH-HHCCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH-HcCCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 2221100 00000 122467899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.48 Aligned_cols=257 Identities=15% Similarity=0.276 Sum_probs=202.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEe--CCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVE--GDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 146 (415)
.++|++.+.||+|+||.||+|... +++.||+|++..... +.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 477999999999999999999875 789999999975443 56888999999997 9999999999987 6678999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeecccccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLF 225 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~ 225 (415)
|||+++++|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999884 478899999999999999999999 999999999999999777 8999999999866
Q ss_pred CCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH--------HHHHh
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA--------WKLYE 296 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~--------~~~~~ 296 (415)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .... .....
T Consensus 182 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHHHH
T ss_pred CCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-HHHHHhcCCchhhhHHH
Confidence 4432 2334578999999999887 679999999999999999999999986443322111 1000 00111
Q ss_pred hCcc--------------hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKL--------------VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... ................+.++.+|+.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1000 0000001111122224678999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=340.81 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=199.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec--CCC--EEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK--DGT--LAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|.+. ++. .||+|++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999864 333 6899998754 2344578899999999999999999999998765 8
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999997643 2688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .........+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC-
Confidence 76543222 2233557888999999999899999999999999999999 88887654321 12222221111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+...+..+.+++.+||+.+|.+||++.++++.|.....
T Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111223345779999999999999999999999999986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.06 Aligned_cols=258 Identities=20% Similarity=0.341 Sum_probs=203.1
Q ss_pred chhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcC--CcceeeeeeEEE
Q 044232 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIK--HENLVELYGCCV 138 (415)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 138 (415)
.++.+.+..++|++.+.||+|+||.||+|...+++.||+|++... .......+.+|+.++.+++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344455667889999999999999999999888999999998654 3445578899999999997 599999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEee
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISD 218 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 218 (415)
+.+..++||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+++ +.+||+|
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 9999999999 66889999998765 688999999999999999999999 9999999999999964 8999999
Q ss_pred eccccccCCCCcc-eecccccCCCCCChhhhhc-----------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhh
Q 044232 219 FGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIR-----------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY 286 (415)
Q Consensus 219 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~ 286 (415)
||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--- 246 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--- 246 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence 9999866433221 2234568999999999875 478899999999999999999999986543211
Q ss_pred HHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 287 LLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....... +.......+...+..+.+++.+||+.||.+||++.|+++
T Consensus 247 --~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 --SKLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --HHHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 111222222233467899999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=354.51 Aligned_cols=254 Identities=10% Similarity=0.021 Sum_probs=184.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhc--CCcceeeee-------eEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDI--KHENLVELY-------GCC 137 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 137 (415)
..+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 355888999999999999999976 78999999998753 23445677885555444 699988755 454
Q ss_pred EeC-----------------CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 044232 138 VEG-----------------DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTR------RNICIGVAKGLAFLHEEVQP 194 (415)
Q Consensus 138 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~ 194 (415)
... ...++||||++ |+|.+++...+. .+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 432 34799999998 899999986532 3445555 78889999999999999
Q ss_pred CcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhC
Q 044232 195 HIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSG 272 (415)
Q Consensus 195 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg 272 (415)
+|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999865422 224557799999999987 6799999999999999999999
Q ss_pred CcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 273 RCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 273 ~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
+.||....+..... +.....................+..+.+|+.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99988764432100 0000000000111111111244678999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=354.70 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=197.8
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-------
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE------- 139 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 139 (415)
+...++|++.+.||+|+||.||+|... +|+.||+|++..+... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999975 7999999998765322 2369999999999999999999854
Q ss_pred -------------------------------CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHH
Q 044232 140 -------------------------------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188 (415)
Q Consensus 140 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L 188 (415)
....++||||++ |+|.+.+.........+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 588777764322233789999999999999999999
Q ss_pred HhcCCCCcEecCCCCCCeeec-CCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhH
Q 044232 189 HEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLL 266 (415)
Q Consensus 189 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl 266 (415)
|+. +|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999998 68899999999998764432 23345689999999998775 589999999999999
Q ss_pred HHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh---------------cccccCCCCCHHHHHHHHHHHHHcCCcC
Q 044232 267 LEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL---------------VDASLNGDYSVEEAHRYLKIALLCTQDM 331 (415)
Q Consensus 267 ~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~ 331 (415)
|||++|+.||.......... .............+ .........+...+.++.+|+.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999987654332211 11111110000000 0000000112234567899999999999
Q ss_pred CCCCCCHHHHHH
Q 044232 332 PKRRPSMSTLVN 343 (415)
Q Consensus 332 P~~RPs~~evl~ 343 (415)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=335.82 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=205.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---------hHhHHHHHHHHHHHhhcC-CcceeeeeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---------RQGVREFLTEINVIKDIK-HENLVELYGCCV 138 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 138 (415)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999986 68999999986542 123456889999999995 999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEee
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISD 218 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 218 (415)
..+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998654 689999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhh------cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAI------RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.|+....... ...
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLR 239 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHH
Confidence 99998764432 233456899999999985 4568899999999999999999999886543211 111
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... .+... .........+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~-~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-cCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 11110 011111234577899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=372.38 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=208.9
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec----CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
..+++..++|++.+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344455678999999999999999999874 2457999998764 3344567999999999999999999999985
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeee
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDF 219 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 219 (415)
.+..++||||+++|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 4568999999999999999986532 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
|+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....+. +...... .+
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~-~~ 608 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIE-NG 608 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-HT
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-cC
Confidence 9998765443333344567889999999999999999999999999999997 88777654322 1111121 11
Q ss_pred cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. ....+..++..+.+++.+||+.||.+||++.+|++.|...+
T Consensus 609 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 11223345578999999999999999999999999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.66 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=203.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Cee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 143 (415)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999976 78899999997543 34446788999999999999999999999764 368
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||++ |+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 5899998764 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence 66433221 1234579999999998764 45899999999999999999999999776544322211 111110000
Q ss_pred h-----------hhcccc-cCCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 V-----------ELVDAS-LNGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~-----------~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ...... ..... ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000 00000 1123467889999999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=349.74 Aligned_cols=201 Identities=21% Similarity=0.303 Sum_probs=175.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc------CCcceeeeeeEEEeCCe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI------KHENLVELYGCCVEGDH 142 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 142 (415)
...+|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999999999999876 68999999997653 3345677888888877 57799999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC--eEEeeec
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT--PKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG 220 (415)
.++||||+. ++|.+++...... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 6899999876432 589999999999999999999999 9999999999999999987 9999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99754332 2346789999999999999999999999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=347.36 Aligned_cols=268 Identities=23% Similarity=0.296 Sum_probs=200.7
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc-----------hHhHHHHHHHHHHHhhcCCcceee
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS-----------RQGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
..++....++|++.+.||+|+||.||+|...++..||+|++.... ....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 356677789999999999999999999998889999999986532 223467899999999999999999
Q ss_pred eeeEEEe-----CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 044232 133 LYGCCVE-----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNIL 207 (415)
Q Consensus 133 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 207 (415)
+++++.. ....++||||++ |+|.+.+.... ..+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999854 336899999997 68888887543 2689999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhh
Q 044232 208 LDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQY 286 (415)
Q Consensus 208 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~ 286 (415)
++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999754332 22344578999999999877 679999999999999999999999987654332211
Q ss_pred HHHHHHHHHhhCcch-----------hhcccccCC-------CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 287 LLEMAWKLYERGKLV-----------ELVDASLNG-------DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 287 ~~~~~~~~~~~~~~~-----------~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
............ ..+...... ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 ---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp ---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111000 000000000 001122466889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=332.53 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=195.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE---------- 139 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 139 (415)
.++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999976 7999999999654 3445788999999999999999999998865
Q ss_pred ---CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 140 ---GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 140 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356899999999999999998653 2678899999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCC-------------cceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 217 SDFGLAKLFPANL-------------THISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 217 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
+|||++....... ........||+.|+|||++.+. .++.++|||||||++|+|+++ +..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~---- 230 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FST---- 230 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSS----
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCC----
Confidence 9999998654221 1122345689999999998764 789999999999999999983 221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... .... .......++...+..+.+++.+||+.||.+|||+.++++
T Consensus 231 -~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 -GMERVNILKK-LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHH-HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -chhHHHHHHh-cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111111 1111 111222334455577899999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=350.38 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=184.4
Q ss_pred hcCCCC-CCcccccCeEEEEEEEec---CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeE
Q 044232 71 TENFSP-ANKIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRI 144 (415)
Q Consensus 71 ~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 144 (415)
.+.|++ .++||+|+||.||+|+.+ +++.||+|++...... ..+.+|+.+|+.++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345665 458999999999999965 5788999999765322 467889999999999999999999964 67899
Q ss_pred EEEeeccCCCHHHHhhcCC-----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCCeE
Q 044232 145 LVYGYLENNSLAQTLLGRG-----HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL----DKDLTPK 215 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k 215 (415)
+||||++ |+|.+++.... .....+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 57887775321 1122589999999999999999999999 99999999999999 7778999
Q ss_pred EeeeccccccCCCCc--ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCCh-------hhh
Q 044232 216 ISDFGLAKLFPANLT--HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPY-------EEQ 285 (415)
Q Consensus 216 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~-------~~~ 285 (415)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 223456799999999999874 5899999999999999999999999754321 111
Q ss_pred hHHHHHHHHHhhCcch---hh------------cccccCCCCC---------HHHHHHHHHHHHHcCCcCCCCCCCHHHH
Q 044232 286 YLLEMAWKLYERGKLV---EL------------VDASLNGDYS---------VEEAHRYLKIALLCTQDMPKRRPSMSTL 341 (415)
Q Consensus 286 ~~~~~~~~~~~~~~~~---~~------------~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~ev 341 (415)
.+ ..+.......... .+ +......... ...+..+.+|+.+||+.||.+|||+.|+
T Consensus 253 ~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 253 QL-DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HH-HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HH-HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11 1111111100000 00 0000000000 0113567899999999999999999999
Q ss_pred HH
Q 044232 342 VN 343 (415)
Q Consensus 342 l~ 343 (415)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 97
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=345.32 Aligned_cols=264 Identities=22% Similarity=0.408 Sum_probs=203.8
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
+++.+..++|++.+.||+|+||.||+|..++ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4455667889999999999999999998764 38999987542 2233457789999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 999999999999999997653 2588999999999999999999999 999999999999998 679999999998
Q ss_pred cccCCCC----cceecccccCCCCCChhhhhc---------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH
Q 044232 223 KLFPANL----THISTRVAGTEGYLAPEYAIR---------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 223 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~ 289 (415)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~ 250 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A 250 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 7543211 112233458999999999874 35789999999999999999999888654321 1
Q ss_pred HHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
..+.. ..+...... ....+..+.+++.+||+.+|.+||++.+|++.|.......
T Consensus 251 ~~~~~-~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 IIWQM-GTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHH-HTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHh-ccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11211 112111110 1122356889999999999999999999999998776543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.44 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=198.6
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--------HhHHHHHHHHHHHhhcCCcceeeeeeEEEeC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--------QGVREFLTEINVIKDIKHENLVELYGCCVEG 140 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 140 (415)
..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999976 688999999865421 1224578899999999999999999998765
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC---eEEe
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT---PKIS 217 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 217 (415)
+ .++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999987654 689999999999999999999999 9999999999999987664 9999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ ... .
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 231 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q 231 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence 99999876432 2223456899999999974 46789999999999999999999999875433211 111 1
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+..... +.. ....+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccccC--chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111000 000 0122467889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=343.51 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=193.9
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999976 7889999998753 3344567889999999999999999999997654
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999965 78888752 478999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH------------
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE------------ 289 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~------------ 289 (415)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 12334678999999999999999999999999999999999999987643221100000
Q ss_pred ----HHHHHHhhCc------chhhcccccCCC---CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 290 ----MAWKLYERGK------LVELVDASLNGD---YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 290 ----~~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......... ....+.....+. .....+..+.+|+.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 000000000011 11234678999999999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.61 Aligned_cols=268 Identities=22% Similarity=0.265 Sum_probs=192.0
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe--
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH-- 142 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 142 (415)
......++|++.+.||+|+||.||+|... +++.||||++...... ...+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999986 7899999998654322 2456678888999999999999999976433
Q ss_pred -----eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH--hcCCCCcEecCCCCCCeeecC-CCCe
Q 044232 143 -----RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH--EEVQPHIVHRDIKASNILLDK-DLTP 214 (415)
Q Consensus 143 -----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~ 214 (415)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 555444432222336889999999999999999999 87 9999999999999997 8999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .....
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL---HEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH---HHHHH
Confidence 999999998765432 23345689999999998765 4899999999999999999999998765432211 11111
Q ss_pred HHhhC------------cchhhccc------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 LYERG------------KLVELVDA------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ~~~~~------------~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..... ......+. ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11000 00000000 0011122235678999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=336.12 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=206.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEe-c-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc------eeeeeeEEEeCC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTL-K-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN------LVELYGCCVEGD 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 141 (415)
..++|++.+.||+|+||.||+|.. . +++.||+|++.... ...+.+.+|+.+++.++|++ ++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999987 3 68899999997543 34467889999999987665 999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----------
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK----------- 210 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------- 210 (415)
..++||||+ +++|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8999999987643 2688999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 211 --------DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 211 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999864332 23457899999999999999999999999999999999999998764332
Q ss_pred hhhhHHHHHHHHHhh--------Ccchhhc---------------------cc-ccCCCCCHHHHHHHHHHHHHcCCcCC
Q 044232 283 EEQYLLEMAWKLYER--------GKLVELV---------------------DA-SLNGDYSVEEAHRYLKIALLCTQDMP 332 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~--------~~~~~~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~~P 332 (415)
+.. ......... ....... .. ..........+..+.+|+.+||+.||
T Consensus 241 ~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 EHL---AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHH---HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHH---HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 211 111111100 0000000 00 00011234567889999999999999
Q ss_pred CCCCCHHHHHH
Q 044232 333 KRRPSMSTLVN 343 (415)
Q Consensus 333 ~~RPs~~evl~ 343 (415)
.+|||+.|+++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=345.75 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=185.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------C
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG------D 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 141 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999975 7899999998653 334556788999999999999999999998754 5
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
..++|+|++ +++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 78999888653 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...... ...+.........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 9865432 334678999999999887 6899999999999999999999999876443221 1111111110000
Q ss_pred -----------hhhccccc-CCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 301 -----------VELVDASL-NGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 301 -----------~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..++.... ..... ...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00011 1124678899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=340.40 Aligned_cols=208 Identities=23% Similarity=0.312 Sum_probs=175.7
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-Cc-----ceeeeeeEE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HE-----NLVELYGCC 137 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~ 137 (415)
.......++|++.+.||+|+||+||+|... +++.||||++.... .....+..|+.++..++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 344455689999999999999999999976 68899999997543 33466778888888874 44 499999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCCCeE
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD--KDLTPK 215 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 215 (415)
...+..++||||++ |+|.+++...... .+++..+..++.||+.||.|||++ +.+|+||||||+||||+ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999995 5999999876422 588999999999999999999952 22899999999999995 577899
Q ss_pred EeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCC
Q 044232 216 ISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281 (415)
Q Consensus 216 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p 281 (415)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876432 2346789999999999999999999999999999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=332.27 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=196.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEE-----------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV----------- 138 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 138 (415)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999987 58999999998777777788999999999999999999999873
Q ss_pred ---eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCCe
Q 044232 139 ---EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTP 214 (415)
Q Consensus 139 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 214 (415)
+....++||||++ |+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 6999998643 588999999999999999999999 999999999999997 56799
Q ss_pred EEeeeccccccCCCCc--ceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 215 KISDFGLAKLFPANLT--HISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 215 kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~------ 234 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM------ 234 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 9999999986643211 12234567999999998876 67899999999999999999999998765432211
Q ss_pred HHHHhhCc-------------chhhcccccC-CCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 WKLYERGK-------------LVELVDASLN-GDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~-------------~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........ ....+..... ... ....+.++.+++.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111100 0000000000 000 1123567899999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=344.05 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=205.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHh-----------------HHHHHHHHHHHhhcCCcceeee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQG-----------------VREFLTEINVIKDIKHENLVEL 133 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 133 (415)
.++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999987542211 1678899999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCCHHHH------hhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCe
Q 044232 134 YGCCVEGDHRILVYGYLENNSLAQT------LLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNI 206 (415)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI 206 (415)
++++.+.+..++||||+++|+|.++ +.... ...+++..+..++.||+.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 54321 2378999999999999999999999 8 999999999999
Q ss_pred eecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcC-CCCc-cceEeehhHhHHHHHhCCcCCCCCCChhh
Q 044232 207 LLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTR-KADIYSFGVLLLEIVSGRCNTNRRLPYEE 284 (415)
Q Consensus 207 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvvl~elltg~~p~~~~~p~~~ 284 (415)
+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999865433 33456789999999999877 6666 99999999999999999999876544211
Q ss_pred hhHHHHHHHHHhhCcchhhccc--cc-------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 285 QYLLEMAWKLYERGKLVELVDA--SL-------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.......+......+. .. ........+..+.+++.+||+.||.+||++.|+++
T Consensus 261 ------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111222211000000 00 00001234577899999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=352.86 Aligned_cols=259 Identities=23% Similarity=0.304 Sum_probs=194.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------CeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG------DHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 144 (415)
.+|++.+.||+|+||.||+|++. +|+.||||++..... .+.+|+++|+.++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999986 699999999865432 234699999999999999999998542 2367
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeecccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAK 223 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~ 223 (415)
+||||+++ +|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 66666553222223789999999999999999999999 99999999999999965 578999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc---
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK--- 299 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~--- 299 (415)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...... +.... .......
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~-~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTREQ 280 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCSCCHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCHHH
Confidence 764332 22345789999999998765 799999999999999999999999876533221 11111 1110000
Q ss_pred -------chhhcccccCC-----CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 -------LVELVDASLNG-----DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 -------~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....-+.... .++...+.++.+|+.+||+.||.+||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000 011233577899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.21 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=201.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec--CCCEEEEEEccccch--HhHHHHHHHHHHHhhc---CCcceeeeeeEEE----
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADSR--QGVREFLTEINVIKDI---KHENLVELYGCCV---- 138 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 138 (415)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 688999999865422 1123456677777766 8999999999987
Q ss_pred -eCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEe
Q 044232 139 -EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKIS 217 (415)
Q Consensus 139 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 217 (415)
.....++||||++ |+|.+++...... .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 6999999875432 588999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 218 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..........
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCC
Confidence 99999865432 223346789999999999999999999999999999999999999876433221 1111111110
Q ss_pred Ccchhh----------ccc---ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 GKLVEL----------VDA---SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ~~~~~~----------~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...... +.. ..........+..+.+|+.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000 0000112234567889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=329.34 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 78999999986542 2345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CCeEEeeeccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD---LTPKISDFGLA 222 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla 222 (415)
||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887654 689999999999999999999999 99999999999999764 47999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ... ....+....
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILK-RVETGKYAF 241 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHHCCCCC
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHcCCCCC
Confidence 8664432 1233458899999998765 58999999999999999999999887643221 111 122221110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ... ....+.++.+++.+||+.+|.+|||+.++++
T Consensus 242 ~--~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 D--LPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C--SGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--chh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 000 1123467889999999999999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=340.85 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=201.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Cee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 143 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999976 7899999999754 334456788999999999999999999998754 678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+. ++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6899998764 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc---------eecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH
Q 044232 224 LFPANLTH---------ISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 224 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~ 293 (415)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 76432211 1223568999999998765 6789999999999999999999999876432211 111111
Q ss_pred HHhhCcc------------hhhccccc-CCCC-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 LYERGKL------------VELVDASL-NGDY-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ~~~~~~~------------~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....... .+.+.... .... ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1110000 00000000 0000 1123567889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=348.42 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=194.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------eeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD------HRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 144 (415)
..+|++.+.||+|+||.||+|+...+..||+|++...... ..+|+.+++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999876666888887654322 236999999999999999999996543 378
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCCeEEeeecccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKISDFGLAK 223 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~ 223 (415)
+||||++++. .+.+.........+++..+..++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999997754 433332111123689999999999999999999999 999999999999999 79999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch-
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV- 301 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~- 301 (415)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....... .. ...........
T Consensus 191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~-i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VE-IIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCHHH
T ss_pred cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCCHHH
Confidence 764332 22345789999999998765 5899999999999999999999998765432211 11 11111000000
Q ss_pred ------hhccccc---C-----CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 302 ------ELVDASL---N-----GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 302 ------~~~~~~~---~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
....... . ..++...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000 0 00112245678999999999999999999999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=339.83 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=197.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee----
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR---- 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 143 (415)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999976 7899999999764 334456788999999999999999999999877654
Q ss_pred --EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 144 --ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 144 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
++||||+. ++|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688887732 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ........ ..
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~-~~ 262 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGV-PG 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCC-CC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCC-Cc
Confidence 9855332 334678999999999887 689999999999999999999999987644322111 11110000 00
Q ss_pred hhh---------------cccccCCC---CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VEL---------------VDASLNGD---YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~---------------~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... +....... .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 00000000 01123567899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.94 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=202.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-----------CcceeeeeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-----------HENLVELYGCCV 138 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 138 (415)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467999999999999999999975 78999999997543 33467888999999886 899999999998
Q ss_pred eCC----eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-----
Q 044232 139 EGD----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD----- 209 (415)
Q Consensus 139 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~----- 209 (415)
..+ ..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+++ +|+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 89999999875422 5889999999999999999999953 899999999999994
Q ss_pred -CCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHH
Q 044232 210 -KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288 (415)
Q Consensus 210 -~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~ 288 (415)
.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999865432 23457899999999999999999999999999999999999998764422111111
Q ss_pred HHHHHHHh-hCcchh-----------hccc-------------------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC
Q 044232 289 EMAWKLYE-RGKLVE-----------LVDA-------------------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPS 337 (415)
Q Consensus 289 ~~~~~~~~-~~~~~~-----------~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 337 (415)
........ .+.... .++. .....++...+..+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111110 011000 0000 0112356678889999999999999999999
Q ss_pred HHHHHH
Q 044232 338 MSTLVN 343 (415)
Q Consensus 338 ~~evl~ 343 (415)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.34 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=203.2
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CC-CEEEEEEccccchHhHHHHHHHHHHHhhcCCcc------eeeeeeEEEeCC
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DG-TLAAIKVLSADSRQGVREFLTEINVIKDIKHEN------LVELYGCCVEGD 141 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 141 (415)
..++|++.+.||+|+||.||+|... ++ ..||+|++.... .....+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999975 44 689999997543 33467888999999998776 999999999999
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-------------
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILL------------- 208 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll------------- 208 (415)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777766542 2689999999999999999999999 99999999999999
Q ss_pred ------cCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCCh
Q 044232 209 ------DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPY 282 (415)
Q Consensus 209 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~ 282 (415)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 66789999999999864332 23457999999999999999999999999999999999999998764332
Q ss_pred hhhhHHHHHHHHHhh--------Ccchhhc-cc---------------------ccCCCCCHHHHHHHHHHHHHcCCcCC
Q 044232 283 EEQYLLEMAWKLYER--------GKLVELV-DA---------------------SLNGDYSVEEAHRYLKIALLCTQDMP 332 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~--------~~~~~~~-~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~P 332 (415)
... ......... ....... .. ..........+..+.+|+.+||+.||
T Consensus 246 ~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 EHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 211 111111100 0000000 00 00011223456789999999999999
Q ss_pred CCCCCHHHHHH
Q 044232 333 KRRPSMSTLVN 343 (415)
Q Consensus 333 ~~RPs~~evl~ 343 (415)
.+|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=334.95 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=193.3
Q ss_pred hHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH------hHHHHHHHHHHHhhc----CCcceeeee
Q 044232 66 DLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ------GVREFLTEINVIKDI----KHENLVELY 134 (415)
Q Consensus 66 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~ 134 (415)
......++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455688999999999999999999875 7899999999765321 223456799999998 899999999
Q ss_pred eEEEeCCeeEEEEee-ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCC
Q 044232 135 GCCVEGDHRILVYGY-LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDL 212 (415)
Q Consensus 135 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 212 (415)
+++...+..++|||+ +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 78999999998754 689999999999999999999999 999999999999999 889
Q ss_pred CeEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHH
Q 044232 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMA 291 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~ 291 (415)
.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 9999999999876443 2234568999999999987766 458999999999999999998875320
Q ss_pred HHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 292 WKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... .. ...+...+..+.+++.+||+.+|++||++.|+++
T Consensus 244 -~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -EILE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHhh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 10 1122234567889999999999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=335.61 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=176.9
Q ss_pred HhcCCCCCC-cccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCee
Q 044232 70 ATENFSPAN-KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE----GDHR 143 (415)
Q Consensus 70 ~~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 143 (415)
..++|.+.+ .||+|+||.||+|... +++.||+|++..... ..+ +....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357788865 5999999999999987 799999999865422 112 22334566799999999999976 4568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 220 (415)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999987643 2689999999999999999999999 9999999999999976 4559999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ........+
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~-- 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLG-- 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcc--
Confidence 99865432 2234568999999999988889999999999999999999999986543221100 000000000
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH--Hhhc
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN--MLIG 347 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 347 (415)
............+..+.+|+.+||+.||.+|||+.|+++ .+..
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 001111111234567899999999999999999999998 4443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=332.81 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=180.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHH-HHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEIN-VIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578999999999999999999986 78999999997653 333445666666 77788999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCC-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 147 YGYLENNSLAQTLLGRG-HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 7877775310 11226899999999999999999999852 8999999999999999999999999999865
Q ss_pred CCCCcceecccccCCCCCChhhh----hcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 226 PANLTHISTRVAGTEGYLAPEYA----IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ ... ...
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~~~ 243 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--QVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--HHh
Confidence 4332 22334689999999998 456789999999999999999999998865321100 000 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...............+..+.+++.+||+.||.+||++.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111111234567999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=338.94 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=200.6
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchH------hHHHHHHHHHHHhhcC--Ccceeeeee
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQ------GVREFLTEINVIKDIK--HENLVELYG 135 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~ 135 (415)
.......++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 334455688999999999999999999875 7899999998764211 1235667999999996 599999999
Q ss_pred EEEeCCeeEEEEeeccC-CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCC
Q 044232 136 CCVEGDHRILVYGYLEN-NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLT 213 (415)
Q Consensus 136 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 213 (415)
++...+..++|||++.+ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 89999998754 689999999999999999999999 999999999999999 7899
Q ss_pred eEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH
Q 044232 214 PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW 292 (415)
Q Consensus 214 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~ 292 (415)
+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------ 253 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 253 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------
Confidence 999999999876432 2234568999999999987765 788999999999999999998875320
Q ss_pred HHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 293 KLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.... +.. ..+...+.++.+++.+||+.||++||++.+|++
T Consensus 254 ~~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 EIIR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 110 111223467889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=336.53 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=197.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe-----
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH----- 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 142 (415)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999976 7899999998654 33445678899999999999999999999987654
Q ss_pred -eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 143 -RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 143 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 588777632 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc-
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK- 299 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~- 299 (415)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT 245 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 9864332 234578999999999887 6789999999999999999999999876443221 111111100000
Q ss_pred -------------chhhcccccC---CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 -------------LVELVDASLN---GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 -------------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....+..... .......+..+.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 1122244678999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=342.97 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=189.7
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++..+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3455568899999999987766689999999986643 24577899999876 8999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCc---cCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-------------CCe
Q 044232 151 ENNSLAQTLLGRGHSSIQ---FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-------------LTP 214 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 214 (415)
+ |+|.+++......... ..+..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999876432211 13345678999999999999999 99999999999999754 489
Q ss_pred EEeeeccccccCCCCcc---eecccccCCCCCChhhhhc-------CCCCccceEeehhHhHHHHHh-CCcCCCCCCChh
Q 044232 215 KISDFGLAKLFPANLTH---ISTRVAGTEGYLAPEYAIR-------GQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYE 283 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~ 283 (415)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999976 578999999999999999999 888886543321
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .... +... ............+.++.+++.+||+.||.+||++.+|++
T Consensus 248 ~--------~i~~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S--------NIIR-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--------HHHH-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------HHhc-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1111 1100 011112224567788999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.59 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=182.3
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-H-hHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-Q-GVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
..++|++.+.||+|+||.||+|... +++.||+|++..... . ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3577899999999999999999986 799999999976532 2 223444555678888999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||+ ++.+..+..... ..+++..+..++.||+.||.|||+ . +++||||||+||+++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 556666554422 268999999999999999999998 6 8999999999999999999999999999765
Q ss_pred CCCCcceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... +......... .
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-~ 247 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE-P 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC-C
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC-C
Confidence 4321 223456899999999984 4578899999999999999999998887532211 1112222211 1
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. . ......+.++.+++.+||+.||.+||++.++++
T Consensus 248 ~~-----~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PL-----L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC-----C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-----C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0 001123467889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.99 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=190.3
Q ss_pred HHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEE
Q 044232 68 RVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 68 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 146 (415)
.+...+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+.+..++|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3445678889999999999976655567899999998664322 345799999999 899999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----CCCeEEeeecc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-----DLTPKISDFGL 221 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl 221 (415)
|||++ |+|.+++..... .+.+..+..++.||+.||.|||++ +|+||||||+|||++. ...+||+|||+
T Consensus 97 ~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99995 699999986643 344556789999999999999999 9999999999999943 33688999999
Q ss_pred ccccCCCCc--ceecccccCCCCCChhhhh---cCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHH
Q 044232 222 AKLFPANLT--HISTRVAGTEGYLAPEYAI---RGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLY 295 (415)
Q Consensus 222 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~ 295 (415)
++....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........ . ..
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~-~~ 241 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------N-IL 241 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------H-HH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------H-HH
Confidence 987643321 2234467999999999987 4567889999999999999999 8888754322111 0 11
Q ss_pred hhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
....... ...........+.+|+.+||+.||.+|||+.+|++
T Consensus 242 ~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCcc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1110000 01112345566889999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.97 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe------CCe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE------GDH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 142 (415)
.++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999975 6899999998765 34455678999999999999999999999765 667
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCC---eEEeee
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLT---PKISDF 219 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 219 (415)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986543 22588899999999999999999999 9999999999999997765 999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC-
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG- 298 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~- 298 (415)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+........
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC----
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccc
Confidence 9998764432 2344679999999999999999999999999999999999999986532110 0000000000
Q ss_pred -------cchhhc--cc--ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHH
Q 044232 299 -------KLVELV--DA--SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMST 340 (415)
Q Consensus 299 -------~~~~~~--~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 340 (415)
.....+ .. ..........+..+.+++..||+.||.+|||+.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 00 1112344557889999999999999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=351.28 Aligned_cols=240 Identities=20% Similarity=0.321 Sum_probs=193.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEec--CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe---
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH--- 142 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 142 (415)
+..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34578999999999999999999975 6899999998654 34455678899999999999999999999987665
Q ss_pred --eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 143 --RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 143 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
.+|||||++|++|.+++.. .+++..++.|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred ceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999887643 589999999999999999999999 99999999999999986 99999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+++..... ....||+.|+|||++.++. +.++|||||||++|+|++|..|+.......
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------- 283 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------- 283 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence 99866432 3457999999999987764 899999999999999999977765321100
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-HHHHHHHhhc
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-MSTLVNMLIG 347 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L~~ 347 (415)
..........+..+.+++.+||+.||.+||+ ++++...|.+
T Consensus 284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000111223467889999999999999995 5555555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=314.54 Aligned_cols=231 Identities=12% Similarity=0.022 Sum_probs=186.0
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3477999999999999999999986 58999999997652 3445788999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||++|++|.+++... .....+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999998532 24456888999999999999999 99999999999999999999997443
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
|++| ++.++|||||||++|||++|+.||....+..... .....+.
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~ 219 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTA 219 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTT
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhc
Confidence 4443 6899999999999999999999998754432100 0000000
Q ss_pred cccC--CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 306 ASLN--GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 306 ~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.... .......+..+.+++.+||+.||.+| |+.|+++.|.....
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000 00112235678999999999999999 99999999987544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.28 Aligned_cols=227 Identities=18% Similarity=0.292 Sum_probs=179.5
Q ss_pred hcCCCCC-CcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHH-hhcCCcceeeeeeEEEe----CCee
Q 044232 71 TENFSPA-NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVI-KDIKHENLVELYGCCVE----GDHR 143 (415)
Q Consensus 71 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 143 (415)
.++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 77999999999999975 7899999998643 3466788888 55699999999999987 6788
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 220 (415)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987542 2689999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
++.... +..++.++|||||||++|||++|+.||........ . ...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~-~~~ 210 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------S-PGM 210 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------h-HHH
Confidence 986432 23467899999999999999999999865432110 0 000
Q ss_pred hhhcccccCCCCC----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYS----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+... ....+ ...+.++.+++.+||+.||.+|||+.|+++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 01111 123577899999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.48 Aligned_cols=243 Identities=13% Similarity=0.112 Sum_probs=180.7
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCC-ccee--------------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKH-ENLV-------------- 131 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv-------------- 131 (415)
...|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++..++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777889999999999999965 79999999987432 2234678899999999976 2211
Q ss_pred -e------eeeEEEe-----CCeeEEEEeeccCCCHHHHhhcC---CCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 044232 132 -E------LYGCCVE-----GDHRILVYGYLENNSLAQTLLGR---GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHI 196 (415)
Q Consensus 132 -~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 196 (415)
. +..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1 1111111 12356777765 78999888421 12233688899999999999999999999 99
Q ss_pred EecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccccCCCCCChhhh----------hcCCCCccceEeehhHhH
Q 044232 197 VHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA----------IRGQLTRKADIYSFGVLL 266 (415)
Q Consensus 197 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvvl 266 (415)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998864322 345567 999999999 445688899999999999
Q ss_pred HHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 267 LEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 267 ~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
|||++|+.||....+... ....+.. ... .+..+.+|+.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999875432211 1111111 112 2367899999999999999999888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=320.04 Aligned_cols=242 Identities=20% Similarity=0.224 Sum_probs=183.4
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccc--------hHhHHHHHHHHHHHhhcC---------Ccceee
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--------RQGVREFLTEINVIKDIK---------HENLVE 132 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 132 (415)
..++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356799999999999999999998 67999999997652 223367888999998886 666666
Q ss_pred eeeEE-----------------Ee-------------CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHH
Q 044232 133 LYGCC-----------------VE-------------GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182 (415)
Q Consensus 133 l~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~ 182 (415)
+.+++ .+ .+..++||||+++|++.+.+... .+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHH
Confidence 65553 32 67899999999999777666442 578999999999999
Q ss_pred HHHHHHH-hcCCCCcEecCCCCCCeeecCCC--------------------CeEEeeeccccccCCCCcceecccccCCC
Q 044232 183 KGLAFLH-EEVQPHIVHRDIKASNILLDKDL--------------------TPKISDFGLAKLFPANLTHISTRVAGTEG 241 (415)
Q Consensus 183 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 241 (415)
.||+||| +. +|+||||||+||||+.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999866432 3479999
Q ss_pred CCChhhhhcCCCCccceEeehhHh-HHHHHhCCcCCCCCCChhhhhHHHHHH-HHHhhCcchhhcccccCCCCCHHHHHH
Q 044232 242 YLAPEYAIRGQLTRKADIYSFGVL-LLEIVSGRCNTNRRLPYEEQYLLEMAW-KLYERGKLVELVDASLNGDYSVEEAHR 319 (415)
Q Consensus 242 y~aPE~~~~~~~~~~~DvwSlGvv-l~elltg~~p~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (415)
|+|||++.+.. +.++||||||++ .+++++|..| +.......... ........ ............+.+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHP------YSNVLWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCT------HHHHHHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCC------CcchhhhhHHHHhhhhhhcc----CcccchhhhhhcCHH
Confidence 99999998666 899999998777 6777777554 44322211111 11111100 011111123457888
Q ss_pred HHHHHHHcCCcCCCCCCCHHHHH
Q 044232 320 YLKIALLCTQDMPKRRPSMSTLV 342 (415)
Q Consensus 320 l~~li~~cl~~~P~~RPs~~evl 342 (415)
+.+|+.+||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999965 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-34 Score=290.87 Aligned_cols=185 Identities=16% Similarity=0.115 Sum_probs=132.5
Q ss_pred cccccCeEEEEEEEec-CCCEEEEEEcccc----------chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEE
Q 044232 79 KIGQGGFGSVYKGTLK-DGTLAAIKVLSAD----------SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 79 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 146 (415)
..+.|++|.+..++.. .|+.+|+|++... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4567777777666533 5888999998654 123346799999999999 799999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++|++|.++|...+ +++.. +|+.||+.||+|||++ |||||||||+||||+.+|++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998765 45543 5899999999999999 99999999999999999999999999998765
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcC
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN 275 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p 275 (415)
... ......+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 432 23445679999999998865 567889999999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=254.97 Aligned_cols=184 Identities=19% Similarity=0.207 Sum_probs=143.4
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccc--------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADS--------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
+...+.||+|+||.||+|.. .+..+++|...... ....+.+.+|+.++++++||||+++..++...+..+|
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567899999999999954 46778888754321 1123568999999999999999977777777888899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999864 457999999999999999 9999999999999998 9999999999977
Q ss_pred CCCCcce------ecccccCCCCCChhhhhc--CCCCccceEeehhHhHHHHHhCCcC
Q 044232 226 PANLTHI------STRVAGTEGYLAPEYAIR--GQLTRKADIYSFGVLLLEIVSGRCN 275 (415)
Q Consensus 226 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~p 275 (415)
....... .....||+.|+|||++.. ..|+..+|+||.++-..+-+.++.+
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 5432211 235679999999999987 5678889999998888887766543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=214.24 Aligned_cols=147 Identities=13% Similarity=0.110 Sum_probs=120.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccch------------------HhHHHHHHHHHHHhhcCCcceee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR------------------QGVREFLTEINVIKDIKHENLVE 132 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~ 132 (415)
...|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+.++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 455667799999999999999997799999999965321 13456889999999999 5 67
Q ss_pred eeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 044232 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL 212 (415)
Q Consensus 133 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 212 (415)
+.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TT
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CC
Confidence 7775544 56799999999999987 421 23457999999999999999 999999999999999 99
Q ss_pred CeEEeeeccccccCCCCcceecccccCCCCCChhhhhc
Q 044232 213 TPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250 (415)
Q Consensus 213 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 250 (415)
.+||+|||+++. +..++|||++.+
T Consensus 230 ~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 230 GIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred cEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999999999862 345789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.4e-22 Score=181.75 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=107.3
Q ss_pred CCCCCcccccCeEEEEEEEe-cCCCE--EEEEEccccchH------------------------hHHHHHHHHHHHhhcC
Q 044232 74 FSPANKIGQGGFGSVYKGTL-KDGTL--AAIKVLSADSRQ------------------------GVREFLTEINVIKDIK 126 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 126 (415)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 58888 999987543111 1135788999999998
Q ss_pred Ccce--eeeeeEEEeCCeeEEEEeeccC-C----CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCCcEe
Q 044232 127 HENL--VELYGCCVEGDHRILVYGYLEN-N----SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH-EEVQPHIVH 198 (415)
Q Consensus 127 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH 198 (415)
|+++ +.++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 344432 357899999942 4 77766532 234567889999999999999 88 9999
Q ss_pred cCCCCCCeeecCCCCeEEeeecccccc
Q 044232 199 RDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 199 ~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-19 Score=172.77 Aligned_cols=136 Identities=15% Similarity=0.193 Sum_probs=98.7
Q ss_pred CCCCCcccccCeEEEEEEEecCCCEEEEEEccccch--------------HhHHH--------HHHHHHHHhhcCCccee
Q 044232 74 FSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR--------------QGVRE--------FLTEINVIKDIKHENLV 131 (415)
Q Consensus 74 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~niv 131 (415)
|++.+.||+|++|.||+|...+|+.||||+++.... ..... ...|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 889999999999999999998999999998753210 00011 23466666666444332
Q ss_pred eeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 132 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
-..-+.. ...+|||||++|++|.++.. ......++.||+.+|.+||+. |||||||||.|||++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 2111111 22479999999988865432 123457889999999999998 99999999999999887
Q ss_pred C----------CeEEeeeccccc
Q 044232 212 L----------TPKISDFGLAKL 224 (415)
Q Consensus 212 ~----------~~kl~DfGla~~ 224 (415)
+ .+.|+||+.+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 389999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=126.92 Aligned_cols=144 Identities=13% Similarity=0.071 Sum_probs=112.9
Q ss_pred HhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEe
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 148 (415)
..+.|++...+|.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3467888888999999999999754 6789999987532122235778999999884 6778899999999889999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV------------------------------------ 192 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 192 (415)
|++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876321 1223478889999999999810
Q ss_pred --------------------CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 193 --------------------QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 193 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=9e-13 Score=120.41 Aligned_cols=136 Identities=13% Similarity=0.120 Sum_probs=99.9
Q ss_pred CCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc--eeeeeeEEEeCCeeEEEEeec
Q 044232 73 NFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN--LVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 150 (415)
++.+....+.|..+.||++...+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 344333334566699999987777889999976542 245677999999886544 566888888888899999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-------------------------------------- 192 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 192 (415)
+|.+|. .. ... ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998884 21 111 2356777888888888752
Q ss_pred -----------------CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 193 -----------------QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 193 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
...++|+|++|.|||+++++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-11 Score=117.98 Aligned_cols=142 Identities=14% Similarity=0.226 Sum_probs=106.0
Q ss_pred CCCcccccCeEEEEEEEecCCCEEEEEEcc--ccc-hHhHHHHHHHHHHHhhcC--CcceeeeeeEEEeC---CeeEEEE
Q 044232 76 PANKIGQGGFGSVYKGTLKDGTLAAIKVLS--ADS-RQGVREFLTEINVIKDIK--HENLVELYGCCVEG---DHRILVY 147 (415)
Q Consensus 76 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 147 (415)
.++.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35679999999999988765 567888776 332 122346778999999886 45688899988776 3479999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV----------------------------------- 192 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 192 (415)
||++|..+.+... ..++...+..++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987743211 14667788899999999999999731
Q ss_pred --------------------CCCcEecCCCCCCeeecCCCC--eEEeeeccccc
Q 044232 193 --------------------QPHIVHRDIKASNILLDKDLT--PKISDFGLAKL 224 (415)
Q Consensus 193 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~ 224 (415)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.4e-11 Score=114.01 Aligned_cols=182 Identities=19% Similarity=0.239 Sum_probs=120.9
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC-Ccc--eeeeeeEEEeCC---eeEEEEeec
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HEN--LVELYGCCVEGD---HRILVYGYL 150 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 150 (415)
++.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4678999999999854 34788886543 33467888999998873 332 445555543333 348899999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE--------------------------------------- 191 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 191 (415)
+|.+|.+.... .++...+..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99988754321 356677788888888888888861
Q ss_pred ----------------CCCCcEecCCCCCCeeecC--CCCeEEeeeccccccCCCCcceecccccCCCC---CChhhhhc
Q 044232 192 ----------------VQPHIVHRDIKASNILLDK--DLTPKISDFGLAKLFPANLTHISTRVAGTEGY---LAPEYAIR 250 (415)
Q Consensus 192 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 250 (415)
..+.++|+|++|.||++++ +..+.|+||+.+..-..... ......+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHH
Confidence 1235799999999999998 45688999998875422110 0011111 23332211
Q ss_pred -----CCC---------CccceEeehhHhHHHHHhCCcC
Q 044232 251 -----GQL---------TRKADIYSFGVLLLEIVSGRCN 275 (415)
Q Consensus 251 -----~~~---------~~~~DvwSlGvvl~elltg~~p 275 (415)
+.. ....+.|++|.++|.+.+|..+
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence 111 1235889999999999998543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=4.3e-08 Score=89.89 Aligned_cols=135 Identities=17% Similarity=0.121 Sum_probs=98.4
Q ss_pred cccccCeE-EEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEEeeccCCCH
Q 044232 79 KIGQGGFG-SVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVYGYLENNSL 155 (415)
Q Consensus 79 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 155 (415)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555555 68987765 5667888986543 2356778999998874 33477889999999999999999999988
Q ss_pred HHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 044232 156 AQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE-------------------------------------------- 191 (415)
Q Consensus 156 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 191 (415)
.+..... ......++.+++..|..||..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765322 123345666777777777742
Q ss_pred -----------CCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 192 -----------VQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 192 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.2e-07 Score=88.81 Aligned_cols=136 Identities=15% Similarity=0.195 Sum_probs=94.7
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc---ceeeeeeEEE-eCCeeEEEEeeccC
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE---NLVELYGCCV-EGDHRILVYGYLEN 152 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 152 (415)
++.++.|....||+. +..+++|+... ......+.+|+.+|+.+.+. .+.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999987 45578887532 23346788999999999652 3666777764 34567899999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE----------------------------------------- 191 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 191 (415)
..|.+.... .++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888763221 234444555555555555555542
Q ss_pred ----------------CCCCcEecCCCCCCeeecC---CCC-eEEeeeccccc
Q 044232 192 ----------------VQPHIVHRDIKASNILLDK---DLT-PKISDFGLAKL 224 (415)
Q Consensus 192 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~ 224 (415)
..+.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-07 Score=90.20 Aligned_cols=79 Identities=11% Similarity=0.045 Sum_probs=54.9
Q ss_pred Ccc-cccCeEEEEEEEec-------CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCC---cceeeeeeEEEeC---
Q 044232 78 NKI-GQGGFGSVYKGTLK-------DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKH---ENLVELYGCCVEG--- 140 (415)
Q Consensus 78 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 140 (415)
+.| +.|..+.+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998764 25678888865432 0011346678888888742 3577788887655
Q ss_pred CeeEEEEeeccCCCHH
Q 044232 141 DHRILVYGYLENNSLA 156 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~ 156 (415)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1e-06 Score=85.40 Aligned_cols=75 Identities=12% Similarity=0.116 Sum_probs=49.8
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccccch-------HhHHHHHHHHHHHhhcCC--c-ceeeeeeEEEeCCeeEE
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-------QGVREFLTEINVIKDIKH--E-NLVELYGCCVEGDHRIL 145 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 145 (415)
.+.||.|..+.||++... +++.+++|....... ....++..|..+|+.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999765 567899997653211 122356678888887742 3 34456644 3456789
Q ss_pred EEeeccCC
Q 044232 146 VYGYLENN 153 (415)
Q Consensus 146 v~e~~~~g 153 (415)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=3.2e-06 Score=79.88 Aligned_cols=141 Identities=16% Similarity=0.222 Sum_probs=79.6
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC--cceeeeee------EEEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH--ENLVELYG------CCVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 149 (415)
+.|+.|..+.||+....+|. +++|+.... . ..+..|+.+++.+.. -.+.+++. +....+..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 45666778999999876554 888988753 2 223345555555421 12334443 12346678999999
Q ss_pred ccCCCHH--------------HHhhcC--CC--C-C-----CccCHHHH-------------------------------
Q 044232 150 LENNSLA--------------QTLLGR--GH--S-S-----IQFNWQTR------------------------------- 174 (415)
Q Consensus 150 ~~~gsL~--------------~~l~~~--~~--~-~-----~~l~~~~~------------------------------- 174 (415)
++|..+. ..++.. .. . . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111111 00 0 0 00122110
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 175 RNICIGVAKGLAFLHE----------EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 175 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
..+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345666653 123489999999999999888899999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.12 E-value=8.1e-06 Score=75.40 Aligned_cols=80 Identities=18% Similarity=0.194 Sum_probs=57.7
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc---ceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE---NLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 148 (415)
.....++.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.+.-. -+++++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 445556789999999999999999999999987654333334577899998887421 345555542 3478999
Q ss_pred eccCCCH
Q 044232 149 YLENNSL 155 (415)
Q Consensus 149 ~~~~gsL 155 (415)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.1e-05 Score=72.34 Aligned_cols=139 Identities=15% Similarity=0.135 Sum_probs=91.8
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC---CcceeeeeeEEEeCCeeEEEEeeccCC
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK---HENLVELYGCCVEGDHRILVYGYLENN 153 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 153 (415)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.+. ...+++++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35789999999999886 4567888987543 2356788999998883 357888999888888899999999987
Q ss_pred CHH-----------HHhhcCCC-CC-----------------CccCHHHHH---HHH----------------HHHHHHH
Q 044232 154 SLA-----------QTLLGRGH-SS-----------------IQFNWQTRR---NIC----------------IGVAKGL 185 (415)
Q Consensus 154 sL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~~i~~~L 185 (415)
.+. ..|+.... .. ..-+|.... ++. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 642 12232221 00 011343221 111 1111122
Q ss_pred -HHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 186 -AFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 186 -~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
..|.. ..++.++|+|+.+.|++++.++ +.|+|++
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2256899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.5e-05 Score=76.28 Aligned_cols=78 Identities=13% Similarity=0.161 Sum_probs=46.8
Q ss_pred CCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcceecccc-cCCCCCChhhhhcC---CCCccceEeehhHhHHHH
Q 044232 194 PHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVA-GTEGYLAPEYAIRG---QLTRKADIYSFGVLLLEI 269 (415)
Q Consensus 194 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~el 269 (415)
..++|+|++|.|||++.++ ++|+||+.+..-+.... ...... -...|++|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 99999998874322111 000000 01235555544311 111234555777888887
Q ss_pred HhCC
Q 044232 270 VSGR 273 (415)
Q Consensus 270 ltg~ 273 (415)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.77 E-value=3.2e-05 Score=75.73 Aligned_cols=73 Identities=15% Similarity=0.216 Sum_probs=49.7
Q ss_pred CCcccccCeEEEEEEEecC--------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEE
Q 044232 77 ANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVY 147 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 147 (415)
++.|+.|....||++...+ +..+++|+...... ...+.+|+.++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578889999999998653 47889998854211 1345578888888853333 566765532 3899
Q ss_pred eeccCCCH
Q 044232 148 GYLENNSL 155 (415)
Q Consensus 148 e~~~~gsL 155 (415)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.3e-05 Score=69.81 Aligned_cols=139 Identities=14% Similarity=0.166 Sum_probs=75.4
Q ss_pred CCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeec-cCCC
Q 044232 77 ANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYL-ENNS 154 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 154 (415)
++.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++++ +.+.-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 447888876542211 122457777777643222 455554 344457899999 6654
Q ss_pred HHH------------------HhhcCCC-CCCccC-HHHHHHHHHH--------------HHHHHH----HHHh-cCCCC
Q 044232 155 LAQ------------------TLLGRGH-SSIQFN-WQTRRNICIG--------------VAKGLA----FLHE-EVQPH 195 (415)
Q Consensus 155 L~~------------------~l~~~~~-~~~~l~-~~~~~~i~~~--------------i~~~L~----~LH~-~~~~~ 195 (415)
|.. .++.... ...... +.....+... +...+. .+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 0111110 000011 1111111110 111111 1111 12335
Q ss_pred cEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 196 IVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 196 ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=67.79 Aligned_cols=143 Identities=15% Similarity=0.129 Sum_probs=73.0
Q ss_pred CcccccCeEE-EEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCCeeEEEEeeccCCC
Q 044232 78 NKIGQGGFGS-VYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH--ENLVELYGCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 78 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 154 (415)
+.|+.|+... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665555 6677654466777776544321 123346666666632 2355666653322 378999998777
Q ss_pred HHHHhhcCC---------------------CCC-CccCHHHHH-------HHH-------------HHHHHHHHHHHh--
Q 044232 155 LAQTLLGRG---------------------HSS-IQFNWQTRR-------NIC-------------IGVAKGLAFLHE-- 190 (415)
Q Consensus 155 L~~~l~~~~---------------------~~~-~~l~~~~~~-------~i~-------------~~i~~~L~~LH~-- 190 (415)
+.+.+.... ... ..+...... .+. ..+...+..+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654442210 000 011111100 000 011122222211
Q ss_pred -cCCCCcEecCCCCCCeeecCC----CCeEEeeecccccc
Q 044232 191 -EVQPHIVHRDIKASNILLDKD----LTPKISDFGLAKLF 225 (415)
Q Consensus 191 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~~ 225 (415)
.....++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999875 68999999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=8e-05 Score=71.48 Aligned_cols=142 Identities=18% Similarity=0.199 Sum_probs=83.6
Q ss_pred CCcccccCeEEEEEEEec--------CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCeeEEEE
Q 044232 77 ANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 147 (415)
++.|..|-...+|++... ++..+++|+..... .......+|..+++.+. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 467888889999999864 24788999864321 22345568999988874 2223566666543 2899
Q ss_pred eeccCCCHHHH-----------------hhcCCC-CCCcc--CHHHHHHHHHHHHH-------------------HHHHH
Q 044232 148 GYLENNSLAQT-----------------LLGRGH-SSIQF--NWQTRRNICIGVAK-------------------GLAFL 188 (415)
Q Consensus 148 e~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------~L~~L 188 (415)
||++|..|... |+.... ..... .+.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 111111 01111 24555556544422 23333
Q ss_pred Hh----c-CCCCcEecCCCCCCeeecCC----CCeEEeeecccc
Q 044232 189 HE----E-VQPHIVHRDIKASNILLDKD----LTPKISDFGLAK 223 (415)
Q Consensus 189 H~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~ 223 (415)
.+ . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 1 13368999999999999876 789999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00011 Score=64.04 Aligned_cols=102 Identities=18% Similarity=0.145 Sum_probs=67.1
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
-+|.+.|...+. ++++.+++.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 479999987764 8999999999999999988762210 111233457899999999998864 1110
Q ss_pred ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc
Q 044232 233 STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC 274 (415)
Q Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 274 (415)
.....+.|||... ...+.+.=|||||+++|.-+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122366888653 345678889999999999886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.60 E-value=9.4e-05 Score=72.86 Aligned_cols=74 Identities=11% Similarity=0.075 Sum_probs=47.5
Q ss_pred CCcccccCeEEEEEEEecC-CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEeeccCCC
Q 044232 77 ANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 154 (415)
++.|+.|-...+|++...+ +..+++|+......... .-.+|..++..+...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888899999998765 46788888754321111 11468888888864444 56777663 2 35999998755
Q ss_pred H
Q 044232 155 L 155 (415)
Q Consensus 155 L 155 (415)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00018 Score=67.16 Aligned_cols=143 Identities=10% Similarity=0.123 Sum_probs=78.9
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc--eeeeeeE------EEeCCeeEEEEee
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN--LVELYGC------CVEGDHRILVYGY 149 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~ 149 (415)
+.|+.|....+|+....+| .+++|+...... ...+..|+.++..+.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987666 477888765311 123445777777663212 3333321 1234567899999
Q ss_pred ccCCCHHH--------------HhhcC----CCCC---Cc-cCHHHHHH------------HHHHHHHHHHHHHhc----
Q 044232 150 LENNSLAQ--------------TLLGR----GHSS---IQ-FNWQTRRN------------ICIGVAKGLAFLHEE---- 191 (415)
Q Consensus 150 ~~~gsL~~--------------~l~~~----~~~~---~~-l~~~~~~~------------i~~~i~~~L~~LH~~---- 191 (415)
++|..+.. .++.. .... .. ..|..... +...+...++.+...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865311 11111 1000 00 11222100 001234455555532
Q ss_pred CCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 192 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
...+++|+|+++.|||+++++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13479999999999999987666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00042 Score=64.84 Aligned_cols=143 Identities=14% Similarity=0.122 Sum_probs=80.3
Q ss_pred CcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCc--ceeeeeeE-----EEeCCeeEEEEeec
Q 044232 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHE--NLVELYGC-----CVEGDHRILVYGYL 150 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 150 (415)
..|+ |....||+....+|+.+++|+...... ....+..|..++..+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 888899998877777789999864311 124555688877777422 24444443 22345668899999
Q ss_pred cCCCHH-----H------H---hhc----CCC-CCCccCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 044232 151 ENNSLA-----Q------T---LLG----RGH-SSIQFNWQTR----RNI---------------CIGVAKGLAFLHEE- 191 (415)
Q Consensus 151 ~~gsL~-----~------~---l~~----~~~-~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~- 191 (415)
+|..+. . . ++. ... ....+.+... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885432 0 0 111 110 0011221110 000 11111223333221
Q ss_pred ---CCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 192 ---VQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 192 ---~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233689999999999999 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00012 Score=70.11 Aligned_cols=73 Identities=15% Similarity=0.176 Sum_probs=44.4
Q ss_pred CcccccCeEEEEEEEecC---------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCCeeEEEE
Q 044232 78 NKIGQGGFGSVYKGTLKD---------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN-LVELYGCCVEGDHRILVY 147 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 147 (415)
+.|+.|....+|+....+ +..+++|+........ .....|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888889999998653 2678899876542221 12346888888774333 44666543 2 36899
Q ss_pred eeccCCCH
Q 044232 148 GYLENNSL 155 (415)
Q Consensus 148 e~~~~gsL 155 (415)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00036 Score=65.94 Aligned_cols=68 Identities=10% Similarity=0.116 Sum_probs=43.9
Q ss_pred cccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC---CcceeeeeeE------EEeCCeeEEEEeecc
Q 044232 81 GQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK---HENLVELYGC------CVEGDHRILVYGYLE 151 (415)
Q Consensus 81 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 151 (415)
|.|....||+....+| .+++|+...... ..|+.++..|. -|++++++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999987777 889998765432 24555555552 2224454432 234567899999999
Q ss_pred CCCH
Q 044232 152 NNSL 155 (415)
Q Consensus 152 ~gsL 155 (415)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0034 Score=60.95 Aligned_cols=142 Identities=9% Similarity=0.100 Sum_probs=84.7
Q ss_pred CCcccccCeEEEEEEEecC--------CCEEEEEEccccchHhHHHHHHHHHHHhhcCC-cceeeeeeEEEeCCeeEEEE
Q 044232 77 ANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADSRQGVREFLTEINVIKDIKH-ENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 147 (415)
++.|..|-...+|+....+ +..+++++........ -...+|..+++.+.- .-..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567888889999998753 5778999875432211 122468888877742 2245555533 2 37899
Q ss_pred eeccCCCHHH--------------H---hhcC-------CC--CCCccCHHHHHHHHHHH-------------------H
Q 044232 148 GYLENNSLAQ--------------T---LLGR-------GH--SSIQFNWQTRRNICIGV-------------------A 182 (415)
Q Consensus 148 e~~~~gsL~~--------------~---l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~ 182 (415)
||++|..|.. . ++.. .. ...+..|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0 1110 00 11122355555544332 2
Q ss_pred HHHHHHHhc---------------------CCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 183 KGLAFLHEE---------------------VQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 183 ~~L~~LH~~---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
..+..|.+. ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236899999999999 8888999999988763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.029 Score=53.98 Aligned_cols=30 Identities=27% Similarity=0.409 Sum_probs=25.0
Q ss_pred CcEecCCCCCCeee------cCCCCeEEeeeccccc
Q 044232 195 HIVHRDIKASNILL------DKDLTPKISDFGLAKL 224 (415)
Q Consensus 195 ~ivH~Dlkp~NIll------~~~~~~kl~DfGla~~ 224 (415)
.++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999988863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.68 E-value=0.032 Score=54.82 Aligned_cols=62 Identities=6% Similarity=0.091 Sum_probs=19.5
Q ss_pred CCCCcccccCeEEEEEEEecC-CCEEEE------EEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 75 SPANKIGQGGFGSVYKGTLKD-GTLAAI------KVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
.+.+.|| ||.||+|.+.. ..+||+ |..... ..+....|.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4457787 99999999864 467888 666543 22334568889999999999999999988653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.80 E-value=0.96 Score=39.20 Aligned_cols=85 Identities=11% Similarity=0.063 Sum_probs=60.7
Q ss_pred CCcceeeeeeEEEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHH-HHHhcCCCCcEecCCCCC
Q 044232 126 KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA-FLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 126 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~ 204 (415)
.||++ -..+-.+.+.+.+.++.-+++.=...+. .++...+++++.+|+.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 67777 3444466777777777654443333443 4677888888888877666 454 4588899999
Q ss_pred CeeecCCCCeEEeeeccccc
Q 044232 205 NILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~ 224 (415)
||++|.++.++|.-.|+-..
T Consensus 114 NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GEEECTTCCEEESCCEETTT
T ss_pred eEEEeCCCcEEEEEcCCccc
Confidence 99999999999987776543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.62 E-value=0.5 Score=40.88 Aligned_cols=85 Identities=9% Similarity=0.120 Sum_probs=61.9
Q ss_pred CCcceeeeeeEEEeCCeeEEEEeeccCC-CHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 126 KHENLVELYGCCVEGDHRILVYGYLENN-SLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 126 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. +. .++...+++++.+|+....+++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888866 5666667666666654422 3322 32 56778899999999887766654 388899999
Q ss_pred CeeecCCCCeEEeeeccccc
Q 044232 205 NILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~ 224 (415)
||+++.++.+++.=.|+-..
T Consensus 109 NL~f~~~~~p~i~~RGik~~ 128 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV 128 (215)
T ss_dssp GEEECTTSCEEESCCEETTT
T ss_pred eEEEcCCCCEEEEEccCccC
Confidence 99999999999987776543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 415 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-68 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 1e-70
Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 26/280 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVL--SADSRQGVREFLTEINVIKDIKHEN 129
+ +IG G FG+VYKG A+K+L +A + Q ++ F E+ V++ +H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
++ G +V + E +SL L +F +I A+G+ +LH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP-ANLTHISTRVAGTEGYLAPEYA 248
I+HRD+K++NI L +DLT KI DFGLA + + +H +++G+ ++APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 249 ---IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ + ++D+Y+FG++L E+++G +LPY + + RG L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ C + RP ++ +
Sbjct: 233 -----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 6e-70
Identities = 83/274 (30%), Positives = 134/274 (48%), Gaps = 22/274 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
E ++G G FG V+ G T A+K L S FL E N++K ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
LY + + ++ Y+EN SL L + S I+ ++ +A+G+AF+ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+ +HRD++A+NIL+ L+ KI+DFGLA+L N + APE G
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
T K+D++SFG+LL EIV T+ R+PY E+ L ++V +
Sbjct: 186 TFTIKSDVWSFGILLTEIV-----THGRIPYPGMTNPEVIQNLERGYRMVRPDNCP---- 236
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
EE + ++ LC ++ P+ RP+ L ++L
Sbjct: 237 ---EELY---QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
++ + ++G G FG V G + AIK++ S EF+ E V+ ++ HE LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LYG C + ++ Y+ N L L H +F Q +C V + + +L
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+HRD+ A N L++ K+SDFGL++ + S + PE +
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
+ + K+DI++FGVL+ EI + ++PYE E A + + +L AS
Sbjct: 177 KFSSKSDIWAFGVLMWEIY-----SLGKMPYERFTNSETAEHIAQGLRLYRPHLAS---- 227
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+ I C + RP+ L++ ++
Sbjct: 228 ------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 23/289 (7%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
E+ K+GQG FG V+ GT T AIK L + FL E V+K ++HE LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LY + +V Y+ SL +G + ++ +A G+A++
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
+ + VHRD++A+NIL+ ++L K++DFGLA+L N + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
+ T K+D++SFG+LL E+ T R+PY E +++ V+
Sbjct: 190 RFTIKSDVWSFGILLTELT-----TKGRVPYPGMVNRE----------VLDQVERGYRMP 234
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVNKEEISKPG 360
E + C + P+ RP+ L L + + E +PG
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL-EDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-67
Identities = 73/274 (26%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
+ +IG G FG V+ G + AIK + + +F+ E V+ + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
+LYG C+E LV+ ++E+ L+ L + F +T +C+ V +G+A+L E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE- 119
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
++HRD+ A N L+ ++ K+SDFG+ + + ST + +PE
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 252 QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311
+ + K+D++SFGVL+ E+ S ++PYE + E+ + +L + AS
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSE-----GKIPYENRSNSEVVEDISTGFRLYKPRLAS---- 228
Query: 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+I C ++ P+ RP+ S L+ L
Sbjct: 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 2e-66
Identities = 70/302 (23%), Positives = 128/302 (42%), Gaps = 39/302 (12%)
Query: 62 YGYKDLRVATENFSPA---------NKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD- 107
+ ++D A F+ IG G FG V G LK AIK L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 108 SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSI 167
+ + R+FL+E +++ H N++ L G + +++ ++EN SL L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 168 QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227
QF + G+A G+ +L + VHRD+ A NIL++ +L K+SDFGL++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 228 NLTHISTRVA----GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
+ + + A + APE + T +D++S+G+++ E++ + PY
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM-----SYGERPYW 235
Query: 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ ++ + + +L ++ ++ L C Q RP +VN
Sbjct: 236 DMTNQDVINAIEQDYRL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 344 ML 345
L
Sbjct: 286 TL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 3e-66
Identities = 66/283 (23%), Positives = 122/283 (43%), Gaps = 22/283 (7%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVI 122
Y + + + +K+G G +G VY+G K A+K L D+ + V EFL E V+
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 123 KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
K+IKH NLV+L G C ++ ++ +L L + + + ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQIS 125
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
+ +L + + +HRD+ A N L+ ++ K++DFGL++L + +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
APE + + K+D+++FGVLL EI + PY + ++ E
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATY-----GMSPYPGI----------DLSQVYE 227
Query: 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
L++ + + ++ C Q P RPS + +
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-65
Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 41/332 (12%)
Query: 67 LRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVIKD 124
+ + ++F +++G G G V+K + K G + A K++ + + +R + E+ V+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+V YG + +++ SL Q L G Q + I V KG
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKG 116
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
L +L E + I+HRD+K SNIL++ K+ DFG++ ++ GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMS 171
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGR-----------------------CNTNRRLP 281
PE + ++DI+S G+ L+E+ GR T R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIAL----LCTQDMPKRRPS 337
+ L + EL+D +N + + C P R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 338 MSTLVNM-LIGEIDVNKEEISKPGLLSDLLGL 368
+ L+ I D EE+ G L +GL
Sbjct: 292 LKQLMVHAFIKRSD--AEEVDFAGWLCSTIGL 321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-63
Identities = 68/288 (23%), Positives = 126/288 (43%), Gaps = 29/288 (10%)
Query: 65 KDLRVATENFSPAN-KIGQGGFGSVYKGTLK---DGTLAAIKVLSADSRQG-VREFLTEI 119
K L + +N A+ ++G G FGSV +G + AIKVL + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 120 NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
++ + + +V L G C + + +LV L + L+G+ + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--VA 237
V+ G+ +L + + VHRD+ A N+LL KISDFGL+K A+ ++ + R
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 238 GTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297
+ APE + + ++D++S+GV + E + + + PY++ E+ + E+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL-----SYGQKPYKKMKGPEVMAFI-EQ 227
Query: 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
GK +E + E + C + RP T+ +
Sbjct: 228 GKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 7e-63
Identities = 85/305 (27%), Positives = 138/305 (45%), Gaps = 35/305 (11%)
Query: 50 NEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLS 105
N ++ + + G L V +F+ IG+G FG VY GTL D A+K L+
Sbjct: 10 NPELVQAVQHVVIGPSSLIV---HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 106 ADSRQG-VREFLTEINVIKDIKHENLVELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRG 163
+ G V +FLTE ++KD H N++ L G C+ + +V Y+++ L +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 164 HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223
H + + VAKG+ FL VHRD+ A N +LD+ T K++DFGLA+
Sbjct: 125 H---NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 224 LFP---ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRL 280
+ H T ++A E + T K+D++SFGVLL E+++
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-----GAP 233
Query: 281 PYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMST 340
PY + ++ L + +L L +Y + + + L C + RPS S
Sbjct: 234 PYPDVNTFDITVYLLQGRRL-------LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSE 283
Query: 341 LVNML 345
LV+ +
Sbjct: 284 LVSRI 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-62
Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 28/275 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLV 131
+ IG+G FG V G + G A+K + D+ + FL E +V+ ++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 132 ELYGCCVEGDHRI-LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
+L G VE + +V Y+ SL L RG S + V + + +L
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLE- 120
Query: 191 EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
+ VHRD+ A N+L+ +D K+SDFGL K + + APE
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ + K+D++SFG+LL EI + R+PY L ++ ++ E+G ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIY-----SFGRVPYPRIPLKDVVPRV-EKGYKMDAPD----- 223
Query: 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ C RPS L L
Sbjct: 224 GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 68/285 (23%), Positives = 129/285 (45%), Gaps = 29/285 (10%)
Query: 69 VATENFSPANKIGQGGFGSVYKGTLKDGT-----LAAIKVLSADSRQGVR-EFLTEINVI 122
+ + IG G FG VYKG LK + AIK L A + R +FL E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 123 KDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
H N++ L G + +++ Y+EN +L + L + +F+ + G+A
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIA 120
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN--LTHISTRVAGTE 240
G+ +L + VHRD+ A NIL++ +L K+SDFGL+++ + T+ ++
Sbjct: 121 AGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
+ APE + T +D++SFG+++ E+++ L E +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------V 222
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ ++ ++ ++ + C Q RRP + +V++L
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 3e-62
Identities = 66/310 (21%), Positives = 125/310 (40%), Gaps = 46/310 (14%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVR-EFL 116
L N IG+G FG V++ T+ A+K+L ++ ++ +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 117 TEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSI--------- 167
E ++ + + N+V+L G C G L++ Y+ L + L ++
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 168 -----------QFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216
+ + I VA G+A+L E VHRD+ N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 217 SDFGLAK-LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN 275
+DFGL++ ++ A+ A ++ PE + T ++D++++GV+L EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY--- 238
Query: 276 TNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRR 335
PY E+ + + G ++ + + LC +P R
Sbjct: 239 --GLQPYYGMAHEEVIYYV-RDGNILACPE---------NCPLELYNLMRLCWSKLPADR 286
Query: 336 PSMSTLVNML 345
PS ++ +L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-62
Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 30/290 (10%)
Query: 79 KIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCV 138
IG+G FG V++G + G A+K+ S+ + EI ++HEN++
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 139 EGD----HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-- 192
+ + LV Y E+ SL L + + + A GLA LH E+
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 193 ---QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS---TRVAGTEGYLAPE 246
+P I HRD+K+ NIL+ K+ T I+D GLA + I GT+ Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 247 Y------AIRGQLTRKADIYSFGVLLLEIVSGR----CNTNRRLPYEEQYLLEMAWKLYE 296
+ ++ADIY+ G++ EI + + +LPY + + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 297 RGKLVELVDASLNGDYSVEEAHRYL-KIALLCTQDMPKRRPSMSTLVNML 345
+ + + ++ + EA R + KI C R + + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-61
Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 78 NKIGQGGFGSVYKGTLKD---GTLAAIKVLSADSRQG--VREFLTEINVIKDIKHENLVE 132
++G G FG+V KG + A+K+L ++ E L E NV++ + + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 133 LYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV 192
+ G C E + +LV E L + L H + + V+ G+ +L
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE--- 124
Query: 193 QPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTR--VAGTEGYLAPEYAIR 250
+ + VHRD+ A N+LL KISDFGL+K A+ + + + APE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ + K+D++SFGVL+ E + + PY E+ L E+G+ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAF-----SYGQKPYRGMKGSEVTAML-EKGERMGCPA----- 233
Query: 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
E + LC + RP + + L
Sbjct: 234 GCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 1e-60
Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG---VREFLTEINVIKDIK 126
+ FS +IG G FG+VY +++ + AIK +S +Q ++ + E+ ++ ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H N ++ GC + LV Y ++ + + + G +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+LH +++HRD+KA NILL + K+ DFG A + + GT ++APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPE 181
Query: 247 YAI---RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303
+ GQ K D++S G+ +E+ + P + + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNESP--- 232
Query: 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+L + E ++ C Q +P+ RP+ L+
Sbjct: 233 ---ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 69/274 (25%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 78 NKIGQGGFGSVYKGTLKD-GTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELY 134
+IG+G F +VYKG + A L ++ + F E ++K ++H N+V Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 135 GCCVE----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
+LV + + +L L + R+ C + KGL FLH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT 130
Query: 191 EVQPHIVHRDIKASNILL-DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
P I+HRD+K NI + + KI D GLA L A+ V GT ++APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-Y 185
Query: 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309
+ D+Y+FG+ +LE+ + PY E ++ G D
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFD---- 235
Query: 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
++ E I C + R S+ L+N
Sbjct: 236 -KVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-59
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 24/279 (8%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHE 128
E++ IG G +G K K DG + K L S + ++E+N+++++KH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 129 NLVELYGCCVEGDHRIL--VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
N+V Y ++ + L V Y E LA + + + + + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 187 FLHE--EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
H + ++HRD+K +N+ LD K+ DFGLA++ + T + GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 245 PEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
PE R K+DI+S G LL E+ + P+ E+A K+ GK +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKELAGKI-REGKFRRIP 235
Query: 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
YS E +I RPS+ ++
Sbjct: 236 Y-----RYSDE----LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-59
Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 37/297 (12%)
Query: 59 TNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSAD---SRQG 111
T L G KDLR+ K+G G FG V +G A+K L D +
Sbjct: 2 TCLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 54
Query: 112 VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNW 171
+ +F+ E+N + + H NL+ LYG + ++ V SL L F
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLL 110
Query: 172 QTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231
T + VA+G+ +L +HRD+ A N+LL KI DFGL + P N H
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 232 --ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289
+ + APE + +D + FGV L E+ T + P+ +
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF-----TYGQEPWIGLNGSQ 222
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
+ K+ + G+ + + D + + + C P+ RP+ L + L+
Sbjct: 223 ILHKIDKEGERLPRPE-----DCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-59
Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 40/301 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQGVRE-FLTEINVIKD 124
S +G G FG V + T A+K+L + RE ++E+ V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 125 IK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS--------------SIQF 169
+ H N+V L G C G +++ Y L L + S +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 170 NWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229
+ + + VAKG+AFL + + +HRD+ A NILL KI DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 230 TH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288
+ + ++APE T ++D++S+G+ L E+ S + +P + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 289 EMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348
+++ I C P +RP+ +V ++ +
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 349 I 349
I
Sbjct: 306 I 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 71/302 (23%), Positives = 111/302 (36%), Gaps = 45/302 (14%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD------GTLAAIKVLSADSRQGVRE-FLTEINVIKD 124
EN +G G FG V T A+K+L + RE ++E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 125 I-KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ--------------- 168
+ HEN+V L G C L++ Y L L + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 169 ----FNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224
++ VAKG+ FL VHRD+ A N+L+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 225 FPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
++ + + ++APE G T K+D++S+G+LL EI + PY
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF-----SLGVNPYP 268
Query: 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ +KL + G D I C ++RPS L +
Sbjct: 269 GIPVDANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 344 ML 345
L
Sbjct: 320 FL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-58
Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTL---AAIKVLSAD-SRQGVREFLTEINVIKDI-K 126
+ + IG+G FG V K +K L AAIK + S+ R+F E+ V+ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTR 174
H N++ L G C + L Y + +L L ++ + Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 175 RNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIST 234
+ VA+G+ +L Q +HRD+ A NIL+ ++ KI+DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
++A E T +D++S+GVLL EIVS PY E+ KL
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTCAELYEKL 239
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ +L + ++ +E + + C ++ P RPS + ++ L
Sbjct: 240 PQGYRLEKPLNCD-------DEVY---DLMRQCWREKPYERPSFAQILVSL 280
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 30/287 (10%)
Query: 67 LRVATEN-FSPANKIGQGGFGSVYKGTLK-DGTLAAIKVL-----SADSRQGVREFLTEI 119
LR+ E F +G G FG+VYKG +G I V A S + +E L E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 120 NVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICI 179
V+ + + ++ L G C+ +++ + L + Q N C+
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKD---NIGSQYLLNWCV 118
Query: 180 GVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN-LTHISTRVAG 238
+AKG+ +L +VHRD+ A N+L+ KI+DFGLAKL A + +
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
++A E + T ++D++S+GV + E++ T PY+
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELM-----TFGSKPYDG----------IPAS 220
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
++ +++ I + C RP L+
Sbjct: 221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 60/279 (21%), Positives = 116/279 (41%), Gaps = 27/279 (9%)
Query: 71 TENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+ + ++G G FG VYK K+ LAA KV+ S + + +++ EI+++ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+L ++ ++ + ++ +L + +C L +LH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLH 127
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
+ I+HRD+KA NIL D K++DFG++ + + + GT ++APE +
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 250 -----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304
KAD++S G+ L+E+ P+ E + + K+ +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEI------EPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ + +LK C + R + S L+
Sbjct: 238 PSRWS-----SNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-58
Identities = 75/316 (23%), Positives = 135/316 (42%), Gaps = 32/316 (10%)
Query: 56 IQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLS-ADS 108
++Y + VA E + + ++GQG FG VY+G K T AIK ++ A S
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 109 RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTL------LGR 162
+ EFL E +V+K+ ++V L G +G +++ + L L +
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 163 GHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222
+ + +A G+A+L+ VHRD+ A N ++ +D T KI DFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 223 KLFP-ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLP 281
+ + + +++PE G T +D++SFGV+L EI + P
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-----AEQP 235
Query: 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTL 341
Y+ ++ + G L++ D ++ +C Q PK RPS +
Sbjct: 236 YQGLSNEQV-LRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 342 VNMLIGEIDVNKEEIS 357
++ + E++ E+S
Sbjct: 286 ISSIKEEMEPGFREVS 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-58
Identities = 62/277 (22%), Positives = 108/277 (38%), Gaps = 33/277 (11%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLS---ADSRQGVREFLTEINVIKDIKH 127
E+F +G+G FG+VY K + A+KVL + + E+ + ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
N++ LYG + L+ Y ++ + L F+ Q +A L++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
H + ++HRDIK N+LL KI+DFG + P++ + GT YL PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE-RGKLVELVDA 306
K D++S GVL E + G + P+E E ++ + V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ + P +RP + ++
Sbjct: 230 GA------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-57
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 24/274 (8%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN 129
+ ++ KIGQG G+VY + G AI+ ++ + + EI V+++ K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V + GD +V YL SL + +C + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH 133
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
++HRDIK+ NILL D + K++DFG + ST V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 250 RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309
R K DI+S G++ +E++ G PY + L + + G L+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG------EPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+L C ++R S L+
Sbjct: 244 -----AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-57
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 25/276 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVRE-FLTEINVIKDIKHEN 129
E++ +G+G +G V + A+K++ E EI + K + HEN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+ YG EG+ + L Y L + + + G+ +LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN-LTHISTRVAGTEGYLAPEYA 248
I HRDIK N+LLD+ KISDFGLA +F N + ++ GT Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 249 IRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
R + D++S G++L +++G ++ ++Y K Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------ 225
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
LN ++ A L +L P R ++ +
Sbjct: 226 LNPWKKIDSAPLALLHKILVEN--PSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-55
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 27/279 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSADSRQGVRE-FLTEINVIKDIK 126
E IG+G FG V++G AIK + VRE FL E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H ++V+L G E + ++ L L R +S + + ++ LA
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALA 122
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
+L VHRDI A N+L+ + K+ DFGL++ + + +++ ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306
+ T +D++ FGV + EI+ + P++ ++ ++ +L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERL------ 228
Query: 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ + + C P RRP + L L
Sbjct: 229 PMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 3e-52
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 39/296 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADSRQG-VREFLTEINVIKD 124
+ +G+G FG V + A+K+L + R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 125 IKHE-NLVELYGCCVE-GDHRILVYGYLENNSLAQTLLGRGHSSIQ------------FN 170
I H N+V L G C + G +++ + + +L+ L + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 171 WQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230
+ VAKG+ FL +HRD+ A NILL + KI DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 231 HI-STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289
++ ++APE T ++D++SFGVLL EI S PY + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ + G + DY+ E + L C P +RP+ S LV L
Sbjct: 245 EFCRRLKEGTRMRAP------DYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 3e-52
Identities = 70/297 (23%), Positives = 123/297 (41%), Gaps = 41/297 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK--------DGTLAAIKVLSAD-SRQGVREFLTEINVI 122
+ +G+G FG V T A+K+L +D + + + + ++E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 123 KDI-KHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSI------------QF 169
K I KH+N++ L G C + ++ Y +L + L R + Q
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 170 NWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229
+ + + VA+G+ +L +HRD+ A N+L+ +D KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 230 THISTRV-AGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLL 288
+ T ++APE T ++D++SFGVLL EI T PY +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF-----TLGGSPYPGVPVE 244
Query: 289 EMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
E+ L E ++ D + + C +P +RP+ LV L
Sbjct: 245 ELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-51
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 35/284 (12%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS---ADSRQGVREFLTEINVIK 123
+ E+F +G+G F +V L AIK+L V E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ H V+LY + + Y +N L + + G F+ R +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 119
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF-PANLTHISTRVAGTEGY 242
L +LH I+HRD+K NILL++D+ +I+DFG AK+ P + + GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302
++PE + +D+++ G ++ ++V+G P+ + K+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG------LPPFRAGNEYLIFQKI-------- 222
Query: 303 LVDASLNGDYSV-EEAHRYLK--IALLCTQDMPKRRPSMSTLVN 343
+ +Y E+ + + L D +R +
Sbjct: 223 -----IKLEYDFPEKFFPKARDLVEKLLVLD-ATKRLGCEEMEG 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 4e-50
Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 26/276 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+++ ++G G FG V++ T G A K + EI + ++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
V L+ + + +++Y ++ L + + + + + V KGL +HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE 142
Query: 191 EVQPHIVHRDIKASNILL--DKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
+ VH D+K NI+ + K+ DFGL + T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE-RGKLVELVDAS 307
+ D++S GVL ++SG P+ + E + + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSG------LSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
++ E+ +++ P R ++ +
Sbjct: 252 IS-----EDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 3e-48
Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 26/276 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
+ + ++G G FG V++ G + K ++ EI+++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
+ L+ + +L+ +L L + + + + N +GL +HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE 145
Query: 191 EVQPHIVHRDIKASNILLD--KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
IVH DIK NI+ + K + KI DFGLA + I T + APE
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIV 200
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE-RGKLVELVDAS 307
R + D+++ GVL ++SG P+ + LE + + E +S
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSG------LSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
++ EA ++K Q P++R ++ +
Sbjct: 255 VS-----PEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 2e-47
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 18/230 (7%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLS---ADSRQGVREFLTEINVI---KD 124
+FS IG+GGFG VY D G + A+K L +QG L E ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 125 IKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKG 184
+V + D + + L L G F+ R + G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILG 119
Query: 185 LAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLA 244
L +H +V+RD+K +NILLD+ +ISD GLA F H S GT GY+A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 245 PEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK 293
PE +G AD +S G +L +++ G + ++ + M
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 2e-46
Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 21/282 (7%)
Query: 64 YKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE-FLTEINV 121
+K + + + +G G F V + L AIK ++ + +G EI V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 122 IKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGV 181
+ IKH N+V L G H L+ + L ++ +G + + + V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQV 116
Query: 182 AKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEG 241
+ +LH+ H + LD+D ISDFGL+K+ + + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPG 174
Query: 242 YLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301
Y+APE + ++ D +S GV+ ++ G P+ ++ ++ ++ +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKLFEQILKAEY-- 226
Query: 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
D+ D S + A +++ + P++R + +
Sbjct: 227 -EFDSPYWDDIS-DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 2e-46
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLS---ADSRQGVREFLTEINVIKDIKH 127
++F +G G FG V+ + +G A+KVL + V E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
++ ++G + ++ Y+E L S +F + V L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
LH I++RD+K NILLDK+ KI+DFG AK P ++ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
+ D +SFG+L+ E+++G P+ + ++ K+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAG------YTPFYDSNTMKTYEKI 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 4e-45
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 30/291 (10%)
Query: 66 DLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKD 124
+LRV + KIG G FG +Y GT + G AIK+ ++ + E + K
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 125 IKHENLVELYG-CCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
++ + C EGD+ ++V L + F+ +T + +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMIS 114
Query: 184 GLAFLHEEVQPHIVHRDIKASNIL---LDKDLTPKISDFGLAKLFPANLTHI------ST 234
+ ++H + + +HRD+K N L K I DFGLAK + TH +
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
+ GT Y + + + +R+ D+ S G +L+ G ++ E +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
+ L Y E + C +P S L +
Sbjct: 232 KMSTPIEVLCK-----GYPSE----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-45
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVI-KDIK 126
E+F +G+G FG V+ K AIK L D V + E V+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 127 HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLA 186
H L ++ ++ V YL L + F+ + GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 187 FLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPE 246
FLH IV+RD+K NILLDKD KI+DFG+ K +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 247 YAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ + D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-45
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 9/205 (4%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHE 128
ENF KIG+G +G VYK K G + A+K + D + + EI+++K++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N+V+L + LV+ +L + + ++ + +GLAF
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H ++HRD+K N+L++ + K++DFGLA+ F + + V
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGR 273
+ DI+S G + E+V+ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 17/281 (6%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG-VREFLTEINVIKDIKHE 128
++ + IG+G +G V + AIK +S Q + L EI ++ +HE
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N++ + + YL + + L + + + +GL ++
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHIS--TRVAGTEGYLAPE 246
H +++HRD+K SN+LL+ KI DFGLA++ + H T T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 247 YAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305
+ + T+ DI+S G +L E++S R + ++ L+ + L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSN------RPIFPGKHYLDQLNHILG--ILGSPSQ 234
Query: 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346
LN +++ + L + + P+ + L+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 4e-44
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVL--SADSRQGVREFLTEINVIKDIKHEN 129
E + KIG+G +G VYK G A+K + + + EI+++K++KH N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+V+LY +LV+ +L+ + + G T ++ + + G+A+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117
Query: 190 EEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAI 249
+ ++HRD+K N+L++++ KI+DFGLA+ F + + +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 250 RGQLTRKADIYSFGVLLLEIVSGR 273
+ + DI+S G + E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 4e-44
Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 39/289 (13%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVL--------SADSRQGVRE-FLTEINV 121
EN+ P +G+G V + A+K++ SA+ Q +RE L E+++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 122 IKDIK-HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
++ + H N+++L LV+ ++ L L + + + R I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
+ + + LH+ +IVHRD+K NILLD D+ K++DFG + V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTP 173
Query: 241 GYLAPEYA------IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294
YLAPE ++ D++S GV++ +++G P+ + + M +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------SPPFWHRKQMLMLRMI 227
Query: 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ DYS + + P++R + +
Sbjct: 228 MSG---NYQFGSPEWDDYS-DTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-44
Identities = 49/275 (17%), Positives = 100/275 (36%), Gaps = 25/275 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL 130
E + A +G+G FG V++ K + EI+++ +H N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 131 VELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE 190
+ L+ + ++++ ++ + + + + N + + V + L FLH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHS 120
Query: 191 EVQPHIVHRDIKASNILLD--KDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
+I H DI+ NI+ + T KI +FG A+ Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVH 175
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
++ D++S G L+ ++SG P+ + ++ + + D
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG------INPFLAETNQQIIENI-MNAEYT--FDEEA 226
Query: 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ S EA ++ K R + S +
Sbjct: 227 FKEIS-IEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 9e-44
Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 31/287 (10%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH-EN 129
++ +IG+G FG +++GT L + AIK R + E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
+ +Y EG H +LV L SL L G +F+ +T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVI-DLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 118
Query: 190 EEVQPHIVHRDIKASNILLDKDLTP-----KISDFGLAKLFPANLTHI------STRVAG 238
+ +V+RDIK N L+ + + + DFG+ K + +T ++G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 239 TEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298
T Y++ + + +R+ D+ + G + + + G + E + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 299 KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNML 345
L E L + E + K P L +
Sbjct: 236 PLRE-----LCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (382), Expect = 2e-43
Identities = 58/287 (20%), Positives = 113/287 (39%), Gaps = 31/287 (10%)
Query: 71 TENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSAD---SRQGVREFLTEINVIKDIK 126
++ + +G GG V+ L+ A+KVL AD F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 127 HENLVELYGCCVE----GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
H +V +Y G +V Y++ +L + G + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI--STRVAGTE 240
+ L F H+ I+HRD+K +NI++ K+ DFG+A+ + + + V GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
YL+PE A + ++D+YS G +L E+++G P+ + +A++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQHVREDP- 231
Query: 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-SMSTLVNMLI 346
+ ++ + S + + L P+ R + + + L+
Sbjct: 232 --IPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-43
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 26/285 (9%)
Query: 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQG-----VREFLTEINVIKDIKHENLV 131
+ +G+G F +VYK K + AIK + R R L EI +++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L + LV+ ++E + +S+ + + +GL +LH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 192 VQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRG 251
I+HRD+K +N+LLD++ K++DFGLAK F + + +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 252 QL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
++ D+++ G +L E++ ++ + + ++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 311 DYSVEEAHRYLKIALLCTQDM-----------PKRRPSMSTLVNM 344
+ I D+ P R + + + M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-43
Identities = 61/311 (19%), Positives = 118/311 (37%), Gaps = 37/311 (11%)
Query: 70 ATENFSPANKIGQGGFGSVYKGTLK--DGTLAAIKVLSADSRQG--VREFLTEINVIKDI 125
A + + +IG+G +G V+K G A+K + + + + E+ V++ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 126 K---HENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQ--FNWQTRRNICIG 180
+ H N+V L+ C L + Q L + +T +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTE 240
+ +GL FLH +VHRD+K NIL+ K++DFGLA+++ + T V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 241 GYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300
Y APE ++ D++S G + E+ + + ++ K+ + L
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR------KPLFRGSSDVDQLGKILDVIGL 233
Query: 301 VELVDASLNGDYSVEEAHRYLKIALL----------------CTQDMPKRRPSMSTLVNM 344
D + + H + C P +R S + ++
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
Query: 345 -LIGEIDVNKE 354
+++ KE
Sbjct: 294 PYFQDLERCKE 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 68 RVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIK 123
+V +F +G+G FG V K G A+K+L + ++ V +TE V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 124 DIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAK 183
+ +H L L D V Y L L F + R +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVS 116
Query: 184 GLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYL 243
L +LH +V+RDIK N++LDKD KI+DFGL K ++ + T GT YL
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
APE R D + GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-41
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 33/276 (11%)
Query: 79 KIGQGGFGSVYKGTLK-DGTLAAIKVL------SADSRQGVREFLTEINVIKDIKHENLV 131
++G G F V K K G A K + S+ + E++++K+I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 132 ELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE 191
L+ IL+ + L L + + + G+ +LH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 192 VQPHIVHRDIKASNILLDKDLTP----KISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
I H D+K NI+L P KI DFGLA + + + GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 187
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
L +AD++S GV+ ++SG P+ E + V+
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGAS------PFLGDTKQETLANVSA-------VNYE 234
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+Y + PK+R ++ +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-41
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 17/219 (7%)
Query: 63 GYKDLRVATENFSPANKIGQGGFGSVYKGTLKD-GTLAAIKVLSADSRQGVREFLTEINV 121
G R +++ IG G FG VY+ L D G L AIK + D R R E+ +
Sbjct: 11 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQI 66
Query: 122 IKDIKHENLVELYGCCVEGD------HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRR 175
++ + H N+V L + LV Y+ + + +
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVK 125
Query: 176 NICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHIST 234
+ + LA++H I HRDIK N+LLD D K+ DFG AK +
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS 181
Query: 235 RVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
+ T D++S G +L E++ G+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 55/290 (18%), Positives = 112/290 (38%), Gaps = 27/290 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVL--SADSRQGVREFLTEINVIKDIKHE 128
+ + KIG+G +G+V+K + + A+K + D L EI ++K++KH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 129 NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFL 188
N+V L+ LV+ + + + G + + ++ + KGL F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFC 117
Query: 189 HEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
H +++HRD+K N+L++++ K+++FGLA+ F + S V
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 249 IRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308
+ D++S G + E+ + ++Q L+ ++L + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTK 232
Query: 309 NGDYSVEEAHRYLK-------------IALL--CTQDMPKRRPSMSTLVN 343
DY + LL + P +R S +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-40
Identities = 60/276 (21%), Positives = 98/276 (35%), Gaps = 43/276 (15%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVRE------FLTEINVIKDIK--HEN 129
+G GGFGSVY G + D AIK + D E E+ ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 130 LVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH 189
++ L D +L+ E + + + R+ V + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 190 EEVQPHIVHRDIKASNILLDKD-LTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYA 248
++HRDIK NIL+D + K+ DFG L + T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 249 IRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307
+ R A ++S G+LL ++V G +P+E + + + E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQRVSSECQH-- 233
Query: 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
+ C P RP+ + N
Sbjct: 234 ---------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV 103
+R EV + E++ Y+DL+ +G G +G+V + G AIK
Sbjct: 5 YRQEVTKTAWEVRAV----YRDLQ----------PVGSGAYGAVCSAVDGRTGAKVAIKK 50
Query: 104 LSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161
L S + E+ ++K ++HEN++ L + + T LG
Sbjct: 51 LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG 110
Query: 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221
+ + + + + KGL ++H I+HRD+K N+ +++D KI DFGL
Sbjct: 111 KLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167
Query: 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
A+ + +T V + T+ DI+S G ++ E+++G+
Sbjct: 168 ARQADSEMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 6e-39
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 39/303 (12%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQG--VREFLTEINVIKDIKHE 128
+ KIGQG FG V+K K G A+K + ++ + L EI +++ +KHE
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 129 NLVELYGCCVEGDHRI--------LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIG 180
N+V L C LV+ + E++ F + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 181 VAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT---HISTRVA 237
+ GL ++H I+HRD+KA+N+L+ +D K++DFGLA+ F + T
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 238 GTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR----CNTNRRL----------PY 282
T Y PE + + D++ G ++ E+ + NT +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLK--IALLCTQDMPKRRPSMST 340
E + ++LYE+ +LV+ + Y I L D P +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-PAQRIDSDD 301
Query: 341 LVN 343
+N
Sbjct: 302 ALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 50/273 (18%), Positives = 109/273 (39%), Gaps = 30/273 (10%)
Query: 80 IGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINV-IKDIKHENLVELYGCC 137
+G G G V + + A+K+L Q + E+ + + + ++V +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 138 ----VEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQ 193
++V L+ L + RG + F + I + + + +LH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI-- 130
Query: 194 PHIVHRDIKASNILLDK---DLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIR 250
+I HRD+K N+L + K++DFG AK ++ + + T Y+APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 251 GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310
+ + D++S GV++ ++ G P+ + L ++ + R ++ + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCG------YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343
EE ++ + P +R +++ +N
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 6e-37
Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLS---ADSRQGVREFLTEINVIKDIKH 127
+ F +G G FG V + G A+K+L + + L E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
LV+L + + +V Y+ + L G F+ R + +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGYLAPEY 247
LH +++RD+K N+L+D+ +++DFG AK + GT LAPE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEI 209
Query: 248 AIRGQLTRKADIYSFGVLLLEIVSGR 273
+ + D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-35
Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 25/254 (9%)
Query: 55 EIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGTL----KDGTLAAIKVLS----A 106
E++ NL G+ + +V ENF +G G +G V+ G L A+KVL
Sbjct: 8 ELRTANLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 107 DSRQGVREFLTEINVIKDIKHE-NLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHS 165
+ TE V++ I+ LV L+ L+ Y+ L L R
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 166 SIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225
+ I + L + I++RDIK NILLD + ++DFGL+K F
Sbjct: 127 TEHEVQIYVGEIVLA-------LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 226 PANLTHISTRVAGTEGYLAPEYAIRGQ--LTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283
A+ T + GT Y+AP+ G + D +S GVL+ E+++G P+
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG------ASPFT 233
Query: 284 EQYLLEMAWKLYER 297
++ R
Sbjct: 234 VDGEKNSQAEISRR 247
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 23/232 (9%)
Query: 45 HRVEVNEDVSEIQDTNLYGYKDLRVATENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKV 103
+R E+N+ + E+ + Y++L +G G +GSV K G A+K
Sbjct: 5 YRQELNKTIWEVPER----YQNLS----------PVGSGAYGSVCAAFDTKTGLRVAVKK 50
Query: 104 LSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLENNSLAQTLLG 161
LS S + E+ ++K +KHEN++ L L L
Sbjct: 51 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 110
Query: 162 RGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221
+ + + + +GL ++H I+HRD+K SN+ +++D KI DFGL
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
A+ ++ VA + DI+S G ++ E+++GR
Sbjct: 168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 6e-34
Identities = 44/237 (18%), Positives = 99/237 (41%), Gaps = 24/237 (10%)
Query: 46 RVEVNEDVSEIQDTNLYGYKDLRVAT---ENFSPANKIGQGGFGSVYKGT-LKDGTLAAI 101
R V DV+ + + Y+ V +++ K+G+G + V++ + + +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 102 KVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHR--ILVYGYLENNSLAQT 158
K+L ++ + EI ++++++ N++ L + R LV+ ++ N Q
Sbjct: 66 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ- 121
Query: 159 LLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD-KDLTPKIS 217
L R + K L + H I+HRD+K N+++D + ++
Sbjct: 122 LYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 218 DFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGR 273
D+GLA+ + + + + PE + Q+ D++S G +L ++ +
Sbjct: 173 DWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-31
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 72 ENFSPANKIGQGGFGSVYKGT-LKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHE 128
+ + IG G G V AIK LS ++ + E+ ++K + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 129 NLVELYGCCV------EGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVA 182
N++ L E LV ++ N ++ + + + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQML 129
Query: 183 KGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHISTRVAGTEGY 242
G+ LH I+HRD+K SNI++ D T KI DFGLA+ + + T T Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYY 184
Query: 243 LAPEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
APE + DI+S G ++ E+V +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 3e-28
Identities = 41/210 (19%), Positives = 79/210 (37%), Gaps = 18/210 (8%)
Query: 79 KIGQGGFGSVYKGT-LKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCC 137
K+G G F +V+ + + T A+K++ D + EI +++ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 138 VEGDHRILVYGY------------LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGL 185
++L + E L + + + I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 186 AFLHEEVQPHIVHRDIKASNILLDK-DLTPKISDFGLAKLFPANLTHIS-TRVAGTEGYL 243
++H + I+H DIK N+L++ D + +A L A T T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 244 APEYAIRGQLTRKADIYSFGVLLLEIVSGR 273
+PE + ADI+S L+ E+++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 3e-22
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 21/156 (13%)
Query: 78 NKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR----------QGVREFLTEINVIKDIKH 127
+G+G +V+ + +K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 128 ENLVELYGCCVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAF 187
L +L G V + E N++ L+ + + + +A
Sbjct: 66 RALQKLQGLAVPKVY------AWEGNAVLMELIDAKELYRVRVENPDE-VLDMILEEVAK 118
Query: 188 LHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223
+ IVH D+ N+L+ + I DF +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.96 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-58 Score=430.86 Aligned_cols=266 Identities=24% Similarity=0.415 Sum_probs=223.9
Q ss_pred hhhHHHHhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCe
Q 044232 64 YKDLRVATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDH 142 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 142 (415)
+++|++..++|++.++||+|+||+||+|.++ +++.||||+++.+.. ..++|.+|+++|++++|||||+++|+|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3455666788999999999999999999986 688999999976543 34679999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+++|+|.+++..... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence 9999999999999999976543 2789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
+..............||+.|+|||++.++.++.++|||||||++|||++|+.|+........ .......+
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~---- 232 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD---- 232 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTT----
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcC----
Confidence 97765544445556789999999999999999999999999999999998777654333221 12222222
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
.....+...+.++.+|+.+||+.||++|||+.||++.|.....
T Consensus 233 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2233344556789999999999999999999999999976543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-58 Score=421.47 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
++|++.++||+|+||+||+|++.+++.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 56888999999999999999998888999999976543 34689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++..... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999876532 688999999999999999999999 9999999999999999999999999999877554444
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNGD 311 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (415)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... .+..... ..+ ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~i-~~~---------~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDI-STG---------FRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHHH-HHT---------CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHHH-Hhc---------CCCC
Confidence 444567899999999999999999999999999999999965554332221 1122222 112 1122
Q ss_pred CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 312 YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.+..++.++.+|+.+||+.||++||||+||++.|++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2334457899999999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-58 Score=424.58 Aligned_cols=262 Identities=30% Similarity=0.469 Sum_probs=215.9
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
++|++..++|++.++||+|+||+||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 345566688999999999999999999998888999999976543 34679999999999999999999998754 5679
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... ..+++..++.|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+.
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence 99999999999998765432 2589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.............||+.|+|||++.++.++.++|||||||++|||+||+.|+....... +.... ...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~~~~~-i~~~------ 226 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQN-LERG------ 226 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH-HHTT------
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----HHHHH-HHhc------
Confidence 76554444556779999999999999999999999999999999999766554332221 11111 2222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+..++.++.+|+.+||+.||++||||++|++.|...
T Consensus 227 ---~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 227 ---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 12222334557799999999999999999999999988754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=420.39 Aligned_cols=262 Identities=25% Similarity=0.427 Sum_probs=208.1
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
|++..++|++.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 44556889999999999999999998753 5999998754 34556789999999999999999999998754 5689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|.+++..... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999976542 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-cceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 225 FPANL-THISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 225 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
..... ........||+.|+|||++.+ +.++.++|||||||++|||+||+.||....+... .......+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~ 227 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYL 227 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC
Confidence 64332 233455679999999999864 3589999999999999999999999876544321 1222222221
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.... ...+..++.++.+|+.+||+.||++|||++||++.|+..
T Consensus 228 ~p~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 228 SPDL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCCG-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 112334457899999999999999999999999988643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=419.35 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=205.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|++++.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999986 79999999987653 23345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997654 799999999999999999999999 99999999999999999999999999998764332
Q ss_pred -cceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 230 -THISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 230 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... . ......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~-~~~~~~-------- 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----S-DWKEKK-------- 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----H-HHHTTC--------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----H-HHhcCC--------
Confidence 223455789999999999988775 678999999999999999999987543322110 0 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.........+.++.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111233467889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-57 Score=414.25 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=209.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999986 78999999986542 233467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+ .... ..++.
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~-i~~~~-------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKR-ISRVE-------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTTC--------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHH-HHcCC--------
Confidence 3 2345679999999999999999999999999999999999999987643321 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1223334577899999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=416.23 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=211.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++|++.++||+|+||+||+|... +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 79999999987665445577999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
+||+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 999999988754 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 231 HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ........+.. ..
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~ 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------EL 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CC
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CC
Confidence 23345679999999999999999999999999999999999999886543322 22222222211 11
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223344577899999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=419.52 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=197.6
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--CCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE--GDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 146 (415)
++|++++.||+|+||+||+|+.+ +|+.||+|++... .....+.+.+|++++++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999976 7999999998765 34445678999999999999999999999865 4568999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV--QPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
|||+++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754322337999999999999999999999971 11399999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+. +.... ...+...
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~-i~~~~~~--- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGK-IREGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH-HHHTCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHH-HHcCCCC---
Confidence 65432 2334578999999999999999999999999999999999999998754321 11122 2222211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122334567899999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=410.87 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=215.0
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeecc
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLE 151 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 151 (415)
++|++.++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 689999999999999999999988889999999875433 3689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcc
Q 044232 152 NNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTH 231 (415)
Q Consensus 152 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 231 (415)
+|+|.+++..... .+++..+.+++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999765532 688999999999999999999999 9999999999999999999999999999876554444
Q ss_pred eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccCC
Q 044232 232 ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLNG 310 (415)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (415)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+. .+ ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~-~~---------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIA-QG---------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHH-TT---------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHHH-hC---------CCC
Confidence 4445678999999999999999999999999999999998 7777765432 22222222 22 112
Q ss_pred CCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 311 DYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
..+...+..+.+|+.+||+.||++|||+.+|++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2333455789999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-56 Score=421.01 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=200.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CC---CEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DG---TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
++|++.+.||+|+||+||+|.++ ++ ..||||.+... .....+.|.+|+.+|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 55777889999999999999975 33 36899988764 444557899999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++..... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998876532 689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcce----ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 227 ANLTHI----STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 227 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||....+. +....+ ..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i-~~~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAI-EQD--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHH-HTT---
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcC---
Confidence 432211 122457899999999999999999999999999999998 78787654322 122212 211
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 302 ELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.....+..++..+.+|+.+||+.||++|||+.||++.|+..+
T Consensus 250 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 250 ------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 122334456678999999999999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=417.39 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=210.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
+.|++++.||+|+||+||+|++. +++.||+|++........+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999976 79999999998766666678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 99999999875432 689999999999999999999999 9999999999999999999999999999754322 1
Q ss_pred ceecccccCCCCCChhhhh-----cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 231 HISTRVAGTEGYLAPEYAI-----RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||....+.+. ........ .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~-~----- 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE-P----- 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSC-C-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC-C-----
Confidence 2234567999999999984 45689999999999999999999999877654432 11122211 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 --PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223344578899999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=415.31 Aligned_cols=266 Identities=29% Similarity=0.443 Sum_probs=211.4
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
++|++..++|++.+.||+|+||+||+|+++++..||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 334455678999999999999999999998888899999976543 34679999999999999999999999854 5689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||+++|+|..++..... ..++|..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999988875432 1589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.............||+.|+|||++.++.++.++|||||||++|||++|+.|+....... +... ....+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~-~i~~~------ 230 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-QVERG------ 230 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH-HHHTT------
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHH-HHHhc------
Confidence 65444444455679999999999999999999999999999999999876654433222 1111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCCCC
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEIDVN 352 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 352 (415)
.....+..++.++.+|+.+||+.||++||++++|+++|.......
T Consensus 231 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122334455678999999999999999999999999998876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=411.97 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=208.0
Q ss_pred cCCCCCC-cccccCeEEEEEEEec---CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPAN-KIGQGGFGSVYKGTLK---DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999864 3557999999765 34456789999999999999999999999865 568999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865432 689999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 227 ANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 227 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ .. .....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~-~~i~~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VM-AFIEQGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HH-HHHHTTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HH-HHHHcCC----
Confidence 43322 2234568999999999999999999999999999999998 888887543321 11 1222222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+..++.++.+|+.+||+.+|++||||.+|++.|..
T Consensus 230 -----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 223344556789999999999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=422.15 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=207.5
Q ss_pred HhcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 70 ATENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 70 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
..++|+++++||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|+.++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999976 78999999987652 334467899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
||++||+|.+++...+ .+++..++.++.||+.||.|||+ + +|+||||||+||||+.++++||+|||+|+.+.
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998765 68999999999999999999997 5 89999999999999999999999999998653
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHH-------------
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWK------------- 293 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~------------- 293 (415)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 157 ~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 D---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 223456899999999999999999999999999999999999999976443221110000000
Q ss_pred ------H-Hhh---Ccchhhccccc---CCCC-CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 294 ------L-YER---GKLVELVDASL---NGDY-SVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 294 ------~-~~~---~~~~~~~~~~~---~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ... ....+..+... .+.. ....+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 000 00000000000 0000 1112467889999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=413.29 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++++.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999986 79999999987542 234467899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||++||+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988765 789999999999999999999999 999999999999999999999999999987654
Q ss_pred CC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ...+.. .+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~-~~~------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKII-KLE------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-TTC-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHH-cCC-------
Confidence 32 223345679999999999999999999999999999999999999987653322 111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..++...+.++.+|+.+||+.||++|||++|+++
T Consensus 227 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1122334567899999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=406.81 Aligned_cols=246 Identities=27% Similarity=0.383 Sum_probs=201.0
Q ss_pred CcccccCeEEEEEEEec---CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeeccC
Q 044232 78 NKIGQGGFGSVYKGTLK---DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYLEN 152 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 152 (415)
++||+|+||+||+|.++ .++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999865 3568999998654 23345689999999999999999999999865 457899999999
Q ss_pred CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCcce
Q 044232 153 NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLTHI 232 (415)
Q Consensus 153 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 232 (415)
|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998765 689999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --ecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccccC
Q 044232 233 --STRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASLN 309 (415)
Q Consensus 233 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (415)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||....+. +. ......+. .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~-~~~i~~~~---------~ 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EV-TAMLEKGE---------R 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HH-HHHHHTTC---------C
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HH-HHHHHcCC---------C
Confidence 234578999999999999999999999999999999998 88887654321 11 11222222 2
Q ss_pred CCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 310 GDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
...+..++.++.+|+.+||+.||++|||+++|++.|..
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 23344556789999999999999999999999988864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=418.32 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=212.5
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecC-C-----CEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKD-G-----TLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
|++..++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.+|.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 44566889999999999999999998752 2 36899998654 233446788999999998 8999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCC-------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGH-------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 199 (415)
+.+..++|||||++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999976532 112589999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCC
Q 044232 200 DIKASNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTN 277 (415)
Q Consensus 200 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~ 277 (415)
||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986644332 23345678999999999999999999999999999999998 888886
Q ss_pred CCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhh
Q 044232 278 RRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLI 346 (415)
Q Consensus 278 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 346 (415)
+...... ..+....+ .....+..++.++.+|+.+||+.||++|||++||++.|.
T Consensus 269 ~~~~~~~------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH------HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5433221 12222222 222334455678999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=409.52 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=205.3
Q ss_pred cCCCCCCcccccCeEEEEEEEecC-C----CEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKD-G----TLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
..|+..+.||+|+||+||+|.+++ + ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 457778899999999999998763 2 36999998765 33444679999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
||||+.+|++.+.+..... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876543 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc--ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLT--HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
..... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+....+... . ......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-----~-~~~i~~------ 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----V-MKAIND------ 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H-HHHHHT------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-----H-HHHHhc------
Confidence 44322 222345689999999999999999999999999999999998766554333221 1 112222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
......+..++..+.+|+.+||+.+|++||||.||++.|+..+.
T Consensus 229 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 ---GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 22233444566789999999999999999999999999976543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-55 Score=403.50 Aligned_cols=244 Identities=26% Similarity=0.397 Sum_probs=199.1
Q ss_pred CCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe----CCeeEEEE
Q 044232 75 SPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE----GDHRILVY 147 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 147 (415)
++.++||+|+||+||+|.+. ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999976 6889999998654 34455679999999999999999999999875 34689999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeec-CCCCeEEeeeccccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPH--IVHRDIKASNILLD-KDLTPKISDFGLAKL 224 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla~~ 224 (415)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ + |+||||||+||||+ .++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998765 689999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ .......+.....
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~~- 233 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS- 233 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG-
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCcc-
Confidence 5432 2345679999999998865 699999999999999999999999865433221 1122222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 234 -------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11123356889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-55 Score=413.81 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=194.0
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch-HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR-QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
.+.|++.+.||+|+||+||+|+.+ +++.||||++..... .....+.+|+.+|+.++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999976 799999999976532 233567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCCeEEeeecccccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPKISDFGLAKLF 225 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~ 225 (415)
||+||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||+. .++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999998665 799999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcc
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVD 305 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 305 (415)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +..
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~-~~~----- 226 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILK-AEY----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHT-TCC-----
T ss_pred cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhc-cCC-----
Confidence 433 22345679999999999999999999999999999999999999987643221 1111221 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 306 ASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..........+.++.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111222344577899999999999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-55 Score=412.94 Aligned_cols=245 Identities=24% Similarity=0.425 Sum_probs=204.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
+.|+.+++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999976 78999999987643 344567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
|||++|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987776554 789999999999999999999999 999999999999999999999999999986533
Q ss_pred CCcceecccccCCCCCChhhhhc---CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIR---GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELV 304 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (415)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||....+. +.......... ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~-~~-- 233 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PA-- 233 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CC--
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-CC--
Confidence 234679999999999864 46899999999999999999999988654332 22222222211 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 305 DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111233467899999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-54 Score=412.99 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=211.8
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
-++|++++.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999976 7999999999877666667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCCeEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK--DLTPKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 227 (415)
|+||+|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999865432 699999999999999999999999 9999999999999964 67899999999987654
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+. +......... . .
T Consensus 179 ~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~-~------~ 243 (350)
T d1koaa2 179 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD-W------N 243 (350)
T ss_dssp T--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-C------C
T ss_pred c--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C------C
Confidence 3 2334567999999999999999999999999999999999999998764322 1222222111 1 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
.........+.++.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112334678899999999999999999999983
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-54 Score=411.30 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=212.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++|++++.||+|+||+||+|... +|+.||||++..........+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 67999999999999999999976 79999999998776666678889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCCCeEEeeeccccccCCC
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD--KDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~ 228 (415)
+||+|.+++...+. ++++..++.|+.||+.||+|||++ ||+||||||+||||+ .++.+||+|||+|..+...
T Consensus 109 ~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988865532 699999999999999999999999 999999999999998 6789999999999877543
Q ss_pred CcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccccc
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDASL 308 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (415)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ....... +.. ..
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~-~~~------~~ 247 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKR-CDW------EF 247 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHH-CCC------CC
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC------CC
Confidence 23445679999999999999999999999999999999999999987543322 1222211 111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 309 NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222334577899999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-55 Score=403.33 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=200.7
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecC----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
+..++|++.+.||+|+||.||+|.+.. +..||||.++.. .....+.|.+|+.++++++|||||+++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998652 356899988654 3444567999999999999999999999986 4678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998776542 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchh
Q 044232 224 LFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVE 302 (415)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~ 302 (415)
..............||+.|+|||++.+..++.++|||||||++|||++ |..|+....+.+. ... ...+.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------~~~-i~~~~--- 226 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGR-IENGE--- 226 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHH-HHTTC---
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------HHH-HHcCC---
Confidence 765544444556678999999999999999999999999999999998 7777765443221 111 12221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 303 LVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+..++..+.+|+.+||+.||++|||+.||++.|...+
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12233445678999999999999999999999999987643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-54 Score=405.51 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=214.3
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhcCCcceeeeeeEEEe
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDIKHENLVELYGCCVE 139 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 139 (415)
++...++|++.+.||+|+||+||+|+++ +++.||||++.... ....++|.+|+.+|++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 4456688999999999999999999864 35789999997653 3345679999999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHhhcCCC--------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 044232 140 GDHRILVYGYLENNSLAQTLLGRGH--------------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHR 199 (415)
Q Consensus 140 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 199 (415)
.+..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||++ +|+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 9999999999999999999975431 123588999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCCeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc-CCC
Q 044232 200 DIKASNILLDKDLTPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC-NTN 277 (415)
Q Consensus 200 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-p~~ 277 (415)
||||+||||+.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|.. |+.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998664332 223345678999999999999999999999999999999999964 444
Q ss_pred CCCChhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 278 RRLPYEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 278 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
...+ .+....+ ..+.. ...+..++.++.+|+.+||+.+|++||||.||+++|++..
T Consensus 245 ~~~~------~e~~~~v-~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAH------EEVIYYV-RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCH------HHHHHHH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCH------HHHHHHH-HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3322 2222222 22222 2223345578999999999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=401.55 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=208.2
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc------hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS------RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999986 79999999986532 12346789999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----CeEEeee
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL----TPKISDF 219 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 219 (415)
+||||||++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998765 689999999999999999999999 999999999999998876 4999999
Q ss_pred ccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 220 GLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 220 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+.+ ....... +.
T Consensus 162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~-~~ 232 (293)
T d1jksa_ 162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSA-VN 232 (293)
T ss_dssp TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHT-TC
T ss_pred hhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHh-cC
Confidence 999876443 22345679999999999999999999999999999999999999987643322 1122211 11
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 0000001123467889999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-53 Score=400.65 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=208.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++++.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999976 79999999987542 234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||++||+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999998776 678899999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+ ....... +.
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~-~~-------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILN-AE-------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-CC--------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHc-CC--------
Confidence 3 345789999999999999999999999999999999999999987643322 2222221 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
..++...+.++.+++.+||+.||.+|| |++++++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 112233446788999999999999996 8999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=405.40 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=210.6
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 146 (415)
-++|++++.||+|+||+||+|+.+ +|+.||+|++.+. .....+.+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999976 7999999999754 223456788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||++||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+ ... ....+.
T Consensus 157 ~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~-~i~~~~------- 221 (337)
T d1o6la_ 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFE-LILMEE------- 221 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHHCC-------
T ss_pred cC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHH-HHhcCC-------
Confidence 33 223455789999999999999999999999999999999999999987654321 111 111121
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
..++...+.++.+|+.+||+.||.+||+ +.|+++
T Consensus 222 ---~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1223344567889999999999999995 788876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=396.86 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=199.9
Q ss_pred HHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCeeEEEE
Q 044232 69 VATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVE-GDHRILVY 147 (415)
Q Consensus 69 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 147 (415)
+..++|++.+.||+|+||.||+|.++ |..||||+++.+. ..+.|.+|++++++++||||++++|+|.+ .+.+++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 34467888999999999999999985 6789999997654 33679999999999999999999999865 45689999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+++|+|.+++..... ..+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999976431 2589999999999999999999999 999999999999999999999999999986533
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
. .....+|+.|+|||++.++.++.++|||||||++|||+| |+.|+..... .. .... ..+
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~-----~~~~-i~~--------- 215 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD-----VVPR-VEK--------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GG-----HHHH-HTT---------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HH-----HHHH-HHc---------
Confidence 2 234568899999999999999999999999999999998 5666554322 21 1111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
....+.+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22333444556789999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=402.91 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=203.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCC----EEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGT----LAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRIL 145 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 145 (415)
++|++++.||+|+||+||+|.+. +|+ .||+|.+... .....+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 444 5889988654 334557899999999999999999999999865 5678
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLF 225 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 225 (415)
++||+.+|+|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876543 689999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 226 PANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 226 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..|+......+- ......+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~~~----- 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKG----- 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHHHT-----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcC-----
Confidence 543322 2334568999999999999999999999999999999998 6767665432221 1122222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
.....+..++.++.+|+.+||+.||.+|||+.||++.|...
T Consensus 230 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22233445567899999999999999999999999988654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-52 Score=402.02 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=208.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 147 (415)
++|++++.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 79999999986542 233467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCC
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPA 227 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 227 (415)
||+.+|+|..++...+ .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||.+..+.. ....... +.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~-~~-------- 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVS-GK-------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC--------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHhc-CC--------
Confidence 3 235679999999999999999999999999999999999999987653322 1112211 11
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCC-----CHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRP-----SMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 343 (415)
...+...+.++.+++.+||+.||.+|+ +++++++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112233456788999999999999994 8999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=399.10 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=205.2
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
..|++..++|++.++||+|+||.||+|.+. +++.||||+++.. .....+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 455566688999999999999999999864 2468999999764 334456788888888877 68899999999
Q ss_pred EEeC-CeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 044232 137 CVEG-DHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKA 203 (415)
Q Consensus 137 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 203 (415)
+... ..+++|||||++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 8764 468999999999999999976432 123588999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc-CCCCCCC
Q 044232 204 SNILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC-NTNRRLP 281 (415)
Q Consensus 204 ~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-p~~~~~p 281 (415)
+||||+.++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||++|.. |+.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986644322 23345679999999999999999999999999999999999754 5543322
Q ss_pred hhhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 282 YEEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.. ........+. ....+...+.++.+++.+||+.||++|||+.||++.|++.+
T Consensus 243 ~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1222223322 12233344577999999999999999999999999997653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=394.31 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=199.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec--CC--CEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK--DG--TLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHR 143 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 143 (415)
.++|++.+.||+|+||.||+|+++ ++ ..||||++... .....++|.+|+.+|++++||||++++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367899999999999999999864 23 36899998764 23445789999999999999999999999975 467
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
++||||+++|+|.+.+..... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999988876532 689999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCcc--eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 224 LFPANLTH--ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 224 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSC--
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCC--
Confidence 77544332 2334567889999999999999999999999999999998 777765432 223333333322
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhc
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIG 347 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 347 (415)
.....+...+..+.+|+.+||+.||++||||.+|++.|..
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1222333445779999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-52 Score=389.54 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=205.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc---chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----e
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD---SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----H 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 142 (415)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. .......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999975 7999999999754 3344567999999999999999999999998654 4
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.+|||||++|++|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999988765 789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC--cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 223 KLFPANL--THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 223 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....+. +........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC
Confidence 7653322 22344567999999999999999999999999999999999999998765432 222333333221
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCC-CHHHHHHHhhc
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRP-SMSTLVNMLIG 347 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~ 347 (415)
.. ... ....+.++.+++.+||+.||.+|| |++++++.|.+
T Consensus 233 ~~---~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 PP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CG---GGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CC---chh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11 111 122346788999999999999999 89999888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=398.93 Aligned_cols=266 Identities=24% Similarity=0.416 Sum_probs=216.9
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeEEE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGCCV 138 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 138 (415)
|++..++|++.++||+|+||.||+|++. +++.||||+++... ......|.+|+.+++++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4556688999999999999999999852 46789999997653 34456789999999999 6999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHhhcCCC--------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 139 EGDHRILVYGYLENNSLAQTLLGRGH--------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 139 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
+.+..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 99999999999999999999976532 223688999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCCc-ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANLT-HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYE 283 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~ 283 (415)
|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.|+....+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997654332 33345679999999999999999999999999999999999555543322221
Q ss_pred hhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 284 EQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
. .+++....+ .....+...+.++.+|+.+||+.||++||||.+|+++|++.+
T Consensus 255 ~-----~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 S-----KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H-----HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-----HHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1 122222222 222333345678999999999999999999999999998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=397.14 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=206.8
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCC--EEEEEEcccc-chHhHHHHHHHHHHHhhc-CCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGT--LAAIKVLSAD-SRQGVREFLTEINVIKDI-KHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 146 (415)
++|++.++||+|+||+||+|.++ +|. .||||.+... .....+.|.+|+.+|+++ +|||||+++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999976 444 4778887543 333456799999999998 799999999999999999999
Q ss_pred EeeccCCCHHHHhhcCC------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCe
Q 044232 147 YGYLENNSLAQTLLGRG------------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTP 214 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 214 (415)
|||+++|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2234789999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcC-CCCCCChhhhhHHHHHHH
Q 044232 215 KISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCN-TNRRLPYEEQYLLEMAWK 293 (415)
Q Consensus 215 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p-~~~~~p~~~~~~~~~~~~ 293 (415)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|..| +.... ..+....
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH
Confidence 99999999855332 122345689999999999999999999999999999999998654 43322 1122111
Q ss_pred HHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 294 LYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
+ .. ......+..++.++.+|+.+||+.||++||||.||++.|.+.+.
T Consensus 239 i-~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 L-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp G-GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-Hh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 11 12233444566789999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-52 Score=385.86 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=207.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---------hHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeC
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---------RQGVREFLTEINVIKDIK-HENLVELYGCCVEG 140 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 140 (415)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 79999999986542 112346889999999997 99999999999999
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
+..+|||||+++|+|.+++..++ .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998765 789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhc------CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHH
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIR------GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKL 294 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~ 294 (415)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+.. .....
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 227 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHH
Confidence 998765432 2345679999999999864 346889999999999999999999987654321 11222
Q ss_pred HhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 295 YERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. +.. ..........+.++.+|+.+||+.||++|||++||++
T Consensus 228 ~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hh-CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22 211 0111122244578999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=392.82 Aligned_cols=251 Identities=18% Similarity=0.247 Sum_probs=208.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
.++|++.+.||+|+||+||+|..+ +++.||+|+++..... ...+.+|+++|+.++|||||++++++.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999986 7889999999876544 35688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--CCeEEeeeccccccCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD--LTPKISDFGLAKLFPA 227 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~ 227 (415)
|+||+|.+++...+. .+++..++.|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999976542 689999999999999999999999 99999999999999854 5899999999987644
Q ss_pred CCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 228 NLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ......... .. ++..
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~-~~--~~~~ 225 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAE-YT--FDEE 225 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-CC--CCHH
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CC--CChh
Confidence 3 23345678999999999999999999999999999999999999987654321 222222211 10 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001 12466889999999999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-52 Score=398.87 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHH---HHHHHHHhhcCCcceeeeeeEEEeCCeeE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREF---LTEINVIKDIKHENLVELYGCCVEGDHRI 144 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 144 (415)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+ .+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999976 79999999986432 1111223 34577778889999999999999999999
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
+||||++||+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998765 688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhh
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVEL 303 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (415)
+... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +....
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------~~~~~----- 221 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------IDRMT----- 221 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-------HHHHS-----
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhc-----
Confidence 6543 2345679999999999975 468999999999999999999999997654322111 11100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 304 VDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
.......+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 222 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 --LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111222334567899999999999999999 688875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=393.47 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=210.4
Q ss_pred HHHHhcCCCCCCcccccCeEEEEEEEecC--------CCEEEEEEccccc-hHhHHHHHHHHHHHhhc-CCcceeeeeeE
Q 044232 67 LRVATENFSPANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADS-RQGVREFLTEINVIKDI-KHENLVELYGC 136 (415)
Q Consensus 67 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 136 (415)
|.+..++|++.+.||+|+||.||+|+... +..||||+++.+. .....++.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 33456789999999999999999998642 2479999997764 34457888999999888 89999999999
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGH------------SSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKAS 204 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 204 (415)
|.+++..++||||+++|+|.+++..+.. ....+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999976542 123689999999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeeeccccccCCCC-cceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHh-CCcCCCCCCCh
Q 044232 205 NILLDKDLTPKISDFGLAKLFPANL-THISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVS-GRCNTNRRLPY 282 (415)
Q Consensus 205 NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~p~~~~~p~ 282 (415)
|||++.++.+||+|||+++...... ........||+.|+|||++.++.++.++||||||||+|||++ |..|+......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999999998664432 223445678999999999999999999999999999999998 56665543221
Q ss_pred hhhhHHHHHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 283 EEQYLLEMAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
.+...+..+. ....+...+.++.+|+.+||+.||.+|||+.||++.|++.+
T Consensus 245 -------~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 -------ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -------HHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1222223222 22333345577999999999999999999999999997654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=395.12 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=216.4
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEec------CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEE
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLK------DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCC 137 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 137 (415)
++|++..++|++.++||+|+||+||+|.++ +++.||||+++.. .......|.+|++++++++||||++++|+|
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 345566688999999999999999999864 2578999999764 344446789999999999999999999999
Q ss_pred EeCCeeEEEEeeccCCCHHHHhhcCC------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 044232 138 VEGDHRILVYGYLENNSLAQTLLGRG------HSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD 211 (415)
Q Consensus 138 ~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 211 (415)
...+..++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+||||+.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 99999999999999999999886431 1123578999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccccccCCCCcc-eecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCc-CCCCCCChhhhhHHH
Q 044232 212 LTPKISDFGLAKLFPANLTH-ISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRC-NTNRRLPYEEQYLLE 289 (415)
Q Consensus 212 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-p~~~~~p~~~~~~~~ 289 (415)
+++||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+. |+.. ....+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~~~~ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LSNEQ 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC------CCHHH
Confidence 99999999999866443222 2334568999999999999999999999999999999999964 4332 22222
Q ss_pred HHHHHHhhCcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCCC
Q 044232 290 MAWKLYERGKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEID 350 (415)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 350 (415)
....+. .+.. ...+..++..+.+|+.+||+.+|++||||.+|++.|.+.++
T Consensus 244 ~~~~i~-~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVM-EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHH-hCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222222 2221 12233445789999999999999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=396.31 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=206.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc---hHhHHHHHHHHHHHh-hcCCcceeeeeeEEEeCCeeEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS---RQGVREFLTEINVIK-DIKHENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 146 (415)
++|++++.||+|+||+||+|+.+ +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 79999999997542 233456677777765 68999999999999999999999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccC
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFP 226 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 226 (415)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998765 688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc
Q 044232 227 ANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA 306 (415)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (415)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+.. ..... ..+.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i-~~~~------- 219 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSI-RMDN------- 219 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC-------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHH-HcCC-------
Confidence 332 23345679999999999999999999999999999999999999987654322 11111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHH-HHHH
Q 044232 307 SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMS-TLVN 343 (415)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 343 (415)
..++...+.++.+|+.+||+.||++||++. +|++
T Consensus 220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122333457789999999999999999995 6754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=388.57 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=203.9
Q ss_pred CCcccccCeEEEEEEEecC----CCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe-CCeeEEEEeec
Q 044232 77 ANKIGQGGFGSVYKGTLKD----GTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVE-GDHRILVYGYL 150 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 150 (415)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999753 235899998753 45566789999999999999999999999876 45889999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876543 577889999999999999999999 999999999999999999999999999987644322
Q ss_pred ---ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhcccc
Q 044232 231 ---HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDAS 307 (415)
Q Consensus 231 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (415)
.......||+.|+|||++.++.++.++||||||+++|||+||+.|+...... .+.... ...+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~-i~~g~-------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVY-LLQGR-------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHH-HHTTC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHH-HHcCC--------
Confidence 1223456899999999999999999999999999999999988876543211 111111 12221
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 308 LNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+..++.++.+|+.+||+.||++||+|.||++.|++..
T Consensus 252 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223344578999999999999999999999999997654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=395.40 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=199.9
Q ss_pred hcCCCCCC-cccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhc-CCcceeeeeeEEEe----CCee
Q 044232 71 TENFSPAN-KIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDI-KHENLVELYGCCVE----GDHR 143 (415)
Q Consensus 71 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 143 (415)
.++|++.+ .||+|+||+||+|+.. +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 5999999999999975 7999999998653 3466799987655 89999999999875 4578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCCeEEeeec
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK---DLTPKISDFG 220 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 220 (415)
|||||||+||+|.+++...+. ..+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999986542 2699999999999999999999999 9999999999999985 5679999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+........ .....-.
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~------~~~~~i~- 230 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTRIR- 230 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCC-
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH------HHHHHHh-
Confidence 998765432 2345679999999999999999999999999999999999999987543322100 0000000
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..............+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000001111234678999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=388.23 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=196.6
Q ss_pred CCcccccCeEEEEEEEec-CCCEEEEEEccccchHh-----HHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEeec
Q 044232 77 ANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQG-----VREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGYL 150 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 150 (415)
++.||+|+||+||+|+.+ +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999976 79999999987543221 246889999999999999999999999999999999999
Q ss_pred cCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCCc
Q 044232 151 ENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANLT 230 (415)
Q Consensus 151 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 230 (415)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887776665433 688899999999999999999999 999999999999999999999999999986644322
Q ss_pred ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc---
Q 044232 231 HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA--- 306 (415)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 306 (415)
......||+.|+|||++.+. .++.++|||||||++|||++|..||....+.+. ...+.+...........+.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence 23345799999999998754 689999999999999999999988876543322 1111111111000000000
Q ss_pred ------ccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 307 ------SLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 307 ------~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......+ ...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000111 122467899999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=389.95 Aligned_cols=266 Identities=27% Similarity=0.343 Sum_probs=199.8
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----eeEEEE
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----HRILVY 147 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 147 (415)
++|.+.++||+|+||.||+|++ +|+.||||++....... ..+..|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577788999999999999987 57899999997653321 22334555667789999999999998654 679999
Q ss_pred eeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 148 GYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEV-----QPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 148 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
||+++|+|.+++... .++|..+..++.|++.||+|||+.. +++|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999865 5899999999999999999999731 239999999999999999999999999999
Q ss_pred cccCCCCcc---eecccccCCCCCChhhhhcCC------CCccceEeehhHhHHHHHhCCcCCCCCC----Chhhh----
Q 044232 223 KLFPANLTH---ISTRVAGTEGYLAPEYAIRGQ------LTRKADIYSFGVLLLEIVSGRCNTNRRL----PYEEQ---- 285 (415)
Q Consensus 223 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltg~~p~~~~~----p~~~~---- 285 (415)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+.... ++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876443222 234567999999999987643 5778999999999999999988765322 22211
Q ss_pred hHHHHHHHHHhhCcchhhcccccCCC-CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcC
Q 044232 286 YLLEMAWKLYERGKLVELVDASLNGD-YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGE 348 (415)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 348 (415)
............+.. ++.+... .+.+.+..+.+|+.+||+.||++|||+.||++.|...
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011111112111111 1111111 1234667899999999999999999999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=383.19 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|+++++||+|+||+||+|++. +|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999975 799999999965432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
|+.++ +..++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765 4444433322 2689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceecccccCCCCCChhhhhcCC-CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcchhhccc-
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLVELVDA- 306 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (415)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+..+.... ....... +...+..-.
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~---~~i~~~~--~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL---FRIFRTL--GTPDEVVWPG 229 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH--CCCCTTTSTT
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH---HHHHHhc--CCCchhhccc
Confidence 2 2334457999999999887655 588999999999999999999998764332211 1111111 110000000
Q ss_pred -----ccCCC------C-----CHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 307 -----SLNGD------Y-----SVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 307 -----~~~~~------~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..... . ....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0 01224678899999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-51 Score=380.17 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=202.3
Q ss_pred cCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccch--HhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR--QGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 149 (415)
++|+++++||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999999999999999976532 2346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCCC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPANL 229 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 229 (415)
+.++.+..+....+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877776665544 799999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch------h
Q 044232 230 THISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV------E 302 (415)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~------~ 302 (415)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.... ............. .
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhh
Confidence 22334568999999999875 46799999999999999999999998764332211 1111111110000 0
Q ss_pred hc--cccc-------CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 303 LV--DASL-------NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 303 ~~--~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. +... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 00111223467889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=381.75 Aligned_cols=239 Identities=26% Similarity=0.412 Sum_probs=197.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccch------HhHHHHHHHHHHHhhcC--CcceeeeeeEEEeCCe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSR------QGVREFLTEINVIKDIK--HENLVELYGCCVEGDH 142 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 142 (415)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999976 799999999865321 11234668999999986 8999999999999999
Q ss_pred eEEEEeeccC-CCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CCeEEeeec
Q 044232 143 RILVYGYLEN-NSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKD-LTPKISDFG 220 (415)
Q Consensus 143 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 220 (415)
.++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 67888887655 689999999999999999999999 99999999999999854 799999999
Q ss_pred cccccCCCCcceecccccCCCCCChhhhhcCCC-CccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc
Q 044232 221 LAKLFPANLTHISTRVAGTEGYLAPEYAIRGQL-TRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK 299 (415)
Q Consensus 221 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~ 299 (415)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... .+.
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~-~~~ 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-RGQ 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-HCC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHh-hcc
Confidence 99865432 2345679999999999987765 678999999999999999998886420 011 111
Q ss_pred chhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 300 LVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. .++...+.++.+|+.+||+.||++|||++|+++
T Consensus 221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 111223467889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=379.68 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=198.3
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-C-CCEEEEEEccccch--HhHHHHHHHHHHHhhc---CCcceeeeeeEEEe----
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-D-GTLAAIKVLSADSR--QGVREFLTEINVIKDI---KHENLVELYGCCVE---- 139 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 139 (415)
.++|+++++||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 67799999865422 1223456777777666 79999999999863
Q ss_pred -CCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEee
Q 044232 140 -GDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISD 218 (415)
Q Consensus 140 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 218 (415)
....+++|||++++++........ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346899999998887665444332 2688999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhC
Q 044232 219 FGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERG 298 (415)
Q Consensus 219 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~ 298 (415)
||++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+..... .........
T Consensus 160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLP 234 (305)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC
T ss_pred hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCC
Confidence 999985433 233455779999999999999999999999999999999999999997654332211 111111100
Q ss_pred cchhh----------ccc---ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 299 KLVEL----------VDA---SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 299 ~~~~~----------~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
..... ... .....+....+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000 0001112233467889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-49 Score=367.90 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=209.1
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCC-cceeeeeeEEEeCCeeEEEEe
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKH-ENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 148 (415)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ..+.+|++++..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999976 7899999998654322 356678899998865 899999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----CCCeEEeeecccc
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDK-----DLTPKISDFGLAK 223 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~ 223 (415)
|+ +++|.+++...+. .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 7899999876543 689999999999999999999999 9999999999999974 5789999999998
Q ss_pred ccCCCCc------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhh
Q 044232 224 LFPANLT------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYER 297 (415)
Q Consensus 224 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~ 297 (415)
.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7643321 1233467999999999999999999999999999999999999999865544433222222211111
Q ss_pred CcchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 298 GKLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
....+ +... .+.++.+++..|++.+|++||+++.+.+.|...+
T Consensus 235 ~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 1112 3467889999999999999999999888776554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=372.38 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe--------C
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE--------G 140 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 140 (415)
++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999975 7999999998654 22334678899999999999999999999865 3
Q ss_pred CeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeec
Q 044232 141 DHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFG 220 (415)
Q Consensus 141 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 220 (415)
...++||||+.++.+........ .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 46899999998877665544333 688899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc---ceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHh
Q 044232 221 LAKLFPANLT---HISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYE 296 (415)
Q Consensus 221 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~ 296 (415)
+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+...... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH---HHHhcC
Confidence 9986643221 222345799999999998765 689999999999999999999999876543322211 111111
Q ss_pred hCcchhh------------cccccCCCCCH-------HHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 297 RGKLVEL------------VDASLNGDYSV-------EEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 297 ~~~~~~~------------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
. ..... +.......... .....+.+|+.+||+.||++|||++|+++
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 240 S-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp C-CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 00000 00000001111 11345678999999999999999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=372.11 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec----CCCEEEEEEccccc----hHhHHHHHHHHHHHhhcCC-cceeeeeeEEEeCCe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK----DGTLAAIKVLSADS----RQGVREFLTEINVIKDIKH-ENLVELYGCCVEGDH 142 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 142 (415)
++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 48899999986532 2233567889999999977 799999999999999
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.++||||+.+|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998776 577889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcC--CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRG--QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
+.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~-- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKS-- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccC--
Confidence 87655444445567799999999998764 478899999999999999999999977654432211 11111111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCC-----HHHHHH
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPS-----MSTLVN 343 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 343 (415)
....+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11233345678999999999999999994 788875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=372.67 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=196.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC------
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD------ 141 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 141 (415)
.++|+++++||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999976 7999999999754 3344567899999999999999999999997654
Q ss_pred eeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeecc
Q 044232 142 HRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGL 221 (415)
Q Consensus 142 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 221 (415)
.+++||||+ +++|..++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 67788877654 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHH-----HHH
Q 044232 222 AKLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAW-----KLY 295 (415)
Q Consensus 222 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~-----~~~ 295 (415)
++..... .+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||................ ...
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9866433 3456799999999998764 67899999999999999999999987653322111110000 000
Q ss_pred hhCcc------hhhccccc---CCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 296 ERGKL------VELVDASL---NGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 296 ~~~~~------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
..... ...+.... ........+.++.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000000 001112234568899999999999999999999973
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=374.04 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=198.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc-chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCC----eeE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-SRQGVREFLTEINVIKDIKHENLVELYGCCVEGD----HRI 144 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 144 (415)
+++|+++++||+|+||+||+|..+ +|+.||||++... .....+.+++|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999875 8999999999754 3444568899999999999999999999997643 235
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccc
Q 044232 145 LVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKL 224 (415)
Q Consensus 145 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 224 (415)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999765 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc--ceecccccCCCCCChhhhh-cCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 225 FPANLT--HISTRVAGTEGYLAPEYAI-RGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 225 ~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
...... .......||+.|+|||++. +..++.++||||+||++|+|++|+.||.............. ........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~---~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG---ILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---HHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh---hccCCChh
Confidence 543221 1234467999999999985 45678999999999999999999999876543322111111 00000000
Q ss_pred -----------h-hcccccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHHH
Q 044232 302 -----------E-LVDASLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVNM 344 (415)
Q Consensus 302 -----------~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 344 (415)
. ..........+ ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000011 1123568899999999999999999999973
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-48 Score=362.83 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=199.2
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce-eeeeeEEEeCCeeEEEEee
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL-VELYGCCVEGDHRILVYGY 149 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 149 (415)
++|++.+.||+|+||.||+|++. +|+.||||++...... .++..|+++++.++|+|+ +.+.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 7899999998765332 457789999999987765 5555666788899999999
Q ss_pred ccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCCeEEeeeccccccC
Q 044232 150 LENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLD---KDLTPKISDFGLAKLFP 226 (415)
Q Consensus 150 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~~ 226 (415)
+ +++|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 5667666654432 689999999999999999999999 999999999999875 45579999999999764
Q ss_pred CCCc------ceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcc
Q 044232 227 ANLT------HISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKL 300 (415)
Q Consensus 227 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~ 300 (415)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 4322 1234567999999999999999999999999999999999999998765443322221111111111111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHHHhhcCC
Q 044232 301 VELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVNMLIGEI 349 (415)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 349 (415)
+.... ..+.++.+++..||+.+|++||++.+|.+.|....
T Consensus 238 -----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 238 -----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11111 23467889999999999999999999988876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=362.29 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccc--hHhHHHHHHHHHHHhhcCCcceeeeeeEEEeCCeeEEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADS--RQGVREFLTEINVIKDIKHENLVELYGCCVEGDHRILVYG 148 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 148 (415)
++|+++++||+|+||+||+|++. +++.||||+++... ......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999976 79999999986542 3345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccccccCCC
Q 044232 149 YLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLAKLFPAN 228 (415)
Q Consensus 149 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 228 (415)
++.+++|..++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988887655 688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceecccccCCCCCChhhhhcCC-CCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCc---c---h
Q 044232 229 LTHISTRVAGTEGYLAPEYAIRGQ-LTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGK---L---V 301 (415)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~---~---~ 301 (415)
.. ......+++.|+|||++.... ++.++|||||||++|||++|+.||......... ...+........ . .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhh
Confidence 22 233445788899999987654 699999999999999999999987543332221 111111111100 0 0
Q ss_pred hhccc---------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 ELVDA---------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
...+. .............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001112233467889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=372.53 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=193.3
Q ss_pred CCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC------CeeEE
Q 044232 73 NFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENLVELYGCCVEG------DHRIL 145 (415)
Q Consensus 73 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 145 (415)
+|+..++||+|+||+||+|++. +|+.||||++..+... ..+|+++|++++||||+++++++... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999986 7999999999765322 34699999999999999999998642 35789
Q ss_pred EEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeeccccc
Q 044232 146 VYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKL 224 (415)
Q Consensus 146 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 224 (415)
||||++++.+.. +.........+++..++.|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998764433 322111223789999999999999999999999 999999999999999875 899999999987
Q ss_pred cCCCCcceecccccCCCCCChhhhhc-CCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH--------HHHHH
Q 044232 225 FPANLTHISTRVAGTEGYLAPEYAIR-GQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM--------AWKLY 295 (415)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~--------~~~~~ 295 (415)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. .+...
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 64432 2344679999999998775 5789999999999999999999999876443221111000 00000
Q ss_pred hhC----cchhhcccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 296 ERG----KLVELVDASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 296 ~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... ..................+.++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000000000111234567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.6e-48 Score=365.95 Aligned_cols=258 Identities=15% Similarity=0.259 Sum_probs=199.5
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeC--CeeEEE
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEG--DHRILV 146 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 146 (415)
.++|+++++||+|+||+||+|+.. +|+.||||+++... .+++.+|+++|+.++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999975 79999999997654 356788999999995 99999999999843 568999
Q ss_pred EeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-CeEEeeecccccc
Q 044232 147 YGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDL-TPKISDFGLAKLF 225 (415)
Q Consensus 147 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~ 225 (415)
|||+++++|..... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999876532 588999999999999999999999 999999999999998765 6999999999876
Q ss_pred CCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHH-------HHHHHhh
Q 044232 226 PANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEM-------AWKLYER 297 (415)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~-------~~~~~~~ 297 (415)
.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............. .......
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 23456789999999998765 579999999999999999999999876544322111100 0000110
Q ss_pred Ccc---hh---hc--------ccccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 298 GKL---VE---LV--------DASLNGDYSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 298 ~~~---~~---~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
... .. .. ............+.++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 00 000111112234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=362.01 Aligned_cols=260 Identities=23% Similarity=0.257 Sum_probs=192.0
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEe------CCe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVE------GDH 142 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 142 (415)
++|+++++||+|+||+||+|.+. +|+.||||++... .......+.+|+.+|++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 7999999999754 34455678899999999999999999999963 368
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
+|+||||+.++.+ +.+.. .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHH-Hhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999976544 44421 578999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH-------------
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE------------- 289 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~------------- 289 (415)
+..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...........
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 865432 23345679999999999999999999999999999999999999987543221110000
Q ss_pred ---HHHHHHhhC------cchhhcccccCCC---CCHHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 290 ---MAWKLYERG------KLVELVDASLNGD---YSVEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 290 ---~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
......... .....+....... .....+.++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000011110 0011111111111 12335678899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=362.81 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=196.4
Q ss_pred hcCCCCCCcccccCeEEEEEEEec-CCCEEEEEEcccc--chHhHHHHHHHHHHHhhcCCcceeeeeeEEEeC-----Ce
Q 044232 71 TENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD--SRQGVREFLTEINVIKDIKHENLVELYGCCVEG-----DH 142 (415)
Q Consensus 71 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 142 (415)
.++|+++++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 478999999999999999999975 7999999999764 334456788999999999999999999998643 34
Q ss_pred eEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEEeeeccc
Q 044232 143 RILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKISDFGLA 222 (415)
Q Consensus 143 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 222 (415)
.+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46777888899999998654 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceecccccCCCCCChhhhhcC-CCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHHHHHHHHhhCcch
Q 044232 223 KLFPANLTHISTRVAGTEGYLAPEYAIRG-QLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLEMAWKLYERGKLV 301 (415)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~~~~~~~~~~~~~ 301 (415)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+........ .+....... ..
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~-~~ 240 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTP-GA 240 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC-CH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCC-Ch
Confidence 75432 23456789999999987765 56899999999999999999999987643322111 111110000 00
Q ss_pred hh------------ccc-ccCCCCC-----HHHHHHHHHHHHHcCCcCCCCCCCHHHHHH
Q 044232 302 EL------------VDA-SLNGDYS-----VEEAHRYLKIALLCTQDMPKRRPSMSTLVN 343 (415)
Q Consensus 302 ~~------------~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 343 (415)
.. ... ....... ...+.++.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 000 0000000 122456889999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-41 Score=325.74 Aligned_cols=262 Identities=20% Similarity=0.241 Sum_probs=191.4
Q ss_pred cCCCCCCcccccCeEEEEEEEec-CCCEEEEEEccccchHhHHHHHHHHHHHhhcC-----------CcceeeeeeEEEe
Q 044232 72 ENFSPANKIGQGGFGSVYKGTLK-DGTLAAIKVLSADSRQGVREFLTEINVIKDIK-----------HENLVELYGCCVE 139 (415)
Q Consensus 72 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 139 (415)
.+|+++++||+|+||+||+|+.. +|+.||||+++.+.. ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999975 799999999976533 3356788999888775 5789999998864
Q ss_pred --CCeeEEEEeeccCCCHH-HHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCC--
Q 044232 140 --GDHRILVYGYLENNSLA-QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLT-- 213 (415)
Q Consensus 140 --~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~-- 213 (415)
....+++++++..+... ....... ...+++..+..++.||+.||+|||+ . ||+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 34666777776555433 2222222 2267889999999999999999998 6 9999999999999986653
Q ss_pred ----eEEeeeccccccCCCCcceecccccCCCCCChhhhhcCCCCccceEeehhHhHHHHHhCCcCCCCCCChhhhhHHH
Q 044232 214 ----PKISDFGLAKLFPANLTHISTRVAGTEGYLAPEYAIRGQLTRKADIYSFGVLLLEIVSGRCNTNRRLPYEEQYLLE 289 (415)
Q Consensus 214 ----~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~p~~~~~p~~~~~~~~ 289 (415)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||............+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865332 245679999999999999999999999999999999999999987543221111111
Q ss_pred HHHH---HH--------hhCcc-hhhccc-------------------ccCCCCCHHHHHHHHHHHHHcCCcCCCCCCCH
Q 044232 290 MAWK---LY--------ERGKL-VELVDA-------------------SLNGDYSVEEAHRYLKIALLCTQDMPKRRPSM 338 (415)
Q Consensus 290 ~~~~---~~--------~~~~~-~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 338 (415)
.... .+ ..+.. ....+. ..........+.++.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1110 10 00000 000000 01123455678899999999999999999999
Q ss_pred HHHHH
Q 044232 339 STLVN 343 (415)
Q Consensus 339 ~evl~ 343 (415)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2e-26 Score=200.46 Aligned_cols=163 Identities=13% Similarity=0.137 Sum_probs=121.1
Q ss_pred CCCCcccccCeEEEEEEEecCCCEEEEEEccccch------------------HhHHHHHHHHHHHhhcCCcceeeeeeE
Q 044232 75 SPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSR------------------QGVREFLTEINVIKDIKHENLVELYGC 136 (415)
Q Consensus 75 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 136 (415)
.+.++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35688999999999999988899999998753210 112334568899999999999998865
Q ss_pred EEeCCeeEEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCCeEE
Q 044232 137 CVEGDHRILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEEVQPHIVHRDIKASNILLDKDLTPKI 216 (415)
Q Consensus 137 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 216 (415)
. ..+++|||++++.+. .++......++.|++.+|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 247999999886543 234455678999999999999999 99999999999999965 5899
Q ss_pred eeeccccccCCCCcceecccccCCCCCCh------hhhhcCCCCccceEeehhHhH
Q 044232 217 SDFGLAKLFPANLTHISTRVAGTEGYLAP------EYAIRGQLTRKADIYSFGVLL 266 (415)
Q Consensus 217 ~DfGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGvvl 266 (415)
+|||+|......... .|... + +....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 999999765322111 01111 1 1245678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.79 E-value=1e-08 Score=91.33 Aligned_cols=149 Identities=13% Similarity=0.098 Sum_probs=102.5
Q ss_pred hhHHHHhcCCCCCCcccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcC-CcceeeeeeEEEeCCee
Q 044232 65 KDLRVATENFSPANKIGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIK-HENLVELYGCCVEGDHR 143 (415)
Q Consensus 65 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 143 (415)
.+++...+.|+..+..+.++.+.||+.... +..+++|+...........+.+|...+..+. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 345555567777666555556799988654 4556778776554333345667888887773 33467788888888899
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 044232 144 ILVYGYLENNSLAQTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLHEE-------------------------------- 191 (415)
Q Consensus 144 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------- 191 (415)
++||++++|.++.+..... .....++.+++..|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998886654321 11233455566666666642
Q ss_pred ---------------------C---CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 192 ---------------------V---QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 192 ---------------------~---~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
. ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 1237899999999999987667799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=8.8e-07 Score=77.97 Aligned_cols=129 Identities=14% Similarity=0.145 Sum_probs=84.5
Q ss_pred ccccCe-EEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCC--cceeeeeeEEEeCCeeEEEEeeccCCCHH
Q 044232 80 IGQGGF-GSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKH--ENLVELYGCCVEGDHRILVYGYLENNSLA 156 (415)
Q Consensus 80 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 156 (415)
+..|.. +.||+...+++..+++|........ .+..|+..++.+.. -.+.+++.+..+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 6799998888888889987655332 35567777776633 33677888888888899999999887653
Q ss_pred HHhhcCCCCCCccCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 044232 157 QTLLGRGHSSIQFNWQTRRNICIGVAKGLAFLH----------------------------------------------- 189 (415)
Q Consensus 157 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH----------------------------------------------- 189 (415)
+.. .. ....+.++...|.-||
T Consensus 95 ~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 95 SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 210 00 0111222333333333
Q ss_pred ----hcC----CCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 190 ----EEV----QPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 190 ----~~~----~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
... ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 2247999999999999987677899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.05 E-value=5.6e-06 Score=77.84 Aligned_cols=76 Identities=13% Similarity=0.118 Sum_probs=48.7
Q ss_pred CcccccCeEEEEEEEec-CCCEEEEEEcccc-------chHhHHHHHHHHHHHhhcC-C--cceeeeeeEEEeCCeeEEE
Q 044232 78 NKIGQGGFGSVYKGTLK-DGTLAAIKVLSAD-------SRQGVREFLTEINVIKDIK-H--ENLVELYGCCVEGDHRILV 146 (415)
Q Consensus 78 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 146 (415)
+.||.|....||+.... +++.+++|.-... ......+...|...|+.+. + ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 56899999999999865 4678889864321 0112234456888887662 2 345666654 45567899
Q ss_pred EeeccCCCH
Q 044232 147 YGYLENNSL 155 (415)
Q Consensus 147 ~e~~~~gsL 155 (415)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.47 E-value=0.00014 Score=65.98 Aligned_cols=69 Identities=10% Similarity=0.071 Sum_probs=45.5
Q ss_pred eEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcce--eeee-----eEEEeCCeeEEEEeeccCCC
Q 044232 85 FGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHENL--VELY-----GCCVEGDHRILVYGYLENNS 154 (415)
Q Consensus 85 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gs 154 (415)
-..||++..++|..+++|+.+... ...+++..|...+..|....+ +..+ ..+......+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 368999999999999999987642 223556678888877742221 1111 12344567788999997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.30 E-value=0.00025 Score=66.21 Aligned_cols=73 Identities=14% Similarity=0.184 Sum_probs=49.4
Q ss_pred CCcccccCeEEEEEEEecC--------CCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc-eeeeeeEEEeCCeeEEEE
Q 044232 77 ANKIGQGGFGSVYKGTLKD--------GTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN-LVELYGCCVEGDHRILVY 147 (415)
Q Consensus 77 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 147 (415)
++.|+.|-.-.+|++...+ ...|.+++..... .. ....+|..+++.+.-.+ ..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3678999999999998653 3467777765322 22 33457888888874333 4577777643 6899
Q ss_pred eeccCCCH
Q 044232 148 GYLENNSL 155 (415)
Q Consensus 148 e~~~~gsL 155 (415)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.96 E-value=0.0011 Score=59.35 Aligned_cols=157 Identities=11% Similarity=0.047 Sum_probs=79.5
Q ss_pred hhhHHHHhcCCCCCCc-----ccccCeEEEEEEEecCCCEEEEEEccccchHhHHHHHHHHHHHhhcCCcc--eeeeee-
Q 044232 64 YKDLRVATENFSPANK-----IGQGGFGSVYKGTLKDGTLAAIKVLSADSRQGVREFLTEINVIKDIKHEN--LVELYG- 135 (415)
Q Consensus 64 ~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~- 135 (415)
.++++....+|.+.+. |..|--.+.|+.+..+|+ +++|+....... .+...|++++..+...+ +...+-
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhcccccccccee
Confidence 3556666677876543 346666889999887765 788987653211 23344666666663222 111111
Q ss_pred -----EEEeCCeeEEEEeeccCCCHHH--------------Hhhc----CCCC-CCc------------------cCHHH
Q 044232 136 -----CCVEGDHRILVYGYLENNSLAQ--------------TLLG----RGHS-SIQ------------------FNWQT 173 (415)
Q Consensus 136 -----~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~-~~~------------------l~~~~ 173 (415)
+.........++.++.+..... .++. .... ... .....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1122344566666665543210 0000 0000 000 00011
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCCeEEeeecccc
Q 044232 174 RRNICIGVAKGLAFLHE-EVQPHIVHRDIKASNILLDKDLTPKISDFGLAK 223 (415)
Q Consensus 174 ~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 223 (415)
....+..+...+.-.+. ....++||+|+.++||+++++...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222222221 124479999999999999998777899999875
|